1 00:00:05,842 --> 00:00:07,177 GOOD MORNING, EVERYONE. 2 00:00:07,177 --> 00:00:08,611 I'M DR. MONICA BERTAGNOLLI, 3 00:00:08,611 --> 00:00:10,146 DIRECTOR OF THE NATIONAL 4 00:00:10,146 --> 00:00:11,448 INSTITUTES OF HEALTH. 5 00:00:11,448 --> 00:00:14,584 WELCOME TO THE 129TH MEETING OF 6 00:00:14,584 --> 00:00:15,819 THE ADVISORY COMMITTEE TO THE 7 00:00:15,819 --> 00:00:17,253 DIRECTOR AND I WILL NOW GAVEL 8 00:00:17,253 --> 00:00:19,556 THE MEETING IN. 9 00:00:19,556 --> 00:00:22,158 AND WITH THAT, I'M GOING TO TURN 10 00:00:22,158 --> 00:00:24,260 TO DR. LARRY TABAK, WHO WILL 11 00:00:24,260 --> 00:00:27,097 GIVE US SOME RULES OF THE GAME 12 00:00:27,097 --> 00:00:27,964 HERE. 13 00:00:27,964 --> 00:00:29,165 >> THANKS VERY MUCH. 14 00:00:29,165 --> 00:00:31,134 AND GOOD MORNING, EVERYBODY. 15 00:00:31,134 --> 00:00:34,738 JUST TO REMIND ALL OF YOU, THIS 16 00:00:34,738 --> 00:00:37,040 MEETING IS OPEN TO THE PUBLIC. 17 00:00:37,040 --> 00:00:39,008 INCLUDING MEMBERS OF THE PRESS, 18 00:00:39,008 --> 00:00:42,278 AND IS BEING WEBCAST. 19 00:00:42,278 --> 00:00:44,814 MEETING PRESENTATIONS AND ANY 20 00:00:44,814 --> 00:00:46,549 SUPPLEMENTAL MATERIALS WILL BE 21 00:00:46,549 --> 00:00:48,651 POSTED ON THE ACD WEBSITE 22 00:00:48,651 --> 00:00:50,487 SHORTLY AFTER THE MEETING. 23 00:00:50,487 --> 00:00:53,223 THE MEETING WAS ANNOUNCED IN THE 24 00:00:53,223 --> 00:00:56,726 FEDERAL REGISTER ON 25 00:00:56,726 --> 00:00:57,594 NOVEMBER 4TH, 2024. 26 00:00:57,594 --> 00:00:59,662 OF KNOWS, WE DID RECEIVE PUBLIC 27 00:00:59,662 --> 00:01:01,331 COMMENT, WHICH ACD MEMBERS CAN 28 00:01:01,331 --> 00:01:04,834 REVIEW ON THEIR SHAREFILE SITE. 29 00:01:04,834 --> 00:01:06,469 ACD MEMBERS AND PRESENTERS ARE 30 00:01:06,469 --> 00:01:09,506 ALL JOINING US TODAY VIA ZOOM, 31 00:01:09,506 --> 00:01:11,174 AND TO CONDUCT THE MEETING BOTH 32 00:01:11,174 --> 00:01:13,877 TODAY AND TOMORROW. 33 00:01:13,877 --> 00:01:19,582 PLEASE RAISE YOUR HAND VIRTUALLY 34 00:01:19,582 --> 00:01:21,551 VIA ZOOM RATHER THAN USING THE 35 00:01:21,551 --> 00:01:23,353 CHAT TO POST QUESTIONS OR TO 36 00:01:23,353 --> 00:01:26,022 MAKE A COMMENT, AND I WILL BE 37 00:01:26,022 --> 00:01:27,357 MONITORING THAT AND WE'LL CALL 38 00:01:27,357 --> 00:01:29,859 ON YOU. 39 00:01:29,859 --> 00:01:32,495 ACD MEMBERS ARE ENCOURAGED TO 40 00:01:32,495 --> 00:01:36,866 KEEP THEIR CAMERAS ON AS MUCH AS 41 00:01:36,866 --> 00:01:37,133 POSSIBLE. 42 00:01:37,133 --> 00:01:37,967 BUT PARTICULARLY IF YOU'RE 43 00:01:37,967 --> 00:01:39,669 POSING A QUESTION OR YOU WANT TO 44 00:01:39,669 --> 00:01:42,906 MAKE A COMMENT, IF THAT'S 45 00:01:42,906 --> 00:01:44,207 FEASIBLE FOR YOU TO DO, PLEASE 46 00:01:44,207 --> 00:01:46,943 DO TAKE ON YOUR -- TAKE YOUR 47 00:01:46,943 --> 00:01:50,880 CAMERA ON, AND WITH THAT, I'LL 48 00:01:50,880 --> 00:01:54,484 JUST REMIND EVERYBODY THAT IF 49 00:01:54,484 --> 00:01:58,755 SOMEHOW WE 1/2 DATE NAVIGATE TC 50 00:01:58,755 --> 00:02:00,490 THAT YOU FEEL YOU MIGHT HAVE A 51 00:02:00,490 --> 00:02:02,459 PERCEIVED CONFLICT, JUST PLEASE 52 00:02:02,459 --> 00:02:03,993 LET ME KNOW BY DIRECT CHAT AND 53 00:02:03,993 --> 00:02:07,397 WE CAN PUT YOU INTO ONE OF THE 54 00:02:07,397 --> 00:02:08,431 SO-CALLED WAITING ROOMS. 55 00:02:08,431 --> 00:02:11,000 SO WITH THAT, I WILL TURN IT 56 00:02:11,000 --> 00:02:13,636 BACK TO THE NIH DIRECTOR. 57 00:02:13,636 --> 00:02:14,938 >> THANK YOU, LARRY. 58 00:02:14,938 --> 00:02:16,272 WELL, WE'VE GOT A LOT TO COVER 59 00:02:16,272 --> 00:02:18,541 TODAY. 60 00:02:18,541 --> 00:02:22,579 SO MANY THINGS THAT WERE JUST IN 61 00:02:22,579 --> 00:02:24,347 DEVELOPMENT WHEN WE LAST MET SIX 62 00:02:24,347 --> 00:02:25,648 MONTHS AGO ARE NOW REALITY, SO 63 00:02:25,648 --> 00:02:26,749 WE'RE GOING TO BE ABLE TO GIVE 64 00:02:26,749 --> 00:02:28,218 YOU SOME GREAT PROGRESS REPORTS 65 00:02:28,218 --> 00:02:28,818 ON THAT. 66 00:02:28,818 --> 00:02:30,787 AS PART OF MY REPORT, I'LL ALSO 67 00:02:30,787 --> 00:02:32,222 REVIEW RECENT CHANGES TO 68 00:02:32,222 --> 00:02:34,290 LEADERSHIP ACROSS NIH. 69 00:02:34,290 --> 00:02:36,960 AND MENTION SOME AWARDS THAT OUR 70 00:02:36,960 --> 00:02:38,027 STAFF HAVE RECEIVED. 71 00:02:38,027 --> 00:02:38,995 DO WE HAVE THE SLIDES UP? 72 00:02:38,995 --> 00:02:41,164 I JUST WANT TO MAKE SURE THAT WE 73 00:02:41,164 --> 00:02:42,599 HAVE THAT. 74 00:02:42,599 --> 00:02:43,466 I'M NOT SEEING THEM. 75 00:02:43,466 --> 00:02:43,933 ALL RIGHT. 76 00:02:43,933 --> 00:02:54,043 GREAT. 77 00:02:54,911 --> 00:02:56,145 OKAY. 78 00:02:56,145 --> 00:02:57,480 SO AGAIN IN THE INITIAL PART, 79 00:02:57,480 --> 00:02:58,348 REVIEW SOME CHANGES IN 80 00:02:58,348 --> 00:02:58,882 LEADERSHIP. 81 00:02:58,882 --> 00:03:00,717 I'M GOING TO SHARE SOME PHOTOS 82 00:03:00,717 --> 00:03:01,784 FROM EVENTS THAT I'VE ATTENDED 83 00:03:01,784 --> 00:03:03,286 WITH THE TEAM HERE ACROSS THE 84 00:03:03,286 --> 00:03:05,021 COUNTRY SINCE WE LAST SPOKE. 85 00:03:05,021 --> 00:03:07,557 THEN I'LL HAND IT OVER TO NEIL 86 00:03:07,557 --> 00:03:08,958 SHAPIRO FOR A BUDGET UPDATE 87 00:03:08,958 --> 00:03:11,461 FOLLOWED BY OUR LEGISLATIVE 88 00:03:11,461 --> 00:03:14,964 UPDATE WITH KI KATE KLIMCZAK. 89 00:03:14,964 --> 00:03:16,633 I'M GOING TO COVER VARIOUS 90 00:03:16,633 --> 00:03:17,800 POLICY ISSUES AS WELL AS 91 00:03:17,800 --> 00:03:19,335 PROGRESS REPORTS ON WORK WE'VE 92 00:03:19,335 --> 00:03:21,871 DONE TO IMPLEMENT YOUR 93 00:03:21,871 --> 00:03:22,405 RECOMMENDATIONS, THE 94 00:03:22,405 --> 00:03:23,072 RECOMMENDATIONS FROM THIS 95 00:03:23,072 --> 00:03:23,339 COMMITTEE. 96 00:03:23,339 --> 00:03:25,041 I WILL ALSO PROVIDE SOME UPDATE 97 00:03:25,041 --> 00:03:26,242 AS I'VE ALREADY MENTIONED ON 98 00:03:26,242 --> 00:03:28,211 OTHER PROGRAMS AND INITIATIVES 99 00:03:28,211 --> 00:03:30,346 AT NIH, INCLUDING CARE FOR 100 00:03:30,346 --> 00:03:31,714 HEALTH, AND THEN WE'LL CLOSE 101 00:03:31,714 --> 00:03:33,883 WITH A FEW POINTS ABOUT THE 102 00:03:33,883 --> 00:03:42,525 IMPORTANCE OF BASIC RESEARCH. 103 00:03:42,525 --> 00:03:46,029 NEXT SLIDE, PLEASE. 104 00:03:46,029 --> 00:03:49,198 LEADERSHIP CHANGES. 105 00:03:49,198 --> 00:03:50,967 FOLLOWING THE DEPARTURE OF 106 00:03:50,967 --> 00:03:55,238 FORMER NIMH DIRECTOR JOSHUA 107 00:03:55,238 --> 00:03:57,407 GORDON, SHELLI AVENEVOLI WAS 108 00:03:57,407 --> 00:03:58,174 NAMED ACTING DIRECTOR. 109 00:03:58,174 --> 00:03:59,842 SHE WAS PREVIOUSLY DEPUTY 110 00:03:59,842 --> 00:04:00,810 DIRECTOR. 111 00:04:00,810 --> 00:04:02,145 SHE HAS CONTRIBUTED 112 00:04:02,145 --> 00:04:03,313 SIGNIFICANTLY TO SEVERAL LARGE 113 00:04:03,313 --> 00:04:06,149 SCALE NIH INITIATIVES INCLUDING 114 00:04:06,149 --> 00:04:09,452 THE NIMH STRATEGIC PLAN, THE 115 00:04:09,452 --> 00:04:11,187 ADOLESCENT BRAIN COGNITIVE 116 00:04:11,187 --> 00:04:13,590 DEVELOPMENT STUDY, HEALTHY BRAIN 117 00:04:13,590 --> 00:04:15,925 AND CHILD DEVELOPMENT STUDY, 118 00:04:15,925 --> 00:04:17,660 ENVIRONMENTAL INFLUENCES ON 119 00:04:17,660 --> 00:04:21,164 CHILD HEALTH OUT C OUTCOME STUDE 120 00:04:21,164 --> 00:04:22,699 ALL-OF-US RESEARCH PROGRAM, AND 121 00:04:22,699 --> 00:04:25,735 THE UNITE EFFORT. 122 00:04:25,735 --> 00:04:26,936 DEMONSTRATING, AS ALL OF OUR 123 00:04:26,936 --> 00:04:29,138 LEADERS DO, A REAL EFFORT NOT 124 00:04:29,138 --> 00:04:32,408 ONLY TO FOCUS ON THEIR OWN 125 00:04:32,408 --> 00:04:35,211 INSTITUTE, BUT ALSO ON STRATEGIC 126 00:04:35,211 --> 00:04:36,145 COORDINATION THROUGHOUT ALL OF 127 00:04:36,145 --> 00:04:37,880 NIH. 128 00:04:37,880 --> 00:04:39,082 SHELLI WILL CONTINUE TO SERVE IN 129 00:04:39,082 --> 00:04:40,750 THIS ROLE WHILE NIH CONDUCTS A 130 00:04:40,750 --> 00:04:41,918 NATIONAL SEARCH FOR A 131 00:04:41,918 --> 00:04:45,221 REPLACEMENT. 132 00:04:45,221 --> 00:04:49,258 ON NOVEMBER 3RD, RENATE MYLES 133 00:04:49,258 --> 00:04:51,561 WAS SELECTED AS ASSOCIATE 134 00:04:51,561 --> 00:04:52,795 DIRECTOR FOR COMMUNICATIONS AND 135 00:04:52,795 --> 00:04:54,530 PUBLIC LIAISON AND ALSO DIRECTOR 136 00:04:54,530 --> 00:04:55,865 OF OUR OFFICE OF COMMUNICATIONS 137 00:04:55,865 --> 00:04:57,800 AND PUBLIC REALLY ASSON. 138 00:04:57,800 --> 00:04:59,002 SHE HAS BEEN SERVING IN THIS 139 00:04:59,002 --> 00:05:02,505 ROLE IN AN ACTING CAPACITY SINCE 140 00:05:02,505 --> 00:05:03,239 APRIL 2021 WHILE CONTINUING TO 141 00:05:03,239 --> 00:05:06,442 SERVE AS NIH'S OCPL'S DEPUTY 142 00:05:06,442 --> 00:05:07,577 DIRECTOR FOR PUBLIC AFFAIRS, A 143 00:05:07,577 --> 00:05:11,914 POSITION SHE'S HELD SINCE 144 00:05:11,914 --> 00:05:12,649 NOVEMBER 2018. 145 00:05:12,649 --> 00:05:14,017 AS DIRECTOR FOR PRINCIPAL 146 00:05:14,017 --> 00:05:15,084 COMMUNICATIONS OFFICE, SHE 147 00:05:15,084 --> 00:05:16,953 PROVIDES EXECUTIVE LEADERSHIP TO 148 00:05:16,953 --> 00:05:19,222 ENSURE CLEAR, EFFECTIVE 149 00:05:19,222 --> 00:05:21,190 COMMUNICATION WITH NIH'S DIVERSE 150 00:05:21,190 --> 00:05:23,926 AUDIENCES INCLUDING STAFF, THE 151 00:05:23,926 --> 00:05:26,663 SCIENTIFIC COMMUNITY, 152 00:05:26,663 --> 00:05:27,530 POLICYMAKERS, INTEREST GROUPS, 153 00:05:27,530 --> 00:05:29,732 AND THE PUBLIC, AND I JUST WANT 154 00:05:29,732 --> 00:05:31,567 TO ADD A PERSONAL NOTE OF 155 00:05:31,567 --> 00:05:34,003 GRATITUDE TO RENATE AS SHE HAS 156 00:05:34,003 --> 00:05:35,438 JUST BEEN A TREMENDOUS PARTNER 157 00:05:35,438 --> 00:05:37,707 FOR ME OVER THE LAST YEAR AS WE 158 00:05:37,707 --> 00:05:40,643 NAVIGATED A LOT OF REALLY 159 00:05:40,643 --> 00:05:41,144 IMPORTANT COMMUNICATION 160 00:05:41,144 --> 00:05:48,651 CHALLENGES. 161 00:05:48,651 --> 00:05:51,721 GERI DONENBERG WAS SELECTED FOR 162 00:05:51,721 --> 00:05:52,588 ASSOCIATE DIRECTOR FOR AIDS 163 00:05:52,588 --> 00:05:54,891 RESEARCH, PART OF DIVISION OF 164 00:05:54,891 --> 00:05:56,959 PROGRAM COORDINATION, PLANNING 165 00:05:56,959 --> 00:05:58,528 AND STRATEGIC INITIATIVES IN THE 166 00:05:58,528 --> 00:05:59,262 NIH OFFICE OF THE DIRECTOR. 167 00:05:59,262 --> 00:06:01,097 SHE JOINED NIH JUST IN OCTOBER 168 00:06:01,097 --> 00:06:03,533 TO LEAD THE ADVANCEMENT AND 169 00:06:03,533 --> 00:06:04,734 COORDINATION OF HIV/AIDS 170 00:06:04,734 --> 00:06:06,369 RESEARCH AT NIH, WORKING CLOSELY 171 00:06:06,369 --> 00:06:08,137 WITH ALL OF THE CRITICALLY 172 00:06:08,137 --> 00:06:09,372 INVOLVED NIH INSTITUTES AND 173 00:06:09,372 --> 00:06:10,306 CENTERS. 174 00:06:10,306 --> 00:06:13,242 SHE BRINGS MORE THAN 25 YEARS OF 175 00:06:13,242 --> 00:06:14,477 HIV/AIDS RESEARCH EXPERIENCE TO 176 00:06:14,477 --> 00:06:18,281 THIS ROLE, AND I ALSO WANT TO 177 00:06:18,281 --> 00:06:20,483 THANK BILL AND DIANA, WHO BOTH 178 00:06:20,483 --> 00:06:23,986 PREVIOUSLY SERVED AS ACTING OAR 179 00:06:23,986 --> 00:06:26,522 DIRECTOR UNTIL DR. DONENBERG 180 00:06:26,522 --> 00:06:29,559 BEGAN IN OCTOBER. 181 00:06:29,559 --> 00:06:33,262 DR. CAROLYN HUTTER HAS BEEN 182 00:06:33,262 --> 00:06:35,364 NAMED DIRECTOR OF THE OFFICE OF 183 00:06:35,364 --> 00:06:36,199 STRATEGIC COWARD YAITION, PART 184 00:06:36,199 --> 00:06:38,201 OF THE DIVISION OF PROGRAM 185 00:06:38,201 --> 00:06:38,968 COORDINATION PLANNING AND 186 00:06:38,968 --> 00:06:39,936 STRATEGIC INITIATIVES IN THE 187 00:06:39,936 --> 00:06:40,503 DIRECTOR'S OFFICE. 188 00:06:40,503 --> 00:06:44,741 THIS OFFICE PLANS, MANAGES AND 189 00:06:44,741 --> 00:06:46,976 OVERSEES ACTIVITIES FUNDED BY 190 00:06:46,976 --> 00:06:50,880 THE CRITICAL NIH COMMON FUND. 191 00:06:50,880 --> 00:06:51,714 DR. HUTTER BRINGS MORE THAN 20 192 00:06:51,714 --> 00:06:54,283 YEARS OF EXPERIENCE IN GENETICS 193 00:06:54,283 --> 00:06:55,251 AND EPIDEMIOLOGY AS WELL AS IN 194 00:06:55,251 --> 00:06:56,786 MANAGING VERY LARGE RESEARCH 195 00:06:56,786 --> 00:06:57,220 COLLABORATIONS. 196 00:06:57,220 --> 00:06:58,488 SHE WAS PREVIOUSLY THE DIRECTOR 197 00:06:58,488 --> 00:07:01,390 OF THE DIVISION OF GENOME 198 00:07:01,390 --> 00:07:03,459 SCIENCES AT N HGRI. 199 00:07:03,459 --> 00:07:05,428 I ALSO WANT TO THANK DR. DOUG 200 00:07:05,428 --> 00:07:08,998 SHEELY, WHO'S BEEN SERVING AS 201 00:07:08,998 --> 00:07:10,333 ACTING DIRECTOR SINCE THE 202 00:07:10,333 --> 00:07:12,201 JANUARY 2023 RETIREMENT OF 203 00:07:12,201 --> 00:07:19,642 ELIZABETH WILDER. 204 00:07:19,642 --> 00:07:21,511 SO DR. MARIE BERNARD, CHIEF 205 00:07:21,511 --> 00:07:23,246 OFFICER FOR SCIENTIFIC WORKFORCE 206 00:07:23,246 --> 00:07:24,781 DIVERSITY, HAS BEEN TELLING 207 00:07:24,781 --> 00:07:27,583 DR. TABAK AND ME FOR MORE THAN A 208 00:07:27,583 --> 00:07:29,285 YEAR THAT SHE INTENDS TO RETIRE 209 00:07:29,285 --> 00:07:34,090 FROM FEDERAL SERVICE ON DECEMBE. 210 00:07:34,090 --> 00:07:36,159 WE WERE KIND OF HOPING SHE WAS 211 00:07:36,159 --> 00:07:37,260 KIDDING, BUT IT TURNS OUT THAT 212 00:07:37,260 --> 00:07:39,028 WE ARE GOING TO HAVE TO 213 00:07:39,028 --> 00:07:40,696 CONGRATULATE HER ON ACHIEVING 214 00:07:40,696 --> 00:07:42,732 THIS REALLY IMPORTANT NEW LIFE 215 00:07:42,732 --> 00:07:44,367 TRANSITION. 216 00:07:44,367 --> 00:07:46,869 SO SINCE TAKING THE ROLE IN 217 00:07:46,869 --> 00:07:48,304 OCTOBER 2020, MARIE HAS MADE 218 00:07:48,304 --> 00:07:50,173 TREMENDOUS PROGRESS IN BUILDING, 219 00:07:50,173 --> 00:07:52,241 DISSEMINATING AND ACTING ON 220 00:07:52,241 --> 00:07:55,878 EVIDENCE TO STRENGTHEN THE 221 00:07:55,878 --> 00:07:56,946 SCIENTIFIC WORKFORCE THROUGH 222 00:07:56,946 --> 00:07:59,348 EQUITY, INCLUSION AND SIBILITYD. 223 00:07:59,348 --> 00:08:00,016 ACCESSIBILITY. 224 00:08:00,016 --> 00:08:01,450 UNDER HER LEADERSHIP NIH 225 00:08:01,450 --> 00:08:02,952 LAUNCHED THE 21ST CENTURY 226 00:08:02,952 --> 00:08:04,487 SCHOLARS PROGRAM TO BUILD A 227 00:08:04,487 --> 00:08:07,456 CULTURE TO MENTOR AND SUPPORT 228 00:08:07,456 --> 00:08:09,525 NIH PROGRAM OFFICERS AND 229 00:08:09,525 --> 00:08:11,727 SCIENTIFIC REVIEW OFFICERS. 230 00:08:11,727 --> 00:08:13,029 MARIE ALSO LAUNCHED THE 231 00:08:13,029 --> 00:08:14,463 ENGAGEMENT IN ACCESS FOR 232 00:08:14,463 --> 00:08:16,299 RESEARCH ACTIVE INSTITUTIONS, 233 00:08:16,299 --> 00:08:20,336 DESIGNED TO HELP INSTITUTIONS 234 00:08:20,336 --> 00:08:22,305 THAT HAVE BEEN LESS ABLE TO 235 00:08:22,305 --> 00:08:24,841 RECEIVE NIH FUNDING, HELP THEM 236 00:08:24,841 --> 00:08:26,809 NAVIGATE FUNDING OPPORTUNITIES, 237 00:08:26,809 --> 00:08:28,010 ACCESSORY SOURCES AND CONNECT 238 00:08:28,010 --> 00:08:30,446 WITH ALL NIH INSTITUTES, CENTERS 239 00:08:30,446 --> 00:08:34,217 AND OFFICES TO UNDERSTAND 240 00:08:34,217 --> 00:08:34,550 OPPORTUNITIES. 241 00:08:34,550 --> 00:08:36,552 WE THANK MARIE FOR HER 242 00:08:36,552 --> 00:08:37,553 LEADERSHIP AND WISH HER THE VERY 243 00:08:37,553 --> 00:08:43,326 BEST IN THIS NEXT CHAPTER. 244 00:08:43,326 --> 00:08:46,729 ALL OF NIH MOURNS THE LOSS OF 245 00:08:46,729 --> 00:08:48,497 DR. JOHN GALLIN, THE 246 00:08:48,497 --> 00:08:49,332 LONGEST-SERVING DIRECTOR OF THE 247 00:08:49,332 --> 00:08:52,702 NIH CLINICAL CENTER. 248 00:08:52,702 --> 00:08:53,369 I'D LIKE TO TAKE THIS 249 00:08:53,369 --> 00:08:54,470 OPPORTUNITY TO HONOR THE MEMORY 250 00:08:54,470 --> 00:08:56,672 OF DR. JOHN GALLIN. 251 00:08:56,672 --> 00:09:00,343 HIS ILLUSTRIOUS CAREER AT NIH IN 252 00:09:00,343 --> 00:09:01,344 MORE THAN 50 YEARS IN ADDITION 253 00:09:01,344 --> 00:09:02,578 TO LEADING THE CLINICAL CENTER, 254 00:09:02,578 --> 00:09:04,013 WHICH HE REFERRED TO AS THE 255 00:09:04,013 --> 00:09:05,748 HOUSE OF HOPE. 256 00:09:05,748 --> 00:09:07,049 JOHN WAS PASSIONATE ABOUT 257 00:09:07,049 --> 00:09:09,785 TRAINING THE NEXT GENERATION OF 258 00:09:09,785 --> 00:09:10,319 SCIENTISTS. 259 00:09:10,319 --> 00:09:13,956 AS A RESULT, HIS LEGACY LIVES 260 00:09:13,956 --> 00:09:15,524 FAR BEYOND HIS TIME HERE WITH 261 00:09:15,524 --> 00:09:15,925 US. 262 00:09:15,925 --> 00:09:18,427 JOHN WAS A TREASURE, AND THE NIH 263 00:09:18,427 --> 00:09:22,265 COMMUNITY WILL MISS HIM DEARLY. 264 00:09:22,265 --> 00:09:23,466 NOW I'D LIKE TO RECOGNIZE 265 00:09:23,466 --> 00:09:24,567 MEMBERS OF THE NIH COMMUNITY WHO 266 00:09:24,567 --> 00:09:25,601 HAVE RECEIVED ACCOLADES FOR 267 00:09:25,601 --> 00:09:28,504 THEIR WORK. 268 00:09:28,504 --> 00:09:30,072 WE WERE REALLY PROUD TO ADD 269 00:09:30,072 --> 00:09:32,575 THREE NAMES TO THE LIST OF NOBLE 270 00:09:32,575 --> 00:09:33,743 LAUREATES WHOSE WORK HAS BEEN 271 00:09:33,743 --> 00:09:35,511 SUPPORTED BY NIH. 272 00:09:35,511 --> 00:09:36,379 THE 2024 NOBEL PRIZE IN 273 00:09:36,379 --> 00:09:38,281 PHYSIOLOGY OR MEDICINE WAS 274 00:09:38,281 --> 00:09:41,117 JOINTLY AWARDED TO VICTOR AMBROS 275 00:09:41,117 --> 00:09:43,853 AND GARY RUVKUN FOR THEIR DISCO 276 00:09:43,853 --> 00:09:45,354 ROOFER HE MOOF KROI RNA AND ITS 277 00:09:45,354 --> 00:09:47,423 ROLE IN POST TRANSCRIPTIONAL 278 00:09:47,423 --> 00:09:47,857 GENE REGULATION. 279 00:09:47,857 --> 00:09:49,759 IN ADDITION, DAVID BAKER, ONE OF 280 00:09:49,759 --> 00:09:51,127 THREE AWARDEES OF THE NOBEL 281 00:09:51,127 --> 00:09:53,195 PRIZE IN CHEMISTRY FOR HIS WORK 282 00:09:53,195 --> 00:09:55,831 IN DESIGNING NEW COMPUTATIONAL 283 00:09:55,831 --> 00:09:57,266 PROTEINS IS A LONG-TIME 284 00:09:57,266 --> 00:10:02,505 RECIPIENT OF NIH SUPPORT. 285 00:10:02,505 --> 00:10:05,141 THIS IS ALSO JUST A WONDERFUL 286 00:10:05,141 --> 00:10:07,310 TESTAMENT TO THE STRENGTH OF OUR 287 00:10:07,310 --> 00:10:07,643 NIH STAFF. 288 00:10:07,643 --> 00:10:11,380 HERE WE HAVE LISTED NIH STAFF 289 00:10:11,380 --> 00:10:12,615 NEW MEMBERS OF THE NATIONAL 290 00:10:12,615 --> 00:10:13,783 ACADEMIES. 291 00:10:13,783 --> 00:10:15,318 WE CONGRATULATE THEM FOR THIS 292 00:10:15,318 --> 00:10:17,053 ESTEEMED HONOR, RECOGNIZING 293 00:10:17,053 --> 00:10:19,322 THEIR PROFESSIONAL ACHIEVEMENTS, 294 00:10:19,322 --> 00:10:20,790 THEIR ORIGINAL RESEARCH 295 00:10:20,790 --> 00:10:22,191 CONTRIBUTIONS, AND THEIR 296 00:10:22,191 --> 00:10:28,097 COMMITMENT TO SERVICE. 297 00:10:28,097 --> 00:10:28,931 NIAID'S CHIEF INFORMATION 298 00:10:28,931 --> 00:10:31,400 OFFICER MIKE TARTAKOVSKY 299 00:10:31,400 --> 00:10:32,935 RECEIVED A MERITORIOUS 300 00:10:32,935 --> 00:10:35,104 PRESIDENTIAL RANK AWARD FOR HIS 301 00:10:35,104 --> 00:10:37,306 INNOVATIVE LEADERSHIP IN 302 00:10:37,306 --> 00:10:39,809 ADVANCING NIAID'S 303 00:10:39,809 --> 00:10:40,676 CYBERINFRASTRUCTURE AND 304 00:10:40,676 --> 00:10:43,079 PIONEERING INITIATIVES, LIKE THE 305 00:10:43,079 --> 00:10:45,514 NIH 3D PRINT EXCHANGE, WHICH HAS 306 00:10:45,514 --> 00:10:47,683 HAD A LASTING IMPACT ON GLOBAL 307 00:10:47,683 --> 00:10:51,620 HEALTH RESEARCH. 308 00:10:51,620 --> 00:10:53,923 AND RECENTLY FORMER NIH DIRECTOR 309 00:10:53,923 --> 00:10:55,558 DR. FRANCIS COLLINS RECEIVED THE 310 00:10:55,558 --> 00:10:57,693 ASSISTANT SECRETARY FOR HEALTH'S 311 00:10:57,693 --> 00:10:59,395 EXCEPTIONAL SERVICE MEDALLION. 312 00:10:59,395 --> 00:11:01,797 THIS AWARD IS GIVEN TO A MEMBER 313 00:11:01,797 --> 00:11:05,634 OF ANY UNIFORM SERVICE OR A 314 00:11:05,634 --> 00:11:06,936 CIVILIAN FOR EXCEPTIONAL 315 00:11:06,936 --> 00:11:09,138 CONTRIBUTIONS TO INITIATIVES OF 316 00:11:09,138 --> 00:11:09,905 THE ASSISTANT SECRETARY FOR 317 00:11:09,905 --> 00:11:12,408 HEALTH. 318 00:11:12,408 --> 00:11:14,143 NOW I'D LIKE TO SHARE SOME 319 00:11:14,143 --> 00:11:18,948 EVENTS THAT I'VE ATTENDED WITH 320 00:11:18,948 --> 00:11:19,849 MANY OF THE CONTRIBUTIONS FROM 321 00:11:19,849 --> 00:11:21,384 MANY OF THE STAFF AND FACULTY 322 00:11:21,384 --> 00:11:24,120 HERE AT NIH, BOTH ON AND OFF 323 00:11:24,120 --> 00:11:26,722 CAMPUS SINCE WE LAST MET. 324 00:11:26,722 --> 00:11:30,059 OVER THE SUMMER, I VISITED THE 325 00:11:30,059 --> 00:11:33,829 DOYA NATSU HEALING CENTER IN 326 00:11:33,829 --> 00:11:35,364 WYOMING ON THE WIND RIVER INDIAN 327 00:11:35,364 --> 00:11:38,000 RESERVATION WITH MY UNCLE AND 328 00:11:38,000 --> 00:11:40,736 INSPIRATION, DR. PIERRE. 329 00:11:40,736 --> 00:11:42,605 THE CENTER PROVIDES 330 00:11:42,605 --> 00:11:45,007 COMMUNITY-BASED PRACTICES TO 331 00:11:45,007 --> 00:11:48,044 PEOPLE AFFECTED BY SUBSTANCE USE 332 00:11:48,044 --> 00:11:48,310 DISORDERS. 333 00:11:48,310 --> 00:11:51,547 IT WAS A WONDERFUL OPPORTUNITY 334 00:11:51,547 --> 00:11:55,618 TO LEARN HOW COMBINING THE MOST 335 00:11:55,618 --> 00:11:58,821 MODERN SCIENTIFIC APPROACHES TO 336 00:11:58,821 --> 00:12:00,790 SUBSTANCE ABUSE WITH THE 337 00:12:00,790 --> 00:12:03,926 TRADITIONAL CULTURAL HEALING 338 00:12:03,926 --> 00:12:05,327 PRACTICES OF THE EASTERN 339 00:12:05,327 --> 00:12:07,763 SHOSHONE AND NORTHERN ARAPAHO 340 00:12:07,763 --> 00:12:08,964 TRIBES CONTRIBUTE POWERFUL 341 00:12:08,964 --> 00:12:11,367 FORCES FOR HEALING. 342 00:12:11,367 --> 00:12:14,637 IN AUGUST, NORA VOLKOW, KARINA 343 00:12:14,637 --> 00:12:16,939 WALTERS, SUSAN GREGORY AND I 344 00:12:16,939 --> 00:12:17,807 VISITED THE UNIVERSITY OF 345 00:12:17,807 --> 00:12:18,240 OKLAHOMA. 346 00:12:18,240 --> 00:12:20,876 WE TOURED OU'S CANCER CENTER AND 347 00:12:20,876 --> 00:12:21,877 DISCUSSED THE MANY WAYS THAT 348 00:12:21,877 --> 00:12:26,148 DATA SIGH E SCIENCE CAN REVOLUTE 349 00:12:26,148 --> 00:12:27,349 HEALTH RESEARCH, PARTICULARLY 350 00:12:27,349 --> 00:12:29,518 WHEN IT COMES TO OUTREACH TO SO 351 00:12:29,518 --> 00:12:30,820 MANY COMMUNITIES THAT ARE LEFT 352 00:12:30,820 --> 00:12:32,254 OUT OF RESEARCH AND NEED US. 353 00:12:32,254 --> 00:12:35,091 WE ALSO MET WITH EXPERTS AT THE 354 00:12:35,091 --> 00:12:36,826 ABSENTEE SHAWNEE TRIBE HEALTH 355 00:12:36,826 --> 00:12:38,828 CENTER WHO ARE LEADING RESEARCH 356 00:12:38,828 --> 00:12:41,063 TO ADDRESS OVERDOSE, SUBSTANCE 357 00:12:41,063 --> 00:12:42,531 USE, AND PAIN. 358 00:12:42,531 --> 00:12:44,767 THEIR WORK IS SUPPORTED BY NIH'S 359 00:12:44,767 --> 00:12:45,601 NATIVE COLLECTIVE RESEARCH 360 00:12:45,601 --> 00:12:49,405 EFFORT TO ENHANCE WELLNESS OR 361 00:12:49,405 --> 00:12:51,040 NCRU PROGRAM. 362 00:12:51,040 --> 00:12:54,343 IN SEPTEMBER, SENATOR JACK REED 363 00:12:54,343 --> 00:12:56,212 VISITED THE NIH CAMPUS AND 364 00:12:56,212 --> 00:12:57,713 TOURED THE NIH CLINICAL CENTER. 365 00:12:57,713 --> 00:13:00,416 HE GOT TO HEAR ABOUT RECENT 366 00:13:00,416 --> 00:13:02,485 FINDINGS IN RNA SEQUENCING, AS 367 00:13:02,485 --> 00:13:04,186 WELL AS ADVANCES IN CHILDHOOD 368 00:13:04,186 --> 00:13:05,588 CANCER RESEARCH AND 369 00:13:05,588 --> 00:13:06,822 INTERNATIONAL RESEARCH. 370 00:13:06,822 --> 00:13:09,892 LATER THAT DAY, I WELCOMED A NEW 371 00:13:09,892 --> 00:13:11,727 GROUP OF HOUSE DEMOCRATIC 372 00:13:11,727 --> 00:13:12,728 CONGRESSIONAL STAFF FOR AN 373 00:13:12,728 --> 00:13:16,432 INTRODUCTION TO NIH. 374 00:13:16,432 --> 00:13:18,067 MANY OF US WERE DELIGHTED TO 375 00:13:18,067 --> 00:13:19,735 TAKE PART IN THIS SPECIAL EVENT 376 00:13:19,735 --> 00:13:21,637 IN SEPTEMBER HONORING THE GROUND 377 00:13:21,637 --> 00:13:24,306 BREAKS WORK OF DR. STEVEN A. 378 00:13:24,306 --> 00:13:25,407 ROSENBERG, THE CHIEF OF THE 379 00:13:25,407 --> 00:13:26,942 SURGERY BRANCH AT THE NATIONAL 380 00:13:26,942 --> 00:13:27,877 CANCER INSTITUTE. 381 00:13:27,877 --> 00:13:30,546 A TWO-DAY SCIENTIFIC SYMPOSIUM 382 00:13:30,546 --> 00:13:33,282 CELEBRATED STEVEN'S 50 YEARS AT 383 00:13:33,282 --> 00:13:35,351 NCI, AND SERVED AS A WONDERFUL 384 00:13:35,351 --> 00:13:36,886 TRIBUTE TO HIS DECADES WORKING 385 00:13:36,886 --> 00:13:38,420 TO ADVANCE IMMUNOTHERAPY 386 00:13:38,420 --> 00:13:39,288 TREATMENT FOR PATIENT WITH 387 00:13:39,288 --> 00:13:41,824 CANCER. 388 00:13:41,824 --> 00:13:44,226 STEVE SERVED AS AN INSPIRATION 389 00:13:44,226 --> 00:13:46,629 TO ME VERY EARLY IN MY CAREER, 390 00:13:46,629 --> 00:13:50,766 AND THROUGHOUT MY ENTIRE CAREER. 391 00:13:50,766 --> 00:13:52,868 WHEN I WAS AN ONCOLOGY RESIDENT 392 00:13:52,868 --> 00:13:54,303 AND POSTDOCTORAL FELLOW WHEN I 393 00:13:54,303 --> 00:13:56,272 FIRST BECAME AWARE OF HIS 394 00:13:56,272 --> 00:13:59,275 INCREDIBLE RESULTS. 395 00:13:59,275 --> 00:14:00,543 HIS DEDICATION TO HIS WORK 396 00:14:00,543 --> 00:14:03,946 CONTINUES TO INSPIRE ME TODAY. 397 00:14:03,946 --> 00:14:05,814 IN OCTOBER, WE WERE HONORED TO 398 00:14:05,814 --> 00:14:08,250 UNVEIL A NEW PLAQUE IN THE 399 00:14:08,250 --> 00:14:09,685 NATIONAL LIBRARY OF MEDICINE'S 400 00:14:09,685 --> 00:14:14,790 HERB GA GARDEN COMMEMORATING THE 401 00:14:14,790 --> 00:14:15,824 PARTNERSHIP BETWEEN NIH AND THE 402 00:14:15,824 --> 00:14:17,059 VOICES OF OUR FATHERS LEGACY 403 00:14:17,059 --> 00:14:17,393 FOUNDATION. 404 00:14:17,393 --> 00:14:19,328 THIS NON-PROFIT GROUP WAS 405 00:14:19,328 --> 00:14:21,330 ORGANIZED BY THE DESCENDANTS OF 406 00:14:21,330 --> 00:14:23,832 BLACK MEN WHO WERE UNETHICALLY 407 00:14:23,832 --> 00:14:26,435 TREATED DURING A STUDY CALLED 408 00:14:26,435 --> 00:14:28,137 THE UNITED STATES PUBLIC HEALTH 409 00:14:28,137 --> 00:14:31,140 SERVICE STUDY OF UNTREATED 410 00:14:31,140 --> 00:14:34,543 SYPHILIS IN THE NEGRO MALE AT 411 00:14:34,543 --> 00:14:39,048 TUSKEGEE AND MACON COUNTY, 412 00:14:39,048 --> 00:14:41,016 ALABAMA FROM 1932 TO 1972. 413 00:14:41,016 --> 00:14:44,420 WE ALL KNOW THIS AS THE INFAMOUS 414 00:14:44,420 --> 00:14:44,987 TUSKEGEE STUDY. 415 00:14:44,987 --> 00:14:46,889 NIH WORKED WITH THE FOUNDATION 416 00:14:46,889 --> 00:14:48,891 TO LOCATE AND PRESERVE A 417 00:14:48,891 --> 00:14:50,526 COLLECTION OF PHYSICAL DOCUMENTS 418 00:14:50,526 --> 00:14:52,595 FROM THIS STUDY WHICH ARE NOW 419 00:14:52,595 --> 00:14:54,930 HOUSED AT NLM AND NOW AVAILABLE 420 00:14:54,930 --> 00:14:56,198 AS A DIGITAL COLLECTION THROUGH 421 00:14:56,198 --> 00:14:59,368 THE LIBRARY'S WEBSITE, WE INTEND 422 00:14:59,368 --> 00:15:01,136 FOR THIS IMPORTANT MEMORIAL 423 00:15:01,136 --> 00:15:03,973 PLAQUE TO CONTINUALLY REMIND US 424 00:15:03,973 --> 00:15:06,008 TO NEVER REPRODUCE MISTAKES OF 425 00:15:06,008 --> 00:15:10,846 THE PAST. 426 00:15:10,846 --> 00:15:14,783 IN OCTOBER I JOINED SENATOR JOHN 427 00:15:14,783 --> 00:15:16,652 BOZEMAN AND CONGRESSMAN STEVE 428 00:15:16,652 --> 00:15:17,953 WOMACK ON A TOUR OF THE RIVER 429 00:15:17,953 --> 00:15:21,156 VALLEY AND NORTHWEST ARKANSAS. 430 00:15:21,156 --> 00:15:22,791 IT WAS SO INSPIRING TO SEE HOW 431 00:15:22,791 --> 00:15:26,195 THE ENTIRE COMMUNITY, ACADEMIC 432 00:15:26,195 --> 00:15:26,929 INSTITUTIONS, PUBLIC HEALTH 433 00:15:26,929 --> 00:15:27,496 DEPARTMENTS, HEALTHCARE 434 00:15:27,496 --> 00:15:29,565 PROVIDERS, BUSINESSES AND STATE 435 00:15:29,565 --> 00:15:32,067 AND FEDERAL GOVERNMENT ALL WORK 436 00:15:32,067 --> 00:15:35,904 TOGETHER TO PLAY A CRITICAL ROLE 437 00:15:35,904 --> 00:15:37,339 TO MAKE HEALTH BETTER FOR 438 00:15:37,339 --> 00:15:38,774 EVERYONE IN THESE COMMUNITIES IN 439 00:15:38,774 --> 00:15:40,576 NORTHWEST ARKANSAS. 440 00:15:40,576 --> 00:15:42,678 I WAS ESPECIALLY EXCITED TO CHAT 441 00:15:42,678 --> 00:15:44,980 WITH STUDENTS AT THE SPRINGDALE 442 00:15:44,980 --> 00:15:46,849 HIGH SCHOOL TO SEE HOW THE WORK 443 00:15:46,849 --> 00:15:50,452 THAT NIH IS DOING IS INSPIRING 444 00:15:50,452 --> 00:15:53,422 THE NEXT GENERATION. 445 00:15:53,422 --> 00:15:54,723 SO, NOW WITH THAT INTRODUCTION, 446 00:15:54,723 --> 00:15:57,559 I'D LIKE TO HAPPE HAND THIS OVEO 447 00:15:57,559 --> 00:15:59,094 NEIL SHAPIRO FOR A PRESENTATION 448 00:15:59,094 --> 00:16:01,163 ON ITEMS FINANCIAL. 449 00:16:01,163 --> 00:16:01,764 THERE YOU GO. 450 00:16:01,764 --> 00:16:03,565 >> THANK YOU. 451 00:16:03,565 --> 00:16:05,234 AND GOOD MORNING. 452 00:16:05,234 --> 00:16:14,209 WE CAN GO TO THE NEXT SLIDE SET. 453 00:16:14,209 --> 00:16:16,211 >> WE NEED TO CUE OF 454 00:16:16,211 --> 00:16:16,845 MR. SHAPIRO'S PRESENTATION, 455 00:16:16,845 --> 00:16:26,989 PLEASE. 456 00:16:33,295 --> 00:16:36,198 >> THANK YOU. 457 00:16:36,198 --> 00:16:36,832 OKAY. 458 00:16:36,832 --> 00:16:38,033 SO CURRENTLY WHERE WE ARE IN 459 00:16:38,033 --> 00:16:39,735 TERMS OF THE BUDGET, WE'RE IN 460 00:16:39,735 --> 00:16:41,870 FISCAL YEAR 2025, AND THE 461 00:16:41,870 --> 00:16:42,805 CURRENT CONTINUING RESOLUTION 462 00:16:42,805 --> 00:16:44,039 THAT WE'RE UNDER FOR TEMPORARY 463 00:16:44,039 --> 00:16:46,108 FUNDING UNTIL CONGRESS PROVIDES 464 00:16:46,108 --> 00:16:47,543 FINAL APPROPRIATIONS IS 465 00:16:47,543 --> 00:16:51,380 SCHEDULED TO LAST UNTIL DECEMBEM 466 00:16:51,380 --> 00:16:51,714 TOMORROW. 467 00:16:51,714 --> 00:16:53,916 AND WE'RE VERY HOPEFUL THAT WE 468 00:16:53,916 --> 00:16:56,318 WILL SOON KNOW MORE ABOUT WHAT'S 469 00:16:56,318 --> 00:17:00,122 LIKELY TO BE A CONTINUATION OF 470 00:17:00,122 --> 00:17:02,091 THAT CONTINUING RESOLUTION OR 471 00:17:02,091 --> 00:17:03,959 C.R. AS WE SOMETIMES CALL IT. 472 00:17:03,959 --> 00:17:06,161 MOST ACCOUNTS THAT IT MAY GO 473 00:17:06,161 --> 00:17:10,833 INTO MARCH, BUT WE HOPE TO KNOW 474 00:17:10,833 --> 00:17:12,067 POSSIBLY TODAY OR VERY SOON WHAT 475 00:17:12,067 --> 00:17:15,237 THE DETAILS WILL BE ON THAT NEXT 476 00:17:15,237 --> 00:17:16,772 FUNDING ROUND, AND THEN 477 00:17:16,772 --> 00:17:18,407 HOPEFULLY BY THE END OF THAT 478 00:17:18,407 --> 00:17:20,376 CONTINUING RESOLUTION, WE'LL 479 00:17:20,376 --> 00:17:21,510 KNOW OUR FINAL APPROPRIATIONS 480 00:17:21,510 --> 00:17:22,811 FOR THIS FISCAL YEAR, WHICH 481 00:17:22,811 --> 00:17:26,181 STARTED ON OCTOBER 1ST. 482 00:17:26,181 --> 00:17:27,015 THE FUNDING LEVEL THAT WE'RE 483 00:17:27,015 --> 00:17:29,885 UNDER NOW, BECAUSE IT'S A C.R., 484 00:17:29,885 --> 00:17:30,953 IS THE 2024 LEVEL, SO THE LEVEL 485 00:17:30,953 --> 00:17:34,022 WE HAD IN A PREVIOUS YEAR THAT 486 00:17:34,022 --> 00:17:35,691 ENDED SEPTEMBER 30TH. 487 00:17:35,691 --> 00:17:38,861 IT'S ALSO PRO-RATED FOR THE TIME 488 00:17:38,861 --> 00:17:40,529 PERIOD, SO UP TO DECEMBER 20TH, 489 00:17:40,529 --> 00:17:42,297 WE HAVE APPROXIMATELY A QUARTER 490 00:17:42,297 --> 00:17:43,298 OF THE AMOUNT THAT WE HAD 491 00:17:43,298 --> 00:17:45,534 AVAILABLE FOR THE FULL YEAR LAST 492 00:17:45,534 --> 00:17:47,169 YEAR. 493 00:17:47,169 --> 00:17:48,704 THE ONE DIFFERENCE IN THAT LEVEL 494 00:17:48,704 --> 00:17:51,306 IS THAT THE TYPE 1 DIABETES 495 00:17:51,306 --> 00:17:53,075 FUNDING, WHICH IS CALLED 496 00:17:53,075 --> 00:17:54,610 MANDATORY FUNDING, THAT GOES ON 497 00:17:54,610 --> 00:17:55,978 A LITTLE DIFFERENT SCHEDULE, BUT 498 00:17:55,978 --> 00:18:00,716 IT WAS EX-TENDED LAST YEAR UNTIL 499 00:18:00,716 --> 00:18:02,251 DECEMBER 31ST, SO WE HAVE 500 00:18:02,251 --> 00:18:03,285 ESSENTIALLY THE FIRST QUARTER'S 501 00:18:03,285 --> 00:18:06,722 WORTH OF FUNDING FOR THAT THAT'S 502 00:18:06,722 --> 00:18:07,856 ALREADY BEEN PROVIDED AND IT 503 00:18:07,856 --> 00:18:08,724 AVAILABLE TO SPEND. 504 00:18:08,724 --> 00:18:09,792 ONE DIFFERENCE THERE WAS THAT 505 00:18:09,792 --> 00:18:13,295 THE LEVEL HAD TYPICALLY BEEN 506 00:18:13,295 --> 00:18:14,029 $150 MILLION PER YEAR. 507 00:18:14,029 --> 00:18:16,799 CONGRESS WANTED TO INCREASE THAT 508 00:18:16,799 --> 00:18:21,170 TO 160, SO THE AMOUNT THEY GAVE 509 00:18:21,170 --> 00:18:22,371 US, SORT OF A PRO-RATED LEVEL 510 00:18:22,371 --> 00:18:24,440 BASED ON THAT NEW 160 AMOUNT 511 00:18:24,440 --> 00:18:25,541 WHICH WE'RE ASSUMING WILL 512 00:18:25,541 --> 00:18:27,509 CONTINUE ONCE WE GET ADDITIONAL 513 00:18:27,509 --> 00:18:28,610 FUNDING FOR THE REST OF THIS 514 00:18:28,610 --> 00:18:29,578 YEAR. 515 00:18:29,578 --> 00:18:31,046 IN ORDER TO COME UP WITH THAT 516 00:18:31,046 --> 00:18:32,648 FUNDING, THE FINAL 517 00:18:32,648 --> 00:18:33,415 APPROPRIATIONS, CONGRESS IS 518 00:18:33,415 --> 00:18:36,685 GOING TO NEED TO REACH AN 519 00:18:36,685 --> 00:18:37,352 AGREEMENT ON OVERALL SPENDING 520 00:18:37,352 --> 00:18:38,987 LEVELS AND THEN HOW TO ALLOCATE 521 00:18:38,987 --> 00:18:40,355 THAT AMONG THE VARIOUS BILLS 522 00:18:40,355 --> 00:18:42,391 THAT COME THROUGH THEIR 523 00:18:42,391 --> 00:18:47,095 SUBCOMMITTEES, AND TO GET THE 524 00:18:47,095 --> 00:18:48,864 PROGRESS DOWN TO THE FINAL 525 00:18:48,864 --> 00:18:49,331 APPROPRIATIONS. 526 00:18:49,331 --> 00:18:53,001 SO I WANTED TO GIVE A SENSE OF 527 00:18:53,001 --> 00:18:55,504 WHAT WE'VE SEEN SO FAR FROM 528 00:18:55,504 --> 00:18:56,905 CONGRESS, WHAT THE PRESIDENT'S 529 00:18:56,905 --> 00:18:58,907 BUDGET INCLUDED, WHICH I 530 00:18:58,907 --> 00:18:59,908 DISCUSSED AT THE LAST MEETING 531 00:18:59,908 --> 00:19:03,946 AND ALSO WHAT WE'VE HEARD SO FAR 532 00:19:03,946 --> 00:19:05,747 FROM THE HOUSE AND THE SENATE IN 533 00:19:05,747 --> 00:19:07,015 TERMS OF THEIR REACTION AND 534 00:19:07,015 --> 00:19:08,183 THEIR PROPOSALS TO GO FORWARD. 535 00:19:08,183 --> 00:19:10,319 THEY WERE EACH ABLE TO INTRODUCE 536 00:19:10,319 --> 00:19:13,121 A BILL, GOT THE BILL THROUGH THE 537 00:19:13,121 --> 00:19:14,990 FULL COMMITTEE, AND THOSE 538 00:19:14,990 --> 00:19:17,059 PROVIDED THE LEVELS THAT ARE 539 00:19:17,059 --> 00:19:20,028 SHOWN HERE, THE PROGRAM LEVEL, 540 00:19:20,028 --> 00:19:21,463 WHICH IS THE LARGEST MEASURE OF 541 00:19:21,463 --> 00:19:23,098 NIH FUND, THAT INCLUDES BOTH 542 00:19:23,098 --> 00:19:25,968 WHAT COMES OUT OF THOSE BILLS AS 543 00:19:25,968 --> 00:19:28,103 WELL AS THE TYPE 1 DIABETES 544 00:19:28,103 --> 00:19:29,638 FUNDING AND OTHER SOURCES OF 545 00:19:29,638 --> 00:19:31,707 FUNDING, SO THAT'S A LARGER 546 00:19:31,707 --> 00:19:32,374 MEASURE. 547 00:19:32,374 --> 00:19:41,016 THE PRESIDENT'S BUDGET WAS 548 00:19:41,016 --> 00:19:41,650 $2.73 BILLION INCREASE PROPOSE 549 00:19:41,650 --> 00:19:43,218 AS YOU MAY RECALL, AND THAT 550 00:19:43,218 --> 00:19:45,687 INCLUDED A MANDATORY PROPOSAL 551 00:19:45,687 --> 00:19:48,457 FOR ABOUT $1.5 BILLION FOR THE 552 00:19:48,457 --> 00:19:50,192 CANCER MOONSHOT TO ADVANCE THAT 553 00:19:50,192 --> 00:19:52,160 BEYOND WHAT WE'VE BEEN ABLE TO 554 00:19:52,160 --> 00:19:52,728 DO ALREADY. 555 00:19:52,728 --> 00:19:55,330 THAT MANDATORY FUNDING HAS NOT 556 00:19:55,330 --> 00:19:57,366 MOVED FORWARD IN A CONGRESSIONAL 557 00:19:57,366 --> 00:20:00,402 BILL AT THIS POINT. 558 00:20:00,402 --> 00:20:03,772 I ALSO WANTED TO MENTION THAT 559 00:20:03,772 --> 00:20:04,673 THE CURES ACT FUNDING IS PRETTY 560 00:20:04,673 --> 00:20:11,313 MUCH THE SAME ACROSS ALL THESE 561 00:20:11,313 --> 00:20:12,581 DIFFERENT THAN THE PRESIDENT'S 562 00:20:12,581 --> 00:20:14,283 BUDGET HOUSE OR SENATE BECAUSE 563 00:20:14,283 --> 00:20:15,517 IT WAS PREVIOUSLY PROVIDED IN 564 00:20:15,517 --> 00:20:16,785 THE CURES ACT THAT SET 565 00:20:16,785 --> 00:20:17,653 AUTHORIZATION LEVELS THAT 566 00:20:17,653 --> 00:20:18,420 CONGRESS HAS BEEN ABLE TO 567 00:20:18,420 --> 00:20:19,555 PROVIDE THROUGHOUT THESE YEARS, 568 00:20:19,555 --> 00:20:20,522 BUT BECAUSE OF THE NATURE OF 569 00:20:20,522 --> 00:20:22,157 THAT BILL, THE FUNDING WENT UP 570 00:20:22,157 --> 00:20:24,526 SOME YEARS AND IN RECENT YEARS, 571 00:20:24,526 --> 00:20:26,528 IT'S COME DOWN, IT'S SCHEDULED 572 00:20:26,528 --> 00:20:29,798 TO END IN ANOTHER TWO YEARS, SO 573 00:20:29,798 --> 00:20:32,100 THERE'S BEEN A LARGE DROPOFF 574 00:20:32,100 --> 00:20:39,808 FROM THE PEAK OF $1.0785 BILLION 575 00:20:39,808 --> 00:20:43,045 DOWN IN 2023, NOW WE'RE DOWN TO 576 00:20:43,045 --> 00:20:44,112 $127 MILLION, SO THAT HAS 577 00:20:44,112 --> 00:20:44,780 SIGNIFICANT IMPACT ON THE 578 00:20:44,780 --> 00:20:45,447 PROGRAMS THAT WERE FUNDED 579 00:20:45,447 --> 00:20:46,315 THROUGH THE CURES ACT. 580 00:20:46,315 --> 00:20:49,251 IN TERMS OF THE HOUSE AND THE 581 00:20:49,251 --> 00:20:52,821 SENATE, THE HOUSE WAS RELATIVELY 582 00:20:52,821 --> 00:20:54,523 FLAT, OVERALL LOOKING AT THE 583 00:20:54,523 --> 00:20:55,657 OVERALL PICTURE, AND THAT'S 584 00:20:55,657 --> 00:20:57,693 BECAUSE AS YOU CAN SEE ON THE 585 00:20:57,693 --> 00:21:00,862 TABLE, THEY REDUCED FUNDING FOR 586 00:21:00,862 --> 00:21:04,933 ARPA-H BY $1 BILLION FROM 1.5 TO 587 00:21:04,933 --> 00:21:08,003 HALF A BILLION DOLLARS, AND THEY 588 00:21:08,003 --> 00:21:09,504 INCREASED THE FUNDING FOR THE 589 00:21:09,504 --> 00:21:11,273 NIH INSTITUTES AND CENTERS BY 590 00:21:11,273 --> 00:21:12,441 THE SAME BILLION DOLLARS. 591 00:21:12,441 --> 00:21:17,179 IT'S A LITTLE BIT LESS IN TOTAL 592 00:21:17,179 --> 00:21:17,913 .92 BECAUSE OF THE EFFECT OF 593 00:21:17,913 --> 00:21:19,114 THAT TYPE 1 DIABETES CHANGE THAT 594 00:21:19,114 --> 00:21:20,983 I MENTIONED BEFORE. 595 00:21:20,983 --> 00:21:22,317 THE SENATE, ON THE OTHER HAND, 596 00:21:22,317 --> 00:21:25,587 PROVIDED AN ADDITIONAL 597 00:21:25,587 --> 00:21:26,788 $1.7 BILLION, SO NOT AS MUCH AS 598 00:21:26,788 --> 00:21:30,726 WE REQUESTED, BUT STILL A 599 00:21:30,726 --> 00:21:32,027 GENEROUS PROPOSAL THERE. 600 00:21:32,027 --> 00:21:35,864 AND WE WILL SEE WHERE WE END UP 601 00:21:35,864 --> 00:21:37,499 WHEN THIS ALL SETTLES OUT. 602 00:21:37,499 --> 00:21:39,701 THE NEXT SLIDE HAS A LITTLE MORE 603 00:21:39,701 --> 00:21:42,537 DETAIL ON THE SPECIFICS OF WHAT 604 00:21:42,537 --> 00:21:44,940 THE SENATE AND THE HOUSE DID. 605 00:21:44,940 --> 00:21:48,477 THEIR BILL AS I SAID HAD A 606 00:21:48,477 --> 00:21:49,111 $1.7 BILLION INCREASE. 607 00:21:49,111 --> 00:21:51,847 OF THAT, $1.2 BILLION WAS 608 00:21:51,847 --> 00:21:53,582 DESIGNATED AS EMERGENCY FUNDING, 609 00:21:53,582 --> 00:21:55,751 SO THAT IS A TYPE OF FUNDING 610 00:21:55,751 --> 00:22:00,689 THAT DOESN'T COUNT AGAINST THE 611 00:22:00,689 --> 00:22:01,490 DISCRETIONARY CAPS THAT WERE SET 612 00:22:01,490 --> 00:22:02,891 IN THE LAST BUDGET DEAL, SO 613 00:22:02,891 --> 00:22:04,393 SOMEWHAT EASIER TO PROVIDE IF 614 00:22:04,393 --> 00:22:06,161 CONGRESS IS WILLING TO DO 615 00:22:06,161 --> 00:22:07,362 EMERGENCY FUNDING. 616 00:22:07,362 --> 00:22:09,231 THE SENATE WAS, THE HOUSE WAS 617 00:22:09,231 --> 00:22:10,699 NOT, SO THAT'S ONE OF THE 618 00:22:10,699 --> 00:22:12,167 DIFFERENCES BETWEEN THE TWO 619 00:22:12,167 --> 00:22:14,569 LEVELS. 620 00:22:14,569 --> 00:22:17,773 IN TERMS OF THE CURES ACT 621 00:22:17,773 --> 00:22:19,408 PROGRAMS I MENTIONED BEFORE, THE 622 00:22:19,408 --> 00:22:21,476 SENATE PROPOSED RESTORING THEM 623 00:22:21,476 --> 00:22:22,244 TO THE 2023 LEVEL. 624 00:22:22,244 --> 00:22:24,312 THEY USED MOST OF THE EMERGENCY 625 00:22:24,312 --> 00:22:26,348 FUNDING IN ORDER TO DO THAT. 626 00:22:26,348 --> 00:22:30,986 AND THAT WOULD RE WOULD REVISE E 627 00:22:30,986 --> 00:22:33,722 SPECIFIC FUNDING FOR THE CANCER 628 00:22:33,722 --> 00:22:34,723 MOONSHOT. 629 00:22:34,723 --> 00:22:37,659 THAT HAD $216 MILLION IN TWEP 630 00:22:37,659 --> 00:22:42,464 23,2023AND IT DID NOT HAVE FUNDN 631 00:22:42,464 --> 00:22:44,332 CURES IN 2024. 632 00:22:44,332 --> 00:22:45,734 23 WAS THE FINAL YEAR FOR THE 633 00:22:45,734 --> 00:22:48,036 CANCER MOONSHOT, AND THE SENATE 634 00:22:48,036 --> 00:22:49,771 FUNDS WOULD ALSO OFFSET THE 635 00:22:49,771 --> 00:22:50,939 REDUCTIONS TO THE ALL-OF-US 636 00:22:50,939 --> 00:22:52,741 RESEARCH PROGRAM AND THE BRAIN 637 00:22:52,741 --> 00:22:53,375 INITIATIVE. 638 00:22:53,375 --> 00:22:54,943 BOTH OF THOSE HAD A COMBINATION 639 00:22:54,943 --> 00:22:57,245 OF BASE FUNDING AND CURES ACT 640 00:22:57,245 --> 00:22:57,779 FUNDING. 641 00:22:57,779 --> 00:23:01,149 THE CANCER MOONSHOT WAS TOTALLY 642 00:23:01,149 --> 00:23:02,684 CURES ACT, SO THE SENATE WAS 643 00:23:02,684 --> 00:23:05,854 PROPOSING TO RESTORE THE TOTAL 644 00:23:05,854 --> 00:23:07,622 LEVEL, THE CURES PLUS BASE 645 00:23:07,622 --> 00:23:08,924 LEVELS, FOR ALL-OF-US AND FOR 646 00:23:08,924 --> 00:23:10,525 BRAIN TO WHERE THEY WERE IN 647 00:23:10,525 --> 00:23:13,628 2023. 648 00:23:13,628 --> 00:23:15,297 THE SENATE INCREASES THAT I 649 00:23:15,297 --> 00:23:17,065 MENTIONED, THOUGH, WERE TARGETED 650 00:23:17,065 --> 00:23:20,402 NOT ONLY TO THE CURES ACT 651 00:23:20,402 --> 00:23:21,570 PROGRAMS BUT TO SOME OTHERS, BUT 652 00:23:21,570 --> 00:23:23,371 THERE WAS NOT A GENERAL 653 00:23:23,371 --> 00:23:23,939 INCREASE. 654 00:23:23,939 --> 00:23:25,006 THE INSTITUTES AND CENTERS THAT 655 00:23:25,006 --> 00:23:28,076 DID NOT HAVE TARGETED INCREASES 656 00:23:28,076 --> 00:23:32,881 WERE THE SAME AS IN 2024. 657 00:23:32,881 --> 00:23:34,516 SO THE HOUSE BILL AS I MENTIONED 658 00:23:34,516 --> 00:23:37,152 BEFORE WAS RATHER DIFFERENT THAN 659 00:23:37,152 --> 00:23:38,920 THE SENATE BILL. 660 00:23:38,920 --> 00:23:41,189 THE TOTAL FUNDING IN THAT BILL 661 00:23:41,189 --> 00:23:43,692 WAS FLAT BASED ON THAT BILLION 662 00:23:43,692 --> 00:23:46,328 DOLLAR SHIFT FROM ARPA-H. 663 00:23:46,328 --> 00:23:48,630 THE CURES ACT FUNDING LEVELS 664 00:23:48,630 --> 00:23:53,001 WEREN'T RESTORED, SO YOU DIDN'T 665 00:23:53,001 --> 00:23:55,871 HAVE THAT BACKFILL OF THE BASE 666 00:23:55,871 --> 00:23:59,574 FUNDING FOR ALL OF US FOR THE 667 00:23:59,574 --> 00:24:00,742 BRAIN INITIATIVE AND THE HOUSE 668 00:24:00,742 --> 00:24:03,211 ALSO INCLUDED A REORGANIZATION, 669 00:24:03,211 --> 00:24:05,380 THEY HAD COORDINATED WITH THE 670 00:24:05,380 --> 00:24:06,114 AUTHORIZING COMMITTEE ENERGIES 671 00:24:06,114 --> 00:24:09,384 AND COMMISSIONERS, AND THAT COMD 672 00:24:09,384 --> 00:24:13,255 REDUCE THE NUMBER OF INSTITUTES 673 00:24:13,255 --> 00:24:14,556 AND CENTERS WITH THEIR OWN 674 00:24:14,556 --> 00:24:16,792 APPROPRIATIONS WHICH IS 24 OUT 675 00:24:16,792 --> 00:24:17,859 OF 27, IT WOULD REDUCE THAT 676 00:24:17,859 --> 00:24:18,960 NUMBER DOWN TO 12 INSTITUTES. 677 00:24:18,960 --> 00:24:21,096 SO A MUCH DIFFERENT BILL THAN 678 00:24:21,096 --> 00:24:24,733 THE SENATE ONE. 679 00:24:24,733 --> 00:24:26,134 SO I WANT TO TALK A LITTLE BIT 680 00:24:26,134 --> 00:24:28,236 ABOUT SOME OF THESE SPECIFIC 681 00:24:28,236 --> 00:24:30,438 TARGETED INITIATIVES THAT WERE 682 00:24:30,438 --> 00:24:31,973 IN THE HOUSE AND THE SENATE 683 00:24:31,973 --> 00:24:32,274 BILLS. 684 00:24:32,274 --> 00:24:34,776 AS I MENTIONED, THAT WAS WHERE 685 00:24:34,776 --> 00:24:36,111 THE FUNDING WAS GENERALLY GOING 686 00:24:36,111 --> 00:24:38,613 AS OPPOSED TO ACROSS THE BOARD. 687 00:24:38,613 --> 00:24:41,950 FOR NCI, THE BUDGET PROPOSED 688 00:24:41,950 --> 00:24:42,684 OVER $2 BILLION INCREASE. 689 00:24:42,684 --> 00:24:43,985 MUCH OF THAT WAS THE MANDATORY 690 00:24:43,985 --> 00:24:47,889 FUNDING THAT I MENTIONED BEFORE. 691 00:24:47,889 --> 00:24:49,558 THE HOUSE, WHILE IT DID NOT 692 00:24:49,558 --> 00:24:50,992 SPECIFY FUNDING FOR THE CANCER 693 00:24:50,992 --> 00:24:52,527 MOONSHOT, IT DID PROVIDE A 694 00:24:52,527 --> 00:24:54,496 SIGNIFICANT INCREASE FOR NCI 695 00:24:54,496 --> 00:24:57,666 FROM THOSE FUNDS THAT HAD BEEN 696 00:24:57,666 --> 00:24:58,233 SHIFTED. 697 00:24:58,233 --> 00:25:01,336 THE SENATE RESTORED THE 698 00:25:01,336 --> 00:25:02,370 $216 MILLION THAT CAME OUT OF 699 00:25:02,370 --> 00:25:04,339 THE END OF THE CURES ACT FUNDING 700 00:25:04,339 --> 00:25:07,142 AS WELL AS AN ADDITIONAL 701 00:25:07,142 --> 00:25:08,677 $50 MILLION THERE FOR NCI. 702 00:25:08,677 --> 00:25:12,180 THE OTHER ITEMS THAT I WANTED TO 703 00:25:12,180 --> 00:25:13,281 HIGHLIGHT, MENTAL HEALTH 704 00:25:13,281 --> 00:25:14,616 RESEARCH, THAT WAS PROPOSED IN 705 00:25:14,616 --> 00:25:18,420 THE PRESIDENT'S BUDGET, ALSO 706 00:25:18,420 --> 00:25:19,654 SUPPORTED AT DIFFERENT LEVELS BY 707 00:25:19,654 --> 00:25:20,288 THE HOUSE AND THE SENATE. 708 00:25:20,288 --> 00:25:23,358 THEY CONTINUED TRYING TO RAMP UP 709 00:25:23,358 --> 00:25:24,125 FUNDING FOR ALZHEIMER'S 710 00:25:24,125 --> 00:25:24,593 RESEARCH. 711 00:25:24,593 --> 00:25:26,862 THEY SUPPORTED TO 712 00:25:26,862 --> 00:25:27,629 VARYING DEGREES OUR PROPOSAL TO 713 00:25:27,629 --> 00:25:28,930 DOUBLE THE SIZE OF FUNDING FOR 714 00:25:28,930 --> 00:25:31,132 THE OFFICE OF WOMEN'S HEALTH, 715 00:25:31,132 --> 00:25:34,069 AND ALSO ON THE SENATE SIDE, 716 00:25:34,069 --> 00:25:35,604 SUPPORTED OUR PROPOSAL TO 717 00:25:35,604 --> 00:25:37,405 INCREASE FUNDING FOR THE 718 00:25:37,405 --> 00:25:38,139 NATIONAL LIBRARY OF MEDICINE AND 719 00:25:38,139 --> 00:25:43,378 MAKING IT A CENTER FOR DATA 720 00:25:43,378 --> 00:25:46,648 THROUGHOUT NIH THAT WOULD BE 721 00:25:46,648 --> 00:25:47,849 EXTREMELY HELPFUL. 722 00:25:47,849 --> 00:25:49,818 SO JUST WANTED TO POINT THOSE 723 00:25:49,818 --> 00:25:52,654 OUT TO INDICATE THAT SOME OF THE 724 00:25:52,654 --> 00:25:55,056 FUNDING THAT WAS SUPPORTED IN 725 00:25:55,056 --> 00:25:56,925 THE PRESIDENT'S BUDGET HAS ALSO 726 00:25:56,925 --> 00:25:57,692 RECEIVED SUPPORT AT THE 727 00:25:57,692 --> 00:25:58,560 INITIATIVE LEVEL FROM THE HOUSE 728 00:25:58,560 --> 00:26:01,630 AND THE SENATE. 729 00:26:01,630 --> 00:26:02,731 WITH THAT, I'LL HAND OFF. 730 00:26:02,731 --> 00:26:03,365 >> OKAY. 731 00:26:03,365 --> 00:26:08,069 THANK YOU SO MUCH, NEIL. 732 00:26:08,069 --> 00:26:09,671 NOW LET'S TURN TO KATE KLIMCZAK 733 00:26:09,671 --> 00:26:15,443 FOR OUR LEGISLATIVE U UPDATE. 734 00:26:15,443 --> 00:26:15,877 >> GREAT. 735 00:26:15,877 --> 00:26:17,913 THANK YOU. 736 00:26:17,913 --> 00:26:19,147 I'M GOING TO START BY GIVING A 737 00:26:19,147 --> 00:26:23,084 LITTLE BIT OF AN OVERVIEW OF 738 00:26:23,084 --> 00:26:26,688 SOME OF THE CONGRESSIONAL 739 00:26:26,688 --> 00:26:27,589 ENGAGEMENTS THAT THE DIRECTOR 740 00:26:27,589 --> 00:26:28,990 HAS HAD AND NIH HAS HAD OVER THE 741 00:26:28,990 --> 00:26:30,292 PAST YEAR, AND THEN I'LL TALK A 742 00:26:30,292 --> 00:26:34,562 LITTLE BIT ABOUT THE END OF YEAR 743 00:26:34,562 --> 00:26:36,631 LEGISLATIVE ACTIVITY THAT WE CAN 744 00:26:36,631 --> 00:26:38,166 EXPECT TO SEE AND THEN TALK A 745 00:26:38,166 --> 00:26:41,002 LITTLE BIT ABOUT THE 119TH 746 00:26:41,002 --> 00:26:42,237 CONGRESS, WHICH WILL BEGIN EARLY 747 00:26:42,237 --> 00:26:47,642 NEXT YEAR. 748 00:26:47,642 --> 00:26:49,444 SO WE HAVE SPENT THE PAST YEAR 749 00:26:49,444 --> 00:26:51,713 AND A HALF WITH DIRECTOR 750 00:26:51,713 --> 00:26:52,714 BERTAGNOLLI, SPENDING A LOT OF 751 00:26:52,714 --> 00:26:54,249 TIME GETTING TO KNOW MANY 752 00:26:54,249 --> 00:26:58,286 MEMBERS OF CONGRESS AND 753 00:26:58,286 --> 00:27:00,388 ADVOCATING FOR NIH WITH MEMBERS 754 00:27:00,388 --> 00:27:02,223 OF CONGRESS AND ON THE HILL. 755 00:27:02,223 --> 00:27:04,526 WE'VE HAD OVER 50 MEETINGS AND 756 00:27:04,526 --> 00:27:06,695 PHONE CALLS WITH MEMBERS ON A 757 00:27:06,695 --> 00:27:10,298 VARIETY OF TOPICS, NIH 758 00:27:10,298 --> 00:27:11,099 PRIORITIES AND MEMBER 759 00:27:11,099 --> 00:27:12,934 PRIORITIES. 760 00:27:12,934 --> 00:27:16,237 WE'VE ALSO HAD NINE CAMPUS OR 761 00:27:16,237 --> 00:27:18,940 DISTRICT SITE VISITS. 762 00:27:18,940 --> 00:27:21,142 HERE I'VE PUT UP A PHOTO OF A 763 00:27:21,142 --> 00:27:23,211 VISIT THAT WE HAD TO WEST 764 00:27:23,211 --> 00:27:26,081 VIRGINIA UNIVERSITY, SENATOR 765 00:27:26,081 --> 00:27:28,116 SHELLEY MOORE CAPITO HELPED 766 00:27:28,116 --> 00:27:34,389 ORGANIZE THAT VISIT AND SENATOR 767 00:27:34,389 --> 00:27:36,358 MANCHIN ALSO JOINED AS WELL. 768 00:27:36,358 --> 00:27:37,692 THE DIRECTOR ALSO HAD TWO 769 00:27:37,692 --> 00:27:38,526 CONGRESSIONAL HEARINGS THIS YEAR 770 00:27:38,526 --> 00:27:40,195 AS WELL, BOTH OF THOSE HEARINGS 771 00:27:40,195 --> 00:27:42,964 WERE ON THE AGENCY'S FY 25 772 00:27:42,964 --> 00:27:47,402 BUDGET REQUEST. 773 00:27:47,402 --> 00:27:49,170 IN ADDITION, I ALSO WANTED TO 774 00:27:49,170 --> 00:27:51,106 SHARE A LITTLE BIT OF AN 775 00:27:51,106 --> 00:27:54,075 OVERVIEW OF THE CONGRESSIONAL 776 00:27:54,075 --> 00:27:55,777 ACTIVITY THIS YEAR. 777 00:27:55,777 --> 00:27:58,913 WE'VE HAD OVER 150 BRIEFINGS FOR 778 00:27:58,913 --> 00:28:00,949 MEMBERS OF CONGRESS AND THEIR 779 00:28:00,949 --> 00:28:01,616 STAFF. 780 00:28:01,616 --> 00:28:03,585 THESE BRIEFINGS HAVE COVERED A 781 00:28:03,585 --> 00:28:06,588 RANGE OF TOPICS, NEARLY EVERY IC 782 00:28:06,588 --> 00:28:09,057 HAS BEEN INVOLVED IN AT LEAST 783 00:28:09,057 --> 00:28:12,994 ONE, USUALLY MANY MORE 784 00:28:12,994 --> 00:28:13,328 BRIEFINGS. 785 00:28:13,328 --> 00:28:15,163 WE'VE ALSO HAD OVER 150 REQUESTS 786 00:28:15,163 --> 00:28:16,398 FOR TECHNICAL ASSISTANCE ON 787 00:28:16,398 --> 00:28:19,434 PIECES OF LEGISLATION THAT 788 00:28:19,434 --> 00:28:20,201 CONGRESSIONAL MEMBERS ARE 789 00:28:20,201 --> 00:28:23,471 WORKING ON THAT RELATE TO NIH 790 00:28:23,471 --> 00:28:26,975 PROGRAMS OR RESEARCH ISSUES. 791 00:28:26,975 --> 00:28:29,611 WE HOSTED 10 CAMPUS VISITS, OVER 792 00:28:29,611 --> 00:28:33,014 40 MEETINGS WITH NIH LEADERSHIP 793 00:28:33,014 --> 00:28:35,950 ON THE HILL, AND IN TOTAL, WE'VE 794 00:28:35,950 --> 00:28:37,085 HAD FIVE CONGRESSIONAL HEARINGS, 795 00:28:37,085 --> 00:28:38,787 WHICH INCLUDES THE DIRECTOR'S 796 00:28:38,787 --> 00:28:39,988 BUDGET HEARINGS THAT I JUST 797 00:28:39,988 --> 00:28:41,322 MENTIONED. 798 00:28:41,322 --> 00:28:44,059 WE'VE ALSO BEEN WORKING ON A 799 00:28:44,059 --> 00:28:46,995 NUMBER OF PROACTIVE OUTREACH 800 00:28:46,995 --> 00:28:51,266 EFFORTS TO SHARE MORE 801 00:28:51,266 --> 00:28:54,436 INFORMATION ABOUT NIH AS AN 802 00:28:54,436 --> 00:28:55,870 ORGANIZATION, OUR PROGRAMS, OUR 803 00:28:55,870 --> 00:28:56,137 RESEARCH. 804 00:28:56,137 --> 00:28:57,105 THIS YEAR WE STARTED HOSTING 805 00:28:57,105 --> 00:28:59,240 SOMETHING CALLED LUNCH & LEARNS 806 00:28:59,240 --> 00:29:00,675 FOR CONGRESSIONAL STAFF EVERY 807 00:29:00,675 --> 00:29:01,242 FRIDAY. 808 00:29:01,242 --> 00:29:04,913 WE'VE HAD JUST SHY OF 40 LUNCH & 809 00:29:04,913 --> 00:29:05,513 LEARN BRIEFINGS. 810 00:29:05,513 --> 00:29:06,714 THESE AGAIN HAVE BEEN ON A 811 00:29:06,714 --> 00:29:12,921 VARIETY OF TOPICS WITH 33 OF OUR 812 00:29:12,921 --> 00:29:15,890 ICs, CENTERS, OFFICES. 813 00:29:15,890 --> 00:29:18,093 THE ENGAGEMENT ON THESE HAS BEEN 814 00:29:18,093 --> 00:29:18,526 EXCELLENT. 815 00:29:18,526 --> 00:29:22,263 WE'VE HAD OVER 515 HOUSE HEALTH 816 00:29:22,263 --> 00:29:24,132 STAFFERS ATTEND, OVER 400 SENATE 817 00:29:24,132 --> 00:29:34,542 HEALTH STAFFERS ATTEND. 818 00:29:39,814 --> 00:29:41,249 NOW I'M GOING TO TALK A LITTLE 819 00:29:41,249 --> 00:29:42,450 BIT ABOUT THE LAME DUCK SESSION. 820 00:29:42,450 --> 00:29:43,918 WE HAVE JUST A COUPLE MORE WEEKS 821 00:29:43,918 --> 00:29:46,654 BEFORE THE END OF THE YEAR. 822 00:29:46,654 --> 00:29:49,057 THE 118TH CONGRESS IS WRAPPING 823 00:29:49,057 --> 00:29:53,294 UP. 824 00:29:53,294 --> 00:29:54,162 EVEN THOUGH WE ONLY HAVE A 825 00:29:54,162 --> 00:29:57,232 COUPLE WEEKS, THERE HAS BEEN 826 00:29:57,232 --> 00:29:59,534 SOME NEW MEMBERS JOINING THE 827 00:29:59,534 --> 00:30:00,535 118TH CONGRESS THAT I JUST 828 00:30:00,535 --> 00:30:01,169 WANTED TO NOTE. 829 00:30:01,169 --> 00:30:04,139 THERE WERE A COUPLE HOUSE RACES, 830 00:30:04,139 --> 00:30:05,006 SPECIAL AND GENERAL ELECTIONS 831 00:30:05,006 --> 00:30:06,441 THAT HAPPENED IN NOVEMBER. 832 00:30:06,441 --> 00:30:08,510 SO A FEW NEW MEMBERS THERE. 833 00:30:08,510 --> 00:30:10,245 AND THEN ON THE SENATE SIDE, I 834 00:30:10,245 --> 00:30:14,749 DID WANT TO NOTE THAT WE NOW 835 00:30:14,749 --> 00:30:19,521 HAVE TWO NEW SENATORS, SENATOR 836 00:30:19,521 --> 00:30:20,321 MENENDEZ FROM NEW JERSEY 837 00:30:20,321 --> 00:30:21,389 RESIGNED EARLIER THIS YEAR. 838 00:30:21,389 --> 00:30:23,158 THERE WAS A SPECIAL ELECTION IN 839 00:30:23,158 --> 00:30:24,926 NOVEMBER, SO SENATOR ELECT ANDY 840 00:30:24,926 --> 00:30:26,661 KIM FROM NEW JERSEY WAS JUST 841 00:30:26,661 --> 00:30:27,996 SWORN IN LAST WEEK. 842 00:30:27,996 --> 00:30:32,800 AND THEN IN CALIFORNIA, THERE 843 00:30:32,800 --> 00:30:36,104 HAD BEEN A SENATOR BUTLER WHO 844 00:30:36,104 --> 00:30:37,405 HAD BEEN SERVING IN THAT BUT SHE 845 00:30:37,405 --> 00:30:39,307 DID NOT RUN FOR RE-ELECTION OR 846 00:30:39,307 --> 00:30:40,675 IN THE SPECIAL ELECTION THAT WAS 847 00:30:40,675 --> 00:30:42,310 HELD IN NOVEMBER. 848 00:30:42,310 --> 00:30:47,582 SO SENATOR-ELECT ADAM SCHIFF WAS 849 00:30:47,582 --> 00:30:49,117 ALSO SWORN IN ON DECEMBER 8TH. 850 00:30:49,117 --> 00:30:51,486 SO THESE MEMBERS WILL JOIN, 851 00:30:51,486 --> 00:30:53,154 THERE WILL BE A FEW VOTES THAT 852 00:30:53,154 --> 00:30:54,889 THEY WILL PARTICIPATE IN AND 853 00:30:54,889 --> 00:30:56,991 PARTICULARLY FOR THE SENATORS, 854 00:30:56,991 --> 00:30:59,060 THIS MEANS THAT THEY ARE JOINING 855 00:30:59,060 --> 00:31:00,828 AN EARLIER SENATE CLASS AND THIS 856 00:31:00,828 --> 00:31:02,230 WILL HELP THEIR SENIORITY DOWN 857 00:31:02,230 --> 00:31:10,104 THE LINE. 858 00:31:10,104 --> 00:31:12,941 SO THE CONGRESS' TO DO LIST FOR 859 00:31:12,941 --> 00:31:14,375 THE NEXT COUPLE OF WEEKS IS 860 00:31:14,375 --> 00:31:15,476 STILL PRETTY LONG. 861 00:31:15,476 --> 00:31:17,111 AS NEIL MENTIONED, ONE OF THE 862 00:31:17,111 --> 00:31:20,748 TOP PRIORITIES IS FIGURING OUT 863 00:31:20,748 --> 00:31:22,917 WHAT TO DO ABOUT FY 25 864 00:31:22,917 --> 00:31:26,187 APPROPRIATIONS AND A NEW SHORT 865 00:31:26,187 --> 00:31:27,488 TERM CONGRESSIONAL CONTINUING 866 00:31:27,488 --> 00:31:28,356 RESOLUTION. 867 00:31:28,356 --> 00:31:30,658 I WON'T GET INTO THAT ANY MORE, 868 00:31:30,658 --> 00:31:32,293 BUT THERE ARE A FEW OTHER THINGS 869 00:31:32,293 --> 00:31:34,495 ON THEIR TO DO LIST. 870 00:31:34,495 --> 00:31:37,665 THEY ARE NEGOTIATING A DISASTER 871 00:31:37,665 --> 00:31:39,300 SUPPLEMENTAL IN RESPONSE TO THE 872 00:31:39,300 --> 00:31:42,136 RECENT HURRICANES HELENE AND 873 00:31:42,136 --> 00:31:45,640 MILTON, AS WELL AS OTHER NATURAL 874 00:31:45,640 --> 00:31:45,907 DISASTERS. 875 00:31:45,907 --> 00:31:48,943 CONGRESS ALSO HAS TO WRAP UP THE 876 00:31:48,943 --> 00:31:52,547 FY 25 NATIONAL DEFENSE 877 00:31:52,547 --> 00:31:53,314 AUTHORIZATION ACT. 878 00:31:53,314 --> 00:31:54,415 THIS IS THE DEFENSE 879 00:31:54,415 --> 00:31:56,050 AUTHORIZATION BILL THAT IS 880 00:31:56,050 --> 00:31:59,220 TYPICALLY DONE EVERY YEAR. 881 00:31:59,220 --> 00:32:00,421 THE HOUSE HAS ALREADY VOTED ON 882 00:32:00,421 --> 00:32:01,656 THE MEASURE AND IT IS NOW MOVING 883 00:32:01,656 --> 00:32:04,626 TO THE SENATE. 884 00:32:04,626 --> 00:32:08,730 IT CAN OFTEN HAVE LANGUAGE THAT 885 00:32:08,730 --> 00:32:09,931 DOES TOUCH SOME OF OUR PROGRAMS 886 00:32:09,931 --> 00:32:11,466 OR POLICIES, SO WE DO PAY 887 00:32:11,466 --> 00:32:14,669 ATTENTION TO IT VERY CLOSELY. 888 00:32:14,669 --> 00:32:16,170 CONGRESS IS ALSO WORKING ON AN 889 00:32:16,170 --> 00:32:22,410 END OF YEAR HEALTH PACKAGE, SO 890 00:32:22,410 --> 00:32:23,344 THIS PACKAGE WILL TYPICALLY 891 00:32:23,344 --> 00:32:27,682 INCLUDE A NUMBER OF HEALTH 892 00:32:27,682 --> 00:32:29,083 POLICY PIECES OF LEGISLATION, 893 00:32:29,083 --> 00:32:33,788 SOME OF WHICH MAY HAVE NIH 894 00:32:33,788 --> 00:32:35,223 EQUITIES BUT MANY OF OUR SISTER 895 00:32:35,223 --> 00:32:36,524 AGENCIES AS WELL, SO WE ARE 896 00:32:36,524 --> 00:32:37,659 TRACKING THAT. 897 00:32:37,659 --> 00:32:41,362 I ALSO WANTED TO NOTE THAT ANY 898 00:32:41,362 --> 00:32:42,330 OVERSIGHT INVESTIGATIONS THAT 899 00:32:42,330 --> 00:32:45,400 HAVE BEEN OPENED DURING THE 900 00:32:45,400 --> 00:32:46,501 118TH CONGRESS MUST WRAP UP BY 901 00:32:46,501 --> 00:32:49,470 THE END OF THE YEAR. 902 00:32:49,470 --> 00:32:52,106 ANY REPORT THAT COMMITTEES ARE 903 00:32:52,106 --> 00:32:53,875 WORKING ON ALSO HAVE TO WRAP UP 904 00:32:53,875 --> 00:32:55,043 BY THE END OF THE YEAR, THEN 905 00:32:55,043 --> 00:32:55,910 FINALLY JUST WANTED TO NOTE THAT 906 00:32:55,910 --> 00:32:59,280 THE FARM BILL IS STILL 907 00:32:59,280 --> 00:32:59,614 OUTSTANDING. 908 00:32:59,614 --> 00:33:00,715 CONGRESS IS GOING TO HAVE TO 909 00:33:00,715 --> 00:33:01,783 WORK THROUGH ANOTHER EXTENSION 910 00:33:01,783 --> 00:33:09,157 FOR THAT. 911 00:33:09,157 --> 00:33:12,827 SO AS YOU ALL KNOW, 2024 912 00:33:12,827 --> 00:33:15,396 ELECTION RESULTS, 913 00:33:15,396 --> 00:33:16,364 PRESIDENT-ELECT TRUMP WILL COME 914 00:33:16,364 --> 00:33:20,968 INTO OFFICE ON JANUARY 20TH. 915 00:33:20,968 --> 00:33:22,503 THE 119TH CONGRESS WILL BEGIN 916 00:33:22,503 --> 00:33:26,974 EARLY IN JANUARY. 917 00:33:26,974 --> 00:33:28,509 THE SENATE, PREVIOUSLY DEMOCRATS 918 00:33:28,509 --> 00:33:29,944 WERE IN THE MAJORITY, THAT HAS 919 00:33:29,944 --> 00:33:31,512 NOW FLIPPED, REPUBLICANS WILL BE 920 00:33:31,512 --> 00:33:33,147 IN THE MAJORITY, THEY WERE ABLE 921 00:33:33,147 --> 00:33:36,617 TO FLIP A NUMBER OF SEATS FROM 922 00:33:36,617 --> 00:33:39,053 DEMOCRAT TO REPUBLICAN IN WEST 923 00:33:39,053 --> 00:33:42,290 VIRGINIA, OHIO, PENNSYLVANIA AND 924 00:33:42,290 --> 00:33:42,523 MONTANA. 925 00:33:42,523 --> 00:33:44,625 THE HOUSE OF REPRESENTATIVES HAD 926 00:33:44,625 --> 00:33:46,260 A REPUBLICAN MAJORITY, THAT WILL 927 00:33:46,260 --> 00:33:54,369 REMAIN. 928 00:33:54,369 --> 00:33:56,104 SO HERE IS THE BREAKDOWN OF BOTH 929 00:33:56,104 --> 00:33:56,971 THE SENATE AND THE HOUSE. 930 00:33:56,971 --> 00:33:58,306 WHAT I WANTED TO ILLUSTRATE HERE 931 00:33:58,306 --> 00:34:02,343 IN THIS SLIDE IS THAT THE 932 00:34:02,343 --> 00:34:03,444 REPUBLICAN MAJORITIES IN BOTH 933 00:34:03,444 --> 00:34:05,279 THE SENATE AND THE HOUSE ARE 934 00:34:05,279 --> 00:34:08,349 VERY, VERY SLIM MAJORITIES, 935 00:34:08,349 --> 00:34:10,284 PARTICULARLY IN THE HOUSE OF 936 00:34:10,284 --> 00:34:11,753 REPRESENTATIVES, WHICH MEANS 937 00:34:11,753 --> 00:34:14,188 THAT IN BOTH CHAMBERS, THERE 938 00:34:14,188 --> 00:34:17,024 WILL LIKELY HAVE TO BE A LOT OF 939 00:34:17,024 --> 00:34:18,359 BIPARTISAN NEGOTIATION TO MOVE 940 00:34:18,359 --> 00:34:24,465 LEGISLATION THROUGH NEXT YEAR. 941 00:34:24,465 --> 00:34:25,566 NOW I'M GOING TO TALK A LITTLE 942 00:34:25,566 --> 00:34:26,667 BIT ABOUT CONGRESSIONAL 943 00:34:26,667 --> 00:34:27,201 LEADERSHIP. 944 00:34:27,201 --> 00:34:29,170 MUCH HAS STAYED THE SAME ACROSS 945 00:34:29,170 --> 00:34:31,272 THE TWO CHAMBERS AND THE TWO 946 00:34:31,272 --> 00:34:32,573 PARTIES, BUT THERE HAVE BEEN 947 00:34:32,573 --> 00:34:33,040 SOME CHANGES. 948 00:34:33,040 --> 00:34:38,613 I WANT TO MAKE SURE I NOTE. 949 00:34:38,613 --> 00:34:39,914 SO WE'LL START IN THE HOUSE. 950 00:34:39,914 --> 00:34:42,650 SO IN THE 119TH CONGRESS, IT IS 951 00:34:42,650 --> 00:34:44,852 EXPECTED THAT CURRENT SPEAKER 952 00:34:44,852 --> 00:34:47,889 MIKE JOHNSON WILL ALSO -- WILL 953 00:34:47,889 --> 00:34:51,426 CONTINUE TO BE SPEAKER IN THE 954 00:34:51,426 --> 00:34:52,093 119TH CONGRESS. 955 00:34:52,093 --> 00:34:55,129 HE WILL -- THE OFFICIAL VOTE 956 00:34:55,129 --> 00:34:56,364 WILL HAPPEN EARLY NEXT YEAR. 957 00:34:56,364 --> 00:34:58,566 THE NUMBER TWO IN THE HOUSE WILL 958 00:34:58,566 --> 00:35:01,068 CONTINUE TO BE STEVE SCALISE, 959 00:35:01,068 --> 00:35:02,737 ALSO OF LOUISIANA, AND THEN 960 00:35:02,737 --> 00:35:06,107 MAJORITY WHIP WILL BE TOM EMMER. 961 00:35:06,107 --> 00:35:09,243 TWO NEW LEADERSHIP -- THERE ARE 962 00:35:09,243 --> 00:35:11,112 TWO CHANGES TO REPUBLICAN 963 00:35:11,112 --> 00:35:12,814 LEADERSHIP. 964 00:35:12,814 --> 00:35:15,082 LISA MCCLAIN WILL NOW BE 965 00:35:15,082 --> 00:35:18,486 CONFERENCE CHAIR AND KEVIN HERN 966 00:35:18,486 --> 00:35:19,787 WILL BE THE POLICY COMMITTEE 967 00:35:19,787 --> 00:35:20,121 CHAIR. 968 00:35:20,121 --> 00:35:22,190 ON THE DEMOCRATIC SIDE, THE 969 00:35:22,190 --> 00:35:23,624 LEADERSHIP TEAM IS BROADLY THE 970 00:35:23,624 --> 00:35:25,159 SAME. 971 00:35:25,159 --> 00:35:26,394 HAKEEM JEFFRIES OF NEW YORK WILL 972 00:35:26,394 --> 00:35:29,864 CONTINUE TO BE MINORITY LEADER, 973 00:35:29,864 --> 00:35:30,865 KATHERINE CLARKE WILL BE THE 974 00:35:30,865 --> 00:35:33,067 WHRIP, PETE AGUILAR WILL BE 975 00:35:33,067 --> 00:35:35,603 CAUCUS CHAIR AND DEBBIE DINGELL 976 00:35:35,603 --> 00:35:37,205 IS CHAIR OF THE POLICY AND 977 00:35:37,205 --> 00:35:40,608 COMMUNICATIONS COMMITTEE. 978 00:35:40,608 --> 00:35:43,711 IN THE SENATE, AS I NOTED, 979 00:35:43,711 --> 00:35:44,579 REPUBLICANS ARE NOW MOVING INTO 980 00:35:44,579 --> 00:35:46,113 THE MAJORITY. 981 00:35:46,113 --> 00:35:50,384 JUST A COUPLE WEEKS AGO, JOHN 982 00:35:50,384 --> 00:35:52,019 THUNE OF SOUTH DAKOTA WAS 983 00:35:52,019 --> 00:35:53,154 ELECTED AS THE NEW MAJORITY 984 00:35:53,154 --> 00:35:53,554 LEADER. 985 00:35:53,554 --> 00:35:56,090 HE IS TAKING OVER FOR MITCH 986 00:35:56,090 --> 00:35:58,025 MCCONNELL, WHO WILL REMAIN IN 987 00:35:58,025 --> 00:36:00,228 THE SENATE AND FINISH UP HIS 988 00:36:00,228 --> 00:36:01,529 TERM, BUT ANNOUNCED EARLIER THIS 989 00:36:01,529 --> 00:36:02,964 YEAR THAT HE WAS STEPPING DOWN 990 00:36:02,964 --> 00:36:05,466 FROM HIS LEADERSHIP POSITION. 991 00:36:05,466 --> 00:36:08,202 AS YOU MAY KNOW, MITCH 992 00:36:08,202 --> 00:36:09,203 MCCONNELL, KENTUCKY, HAS BEEN 993 00:36:09,203 --> 00:36:10,571 THE REPUBLICAN MAJORITY -- HAS 994 00:36:10,571 --> 00:36:13,040 BEEN THE REPUBLICAN LEADER FOR 995 00:36:13,040 --> 00:36:15,109 MANY, MANY YEARS, SO THIS IS A 996 00:36:15,109 --> 00:36:18,646 VERY SIGNIFICANT CHANGE IN 997 00:36:18,646 --> 00:36:19,514 REPUBLICAN LEADERSHIP. 998 00:36:19,514 --> 00:36:22,984 JOHN BARRASSO OF WI WYOMING WILL 999 00:36:22,984 --> 00:36:26,053 NOW BE THE MAJORITY WHIP, TOM 1000 00:36:26,053 --> 00:36:27,688 COTTON WILL BE CONFERENCE CHAIR 1001 00:36:27,688 --> 00:36:31,526 AND SHELLEY MOORE CAPITO WILL 1002 00:36:31,526 --> 00:36:32,793 SERVE AS REPUBLICAN POLICY 1003 00:36:32,793 --> 00:36:33,394 COMMITTEE CHAIR. 1004 00:36:33,394 --> 00:36:42,503 ON THE DREAM TICK DEMOCRATIC SK 1005 00:36:42,503 --> 00:36:44,972 SCHUMER WILL NOW SERVE AS 1006 00:36:44,972 --> 00:36:50,378 MINORITY LEADER, DICK DURBIN AS 1007 00:36:50,378 --> 00:36:53,681 MINORITY WHIP AND AMY KLOBUCHAR 1008 00:36:53,681 --> 00:36:56,050 AS POLICY AND COMMUNICATIONS 1009 00:36:56,050 --> 00:36:57,852 HEAD FOR DEMOCRATIC MINORITY. 1010 00:36:57,852 --> 00:36:59,253 NOW I'M GOING TO TALK A LITTLE 1011 00:36:59,253 --> 00:37:00,154 ABOUT COMMITTEE LEADERSHIP 1012 00:37:00,154 --> 00:37:00,488 CHANGES. 1013 00:37:00,488 --> 00:37:01,822 WE HAVE SOME INFORMATION ABOUT 1014 00:37:01,822 --> 00:37:02,657 COMMITTEES THOUGH THERE ARE SOME 1015 00:37:02,657 --> 00:37:06,060 POSTS THAT ARE STILL BEING 1016 00:37:06,060 --> 00:37:07,929 DETERMINED. 1017 00:37:07,929 --> 00:37:13,167 SO AS A REMINDER, THE PRIMARY 1018 00:37:13,167 --> 00:37:15,369 COMMITTEES THAT RELATE TO NIH 1019 00:37:15,369 --> 00:37:17,038 ARE THE AUTHORIZING COMMITTEES, 1020 00:37:17,038 --> 00:37:18,606 SO IN THE HOUSE, THAT IS THE 1021 00:37:18,606 --> 00:37:20,775 HOUSE ENERGY AND COMMERCE 1022 00:37:20,775 --> 00:37:21,509 COMMITTEE. 1023 00:37:21,509 --> 00:37:23,277 UNDERNEATH THAT COMMITTEE, THERE 1024 00:37:23,277 --> 00:37:25,112 ARE TWO SUBCOMMITTEES THAT WE 1025 00:37:25,112 --> 00:37:27,214 PAY PARTICULAR ATTENTION TO. 1026 00:37:27,214 --> 00:37:28,950 THE HEALTH SUBCOMMITTEE AND THEN 1027 00:37:28,950 --> 00:37:30,952 THE OVERSIGHT AND INVESTIGATIONS 1028 00:37:30,952 --> 00:37:32,019 SUBCOMMITTEE. 1029 00:37:32,019 --> 00:37:34,221 ON THE SENATE SIDE, IT IS THE 1030 00:37:34,221 --> 00:37:35,523 SENATE HEALTH, EDUCATION, LABOR 1031 00:37:35,523 --> 00:37:37,758 AND PENSIONS COMMITTEE. 1032 00:37:37,758 --> 00:37:39,694 THESE COMMITTEES ARE RESPONSIBLE 1033 00:37:39,694 --> 00:37:42,863 FOR DRAFTING THE AUTHORIZING 1034 00:37:42,863 --> 00:37:43,965 LEGISLATION THAT GIVES US OUR 1035 00:37:43,965 --> 00:37:46,067 POLICY AND OVERSIGHT DIRECTION. 1036 00:37:46,067 --> 00:37:48,569 THE OTHER COMMITTEES OF 1037 00:37:48,569 --> 00:37:50,171 IMPORTANCE ARE THE 1038 00:37:50,171 --> 00:37:51,105 APPROPRIATIONS COMMITTEES, HOUSE 1039 00:37:51,105 --> 00:37:55,042 AND SENATE, AND THE RELEVANT 1040 00:37:55,042 --> 00:37:57,011 SUBCOMMITTEE IS LABOR, HEALTH 1041 00:37:57,011 --> 00:37:57,511 AND HUMAN SERVICES AND 1042 00:37:57,511 --> 00:38:02,683 EDUCATION. 1043 00:38:02,683 --> 00:38:04,852 FOR ENERGY AND COMMERCE ON THE 1044 00:38:04,852 --> 00:38:07,989 HOUSE SIDE, THE CURRENT CHAIR, 1045 00:38:07,989 --> 00:38:13,027 CATHY MA MCMORRIS RODGERS, IS 1046 00:38:13,027 --> 00:38:14,095 RETIRING THE END OF THIS YEAR. 1047 00:38:14,095 --> 00:38:16,197 JUST EARLIER THIS WEEK, 1048 00:38:16,197 --> 00:38:17,531 REPRESENTATIVE BRETT GUTHRIE OF 1049 00:38:17,531 --> 00:38:19,934 KENTUCKY WAS ELECTED AS THE NEW 1050 00:38:19,934 --> 00:38:21,602 INCOMING CHAIR NEXT YEAR. 1051 00:38:21,602 --> 00:38:23,371 HE HAD PREVIOUSLY SERVED AS 1052 00:38:23,371 --> 00:38:26,941 CHAIR OF THE HEALTH SUBCOMMITTEE 1053 00:38:26,941 --> 00:38:28,909 ON THE DEMOCRATIC SIDE, 1054 00:38:28,909 --> 00:38:30,711 REPRESENTATIVE FRANK PALLONE OF 1055 00:38:30,711 --> 00:38:31,979 NEW JERSEY WILL CONTINUE TO 1056 00:38:31,979 --> 00:38:34,515 SERVE AS THE RANKING MEMBER. 1057 00:38:34,515 --> 00:38:37,551 AND THEN IN THE SENATE, SENATOR 1058 00:38:37,551 --> 00:38:39,587 BILL CASSIDY HAD BEEN SERVING AS 1059 00:38:39,587 --> 00:38:39,954 RANKING MEMBER. 1060 00:38:39,954 --> 00:38:43,691 HE WILL NOW BE CHAIR OF HEALTH, 1061 00:38:43,691 --> 00:38:45,693 AND THE CURRENT CHAIR, SENATOR 1062 00:38:45,693 --> 00:38:48,963 BERNIE SANDERS OF VER MONTH, HEE 1063 00:38:48,963 --> 00:38:51,799 WILL NOW BE RANKING MEMBER. 1064 00:38:51,799 --> 00:38:56,103 THEY WILL SWAP THERE. 1065 00:38:56,103 --> 00:38:58,205 ON THE HOUSE SIDE THERE WILL BE 1066 00:38:58,205 --> 00:38:59,540 GENERALLY SPEAKING CONTINUITY ON 1067 00:38:59,540 --> 00:39:00,675 THE APPROPRIATION SIDE. 1068 00:39:00,675 --> 00:39:01,842 THE FULL APPROPRIATIONS 1069 00:39:01,842 --> 00:39:04,311 COMMITTEE CHAIR, TOM COLE, WILL 1070 00:39:04,311 --> 00:39:06,047 CONTINUE TO SERVE IN THAT ROLE 1071 00:39:06,047 --> 00:39:10,317 AND ROSA DELAURO OF CONNECTICUT 1072 00:39:10,317 --> 00:39:11,419 WILL CONTINUE TO SERVE IN THAT 1073 00:39:11,419 --> 00:39:11,652 ROLE. 1074 00:39:11,652 --> 00:39:12,987 ON THE SENATE SIDE, WE WILL 1075 00:39:12,987 --> 00:39:14,188 CONTINUE TO HAVE SENATOR PATTI 1076 00:39:14,188 --> 00:39:16,157 MURRAY OF WASHINGTON SERVE AS 1077 00:39:16,157 --> 00:39:17,725 THE TOP DEMOCRAT. 1078 00:39:17,725 --> 00:39:19,727 SHE WILL BE VICE CHAIR AND THEN 1079 00:39:19,727 --> 00:39:21,362 SUSAN COLLINS OF MAINE WILL BE 1080 00:39:21,362 --> 00:39:24,098 TAKING OVER AS CHAIR OF THE FULL 1081 00:39:24,098 --> 00:39:29,804 APPROPRIATIONS COMMITTEE. 1082 00:39:29,804 --> 00:39:35,443 LOOKING AHEAD TO THE 119TH 1083 00:39:35,443 --> 00:39:39,213 CONGRESS, THE CONGRESSIONAL 1084 00:39:39,213 --> 00:39:40,314 CALENDARS HAVE BEEN POSTED FOR 1085 00:39:40,314 --> 00:39:41,315 BOTH THE SENATE AND THE HOUSE. 1086 00:39:41,315 --> 00:39:43,284 I JUST WANTED TO NOTE THAT THE 1087 00:39:43,284 --> 00:39:47,221 SENATE SCHEDULE IS A 1088 00:39:47,221 --> 00:39:48,155 PARTICULARLY AGGRESSIVE 1089 00:39:48,155 --> 00:39:51,358 SCHEDULE. 1090 00:39:51,358 --> 00:39:53,394 THEY ARE SCHEDULED TO BE IN 180 1091 00:39:53,394 --> 00:39:54,428 DAYS, WHICH IS MORE THAN THEY 1092 00:39:54,428 --> 00:39:58,365 HAD BEEN IN THE PREVIOUS FEW 1093 00:39:58,365 --> 00:39:58,833 YEARS. 1094 00:39:58,833 --> 00:40:00,701 THE MAJORITY LEADER, JOHN THUNE, 1095 00:40:00,701 --> 00:40:02,436 HAS SAID THAT THE SENATE WILL BE 1096 00:40:02,436 --> 00:40:05,506 WORKING OVERTIME IN JANUARY, 1097 00:40:05,506 --> 00:40:06,874 FEBRUARY, MARCH, TO CHURN 1098 00:40:06,874 --> 00:40:10,377 THROUGH A NUMBER OF NOMINATIONS 1099 00:40:10,377 --> 00:40:12,213 AND OTHER TRUMP ADMINISTRATION 1100 00:40:12,213 --> 00:40:12,513 PRIORITIES. 1101 00:40:12,513 --> 00:40:14,515 THE HOUSE WILL BE SCHEDULED -- 1102 00:40:14,515 --> 00:40:18,552 IS SCHEDULED TO BE IN ABOUT 136 1103 00:40:18,552 --> 00:40:24,258 DAYS. 1104 00:40:24,258 --> 00:40:25,359 SO ONCE ALL THE MEMBERS ARE 1105 00:40:25,359 --> 00:40:27,228 SWORN IN AND THE 119TH SESSION 1106 00:40:27,228 --> 00:40:32,800 GETS GOING, REPUBLICAN LEADERS, 1107 00:40:32,800 --> 00:40:34,435 BOTH SPEAKER JOHNSON AND 1108 00:40:34,435 --> 00:40:35,436 MAJORITY LEADER THUNE HAVE 1109 00:40:35,436 --> 00:40:36,971 INDICATED TO THEIR MEMBERS AND 1110 00:40:36,971 --> 00:40:37,972 PRESS REPORTS THAT THEY WANT TO 1111 00:40:37,972 --> 00:40:40,040 HIT THE GROUND RUNNING, SO ON 1112 00:40:40,040 --> 00:40:40,708 JANUARY 3RD, THE NEW CONGRESS 1113 00:40:40,708 --> 00:40:41,242 WILL MEET. 1114 00:40:41,242 --> 00:40:44,311 WE'LL HAVE THE HOUSE SPEAKER 1115 00:40:44,311 --> 00:40:45,279 ELECTION. 1116 00:40:45,279 --> 00:40:46,947 JANUARY 6TH THE ELECTORAL VOTES 1117 00:40:46,947 --> 00:40:51,118 WILL BE COUNTED IN A JOINT 1118 00:40:51,118 --> 00:40:52,553 SESSION. 1119 00:40:52,553 --> 00:40:53,954 PRESIDENT TRUMP WILL BE SWORN IN 1120 00:40:53,954 --> 00:40:56,490 ON JANUARY 20TH, AND THEN 1121 00:40:56,490 --> 00:40:58,159 JANUARY, THE CONFIRMATION 1122 00:40:58,159 --> 00:40:59,927 PROCESS FOR TRUMP NOMINEES WILL 1123 00:40:59,927 --> 00:41:02,296 REALLY GET GOING, TYPICALLY THE 1124 00:41:02,296 --> 00:41:04,632 SENATE WILL START WITH NATIONAL 1125 00:41:04,632 --> 00:41:05,833 SECURITY RELATED NOMINATIONS, 1126 00:41:05,833 --> 00:41:07,034 BUT THEN THEY WILL MOVE TO THE 1127 00:41:07,034 --> 00:41:10,104 REST OF THE CABINET, AND THEN 1128 00:41:10,104 --> 00:41:12,072 THE TRUMP ADMINISTRATION WILL BE 1129 00:41:12,072 --> 00:41:13,941 WORKING ON ITS FIRST 100 DAYS 1130 00:41:13,941 --> 00:41:14,375 AGENDA. 1131 00:41:14,375 --> 00:41:17,144 SO FAR WE'VE BEEN HEARING FROM 1132 00:41:17,144 --> 00:41:20,114 BOTH CONGRESSIONAL LEADERS AND 1133 00:41:20,114 --> 00:41:22,516 THE TRUMP ADMINISTRATION THAT 1134 00:41:22,516 --> 00:41:24,218 THEIR GOALS FOR THE FIRST 100 1135 00:41:24,218 --> 00:41:26,353 DAYS WILL REVOLVE AROUND TAX 1136 00:41:26,353 --> 00:41:27,221 LEGISLATION, BUDGET 1137 00:41:27,221 --> 00:41:28,222 RECONCILIATION, AND BORDER 1138 00:41:28,222 --> 00:41:34,662 POLICY. 1139 00:41:34,662 --> 00:41:36,297 I DID JUST WANT TO GO OVER VERY 1140 00:41:36,297 --> 00:41:37,965 QUICKLY THE PROCESS FOR NIH 1141 00:41:37,965 --> 00:41:39,500 DIRECTOR CONFIRMATION. 1142 00:41:39,500 --> 00:41:41,902 ONCE THE PRESIDENT ANNOUNCES A 1143 00:41:41,902 --> 00:41:45,973 NOMINATION, THE NOMINEE WILL BE 1144 00:41:45,973 --> 00:41:47,074 MEETING WITH A NUMBER OF 1145 00:41:47,074 --> 00:41:51,111 MEMBERS, THEY WILL THEN HAVE A 1146 00:41:51,111 --> 00:41:53,180 COMMITTEE HEARING THIS WILL BE 1147 00:41:53,180 --> 00:41:55,182 IN FRONT OF OUR AUTHORIZING 1148 00:41:55,182 --> 00:41:57,051 COMMITTEE ON THE SENATE SIDE, 1149 00:41:57,051 --> 00:41:58,252 HEALTH, EDUCATION AND PENSIONS. 1150 00:41:58,252 --> 00:41:59,386 THERE WILL NEED TO BE A 1151 00:41:59,386 --> 00:42:00,921 COMMITTEE VOTE REPORTING OUT THE 1152 00:42:00,921 --> 00:42:01,922 NOMINEE AND THEN THAT WILL NEED 1153 00:42:01,922 --> 00:42:04,658 TO FOLLOW WITH A FULL SENATE 1154 00:42:04,658 --> 00:42:11,765 CONFIRMATION VOTE ON THE FLOOR. 1155 00:42:11,765 --> 00:42:12,900 AND I WILL LEAVE IT THERE. 1156 00:42:12,900 --> 00:42:17,238 THANK YOU. 1157 00:42:17,238 --> 00:42:17,872 >> OKAY. 1158 00:42:17,872 --> 00:42:18,405 THANK YOU VERY MUCH. 1159 00:42:18,405 --> 00:42:20,074 I THINK WE GO BACK TO THE REST 1160 00:42:20,074 --> 00:42:21,308 OF THE SLIDE DECK. 1161 00:42:21,308 --> 00:42:24,445 I HAVE A FEW MORE COMMENTS TO 1162 00:42:24,445 --> 00:42:25,312 MAKE AND THEN WE'LL TAKE 1163 00:42:25,312 --> 00:42:26,981 QUESTIONS. 1164 00:42:26,981 --> 00:42:30,084 THE NEXT SECTION IS ABOUT 1165 00:42:30,084 --> 00:42:31,051 POLICIES. 1166 00:42:31,051 --> 00:42:34,021 POLICIES AND, AS YOU KNOW, 1167 00:42:34,021 --> 00:42:37,992 POLICYPOLICY'S CRITICALLY IMPORT 1168 00:42:37,992 --> 00:42:40,027 ROLE HERE AT NIH TO SET THESE 1169 00:42:40,027 --> 00:42:41,595 STRUCTURES THAT ALLOW THE ENTIRE 1170 00:42:41,595 --> 00:42:43,230 ENTERPRISE TO FUNCTION 1171 00:42:43,230 --> 00:42:43,497 OPTIMALLY. 1172 00:42:43,497 --> 00:42:44,865 LET ME START WITH THE FIRST ONE. 1173 00:42:44,865 --> 00:42:45,833 YOU'LL HEAR MORE ABOUT THIS 1174 00:42:45,833 --> 00:42:47,434 LATER THIS AFTERNOON, BUT I'LL 1175 00:42:47,434 --> 00:42:49,603 MENTION RIGHT NOW THAT WE'VE 1176 00:42:49,603 --> 00:42:50,271 RESTARTED THE SCIENTIFIC 1177 00:42:50,271 --> 00:42:53,607 MANAGEMENT REVIEW BOARD AND HELD 1178 00:42:53,607 --> 00:42:54,441 THE FIRST MEETING OF THIS BOARD 1179 00:42:54,441 --> 00:42:55,576 ON NOVEMBER 12TH. 1180 00:42:55,576 --> 00:42:57,311 THIS BOARD ADVISES AND MAKES 1181 00:42:57,311 --> 00:42:59,780 RECOMMENDATIONS TO THE HHS 1182 00:42:59,780 --> 00:43:00,948 SECRETARY AND TO THE NIH 1183 00:43:00,948 --> 00:43:04,018 DIRECTOR ON THE USE OF OUR 1184 00:43:04,018 --> 00:43:06,086 ORGANIZATIONAL AUTHORITIES TO 1185 00:43:06,086 --> 00:43:08,522 ESTABLISH OR ABOLISH INSTITUTES 1186 00:43:08,522 --> 00:43:10,624 AND CENTERS AT NIH, TO ORGANIZE 1187 00:43:10,624 --> 00:43:12,793 OFFICES WITHIN THE OFFICE OF THE 1188 00:43:12,793 --> 00:43:14,995 DIRECTOR, AND TO ORGANIZE BOTH 1189 00:43:14,995 --> 00:43:16,764 WITHIN AND ACROSS ALL OF THE 1190 00:43:16,764 --> 00:43:18,499 INSTITUTES AND CENTERS OF NIH. 1191 00:43:18,499 --> 00:43:20,901 WE HAVE NOW REQUESTED THAT THE 1192 00:43:20,901 --> 00:43:24,004 NEWLY CONVENED SMRB EVALUATE THE 1193 00:43:24,004 --> 00:43:26,540 CURRENT STRUCTURE OF NIH, AND 1194 00:43:26,540 --> 00:43:27,508 PROPOSE CHANGES THAT WILL 1195 00:43:27,508 --> 00:43:29,944 ENHANCE THE ABILITY OF THE 1196 00:43:29,944 --> 00:43:34,415 AGENCY TO VILI FUA FULFILL ITS . 1197 00:43:34,415 --> 00:43:36,216 THE SMRB WILL INCLUDE A NUMBER 1198 00:43:36,216 --> 00:43:38,953 OF FACTORS INCLUDING RECENT 1199 00:43:38,953 --> 00:43:39,820 PROPOSALS FROM BOTH THE HOUSE 1200 00:43:39,820 --> 00:43:42,189 AND THE SENATE. 1201 00:43:42,189 --> 00:43:43,023 NOW SPECIFIC POLICY UPDATES 1202 00:43:43,023 --> 00:43:44,458 STARTING WITH THE SCIENTIFIC 1203 00:43:44,458 --> 00:43:44,992 INTEGRITY POLICY. 1204 00:43:44,992 --> 00:43:49,596 LET ME JUST START HERE BY 1205 00:43:49,596 --> 00:43:52,900 THANKING DR. LYRIC JORGENSON WHO 1206 00:43:52,900 --> 00:43:54,335 IS THE LEAD FOR ALL OF OUR 1207 00:43:54,335 --> 00:43:55,769 POLICY OPERATIONS HERE AND ALSO 1208 00:43:55,769 --> 00:43:56,971 DR. LARRY TABAK, WHO HAS REALLY 1209 00:43:56,971 --> 00:43:59,406 BEEN A CRITICAL PARTNER IN 1210 00:43:59,406 --> 00:44:01,375 DEVELOPING THE POLICIES YOU'LL 1211 00:44:01,375 --> 00:44:04,111 HEAR ABOUT TODAY. 1212 00:44:04,111 --> 00:44:06,313 SCIENTIFIC INTEGRITY POLICY, 1213 00:44:06,313 --> 00:44:09,316 ENSURING THE HIGHEST LEVEL OF 1214 00:44:09,316 --> 00:44:12,486 SCIENTIFIC INTEGRITY, PUBLIC 1215 00:44:12,486 --> 00:44:14,221 ACCOUNTABILITY, AND SOCIAL 1216 00:44:14,221 --> 00:44:15,155 RESPONSIBILITY IN THE CONDUCT OF 1217 00:44:15,155 --> 00:44:16,991 SCIENCE IS PARAMOUNT TO 1218 00:44:16,991 --> 00:44:17,558 CULTIVATING TRUST. 1219 00:44:17,558 --> 00:44:19,493 IN OCTOBER WE PUBLISHED OUR 1220 00:44:19,493 --> 00:44:21,462 SCIENTIFIC INTEGRITY POLICY, 1221 00:44:21,462 --> 00:44:23,797 WHICH WILL GO INTO EFFECT ON 1222 00:44:23,797 --> 00:44:26,100 DECEMBER 30TH, 2024. 1223 00:44:26,100 --> 00:44:28,302 THE POLICY REAFFIRMS OUR 1224 00:44:28,302 --> 00:44:29,837 COMMITMENT TO SCIENTIFIC 1225 00:44:29,837 --> 00:44:32,172 INTEGRITY AND TRANSPARENCY. 1226 00:44:32,172 --> 00:44:35,109 IT OUTLINES ALREADY EXISTING 1227 00:44:35,109 --> 00:44:38,812 PROCEDURES AT NIH THAT PROMOTE 1228 00:44:38,812 --> 00:44:40,381 SCIENTIFIC INTEGRITY, WHILE 1229 00:44:40,381 --> 00:44:43,117 INTRODUCING SOME NEW ROLES AND 1230 00:44:43,117 --> 00:44:45,185 RESPONSIBILITIES TO FURTHER 1231 00:44:45,185 --> 00:44:46,520 STRENGTHEN THESE PRACTICES 1232 00:44:46,520 --> 00:44:48,622 ACROSS NIH. 1233 00:44:48,622 --> 00:44:51,458 THIS POLICY ALIGNS WITH THE 1234 00:44:51,458 --> 00:44:51,959 OVERALL HEALTH AND HUMAN 1235 00:44:51,959 --> 00:44:53,694 SERVICES SCIENTIFIC INTEGRITY 1236 00:44:53,694 --> 00:44:55,529 POLICY, BOTH OF WHICH WERE 1237 00:44:55,529 --> 00:44:59,033 INFORMED BY A 2021 PRESIDENTIAL 1238 00:44:59,033 --> 00:45:01,101 MEMORANDUM ON RESTORING TRUST IN 1239 00:45:01,101 --> 00:45:03,203 GOVERNMENT THROUGH SCIENTIFIC 1240 00:45:03,203 --> 00:45:06,173 INTEGRITY AND EVIDENCE-BASED 1241 00:45:06,173 --> 00:45:07,041 POLICYMAKING. 1242 00:45:07,041 --> 00:45:09,510 AND ALSO GUIDANCE FROM THE 1243 00:45:09,510 --> 00:45:11,045 NATIONAL SCIENCE AND TECHNOLOGY 1244 00:45:11,045 --> 00:45:12,246 COUNCIL. 1245 00:45:12,246 --> 00:45:14,648 THE POLICY AIMS TO ENSURE THAT 1246 00:45:14,648 --> 00:45:16,950 SCIENTIFIC FINDINGS ARE 1247 00:45:16,950 --> 00:45:18,952 OBJECTIVE, CREDIBLE, AND RED LEA 1248 00:45:18,952 --> 00:45:20,254 AVAILABLE TO THE PUBLIC, AND 1249 00:45:20,254 --> 00:45:22,556 THAT THE DEVELOPMENT AND 1250 00:45:22,556 --> 00:45:24,525 IMPLEMENTATION OF POLICIES AND 1251 00:45:24,525 --> 00:45:27,094 PROGRAMS IS TRANSPARENT, 1252 00:45:27,094 --> 00:45:28,829 ACCOUNTABLE AND ALSO 1253 00:45:28,829 --> 00:45:29,763 EVIDENCE-BASED. 1254 00:45:29,763 --> 00:45:31,598 THE POLICY OUTLINES EXISTING 1255 00:45:31,598 --> 00:45:32,699 PROCEDURES AND INTRODUCES NEW 1256 00:45:32,699 --> 00:45:35,969 ROLES AND RESPONSIBILITIES. 1257 00:45:35,969 --> 00:45:39,373 SUCH AS THE NIH CHIEF SCIENTIST. 1258 00:45:39,373 --> 00:45:40,607 CURRENTLY THIS ROLE IS HELD BY 1259 00:45:40,607 --> 00:45:45,946 THE NIH PRINCI PRINCIPAL DEPUTY 1260 00:45:45,946 --> 00:45:47,147 DIRECTOR, DR. LARRY TABAK, 1261 00:45:47,147 --> 00:45:50,284 PROVIDES OVERSIGHT OF ALL NIH 1262 00:45:50,284 --> 00:45:50,951 SCIENTIFIC INTEGRITY POLICIES 1263 00:45:50,951 --> 00:45:51,885 AND PROCEDURES. 1264 00:45:51,885 --> 00:45:57,157 THE SCIENTIFIC INTEGRITY 1265 00:45:57,157 --> 00:46:00,627 OFFICIAL, THIS ROLE RESIDES IN 1266 00:46:00,627 --> 00:46:01,662 THE ASSOCIATE DIRECTOR FOR 1267 00:46:01,662 --> 00:46:03,630 SCIENCE POLICY, DR. LYRIC 1268 00:46:03,630 --> 00:46:04,731 JORGENSON OVERSEES THE 1269 00:46:04,731 --> 00:46:06,066 IMPLEMENTATION AND ITERATIVE 1270 00:46:06,066 --> 00:46:07,401 IMPROVEMENT OF NIH POLICIES AND 1271 00:46:07,401 --> 00:46:08,602 PROCEDURES THAT PROMOTE 1272 00:46:08,602 --> 00:46:09,470 SCIENTIFIC INTEGRITY, AND 1273 00:46:09,470 --> 00:46:10,838 FINALLY A SCIENTIFIC INTEGRITY 1274 00:46:10,838 --> 00:46:13,640 COUNCIL THAT COMPRISES CAREER 1275 00:46:13,640 --> 00:46:14,975 EMPLOYEES WILL ASSIST THE 1276 00:46:14,975 --> 00:46:17,845 SCIENTIFIC INTEGRITY OFFICIAL IN 1277 00:46:17,845 --> 00:46:19,379 ITERATIVE REVIEW, POLICY 1278 00:46:19,379 --> 00:46:20,481 DEVELOPMENT AND PRIORITY 1279 00:46:20,481 --> 00:46:23,217 SETTING, TO ENSURE THAT THE 1280 00:46:23,217 --> 00:46:25,119 EXISTING POLICIES AND PROCEDURES 1281 00:46:25,119 --> 00:46:27,621 ARE ALWAYS RESPONSIVE TO ISSUES 1282 00:46:27,621 --> 00:46:30,491 THAT ARISE IN THE SCIENTIFIC 1283 00:46:30,491 --> 00:46:31,058 INTEGRITY SPACE. 1284 00:46:31,058 --> 00:46:33,160 LET ME JUST EMPHASIZE AGAIN, 1285 00:46:33,160 --> 00:46:34,995 SCIENTIFIC INTEGRITY IS A CORE 1286 00:46:34,995 --> 00:46:38,565 OF WHAT WE DO AT NIH BUT LIKE 1287 00:46:38,565 --> 00:46:40,834 ANYTHING IN THE POLICY ARENA, 1288 00:46:40,834 --> 00:46:42,603 CONTINUAL ATTENTION AND REFRESH 1289 00:46:42,603 --> 00:46:47,841 IS ALWAYS IMPORTANT. 1290 00:46:47,841 --> 00:46:50,177 NIH HAS LONG CHAMPIONED ROBUST 1291 00:46:50,177 --> 00:46:51,778 OVERSIGHT TO RESPONSIBLY FUEL 1292 00:46:51,778 --> 00:46:53,013 KNOWLEDGE IN SUPPORT OF 1293 00:46:53,013 --> 00:46:56,683 IMPROVING HUMAN HEALTH. 1294 00:46:56,683 --> 00:46:58,952 A NEW POLICY FOR OVERSIGHT OF 1295 00:46:58,952 --> 00:47:01,855 DUAL USE RESEARCH OF CONCERN AND 1296 00:47:01,855 --> 00:47:04,291 PATHOGENS WITH ENHANCED PANDEMIC 1297 00:47:04,291 --> 00:47:05,859 POTENTIAL. 1298 00:47:05,859 --> 00:47:08,162 WAS ISSUED ON MAY 6, 1299 00:47:08,162 --> 00:47:11,465 2024, AND GOES INTO EFFECT ON 1300 00:47:11,465 --> 00:47:15,202 MAY 6, 2025. 1301 00:47:15,202 --> 00:47:16,470 THIS POLICY, WHICH NIH IS NOW IN 1302 00:47:16,470 --> 00:47:19,239 THE PROCESS OF IMPLEMENTING, 1303 00:47:19,239 --> 00:47:20,240 STRENGTHENS PAST OVERSIGHT OF 1304 00:47:20,240 --> 00:47:24,077 THIS TYPE OF RESEARCH AND MERGES 1305 00:47:24,077 --> 00:47:25,479 EXISTING BIOSECURITY POLICIES TO 1306 00:47:25,479 --> 00:47:27,948 UNIFY AND HARMONIZE APPROACHES 1307 00:47:27,948 --> 00:47:30,450 FOR PROMOTING THE BENEFITS OF 1308 00:47:30,450 --> 00:47:32,986 RESEARCH WHILE MITIGATING THE 1309 00:47:32,986 --> 00:47:33,954 RISKS. 1310 00:47:33,954 --> 00:47:36,490 THE POLICY FORECASTED NEEDS 1311 00:47:36,490 --> 00:47:37,824 ASSOCIATED WITH INCREASING 1312 00:47:37,824 --> 00:47:40,227 EVOLUTION AND USE OF NEW 1313 00:47:40,227 --> 00:47:42,129 COMPUTATIONAL MODELS AND 1314 00:47:42,129 --> 00:47:43,764 APPROACHES INCLUDING THE USE OF 1315 00:47:43,764 --> 00:47:45,465 ARTIFICIAL INTELLIGENCE. 1316 00:47:45,465 --> 00:47:48,368 LOOKING AHEAD, WE MUST ALSO 1317 00:47:48,368 --> 00:47:49,736 CONTINUE TO STRENGTHEN AND 1318 00:47:49,736 --> 00:47:52,005 EVOLVE AS WE CONSIDER HOW TO 1319 00:47:52,005 --> 00:47:55,075 BEST SAFEGUARD INSILICO RESEARCH 1320 00:47:55,075 --> 00:47:56,276 WITH POTENTIAL DUAL USE 1321 00:47:56,276 --> 00:47:58,245 CONCERNS. 1322 00:47:58,245 --> 00:48:00,147 AT THE NOVEMBER 21ST MEETING OF 1323 00:48:00,147 --> 00:48:01,181 THE NATIONAL SCIENCE ADVISORY 1324 00:48:01,181 --> 00:48:04,952 BOARD FOR BIOSECURITY, NIH PUT 1325 00:48:04,952 --> 00:48:08,922 FOOFORWARD A CHARGE TO THE BOARO 1326 00:48:08,922 --> 00:48:10,023 RECOMMEND STRATEGIES FOR 1327 00:48:10,023 --> 00:48:11,358 IDENTIFYING AND OPTIONS FOR 1328 00:48:11,358 --> 00:48:12,826 MITIGATING POTENTIAL RISKS 1329 00:48:12,826 --> 00:48:15,295 ASSOCIATED WITH INSILICO 1330 00:48:15,295 --> 00:48:17,264 RESEARCH, COMPUTATIONAL MODELS, 1331 00:48:17,264 --> 00:48:19,866 INCLUDING THOSE DRIVEN BY A.I., 1332 00:48:19,866 --> 00:48:22,135 AND DATASETS IN LIFE SCIENCE 1333 00:48:22,135 --> 00:48:24,638 SETTINGS. 1334 00:48:24,638 --> 00:48:26,106 ALSO, OUTLINE OPTIONS FOR 1335 00:48:26,106 --> 00:48:27,841 PROMOTING RESPONSIBLE INNOVATION 1336 00:48:27,841 --> 00:48:29,710 WHILE MITIGATING POTENTIAL RISK, 1337 00:48:29,710 --> 00:48:33,046 AND FINALLY, EXPLORE OPTIONS FOR 1338 00:48:33,046 --> 00:48:34,648 PROMOTING THE HIGHEST STANDARDS 1339 00:48:34,648 --> 00:48:38,285 OF TRA TRANSPARENCY WHILE 1340 00:48:38,285 --> 00:48:39,186 SAFEGUARDING RESEARCH AND 1341 00:48:39,186 --> 00:48:39,987 RESEARCH OUTPUTS. 1342 00:48:39,987 --> 00:48:43,590 WE EXPECT TO RECEIVE 1343 00:48:43,590 --> 00:48:45,826 RECOMMENDATIONS FROM THE 1344 00:48:45,826 --> 00:48:48,362 NATIONAL SCIENCE ADVISORY BOARD 1345 00:48:48,362 --> 00:48:49,496 FOR BIOSECURITY IN 1346 00:48:49,496 --> 00:48:52,466 DECEMBER 2025. 1347 00:48:52,466 --> 00:48:54,768 WE MUST BRING THE BENEFITS OF 1348 00:48:54,768 --> 00:48:56,503 RESEARCH TO ALL AMERICANS 1349 00:48:56,503 --> 00:48:58,872 REGARDLESS OF WHERE THEY LIVE. 1350 00:48:58,872 --> 00:49:01,041 WE KNOW THAT MEANINGFUL 1351 00:49:01,041 --> 00:49:06,079 ENGAGEMENT BETWEEN COMMUNITIES 1352 00:49:06,079 --> 00:49:07,214 AND RESEARCHERS IS ESSENTIAL TO 1353 00:49:07,214 --> 00:49:09,516 LEAD TO HIGHER QUALITY SCIENCE, 1354 00:49:09,516 --> 00:49:11,585 ESSENTIAL TO ENGENDER TRUST IN 1355 00:49:11,585 --> 00:49:14,054 SCIENCE BY ADDRESSING THE NEEDS 1356 00:49:14,054 --> 00:49:16,890 OF DIFFERENT COMMUNITIES, AND 1357 00:49:16,890 --> 00:49:18,425 FOCUSES RESEARCH ON THE ISSUES 1358 00:49:18,425 --> 00:49:19,726 MOST IMPORTANT TO DIVERSE 1359 00:49:19,726 --> 00:49:22,429 COMMUNITIES. 1360 00:49:22,429 --> 00:49:24,197 WITHOUT THIS, WE RUN THE RISK OF 1361 00:49:24,197 --> 00:49:25,599 ONLY SERVING THE FEW. 1362 00:49:25,599 --> 00:49:29,102 AND WE ARE HERE TO SERVE 1363 00:49:29,102 --> 00:49:29,469 EVERYONE. 1364 00:49:29,469 --> 00:49:30,871 WE TURN TO THE NOVEL AND 1365 00:49:30,871 --> 00:49:33,407 EXCEPTIONAL TECHNOLOGY AND 1366 00:49:33,407 --> 00:49:34,608 RESEARCH ADVISORY COMMITTEE, 1367 00:49:34,608 --> 00:49:39,446 BETTER KNOWN AS NEXTTRAK, TO 1368 00:49:39,446 --> 00:49:41,948 ASSIST NIH IN ESTABLISHING AN 1369 00:49:41,948 --> 00:49:43,750 AGENCY-WIDE VISION AND FRAMEWORK 1370 00:49:43,750 --> 00:49:44,618 FOR ROUTINELY INCLUDING PUBLIC 1371 00:49:44,618 --> 00:49:46,586 VOICES THROUGHOUT THE CLINICAL 1372 00:49:46,586 --> 00:49:50,090 RESEARCH LIFECYCLE. 1373 00:49:50,090 --> 00:49:52,659 THE NEXTTRAK PROVIDES 1374 00:49:52,659 --> 00:49:53,627 RECOMMENDATIONS TO THE NIH 1375 00:49:53,627 --> 00:49:54,428 DIRECTOR AS WELL AS A PUBLIC 1376 00:49:54,428 --> 00:49:56,930 FORUM FOR THE DISCUSSION OF THE 1377 00:49:56,930 --> 00:49:58,031 SCIENTIFIC, SAFETY AND ETHICAL 1378 00:49:58,031 --> 00:50:02,536 ISSUES ASSOCIATED WITH PRESENT 1379 00:50:02,536 --> 00:50:03,937 AND EMERGING BIOTECHNOLOGIES. 1380 00:50:03,937 --> 00:50:06,073 YOU'LL HEAR MORE ABOUT THIS FROM 1381 00:50:06,073 --> 00:50:07,040 LYRIC JORGENSON LATER TODAY, BUT 1382 00:50:07,040 --> 00:50:10,677 I WANTED TO BRIEFLY MENTION ONE 1383 00:50:10,677 --> 00:50:14,081 WORKING GROUP OF NEXTTRAK, THE 1384 00:50:14,081 --> 00:50:15,615 ENGAGE WORKING GROUP, AND LET 1385 00:50:15,615 --> 00:50:16,850 YOU KNOW WHY IT'S SO IMPORTANT. 1386 00:50:16,850 --> 00:50:19,953 I SEE TREMENDOUS VALUE IN 1387 00:50:19,953 --> 00:50:23,990 PROVIDING INSTITUTIONS, 1388 00:50:23,990 --> 00:50:26,059 RESEARCHERS, AND COMMUNITIES 1389 00:50:26,059 --> 00:50:28,261 EVERYWHERE, A ROTE MAP FOR HOW 1390 00:50:28,261 --> 00:50:29,930 TO ENGAGE BOTH WITH EACH OTHER 1391 00:50:29,930 --> 00:50:32,999 AND WITH US TO BRING THE VISION 1392 00:50:32,999 --> 00:50:37,804 OF PARTICIPANTS IN AS PARTNERS 1393 00:50:37,804 --> 00:50:39,406 AND MAKE THIS A REALITY, NOT 1394 00:50:39,406 --> 00:50:40,707 SOMETHING THAT EXISTS ONLY IN 1395 00:50:40,707 --> 00:50:42,476 THEORY. 1396 00:50:42,476 --> 00:50:45,479 IT'S ONE THING TO HAVE GOOD 1397 00:50:45,479 --> 00:50:45,779 INTENTIONS. 1398 00:50:45,779 --> 00:50:46,546 IT'S ABSOLUTELY CRITICAL THAT WE 1399 00:50:46,546 --> 00:50:48,315 ARE ABLE TO EXECUTE. 1400 00:50:48,315 --> 00:50:53,620 AS SUCH, WE'VE ASKED NETRAC TO 1401 00:50:53,620 --> 00:50:54,921 ESTABLISH A FRAMEWORK FOR PUBLIC 1402 00:50:54,921 --> 00:50:57,224 ENGAGEMENT THAT INCLUDES 1403 00:50:57,224 --> 00:50:57,991 APPROACHES THAT ARE APPROPRIATE 1404 00:50:57,991 --> 00:50:59,860 FOR THE BREADTH AND DIVERSITY OF 1405 00:50:59,860 --> 00:51:02,062 NIH FUNDED CLINICAL RESEARCH 1406 00:51:02,062 --> 00:51:02,963 STUDIES. 1407 00:51:02,963 --> 00:51:04,364 ADDITIONALLY TO SUPPORT THESE 1408 00:51:04,364 --> 00:51:06,600 EFFORTS WITHIN NIH, WE'VE 1409 00:51:06,600 --> 00:51:08,568 CONVENED INTERNAL NIH EXPERTS 1410 00:51:08,568 --> 00:51:11,204 COMMITTED TO EMBEDDING COMMUNITY 1411 00:51:11,204 --> 00:51:15,409 ENGAGEMENT IN NIH PROGRAMS TO 1412 00:51:15,409 --> 00:51:16,510 CENTRALLY ADDRESS ISSUES AND 1413 00:51:16,510 --> 00:51:17,911 SOLUTIONS FOR IMPROVING 1414 00:51:17,911 --> 00:51:19,546 MEANINGFUL PUBLIC ENGAGEMENT 1415 00:51:19,546 --> 00:51:23,483 ACROSS THE AGENCY. 1416 00:51:23,483 --> 00:51:24,985 NEXT THE PUBLIC ACCESS POLICY. 1417 00:51:24,985 --> 00:51:26,853 NIH HAS A LONG HISTORY OF 1418 00:51:26,853 --> 00:51:28,422 PROVIDING PUBLIC ACCESS TO 1419 00:51:28,422 --> 00:51:29,423 SCHOLARLY PUBLICATIONS, 1420 00:51:29,423 --> 00:51:32,826 RESULTING FROM THE RESEARCH IT 1421 00:51:32,826 --> 00:51:34,461 SUPPORTS. 1422 00:51:34,461 --> 00:51:35,896 OUR 2028 PUBLIC ACCESS POLICY 1423 00:51:35,896 --> 00:51:40,500 HAS RESULTED IN OVER 1.5 MILLION 1424 00:51:40,500 --> 00:51:41,735 ARTICLES FROM NIH SUPPORTED 1425 00:51:41,735 --> 00:51:43,069 RESEARCH BEING MADE FREELY 1426 00:51:43,069 --> 00:51:44,838 AVAILABLE ON THE NATIONAL 1427 00:51:44,838 --> 00:51:46,673 LIBRARY OF MEDICINE HOSTED 1428 00:51:46,673 --> 00:51:49,743 PUBMED CENTRAL. 1429 00:51:49,743 --> 00:51:53,313 HOWEVER, THIS POLICY IMPLEMENTED 1430 00:51:53,313 --> 00:51:55,482 IN 2028 ALLOWS FOR AN EMBARGO OF 1431 00:51:55,482 --> 00:51:58,552 UP TO 12 MONTHS BEFORE THESE 1432 00:51:58,552 --> 00:52:00,053 ARTICLES NEED TO BE MADE FREELY 1433 00:52:00,053 --> 00:52:01,021 AVAILABLE TO THE PUBLIC. 1434 00:52:01,021 --> 00:52:03,757 WELL, THIS SUMMER, WE RELEASED A 1435 00:52:03,757 --> 00:52:05,292 DRAFT PUBLIC ACCESS POLICY THAT 1436 00:52:05,292 --> 00:52:07,294 PROPOSES REMOVING THIS EMBARGO 1437 00:52:07,294 --> 00:52:11,698 PERIOD TO ALLOW ENHANCED AND 1438 00:52:11,698 --> 00:52:12,566 MORE TIMELY ACCESS TO THE 1439 00:52:12,566 --> 00:52:13,600 RESULTS OF RESEARCH. 1440 00:52:13,600 --> 00:52:15,469 THIS DRAFT POLICY IS CONSISTENT 1441 00:52:15,469 --> 00:52:17,437 WITH THE GUIDANCE FROM A 2022 1442 00:52:17,437 --> 00:52:19,906 WHITE HOUSE OFFICE OF SCIENCE 1443 00:52:19,906 --> 00:52:21,408 AND TECHNOLOGY POLICY 1444 00:52:21,408 --> 00:52:23,443 MEMORANDUM, APPLICABLE TO ALL 1445 00:52:23,443 --> 00:52:27,414 U.S. GOVERNMENT AGENCIES FUNDING 1446 00:52:27,414 --> 00:52:28,215 RESEARCH. 1447 00:52:28,215 --> 00:52:30,116 NIH RECEIVED 144 COMMENTS FROM A 1448 00:52:30,116 --> 00:52:31,751 VARIETY OF CONSTITUENCIES AND WE 1449 00:52:31,751 --> 00:52:32,919 REACHED OUT FOR INPUT ON THIS. 1450 00:52:32,919 --> 00:52:36,056 WE PUBLISHED THE COMPILED PUBLIC 1451 00:52:36,056 --> 00:52:38,158 COMMENTS ONLINE, AND I AM NOW -- 1452 00:52:38,158 --> 00:52:39,426 CAN NOW ANNOUNCE THAT THE 1453 00:52:39,426 --> 00:52:40,527 UPDATED PUBLIC ACCESS POLICY 1454 00:52:40,527 --> 00:52:42,395 WILL BE RELEASED BEFORE THE END 1455 00:52:42,395 --> 00:52:47,167 OF THIS CALENDAR YEAR. 1456 00:52:47,167 --> 00:52:48,301 WE'VE DISCUSSED THIS ONE BEFORE. 1457 00:52:48,301 --> 00:52:49,936 HERE'S A FOLLOW-UP. 1458 00:52:49,936 --> 00:52:51,805 THE ACD WORKING GROUP ON 1459 00:52:51,805 --> 00:52:54,207 DIVERSITY'S SUBGROUP ON 1460 00:52:54,207 --> 00:52:55,809 INDIVIDUALS WITH DISABILITIES 1461 00:52:55,809 --> 00:52:58,111 RECOMMENDED THAT WE REMOVE THE 1462 00:52:58,111 --> 00:53:03,016 LANGUAGE OF "REDUCING 1463 00:53:03,016 --> 00:53:06,186 DISABILITY" FROM THE NIH MISSION 1464 00:53:06,186 --> 00:53:07,220 STATEMENT. 1465 00:53:07,220 --> 00:53:08,655 NIH ISSUES A REQUEST FOR 1466 00:53:08,655 --> 00:53:09,589 INFORMATION INVITING COMMENTS 1467 00:53:09,589 --> 00:53:11,825 AND SUGGESTIONS ON UPDATING OUR 1468 00:53:11,825 --> 00:53:14,160 MISSION STATEMENT IN THIS WAY. 1469 00:53:14,160 --> 00:53:15,795 BEING RESPONSIVE TO OUR ACD 1470 00:53:15,795 --> 00:53:17,797 WORKING GROUP. 1471 00:53:17,797 --> 00:53:22,836 IN OCTOBER, WE POSTED A PUBLIC 1472 00:53:22,836 --> 00:53:23,870 REPORT ON THIS REQUEST FOR 1473 00:53:23,870 --> 00:53:25,505 INFORMATION TO THE NIH WEBSITE. 1474 00:53:25,505 --> 00:53:28,575 THE REPORT NOTES THAT WE 1475 00:53:28,575 --> 00:53:31,511 RECEIVED VERY STRONG OPPOSING 1476 00:53:31,511 --> 00:53:33,747 VIEWS IN RESPONSE TO THE RFI, 1477 00:53:33,747 --> 00:53:35,181 AND THAT THESE INDICATE THAT WE 1478 00:53:35,181 --> 00:53:37,384 NEED MORE INPUT TO BETTER 1479 00:53:37,384 --> 00:53:39,286 UNDERSTAND ALL PERSPECTIVES 1480 00:53:39,286 --> 00:53:43,490 BEFORE TBIENL FIENL FINALIZING N 1481 00:53:43,490 --> 00:53:44,124 STATEMENT. 1482 00:53:44,124 --> 00:53:45,258 TRULY WE NEED OUR MISSION 1483 00:53:45,258 --> 00:53:46,359 STATEMENT TO BE RESPONSIVE TO 1484 00:53:46,359 --> 00:53:48,194 THE COMMUNITIES THAT WE SERVE, 1485 00:53:48,194 --> 00:53:51,097 AND IF THERE IS DEBATE 1486 00:53:51,097 --> 00:53:52,732 PARTICULARLY WITHIN THE 1487 00:53:52,732 --> 00:53:56,369 DISABILITY COMMUNITY, AS TO WHAT 1488 00:53:56,369 --> 00:53:57,637 THE RIGHT WAY TO PROCEED FOR 1489 00:53:57,637 --> 00:53:59,339 ISSUES RELEVANT TO THEM, WE NEED 1490 00:53:59,339 --> 00:54:00,440 TO START THIS OUT BETTER BEFORE 1491 00:54:00,440 --> 00:54:01,641 MOVING FORWARD. 1492 00:54:01,641 --> 00:54:03,243 SO THAT'S WHAT WE'RE DOING. 1493 00:54:03,243 --> 00:54:05,645 WE'VE HOSTED A SERIES OF VIRTUAL 1494 00:54:05,645 --> 00:54:07,948 COMMUNITY ROUNDTABLES AND A 1495 00:54:07,948 --> 00:54:11,818 VIRTUAL TOWN HALL TO TBEAR MOREE 1496 00:54:11,818 --> 00:54:13,353 COMMUNITY INPUT ON THE MISSION 1497 00:54:13,353 --> 00:54:15,055 STATEMENT, ALL OF IT, BUT MOST 1498 00:54:15,055 --> 00:54:16,656 SPECIFICALLY, TOPICS RELATED TO 1499 00:54:16,656 --> 00:54:18,291 THE DISABILITY RESEARCH 1500 00:54:18,291 --> 00:54:20,293 STRATEGIC PLAN DEVELOPMENT 1501 00:54:20,293 --> 00:54:21,194 PROCESS, AND YOU'LL HEAR MORE 1502 00:54:21,194 --> 00:54:22,529 ABOUT THIS IN A SESSION LATER 1503 00:54:22,529 --> 00:54:24,831 THIS AFTERNOON. 1504 00:54:24,831 --> 00:54:25,332 SO ADDITIONAL COMMUNITY 1505 00:54:25,332 --> 00:54:27,067 ENGAGEMENT IS PLANNED OVER THE 1506 00:54:27,067 --> 00:54:27,500 NEXT SEVERAL MONTHS. 1507 00:54:27,500 --> 00:54:29,469 WE REALLY LOOK FORWARD TO 1508 00:54:29,469 --> 00:54:32,339 WORKING WITH EVERYONE CONCERNED 1509 00:54:32,339 --> 00:54:37,611 ABOUT HOW BEST TO SERVE PEOPLE 1510 00:54:37,611 --> 00:54:38,445 WITH DISABILITIES THROUGH THIS 1511 00:54:38,445 --> 00:54:41,181 WORK. 1512 00:54:41,181 --> 00:54:41,915 OKAY. 1513 00:54:41,915 --> 00:54:45,452 YOU'VE HEARD THAT WE'RE HAVING 1514 00:54:45,452 --> 00:54:46,753 THE OUTLINES OF WHAT WE EXPECT 1515 00:54:46,753 --> 00:54:48,355 TO SEE WITH AN INCOMING 1516 00:54:48,355 --> 00:54:50,523 ADMINISTRATION AND A NEW 1517 00:54:50,523 --> 00:54:51,191 CONGRESS. 1518 00:54:51,191 --> 00:54:52,926 THE EXCEPTIONALLY TALENTED TEAM 1519 00:54:52,926 --> 00:54:54,728 AT NIH, ITS LEADERS, 1520 00:54:54,728 --> 00:54:56,262 ADMINISTRATIVE STAFF, 1521 00:54:56,262 --> 00:54:59,199 RESEARCHERS, TRAINEES, AND ALL 1522 00:54:59,199 --> 00:55:02,102 OF NIH'S AMAZING SUPPORT STAFF 1523 00:55:02,102 --> 00:55:03,970 ARE READY -- STAND READY TO 1524 00:55:03,970 --> 00:55:07,807 CONTINUE TO SERVE OUR NATION BY 1525 00:55:07,807 --> 00:55:09,142 DRIVING SCIENTIFIC ADVANCES THAT 1526 00:55:09,142 --> 00:55:11,811 IMPROVE HEALTH FOR EVERYONE. 1527 00:55:11,811 --> 00:55:13,546 TIMES OF TRANSITION ARE ALWAYS 1528 00:55:13,546 --> 00:55:15,315 CHALLENGING, BUT UNWAVERING 1529 00:55:15,315 --> 00:55:16,683 COMMITMENT TO OUR MISSION ON 1530 00:55:16,683 --> 00:55:18,618 BEHALF OF THE AMERICAN PEOPLE 1531 00:55:18,618 --> 00:55:22,455 GROUNDS EVERYBODY AT NIH. 1532 00:55:22,455 --> 00:55:23,456 NIH WILL CONTINUE TO BENEFIT 1533 00:55:23,456 --> 00:55:27,127 FROM SOLID CONGRESSIONAL SUPPORT 1534 00:55:27,127 --> 00:55:29,529 ON BOTH SIDES OF THE POLITICAL 1535 00:55:29,529 --> 00:55:31,264 DIVIDE, AS WELL AS SUPPORT FROM 1536 00:55:31,264 --> 00:55:34,834 PARTNERS IN ACADEMIA, INDUSTRY, 1537 00:55:34,834 --> 00:55:37,237 NON-PROFIT FOUNDATIONS, AND MOST 1538 00:55:37,237 --> 00:55:39,973 IMPORTANT OF ALL FROM PEOPLE IN 1539 00:55:39,973 --> 00:55:42,208 ALL WALKS OF LIFE THROUGHOUT THE 1540 00:55:42,208 --> 00:55:42,809 UNITED STATES. 1541 00:55:42,809 --> 00:55:44,811 SO WE ARE SURE THAT WE CAN ALL 1542 00:55:44,811 --> 00:55:47,781 MOVE FORWARD WITH OPTIMISM AND 1543 00:55:47,781 --> 00:55:49,783 ENERGY AS WE NAVIGATE CHANGES 1544 00:55:49,783 --> 00:55:50,583 BROUGHT ON BY A NEW 1545 00:55:50,583 --> 00:55:54,621 ADMINISTRATION. 1546 00:55:54,621 --> 00:55:54,954 OKAY. 1547 00:55:54,954 --> 00:55:56,356 NOW I WOULD LIKE TO TALK ABOUT 1548 00:55:56,356 --> 00:55:58,391 SOME UPDATES ON HOW WE FOLLOWED 1549 00:55:58,391 --> 00:56:00,827 UP ON WORKING GROUP 1550 00:56:00,827 --> 00:56:01,795 RECOMMENDATIONS FROM THIS 1551 00:56:01,795 --> 00:56:07,067 COMMITTEE. 1552 00:56:07,067 --> 00:56:08,535 AT OUR LAST MEETING IN JUNE I 1553 00:56:08,535 --> 00:56:09,736 DISCUSSED A NUMBER OF EFFORTS 1554 00:56:09,736 --> 00:56:11,271 NIH IS TAKING TO ADDRESS MANY 1555 00:56:11,271 --> 00:56:12,806 CHALLENGES AFFECTING THE 1556 00:56:12,806 --> 00:56:15,575 POSTDOCTORAL TRAINEE COMMUNITY, 1557 00:56:15,575 --> 00:56:18,745 INCLUDING INCREASED POSTDOCTORAL 1558 00:56:18,745 --> 00:56:21,147 STIPENDS AND CHILD CARE SUPPORT, 1559 00:56:21,147 --> 00:56:23,049 TIGHTENED THE DEFINITION OF WHAT 1560 00:56:23,049 --> 00:56:24,818 CONSTITUTES A POSTDOCTORAL 1561 00:56:24,818 --> 00:56:26,252 SCHOLAR, AND CLARIFIED MANY OF 1562 00:56:26,252 --> 00:56:29,022 THE POLICIES RELATED TO 1563 00:56:29,022 --> 00:56:29,823 POSTDOCTORAL TRAINING. 1564 00:56:29,823 --> 00:56:32,659 I WILL NOTE THAT AS OUR BUDGETS 1565 00:56:32,659 --> 00:56:34,294 ALLOW, NIH WILL CONTINUE TO MAKE 1566 00:56:34,294 --> 00:56:36,863 PROGRESS TOWARD INCREASING THE 1567 00:56:36,863 --> 00:56:38,298 NRSA'S POSTDOCTORAL SCHOLAR 1568 00:56:38,298 --> 00:56:40,967 STIPENDS TO ACHIEVE A MINIMUM OF 1569 00:56:40,967 --> 00:56:44,370 $70,000 A YEAR. 1570 00:56:44,370 --> 00:56:45,805 I ALSO MENTIONED THAT WE WERE 1571 00:56:45,805 --> 00:56:47,540 DEVELOPING IMPLEMENTATION TEAMS 1572 00:56:47,540 --> 00:56:49,075 AND FINALIZING ANOTHER REQUEST 1573 00:56:49,075 --> 00:56:52,545 FOR IMPLEMENTATION ON THIS TOPIC 1574 00:56:52,545 --> 00:56:53,947 THAT THE WORKING GROUP HERE GAVE 1575 00:56:53,947 --> 00:56:56,149 US A LOT OF DEEP ISSUES TO WORK 1576 00:56:56,149 --> 00:56:57,617 THROUGH AND WE CONTINUE DOING 1577 00:56:57,617 --> 00:56:58,184 THIS. 1578 00:56:58,184 --> 00:57:01,554 WE ISSUED A FOLLOW-UP RFI ON 1579 00:57:01,554 --> 00:57:03,823 JULY 25TH, AND IT CLOSED ON 1580 00:57:03,823 --> 00:57:04,491 OCTOBER 23RD, AND WE'RE IN THE 1581 00:57:04,491 --> 00:57:05,658 PROCESS OF REVIEWING THE 1582 00:57:05,658 --> 00:57:07,327 RESPONSES. 1583 00:57:07,327 --> 00:57:09,462 THIS REQUESTED INPUT FROM THE 1584 00:57:09,462 --> 00:57:12,098 BIOMEDICAL RESEARCH COMMUNITY ON 1585 00:57:12,098 --> 00:57:15,034 HOW WE CAN BEST IMPLEMENT THE 1586 00:57:15,034 --> 00:57:16,269 ADDITIONAL REQUIREMENTS OF THE 1587 00:57:16,269 --> 00:57:18,505 ACD WORKING GROUP. 1588 00:57:18,505 --> 00:57:21,775 ONE RECOMMENDATION NOTED THAT WE 1589 00:57:21,775 --> 00:57:24,277 SHOULD LIMIT THE TOTAL NUMB WE F 1590 00:57:24,277 --> 00:57:25,879 YEARS THAT A PERSON CAN BE 1591 00:57:25,879 --> 00:57:27,614 SUPPORTED BY NIH FUNDS IN A 1592 00:57:27,614 --> 00:57:28,915 POSTDOCTORAL POSITION TO NO MORE 1593 00:57:28,915 --> 00:57:30,450 THAN FIVE YEARS. 1594 00:57:30,450 --> 00:57:33,820 THE GOAL HERE IS TO FACILITATE A 1595 00:57:33,820 --> 00:57:35,688 FASTER TRANSITION OF OUR 1596 00:57:35,688 --> 00:57:37,857 TRAINEES TO INDEPENDENT RESEARCH 1597 00:57:37,857 --> 00:57:38,091 CAREERS. 1598 00:57:38,091 --> 00:57:40,994 THE RFA ASKED RESPONDENTS TO 1599 00:57:40,994 --> 00:57:44,497 CONSIDER FACTORS LIKE EXISTING 1600 00:57:44,497 --> 00:57:48,034 POLICIES THAT ARE OPERATIVE IN 1601 00:57:48,034 --> 00:57:53,740 OUR INSTITUTIONS AND OTHER 1602 00:57:53,740 --> 00:57:58,444 TRAINEE SUPPORT ORGANIZATIONS. 1603 00:57:58,444 --> 00:58:00,947 HOW WOULD A CHANGE IN POLICY -- 1604 00:58:00,947 --> 00:58:03,550 HOW THEIR POLICIES WOULD WORK IF 1605 00:58:03,550 --> 00:58:05,819 NIH WERE TO LIMIT TOTAL YEARS OF 1606 00:58:05,819 --> 00:58:08,121 NIH SUPPORTED FUNDING, AND WHAT 1607 00:58:08,121 --> 00:58:09,756 MECHANISMS COULD BE PUT INTO 1608 00:58:09,756 --> 00:58:11,925 PLACE TO BETTER SUPPORT 1609 00:58:11,925 --> 00:58:13,226 TRANSITION TO INDEPENDENT 1610 00:58:13,226 --> 00:58:13,760 CAREERS. 1611 00:58:13,760 --> 00:58:15,662 THE LAST THING WE WANT TO DO IS 1612 00:58:15,662 --> 00:58:16,996 TO INTRODUCE HARM BY ANY CHANGE 1613 00:58:16,996 --> 00:58:19,098 IN POLICIES THAT'S INTENDED TO 1614 00:58:19,098 --> 00:58:21,501 BE MORE SUPPORTIVE. 1615 00:58:21,501 --> 00:58:23,069 THE WORKING GROUP ALSO 1616 00:58:23,069 --> 00:58:27,140 RECOMMENDED THAT NIH REVISED THE 1617 00:58:27,140 --> 00:58:29,742 K99/R00 MECHANISM TO FOCUS ON 1618 00:58:29,742 --> 00:58:35,281 IDEAS AND CREATIVITY OVERJUST 1619 00:58:35,281 --> 00:58:37,584 PRODUCTIVITY EXPERIENCE AND TO 1620 00:58:37,584 --> 00:58:38,885 ADAPT THE REVIEW AND AWARD 1621 00:58:38,885 --> 00:58:39,385 PROCESSES. 1622 00:58:39,385 --> 00:58:42,021 THE KEY CONCERN HERE IS THAT 1623 00:58:42,021 --> 00:58:42,989 APPLICATIONS WHO ALREADY HAVE 1624 00:58:42,989 --> 00:58:44,624 MORE RESEARCH AND MORE 1625 00:58:44,624 --> 00:58:46,893 PUBLICATIONS CAN SCORE BETTER IN 1626 00:58:46,893 --> 00:58:48,428 REVIEW AND ARE MORE LIKELY TO BE 1627 00:58:48,428 --> 00:58:49,229 FUNDED. 1628 00:58:49,229 --> 00:58:52,832 THE RFA ASKED RESPONDENTS TO 1629 00:58:52,832 --> 00:58:56,803 CONSIDER CHALLENGES IN LIMITING 1630 00:58:56,803 --> 00:58:59,639 THE ELIGIBILITY TIME FRAME AND 1631 00:58:59,639 --> 00:59:01,307 WAYS THAT THE REVIEW CRITERIA 1632 00:59:01,307 --> 00:59:02,876 COULD BETTER EMPHASIZE NEW 1633 00:59:02,876 --> 00:59:03,810 CREATIVE IDEAS AND RESOURCES 1634 00:59:03,810 --> 00:59:08,014 THAT MIGHT BE NEEDED AGAIN TO BE 1635 00:59:08,014 --> 00:59:09,515 DEVELOPED TO AVOID ANY NEGATIVE 1636 00:59:09,515 --> 00:59:10,917 IMPACT OP TRAINEES WITH MORE OF 1637 00:59:10,917 --> 00:59:15,488 A FOCUS ON CREATIVITY AND IDEAS 1638 00:59:15,488 --> 00:59:17,423 RATHER THAN EXPERIENCES AND 1639 00:59:17,423 --> 00:59:18,424 RESOURCES. 1640 00:59:18,424 --> 00:59:19,525 ANOTHER RECOMMENDATION SAID THAT 1641 00:59:19,525 --> 00:59:21,060 NIH SHOULD PROMOTE TRAINING AND 1642 00:59:21,060 --> 00:59:25,531 PROFESSION DEVELOPMENT TO 1643 00:59:25,531 --> 00:59:26,633 POSTDOCTORAL SCHOLARS AND THEIR 1644 00:59:26,633 --> 00:59:26,900 MENTORS. 1645 00:59:26,900 --> 00:59:28,568 THESE ARE INTEGRAL ELEMENTS OF 1646 00:59:28,568 --> 00:59:30,837 THE POSTDOCTORAL EXPERIENCE BUT 1647 00:59:30,837 --> 00:59:33,539 WE UNDERSTAND THAT MANY 1648 00:59:33,539 --> 00:59:34,741 RESEARCHERS, MANY MENTORS FEEL 1649 00:59:34,741 --> 00:59:36,442 PRESSURE TO FOCUS SOLELY ON 1650 00:59:36,442 --> 00:59:37,777 RESEARCH AND DON'T HAVE TIME TO 1651 00:59:37,777 --> 00:59:39,312 PURSUE THESE OPPORTUNITIES. 1652 00:59:39,312 --> 00:59:41,948 SO THIS RFA ASKED APPLICATIONS 1653 00:59:41,948 --> 00:59:47,720 TO CONSIDER HOW THESE BECOME 1654 00:59:47,720 --> 00:59:49,589 INTEGRATED, MEANING POLICIES TO 1655 00:59:49,589 --> 00:59:50,223 PROMOTE PROFESSIONAL DEVELOPMENT 1656 00:59:50,223 --> 00:59:52,258 OF SCHOLARS AND THEIR MENTORS, 1657 00:59:52,258 --> 00:59:54,994 HOW CAN THESE POLICIES BE 1658 00:59:54,994 --> 00:59:57,163 INTEGRATED AND MEASURED 1659 00:59:57,163 --> 00:59:59,232 COMPONENTS OF THE POSTDOCTORAL 1660 00:59:59,232 --> 01:00:01,401 EXPERIENCE, AND TO ADDRESS 1661 01:00:01,401 --> 01:00:03,036 FACTORS SUCH AS HOW INSTITUTIONS 1662 01:00:03,036 --> 01:00:05,738 CAN ADDRESS BARRIERS TO 1663 01:00:05,738 --> 01:00:07,874 PARTICIPATION, AND OF COURSE HOW 1664 01:00:07,874 --> 01:00:09,242 MENTORS CAN BE BETTER SUPPORTED 1665 01:00:09,242 --> 01:00:10,743 AND MORE EFFECTIVE. 1666 01:00:10,743 --> 01:00:12,245 SO AS PART OF THIS EFFORT, ALL 1667 01:00:12,245 --> 01:00:14,013 OF THESE EFFORTS, THE NIH OFFICE 1668 01:00:14,013 --> 01:00:15,548 OF EXTRAMURAL RESEARCH HAS 1669 01:00:15,548 --> 01:00:17,483 RECENTLY IMPLEMENTED A NEW 1670 01:00:17,483 --> 01:00:20,954 REQUIREMENT FOR MENTOR TRAINING, 1671 01:00:20,954 --> 01:00:22,055 FOR NIH INSTITUTIONAL RESEARCH 1672 01:00:22,055 --> 01:00:22,522 TRAINING GRANTS. 1673 01:00:22,522 --> 01:00:23,990 THIS EFFORT IS IMPLEMENTED TO 1674 01:00:23,990 --> 01:00:25,325 ENSURE THAT MENTORS ARE 1675 01:00:25,325 --> 01:00:27,060 RECEIVING THE SUPPORT AND 1676 01:00:27,060 --> 01:00:29,262 EDUCATION THEY NEED AROUND THE 1677 01:00:29,262 --> 01:00:30,763 MOST EFFECTIVE MENTORING 1678 01:00:30,763 --> 01:00:33,833 PRACTICES SO THAT THEY'RE 1679 01:00:33,833 --> 01:00:35,335 PREPARED TO SUPPORT THE HOLISTIC 1680 01:00:35,335 --> 01:00:39,472 NEEDS OF POSTDOCS AND PRE-DOCS 1681 01:00:39,472 --> 01:00:40,239 OF TODAY AND TOMORROW. 1682 01:00:40,239 --> 01:00:42,208 NOW THAT THE RFI IS CLOSED, 1683 01:00:42,208 --> 01:00:43,810 WE'RE FINALIZING AND CHARGING 1684 01:00:43,810 --> 01:00:44,911 IMPLEMENTATION TEAMS FOCUSED ON 1685 01:00:44,911 --> 01:00:46,980 THE RECOMMENDATIONS. 1686 01:00:46,980 --> 01:00:48,748 WE EXPECT TO PUBLISH AN 1687 01:00:48,748 --> 01:00:49,916 EXECUTIVE SUMMARY AND RESULTS IN 1688 01:00:49,916 --> 01:00:50,984 EARLY SPRING NEXT YEAR, AND I'LL 1689 01:00:50,984 --> 01:00:51,751 LET YOU KNOW. 1690 01:00:51,751 --> 01:00:54,053 THERE WERE MORE THAN 500 1691 01:00:54,053 --> 01:00:55,688 RESPONDENTS WITH VARIOUS 1692 01:00:55,688 --> 01:00:57,757 PROFESSIONAL ROLES AND 1693 01:00:57,757 --> 01:01:00,360 RESPONSIBILITIES, INCLUDING 1694 01:01:00,360 --> 01:01:03,396 POSTDOCTORAL SCHOLARS, FACULTY, 1695 01:01:03,396 --> 01:01:05,598 ACADEMIC LEADERS, RESEARCH 1696 01:01:05,598 --> 01:01:06,833 SCIENTISTS, PEOPLE FROM ADVOCACY 1697 01:01:06,833 --> 01:01:08,534 GROUPS AND PROFESSIONAL SOCIETY, 1698 01:01:08,534 --> 01:01:09,369 GRADUATE STUDENTS AND PEOPLE WHO 1699 01:01:09,369 --> 01:01:11,004 WORK FOR GOVERNMENT AGENCIES AND 1700 01:01:11,004 --> 01:01:11,904 SCIENTIFIC RESEARCH 1701 01:01:11,904 --> 01:01:12,405 ORGANIZATIONS. 1702 01:01:12,405 --> 01:01:16,075 AND THE MAJORITY, 82% OF 1703 01:01:16,075 --> 01:01:17,410 RESPONDENTS, WERE AFFILIATED 1704 01:01:17,410 --> 01:01:19,679 WITH AN ACADEMIC INSTITUTION, A 1705 01:01:19,679 --> 01:01:22,015 MEDICAL SCHOOL OR A HOSPITAL. 1706 01:01:22,015 --> 01:01:25,451 SO LOTS TO DO TO MAKE LIFE 1707 01:01:25,451 --> 01:01:26,953 BETTER FOR OUR TRAINEES, AND 1708 01:01:26,953 --> 01:01:28,721 WE'RE GRATEFUL FOR THE ACD IN 1709 01:01:28,721 --> 01:01:32,525 GUIDING THIS EFFORT. 1710 01:01:32,525 --> 01:01:35,528 LOOKING AHEAD TO FISCAL YEAR 26 1711 01:01:35,528 --> 01:01:37,964 AND 27, NIH PLANS TO CONTINUE TO 1712 01:01:37,964 --> 01:01:39,599 ADDRESS SOME KEY ASPECTS OF 1713 01:01:39,599 --> 01:01:41,034 ADDITIONAL WORKING GROUP 1714 01:01:41,034 --> 01:01:42,402 RECOMMENDATIONS, INCLUDING THOSE 1715 01:01:42,402 --> 01:01:43,736 FOCUSED ON SUPPORTING TRANSITION 1716 01:01:43,736 --> 01:01:45,805 FOR OTHER TYPES OF ROLES, 1717 01:01:45,805 --> 01:01:47,340 INCLUDING TRAINING, SAFE 1718 01:01:47,340 --> 01:01:48,741 ENVIRONMENTS, AND IMPROVED DATA 1719 01:01:48,741 --> 01:01:52,311 SHARING. 1720 01:01:52,311 --> 01:01:59,552 MOVING ON TO NEW APPROACH 1721 01:01:59,552 --> 01:02:01,587 METHODOLOGIES, OTHERWISE KNOWN 1722 01:02:01,587 --> 01:02:04,557 AS NAMs, WHICH ARE LAB OR 1723 01:02:04,557 --> 01:02:05,224 COMPUTER-BASED RESEARCH 1724 01:02:05,224 --> 01:02:07,326 APPROACHES TO MORE ACCURATELY 1725 01:02:07,326 --> 01:02:10,763 MODEL HUMAN BIOLOGY AND 1726 01:02:10,763 --> 01:02:12,598 COMPLEMENT OR IN SOME CASES 1727 01:02:12,598 --> 01:02:13,900 REPLACE TRADITIONAL RESEARCH 1728 01:02:13,900 --> 01:02:14,133 MODELS. 1729 01:02:14,133 --> 01:02:16,069 AS I NOTED IN OUR LAST MEETING, 1730 01:02:16,069 --> 01:02:20,039 NIH IS WORKING TO ADDRESS THE 1731 01:02:20,039 --> 01:02:21,074 RECOMMENDATIONS IN THIS REGARD 1732 01:02:21,074 --> 01:02:23,142 LAID OUT BY THE ACD WORKING 1733 01:02:23,142 --> 01:02:24,677 GROUP. 1734 01:02:24,677 --> 01:02:27,447 NIH'S COMPLEMENT-ANIMAL RESEARCH 1735 01:02:27,447 --> 01:02:29,482 IN EXPERIMENTATION, OTHERWISE 1736 01:02:29,482 --> 01:02:31,884 CALLED COMPLEMENT-ARIE PROGRAM, 1737 01:02:31,884 --> 01:02:33,853 IS SUPPORTED BY THE COMMON FUND. 1738 01:02:33,853 --> 01:02:35,888 IT AIMS TO FURTHER ACD 1739 01:02:35,888 --> 01:02:36,889 RECOMMENDATIONS BY ACCELERATING 1740 01:02:36,889 --> 01:02:40,159 THE DEVELOPMENT, 1741 01:02:40,159 --> 01:02:41,794 STANDARDIZATION, VALIDATION AND 1742 01:02:41,794 --> 01:02:43,629 IMPORTANTLY THE USE OF NEW 1743 01:02:43,629 --> 01:02:45,731 MODELS AND APPROACHES THAT WILL 1744 01:02:45,731 --> 01:02:49,335 MORE ACCURATELY MODEL HUMAN 1745 01:02:49,335 --> 01:02:50,570 BIOLOGY, AND CAN COMPLEMENT OR 1746 01:02:50,570 --> 01:02:52,772 IN SOME CASES REPLACE 1747 01:02:52,772 --> 01:02:55,074 TRADITIONAL MODELS THAT MIGHT 1748 01:02:55,074 --> 01:02:55,975 NOT BE AS GOOD. 1749 01:02:55,975 --> 01:02:58,211 WE PLAN TO ISSUE A NOTICE OF 1750 01:02:58,211 --> 01:02:59,545 FUNDING OPPORTUNITY THIS MONTH 1751 01:02:59,545 --> 01:03:02,148 TO SUPPORT A DATA HUB AND 1752 01:03:02,148 --> 01:03:03,649 COORDINATING CENTER THAT WILL 1753 01:03:03,649 --> 01:03:06,619 COLLECT, STORE, CURATE AND 1754 01:03:06,619 --> 01:03:08,921 DISSEMINATE ALL NAMs RELATED 1755 01:03:08,921 --> 01:03:11,290 DATA, METADATA, ANALYSES, TOOLS, 1756 01:03:11,290 --> 01:03:13,292 COMPUTATIONAL MODELS, AND 1757 01:03:13,292 --> 01:03:15,795 VALIDATION AND QUALIFICATION 1758 01:03:15,795 --> 01:03:16,095 DOCUMENTS. 1759 01:03:16,095 --> 01:03:20,666 ALL OF THESE PRODUCTS GENERATED 1760 01:03:20,666 --> 01:03:26,239 BY THE COMPLEMENT-ARIE PROGRAM, 1761 01:03:26,239 --> 01:03:28,307 AND TO DO SO IN A MANNER THAT 1762 01:03:28,307 --> 01:03:29,609 PROMOTES DEVELOPMENT OF 1763 01:03:29,609 --> 01:03:34,013 STANDARDS EAND SU AND ENSURES TW 1764 01:03:34,013 --> 01:03:37,250 EFFORTS WILL HAVE MAXIMUM 1765 01:03:37,250 --> 01:03:38,351 INTEROPERABILITY WITH DATA FROM 1766 01:03:38,351 --> 01:03:40,419 OTHER NEW APPROACH METHODOLOGIES 1767 01:03:40,419 --> 01:03:41,587 RELATED REPOSITORIES AND 1768 01:03:41,587 --> 01:03:42,121 CONSORTIA. 1769 01:03:42,121 --> 01:03:44,657 ON DECEMBER 10TH, WE PUBLISHED A 1770 01:03:44,657 --> 01:03:45,324 NOTICE OF FUNDING OPPORTUNITY TO 1771 01:03:45,324 --> 01:03:46,359 SUPPORT TECHNOLOGY DEVELOPMENT 1772 01:03:46,359 --> 01:03:47,460 CENTERS THAT WILL WORK 1773 01:03:47,460 --> 01:03:50,530 SPECIFICALLY TO DEVELOP 1774 01:03:50,530 --> 01:03:52,899 COMBINATORIAL PERHAPS. 1775 01:03:52,899 --> 01:03:54,433 COMPLEMENT-ARIE HAS ALSO BEEN 1776 01:03:54,433 --> 01:03:55,735 APPROVED TO LAUNCH A PUBLIC 1777 01:03:55,735 --> 01:03:56,636 PRIVATE PARTNERSHIP WITH THE 1778 01:03:56,636 --> 01:03:58,104 FOUNDATION FOR NIH FOR A 1779 01:03:58,104 --> 01:04:00,072 VALIDATION AND QUALIFICATION 1780 01:04:00,072 --> 01:04:01,941 NETWORK TO SUPPORT THE ADOPTION 1781 01:04:01,941 --> 01:04:03,276 AND IMPLEMENTATION OF NAMs. 1782 01:04:03,276 --> 01:04:05,845 I THINK THIS IS A REALLY 1783 01:04:05,845 --> 01:04:08,481 IMPORTANT SCIENTIFICALLY 1784 01:04:08,481 --> 01:04:11,083 GROUNDED WAY TO MOVE FORWARD 1785 01:04:11,083 --> 01:04:14,820 WITH NEW TECHNOLOGY IN A 1786 01:04:14,820 --> 01:04:16,656 RESPONSIBLE WAY TO MAKE SURE 1787 01:04:16,656 --> 01:04:23,196 THAT EVERYONE BENEFITS. 1788 01:04:23,196 --> 01:04:24,630 NIH CONTINUES TO ADVANCE THE 1789 01:04:24,630 --> 01:04:28,000 VALIDATION AND REGULATORY 1790 01:04:28,000 --> 01:04:29,835 IMPLEMENTATION OF NAMs IN 1791 01:04:29,835 --> 01:04:31,771 PARTNERSHIP WITH OTHER FEDERAL 1792 01:04:31,771 --> 01:04:33,839 AGENCIES BY AN INTERAGENCY 1793 01:04:33,839 --> 01:04:35,608 COORDINATION COMMITTEE ON 1794 01:04:35,608 --> 01:04:36,709 VALIDATION OF ALTERNATIVE 1795 01:04:36,709 --> 01:04:37,176 METHODS. 1796 01:04:37,176 --> 01:04:39,111 UNDER THIS COMMITTEE, THE 1797 01:04:39,111 --> 01:04:39,745 NATIONAL INSTITUTE OF 1798 01:04:39,745 --> 01:04:41,280 ENVIRONMENTAL HEALTH SCIENCES IS 1799 01:04:41,280 --> 01:04:44,984 ACTIVELY DEVELOPING A COLLECTION 1800 01:04:44,984 --> 01:04:46,919 OF ALTERNATIVE METHODS FOR 1801 01:04:46,919 --> 01:04:51,424 REGULATORY APPLICATION OR CAMRA. 1802 01:04:51,424 --> 01:04:52,625 DEVELOPMENTS OF THE NATIONAL 1803 01:04:52,625 --> 01:04:53,793 TOXICOLOGY PROGRAM INTERAGENCY 1804 01:04:53,793 --> 01:04:56,529 CENTER FOR EVALUATION OF 1805 01:04:56,529 --> 01:04:58,731 ALTERNATIVE TOXICOLOGICAL 1806 01:04:58,731 --> 01:05:00,366 METHODS, CAMERA IS A NEW 1807 01:05:00,366 --> 01:05:02,368 INTERACTIVE SEARCHABLE WEB-BASED 1808 01:05:02,368 --> 01:05:04,604 DADATABASE THAT WILL ALLOW THE 1809 01:05:04,604 --> 01:05:08,774 SCIENTIFIC COMMUNITY TO ACCESS 1810 01:05:08,774 --> 01:05:09,842 STANDARDIZED, VALIDATED AND 1811 01:05:09,842 --> 01:05:11,143 QUALIFIED NEW APPROACH 1812 01:05:11,143 --> 01:05:13,980 METHODOLOGIES FOR REGULATORY AND 1813 01:05:13,980 --> 01:05:15,114 OTHER CONTEXT OF USE. 1814 01:05:15,114 --> 01:05:17,783 CAMERA WILL SUPPORT 1815 01:05:17,783 --> 01:05:19,051 REPRODUCIBILITY OF NIH FUNDED 1816 01:05:19,051 --> 01:05:21,287 RESEARCH, AND ADDRESS THE ACD 1817 01:05:21,287 --> 01:05:23,222 RECOMMENDATION TO ESTABLISH A 1818 01:05:23,222 --> 01:05:26,726 CENTRALIZED REPOSITORY TO PERMIT 1819 01:05:26,726 --> 01:05:28,094 NAMs DATA SHARING, ADOPTION 1820 01:05:28,094 --> 01:05:30,296 AND USE, AND A BETA VERSION IS 1821 01:05:30,296 --> 01:05:32,164 ANTICIPATED IN LATE SPRING 2024, 1822 01:05:32,164 --> 01:05:37,703 AND I'LL JUST ADD ANOTHER ASIDE 1823 01:05:37,703 --> 01:05:39,572 HERE, THAT THESE STANDARDS, 1824 01:05:39,572 --> 01:05:41,774 THESE APPROACHES, THESE 1825 01:05:41,774 --> 01:05:44,176 COLLABORATIVE METHODS THAT ARE 1826 01:05:44,176 --> 01:05:45,878 TRANSPARENT TO ALL ARE 1827 01:05:45,878 --> 01:05:47,246 ABSOLUTELY CRITICAL TO BE ABLE 1828 01:05:47,246 --> 01:05:48,547 TO UNDERSTAND DATA 1829 01:05:48,547 --> 01:05:51,250 REPRODUCIBILITY. 1830 01:05:51,250 --> 01:05:52,451 OKAY. 1831 01:05:52,451 --> 01:05:54,387 NEXT, WE HAVE TWO NEW ACD 1832 01:05:54,387 --> 01:05:57,356 WORKING GROUPS. 1833 01:05:57,356 --> 01:05:58,658 THANK YOU VERY MUCH FOR 1834 01:05:58,658 --> 01:06:00,960 ANSWERING THE CALL. 1835 01:06:00,960 --> 01:06:02,662 AS YOU HEARD, WE HAVE A NEW 1836 01:06:02,662 --> 01:06:03,996 EMPHASIS ON WHAT THE NATIONAL 1837 01:06:03,996 --> 01:06:06,198 LIBRARY OF MEDICINE CAN TAKE ON 1838 01:06:06,198 --> 01:06:08,167 TO PRODUCE THE DATA ECOSYSTEM 1839 01:06:08,167 --> 01:06:12,204 THAT OUR RESEARCH COMMUNITIES 1840 01:06:12,204 --> 01:06:14,373 ACROSS ALL ASPECTS, GOVERNMENT, 1841 01:06:14,373 --> 01:06:17,109 INDUSTRY, ACADEMIA, PRIVATE, CAN 1842 01:06:17,109 --> 01:06:17,643 DO. 1843 01:06:17,643 --> 01:06:18,944 AND THESE TWO WORKING GROUPS ARE 1844 01:06:18,944 --> 01:06:22,548 GOING TO HELP US ACHIEVE THAT. 1845 01:06:22,548 --> 01:06:25,117 ONE OF THEM IS THE -- HERE'S THE 1846 01:06:25,117 --> 01:06:27,053 ROSTER FOR THE NEW INFORMATION 1847 01:06:27,053 --> 01:06:30,423 TECHNOLOGY CYBERINFRASTRUCTURE 1848 01:06:30,423 --> 01:06:31,524 AND CYBERSECURITY WORKING GROUP, 1849 01:06:31,524 --> 01:06:32,858 WHICH WILL PROVIDE CRITICAL 1850 01:06:32,858 --> 01:06:35,628 INPUT ON NIH I.T. AND 1851 01:06:35,628 --> 01:06:37,596 CYBERSECURITY GOVERNANCE, AND 1852 01:06:37,596 --> 01:06:39,031 ARTICULATE HIGH PRIORITY AREAS 1853 01:06:39,031 --> 01:06:42,735 FOR NIH INVESTMENT IN 1854 01:06:42,735 --> 01:06:43,369 CYBERINFRASTRUCTURE, 1855 01:06:43,369 --> 01:06:46,872 CYBERSECURITY, A.I., DATA 1856 01:06:46,872 --> 01:06:48,307 SCIENCE, AMONG OTHER DUTIES. 1857 01:06:48,307 --> 01:06:49,742 THIS GROUP WILL PLAN TO PROVIDE 1858 01:06:49,742 --> 01:06:54,113 AN UPDATE TO THE ACD IN DECEMBE. 1859 01:06:54,113 --> 01:06:55,648 THANK YOU SO MUCH FOR TAKING ON 1860 01:06:55,648 --> 01:06:58,617 THIS IMPORTANT TASK. 1861 01:06:58,617 --> 01:06:59,885 HERE IS A ROSTER FOR THE NEXT 1862 01:06:59,885 --> 01:07:02,855 WORKING GROUP, THE ARTIFICIAL 1863 01:07:02,855 --> 01:07:03,723 INTELLIGENCE WORKING GROUP. 1864 01:07:03,723 --> 01:07:05,224 THIS TEAM IS CHARGED WITH 1865 01:07:05,224 --> 01:07:06,859 ARTICULATING A STRATEGIC AND 1866 01:07:06,859 --> 01:07:09,929 INTEGRATED VISION FOR BIOMEDICAL 1867 01:07:09,929 --> 01:07:11,230 RESEARCH OPPORTUNITIES THAT 1868 01:07:11,230 --> 01:07:13,532 WOULD BENEFIT FROM DEVELOPING AN 1869 01:07:13,532 --> 01:07:16,802 APPLICATION OF NOVEL A.I. 1870 01:07:16,802 --> 01:07:17,036 METHODS. 1871 01:07:17,036 --> 01:07:18,404 WE'VE ASKED THIS TEAM TO DELIVER 1872 01:07:18,404 --> 01:07:19,638 A FULL REPORT TO THE ACD TOWARD 1873 01:07:19,638 --> 01:07:24,543 THE END OF NEXT YEAR. 1874 01:07:24,543 --> 01:07:26,412 OKAY, NEXT SLIDE. 1875 01:07:26,412 --> 01:07:27,680 PROGRAMS AND INITIATIVES. 1876 01:07:27,680 --> 01:07:31,650 NEXT. 1877 01:07:31,650 --> 01:07:33,619 I AM SO -- LET ME JUST PREFACE 1878 01:07:33,619 --> 01:07:35,454 THIS WHOLE SECTION BY SAYING I 1879 01:07:35,454 --> 01:07:36,789 JUST CAN'T TELL YOU HOW GRATEFUL 1880 01:07:36,789 --> 01:07:38,691 I AM TO THE INCREDIBLE HARD WORK 1881 01:07:38,691 --> 01:07:43,529 OF THE TEAM OVER THE PAST YEAR. 1882 01:07:43,529 --> 01:07:44,797 AS I MENTIONED IN THE BEGINNING, 1883 01:07:44,797 --> 01:07:47,333 SO MANY THINGS THAT WERE AN IDEA 1884 01:07:47,333 --> 01:07:51,270 A YEAR AGO ARE REALITY TODAY, SO 1885 01:07:51,270 --> 01:07:52,638 PLEASE DON'T LET ANYBODY SAY NIH 1886 01:07:52,638 --> 01:07:53,205 IS SLOW. 1887 01:07:53,205 --> 01:07:56,475 THESE PROGRAMS ARE VERY EXCITING 1888 01:07:56,475 --> 01:07:58,210 AND I'M SO GRATEFUL FOR THE WORK 1889 01:07:58,210 --> 01:07:59,078 OF THE TEAM. 1890 01:07:59,078 --> 01:08:00,312 FIRST ONE, CARE FOR HEALTH. 1891 01:08:00,312 --> 01:08:01,947 NIH'S NEW PRIMARY CARE-BASED 1892 01:08:01,947 --> 01:08:04,850 RESEARCH NETWORK. 1893 01:08:04,850 --> 01:08:05,885 ALLOWS US TO CONNECT WITH 1894 01:08:05,885 --> 01:08:07,286 PRIMARY CARE PROVIDERS AND THEIR 1895 01:08:07,286 --> 01:08:08,487 PATIENTS AND THEIR COMMUNITIES, 1896 01:08:08,487 --> 01:08:11,190 GIVING THEM ACCESS TO RESEARCH, 1897 01:08:11,190 --> 01:08:13,092 INCLUDING THE OPPORTUNITY TO 1898 01:08:13,092 --> 01:08:15,694 PARTICIPATE IN CLINICAL TRIALS. 1899 01:08:15,694 --> 01:08:20,933 WE'RE WORKING ON IMPLEMENTATION 1900 01:08:20,933 --> 01:08:22,368 OF A SUSTAINED INFRASTRUCTURE 1901 01:08:22,368 --> 01:08:23,536 THAT INTEGRATES INNOVATIVE 1902 01:08:23,536 --> 01:08:25,838 RESEARCH WITH ROUTINE CLINICAL 1903 01:08:25,838 --> 01:08:27,473 CARE IN REAL WORLD SETTINGS WITH 1904 01:08:27,473 --> 01:08:30,543 A FOCUS ON SUSTAINED ENGAGEMENT 1905 01:08:30,543 --> 01:08:35,147 WITH HISTORICALLY 1906 01:08:35,147 --> 01:08:36,515 UNDERREPRESENTED COMMUNITIES, 1907 01:08:36,515 --> 01:08:37,082 THOSE EXPERIENCING HEALTH 1908 01:08:37,082 --> 01:08:37,850 DISPARITIES IN CLINICAL 1909 01:08:37,850 --> 01:08:43,322 RESEARCH. 1910 01:08:43,322 --> 01:08:47,126 THIS YEAR SAW BEGINNING WITH A 1911 01:08:47,126 --> 01:08:52,264 TWO-YEAR 30 MILLION-DOLLAR PILOT 1912 01:08:52,264 --> 01:08:54,567 INITIATIVE IN SEPTEMBER, WE 1913 01:08:54,567 --> 01:08:55,334 ANNOUNCED $5 MILLION IN 1914 01:08:55,334 --> 01:08:56,669 FIRST-YEAR FUNDING TO SUPPORT 1915 01:08:56,669 --> 01:08:59,338 THREE NETWORK RESEARCH HUBS, 1916 01:08:59,338 --> 01:09:01,340 THESE INCLUDE OREGON HEALTH AND 1917 01:09:01,340 --> 01:09:03,075 SCIENCE UNIVERSITY, COVERING 1918 01:09:03,075 --> 01:09:04,410 MULTIPLE STATES IN THE 1919 01:09:04,410 --> 01:09:04,710 NORTHWEST. 1920 01:09:04,710 --> 01:09:06,879 THE UNIVERSITY OF 1921 01:09:06,879 --> 01:09:10,916 WISCONSIN-MADISON, AND WEST 1922 01:09:10,916 --> 01:09:11,684 VIRGINIA UNIVERSITY. 1923 01:09:11,684 --> 01:09:13,352 INITIALLY THESE TEAMS WILL WORK 1924 01:09:13,352 --> 01:09:15,054 WITH 50 CLINICAL SITES IN RURAL 1925 01:09:15,054 --> 01:09:16,255 COMMUNITIES THROUGH THESE THREE 1926 01:09:16,255 --> 01:09:20,759 NETWORKS. 1927 01:09:20,759 --> 01:09:22,294 AS PART OF THE PILOT PHASE, 1928 01:09:22,294 --> 01:09:23,829 THESE NEW NETWORK RESEARCH HUBS 1929 01:09:23,829 --> 01:09:25,364 WILL PARTNER WITH THREE ONGOING 1930 01:09:25,364 --> 01:09:28,200 NIH FUNDED CLINICAL TRIALS. 1931 01:09:28,200 --> 01:09:30,069 WE HAVE THE FIRST, CARE FOR 1932 01:09:30,069 --> 01:09:31,604 HEALTH RESEARCH NETWORK MEETING 1933 01:09:31,604 --> 01:09:34,974 LAST WEEK, AND RECEIVED A 1934 01:09:34,974 --> 01:09:35,975 DETAILED OVERVIEW OF EACH OF 1935 01:09:35,975 --> 01:09:36,876 THESE PROJECTS. 1936 01:09:36,876 --> 01:09:39,245 I WANT TO EMPHASIZE THAT THESE 1937 01:09:39,245 --> 01:09:41,447 PROJECTS WERE SELECTED NOT BY 1938 01:09:41,447 --> 01:09:43,616 US, BUT BY THE COMMUNITIES THAT 1939 01:09:43,616 --> 01:09:45,885 ARE PARTICIPATING IN THIS 1940 01:09:45,885 --> 01:09:47,119 RESEARCH AS THE ONES THAT WERE 1941 01:09:47,119 --> 01:09:49,288 THE MOST MEANINGFUL TO THEM, 1942 01:09:49,288 --> 01:09:51,156 WHICH IS A KEY FEATURE OF THIS 1943 01:09:51,156 --> 01:09:52,391 WORK. 1944 01:09:52,391 --> 01:09:53,893 THE FIRST TRIAL KNOWN AS 1945 01:09:53,893 --> 01:09:55,060 BEATPAIN, HAS BEEN SUPPORTED BY 1946 01:09:55,060 --> 01:09:56,762 NIH'S HELPING TO END ADDICTION 1947 01:09:56,762 --> 01:09:58,464 LONG TERM OR HEAL INITIATIVE. 1948 01:09:58,464 --> 01:10:01,534 THE TRIAL IS EVALUATING A 1949 01:10:01,534 --> 01:10:02,835 TELEHEALTH-DELIVERED PHYSICAL 1950 01:10:02,835 --> 01:10:06,005 THERAPY IN PEOPLE WITH BACK PAIN 1951 01:10:06,005 --> 01:10:07,406 SEEKING CARE AT FEDERALLY 1952 01:10:07,406 --> 01:10:08,741 QUALIFIED HEALTH CENTERS. 1953 01:10:08,741 --> 01:10:11,677 THE TRIAL AIMS TO FIND WAYS TO 1954 01:10:11,677 --> 01:10:13,112 IMPROVE PAIN MANAGEMENT AND 1955 01:10:13,112 --> 01:10:14,780 REDUCE RELIANCE ON OPIOIDS, 1956 01:10:14,780 --> 01:10:16,482 WHILE CONSIDERING BARRIERS 1957 01:10:16,482 --> 01:10:18,284 FACING RURAL COMMUNITIES. 1958 01:10:18,284 --> 01:10:18,817 OREGON HEALTH AND SCIENCE 1959 01:10:18,817 --> 01:10:20,185 UNIVERSITY WILL BE WORKING WITH 1960 01:10:20,185 --> 01:10:23,989 THIS TRIAL TEAM TO EXTEND THIS 1961 01:10:23,989 --> 01:10:25,057 THROUGHOUT THEIR RURAL RESEARCH 1962 01:10:25,057 --> 01:10:25,991 NETWORK. 1963 01:10:25,991 --> 01:10:27,826 THE NEXT TRIAL ALSO SUPPORTED BY 1964 01:10:27,826 --> 01:10:30,663 HEAL IS CALLED CO-CARE. 1965 01:10:30,663 --> 01:10:32,865 THE PROJECT DESIGNS AND 1966 01:10:32,865 --> 01:10:34,133 EVALUATES A MULTIDISCIPLINARY 1967 01:10:34,133 --> 01:10:35,601 TREATMENT MODEL TO BE USED IN 1968 01:10:35,601 --> 01:10:39,405 THE PRIMARY CARE SETTING FOSH 1969 01:10:39,405 --> 01:10:46,879 PSETTING FORPEOPLE WITH POLYSUB. 1970 01:10:46,879 --> 01:10:49,248 FINALLY THE LAST TRIAL, WHICH IS 1971 01:10:49,248 --> 01:10:51,083 CALLED TRUST, WAS SELECTED BY 1972 01:10:51,083 --> 01:10:53,385 THE RESEARCHERS AT WEST VIRGINIA 1973 01:10:53,385 --> 01:10:53,819 UNIVERSITY. 1974 01:10:53,819 --> 01:10:55,888 IT COMPARES TWO COMMONLY USED 1975 01:10:55,888 --> 01:10:58,591 TREATMENT METHODS FOR GOUT TO 1976 01:10:58,591 --> 01:11:00,893 SEE HOW WELL THEY CAN IMPROVE 1977 01:11:00,893 --> 01:11:03,529 SYMPTOMS AND ALSO TO UNDERSTAND 1978 01:11:03,529 --> 01:11:05,497 THE EFFECTS OF THESE TREATMENT 1979 01:11:05,497 --> 01:11:09,635 METHODS ON QUALITY OF LIFE. 1980 01:11:09,635 --> 01:11:11,503 SO MOVING ON NOW TO THE NATIONAL 1981 01:11:11,503 --> 01:11:11,971 LIBRARY OF MEDICINE. 1982 01:11:11,971 --> 01:11:12,905 YOU'VE ALREADY HEARD ME TALK 1983 01:11:12,905 --> 01:11:14,340 ABOUT THIS. 1984 01:11:14,340 --> 01:11:16,208 WE HAVE A VISION FOR THE FUTURE 1985 01:11:16,208 --> 01:11:20,012 OF THE NLM AS A PLATFORM FOR 1986 01:11:20,012 --> 01:11:21,413 EVERYONE FOR BIOMEDICAL 1987 01:11:21,413 --> 01:11:22,448 DISCOVERY AND DATA POWERED 1988 01:11:22,448 --> 01:11:23,616 HEALTH. 1989 01:11:23,616 --> 01:11:24,717 AS PART OF THIS EFFORT, WE'VE 1990 01:11:24,717 --> 01:11:26,585 BEEN WORKING TO IMPLEMENT ACROSS 1991 01:11:26,585 --> 01:11:28,988 AGENCY INITIATIVE THAT WOULD 1992 01:11:28,988 --> 01:11:30,856 PROVIDE A FOCUS FOR COLLECTION 1993 01:11:30,856 --> 01:11:34,660 AND PRIVACY PROTECTED USE OF 1994 01:11:34,660 --> 01:11:35,928 DATA COLLECTED FROM THE CLINICAL 1995 01:11:35,928 --> 01:11:37,830 CARE ENVIRONMENT TO GENERATE 1996 01:11:37,830 --> 01:11:40,466 EVIDENCE REQUIRED FOR 1997 01:11:40,466 --> 01:11:43,435 DECISION-MAKING TO IMPROVE 1998 01:11:43,435 --> 01:11:43,836 HEALTH. 1999 01:11:43,836 --> 01:11:47,106 I'LL JUST EMPHASIZE, THIS IS A 2000 01:11:47,106 --> 01:11:50,075 PART OF THIS OVERALL DATA 2001 01:11:50,075 --> 01:11:51,710 ECOSYSTEM THAT INTENDS TO 2002 01:11:51,710 --> 01:11:56,949 ADDRESS OUR NEED TO INCLUDE 2003 01:11:56,949 --> 01:11:57,850 EVERYONE WHO WANTS TO BE 2004 01:11:57,850 --> 01:11:58,917 INCLUDED THROUGHOUT OUR NATION 2005 01:11:58,917 --> 01:12:02,721 IN BIOMEDICAL RESEARCH. 2006 01:12:02,721 --> 01:12:04,690 IN OUR CURRENT STATE, BOTH 2007 01:12:04,690 --> 01:12:06,025 PROCESSED AND RAW DATA FROM 2008 01:12:06,025 --> 01:12:06,992 HEALTH SYSTEMS, POPULATION 2009 01:12:06,992 --> 01:12:08,260 HEALTH DATA, FROM GOVERNMENT, 2010 01:12:08,260 --> 01:12:09,294 AND RESEARCH AND DEVELOPMENT 2011 01:12:09,294 --> 01:12:13,632 DATA FROM PHARMA ARE ALL SILOED 2012 01:12:13,632 --> 01:12:15,267 AND NON-INTEROPERABLE DESPITE 2013 01:12:15,267 --> 01:12:16,368 MANY EFFORTS. 2014 01:12:16,368 --> 01:12:19,104 HEALTHCARE INSTITUTIONS NOW SEND 2015 01:12:19,104 --> 01:12:21,440 DATA TO HHS FOR REQUIRED PUBLIC 2016 01:12:21,440 --> 01:12:23,909 HEALTH REPORTING PROGRAMS. 2017 01:12:23,909 --> 01:12:25,511 OFTEN, THAT SAME DATA FROM THE 2018 01:12:25,511 --> 01:12:27,946 SAME PATIENTS ARE COLLECTED MANY 2019 01:12:27,946 --> 01:12:29,682 TIMES FROM THE SAME INSTITUTION 2020 01:12:29,682 --> 01:12:32,418 TO BE THEN DISTRIBUTED TO 2021 01:12:32,418 --> 01:12:33,519 DIFFERENT FEDERAL AGENCIES. 2022 01:12:33,519 --> 01:12:36,155 THIS LEADS TO COLLECTION 2023 01:12:36,155 --> 01:12:37,556 REDUNDANCIES, EXPENSIVE DATA 2024 01:12:37,556 --> 01:12:39,224 FORMATTING CHALLENGES, AND 2025 01:12:39,224 --> 01:12:41,060 CREATES SILOS OF DATA HOLDING 2026 01:12:41,060 --> 01:12:43,362 ACROSS HHS FOR DATA ON PEOPLE'S 2027 01:12:43,362 --> 01:12:43,896 HEALTH. 2028 01:12:43,896 --> 01:12:45,864 THIS IS ALSO A HUGE BURDEN TO 2029 01:12:45,864 --> 01:12:49,802 THE CLINICAL CARE SITES. 2030 01:12:49,802 --> 01:12:51,904 WE REALLY MUST TRANSITION TO A 2031 01:12:51,904 --> 01:12:54,073 MODEL WHERE DATA IS 2032 01:12:54,073 --> 01:12:54,673 RECONFIGURABLE AND COMPUTABLE 2033 01:12:54,673 --> 01:12:56,275 AND CAN BE ALIGNED TO VARIOUS 2034 01:12:56,275 --> 01:12:58,310 USE CASES IN BOTH RESEARCH AND 2035 01:12:58,310 --> 01:13:01,513 PUBLIC HEALTH. 2036 01:13:01,513 --> 01:13:03,916 AS PART OF THIS NEW CROSS AGENCY 2037 01:13:03,916 --> 01:13:07,653 INITIATIVES, WE, TH THE NLM, WIL 2038 01:13:07,653 --> 01:13:09,588 SUPPORT A FEDERATED AND 2039 01:13:09,588 --> 01:13:10,589 ELECTRONIC HEALTH RECORD AND A 2040 01:13:10,589 --> 01:13:11,890 HEALTH DATA COLLECTION AND 2041 01:13:11,890 --> 01:13:13,525 TRANSMISSION ARCHITECTURE BASED 2042 01:13:13,525 --> 01:13:16,462 ON OPEN INDUSTRY DATA AND 2043 01:13:16,462 --> 01:13:16,995 INTEROPPABILITY STANDARDS 2044 01:13:16,995 --> 01:13:22,401 WORKING HAND IN HAND WITH THE 2045 01:13:22,401 --> 01:13:25,904 HHS OFFICE OF DATA -- OF A.I. 2046 01:13:25,904 --> 01:13:27,206 AND DATA STANDARDS. 2047 01:13:27,206 --> 01:13:28,741 WE WILL BE ABLE TO USE DATA FROM 2048 01:13:28,741 --> 01:13:31,243 THE CLINICAL CARE ENVIRONMENT TO 2049 01:13:31,243 --> 01:13:33,312 SUPPORT -- ALSO SUPPORT BOTH PRE 2050 01:13:33,312 --> 01:13:36,048 AND POST MARKET SURVEILLANCE AND 2051 01:13:36,048 --> 01:13:36,815 EFFECTIVENESS ASSESSMENTS, 2052 01:13:36,815 --> 01:13:38,684 DISEASE SURVEILLANCE AND 2053 01:13:38,684 --> 01:13:39,985 BIOMEDICAL RESEARCH. 2054 01:13:39,985 --> 01:13:43,188 OVERALL, WE WANT HHS TO BE ABLE 2055 01:13:43,188 --> 01:13:44,690 TO COLLECT AND USE THE HIGHEST 2056 01:13:44,690 --> 01:13:46,325 QUALITY DATA IN A MANNER THAT 2057 01:13:46,325 --> 01:13:49,595 REDUCES HEALTH PROVIDER BURDENS 2058 01:13:49,595 --> 01:13:52,631 AND IMPROVES DATA TIMELINESS, 2059 01:13:52,631 --> 01:14:00,305 QUALITY AND ANALYSIS. 2060 01:14:00,305 --> 01:14:01,740 THIS EFFORT REQUIRES A 2061 01:14:01,740 --> 01:14:02,841 COLLABORATIVE TRUSTED DATA 2062 01:14:02,841 --> 01:14:04,443 BROKER THAT CAN ACT AS A PARTNER 2063 01:14:04,443 --> 01:14:05,878 WITH HHS, THE HEALTHCARE 2064 01:14:05,878 --> 01:14:07,079 INDUSTRY, MEDICAL INSTITUTIONS, 2065 01:14:07,079 --> 01:14:09,148 THE RESEARCH COMMUNITY, AND 2066 01:14:09,148 --> 01:14:10,349 ULTIMATELY ALL OF THE PEOPLE WE 2067 01:14:10,349 --> 01:14:11,116 SERVE. 2068 01:14:11,116 --> 01:14:12,451 THIS ORGANIZATION WILL PROVIDE 2069 01:14:12,451 --> 01:14:15,053 THE INFRASTRUCTURE TO COLLECT, 2070 01:14:15,053 --> 01:14:16,555 AGGREGATE, MANAGE AND FACILITATE 2071 01:14:16,555 --> 01:14:19,525 REALTIME ACCESS TO DATA FROM 2072 01:14:19,525 --> 01:14:21,693 DESIGNATED PARTNER HEALTH 2073 01:14:21,693 --> 01:14:22,161 PROVIDER INSTITUTIONS. 2074 01:14:22,161 --> 01:14:25,097 IN ADDITION, THE TRUSTED DATA 2075 01:14:25,097 --> 01:14:26,832 BROKER WILL WORK WITH HHS TO 2076 01:14:26,832 --> 01:14:29,101 INCORPORATE NEW DATA TYPES, 2077 01:14:29,101 --> 01:14:31,637 IMPROVE DATA STANDARDS, AND 2078 01:14:31,637 --> 01:14:34,907 QUALITY, PILOT USE CASES, AND 2079 01:14:34,907 --> 01:14:35,641 ULTIMATELY, FACILITATE WHAT WE 2080 01:14:35,641 --> 01:14:38,844 ARE ALL LOOKING FOR ACROSS OUR 2081 01:14:38,844 --> 01:14:39,812 HEALTHCARE SYSTEM, A LEARNING 2082 01:14:39,812 --> 01:14:45,851 HEALTH SYSTEM. 2083 01:14:45,851 --> 01:14:48,887 WE HAVE AWARDED A $3.9 MILLION 2084 01:14:48,887 --> 01:14:51,089 TO THE FOUNDATION FOR NIH TO 2085 01:14:51,089 --> 01:14:52,925 DEVELOP STRATEGIC PLANS 2086 01:14:52,925 --> 01:14:53,926 INCLUDING INFRASTRUCTURE 2087 01:14:53,926 --> 01:14:59,164 STRATEGY, GOVERNANCE STRUCTURE 2088 01:14:59,164 --> 01:15:00,465 STRATEGY, PROGRAM MANAGEMENT AND 2089 01:15:00,465 --> 01:15:01,900 MONITORING SYSTEM FOR OUR 2090 01:15:01,900 --> 01:15:03,969 TRUSTED DATA BROKER, ESTABLISH 2091 01:15:03,969 --> 01:15:04,970 AN INSTITUTIONAL REVIEW BOARD, 2092 01:15:04,970 --> 01:15:06,271 ESTABLISH A PLATFORM FOR A 2093 01:15:06,271 --> 01:15:07,773 TRUSTED DATA BROKER FOR DATA 2094 01:15:07,773 --> 01:15:09,007 ACQUISITION, AND ALL OF THE 2095 01:15:09,007 --> 01:15:12,144 ACTIVITIES IT NEEDS TO 2096 01:15:12,144 --> 01:15:13,912 ACCOMPLISH, INCLUDING, AND 2097 01:15:13,912 --> 01:15:17,316 PERHAPS MOST ESPECIALLY, 2098 01:15:17,316 --> 01:15:21,453 ENSURING APPROPRIATE SECURITY 2099 01:15:21,453 --> 01:15:23,121 COMPLIANCE, AND ALSO TO 2100 01:15:23,121 --> 01:15:25,190 EVALUATION AND TESTING WITH HHS 2101 01:15:25,190 --> 01:15:28,460 PARTNERS, INCLUDING THE CDC, 2102 01:15:28,460 --> 01:15:35,667 CMS, FDA, AND NIH. 2103 01:15:35,667 --> 01:15:36,902 SO EXAMPLES. 2104 01:15:36,902 --> 01:15:41,039 JUST TO PUT SOME SPECIFICS ON 2105 01:15:41,039 --> 01:15:42,875 WHAT WE INTEND TO DO FOR DATA IN 2106 01:15:42,875 --> 01:15:44,443 THE CLINICAL CARE ENVIRONMENT. 2107 01:15:44,443 --> 01:15:46,678 HERE IS SOME CROSS HEALTH AND 2108 01:15:46,678 --> 01:15:48,914 HUMAN SERVICES PROJECTS 2109 01:15:48,914 --> 01:15:51,650 CURRENTLY UNDERWAY, TO ACHIEVE 2110 01:15:51,650 --> 01:15:53,185 BETTER DATA HEALTH COLLECTION. 2111 01:15:53,185 --> 01:15:55,487 THEY INCLUDE, FOR EXAMPLE, 2112 01:15:55,487 --> 01:15:57,022 CONSOLIDATING AND SIMPLIFYING 2113 01:15:57,022 --> 01:15:59,625 CANCER DATA REPORTING 2114 01:15:59,625 --> 01:16:01,393 REQUIREMENTS, THAT'S CDC, 2115 01:16:01,393 --> 01:16:03,362 NATIONAL PROGRAM OF CANCER 2116 01:16:03,362 --> 01:16:08,166 REGISTRIES, NIH'S SEER PROGRAM, 2117 01:16:08,166 --> 01:16:15,173 AND THE CENTIMET CMS ENHANCING Y 2118 01:16:15,173 --> 01:16:16,608 MODEL ALL NOW REQUIRE. 2119 01:16:16,608 --> 01:16:18,243 WOULDN'T IT BE GREAT IF YOU'RE 2120 01:16:18,243 --> 01:16:20,078 HEALTHCARE PROGRAMS PRODUCE THIS 2121 01:16:20,078 --> 01:16:22,114 DATA IN A STRAIGHTFORWARD, 2122 01:16:22,114 --> 01:16:23,482 SIMPLE ONE-TIME COLLECTION 2123 01:16:23,482 --> 01:16:28,420 SERVING ALL NEEDS METHOD. 2124 01:16:28,420 --> 01:16:29,388 THAT'S WHAT THIS FIRST PROJECT 2125 01:16:29,388 --> 01:16:31,590 IS STRIVING TO ACHIEVE. 2126 01:16:31,590 --> 01:16:33,992 SECOND, THE EXTENSIVE DATA THAT 2127 01:16:33,992 --> 01:16:36,061 FDA REQUIRES FOR SURVEILLANCE 2128 01:16:36,061 --> 01:16:36,528 PROGRAMS. 2129 01:16:36,528 --> 01:16:37,562 THERE'S A MODEL RIGHT NOW 2130 01:16:37,562 --> 01:16:39,531 LOOKING AT POST MARKET EFFECTS 2131 01:16:39,531 --> 01:16:42,601 OF GLP-1 AGONIST MEDICATIONS ON 2132 01:16:42,601 --> 01:16:44,269 CONDITIONS SUCH AS THYROID 2133 01:16:44,269 --> 01:16:45,904 CANCER AND TOBACCO USE THAT WILL 2134 01:16:45,904 --> 01:16:48,740 ALSO HELP DEVELOP THE MODEL TO 2135 01:16:48,740 --> 01:16:49,708 STREAMLINE OVERALL FDA 2136 01:16:49,708 --> 01:16:50,575 SURVEILLANCE DATA COLLECTION IN 2137 01:16:50,575 --> 01:16:51,143 THE FUTURE. 2138 01:16:51,143 --> 01:16:53,645 AND THEN FINALLY, ON THE 2139 01:16:53,645 --> 01:16:56,181 RESEARCH END, IMPROVING 2140 01:16:56,181 --> 01:16:57,449 LONGITUDINAL HEALTH RESEARCH 2141 01:16:57,449 --> 01:16:59,885 DATA COLLECTION REQUIRED FROM 2142 01:16:59,885 --> 01:17:02,287 THE ELECTRONIC HEALTH RECORD FOR 2143 01:17:02,287 --> 01:17:04,456 THE OBSERVATIONAL DATASETS OF 2144 01:17:04,456 --> 01:17:05,157 NIH'S ALL-OF-US PROGRAM. 2145 01:17:05,157 --> 01:17:06,892 SO I THINK WITH THESE EXAMPLES, 2146 01:17:06,892 --> 01:17:10,195 YOU CAN SEE THE COMPREHENSIVE 2147 01:17:10,195 --> 01:17:13,999 AND COLLABORATIVE ENVIRONMENT 2148 01:17:13,999 --> 01:17:16,401 THAT IS BEING USED TO BUILD THIS 2149 01:17:16,401 --> 01:17:20,439 DATA INITIATIVE. 2150 01:17:20,439 --> 01:17:21,440 ULTIMATELY, THIS IS OUR VISION 2151 01:17:21,440 --> 01:17:22,641 FOR THE FUTURE OF HEALTHCARE 2152 01:17:22,641 --> 01:17:23,942 DATA. 2153 01:17:23,942 --> 01:17:25,277 THE RIGHT DATA, THE RIGHT TIME 2154 01:17:25,277 --> 01:17:28,413 AND THE RIGHT PLACE. 2155 01:17:28,413 --> 01:17:30,082 DATA AND INFORMATION ARE BROUGHT 2156 01:17:30,082 --> 01:17:30,983 TOGETHER WITH PATIENT OWNING 2157 01:17:30,983 --> 01:17:33,785 THEIR OWN DATA, AND CONTROLLING 2158 01:17:33,785 --> 01:17:35,120 PERMISSION OF HOW THEIR DATA IS 2159 01:17:35,120 --> 01:17:37,856 USED FOR RESEARCH AND WHAT 2160 01:17:37,856 --> 01:17:38,190 PURPOSE. 2161 01:17:38,190 --> 01:17:39,925 SUCH A SYSTEM THAT WOULD 2162 01:17:39,925 --> 01:17:42,227 INTEGRATE RESEARCHERS WOULD LEAD 2163 01:17:42,227 --> 01:17:44,529 SIGNIFICANT INSIGHTS FOR 2164 01:17:44,529 --> 01:17:46,832 BIOMEDICAL SCIENCE, GUIDE PUBLIC 2165 01:17:46,832 --> 01:17:48,667 POLICY, DRIVE NEEDED HEALTHCARE 2166 01:17:48,667 --> 01:17:51,503 REFORM, AND, ABOVE ALL, ENGENDER 2167 01:17:51,503 --> 01:17:54,139 TRUST IN PATIENTS WHO CAN NOW 2168 01:17:54,139 --> 01:17:55,340 HAVE CONTROL OVER HOW THEIR DATA 2169 01:17:55,340 --> 01:17:57,376 IS USED FOR RESEARCH. 2170 01:17:57,376 --> 01:18:00,045 OKAY. 2171 01:18:00,045 --> 01:18:01,346 NEXT. 2172 01:18:01,346 --> 01:18:03,648 MOVING ON, DR. SARAH REID AND I 2173 01:18:03,648 --> 01:18:04,683 WILL PRESENT MORE ON THIS IN 2174 01:18:04,683 --> 01:18:06,284 DEPTH LATER TODAY BUT I WANTED 2175 01:18:06,284 --> 01:18:07,919 TO QUICKLY DISCUSS OUR RESEARCH 2176 01:18:07,919 --> 01:18:10,956 COVID TO ENHANCE RECOVERY OR 2177 01:18:10,956 --> 01:18:11,923 RECOVER INITIATIVE WHICH SEEKS 2178 01:18:11,923 --> 01:18:14,693 TO UNDERSTAND, DIAGNOSE, PREVENT 2179 01:18:14,693 --> 01:18:16,561 AND TREAT LONG COVID, I THINK 2180 01:18:16,561 --> 01:18:17,429 ANOTHER MAJOR STEP FORWARD OVER 2181 01:18:17,429 --> 01:18:18,096 THE LAST YEAR. 2182 01:18:18,096 --> 01:18:20,165 NIH ESTABLISHED RECOVER IN 2183 01:18:20,165 --> 01:18:21,366 FEBRUARY 2021, AFTER CONGRESS 2184 01:18:21,366 --> 01:18:24,102 INITIALLY APPROPRIATED 2185 01:18:24,102 --> 01:18:26,738 $1.5 BILLION IN THE MIDDLE OF 2186 01:18:26,738 --> 01:18:30,542 OUR HEALTH EMERGENCY TO US TO 2187 01:18:30,542 --> 01:18:32,411 STUDY THE LONG-TERM EFFECTS OF 2188 01:18:32,411 --> 01:18:32,677 COVID-19. 2189 01:18:32,677 --> 01:18:34,146 SINCE THEN, WE'VE MADE PROGRESS 2190 01:18:34,146 --> 01:18:37,649 IN UNDERSTANDING RISK FACTORS, A 2191 01:18:37,649 --> 01:18:38,650 BROAD RANGE OF SYMPTOMS 2192 01:18:38,650 --> 01:18:39,951 ASSOCIATED WITH LONG COVID, THE 2193 01:18:39,951 --> 01:18:43,021 IMPACT OF VACCINATION AND HEALTH 2194 01:18:43,021 --> 01:18:44,556 DISPARITIES. 2195 01:18:44,556 --> 01:18:46,625 WE'VE AMASSED AND SHARED DATA 2196 01:18:46,625 --> 01:18:49,261 FROM PATIENT COHORTS, CONDUCTED 2197 01:18:49,261 --> 01:18:53,398 FUNDAMENTAL PATHOBIOLOGY STUDIES 2198 01:18:53,398 --> 01:18:55,200 AND BEGUN REALLY CRITICAL 2199 01:18:55,200 --> 01:18:57,035 CLINICAL TRIALS. 2200 01:18:57,035 --> 01:18:58,537 BUILDING ON THESE CRITICAL 2201 01:18:58,537 --> 01:19:00,405 INSIGHTS, WE'RE EMBARKING ON THE 2202 01:19:00,405 --> 01:19:04,109 PROGRAM'S NEXT PHASE. 2203 01:19:04,109 --> 01:19:06,111 CALLED RECOVER-TREATING LONG 2204 01:19:06,111 --> 01:19:06,411 COVID. 2205 01:19:06,411 --> 01:19:08,713 TO PUT IT SIMPLY, WE NEED TO 2206 01:19:08,713 --> 01:19:10,782 EVALUATE MORE POTENTIAL 2207 01:19:10,782 --> 01:19:11,883 TREATMENTS FOR LONG COVID. 2208 01:19:11,883 --> 01:19:15,187 THIS IS A PERVASIVE AND VERY 2209 01:19:15,187 --> 01:19:16,054 CHALLENGING DISEASE. 2210 01:19:16,054 --> 01:19:17,923 IN THIS PROCESS, WE'RE ENSURING 2211 01:19:17,923 --> 01:19:19,458 THAT PATIENTS ARE MEANINGFULLY 2212 01:19:19,458 --> 01:19:20,859 ENGAGED AS OUR TRUE AND EQUAL 2213 01:19:20,859 --> 01:19:25,497 PARTNERS IN RESEARCH. 2214 01:19:25,497 --> 01:19:27,332 TO PUT IT QUITE DIRECTLY, WE 2215 01:19:27,332 --> 01:19:28,667 CANNOT SUCCEED WITHOUT HAVING 2216 01:19:28,667 --> 01:19:31,803 PATIENTS AT THE FOREFRONT, 2217 01:19:31,803 --> 01:19:33,271 PARTICULARLY OF THESE CLINICAL 2218 01:19:33,271 --> 01:19:33,505 TRIALS. 2219 01:19:33,505 --> 01:19:35,240 THE ONLY WAY TO DESIGN AND CARRY 2220 01:19:35,240 --> 01:19:37,309 OUT EFFECTIVE RESEARCH FOR LONG 2221 01:19:37,309 --> 01:19:37,542 COVID. 2222 01:19:37,542 --> 01:19:38,977 OUR GOAL IS TO ADDRESS THE NEEDS 2223 01:19:38,977 --> 01:19:40,912 OF THOSE SUFFERING FROM LONG 2224 01:19:40,912 --> 01:19:42,347 COVID BY BEING VERY TRANSPARENT 2225 01:19:42,347 --> 01:19:45,083 IN OUR APPROACH, FLEXIBLE AND 2226 01:19:45,083 --> 01:19:46,551 RESPONSIVE TO A CHANGING 2227 01:19:46,551 --> 01:19:47,519 LANDSCAPE THAT THEY ARE LIVING 2228 01:19:47,519 --> 01:19:52,958 EVERY DAY. 2229 01:19:52,958 --> 01:19:54,292 OKAY. 2230 01:19:54,292 --> 01:19:56,027 NOW ON OCTOBER 29TH, I WAS 2231 01:19:56,027 --> 01:19:57,662 PLEASED TO JOIN A WORKSHOP AT 2232 01:19:57,662 --> 01:19:59,564 THE WHITE HOUSE AS PART OF THE 2233 01:19:59,564 --> 01:20:00,298 WHITE HOUSE INITIATIVE ON 2234 01:20:00,298 --> 01:20:01,833 WOMEN'S HEALTH RESEARCH. 2235 01:20:01,833 --> 01:20:03,168 THE EVENT CONVENED EXPERTS FROM 2236 01:20:03,168 --> 01:20:05,670 ACROSS NIH TO HIGHLIGHT THE 2237 01:20:05,670 --> 01:20:06,238 INTERDISCIPLINARY RESEARCH 2238 01:20:06,238 --> 01:20:09,841 ADVANCES IN WOMEN'S HEALTH THAT 2239 01:20:09,841 --> 01:20:11,243 HAVE BEEN GOING ON, AND TO 2240 01:20:11,243 --> 01:20:12,344 DISCUSS FUTURE PRIORITIES. 2241 01:20:12,344 --> 01:20:16,815 AT NIH, WE TAKE A WHOLE PERSON 2242 01:20:16,815 --> 01:20:21,319 APPROACH THROUGHOUT A WOMEN'S 2243 01:20:21,319 --> 01:20:23,188 LIFETIME, RECOGNIZING THAT MANY 2244 01:20:23,188 --> 01:20:23,922 INTERCONNECTED FACTORS 2245 01:20:23,922 --> 01:20:24,923 CONTRIBUTE TO HEALTH AND KEYS. 2246 01:20:24,923 --> 01:20:27,259 DISEASE. 2247 01:20:27,259 --> 01:20:28,393 CAN YOU READ MORE ABOUT THIS IN 2248 01:20:28,393 --> 01:20:29,861 A NEW FACT SHEET ON THE OFFICE 2249 01:20:29,861 --> 01:20:30,896 OF WOMEN'S HEALTH RESEARCH 2250 01:20:30,896 --> 01:20:31,296 WEBSITE. 2251 01:20:31,296 --> 01:20:32,931 I ALSO PUBLISHED A BLOG LAST 2252 01:20:32,931 --> 01:20:34,266 MONTH EXPLAINING NIH'S OVERALL 2253 01:20:34,266 --> 01:20:34,599 VISION. 2254 01:20:34,599 --> 01:20:36,101 A FOLLOW-UP EVENT AT THE WHITE 2255 01:20:36,101 --> 01:20:38,069 HOUSE HOSTED BID PRESIDENT BIDEN 2256 01:20:38,069 --> 01:20:39,838 AND FIRST LADY JILL BIDEN TOOK 2257 01:20:39,838 --> 01:20:41,907 PLACE YESTERDAY, JOINING LEADERS 2258 01:20:41,907 --> 01:20:44,209 IN GOVERNMENT, ACADEMIC 2259 01:20:44,209 --> 01:20:45,844 RESEARCH, BUSINESS AND 2260 01:20:45,844 --> 01:20:48,480 PHILANTHROPY IN A CALL TO MAKE 2261 01:20:48,480 --> 01:20:49,447 DRAMATICALLY MORE PROGRESS AND 2262 01:20:49,447 --> 01:20:52,951 IMPROVE THE HEALTH OF ALL WOMEN. 2263 01:20:52,951 --> 01:20:56,121 TODAY I'D LIKE TO CLOSE WITH AN 2264 01:20:56,121 --> 01:20:57,455 EMPHASIS ON BASIC SCIENCE. 2265 01:20:57,455 --> 01:20:59,558 THIS IS OUR FOUNDATION. 2266 01:20:59,558 --> 01:21:03,395 NIH FUNDED BASIC RESEARCH 2267 01:21:03,395 --> 01:21:04,896 UNDERLIES ALL DRUGS APPROVED BY 2268 01:21:04,896 --> 01:21:05,897 THE FDA. 2269 01:21:05,897 --> 01:21:09,401 FOR INSTANCE, ALL THERAPIES THAT 2270 01:21:09,401 --> 01:21:12,137 WE PRODUCE FOR ANY NEEDED 2271 01:21:12,137 --> 01:21:15,073 PATIENT GROUP. 2272 01:21:15,073 --> 01:21:19,678 THIS IS JUST A VERY HIGH LEVEL 2273 01:21:19,678 --> 01:21:21,613 HEURISTIC THAT CONSIDERS SOME OF 2274 01:21:21,613 --> 01:21:23,515 THE BIOLOGICAL PROGRAMS THAT 2275 01:21:23,515 --> 01:21:25,417 HUMANS REQUIRE FOR OUR GROWTH 2276 01:21:25,417 --> 01:21:28,220 DEVELOPMENT AND MAINTENANCE OF 2277 01:21:28,220 --> 01:21:28,820 HEALTH. 2278 01:21:28,820 --> 01:21:31,723 EVERY ONE OF US DEVELOPS FROM A 2279 01:21:31,723 --> 01:21:34,159 SINGLE CELL, AND OUR BIOLOGY 2280 01:21:34,159 --> 01:21:35,694 CONSTANTLY CHANGES AS WE 2281 01:21:35,694 --> 01:21:36,761 TRANSITION THROUGHOUT OUR 2282 01:21:36,761 --> 01:21:39,197 VARIOUS LIFE STAGES FROM INFANTS 2283 01:21:39,197 --> 01:21:41,166 ALL THE WAY TO OLDER ADULT. 2284 01:21:41,166 --> 01:21:45,003 AND TO KEEP US HEALTHY IN THE 2285 01:21:45,003 --> 01:21:45,971 FACE OF DEMANDS FROM OUR 2286 01:21:45,971 --> 01:21:50,742 ENVIRONMENT, OUR LIFESTYLE, WE 2287 01:21:50,742 --> 01:21:53,311 MUST BE ABLE TO DO MANY THINGS. 2288 01:21:53,311 --> 01:21:54,412 RENEW EPITHELIUM THAT'S A 2289 01:21:54,412 --> 01:21:56,047 BARRIER BETWEEN US AND THE 2290 01:21:56,047 --> 01:21:58,250 EXTERNAL WORLD, HEAL THE WOUNDS 2291 01:21:58,250 --> 01:22:01,519 OF COMPLEX TISSUES, RESPOND TO 2292 01:22:01,519 --> 01:22:02,988 INFECTIOUS AGENTS, MAINTAIN THE 2293 01:22:02,988 --> 01:22:06,358 INTEGRITY OF OUR DNA. 2294 01:22:06,358 --> 01:22:09,427 FUNCTION IN THE FACE OF EITHER 2295 01:22:09,427 --> 01:22:13,265 FEAST OR FAMINE, AND DETOXIFY 2296 01:22:13,265 --> 01:22:13,798 HARMFUL SUBSTANCES. 2297 01:22:13,798 --> 01:22:15,133 THIS IS JUST A FEW OF THE 2298 01:22:15,133 --> 01:22:16,101 ABSOLUTELY INCREDIBLE THINGS 2299 01:22:16,101 --> 01:22:21,706 THAT OUR BODIES DO EVERY DAY. 2300 01:22:21,706 --> 01:22:23,141 AND WHEN ANY OF THESE CRITICAL 2301 01:22:23,141 --> 01:22:24,476 FUNCTIONS ARE THROWN OUT OF 2302 01:22:24,476 --> 01:22:26,845 BALANCE, DISEASE RESULTS. 2303 01:22:26,845 --> 01:22:28,947 AND THIS HEURISTIC, AS YOU SEE 2304 01:22:28,947 --> 01:22:30,482 LISTED HERE ON THE RIGHT, 2305 01:22:30,482 --> 01:22:32,217 REMINDS US OF THE VALUE OF 2306 01:22:32,217 --> 01:22:33,752 FUNDAMENTAL RESEARCH AS IT 2307 01:22:33,752 --> 01:22:39,157 ADDRESSES UNDERLYING PRINCIPLES 2308 01:22:39,157 --> 01:22:41,126 THAT SPAN MANY ORGAN SYSTEMS AND 2309 01:22:41,126 --> 01:22:42,327 ARE ALL NEEDED TO ADDRESS SO 2310 01:22:42,327 --> 01:22:47,465 MANY DISEASES. 2311 01:22:47,465 --> 01:22:49,000 IT CAN BE MANY YEARS BEFORE A 2312 01:22:49,000 --> 01:22:50,001 STRAND OF FUNDAMENTAL KNOWLEDGE 2313 01:22:50,001 --> 01:22:53,738 ABOUT HOW THE IMMUNE SYSTEM 2314 01:22:53,738 --> 01:22:56,474 WORKS, OR WHAT HAPPENS WITH DNA 2315 01:22:56,474 --> 01:22:58,977 DAMAGE REPAIR. 2316 01:22:58,977 --> 01:23:00,111 MIGHT BE AT FIRST OF INTEREST 2317 01:23:00,111 --> 01:23:03,581 ONLY TO A VERY SMALL NUMBER OF 2318 01:23:03,581 --> 01:23:04,783 ACADEMIC EXPERTS BUT THEN LEADS 2319 01:23:04,783 --> 01:23:06,084 TO A REALLY IMPORTANT NEW 2320 01:23:06,084 --> 01:23:09,154 TREATMENT. 2321 01:23:09,154 --> 01:23:10,155 IT IMPOSSIBLE TO PREDICT WHERE 2322 01:23:10,155 --> 01:23:11,790 IMPORTANT INSIGHTS OR 2323 01:23:11,790 --> 01:23:13,892 DISCOVERIES WILL TAKE PLACE OR I 2324 01:23:13,892 --> 01:23:14,959 PROMISE YOU WE'VE TRIED IF 2325 01:23:14,959 --> 01:23:16,861 POSSIBLE TO PREDICT WHO WILL BE 2326 01:23:16,861 --> 01:23:18,797 INVOLVED IN MAKING THESE. 2327 01:23:18,797 --> 01:23:20,899 IN FACT, THE DEVELOPMENT OF A 2328 01:23:20,899 --> 01:23:22,701 NEW DRUG OR ANY NEW TREATMENT 2329 01:23:22,701 --> 01:23:24,169 OFTEN STEMS FROM THE WORK OF 2330 01:23:24,169 --> 01:23:26,471 THOUSANDS OF SCIENTISTS AT 2331 01:23:26,471 --> 01:23:27,772 THOUSANDS OF ORGANIZATIONS OVER 2332 01:23:27,772 --> 01:23:30,742 MANY DECADES. 2333 01:23:30,742 --> 01:23:32,177 SO I JUST WANT TO REMIND 2334 01:23:32,177 --> 01:23:35,113 EVERYBODY OF NIH'S CORE 2335 01:23:35,113 --> 01:23:36,548 COMMITMENT TO INVESTMENT IN 2336 01:23:36,548 --> 01:23:37,215 BASIC SCIENCE. 2337 01:23:37,215 --> 01:23:39,384 IT MAXIMIZES OUR CHANCES FOR THE 2338 01:23:39,384 --> 01:23:41,353 BREAKTHROUGHS THAT ARE ESSENTIAL 2339 01:23:41,353 --> 01:23:46,925 FOR PROGRESS IN HEALTH. 2340 01:23:46,925 --> 01:23:49,227 I'VE HIGHLIGHTED A NUMBER OF 2341 01:23:49,227 --> 01:23:50,428 EXCITING SCIENTIFIC ADVANCES IN 2342 01:23:50,428 --> 01:23:52,330 THE NIH DIRECTOR'S BLOG 2343 01:23:52,330 --> 01:23:53,465 INCLUDING MANY BASIC RESEARCH 2344 01:23:53,465 --> 01:23:54,099 INSIGHTS. 2345 01:23:54,099 --> 01:23:55,834 I ENCOURAGE EVERYONE TO TAKE A 2346 01:23:55,834 --> 01:23:56,835 LOOK, YOU'LL LEARN MORE ABOUT 2347 01:23:56,835 --> 01:23:58,670 THE AMAZING SCIENCE THAT WE 2348 01:23:58,670 --> 01:24:00,538 SUPPORT ACROSS THE COUNTRY AND 2349 01:24:00,538 --> 01:24:01,873 THE WORLD AND WHAT'S HAPPENED 2350 01:24:01,873 --> 01:24:06,978 OVER THE LAST YEAR. 2351 01:24:06,978 --> 01:24:11,916 AS I END THIS, MY LAST REPORT TO 2352 01:24:11,916 --> 01:24:14,986 THE ACD AS NIH DIRECTOR, I JUST 2353 01:24:14,986 --> 01:24:17,856 WANT TO SAY HOW INCREDIBLY PROUD 2354 01:24:17,856 --> 01:24:21,025 I AM OF THE AMAZING TEAM AT NIH 2355 01:24:21,025 --> 01:24:24,429 OF WHAT THEY HAVE DELIVERED IN 2356 01:24:24,429 --> 01:24:26,097 RESPONSE TO THE NEEDS OF PEOPLE 2357 01:24:26,097 --> 01:24:27,632 ACROSS THE COUNTRY AND INDEED 2358 01:24:27,632 --> 01:24:33,037 THE WORLD OVER THE LAST YEAR CH 2359 01:24:33,037 --> 01:24:35,073 ONE THING, THOUGH, I HAVE TO DO, 2360 01:24:35,073 --> 01:24:36,708 THERE ARE SO MANY PEOPLE I WISH 2361 01:24:36,708 --> 01:24:40,979 I COULD THANK HERE TODAY, BUT 2362 01:24:40,979 --> 01:24:44,849 THERE IS ONE PERSON, TWO PEOPLE 2363 01:24:44,849 --> 01:24:46,284 I REALLY NEED TO CALL OUT WHO 2364 01:24:46,284 --> 01:24:50,555 HAVE BEEN AT MY SIDE EVERY 2365 01:24:50,555 --> 01:24:51,856 SINGLE STEP OF THE WAY. 2366 01:24:51,856 --> 01:24:55,860 THEY ARE DR. LARRY TABAK AND OUR 2367 01:24:55,860 --> 01:24:59,097 CHIEF OF STAFF, JOHN BER CLOA, 2368 01:24:59,097 --> 01:25:00,965 EVERY STEP OF THE WAY. 2369 01:25:00,965 --> 01:25:02,100 I PERSONALLY AS DIRECTOR 2370 01:25:02,100 --> 01:25:03,067 COULDN'T HAVE ACCOMPLISHED 2371 01:25:03,067 --> 01:25:04,068 ANYTHING I DID WITHOUT YOU. 2372 01:25:04,068 --> 01:25:05,804 YOUR WISDOM, DEDICATION TO 2373 01:25:05,804 --> 01:25:10,408 WHAT'S BEST FOR NIH ALWAYS AND 2374 01:25:10,408 --> 01:25:12,710 YOUR JUST PLAIN HARD WORK 2375 01:25:12,710 --> 01:25:14,379 24/7 HAS ALLOWED US TO SUCCEED 2376 01:25:14,379 --> 01:25:15,547 IN EVERYTHING WE'VE DONE OVER 2377 01:25:15,547 --> 01:25:16,681 THE YEAR THAT I'VE BEEN IN THIS 2378 01:25:16,681 --> 01:25:17,148 ROLE. 2379 01:25:17,148 --> 01:25:18,216 SO THANK YOU. 2380 01:25:18,216 --> 01:25:20,318 I'M SO GRATEFUL AND I CAN TELL 2381 01:25:20,318 --> 01:25:22,854 YOU SO ARE EVERYONE WHO ARE 2382 01:25:22,854 --> 01:25:23,721 SERVED BY NIH. 2383 01:25:23,721 --> 01:25:25,256 SO WITH THAT, I'D LIKE TO THANK 2384 01:25:25,256 --> 01:25:26,257 EVERYONE HERE AGAIN FOR JOINING 2385 01:25:26,257 --> 01:25:28,359 US TODAY, AND I'LL NOW OPEN IT 2386 01:25:28,359 --> 01:25:28,960 UP TO DISCUSSION. 2387 01:25:28,960 --> 01:25:32,964 >> SO BEFORE WE GO TO QUESTIONS, 2388 01:25:32,964 --> 01:25:35,800 I, DESPITE THOSE VERY KIND 2389 01:25:35,800 --> 01:25:36,334 WORDS, SCREWED UP AT THE 2390 01:25:36,334 --> 01:25:39,103 BEGINNING AND FAILED TO 2391 01:25:39,103 --> 01:25:40,171 ACKNOWLEDGE SEVERAL AD HOC 2392 01:25:40,171 --> 01:25:43,708 MEMBERS THAT ARE JOINING OUR 2393 01:25:43,708 --> 01:25:44,375 CHARTERED MEMBERS TODAY. 2394 01:25:44,375 --> 01:25:45,777 SO I JUST WANT TO ACKNOWLEDGE 2395 01:25:45,777 --> 01:25:46,878 WHO THOSE FOLKS ARE. 2396 01:25:46,878 --> 01:25:47,979 THEY'RE GOING TO BE COMING IN 2397 01:25:47,979 --> 01:25:51,282 AND OUT OF THE MEETING OVER THE 2398 01:25:51,282 --> 01:25:54,752 NEXT -- SO FIRST IS DR. MARK 2399 01:25:54,752 --> 01:25:56,287 NELSON, UNIVERSITY DISTINGUISHED 2400 01:25:56,287 --> 01:25:57,155 PROFESSOR AND CHAIR OF THE 2401 01:25:57,155 --> 01:25:58,156 DEPARTMENT OF PHARMACOLOGY AT 2402 01:25:58,156 --> 01:25:59,858 THE UNIVERSITY OF VERMONT, 2403 01:25:59,858 --> 01:26:01,993 COLLEGE OF MEDICINE. 2404 01:26:01,993 --> 01:26:04,429 AND IF I BUTCHER YOUR NAMES, 2405 01:26:04,429 --> 01:26:07,565 PLEASE CORRECT ME. 2406 01:26:07,565 --> 01:26:11,069 DR. RUSSELL VAN GELDER IS THE 2407 01:26:11,069 --> 01:26:12,437 PROFESSOR AND CHAIR OF THE 2408 01:26:12,437 --> 01:26:14,372 DEPARTMENT OF OPHTHALMOLOGY AT 2409 01:26:14,372 --> 01:26:15,106 THE UNIVERSITY OF WASHINGTON 2410 01:26:15,106 --> 01:26:16,574 MEDICAL SCHOOL. 2411 01:26:16,574 --> 01:26:21,279 AND DR. ELIZABETH VILLA IS A 2412 01:26:21,279 --> 01:26:22,347 HOWARD U INVESTIGATOR AND 2413 01:26:22,347 --> 01:26:24,682 PROFESSOR OF MOLECULAR BIOLOGY 2414 01:26:24,682 --> 01:26:26,551 AT U.C. SAN DIEGO. 2415 01:26:26,551 --> 01:26:28,853 SO I WANT TO WELCOME THOSE 2416 01:26:28,853 --> 01:26:29,153 INDIVIDUALS. 2417 01:26:29,153 --> 01:26:30,054 I HOPE SOME OF THEM ARE ON AT 2418 01:26:30,054 --> 01:26:30,622 THE MOMENT. 2419 01:26:30,622 --> 01:26:32,657 I KNOW THEY'RE GOING IN AND OUT, 2420 01:26:32,657 --> 01:26:33,825 AS WELL AS, OF COURSE, OUR 2421 01:26:33,825 --> 01:26:34,359 CHARTER MEMBERS. 2422 01:26:34,359 --> 01:26:37,529 WITH THAT, IF YOU COULD USE THE 2423 01:26:37,529 --> 01:26:40,698 RAISE YOUR HAND FUNCTION ON YOUR 2424 01:26:40,698 --> 01:26:43,902 ZOOM, AND IF WE CAN PULL THAT 2425 01:26:43,902 --> 01:26:46,404 UP, THAT WOULD BE GREAT. 2426 01:26:46,404 --> 01:26:50,608 AND WE WILL ANSWER ANY QUESTIONS 2427 01:26:50,608 --> 01:26:55,914 THAT PEOPLE MAY POSE ABOUT 2428 01:26:55,914 --> 01:26:56,581 EVERYTHING THAT HAS BEEN COVERED 2429 01:26:56,581 --> 01:26:58,550 TODAY. 2430 01:26:58,550 --> 01:27:01,052 THE WAY THIS WORKS, IF YOU DON'T 2431 01:27:01,052 --> 01:27:02,320 ASK US QUESTIONS, WE START 2432 01:27:02,320 --> 01:27:04,155 ASKING YOU QUESTION, SO YOU 2433 01:27:04,155 --> 01:27:06,124 PROBABLY WANT TO BE PROACTIVE 2434 01:27:06,124 --> 01:27:12,030 HERE AND PREVENT A LECTURE ABOUT 2435 01:27:12,030 --> 01:27:13,665 THE KREBS CYCLE. 2436 01:27:13,665 --> 01:27:14,499 RUSS, PLEASE, YOU'RE UP. 2437 01:27:14,499 --> 01:27:15,333 >> THANK YOU. 2438 01:27:15,333 --> 01:27:16,301 FIRST THANK YOU FOR THE 2439 01:27:16,301 --> 01:27:20,572 PRIVILEGE OF AD HOCING. 2440 01:27:20,572 --> 01:27:22,340 LET ME JUST EXPRESS MY 2441 01:27:22,340 --> 01:27:23,741 APPRECIATION TO THE DIRECTOR FOR 2442 01:27:23,741 --> 01:27:25,243 THE OUTSTANDING LEADERSHIP OVER 2443 01:27:25,243 --> 01:27:28,947 THE PAST FEW YEARS OF THE NIH, 2444 01:27:28,947 --> 01:27:30,381 WHICH IS GREATLY APPRECIATED BY 2445 01:27:30,381 --> 01:27:30,915 OUR ENTIRE COMMUNITY. 2446 01:27:30,915 --> 01:27:31,816 I HAVE TWO QUESTIONS. 2447 01:27:31,816 --> 01:27:35,753 ONE A BROAD ONE, ONE IS A 2448 01:27:35,753 --> 01:27:36,087 NARROWER ONE. 2449 01:27:36,087 --> 01:27:37,722 THE BROAD ONE IS A MECHANISTIC 2450 01:27:37,722 --> 01:27:39,023 QUESTION AND IT'S REALLY ABOUT 2451 01:27:39,023 --> 01:27:41,559 HOW ANY REORGANIZATION OF NIH 2452 01:27:41,559 --> 01:27:44,729 WOULD PROCEED. 2453 01:27:44,729 --> 01:27:46,064 THERE IS THE PRESCRIBED 2454 01:27:46,064 --> 01:27:47,599 MECHANISM FOR MAKING 2455 01:27:47,599 --> 01:27:48,132 RECOMMENDATIONS WHICH GOES 2456 01:27:48,132 --> 01:27:49,233 THROUGH THE SCIENTIFIC 2457 01:27:49,233 --> 01:27:50,168 MANAGEMENT REVIEW BOARD, WHICH 2458 01:27:50,168 --> 01:27:51,970 IS NOW RECONVENED, AND THEN 2459 01:27:51,970 --> 01:27:53,738 THERE'S THE CONGRESSIONAL 2460 01:27:53,738 --> 01:27:55,406 PROCESSES FOR APPROPRIATIONS, 2461 01:27:55,406 --> 01:27:59,110 WHICH AS YOU NOTED THIS YEAR, 2462 01:27:59,110 --> 01:28:00,645 HAD APPROPRIATIONS IN THE HOUSE 2463 01:28:00,645 --> 01:28:05,183 BILL FOR A MAJOR REORGANIZATION 2464 01:28:05,183 --> 01:28:06,317 WHICH DID NOT HAVE THE SAME 2465 01:28:06,317 --> 01:28:10,088 PROCESS IN TERMS OF COMMITTEE 2466 01:28:10,088 --> 01:28:11,856 EVALUATION AND FORMAL 2467 01:28:11,856 --> 01:28:14,926 RECOMMENDATIONS. 2468 01:28:14,926 --> 01:28:18,863 HOW ARE THOSE TWO PROCESSES 2469 01:28:18,863 --> 01:28:19,230 INTERDIGITATED? 2470 01:28:19,230 --> 01:28:20,732 >> SO I CAN ANSWER THIS AND THEN 2471 01:28:20,732 --> 01:28:21,866 I ALWAYS HAVE LARRY HERE TO 2472 01:28:21,866 --> 01:28:23,701 CORRECT ME IF I GET ANY OF THIS 2473 01:28:23,701 --> 01:28:26,404 WRONG, BUT YOU KNOW, OUR 2474 01:28:26,404 --> 01:28:28,773 INSTITUTES AND CENTERS ARE 2475 01:28:28,773 --> 01:28:30,975 DESIGNATED BY CONGRESS. 2476 01:28:30,975 --> 01:28:33,144 THEY HAVE THE -- THEY HAVE THE 2477 01:28:33,144 --> 01:28:34,178 AUTHORITY. 2478 01:28:34,178 --> 01:28:35,446 AND SO SOMETHING LIKE -- I'LL 2479 01:28:35,446 --> 01:28:37,315 JUST GIVE YOU AN EXAMPLE OF 2480 01:28:37,315 --> 01:28:38,850 SOMETHING THAT WE ACTUALLY HAVE 2481 01:28:38,850 --> 01:28:40,818 PROPOSED RIGHT NOW, AND WE'RE 2482 01:28:40,818 --> 01:28:41,919 WAITING TO SEE IF WE GET THE 2483 01:28:41,919 --> 01:28:43,354 RESULT, WE WOULD LIKE TO CHANGE, 2484 01:28:43,354 --> 01:28:45,523 FOR INSTANCE, THE NAME OF ONE OF 2485 01:28:45,523 --> 01:28:48,059 OUR INSTITUTES AND CENTERS. 2486 01:28:48,059 --> 01:28:55,166 EVEN CHANGING THE NAME, THIS IS 2487 01:28:55,166 --> 01:28:56,067 THE NICHD WE WOULD LIKE TO 2488 01:28:56,067 --> 01:28:57,368 CHANGE THE NAME OF THE NATIONAL 2489 01:28:57,368 --> 01:28:58,336 INSTITUTE OF CHILDHOOD HEALTH 2490 01:28:58,336 --> 01:29:03,374 AND DEVELOPMENT, TO ACKNOWLEDGE 2491 01:29:03,374 --> 01:29:05,043 ITS ALSO CRITICAL ROLE IN 2492 01:29:05,043 --> 01:29:06,310 WOMEN'S HEALTH AND FURTHERING 2493 01:29:06,310 --> 01:29:06,811 WOMEN'S HEALTH. 2494 01:29:06,811 --> 01:29:08,446 AND EVEN DOING THAT, A NAME 2495 01:29:08,446 --> 01:29:10,481 CHANGE, HAS GOT TO BE APPROVED 2496 01:29:10,481 --> 01:29:13,217 BY CONGRESS. 2497 01:29:13,217 --> 01:29:15,119 SO THE ADVISORY COMMITTEE TO THE 2498 01:29:15,119 --> 01:29:17,455 DIRECTOR IS DESIGNED TO BRING 2499 01:29:17,455 --> 01:29:18,890 EXPERTS CONTENT, EXPERTS IN WHAT 2500 01:29:18,890 --> 01:29:21,325 WE DO TO GIVE PROPOSALS TO THE 2501 01:29:21,325 --> 01:29:23,161 DIRECTOR WHICH THEN WILL BE -- 2502 01:29:23,161 --> 01:29:24,796 WHICH WILL THEN BE TRANSMITTED 2503 01:29:24,796 --> 01:29:27,265 TO CONGRESS AS REQUESTS. 2504 01:29:27,265 --> 01:29:27,532 >> OKAY. 2505 01:29:27,532 --> 01:29:28,633 THANK YOU. 2506 01:29:28,633 --> 01:29:30,935 >> AND KATE, I DON'T KNOW IF YOU 2507 01:29:30,935 --> 01:29:32,870 HAVE ANYTHING IN ADDITION TO 2508 01:29:32,870 --> 01:29:33,671 ADD. 2509 01:29:33,671 --> 01:29:37,275 THE SMRB WAS RECONVENED IN PART 2510 01:29:37,275 --> 01:29:38,843 BECAUSE THE NIH DIRECTOR THOUGHT 2511 01:29:38,843 --> 01:29:40,611 THIS WOULD BE A VERY VALUABLE 2512 01:29:40,611 --> 01:29:42,480 TOOL, AND IN PART BECAUSE THE 2513 01:29:42,480 --> 01:29:45,717 CONGRESS ALSO ASKED US TO 2514 01:29:45,717 --> 01:29:45,983 RECONVENE. 2515 01:29:45,983 --> 01:29:48,052 SO IT'S OUR HOPE THAT THE 2516 01:29:48,052 --> 01:29:51,856 CONGRESS WILL BE INFORMED BY THE 2517 01:29:51,856 --> 01:29:54,926 DELIBERATIONS OF THE SMRB, BUT 2518 01:29:54,926 --> 01:29:57,161 AS THE NIH DIRECTOR HAS SAID, 2519 01:29:57,161 --> 01:29:58,663 OBVIOUSLY IT'S ULTIMATELY THE 2520 01:29:58,663 --> 01:29:59,230 CONGRESS' ROLE. 2521 01:29:59,230 --> 01:30:00,965 KATE, ANYTHING TO ADD TO THAT? 2522 01:30:00,965 --> 01:30:03,501 >> NO, I GUESS I WOULD JUST -- 2523 01:30:03,501 --> 01:30:06,671 THE ONLY THING I WOULD ADD IS 2524 01:30:06,671 --> 01:30:08,806 NEXT YEAR IN THE 119TH CONGRESS, 2525 01:30:08,806 --> 01:30:10,408 WE DO EXPECT THERE TO BE SOME 2526 01:30:10,408 --> 01:30:13,044 CONTINUED INTEREST IN NIH 2527 01:30:13,044 --> 01:30:14,545 RE-AUTHORIZATION, AND I THINK 2528 01:30:14,545 --> 01:30:16,447 THE TOPIC OF CONSOLIDATION COULD 2529 01:30:16,447 --> 01:30:18,750 COME UP AGAIN. 2530 01:30:18,750 --> 01:30:22,053 I EXPECT THERE WILL BE A PRETTY 2531 01:30:22,053 --> 01:30:25,356 ROBUST PROCESS, BIPARTISAN, 2532 01:30:25,356 --> 01:30:26,557 BICAMERAL, TO DISCUSS ANY 2533 01:30:26,557 --> 01:30:28,960 CHANGES IF THERE ARE ANY THAT 2534 01:30:28,960 --> 01:30:31,929 CONGRESS WOULD WANT TO PURSUE. 2535 01:30:31,929 --> 01:30:34,232 I THINK THEY DO WANT THE 2536 01:30:34,232 --> 01:30:35,533 RECOMMENDATIONS FROM THE SMRB TO 2537 01:30:35,533 --> 01:30:36,334 INFORM THAT PROCESS. 2538 01:30:36,334 --> 01:30:41,806 YOU KNOW, BOTH THE HOUSE AND THE 2539 01:30:41,806 --> 01:30:45,409 SENATE, AND ENERGY AND COMMERCE, 2540 01:30:45,409 --> 01:30:46,711 HAD A REQUEST FOR INFORMATION. 2541 01:30:46,711 --> 01:30:48,713 SO THEY WERE SEEKING INPUT FROM 2542 01:30:48,713 --> 01:30:50,615 NIH PARTNERS ACROSS THE SPECTRUM 2543 01:30:50,615 --> 01:30:51,015 AS WELL. 2544 01:30:51,015 --> 01:30:52,183 SO MUCH MORE TO COME, BUT IT 2545 01:30:52,183 --> 01:30:55,753 WILL BE A LONGER TERM, I HOPE 2546 01:30:55,753 --> 01:30:56,954 BIPARTISAN PROCESS WITH INPUT 2547 01:30:56,954 --> 01:30:59,457 FROM MANY PARTNERS BEFORE 2548 01:30:59,457 --> 01:31:00,658 CONGRESS ULTIMATELY DECIDES 2549 01:31:00,658 --> 01:31:01,692 WHETHER THEY WOULD WANT TO MAKE 2550 01:31:01,692 --> 01:31:04,529 ANY CHANGES. 2551 01:31:04,529 --> 01:31:05,163 >> EXCELLENT. 2552 01:31:05,163 --> 01:31:05,830 THANK YOU. 2553 01:31:05,830 --> 01:31:09,767 THE SECOND QUESTION IS ABOUT THE 2554 01:31:09,767 --> 01:31:12,970 TRUSTED DATA REPOSITORY WITHIN 2555 01:31:12,970 --> 01:31:16,374 HHS, AND I THINK THIS IS A 2556 01:31:16,374 --> 01:31:18,242 PHENOMENAL OPPORTUNITY. 2557 01:31:18,242 --> 01:31:19,811 WITHIN OUR LITTLE FIELD OF 2558 01:31:19,811 --> 01:31:20,778 OPHTHALMOLOGY, WE HAVE A 2559 01:31:20,778 --> 01:31:21,779 REGISTRY WHICH DEVELOPED REALLY 2560 01:31:21,779 --> 01:31:25,149 OUT OF A CMS COLLABORATION 2561 01:31:25,149 --> 01:31:28,686 CALLED IRIS, WHICH IS A TRUSTED 2562 01:31:28,686 --> 01:31:30,221 BROKER FOR QUALITY OF CARE DATA 2563 01:31:30,221 --> 01:31:34,392 TO GO FORWARD TO CMS, AND HAS 2564 01:31:34,392 --> 01:31:35,493 BEEN WILDLY SUCCESSFUL. 2565 01:31:35,493 --> 01:31:37,128 WE HAVE ALMOST 700 MILLION 2566 01:31:37,128 --> 01:31:39,197 PATIENT VISITS AND 75 MILLION 2567 01:31:39,197 --> 01:31:40,998 PATIENTS IN THIS REGISTRY, ALL 2568 01:31:40,998 --> 01:31:42,433 OF WHOM HAVE AGREED TO HAVE 2569 01:31:42,433 --> 01:31:44,068 THEIR DE-IDENTIFIED DATA BE USED 2570 01:31:44,068 --> 01:31:47,405 FOR REAL WORLD STUDIES. 2571 01:31:47,405 --> 01:31:49,040 IN LOOKING AT EXPANDING THIS, 2572 01:31:49,040 --> 01:31:51,542 THE TRIPPING POINT ENDS UP BEING 2573 01:31:51,542 --> 01:31:55,613 DATA INTEROPERABILITY, AND IN 2574 01:31:55,613 --> 01:31:57,682 PARTICULAR, DICOM-TYPE STANDARDS 2575 01:31:57,682 --> 01:31:59,650 SO THAT EVERYONE'S DATA CAN BE 2576 01:31:59,650 --> 01:32:00,751 HARMONIZED. 2577 01:32:00,751 --> 01:32:02,320 RECENTLY THE NEI, THE FDA, AND 2578 01:32:02,320 --> 01:32:06,390 THE ONC ALL CAME TO AGREEMENT ON 2579 01:32:06,390 --> 01:32:09,894 STANDARDS THAT WOULD ENSURE 2580 01:32:09,894 --> 01:32:10,895 INTEROPERABILITY, BUT CMS WAS 2581 01:32:10,895 --> 01:32:14,165 NOT IN THAT DISCUSSION, AND 2582 01:32:14,165 --> 01:32:15,600 ULTIMATELY IN THE REAL WORLD, 2583 01:32:15,600 --> 01:32:17,268 CMS IS WHERE THE RUBBER MEETS 2584 01:32:17,268 --> 01:32:22,607 THE ROAD IN THAT AN 2585 01:32:22,607 --> 01:32:23,374 OPHTHALMOLOGIST JUST BUYING A 2586 01:32:23,374 --> 01:32:25,309 PIECE OF EQUIPMENT NEEDS TO GET 2587 01:32:25,309 --> 01:32:28,045 REIMBURSED FOR THEIR SERVICES, 2588 01:32:28,045 --> 01:32:30,248 IF CMS SAID IT HAS TO BE A DICOM 2589 01:32:30,248 --> 01:32:31,349 COMPLIANT PIECE OF EQUIPMENT, IT 2590 01:32:31,349 --> 01:32:31,983 WOULD HAPPEN TOMORROW. 2591 01:32:31,983 --> 01:32:34,285 IS THIS NEW SORT OF HHS WIDE 2592 01:32:34,285 --> 01:32:37,255 TRUSTED BROKER THE PLACE WHERE 2593 01:32:37,255 --> 01:32:38,489 THESE SORTS OF DISCUSSIONS WILL 2594 01:32:38,489 --> 01:32:38,723 HAPPEN? 2595 01:32:38,723 --> 01:32:42,727 >> SO, NO, BUT LET ME JUST BE 2596 01:32:42,727 --> 01:32:43,761 VERY CLEAR. 2597 01:32:43,761 --> 01:32:46,264 THE TRUSTED BROKER IS AN 2598 01:32:46,264 --> 01:32:53,604 ORGANIZATION THAT IS AN 2599 01:32:53,604 --> 01:32:54,038 AFFILIATE. 2600 01:32:54,038 --> 01:32:54,906 FOUNDATION FOR THE NIH. 2601 01:32:54,906 --> 01:32:57,575 IT IS INTENTIONALLY DESIGNED TO 2602 01:32:57,575 --> 01:33:01,512 BE OUTSIDE OF GOVERNMENT, BUT TO 2603 01:33:01,512 --> 01:33:03,681 BE RESPONSIVE TO GOVERNMENT 2604 01:33:03,681 --> 01:33:04,348 REQUEST. 2605 01:33:04,348 --> 01:33:08,019 OKAY, SO THAT'S IMPORTANT. 2606 01:33:08,019 --> 01:33:11,055 AND IT'S BASICALLY -- I THINK 2607 01:33:11,055 --> 01:33:12,089 THIS MATTERS A LOT. 2608 01:33:12,089 --> 01:33:15,126 IT IS INTENDED TO BE AN EXTRA 2609 01:33:15,126 --> 01:33:18,229 LEVEL OF SECURITY BETWEEN ANY OF 2610 01:33:18,229 --> 01:33:20,164 US WHEN WE WALK INTO OUR 2611 01:33:20,164 --> 01:33:21,165 DOCTOR'S OFFICE AND SAY YES, YOU 2612 01:33:21,165 --> 01:33:25,703 CAN HAVE MY DATA FOR RESEARCH, 2613 01:33:25,703 --> 01:33:28,773 AND IN SOME CASES EVEN, MAYBE 2614 01:33:28,773 --> 01:33:30,975 YOU CAN IDENTIFY ME BECAUSE I 2615 01:33:30,975 --> 01:33:37,214 WANT TO BE CONTACTED IF SOME 2616 01:33:37,214 --> 01:33:39,417 OPPORTUNITY COMES. 2617 01:33:39,417 --> 01:33:42,286 IT'S DESIGNED TO BE AN 2618 01:33:42,286 --> 01:33:44,922 ADDITIONAL BUFFER THAT WILL 2619 01:33:44,922 --> 01:33:47,124 ENSURE EXTRA SECURITY FOR THAT 2620 01:33:47,124 --> 01:33:49,327 INTERACTION. 2621 01:33:49,327 --> 01:33:49,994 BASICALLY BETWEEN 2622 01:33:49,994 --> 01:33:51,062 FEDERAL GOVERNMENT USE OF DATA 2623 01:33:51,062 --> 01:33:54,799 OR REALLY ANYBODY USE OF DATA, 2624 01:33:54,799 --> 01:33:56,834 AND THE PRIMARY TREATING 2625 01:33:56,834 --> 01:33:57,134 INSTITUTION. 2626 01:33:57,134 --> 01:33:58,369 SO THAT'S WHAT THE TRUSTED 2627 01:33:58,369 --> 01:33:59,370 BROKER IS. 2628 01:33:59,370 --> 01:34:03,641 NOW, THE PROGRAM, THE EFFORT 2629 01:34:03,641 --> 01:34:05,142 WITHIN GOVERNMENT TO USE DATA 2630 01:34:05,142 --> 01:34:08,679 THAT IS NEEDED BY GOVERNMENT 2631 01:34:08,679 --> 01:34:12,516 SUCH AS CMS, CDC, FDA, THAT IS 2632 01:34:12,516 --> 01:34:15,486 AN EFFORT THAT HAS BEEN 2633 01:34:15,486 --> 01:34:19,123 SPEARHEADED BY NIH UNDER THE 2634 01:34:19,123 --> 01:34:21,492 ROOF OF THE NATIONAL LIBRARY OF 2635 01:34:21,492 --> 01:34:23,828 MEDICINE, AND THAT IS WHERE THE 2636 01:34:23,828 --> 01:34:25,863 DATA STANDARDS, THE APPROACHES, 2637 01:34:25,863 --> 01:34:28,165 THE INTEROPERABILITY PLANS, ALL 2638 01:34:28,165 --> 01:34:30,468 OF THAT IS BEING DEVELOPED. 2639 01:34:30,468 --> 01:34:32,136 SO THAT IS BEING DEVELOPED NOT 2640 01:34:32,136 --> 01:34:34,205 IN THE BROKER, THE BROKER IS 2641 01:34:34,205 --> 01:34:35,740 JUST MAKING SURE EVERYTHING 2642 01:34:35,740 --> 01:34:38,909 HAPPENS PROPERLY. 2643 01:34:38,909 --> 01:34:40,244 THEN LAST OF ALL I WANT TO SAY 2644 01:34:40,244 --> 01:34:45,082 THAT -- AND YES, CMS ABSOL ABSOY 2645 01:34:45,082 --> 01:34:46,917 AT THE TABLE. 2646 01:34:46,917 --> 01:34:48,986 AS YOU SEE, FOR ONCOLOGY, CMS IS 2647 01:34:48,986 --> 01:34:49,620 AT THE TABLE. 2648 01:34:49,620 --> 01:34:50,921 THEY'RE NOT AT THE TABLE LATE. 2649 01:34:50,921 --> 01:34:52,323 THEY'RE AT THE TABLE AT THE VERY 2650 01:34:52,323 --> 01:34:53,591 BEGINNING AS WE DEVELOP THE USE 2651 01:34:53,591 --> 01:34:55,426 CASES TO DEVELOP THE STANDARDS, 2652 01:34:55,426 --> 01:34:59,163 AND WE THINK THAT BEING THERE 2653 01:34:59,163 --> 01:35:00,598 FROM THE VERY BEGINNING IS VERY 2654 01:35:00,598 --> 01:35:01,799 HELPFUL IN GETTING ENGAGEMENT 2655 01:35:01,799 --> 01:35:04,001 ACROSS ALL THE AGENCIES. 2656 01:35:04,001 --> 01:35:05,736 LAST OF ALL, I JUST WANT TO 2657 01:35:05,736 --> 01:35:06,670 CONGRATULATE THE OPHTHALMOLOGY 2658 01:35:06,670 --> 01:35:07,038 COMMUNITY. 2659 01:35:07,038 --> 01:35:08,105 YOU WERE THE FIRST. 2660 01:35:08,105 --> 01:35:12,810 I THINK WE CAME ALONG WITH NCODE 2661 01:35:12,810 --> 01:35:13,911 AFTERWARD BUT WE WERE WATCHING 2662 01:35:13,911 --> 01:35:14,812 YOU VERY CAREFULLY. 2663 01:35:14,812 --> 01:35:17,782 THIS IS NOW ALMOST A DECADE AGO, 2664 01:35:17,782 --> 01:35:19,250 AND THE OPHTHALMOLOGY COMMUNITY 2665 01:35:19,250 --> 01:35:20,451 I WILL SAY IS THE FIRST AND BEST 2666 01:35:20,451 --> 01:35:22,086 IN CLASS IN GETTING A COMMUNITY 2667 01:35:22,086 --> 01:35:25,489 OF CLINICIANS BEHIND MAKING THIS 2668 01:35:25,489 --> 01:35:26,157 A REALITY FOR EVERYBODY, SO 2669 01:35:26,157 --> 01:35:26,724 THANK YOU. 2670 01:35:26,724 --> 01:35:29,593 >> THANK YOU. 2671 01:35:29,593 --> 01:35:30,995 >> OTHER QUESTIONS OR COMMENTS, 2672 01:35:30,995 --> 01:35:31,228 PLEASE? 2673 01:35:31,228 --> 01:35:32,797 IF YOU COULD RAISE YOUR HAND. 2674 01:35:32,797 --> 01:35:34,899 YES, COREY. 2675 01:35:34,899 --> 01:35:35,866 >> YES. 2676 01:35:35,866 --> 01:35:36,200 GOOD MORNING. 2677 01:35:36,200 --> 01:35:37,568 I DON'T HAVE A QUESTION, BUT I 2678 01:35:37,568 --> 01:35:40,638 WOULD LIKE TO MAKE A COMMENT. 2679 01:35:40,638 --> 01:35:43,808 LET ME GIVE FIRST A PHYSICAL 2680 01:35:43,808 --> 01:35:45,109 DESCRIPTION FOR INDIVIDUALS WHO 2681 01:35:45,109 --> 01:35:46,577 MAY BE VISUALLY IMPAIRED. 2682 01:35:46,577 --> 01:35:49,647 I AM AN AFRICAN AMERICAN MIDDLE 2683 01:35:49,647 --> 01:35:52,249 AGED MALE AND I HAVE ON A 2684 01:35:52,249 --> 01:35:55,086 STRIPED DRESS SHIRT WITH A 2685 01:35:55,086 --> 01:35:56,887 BACKGROUND OF BLUE AND ORANGE. 2686 01:35:56,887 --> 01:35:59,557 AND SO IN TERMS OF -- IN 2687 01:35:59,557 --> 01:36:01,392 RESPONSE TO THE DIRECTOR'S 2688 01:36:01,392 --> 01:36:08,099 REPORT THIS MORNING REGARDING 2689 01:36:08,099 --> 01:36:09,433 THE MISSION CHANGE, AS 2690 01:36:09,433 --> 01:36:10,734 RECOMMENDED BY THE SUBCOMMITTEE 2691 01:36:10,734 --> 01:36:11,368 ON INDIVIDUALS WITH 2692 01:36:11,368 --> 01:36:13,304 DISABILITIES, I WOULD LIKE TO 2693 01:36:13,304 --> 01:36:15,272 ACKNOWLEDGE THE OUTSTANDING WORK 2694 01:36:15,272 --> 01:36:17,775 THAT THE NIH IS DOING IN ORDER 2695 01:36:17,775 --> 01:36:20,611 TO ENGAGE THE DISABILITY 2696 01:36:20,611 --> 01:36:22,046 COMMUNITY TO GATHER INFORMATION 2697 01:36:22,046 --> 01:36:23,280 FROM THAT COMMUNITY IN TERMS OF 2698 01:36:23,280 --> 01:36:26,584 THEIR PERSPECTIVES AROUND THE 2699 01:36:26,584 --> 01:36:27,651 MISSION CHANGE, AND IN 2700 01:36:27,651 --> 01:36:29,186 PARTICULAR, THE VIRTUAL 2701 01:36:29,186 --> 01:36:33,891 ROUNDTABLE DISCUSSIONS, I THINK 2702 01:36:33,891 --> 01:36:36,360 HAVE BEEN REMARKABLE IN TERMS OF 2703 01:36:36,360 --> 01:36:37,661 GATHERING THESE PERSPECTIVES. 2704 01:36:37,661 --> 01:36:39,363 AND I MYSELF HAD AN OPPORTUNITY 2705 01:36:39,363 --> 01:36:40,564 TO PARTICIPATE ON ONE OF THESE 2706 01:36:40,564 --> 01:36:42,533 ROUNDTABLES ON NOVEMBER THE 2707 01:36:42,533 --> 01:36:43,834 12TH, AND I FELT LIKE THE 2708 01:36:43,834 --> 01:36:47,805 ENGAGEMENT WAS OUTSTANDING. 2709 01:36:47,805 --> 01:36:52,543 SO I AM -- I'M VERY IMPRESSED 2710 01:36:52,543 --> 01:36:54,378 WITH WHAT THE NIH IS DOING IN 2711 01:36:54,378 --> 01:36:58,282 ORDER TO REACH THE DISABLED 2712 01:36:58,282 --> 01:36:59,483 COMMUNITY FOR THEIR 2713 01:36:59,483 --> 01:37:00,017 PERSPECTIVES, BECAUSE WE 2714 01:37:00,017 --> 01:37:01,318 UNDERSTAND THAT THE OPPOSITION 2715 01:37:01,318 --> 01:37:06,290 IN PARTICULAR TO THIS MISSION 2716 01:37:06,290 --> 01:37:07,291 CHANGE HAS BEEN SOMEWHAT STRONG, 2717 01:37:07,291 --> 01:37:12,296 SO I THINK IT'S CRITICAL THAT WE 2718 01:37:12,296 --> 01:37:13,764 ALL CONTINUE TO GET FEEDBACK 2719 01:37:13,764 --> 01:37:17,935 FROM THE COMMUNITY IN TERMS OF 2720 01:37:17,935 --> 01:37:19,036 THE DISABILITY COMMUNITY IN 2721 01:37:19,036 --> 01:37:22,640 ORDER TO MAKE A FINAL DECISION 2722 01:37:22,640 --> 01:37:23,407 AROUND THE MISSION STATEMENT. 2723 01:37:23,407 --> 01:37:24,842 SO I JUST WANTED TO MAKE THAT 2724 01:37:24,842 --> 01:37:25,075 COMMENT. 2725 01:37:25,075 --> 01:37:25,509 THANK YOU. 2726 01:37:25,509 --> 01:37:28,479 >> THANK YOU SO MUCH, COREY. 2727 01:37:28,479 --> 01:37:29,480 I REALLY APPRECIATE IT. 2728 01:37:29,480 --> 01:37:34,218 AND I JUST HAVE TO SAY THAT THIS 2729 01:37:34,218 --> 01:37:35,286 IS A THEME ACROSS EVERYTHING 2730 01:37:35,286 --> 01:37:39,623 THAT WE'RE DOING, IS SERIOUSLY 2731 01:37:39,623 --> 01:37:46,430 ENGAGE WITH PEOPLE WE SERVE, AND 2732 01:37:46,430 --> 01:37:48,499 I WILL SAY I BELIEVE IT WILL 2733 01:37:48,499 --> 01:37:49,600 BRING BENEFIT TO THE PEOPLE WE 2734 01:37:49,600 --> 01:37:51,936 SERVE BUT, OH, IT IS JUST SUCH A 2735 01:37:51,936 --> 01:37:53,137 POSITIVE FOR US AS WELL. 2736 01:37:53,137 --> 01:37:57,841 WE ARE SO MUCH SMARTER, MORE 2737 01:37:57,841 --> 01:38:03,781 ABLE TO GIED THE RESEA GUIDE THA 2738 01:38:03,781 --> 01:38:05,182 POSITIVE DIRECTION FOR 2739 01:38:05,182 --> 01:38:06,317 EVERYBODY, AND I'M JUST REALLY 2740 01:38:06,317 --> 01:38:08,352 GLAD TO SEE THAT THIS HAS NOW 2741 01:38:08,352 --> 01:38:11,222 BECOME A ROUTINE ASPECT OF OUR 2742 01:38:11,222 --> 01:38:11,922 CULTURE, ESPECIALLY WHEN IT 2743 01:38:11,922 --> 01:38:13,490 COMES TO SOLVING CLINICAL 2744 01:38:13,490 --> 01:38:15,960 PROBLEMS FOR PEOPLE, WE ACTUALLY 2745 01:38:15,960 --> 01:38:18,495 ASK THEM WHAT THAT MEANS TO THEM 2746 01:38:18,495 --> 01:38:21,031 AND WHAT THEY WANT TO SEE. 2747 01:38:21,031 --> 01:38:22,233 IT'S NOW A PART OF THE CULTURE, 2748 01:38:22,233 --> 01:38:24,001 AND I THINK IT'S SO INCREDIBLY 2749 01:38:24,001 --> 01:38:27,771 POSITIVE. 2750 01:38:27,771 --> 01:38:29,707 >> TARA, YOU AND YOUR TEAM HAVE 2751 01:38:29,707 --> 01:38:30,474 BEEN DRIVING THIS. 2752 01:38:30,474 --> 01:38:32,443 DO YOU WANT TO ADD ANYTHING IN 2753 01:38:32,443 --> 01:38:32,710 ADDITION? 2754 01:38:32,710 --> 01:38:35,679 >> NO, FIRST OF ALL THANK YOU, 2755 01:38:35,679 --> 01:38:37,348 COREY, FOR THE POSITIVE 2756 01:38:37,348 --> 01:38:38,515 FEEDBACK. 2757 01:38:38,515 --> 01:38:39,817 AND WE'LL DISCUSS A LITTLE BIT 2758 01:38:39,817 --> 01:38:40,417 MORE ABOUT SOME OF THE 2759 01:38:40,417 --> 01:38:42,286 ACTIVITIES THAT WE'RE DOING THIS 2760 01:38:42,286 --> 01:38:46,123 AFTERNOON, SO YOU'LL HEAR. 2761 01:38:46,123 --> 01:38:48,559 EVEN FURTHER THEN ABOUT THESE 2762 01:38:48,559 --> 01:38:49,226 ROUNDTABLES, SOME OF THE 2763 01:38:49,226 --> 01:38:51,729 FEEDBACK THAT WE GOT, AND OUR 2764 01:38:51,729 --> 01:38:52,730 NEXT STEPS AS WE THINK ABOUT 2765 01:38:52,730 --> 01:38:55,466 THIS FURTHER. 2766 01:38:55,466 --> 01:38:58,802 >> THANK YOU. 2767 01:38:58,802 --> 01:38:59,670 TESHIA, YOU'RE NEXT, PLEASE. 2768 01:38:59,670 --> 01:39:00,004 >> THANK YOU. 2769 01:39:00,004 --> 01:39:03,240 I WANT TO FOLLOW ON COREY'S 2770 01:39:03,240 --> 01:39:05,943 STATEMENT OF APPRECIATION FOR 2771 01:39:05,943 --> 01:39:09,246 REACHING OUT TO SPECIFICALLY THE 2772 01:39:09,246 --> 01:39:10,014 INFORMATION YOU SAID ABOUT 2773 01:39:10,014 --> 01:39:11,348 REACHING OUT TO THE NATIVE 2774 01:39:11,348 --> 01:39:11,682 COMMUNITIES. 2775 01:39:11,682 --> 01:39:12,850 I APPRECIATE THAT. 2776 01:39:12,850 --> 01:39:14,718 AND WITH THAT AND THE WORK THAT 2777 01:39:14,718 --> 01:39:20,791 YOU'RE DOING IN WORKING WITH THE 2778 01:39:20,791 --> 01:39:21,625 DISABILITY COMMUNITY, I'M NOT 2779 01:39:21,625 --> 01:39:22,726 SURE WHAT THE PROPER LANGE SJ 2780 01:39:22,726 --> 01:39:26,797 THLANGUAGE ISTHERE, PLEASE FORGI 2781 01:39:26,797 --> 01:39:30,434 WANT TO KNOW HOW WE ARE GOING TO 2782 01:39:30,434 --> 01:39:32,936 MAINTAIN THE STRIDES THAT YOU'VE 2783 01:39:32,936 --> 01:39:35,506 MADE IN DIVERSIFYING ACROSS THE 2784 01:39:35,506 --> 01:39:43,047 NIH, NOT JUST IN THOSE KINDS OF 2785 01:39:43,047 --> 01:39:43,814 COMMUNITIES, BUT IN THE WAY YOU 2786 01:39:43,814 --> 01:39:45,282 ARE REACHING OUT THROUGH 2787 01:39:45,282 --> 01:39:48,786 DIFFERENT MECHANISMS, AND ALSO 2788 01:39:48,786 --> 01:39:49,987 THE DIVERSITY AND THE KINDS OF 2789 01:39:49,987 --> 01:39:54,692 RESEARCH THAT IS DONE. 2790 01:39:54,692 --> 01:39:56,994 SO RESEARCH IS DONE IN PLACE AND 2791 01:39:56,994 --> 01:39:58,329 DIVERSIFYING THE PLACE, 2792 01:39:58,329 --> 01:40:02,066 DIVERSIFYING THE PEOPLE, 2793 01:40:02,066 --> 01:40:03,167 DIVERSIFYING THE MECHANISMS. 2794 01:40:03,167 --> 01:40:04,201 ALL OF THAT HAS BEEN REALLY 2795 01:40:04,201 --> 01:40:06,603 IMPORTANT IN TRYING TO ADDRESS 2796 01:40:06,603 --> 01:40:08,205 HEALTH EQUITY THROUGH SYSTEMS 2797 01:40:08,205 --> 01:40:09,606 APPROACHES, NOT JUST OTHER KINDS 2798 01:40:09,606 --> 01:40:11,475 OF APPROACHES. 2799 01:40:11,475 --> 01:40:13,644 SO WHAT'S THE PICTURE LOOK LIKE 2800 01:40:13,644 --> 01:40:16,113 IN ORDER TO BE ABLE TO MAINTAIN 2801 01:40:16,113 --> 01:40:18,215 THAT WITH THE CHANGES THAT ARE 2802 01:40:18,215 --> 01:40:22,386 COMING IN THE ADMINISTRATION? 2803 01:40:22,386 --> 01:40:29,259 >> SO I REALLY BELIEVE THAT ANY 2804 01:40:29,259 --> 01:40:30,627 ADMINISTRATION CAN GET BEHIND 2805 01:40:30,627 --> 01:40:33,464 OUR GOAL OF SERVING THE PEOPLE 2806 01:40:33,464 --> 01:40:34,231 WHO NEED US. 2807 01:40:34,231 --> 01:40:36,834 CERTAINLY THAT'S BEEN MY 2808 01:40:36,834 --> 01:40:38,602 EXPERIENCE WITH EVERYONE I'VE 2809 01:40:38,602 --> 01:40:40,404 INTERACTED WITH IN CONGRESS ON 2810 01:40:40,404 --> 01:40:41,271 BOTH SIDES OF THE AISLE. 2811 01:40:41,271 --> 01:40:43,774 SO OUR FOCUS IS SERVING THE 2812 01:40:43,774 --> 01:40:45,676 PEOPLE WHO NEED US, THAT'S 2813 01:40:45,676 --> 01:40:45,976 NUMBER ONE. 2814 01:40:45,976 --> 01:40:47,211 AND THEN NUMBER TWO, I THINK 2815 01:40:47,211 --> 01:40:50,280 THERE IS A CRITICAL ELEMENT HERE 2816 01:40:50,280 --> 01:40:53,851 ABOUT THAT ENGAGEMENT WITH THE 2817 01:40:53,851 --> 01:40:54,718 PEOPLE AND COMMUNITIES THAT NEED 2818 01:40:54,718 --> 01:40:55,252 US. 2819 01:40:55,252 --> 01:40:57,454 IT'S GOT TO BE SUSTAINED. 2820 01:40:57,454 --> 01:41:01,625 SO IT'S GOT TO BE BUILT INTO THE 2821 01:41:01,625 --> 01:41:02,993 FABRIC OF WHAT WE'RE DOING. 2822 01:41:02,993 --> 01:41:07,564 THIS IS WHY, FOR INSTANCE, SOME 2823 01:41:07,564 --> 01:41:09,967 OF OUR REAL SIGNATURE 2824 01:41:09,967 --> 01:41:11,435 INITIATIVES NOW, YOU KNOW, NICHE 2825 01:41:11,435 --> 01:41:15,873 TICHS INITIATIVES RIGHT NOW THAE 2826 01:41:15,873 --> 01:41:17,408 NEW, CARE FOR HEALTH, INTENDS TO 2827 01:41:17,408 --> 01:41:18,442 BE IN EVERY COMMUNITY IN THE 2828 01:41:18,442 --> 01:41:19,476 UNITED STATES THAT NEEDS IT. 2829 01:41:19,476 --> 01:41:20,978 IT'S IN PILOT PHASE NOW, AND IT 2830 01:41:20,978 --> 01:41:21,945 WILL EXPAND. 2831 01:41:21,945 --> 01:41:24,381 EVERYBODY WHO'S GOT -- WHO IS 2832 01:41:24,381 --> 01:41:25,449 EXPERIENCING A HEALTH DISPARITY, 2833 01:41:25,449 --> 01:41:26,917 WHO HAS A PRIMARY CARE DOCTOR, 2834 01:41:26,917 --> 01:41:29,887 THAT'S WHERE WE WANT TO BE. 2835 01:41:29,887 --> 01:41:30,754 IT'S IN PILOT. 2836 01:41:30,754 --> 01:41:32,689 AND WE'VE GOTTEN GREAT RESPONSE 2837 01:41:32,689 --> 01:41:34,658 FROM BOTH SIDES OF THE AISLE IN 2838 01:41:34,658 --> 01:41:35,959 CONGRESS TO OUR CARE FOR HEALTH 2839 01:41:35,959 --> 01:41:36,393 INITIATIVE. 2840 01:41:36,393 --> 01:41:38,429 THE SAME THING ABOUT THE DATA. 2841 01:41:38,429 --> 01:41:41,799 DATA HAS TO INCLUDE EVERYBODY. 2842 01:41:41,799 --> 01:41:43,000 ESPECIALLY IN THE WORLD OF A.I., 2843 01:41:43,000 --> 01:41:45,702 WE KNOW THAT IF WE DON'T HAVE 2844 01:41:45,702 --> 01:41:49,640 DATA FROM EVERYONE WHO WE NEED 2845 01:41:49,640 --> 01:41:50,741 TO SERVE, WE'RE GOING TO FAIL. 2846 01:41:50,741 --> 01:41:52,509 SO THAT, I BELIEVE, IS BUILT 2847 01:41:52,509 --> 01:41:56,046 INTO THE FABRIC OF WHAT WE'RE 2848 01:41:56,046 --> 01:41:56,380 DOING. 2849 01:41:56,380 --> 01:41:59,850 SO I THINK THAT'S OUR APPROACH, 2850 01:41:59,850 --> 01:42:02,119 AND IT'S MET WITH GREAT 2851 01:42:02,119 --> 01:42:03,086 ACCEPTANCE ON BOTH SIDES OF THE 2852 01:42:03,086 --> 01:42:04,621 AISLE TODAY, AND THAT'S WHAT I 2853 01:42:04,621 --> 01:42:06,890 EXPECT TO CONTINUE TO SEE. 2854 01:42:06,890 --> 01:42:08,926 >> JUST A FOLLOW-UP TO THAT. 2855 01:42:08,926 --> 01:42:11,428 I THINK ALSO THE CROSS 2856 01:42:11,428 --> 01:42:14,398 COMMUNICATION WITH OTHER HHS 2857 01:42:14,398 --> 01:42:18,535 ENTITIES AND THE WORK TO TRY AND 2858 01:42:18,535 --> 01:42:20,237 MAKE THE EXPERIENCE FOR THE 2859 01:42:20,237 --> 01:42:22,139 PATIENT AT THE HEALTHCARE LEVEL, 2860 01:42:22,139 --> 01:42:24,942 AND THAT INFORMATION, ALONG WITH 2861 01:42:24,942 --> 01:42:26,743 JUST INTEGRATING ALL THAT, MINE, 2862 01:42:26,743 --> 01:42:30,013 ITIMEAN, IT'S A REALLY SMART MO, 2863 01:42:30,013 --> 01:42:30,914 SO THANK YOU FOR ALL THAT. 2864 01:42:30,914 --> 01:42:31,248 >> THANK YOU. 2865 01:42:31,248 --> 01:42:33,684 >> THANK YOU. 2866 01:42:33,684 --> 01:42:35,552 OTHER COMMENTS OR QUESTIONS FROM 2867 01:42:35,552 --> 01:42:43,760 THE GROUP, PLEASE? 2868 01:42:43,760 --> 01:42:46,997 SO PLEASE, LUCILE. 2869 01:42:46,997 --> 01:42:50,300 >> RELATED TO THE A.I. AND HOW 2870 01:42:50,300 --> 01:42:53,804 THE DATA NEED TO BE DIVERSE, 2871 01:42:53,804 --> 01:42:55,305 COULD YOU COMMENT ALSO ON THE 2872 01:42:55,305 --> 01:42:57,908 DIVERSITY OF THE RESEARCHERS OR 2873 01:42:57,908 --> 01:43:00,410 THE DATA SCIENTISTS, INCLUDING 2874 01:43:00,410 --> 01:43:03,347 DIVERSITY OF BACKGROUNDS, 2875 01:43:03,347 --> 01:43:04,748 MEANING COMPUTER SCIENCE, 2876 01:43:04,748 --> 01:43:06,917 MATHEMATICS, STATISTICS, AND SO 2877 01:43:06,917 --> 01:43:07,251 ON? 2878 01:43:07,251 --> 01:43:12,456 AND I SAW YOUR TRAINING EFFORTS 2879 01:43:12,456 --> 01:43:14,024 ARE EXCELLENT, SO I WANT TO 2880 01:43:14,024 --> 01:43:15,092 CONGRATULATE YOU ON THAT AS 2881 01:43:15,092 --> 01:43:16,059 WELL. 2882 01:43:16,059 --> 01:43:19,863 HOW DO YOU SEE US MOVING 2883 01:43:19,863 --> 01:43:22,699 FORWARD, GIVEN THE SPECIALTIES 2884 01:43:22,699 --> 01:43:26,103 NOW GO WAY BEYOND MEDICINE AND 2885 01:43:26,103 --> 01:43:27,971 BIOLOGICAL SCIENCES. 2886 01:43:27,971 --> 01:43:29,306 >> OH, ABSOLUTELY. 2887 01:43:29,306 --> 01:43:31,608 THIS IS A REALLY GREAT QUESTION, 2888 01:43:31,608 --> 01:43:35,546 BECAUSE CLEARLY, AND I THINK 2889 01:43:35,546 --> 01:43:36,580 HAPPILY, THIS IS NOT SOMETHING 2890 01:43:36,580 --> 01:43:39,116 THAT NIH CAN DO ALONE, OKAY? 2891 01:43:39,116 --> 01:43:43,253 WE NEED TO BE PARTNERS NOT 2892 01:43:43,253 --> 01:43:44,988 ONLY -- CERTAINLY ACROSS 2893 01:43:44,988 --> 01:43:47,591 GOVERNMENT IN THE HEALTH SPACE 2894 01:43:47,591 --> 01:43:50,561 TO MAKE SURE THAT WE HAVE THE 2895 01:43:50,561 --> 01:43:53,397 VERY WIDE SPECTRUM OF 2896 01:43:53,397 --> 01:43:55,065 INDIVIDUALS WORKING ON THESE 2897 01:43:55,065 --> 01:43:56,700 ISSUES, AND THEN ALSO -- NOT 2898 01:43:56,700 --> 01:43:59,770 ONLY WITHIN GOVERNMENT, BUT ALSO 2899 01:43:59,770 --> 01:44:01,838 INDUSTRY, NON-PROFITS, AND 2900 01:44:01,838 --> 01:44:02,139 COMMUNITIES. 2901 01:44:02,139 --> 01:44:07,044 SO IT REALLY -- DOING THIS 2902 01:44:07,044 --> 01:44:09,446 PROPERLY IS GOING TO TAKE 2903 01:44:09,446 --> 01:44:09,780 EVERYONE. 2904 01:44:09,780 --> 01:44:13,383 THE APPROACH IS TO HAVE IT OPEN 2905 01:44:13,383 --> 01:44:17,421 AND TRANSPARENT AND CLEARLY 2906 01:44:17,421 --> 01:44:19,056 DEFINED PROCESS WHERE ALL CAN 2907 01:44:19,056 --> 01:44:20,057 ENGAGE IN THIS ACTIVITY. 2908 01:44:20,057 --> 01:44:21,425 YOU KNOW, WHAT'S HAPPENED A 2909 01:44:21,425 --> 01:44:22,759 LITTLE BIT NOW, IF YOU'RE 2910 01:44:22,759 --> 01:44:24,828 SPECIFICALLY TALKING ABOUT DATA 2911 01:44:24,828 --> 01:44:26,563 FROM INDIVIDUALS, IS IT'S JUST 2912 01:44:26,563 --> 01:44:28,832 BEEN INCREDIBLY FRAGMENTED, AND 2913 01:44:28,832 --> 01:44:29,933 THE FRAGMENTATION HAS LED TO 2914 01:44:29,933 --> 01:44:33,303 LACK OF INTEROPERABILITY AND 2915 01:44:33,303 --> 01:44:34,538 LACK OF ACCESS. 2916 01:44:34,538 --> 01:44:37,007 WE'VE NOW HAD LEGISLATION THAT 2917 01:44:37,007 --> 01:44:40,277 HAS BEEN AROUND FOR A GOOD WHILE 2918 01:44:40,277 --> 01:44:41,612 THAT HAS CALLED ON US TO ACHIEVE 2919 01:44:41,612 --> 01:44:43,614 THE KIND OF UNIVERSAL 2920 01:44:43,614 --> 01:44:44,481 INTEROPERABILITY THAT WE NEED, 2921 01:44:44,481 --> 01:44:46,350 SO WE ALREADY HAVE THAT. 2922 01:44:46,350 --> 01:44:49,620 AND NOW WE JUST NEED TO BRING 2923 01:44:49,620 --> 01:44:53,624 THE USER COMMUNITY THERE TO TAKE 2924 01:44:53,624 --> 01:44:54,925 TO THE NEXT LEVEL WHERE WE CAN 2925 01:44:54,925 --> 01:44:56,159 ACTUALLY USE THE DATA. 2926 01:44:56,159 --> 01:44:57,327 SO YOU'VE HIT IT JUST RIGHT, 2927 01:44:57,327 --> 01:45:00,364 THAT USER COMMUNITY CANNOT JUST 2928 01:45:00,364 --> 01:45:02,299 BE INDIVIDUALS SITTING AT NIH, 2929 01:45:02,299 --> 01:45:03,634 OF COURSE WE HAVE TO HAVE THE 2930 01:45:03,634 --> 01:45:05,569 FULL SPECTRUM OF EVERYONE THAT'S 2931 01:45:05,569 --> 01:45:06,103 NEEDED. 2932 01:45:06,103 --> 01:45:07,638 DATA SCIENCE, TECHNOLOGY, PEOPLE 2933 01:45:07,638 --> 01:45:09,206 WHO UNDERSTAND WHAT IT MEANS TO 2934 01:45:09,206 --> 01:45:10,874 WALK INTO A DOCTOR'S OFFICE AND 2935 01:45:10,874 --> 01:45:12,075 ANSWER A QUESTIONNAIRE. 2936 01:45:12,075 --> 01:45:14,478 WE NEED ALL OF THAT SPECTRUM 2937 01:45:14,478 --> 01:45:17,381 BROUGHT BEAR TO THIS. 2938 01:45:17,381 --> 01:45:18,915 AND -- BUT WE NOW HAVE THE 2939 01:45:18,915 --> 01:45:20,884 STRUCTURES AND THE ABILITY FOR 2940 01:45:20,884 --> 01:45:21,885 EVERYONE WHO'S INTERESTED IN 2941 01:45:21,885 --> 01:45:26,323 THAT TO BE ABLE TO ENGAGE. 2942 01:45:26,323 --> 01:45:27,624 PROBABLY HAVEN'T ANSWERED YOUR 2943 01:45:27,624 --> 01:45:28,492 QUESTION COMPLETELY BECAUSE THIS 2944 01:45:28,492 --> 01:45:30,694 NEEDS TO BE A LONG-TERM 2945 01:45:30,694 --> 01:45:31,962 COMMITMENT, BUT WHAT I'M TELLING 2946 01:45:31,962 --> 01:45:36,867 YOU IS, WE NOW VL T HAVE -- THEE 2947 01:45:36,867 --> 01:45:38,268 IS SET, THE ABILITY TO ENGAGE IS 2948 01:45:38,268 --> 01:45:39,670 THERE AND NOW WE CAN PULL IN WHO 2949 01:45:39,670 --> 01:45:40,971 WE NEED. 2950 01:45:40,971 --> 01:45:41,772 >> THANK YOU SO MUCH. 2951 01:45:41,772 --> 01:45:44,975 >> MAYBE TARA, I KNOW YOUR 2952 01:45:44,975 --> 01:45:46,743 OFFICE, ONE OF THE OFFICES IN 2953 01:45:46,743 --> 01:45:49,212 YOUR DIVISION HAS MADE GOOD 2954 01:45:49,212 --> 01:45:50,247 STRIDES IN THIS DIRECTION. 2955 01:45:50,247 --> 01:45:51,415 MAYBE IF YOU COULD QUICKLY 2956 01:45:51,415 --> 01:45:53,483 SUMMARIZE THAT. 2957 01:45:53,483 --> 01:45:56,687 >> WELL, JUST TO COMMENT A 2958 01:45:56,687 --> 01:46:00,891 LITTLE BIT ON THE TRAINING THE 2959 01:46:00,891 --> 01:46:02,526 WORKFORCE COMPONENT THAT WAS 2960 01:46:02,526 --> 01:46:06,096 MENTIONED, AND I THINK YOU WERE 2961 01:46:06,096 --> 01:46:06,930 CONGRATULATING US FOR SOME OF 2962 01:46:06,930 --> 01:46:08,598 OUR PROGRAMS AND I THINK WE'VE 2963 01:46:08,598 --> 01:46:11,234 MADE A LOT OF -- WE'VE PUT A LOT 2964 01:46:11,234 --> 01:46:13,303 OF FOCUS ON TRYING TO INVEST 2965 01:46:13,303 --> 01:46:14,571 FURTHER IN THE TRAINING 2966 01:46:14,571 --> 01:46:16,540 COMPONENT BECAUSE WE NEED THE 2967 01:46:16,540 --> 01:46:20,377 PEOPLE TO BE ABLE TO HAVE THE 2968 01:46:20,377 --> 01:46:21,478 BACKGROUND AND EXPERTISE NEEDED 2969 01:46:21,478 --> 01:46:22,746 TO LAUNCH SOME OF THESE 2970 01:46:22,746 --> 01:46:24,281 PROGRAMS, AND THAT'S AN AREA 2971 01:46:24,281 --> 01:46:26,116 THAT WE NOTED SEVERAL YEARS AGO, 2972 01:46:26,116 --> 01:46:28,218 WE NEEDED TO INVEST FURTHER. 2973 01:46:28,218 --> 01:46:30,053 AND SO THAT WOULD BE THE ONLY 2974 01:46:30,053 --> 01:46:30,787 ADDITIONAL POINT THAT I WOULD 2975 01:46:30,787 --> 01:46:33,757 ADD ON TOP OF WHAT MONICA HAD 2976 01:46:33,757 --> 01:46:35,258 INDICATED, AND WE'RE ALWAYS 2977 01:46:35,258 --> 01:46:36,693 LOOKING FOR ADDITIONAL FEEDBACK 2978 01:46:36,693 --> 01:46:38,328 IN HOW WE CAN CONTINUE TO BUILD 2979 01:46:38,328 --> 01:46:39,696 AND GROW THAT COMMUNITY FURTHER, 2980 01:46:39,696 --> 01:46:43,533 BRING IT TOGETHER, TRY TO WORK 2981 01:46:43,533 --> 01:46:45,502 ACROSS THE VARIOUS DISCIPLINES 2982 01:46:45,502 --> 01:46:46,203 EVEN FURTHER. 2983 01:46:46,203 --> 01:46:47,971 >> AND WE'RE CERTAINLY LOOKING 2984 01:46:47,971 --> 01:46:49,172 FORWARD TO THE OUTPUT OF YOUR 2985 01:46:49,172 --> 01:46:51,374 WORKING GROUP TO HELP US -- HELP 2986 01:46:51,374 --> 01:46:52,709 GUIDE US IN DOING THIS, YOU 2987 01:46:52,709 --> 01:46:53,944 KNOW, SO THANK YOU FOR AGREEING 2988 01:46:53,944 --> 01:46:56,279 TO TAKE THAT ON. 2989 01:46:56,279 --> 01:46:57,147 >> OKAY. 2990 01:46:57,147 --> 01:46:58,982 OTHER QUESTIONS OR COMMENTS, 2991 01:46:58,982 --> 01:47:05,722 PLEASE, FROM THE GROUP? 2992 01:47:05,722 --> 01:47:07,491 I THINK NO ONE HAS HAD THEIR 2993 01:47:07,491 --> 01:47:08,024 MORNING COFFEE YET. 2994 01:47:08,024 --> 01:47:11,495 >> WELL, LET'S GO HAVE MORNING 2995 01:47:11,495 --> 01:47:11,728 COFFEE. 2996 01:47:11,728 --> 01:47:13,430 >> IF THERE ARE NO FURTHER 2997 01:47:13,430 --> 01:47:15,465 COMMENTS OR QUESTIONS, WE'RE 2998 01:47:15,465 --> 01:47:20,504 GOING TO RECONVENE AT 11:15, 2999 01:47:20,504 --> 01:47:23,840 BECAUSE WE NEED TO STAY TRUE TO 3000 01:47:23,840 --> 01:47:26,343 THE SCHEDULE, WHICH IS IN THE 3001 01:47:26,343 --> 01:47:28,011 FEDERAL REGISTER NOTICE, AND 3002 01:47:28,011 --> 01:47:31,381 THERE MAY BE PEOPLE WHO ARE 3003 01:47:31,381 --> 01:47:32,048 SPECIFICALLY GOING TO BE TUNING 3004 01:47:32,048 --> 01:47:33,216 IN FOR THE NEXT PRESENTATION SO 3005 01:47:33,216 --> 01:47:34,551 WE DON'T WANT TO JUMP AHEAD. 3006 01:47:34,551 --> 01:47:36,920 SO WE'LL RECONVENE AT 11:15. 3007 01:47:36,920 --> 01:47:39,890 THANKS, EVERYBODY. 3008 01:47:39,890 --> 01:47:42,426 OKAY, WELL, HELLO, EVERYBODY. 3009 01:47:42,426 --> 01:47:44,594 SO WE'RE GOING TO TALK ABOUT 3010 01:47:44,594 --> 01:47:45,962 RECOVER. 3011 01:47:45,962 --> 01:47:49,633 AND SO I AM GOING TO INTRODUCE 3012 01:47:49,633 --> 01:47:50,367 DR. SARAH READ. 3013 01:47:50,367 --> 01:47:52,436 HOW WE'RE GOING TO DO THIS IS 3014 01:47:52,436 --> 01:47:56,339 DR. READ IS GOING TO TALK ABOUT 3015 01:47:56,339 --> 01:48:00,744 THE NEW ITERATION OF RECOVER 3016 01:48:00,744 --> 01:48:03,713 THAT BEGAN LAST MAY OR SO, THE 3017 01:48:03,713 --> 01:48:07,684 NEW KIND OF RESETTING WE HAD, 3018 01:48:07,684 --> 01:48:09,252 SOME OF THE RECOVER ACTIVITIES. 3019 01:48:09,252 --> 01:48:10,854 SO SHE'S GOING TO DO THAT FIRST, 3020 01:48:10,854 --> 01:48:11,955 AND AFTER SHE DOES THAT, I'LL 3021 01:48:11,955 --> 01:48:14,458 GIVE A PROGRESS REPORT ON THE 3022 01:48:14,458 --> 01:48:16,693 OTHER ONGOING IMPORTANT 3023 01:48:16,693 --> 01:48:20,997 ACTIVITIES BEHIND RECOVER. 3024 01:48:20,997 --> 01:48:24,034 SO WITHOUT FURTHER ADO, LET ME 3025 01:48:24,034 --> 01:48:25,268 TURN THIS OVER TO DR. SARAH 3026 01:48:25,268 --> 01:48:25,469 READ. 3027 01:48:25,469 --> 01:48:25,969 >> THANK YOU. 3028 01:48:25,969 --> 01:48:26,970 I JUST WANT TO CONFIRM THAT YOU 3029 01:48:26,970 --> 01:48:27,437 CAN HEAR ME? 3030 01:48:27,437 --> 01:48:28,271 >> YOU'RE GOOD. 3031 01:48:28,271 --> 01:48:28,738 >> GREAT. 3032 01:48:28,738 --> 01:48:30,674 THANK YOU. 3033 01:48:30,674 --> 01:48:32,008 WELL, GOOD MORNING, EVERYONE, 3034 01:48:32,008 --> 01:48:33,276 AND THANK YOU, DR. BERTAGNOLLI, 3035 01:48:33,276 --> 01:48:34,911 FOR THE INVITATION TO SPEAK THIS 3036 01:48:34,911 --> 01:48:36,713 MORNING ABOUT OUR NEW 3037 01:48:36,713 --> 01:48:37,948 INITIATIVE, WHICH IS CALLED 3038 01:48:37,948 --> 01:48:40,150 RECOVER, TREATING LONG COVID, OR 3039 01:48:40,150 --> 01:48:42,285 RECOVER TLC FOR SHORT. 3040 01:48:42,285 --> 01:48:44,221 THIS IS AN INITIATIVE FOCUSED ON 3041 01:48:44,221 --> 01:48:45,088 CONCEPTUALIZING AND LAUNCHING 3042 01:48:45,088 --> 01:48:47,958 THE NEXT ROUND OF NIH SUPPORTED 3043 01:48:47,958 --> 01:48:49,626 CLINICAL TRIALS TO EVALUATE 3044 01:48:49,626 --> 01:48:50,760 THERAPEUTIC INTERVENTIONS FOR 3045 01:48:50,760 --> 01:48:51,495 LONG COVID. 3046 01:48:51,495 --> 01:48:53,563 AND IMPORTANTLY, BUILDS OFF THE 3047 01:48:53,563 --> 01:48:54,531 LEARNINGS AND EXPERIENCE OF THE 3048 01:48:54,531 --> 01:48:56,066 RECOVER INITIATIVE. 3049 01:48:56,066 --> 01:48:59,236 I'M FILLING IN FOR DR. GINA PLAT 3050 01:48:59,236 --> 01:49:00,837 SEW, DIRECTOR OF NIAID, WHO IS 3051 01:49:00,837 --> 01:49:01,838 CO-CHAIRING A DIFFERENT MEETING 3052 01:49:01,838 --> 01:49:03,707 TODAY BUT JUST TO SAY SHE'S A 3053 01:49:03,707 --> 01:49:04,741 REAL CHAMPION OF THIS PROGRAM 3054 01:49:04,741 --> 01:49:06,176 AND I HOPE TO CHANNEL HER 3055 01:49:06,176 --> 01:49:07,377 ENTHUSIASM AND CONVEY HER 3056 01:49:07,377 --> 01:49:13,517 VISION. 3057 01:49:13,517 --> 01:49:16,353 I'M NOT GOING TO GO TOO MUCH 3058 01:49:16,353 --> 01:49:17,721 INTO THE BACKGROUND OF LONG 3059 01:49:17,721 --> 01:49:19,456 COVID, BUT IT IS COMPLICATED AND 3060 01:49:19,456 --> 01:49:22,259 WE HAVE MUCH TO LEARN STILL. 3061 01:49:22,259 --> 01:49:24,227 IT COVERS A WIDE SPECTRUM OF 3062 01:49:24,227 --> 01:49:25,695 CLINICAL SYMPTOMS AND INVOLVES 3063 01:49:25,695 --> 01:49:27,397 MANY DIFFERENT ORGAN SYSTEMS 3064 01:49:27,397 --> 01:49:29,099 AND, AS SUCH, REQUIRES A 3065 01:49:29,099 --> 01:49:30,100 MULTIDISCIPLINARY APPROACH TO 3066 01:49:30,100 --> 01:49:32,035 STUDYING IT AND POTENTIALLY 3067 01:49:32,035 --> 01:49:32,636 TREATING IT. 3068 01:49:32,636 --> 01:49:34,671 IT CAN AFFECT THE CARDIOVASCULAR 3069 01:49:34,671 --> 01:49:36,640 SYSTEM, PULMONARY SYSTEM, 3070 01:49:36,640 --> 01:49:37,507 NEUROLOGIC SYSTEM, ET CETERA, 3071 01:49:37,507 --> 01:49:39,543 AND THERE ARE MYRIAD OF SYMPTOMS 3072 01:49:39,543 --> 01:49:41,545 WITH VARYING PHYSIOLOGY AS A 3073 01:49:41,545 --> 01:49:42,145 RESULT. 3074 01:49:42,145 --> 01:49:43,547 LONG COVID IS NOT JUST ONE THING 3075 01:49:43,547 --> 01:49:44,648 AND WE NEED TO BE ABLE TO 3076 01:49:44,648 --> 01:49:46,650 UNDERSTAND THE CLINICAL 3077 01:49:46,650 --> 01:49:51,988 PHENOTYPES IN A WAY THAT'S 3078 01:49:51,988 --> 01:49:53,156 RELEVANT TO BE ABLE TO 3079 01:49:53,156 --> 01:49:53,490 INTERVENE. 3080 01:49:53,490 --> 01:49:55,559 AND IN TERMS OF WHAT DRIVES LONG 3081 01:49:55,559 --> 01:49:57,093 COVID, WE STILL HAVE A LOT TO 3082 01:49:57,093 --> 01:49:59,162 LEARN THERE AS WELL. 3083 01:49:59,162 --> 01:50:00,363 IS THERE A RESERVOIR, COULD 3084 01:50:00,363 --> 01:50:02,332 THERE BE REACTIVATION OF VIRUS, 3085 01:50:02,332 --> 01:50:06,102 AND WHAT LEADS TO MITOCHONDRIAL 3086 01:50:06,102 --> 01:50:08,638 DYSFUNCTION, EFFECTS ON THE 3087 01:50:08,638 --> 01:50:09,439 MICROBIOME, VASCULAR 3088 01:50:09,439 --> 01:50:11,041 INFLAMMATION AND SO ON, ALL OF 3089 01:50:11,041 --> 01:50:13,109 WHICH THEN LEAD INTERNALLY TO 3090 01:50:13,109 --> 01:50:14,077 TISSUE DYSFUNCTION AND DAMAGE. 3091 01:50:14,077 --> 01:50:15,445 IT'S VERY COMPLEX, THERE'S NOT 3092 01:50:15,445 --> 01:50:17,314 ONE PHENOTYPE AND WE HAVE TO BE 3093 01:50:17,314 --> 01:50:18,648 FLEXIBLE TO UNDERSTAND THE 3094 01:50:18,648 --> 01:50:22,786 PATHOBIOLOGY. 3095 01:50:22,786 --> 01:50:24,854 AND WHAT ABOUT THE PREVALENCE OF 3096 01:50:24,854 --> 01:50:26,156 LONG COVID? 3097 01:50:26,156 --> 01:50:29,826 IT'S QUITE HARD TO MEASURE AND 3098 01:50:29,826 --> 01:50:30,727 VARYING DEFINITIONS. 3099 01:50:30,727 --> 01:50:31,795 ACCORDING TO THIS REPORT IN 3100 01:50:31,795 --> 01:50:32,929 JAMA, IN SOME POPULATIONS IT 3101 01:50:32,929 --> 01:50:34,497 COULD BE AS HIGH AS 10%. 3102 01:50:34,497 --> 01:50:36,800 THE CDC HAS AN ESTIMATE OF UP TO 3103 01:50:36,800 --> 01:50:38,201 6.8% OF ADULTS IN THE U.S. ARE 3104 01:50:38,201 --> 01:50:39,502 CURRENTLY EXPERIENCING LONG 3105 01:50:39,502 --> 01:50:40,937 COVID AND REGARDLESS OF WHAT THE 3106 01:50:40,937 --> 01:50:42,372 EXACT NUMBER IS, THIS REPRESENTS 3107 01:50:42,372 --> 01:50:43,206 A HUGE BURDEN. 3108 01:50:43,206 --> 01:50:45,175 WHEN WE'RE TALKING ABOUT 5 TO 3109 01:50:45,175 --> 01:50:47,377 10% OF JUST THE U.S. POPULATION 3110 01:50:47,377 --> 01:50:49,079 ALONE, THESE ARE REALLY LARGE 3111 01:50:49,079 --> 01:50:49,946 NUMBERS. 3112 01:50:49,946 --> 01:50:51,948 AND THERE'S A LOT MORE THAT'S 3113 01:50:51,948 --> 01:50:53,350 NOT EASILY MEASURED THAT'S 3114 01:50:53,350 --> 01:50:55,185 UNACCOUNTED FOR IN THESE 3115 01:50:55,185 --> 01:51:00,890 EPIDEMIOLOGIC DATA. 3116 01:51:00,890 --> 01:51:02,826 THERE ARE SEVERAL LINES OF 3117 01:51:02,826 --> 01:51:04,060 INVESTIGATION UNDER WAY THROUGH 3118 01:51:04,060 --> 01:51:05,295 RECOVER AND OTHER EFFORTS 3119 01:51:05,295 --> 01:51:07,197 LOOKING AT THE ORIGINS OF THE 3120 01:51:07,197 --> 01:51:08,798 PATHOGENESIS OF LONG COVID. 3121 01:51:08,798 --> 01:51:11,301 WE HAVE SOME M MODELS WE CAN USE 3122 01:51:11,301 --> 01:51:12,902 FROM OTHER INFECTION ASSOCIATED 3123 01:51:12,902 --> 01:51:14,137 CHRONIC CONDITIONS THAT ARE 3124 01:51:14,137 --> 01:51:17,874 ASSOCIATED WITH EPV, FOR 3125 01:51:17,874 --> 01:51:20,010 EXAMPLE, IN WHICH THERE MIGHT BE 3126 01:51:20,010 --> 01:51:21,111 VIRAL REACTIVATION, THERE COULD 3127 01:51:21,111 --> 01:51:22,479 BE PERSIST 10 OF INFECTION IN 3128 01:51:22,479 --> 01:51:25,248 THE FORM OF PROTEINS THAT CAUSE 3129 01:51:25,248 --> 01:51:26,216 ONGOING IMMUNE STIMULATION. 3130 01:51:26,216 --> 01:51:27,851 THERE COULD BE DYSREGULATION OF 3131 01:51:27,851 --> 01:51:31,821 THE IMMUNE REACTIONS ONGOING, 3132 01:51:31,821 --> 01:51:33,223 PERSISTENCE OF ABERRANT IMMUNE 3133 01:51:33,223 --> 01:51:35,458 RESPONSES CAUSING 3134 01:51:35,458 --> 01:51:36,226 AUTOANTIBODIES, AUTOIMMUNE 3135 01:51:36,226 --> 01:51:37,560 DISEASE AND SO ON AND ALL OF 3136 01:51:37,560 --> 01:51:38,862 THESE ARE VERY ACTIVE AREAS OF 3137 01:51:38,862 --> 01:51:39,663 INVESTIGATION THROUGH THE 3138 01:51:39,663 --> 01:51:40,530 RECOVER PROGRAM AND OTHER 3139 01:51:40,530 --> 01:51:41,898 EFFORTS FOR WHICH WOULD HE LIKE 3140 01:51:41,898 --> 01:51:43,533 TO TAKE ADVANTAGE OF THE WORK 3141 01:51:43,533 --> 01:51:44,968 THAT'S BEEN DONE AND IS ONGOING 3142 01:51:44,968 --> 01:51:47,537 IN ORDER TO INFORM THE NEXT 3143 01:51:47,537 --> 01:51:50,073 ROUND OF CLINICAL TRIALS, 3144 01:51:50,073 --> 01:51:53,343 POTENTIALLY LOOKING AT POTENTIAL 3145 01:51:53,343 --> 01:51:54,544 THERAPEUTICS FOR INTERVENING 3146 01:51:54,544 --> 01:51:58,481 WITH LONG COVID. 3147 01:51:58,481 --> 01:51:59,683 SO THE INITIATIVE THAT WE'RE 3148 01:51:59,683 --> 01:52:00,684 TALKING ABOUT TODAY IS AN EFFORT 3149 01:52:00,684 --> 01:52:02,319 TO BUILD ON EVERYTHING THAT 3150 01:52:02,319 --> 01:52:05,221 RECOVER HAS DONE, AND IN AN 3151 01:52:05,221 --> 01:52:06,089 EFFORT ULTIMATELY TO GET 3152 01:52:06,089 --> 01:52:07,190 SOLUTIONS TO PEOPLE WHO NEED 3153 01:52:07,190 --> 01:52:07,524 THEM. 3154 01:52:07,524 --> 01:52:09,459 WE WANT TO LOOK TO ALL THE WORK 3155 01:52:09,459 --> 01:52:10,560 DONE IN THE RECOVER PROGRAM 3156 01:52:10,560 --> 01:52:12,062 THROUGH COHORT, PATHOGENESIS 3157 01:52:12,062 --> 01:52:14,264 STUDIES AND CLINICAL TRIALS TO 3158 01:52:14,264 --> 01:52:15,265 UNDERSTAND THE PHYSIOLOGY AND 3159 01:52:15,265 --> 01:52:16,633 THE DRIVERS OF THE DISEASE IN 3160 01:52:16,633 --> 01:52:19,035 ORDER TO INTERVENE IN A RATIONAL 3161 01:52:19,035 --> 01:52:28,244 WAY. 3162 01:52:28,244 --> 01:52:29,946 SO WHAT HAVE WE COME UP WITH? 3163 01:52:29,946 --> 01:52:31,581 THE NIH RECOVER TLC INITIATIVE, 3164 01:52:31,581 --> 01:52:32,916 THE GOAL OF THIS IS TO DEVELOP 3165 01:52:32,916 --> 01:52:34,851 SAFE AND EFFECTIVE THERAPEUTIC 3166 01:52:34,851 --> 01:52:35,819 INTERVENTIONS FOR LONG COVID, 3167 01:52:35,819 --> 01:52:38,288 AND TO PROVIDE THESE TO 3168 01:52:38,288 --> 01:52:39,255 HEALTHCARE PROVIDERS AND 3169 01:52:39,255 --> 01:52:40,390 PATIENTS AS RAPIDLY AS POSSIBLE. 3170 01:52:40,390 --> 01:52:41,691 AND WE'VE COME UP WITH FOUR 3171 01:52:41,691 --> 01:52:43,460 SCIENTIFIC AIMS THAT ARE SORT OF 3172 01:52:43,460 --> 01:52:45,662 UNDERPINNING THIS INITIATIVE. 3173 01:52:45,662 --> 01:52:48,231 MAINLY TO IDENTIFY PHARMACOLOGIC 3174 01:52:48,231 --> 01:52:49,432 AND/OR NON-PHARMACOLOGIC 3175 01:52:49,432 --> 01:52:51,301 INTERVENTIONS TO TREAT LONG 3176 01:52:51,301 --> 01:52:53,136 COVID, TO AGAIN BUILD FROM THE 3177 01:52:53,136 --> 01:52:55,972 FINDINGS OF THE RECOVER COHORT, 3178 01:52:55,972 --> 01:52:57,107 PATHOBIOLOGY STUDIES AND 3179 01:52:57,107 --> 01:52:58,808 CLINICAL TRIALS, AND DEVELOP 3180 01:52:58,808 --> 01:53:01,177 RAPID, NIMBLE CLINICAL TRIALS 3181 01:53:01,177 --> 01:53:02,412 DESIGN WITH DIRECT AND 3182 01:53:02,412 --> 01:53:03,079 TRANSPARENT ENGAGEMENT WITH ALL 3183 01:53:03,079 --> 01:53:05,181 OF THE STAKEHOLDERS, SCIENTIFIC, 3184 01:53:05,181 --> 01:53:05,915 INDUSTRY, PATIENT COMMUNITIES 3185 01:53:05,915 --> 01:53:06,516 AND SO ON. 3186 01:53:06,516 --> 01:53:07,617 AND ULTIMATELY TO PROVIDE ACCESS 3187 01:53:07,617 --> 01:53:09,652 AND SHARING OF DATA WITH THE 3188 01:53:09,652 --> 01:53:10,987 PUBLIC AND THE SCIENTIFIC 3189 01:53:10,987 --> 01:53:12,956 COMMUNITIES AS WE PROCEED. 3190 01:53:12,956 --> 01:53:15,425 THERE ARE FOUR GUIDING 3191 01:53:15,425 --> 01:53:16,960 PRINCIPLES THAT WE WILL TURN TO 3192 01:53:16,960 --> 01:53:18,828 WHEN WE'RE WORKING ON THIS 3193 01:53:18,828 --> 01:53:19,162 INITIATIVE. 3194 01:53:19,162 --> 01:53:22,098 WE REALLY WANT THIS EFFORT TO BE 3195 01:53:22,098 --> 01:53:23,833 PATIENT-CENTERED AND TO THINK OF 3196 01:53:23,833 --> 01:53:25,835 PATIENTS AND PARTICIPANTS AS OUR 3197 01:53:25,835 --> 01:53:27,070 PARTNERS, AND THAT MEANS IN 3198 01:53:27,070 --> 01:53:28,972 EVERY STEP OF THE WAY, AND SO WE 3199 01:53:28,972 --> 01:53:31,474 HAVE RIGHT FROM THE BEGINNING 3200 01:53:31,474 --> 01:53:32,876 ENGAGED WITH PEOPLE WHO ARE 3201 01:53:32,876 --> 01:53:33,877 LIVING WITH LONG COVID. 3202 01:53:33,877 --> 01:53:36,613 WE WANT TO BE INCLUSIVE AND HAVE 3203 01:53:36,613 --> 01:53:37,947 DIVERSE PARTICIPATION ON A 3204 01:53:37,947 --> 01:53:40,417 NATIONAL SCALE, AGAIN ENGAGING A 3205 01:53:40,417 --> 01:53:43,586 VERY DIVERSE COMMUNITY OF PEOPLE 3206 01:53:43,586 --> 01:53:44,988 WHO ARE EXPERIENCING THE 3207 01:53:44,988 --> 01:53:46,356 CONSEQUENCES OF LONG COVID, 3208 01:53:46,356 --> 01:53:47,157 WHETHER THEY'RE LIVING WITH IT 3209 01:53:47,157 --> 01:53:48,258 OR THEY'RE CARING FOR PEOPLE 3210 01:53:48,258 --> 01:53:49,793 WITH IT. 3211 01:53:49,793 --> 01:53:52,061 WE'RE HOPING TO DEVELOP PLATFORM 3212 01:53:52,061 --> 01:53:53,029 PROTOCOLS WITH STANDARDIZED 3213 01:53:53,029 --> 01:53:55,331 METHODOLOGY AND COMMON DATA 3214 01:53:55,331 --> 01:53:56,199 ELEMENTS IN ORDER TO BE NIMBLE 3215 01:53:56,199 --> 01:53:58,234 AND TO BE ABLE TO ACCOMMODATE 3216 01:53:58,234 --> 01:53:59,369 NEW THERAPEUTIC CANDIDATES AS 3217 01:53:59,369 --> 01:54:01,271 THEY COME UP IN A SEAMLESS 3218 01:54:01,271 --> 01:54:01,871 FASHION. 3219 01:54:01,871 --> 01:54:03,840 AND WE WANT TO BE ADAPTIVE, BOTH 3220 01:54:03,840 --> 01:54:05,141 IN OUR CLINICAL TRIAL DESIGNS 3221 01:54:05,141 --> 01:54:07,677 AND IN OUR ACCOMMODATION OF 3222 01:54:07,677 --> 01:54:08,812 EMERGENT SCIENCE, WE WANT TO 3223 01:54:08,812 --> 01:54:09,546 STOP THINGS THAT AREN'T WORKING 3224 01:54:09,546 --> 01:54:11,881 AS QUICKLY AS WE CAN, AND TAKE 3225 01:54:11,881 --> 01:54:13,650 IN NEW POTENTIAL CANDIDATES AS 3226 01:54:13,650 --> 01:54:14,951 WE LEARN BOTH FROM OUR TRIALS 3227 01:54:14,951 --> 01:54:17,654 AND THE TRIALS THAT ARE GOING ON 3228 01:54:17,654 --> 01:54:23,026 IN OTHER EFFORTS. 3229 01:54:23,026 --> 01:54:25,462 SO WHY IS NIAID WELL SUITED TO 3230 01:54:25,462 --> 01:54:26,396 BE LEADING THIS EFFORT? 3231 01:54:26,396 --> 01:54:28,498 WE ARE VERY EXPERIENCED WITH 3232 01:54:28,498 --> 01:54:31,668 LARGE SCALE COMPLEX CLINICAL 3233 01:54:31,668 --> 01:54:32,101 TRIALS. 3234 01:54:32,101 --> 01:54:33,736 WE HAVE REGULATORY TEAMS THAT 3235 01:54:33,736 --> 01:54:35,472 HAVE DECADES LONGSTANDING 3236 01:54:35,472 --> 01:54:38,408 INTERACTIONS WITH THE FDA AND 3237 01:54:38,408 --> 01:54:40,243 EXPERIENCE ON HOW TO DEAL WITH 3238 01:54:40,243 --> 01:54:41,678 COMPLEX INDs, FOR EXAMPLE, AND 3239 01:54:41,678 --> 01:54:45,181 GET THINGS MOVING AS QUICKLY AND 3240 01:54:45,181 --> 01:54:45,682 SEAMLESSLY AS POSSIBLE. 3241 01:54:45,682 --> 01:54:50,887 WE HAVE ROBUST BIOSTATISTICAL 3242 01:54:50,887 --> 01:54:52,188 SUPPORT FOR CLINICAL TRIAL 3243 01:54:52,188 --> 01:54:53,356 DESIGN AND DATA ANALYSIS. 3244 01:54:53,356 --> 01:54:54,557 WE HAVE CONTRACTS IN PLACE FOR 3245 01:54:54,557 --> 01:54:56,426 PRODUCT SUPPORT AND CREATION OF 3246 01:54:56,426 --> 01:54:58,061 BOTH BIOSPECIMEN AND DATA 3247 01:54:58,061 --> 01:54:58,695 REPOSITORIES. 3248 01:54:58,695 --> 01:55:01,531 WE HAVE DSMB CAPABILITIES, BROAD 3249 01:55:01,531 --> 01:55:03,099 CONTRACT SUPPORT FOR ALL ASPECTS 3250 01:55:03,099 --> 01:55:04,000 OF CLINICAL TRIALS, INCLUDING 3251 01:55:04,000 --> 01:55:06,202 THINGS LIKE PHARMACY, SITE 3252 01:55:06,202 --> 01:55:07,737 MONITORING AND SO ON. 3253 01:55:07,737 --> 01:55:09,572 AND IMPORTANTLY, WE HAVE 3254 01:55:09,572 --> 01:55:10,807 LONG-STANDING RELATIONSHIPS WITH 3255 01:55:10,807 --> 01:55:13,076 SCIENTIFIC AND ADVOCACY 3256 01:55:13,076 --> 01:55:16,946 COMMUNITIES THROUGH OUR OTHER 3257 01:55:16,946 --> 01:55:17,981 LONG-TIME ONGOING EFFORTS IN 3258 01:55:17,981 --> 01:55:20,717 OTHER AREAS OF SCIENCE, NAMELY 3259 01:55:20,717 --> 01:55:22,986 FROM MY BACKGROUND IN PARTICULAR 3260 01:55:22,986 --> 01:55:24,821 IN THE HIV/AIDS AREA, WHERE WE 3261 01:55:24,821 --> 01:55:27,624 HAVE WORKED WITH COMMUNITY AND 3262 01:55:27,624 --> 01:55:29,359 SCIENTIFIC LEADERS FOR A VERY 3263 01:55:29,359 --> 01:55:30,627 LONG TIME AND HAVE DEVELOPED 3264 01:55:30,627 --> 01:55:32,662 MODELS THAT WE HOPE TO APPLY TO 3265 01:55:32,662 --> 01:55:33,763 LONG COVID AS WELL. 3266 01:55:33,763 --> 01:55:35,832 WE HAVE MEDICAL OFFICERS AND 3267 01:55:35,832 --> 01:55:38,268 PROGRAM STAFF WHO HAVE VERY 3268 01:55:38,268 --> 01:55:38,801 EXTENSIVE CLINICAL TRIALS 3269 01:55:38,801 --> 01:55:40,803 EXPERIENCE, AND MOST RECENTLY, 3270 01:55:40,803 --> 01:55:42,372 WE HAVE HAD EXPERIENCE IN THE 3271 01:55:42,372 --> 01:55:45,308 COVID ARENA IN THE NIH'S 3272 01:55:45,308 --> 01:55:48,411 RESPONSE TO ACUTE COVID THROUGH 3273 01:55:48,411 --> 01:55:50,446 THE ACTIVE PUBLIC-PRIVATE 3274 01:55:50,446 --> 01:55:52,949 PARTNERSHIP STOOD UP BY FRANCIS 3275 01:55:52,949 --> 01:55:53,716 COLLINS IN THE BEGINNING OF THE 3276 01:55:53,716 --> 01:55:55,585 COVID PANDEMIC, AND WE HOPE TO 3277 01:55:55,585 --> 01:55:57,220 REALLY LEVERAGE OUR EXPERIENCES 3278 01:55:57,220 --> 01:55:58,922 FROM THE ACUTE COVID RESPONSE AS 3279 01:55:58,922 --> 01:56:00,590 WELL AS OUR EXPERIENCES IN 3280 01:56:00,590 --> 01:56:05,194 HIV/AIDS AND OTHER AREAS WF 3281 01:56:05,194 --> 01:56:11,167 WE'VE HAD ONGOING CLINICAL 3282 01:56:11,167 --> 01:56:12,302 TRIALS TO TAKE LESSONS LEARNED 3283 01:56:12,302 --> 01:56:14,003 AND APPLY SORT OF THE BEST 3284 01:56:14,003 --> 01:56:15,672 STRATEGIES FROM THOSE PLAYBOOKS. 3285 01:56:15,672 --> 01:56:17,540 IN TERMS OF OUR APPROACH 3286 01:56:17,540 --> 01:56:19,475 OVERALL, WE REALLY WANT TO BE 3287 01:56:19,475 --> 01:56:22,345 ENGAGED SCIENTIFICALLY AGAIN. 3288 01:56:22,345 --> 01:56:23,880 WE PLAN TO AND HAVE ALREADY DONE 3289 01:56:23,880 --> 01:56:26,049 THIS TO ASSESS THE CURRENT 3290 01:56:26,049 --> 01:56:27,350 CLINICAL TRIALS LANDSCAPES, NOT 3291 01:56:27,350 --> 01:56:28,651 JUST WHAT'S BEING DONE WITHIN 3292 01:56:28,651 --> 01:56:30,954 RECOVER, BUT REALLY BROADLY 3293 01:56:30,954 --> 01:56:32,355 GLOBALLY IN THE AREA OF LONG 3294 01:56:32,355 --> 01:56:34,624 COVID SO THAT WE AREN'T 3295 01:56:34,624 --> 01:56:35,758 DUPLICATING EFFORTS AND WE'RE 3296 01:56:35,758 --> 01:56:36,960 NOT REINVENTING THE WHEEL. 3297 01:56:36,960 --> 01:56:38,995 SO WE WANT TO DETERMINE WHAT 3298 01:56:38,995 --> 01:56:40,997 APPROACHES ARE NEEDED FOR TRIALS 3299 01:56:40,997 --> 01:56:42,932 IN TERMS OF MAKING THEM AS 3300 01:56:42,932 --> 01:56:45,902 EFFICIENT AS POSSIBLE, AS ROW 3301 01:56:45,902 --> 01:56:47,537 ROBUST, AND MAKING SURE THAT WE 3302 01:56:47,537 --> 01:56:48,438 REALLY ACHIEVE THE END POINTS 3303 01:56:48,438 --> 01:56:50,707 THAT WE'RE LOOKING FOR BY DOING 3304 01:56:50,707 --> 01:56:52,809 A LANDSCAPE, BY TALKING TO 3305 01:56:52,809 --> 01:56:53,876 STAKEHOLDERS, AND REALLY 3306 01:56:53,876 --> 01:56:55,011 GLEANING FROM WHAT PEOPLE HAVE 3307 01:56:55,011 --> 01:56:55,945 LEARNED ALREADY. 3308 01:56:55,945 --> 01:56:58,214 AND WE WANT TO THEN IDENTIFY 3309 01:56:58,214 --> 01:57:00,083 LESSONS IN ORDER TO INFORM THE 3310 01:57:00,083 --> 01:57:01,484 PROTOCOL DESIGN AND THE LAUNCH 3311 01:57:01,484 --> 01:57:06,522 OF OUR PROGRAM. 3312 01:57:06,522 --> 01:57:08,358 HOW WILL RECOVER TLC WORK? 3313 01:57:08,358 --> 01:57:09,726 WE'VE ALREADY TAKEN A NUMBER OF 3314 01:57:09,726 --> 01:57:09,926 STEPS. 3315 01:57:09,926 --> 01:57:12,328 WE ACTUALLY STARTED FIRST 3316 01:57:12,328 --> 01:57:13,196 CONCEPTUALIZING THIS BACK IN 3317 01:57:13,196 --> 01:57:14,397 JULY AND REALLY KIND OF KICK 3318 01:57:14,397 --> 01:57:17,900 THINGS OFF IN SEPTEMBER, WHEN WE 3319 01:57:17,900 --> 01:57:21,804 ENIMAENGAGE THE FOUNDATION FOR S 3320 01:57:21,804 --> 01:57:22,372 A STRATEGIC PARTNER. 3321 01:57:22,372 --> 01:57:24,340 THIS REALLY HAS BEEN AN AMAZING 3322 01:57:24,340 --> 01:57:25,308 PARTNERSHIP EVEN IN THE FIRST 3323 01:57:25,308 --> 01:57:26,809 FEW MONTHS OF WORKING WITH THEM. 3324 01:57:26,809 --> 01:57:28,578 AGAIN WE'RE TAKING A LESSON 3325 01:57:28,578 --> 01:57:29,879 LEARNED FROM ACTIVE. 3326 01:57:29,879 --> 01:57:34,584 THEY WERE REALLY VERY 3327 01:57:34,584 --> 01:57:35,885 FOUNDATIONAL IN GIVING THE ACT 3328 01:57:35,885 --> 01:57:37,420 OF PUBLIC-PRIVATE PARTNERSHIP 3329 01:57:37,420 --> 01:57:40,156 GOING AND KEEPING THINGS ON 3330 01:57:40,156 --> 01:57:40,490 TRACK. 3331 01:57:40,490 --> 01:57:42,659 WE REALLY TOOK, AGAIN, A LESSON 3332 01:57:42,659 --> 01:57:44,961 FROM THAT PLAYBOOK IN ENGAGING 3333 01:57:44,961 --> 01:57:46,929 WITH THE FNIH AND THEY HAVE 3334 01:57:46,929 --> 01:57:47,664 REALLY BEEN FANTASTIC PARTNERS 3335 01:57:47,664 --> 01:57:48,231 ALREADY. 3336 01:57:48,231 --> 01:57:50,833 WE'RE ALSO ENGAGING WITH OTHER 3337 01:57:50,833 --> 01:57:51,067 ICs. 3338 01:57:51,067 --> 01:57:54,971 WE SEE THE NHLBI AND NINDS IN 3339 01:57:54,971 --> 01:57:58,274 PARTICULAR AS REALLY KEY 3340 01:57:58,274 --> 01:58:00,243 PARTNERS GIVEN OUR ROLE IN 3341 01:58:00,243 --> 01:58:01,644 LEADERSHIP WITH THE RECOVER 3342 01:58:01,644 --> 01:58:03,079 INITIATIVE, BUT ALSO INTEND TO 3343 01:58:03,079 --> 01:58:06,683 ENGAGE OTHER ICs AS NEEDED. 3344 01:58:06,683 --> 01:58:08,184 WE HAVE ALREADY HAD A KICKOFF 3345 01:58:08,184 --> 01:58:09,085 MEETING AT THE END OF SEPTEMBER 3346 01:58:09,085 --> 01:58:10,253 AND I'LL GO INTO MORE DETAIL 3347 01:58:10,253 --> 01:58:14,757 ABOUT THAT IN A MOMENT. 3348 01:58:14,757 --> 01:58:16,025 BUT THROUGH THAT INITIAL 3349 01:58:16,025 --> 01:58:17,126 MEETING, WE WERE ABLE TO 3350 01:58:17,126 --> 01:58:18,394 INTRODUCE THE STRUCTURE OF 3351 01:58:18,394 --> 01:58:20,430 RECOVER TLC TO VARIOUS 3352 01:58:20,430 --> 01:58:22,065 STAKEHOLDERS AND GET INPUT FROM 3353 01:58:22,065 --> 01:58:24,467 THEM AND THEN TAKE INTO ACCOUNT 3354 01:58:24,467 --> 01:58:26,302 THOSE COMMENTS AND THAT 3355 01:58:26,302 --> 01:58:30,907 FEEDBACK. 3356 01:58:30,907 --> 01:58:32,742 AS FAR AS THE STRUCTURE OF TLC, 3357 01:58:32,742 --> 01:58:34,043 IMPORTANTLY WE HAVE AN EXECUTIVE 3358 01:58:34,043 --> 01:58:37,814 COMMITTEE OVERSEEING THE ENTIRE 3359 01:58:37,814 --> 01:58:38,281 INITIATIVE. 3360 01:58:38,281 --> 01:58:39,282 THE IMPORTANCE HERE IS THAT 3361 01:58:39,282 --> 01:58:40,950 WE'RE ENGAGING WITH THE NIH 3362 01:58:40,950 --> 01:58:41,984 DIRECTOR, DR. BERTAGNOLLI, THE 3363 01:58:41,984 --> 01:58:43,986 DIRECTOR OF NIAID AS I'VE 3364 01:58:43,986 --> 01:58:45,188 MENTIONED, AS WELL AS THE 3365 01:58:45,188 --> 01:58:48,357 DIRECTORS OF NHLBI AND NINDS. 3366 01:58:48,357 --> 01:58:52,061 THE LEAD OF THE FNIH, AND ALSO 3367 01:58:52,061 --> 01:58:54,030 IMPORTANTLY WE'LL HAVE AGAIN 3368 01:58:54,030 --> 01:58:54,564 INPUT FROM THE COMMUNITY. 3369 01:58:54,564 --> 01:58:58,935 AND REALLY THIS IS SHOWING THAT 3370 01:58:58,935 --> 01:59:00,136 THIS IS AN EXTREMELY HIGH 3371 01:59:00,136 --> 01:59:01,337 PRIORITY AT NIH AND REALLY 3372 01:59:01,337 --> 01:59:03,039 TAKING OWNERSHIP AT THE HIGHEST 3373 01:59:03,039 --> 01:59:04,941 LEVEL FOR THE OUTPUTS OF THIS 3374 01:59:04,941 --> 01:59:06,042 INITIATIVE. 3375 01:59:06,042 --> 01:59:07,877 UNDER THE EXECUTIVE COMMITTEE, 3376 01:59:07,877 --> 01:59:10,213 WE'LL HAVE A SCIENTIFIC 3377 01:59:10,213 --> 01:59:10,947 OVERSIGHT COMMITTEE WHICH WE'VE 3378 01:59:10,947 --> 01:59:12,782 ALREADY BEEN PUTTING TOGETHER 3379 01:59:12,782 --> 01:59:15,952 THAT TAKES EXPERTISE FROM ACROSS 3380 01:59:15,952 --> 01:59:18,154 THE VARIOUS STAKEHOLDER GROUPS 3381 01:59:18,154 --> 01:59:19,455 INCLUDING WITHIN NIH BUT ALSO 3382 01:59:19,455 --> 01:59:20,223 WITHIN ACADEMIA. 3383 01:59:20,223 --> 01:59:22,191 WE HAVE INDUSTRY 3384 01:59:22,191 --> 01:59:23,092 REPRESENTATIVES, REPRESENTATIVES 3385 01:59:23,092 --> 01:59:25,762 FROM OTHER AGENCIES IN THE U.S. 3386 01:59:25,762 --> 01:59:26,662 GOVERNMENT, AND AGAIN WITH 3387 01:59:26,662 --> 01:59:28,197 COMMUNITY REPRESENTATION. 3388 01:59:28,197 --> 01:59:29,465 AMONG OTHER THINGS, THIS 3389 01:59:29,465 --> 01:59:30,366 COMMITTEE WILL BE RESPONSIBLE 3390 01:59:30,366 --> 01:59:32,368 FOR REVIEWING A LIST OF 3391 01:59:32,368 --> 01:59:33,970 PRIORITIZED THERAPEUTIC 3392 01:59:33,970 --> 01:59:35,037 INTERVENTIONS, AND MAKING 3393 01:59:35,037 --> 01:59:36,239 RECOMMENDATIONS FOR WHICH OF 3394 01:59:36,239 --> 01:59:38,007 THOSE INTERVENTIONS MAKES SENSE 3395 01:59:38,007 --> 01:59:39,842 TO STUDY IN CLINICAL TRIALS, 3396 01:59:39,842 --> 01:59:44,013 WHICH THEN WOULD BE SENT TO THE 3397 01:59:44,013 --> 01:59:45,748 EXECUTIVE COMMITTEE FOR A FINAL 3398 01:59:45,748 --> 01:59:48,918 SIGNOFF AND APPROVAL. 3399 01:59:48,918 --> 01:59:50,553 AND WE ALSO WILL BE PUTTING 3400 01:59:50,553 --> 01:59:52,121 TOGETHER A NUMBER OF WORKING 3401 01:59:52,121 --> 01:59:55,258 GROUPS THAT WILL BE MORE FOCUSED 3402 01:59:55,258 --> 01:59:57,994 ON INDIVIDUAL EITHER MECHANISMS 3403 01:59:57,994 --> 01:59:59,962 OR SYMPTOM-BASED WORKING GROUPS 3404 01:59:59,962 --> 02:00:01,030 DEPENDING ON WHAT THE QUESTION 3405 02:00:01,030 --> 02:00:03,466 IS THAT WE NEED TO ANSWER. 3406 02:00:03,466 --> 02:00:05,001 SO WITHIN THOSE WORKING GROUPS, 3407 02:00:05,001 --> 02:00:06,502 WE'VE PUT TOGETHER THE EXPERTISE 3408 02:00:06,502 --> 02:00:09,705 THAT WILL BE NEEDED TO EVALUATE 3409 02:00:09,705 --> 02:00:11,340 POTENTIAL THERAPEUTICS, AND 3410 02:00:11,340 --> 02:00:12,742 AGAIN, PRIORITIZE AND MAKE 3411 02:00:12,742 --> 02:00:13,976 RECOMMENDATIONS TO THE 3412 02:00:13,976 --> 02:00:18,648 SCIENTIFIC OVERSIGHT COMMITTEE. 3413 02:00:18,648 --> 02:00:20,650 AS FAR AS THE OPERATIONS, WE'RE 3414 02:00:20,650 --> 02:00:22,718 REALLY LOOKING TO LEVERAGE OUR 3415 02:00:22,718 --> 02:00:24,220 EXISTING RESOURCES. 3416 02:00:24,220 --> 02:00:25,855 AS I'VE MENTIONED, WE HAVE A 3417 02:00:25,855 --> 02:00:26,656 NUMBER OF RESOURCES THAT HAVE 3418 02:00:26,656 --> 02:00:29,158 BEEN IN PLACE AND HAVE REALLY 3419 02:00:29,158 --> 02:00:32,762 PROVEN TO WORK WELL AND WORK 3420 02:00:32,762 --> 02:00:33,563 EFFICIENTLY, SO WE'RE GOING TO 3421 02:00:33,563 --> 02:00:36,132 DO OUR BEST TO USE ALL THE 3422 02:00:36,132 --> 02:00:37,900 EXISTING RESOURCES THAT WE CAN 3423 02:00:37,900 --> 02:00:40,736 AS MUCH AS POSSIBLE AND WHERE 3424 02:00:40,736 --> 02:00:40,970 NEEDED. 3425 02:00:40,970 --> 02:00:42,805 WE WILL ENHANCE, SO TO SPEAK, 3426 02:00:42,805 --> 02:00:45,141 AND MAKE USE OF OTHER RESOURCES 3427 02:00:45,141 --> 02:00:46,509 ACROSS THE NIH. 3428 02:00:46,509 --> 02:00:47,844 REALLY THE OVERALL STRATEGY IS 3429 02:00:47,844 --> 02:00:50,279 TO INCREASE OUR EFFICIENCY AS A 3430 02:00:50,279 --> 02:00:55,051 WAY OF REFLECTING THE URGENCY 3431 02:00:55,051 --> 02:00:59,088 AND IMPORTANCE OF THIS PROBLEM. 3432 02:00:59,088 --> 02:01:01,057 I CAN'T UNDERSCORE ENOUGH THE 3433 02:01:01,057 --> 02:01:02,158 IMPORTANCE OF COMMUNITY 3434 02:01:02,158 --> 02:01:02,592 ENGAGEMENT. 3435 02:01:02,592 --> 02:01:03,793 REALLY, WE THINK THIS WILL BE 3436 02:01:03,793 --> 02:01:05,328 CRITICAL TO ALL THE COMPONENTS 3437 02:01:05,328 --> 02:01:07,430 OF RECOVER TLC, AND REALLY WE 3438 02:01:07,430 --> 02:01:08,931 WANT TO MAKE SURE THAT WE HAVE 3439 02:01:08,931 --> 02:01:10,566 AN ONGOING BILATERAL DIALOGUE 3440 02:01:10,566 --> 02:01:11,868 THROUGHOUT ALL OF OUR 3441 02:01:11,868 --> 02:01:12,235 ACTIVITIES. 3442 02:01:12,235 --> 02:01:13,502 WE HAVE ALREADY FROM THE 3443 02:01:13,502 --> 02:01:15,371 BEGINNING ENGAGED COMMUNITY 3444 02:01:15,371 --> 02:01:16,906 GROUPS THAT HAD PREVIOUSLY BEEN 3445 02:01:16,906 --> 02:01:18,407 INTERACTING WITH RECOVER, AS 3446 02:01:18,407 --> 02:01:24,213 WELL AS SOME OF OUR OTHER NIAID 3447 02:01:24,213 --> 02:01:25,514 CLINICAL TRIALS ACTIVITIES. 3448 02:01:25,514 --> 02:01:27,516 WE ARE ESTABLISHING A NEW 3449 02:01:27,516 --> 02:01:28,918 COMMUNITY ENGAGEMENT GROUP FOR 3450 02:01:28,918 --> 02:01:31,220 THE PURPOSE OF RECOVER TLC 3451 02:01:31,220 --> 02:01:33,289 SPECIFICALLY THAT WILL PROVIDE 3452 02:01:33,289 --> 02:01:34,690 FEEDBACK DIRECTLY TO THE 3453 02:01:34,690 --> 02:01:36,025 EXECUTIVE COMMITTEE, AND WE'LL 3454 02:01:36,025 --> 02:01:37,560 HAVE REPRESENTATIVES ENGAGED IN 3455 02:01:37,560 --> 02:01:39,528 EVERY LEVEL OF THE ORGANIZATION 3456 02:01:39,528 --> 02:01:40,930 FROM THE PRIORITIZATION GROUPS 3457 02:01:40,930 --> 02:01:42,398 TO THE SCIENTIFIC OVERSIGHT 3458 02:01:42,398 --> 02:01:43,566 COMMITTEE AND ALL OF THE WORKING 3459 02:01:43,566 --> 02:01:47,837 GROUPS. 3460 02:01:47,837 --> 02:01:49,906 IN TERMS OF THE CLINICAL TRIALS, 3461 02:01:49,906 --> 02:01:51,674 WE REALLY AGAIN ARE HAVING AN 3462 02:01:51,674 --> 02:01:53,075 EYE TOWARDS LEVERAGING OUR 3463 02:01:53,075 --> 02:01:54,277 EXISTING RESOURCES, SO WE WILL 3464 02:01:54,277 --> 02:01:56,145 BE LOOKING ACROSS NOT ONLY NIAID 3465 02:01:56,145 --> 02:01:58,748 AND RECOVER BUT OTHER INSTITUTES 3466 02:01:58,748 --> 02:02:00,549 TO SEE IF THERE ARE ANY OTHER 3467 02:02:00,549 --> 02:02:02,118 CLINICAL TRIAL NETWORKS THAT WE 3468 02:02:02,118 --> 02:02:03,920 CAN BRING TO BEAR FOR THIS 3469 02:02:03,920 --> 02:02:04,787 EFFORT, AND AGAIN THIS IS 3470 02:02:04,787 --> 02:02:06,455 SOMETHING THAT WE DID WITHIN 3471 02:02:06,455 --> 02:02:08,391 ACTIVE THAT WORKED VERY WELL. 3472 02:02:08,391 --> 02:02:11,794 WE REALLY WANT TO MAKE SURE THAT 3473 02:02:11,794 --> 02:02:13,029 WE HAVE CLINICAL TRIAL SITE IN 3474 02:02:13,029 --> 02:02:14,530 THE AREAS WHERE WE NEED THEM, 3475 02:02:14,530 --> 02:02:18,034 MEANING WHERE THE PEOPLE ARE 3476 02:02:18,034 --> 02:02:20,770 LIVING WITH LONG COVID, SO THAT 3477 02:02:20,770 --> 02:02:22,071 MIGHT MEAN EVEN BRINGING IN 3478 02:02:22,071 --> 02:02:23,272 NOVEL SITES WE HAVEN'T ENGAGED 3479 02:02:23,272 --> 02:02:26,342 WITH JUST TO MAKE SURE WE REALLY 3480 02:02:26,342 --> 02:02:27,276 ARE INCLUSIVE AND ACCESSIBLE. 3481 02:02:27,276 --> 02:02:28,844 IN TERMS OF PROTOCOLS, WE WANT 3482 02:02:28,844 --> 02:02:30,179 TO UTILIZE PLATFORM TRIAL 3483 02:02:30,179 --> 02:02:32,348 DESIGNS WHERE POSSIBLE TO ALLOW 3484 02:02:32,348 --> 02:02:35,651 US TO BE NIMBLE AND BE ABLE TO 3485 02:02:35,651 --> 02:02:36,519 ACCOMMODATE ADDITIONAL 3486 02:02:36,519 --> 02:02:39,889 INTERVENTIONS QUICKLY. 3487 02:02:39,889 --> 02:02:42,491 THE DESIGNS, WE REALLY -- OUR 3488 02:02:42,491 --> 02:02:43,926 ULTIMATE AIM IS TO HAVE TRIALS 3489 02:02:43,926 --> 02:02:45,361 THAT ARE LARGE ENOUGH TO BE ABLE 3490 02:02:45,361 --> 02:02:47,530 TO DEFINITIVELY ASSESS CANDIDATE 3491 02:02:47,530 --> 02:02:49,298 THERAPEUTICS FOR SAFETY AND 3492 02:02:49,298 --> 02:02:50,933 EFFICACY, BUT RECOGNIZE THAT NOT 3493 02:02:50,933 --> 02:02:53,135 ALL INTERVENTIONS WILL 3494 02:02:53,135 --> 02:02:56,205 NECESSARILY HAVE THE NECESSARY 3495 02:02:56,205 --> 02:02:57,940 DATA THAT WOULD WARRANT A LARGER 3496 02:02:57,940 --> 02:03:02,111 TRIAL SO WE'RE ALSO MAINTAINING 3497 02:03:02,111 --> 02:03:03,479 FLEXIBILITY AND MIGHT NEED TO DO 3498 02:03:03,479 --> 02:03:05,815 SOME SMALLER EXPLORATORY TRIALS 3499 02:03:05,815 --> 02:03:06,682 AS WARRANTED. 3500 02:03:06,682 --> 02:03:08,217 AND THEN FINALLY, WE WILL HAVE 3501 02:03:08,217 --> 02:03:12,621 AN EYE TOWARD CREATING OR USING 3502 02:03:12,621 --> 02:03:16,826 A BIO REPOSITORY FOR SPECIMENS, 3503 02:03:16,826 --> 02:03:18,394 AS WELL AS A REPOSITORY FOR 3504 02:03:18,394 --> 02:03:18,828 CLINICAL DATA. 3505 02:03:18,828 --> 02:03:22,932 AGAIN, SO THAT WE CAN MAKE THESE 3506 02:03:22,932 --> 02:03:23,966 AVAILABLE TO RESEARCHERS BOTH 3507 02:03:23,966 --> 02:03:25,634 WITHIN THE RECOVER TLC 3508 02:03:25,634 --> 02:03:32,041 INITIATIVE AS WELL AS OUTSIDE. 3509 02:03:32,041 --> 02:03:34,543 THIS IS JUST A SCHEMATIC WITH 3510 02:03:34,543 --> 02:03:36,278 THE EXECUTIVE COMMITTEE 3511 02:03:36,278 --> 02:03:38,714 OVERSEEING EVERYTHING, AND THE 3512 02:03:38,714 --> 02:03:39,482 COMMUNITY ENGAGEMENT GROUP WHICH 3513 02:03:39,482 --> 02:03:41,317 IS DEPICTED ALONG THE LEFT SIDE 3514 02:03:41,317 --> 02:03:42,885 OF THE SLIDE REALLY PLAYING A 3515 02:03:42,885 --> 02:03:43,853 ROLE ACROSS THE ENTIRE 3516 02:03:43,853 --> 02:03:51,060 INITIATIVE. 3517 02:03:51,060 --> 02:03:52,495 SO WE WERE ABLE TO HAVE OUR 3518 02:03:52,495 --> 02:03:53,629 KICKOFF MEETING AS I MENTIONED 3519 02:03:53,629 --> 02:03:54,563 AT THE END OF SEPTEMBER AND IT 3520 02:03:54,563 --> 02:03:57,066 REALLY WAS AN AMAZING EXPERIENCE 3521 02:03:57,066 --> 02:04:00,269 WITH VERY ROBUST INTERACTIONS 3522 02:04:00,269 --> 02:04:04,874 AND PARTICIPATION FROM VARIOUS 3523 02:04:04,874 --> 02:04:05,741 STAKEHOLDERS BOTH IN PERSON, 3524 02:04:05,741 --> 02:04:07,510 THERE WERE ABOUT 180 PEOPLE IN 3525 02:04:07,510 --> 02:04:10,146 PERSON AND MORE THAN 1200 3526 02:04:10,146 --> 02:04:11,881 PARTICIPANTS ONLINE, WITH REALLY 3527 02:04:11,881 --> 02:04:16,585 JUST FANTASTIC DISCUSSION ACROSS 3528 02:04:16,585 --> 02:04:17,553 2 1/2 DAYS. 3529 02:04:17,553 --> 02:04:21,190 WE WERE FORTUNATE TO HAVE 3530 02:04:21,190 --> 02:04:25,461 DR. BERTAGNOLLI AS WELL AS 3531 02:04:25,461 --> 02:04:26,295 DR. GERBERDING PRESENT TO 3532 02:04:26,295 --> 02:04:35,504 PROVIDE WELCOMING REMARKS OF DR 3533 02:04:35,504 --> 02:04:36,305 BADEN. 3534 02:04:36,305 --> 02:04:37,740 THE GOALS OF THE WORKSHOP REALLY 3535 02:04:37,740 --> 02:04:38,941 WERE TO GET FEEDBACK. 3536 02:04:38,941 --> 02:04:40,242 WE REALLY WANTED TO ENGAGE WITH 3537 02:04:40,242 --> 02:04:43,746 ALL THE STAKEHOLDERS FOR WHOM 3538 02:04:43,746 --> 02:04:46,148 RESEARCH ON LONG COVID IS A 3539 02:04:46,148 --> 02:04:46,582 PRIORITY. 3540 02:04:46,582 --> 02:04:48,451 SO WE DESIGNED IT AS A HIGH 3541 02:04:48,451 --> 02:04:49,885 LEVEL SCIENTIFIC REVIEW WHERE WE 3542 02:04:49,885 --> 02:04:50,953 REVIEWED CLINICAL AND 3543 02:04:50,953 --> 02:04:52,288 MECHANISTIC DATA WITH AN 3544 02:04:52,288 --> 02:04:53,589 EMPHASIS ON GETTING INPUT AND 3545 02:04:53,589 --> 02:04:54,557 SPECIFICALLY LOOKING FOR 3546 02:04:54,557 --> 02:04:55,558 IMPLICATIONS FOR CLINICAL TRIAL 3547 02:04:55,558 --> 02:04:55,891 DESIGN. 3548 02:04:55,891 --> 02:04:57,393 THERE WAS OPPORTUNITY TO 3549 02:04:57,393 --> 02:04:58,294 HIGHLIGHT WHICH OF THESE DATA 3550 02:04:58,294 --> 02:05:01,464 MIGHT BE ABLE TO BE APPLIED TO 3551 02:05:01,464 --> 02:05:02,431 CLINICAL TRIALS NOW, WHAT'S 3552 02:05:02,431 --> 02:05:06,502 KNOWN ABOUT MECHANISMS, SYMPTOM 3553 02:05:06,502 --> 02:05:07,603 BURDEN, AND WHAT INTERVENTIONS 3554 02:05:07,603 --> 02:05:09,205 MIGHT BE AVAILABLE. 3555 02:05:09,205 --> 02:05:14,143 AT THE END OF THE MEETING, 3556 02:05:14,143 --> 02:05:16,579 DR. MORAZZO SUMMARIZED THE KEY 3557 02:05:16,579 --> 02:05:17,580 FINDINGS AND ALSO DESCRIBED HOW 3558 02:05:17,580 --> 02:05:18,881 WE WOULD BE MOVING FORWARD AS A 3559 02:05:18,881 --> 02:05:20,082 RESULT OF RECEIVING ALL OF THIS 3560 02:05:20,082 --> 02:05:23,452 INPUT. 3561 02:05:23,452 --> 02:05:27,823 IN TERMS OF THE SCIENTIFIC FOCI, 3562 02:05:27,823 --> 02:05:30,926 WE TALKED ABOUT PATHOLOGY, 3563 02:05:30,926 --> 02:05:31,894 BIOMARKERS, EPIDEMIOLOGY AND THE 3564 02:05:31,894 --> 02:05:34,930 COHORT STUDY ONGOING, POTENTIAL 3565 02:05:34,930 --> 02:05:36,298 CLINICAL TRIAL DESIGNS, WHAT 3566 02:05:36,298 --> 02:05:37,600 STRATEGIES WE'D USE FOR 3567 02:05:37,600 --> 02:05:38,434 PRIORITIZING INTERVENTIONS AS 3568 02:05:38,434 --> 02:05:40,536 WELL AS SELECTING END POINTS. 3569 02:05:40,536 --> 02:05:41,637 AGAIN MANY PARTICIPANTS FROM 3570 02:05:41,637 --> 02:05:42,805 ACROSS ALL THE STAKEHOLDER 3571 02:05:42,805 --> 02:05:44,473 GROUPS WERE INVOLVED. 3572 02:05:44,473 --> 02:05:46,208 INVESTIGATORS FROM BOTH THE U.S. 3573 02:05:46,208 --> 02:05:47,409 AS WELL AS INTERNATIONAL 3574 02:05:47,409 --> 02:05:48,544 COMMUNITY AND PATIENT GROUPS, 3575 02:05:48,544 --> 02:05:49,411 INDUSTRY REPRESENTATIVES, A 3576 02:05:49,411 --> 02:05:51,046 NUMBER OF SCIENTISTS AND 3577 02:05:51,046 --> 02:05:52,148 CLINICIANS FROM ACROSS THE NIH, 3578 02:05:52,148 --> 02:05:54,550 AND A NUMBER OF U.S. GOVERNMENT 3579 02:05:54,550 --> 02:05:56,952 AGENCIES REPRESENTED INCLUDING 3580 02:05:56,952 --> 02:05:58,621 FDA, CDC, AND SO ON AS LISTED ON 3581 02:05:58,621 --> 02:06:02,858 THE SLIDE. 3582 02:06:02,858 --> 02:06:04,360 SO SOME OF THE WORKSHOP OUTCOMES 3583 02:06:04,360 --> 02:06:05,694 AS I MENTIONED WERE SUMMARIZED 3584 02:06:05,694 --> 02:06:11,100 AT THE END OF THE MEETING BY DR. 3585 02:06:11,100 --> 02:06:18,007 I WILLIT WAS A VERY EXTENSIVE 3586 02:06:18,007 --> 02:06:19,208 DISCUSSION AND IT WAS REALLY 3587 02:06:19,208 --> 02:06:20,109 REMARKABLE, THE AMOUNT OF INPUT 3588 02:06:20,109 --> 02:06:21,510 WE WERE ABLE TO GET FROM THESE 3589 02:06:21,510 --> 02:06:24,246 DISCUSSIONS. 3590 02:06:24,246 --> 02:06:26,115 IN TERMS OF COMMUNICATION AND 3591 02:06:26,115 --> 02:06:26,649 STRUCTURE, FIRST WE HEARD 3592 02:06:26,649 --> 02:06:28,217 THERE'S REALLY TREMENDOUS VALUE 3593 02:06:28,217 --> 02:06:30,386 IN JUST ASSEMBLING THIS DIVERSE 3594 02:06:30,386 --> 02:06:31,620 GROUP OF PEOPLE WHO ARE ALL 3595 02:06:31,620 --> 02:06:32,688 PASSIONATE ABOUT IMPROVING LIFE 3596 02:06:32,688 --> 02:06:36,091 FOR PEOPLE LIVING WITH LONG 3597 02:06:36,091 --> 02:06:37,626 COVID AS WELL AS OTHER 3598 02:06:37,626 --> 02:06:38,394 INFECTION-ASSOCIATED CHRONIC 3599 02:06:38,394 --> 02:06:40,229 CONDITIONS. 3600 02:06:40,229 --> 02:06:41,497 PATIENT AND COMMUNITY 3601 02:06:41,497 --> 02:06:43,666 INVOLVEMENT, AGAIN AS WE SAID 3602 02:06:43,666 --> 02:06:45,100 FROM THE OUTSIDE IS REALLY 3603 02:06:45,100 --> 02:06:46,502 CRITICAL IN ALL ASPECTS OF 3604 02:06:46,502 --> 02:06:47,636 PLANNING THESE TRIALS. 3605 02:06:47,636 --> 02:06:49,605 WE HEARD THAT THERE WAS A REAL 3606 02:06:49,605 --> 02:06:57,580 DESIRE FOR LEADERSHIP TO BE 3607 02:06:57,580 --> 02:06:59,215 ACCOUNTABLE AND VISIBLE AND BE 3608 02:06:59,215 --> 02:07:00,115 TRANSPARENT ABOUT THE 3609 02:07:00,115 --> 02:07:00,749 DECISION-MAKING PROCESS AND HOW 3610 02:07:00,749 --> 02:07:02,651 WE WERE GOING TO BE IMPLEMENTING 3611 02:07:02,651 --> 02:07:03,018 CLINICAL TRIALS. 3612 02:07:03,018 --> 02:07:04,153 AND ALSO THAT RECOVER HAS 3613 02:07:04,153 --> 02:07:05,421 ALREADY MADE ADVANCES IN THE 3614 02:07:05,421 --> 02:07:06,488 SCIENCE AND REALLY SHOULD BE 3615 02:07:06,488 --> 02:07:08,057 LEVERAGED FOR FUTURE SUCCESS. 3616 02:07:08,057 --> 02:07:11,193 SO ALL OF THIS REALLY SORT OF 3617 02:07:11,193 --> 02:07:12,294 UNDERSCORING THE GUIDING 3618 02:07:12,294 --> 02:07:13,929 PRINCIPLES THAT WE HAD IN PLACE 3619 02:07:13,929 --> 02:07:16,332 FOR RECOVER TLC, SO VERY 3620 02:07:16,332 --> 02:07:19,301 GRATIFYING TO HEAR THAT 3621 02:07:19,301 --> 02:07:19,568 FEEDBACK. 3622 02:07:19,568 --> 02:07:20,869 SO WHAT WE HAVE COMMITTED TO DO 3623 02:07:20,869 --> 02:07:24,006 IS TO PROVIDE FORUMS FOR REGULAR 3624 02:07:24,006 --> 02:07:25,641 ONGOING DIALOGUE WITH THESE -- 3625 02:07:25,641 --> 02:07:27,076 WITH ALL OF THE STAKEHOLDERS TO 3626 02:07:27,076 --> 02:07:29,712 ENSURE THAT THERE'S MEANINGFUL 3627 02:07:29,712 --> 02:07:31,013 PARTICIPATION OF PATIENTS AND 3628 02:07:31,013 --> 02:07:32,214 ADVOCATES AT EVERY STEP ALONG 3629 02:07:32,214 --> 02:07:33,882 THE WAY, AND TO PROVIDE REGULAR 3630 02:07:33,882 --> 02:07:35,517 UPDATES ON OUR PROGRESS. 3631 02:07:35,517 --> 02:07:36,619 AND I'LL GO INTO A LITTLE BIT 3632 02:07:36,619 --> 02:07:38,254 MORE DETAIL ON THAT, HOW WE PLAN 3633 02:07:38,254 --> 02:07:45,194 TO DO THAT IN UPCOMING SLIDES. 3634 02:07:45,194 --> 02:07:47,162 IN TERMS OF THE CLINICAL TRIALS, 3635 02:07:47,162 --> 02:07:49,164 I WOULD SAY THE THEMES WERE 3636 02:07:49,164 --> 02:07:49,798 INCLUSIVITY AND ACCESSIBILITY. 3637 02:07:49,798 --> 02:07:52,868 WE HEARD A REAL DESIRE FOR THERE 3638 02:07:52,868 --> 02:07:57,273 TO BE VERY CONSIDERED -- VERY 3639 02:07:57,273 --> 02:07:58,707 CAREFUL CONSIDERATION OF WHAT 3640 02:07:58,707 --> 02:08:00,509 THE ENTRY CRITERIA SHOULD BE FOR 3641 02:08:00,509 --> 02:08:01,877 CLINICAL TRIALS WITH AN EYE 3642 02:08:01,877 --> 02:08:07,683 TOWARD MINIMIZING EXCLUSIONS. 3643 02:08:07,683 --> 02:08:09,218 THERE WAS A LOT OF CONCERN THAT 3644 02:08:09,218 --> 02:08:10,319 DIFFERENT SUBPOPULATIONS OF 3645 02:08:10,319 --> 02:08:12,054 PEOPLE LIVING WITH LONG COVID 3646 02:08:12,054 --> 02:08:14,256 MIGHT BE EXCLUDED FROM TRIALS, 3647 02:08:14,256 --> 02:08:15,457 EVEN INADVERTENTLY IF WE WERE 3648 02:08:15,457 --> 02:08:17,092 NOT VERY CAREFUL ABOUT HOW WE 3649 02:08:17,092 --> 02:08:18,594 CRAFT THE ENTRY CRITERIA FOR 3650 02:08:18,594 --> 02:08:19,094 CLINICAL TRIALS. 3651 02:08:19,094 --> 02:08:20,296 AND THEN WE HEARD OVER AND OVER 3652 02:08:20,296 --> 02:08:21,397 AGAIN THAT HE WITH REALLY NEED 3653 02:08:21,397 --> 02:08:23,599 TO BE MINDFUL OF ACCESSIBILITY 3654 02:08:23,599 --> 02:08:26,702 IN TERMS OF HOW WE DESIGN TRIALS 3655 02:08:26,702 --> 02:08:28,537 SO THAT PEOPLE WHO MIGHT HAVE 3656 02:08:28,537 --> 02:08:30,539 PARTICULARLY SEVERE SYMPTOMS WHO 3657 02:08:30,539 --> 02:08:31,940 ARE EVEN HOMEBOUND OR BED BOUND 3658 02:08:31,940 --> 02:08:36,211 STILL MIGHT HAVE ACCESS TO 3659 02:08:36,211 --> 02:08:38,213 CLINICAL TRIALS THROUGH NOVEL 3660 02:08:38,213 --> 02:08:42,851 WAYS OF BRINGING CLINICAL TRIALS 3661 02:08:42,851 --> 02:08:44,553 TO PARTICIPANTS AS OPPOSED TO 3662 02:08:44,553 --> 02:08:45,754 PARTICIPANTS HAVING TO GO TO 3663 02:08:45,754 --> 02:08:46,422 CLINICAL TRIAL SITES. 3664 02:08:46,422 --> 02:08:49,825 SO WE HAVE COMMITTED TO WORKING 3665 02:08:49,825 --> 02:08:50,926 CAREFULLY WHEN WE DESIGN OUR 3666 02:08:50,926 --> 02:08:52,361 TRIALS AND WHEN WE REVIEW SITES 3667 02:08:52,361 --> 02:08:55,230 TO REALLY KEEP IN MIND THESE 3668 02:08:55,230 --> 02:08:56,765 THEMES OF INCLUSIVITY AND 3669 02:08:56,765 --> 02:09:02,838 ACCESSIBILITY. 3670 02:09:02,838 --> 02:09:04,039 AGAIN VERY IMPORTANT TO LINK 3671 02:09:04,039 --> 02:09:05,574 WHATEVER INTERVENTIONS WE WIND 3672 02:09:05,574 --> 02:09:07,109 UP EVALUATING BACK TO THE 3673 02:09:07,109 --> 02:09:07,443 PATHOBIOLOGY. 3674 02:09:07,443 --> 02:09:08,811 IT NEEDS TO MAKE SCIENTIFIC 3675 02:09:08,811 --> 02:09:10,379 SENSE AND WE HAVE A LOT OF WORK 3676 02:09:10,379 --> 02:09:12,381 THAT WE CAN LEVERAGE, IN 3677 02:09:12,381 --> 02:09:13,682 PARTICULAR THE BIOREPOSITORY 3678 02:09:13,682 --> 02:09:14,983 THAT'S BEEN PUT TOGETHER BY 3679 02:09:14,983 --> 02:09:17,119 RECOVER WAS MENTIONED, THAT WE 3680 02:09:17,119 --> 02:09:21,256 REALLY NEED TO TAKE ADVANTAGE OF 3681 02:09:21,256 --> 02:09:24,626 RESOURCES THAT ARE ALREADY IN 3682 02:09:24,626 --> 02:09:28,364 PLACE, AND SO WE HAVE PLEDGED TO 3683 02:09:28,364 --> 02:09:31,233 INVESTIGATE HOW WE CAN USE THOSE 3684 02:09:31,233 --> 02:09:32,534 SPECIMENS AND DATA THROUGH OUR 3685 02:09:32,534 --> 02:09:35,070 WORKING GROUPS AND THROUGH 3686 02:09:35,070 --> 02:09:36,805 INVESTIGATIONS AT AN INDIVIDUAL 3687 02:09:36,805 --> 02:09:37,806 INVESTIGATOR LEVEL, IN ORDER TO 3688 02:09:37,806 --> 02:09:39,975 INFORM OUR CLINICAL TRIAL 3689 02:09:39,975 --> 02:09:45,447 PRIORITIZATION. 3690 02:09:45,447 --> 02:09:46,882 AND AGAIN INVOLVEMENT OF PEOPLE 3691 02:09:46,882 --> 02:09:47,950 LIVING WITH LONG COVID EVERY 3692 02:09:47,950 --> 02:09:49,651 STEP OF THE WAY, THESE ARE SORT 3693 02:09:49,651 --> 02:09:51,820 OF BASIC TENETS OF GOOD 3694 02:09:51,820 --> 02:09:53,589 PARTICIPATORY PRACTICE, WHICH IS 3695 02:09:53,589 --> 02:09:54,790 SOMETHING THAT NIAID HAS 3696 02:09:54,790 --> 02:09:56,792 ESPOUSED FOR A VERY LONG TIME, 3697 02:09:56,792 --> 02:09:58,527 MEANING THAT WE WILL INCLUDE 3698 02:09:58,527 --> 02:10:00,329 PEOPLE LIVING WITH LONG COVID IN 3699 02:10:00,329 --> 02:10:01,930 EVERY ASPECT OF PLANNING 3700 02:10:01,930 --> 02:10:03,365 CLINICAL TRIALS FROM THE 3701 02:10:03,365 --> 02:10:04,566 INTERVENTION SELECTION TO TRIAL 3702 02:10:04,566 --> 02:10:06,468 DESIGN, TRIAL CONDUCT, 3703 02:10:06,468 --> 02:10:08,370 INTERPRETATION, DISSEMINATION, 3704 02:10:08,370 --> 02:10:09,071 AND IMPLEMENTATION OF THE 3705 02:10:09,071 --> 02:10:12,708 FINDINGS. 3706 02:10:12,708 --> 02:10:14,676 SO SINCE THE WORKSHOP, WHAT HAVE 3707 02:10:14,676 --> 02:10:15,144 WE BEEN DOING? 3708 02:10:15,144 --> 02:10:16,779 WE HAVE A WORKSHOP REPORT THAT 3709 02:10:16,779 --> 02:10:18,514 IS COMING OUT IMMINENTLY, MAYBE 3710 02:10:18,514 --> 02:10:19,381 EVEN AS SOON AS TOMORROW, BUT 3711 02:10:19,381 --> 02:10:20,749 CERTAINLY BY NEXT WEEK, AND THEN 3712 02:10:20,749 --> 02:10:24,453 THAT WILL BE FOLLOWED BY A 3713 02:10:24,453 --> 02:10:25,888 MANUSCRIPT THAT ESSENTIALLY WILL 3714 02:10:25,888 --> 02:10:28,424 BE AN EXECUTIVE SUMMARY OF THE 3715 02:10:28,424 --> 02:10:30,592 LONGER WORKSHOP REPORT COMING 3716 02:10:30,592 --> 02:10:32,895 SHORTLY THEREAFTER. 3717 02:10:32,895 --> 02:10:34,663 WE HAVE LAUNCHED A PORTAL FOR 3718 02:10:34,663 --> 02:10:36,532 SUBMISSION OF THERAPEUTICS THAT 3719 02:10:36,532 --> 02:10:38,333 WAS LAUNCHED -- I THINK IT WAS 3720 02:10:38,333 --> 02:10:41,236 THE DAY AFTER THE MEETING 3721 02:10:41,236 --> 02:10:42,538 CONCLUDED, AND THUS FAR, WE HAVE 3722 02:10:42,538 --> 02:10:45,941 HAD OVER 400 SUBMISSIONS FROM 3723 02:10:45,941 --> 02:10:48,043 VARIOUS STAKEHOLDERS, PEOPLE 3724 02:10:48,043 --> 02:10:48,811 LIVING WITH LONG COVID, FROM 3725 02:10:48,811 --> 02:10:59,555 CARE PROVIDERS, FROM ACADEMICI, 3726 02:11:00,589 --> 02:11:03,692 FROM FOLKS WITHIN NIH. 3727 02:11:03,692 --> 02:11:04,893 WE HAD ALREADY STARTED TO PUT 3728 02:11:04,893 --> 02:11:06,728 TOGETHER A CLINICAL TRIALS 3729 02:11:06,728 --> 02:11:07,896 LANDSCAPE AND WE HAVE THAT 3730 02:11:07,896 --> 02:11:09,298 ONGOING MONITORING OF WHAT ELSE 3731 02:11:09,298 --> 02:11:10,499 IS GOING ON BASICALLY IN THE 3732 02:11:10,499 --> 02:11:13,602 FIELD IN ORDER TO, AGAIN, NOT 3733 02:11:13,602 --> 02:11:14,570 DUPLICATE EFFORTS, AND WE HAVE 3734 02:11:14,570 --> 02:11:16,004 ALSO ESTABLISHED OUR 3735 02:11:16,004 --> 02:11:17,439 PRIORITIZATION PROCESS, MEANING 3736 02:11:17,439 --> 02:11:18,540 WE'VE PUT TOGETHER THE CRITERIA 3737 02:11:18,540 --> 02:11:20,609 AND SCORING RUBRIC THAT WE'LL BE 3738 02:11:20,609 --> 02:11:21,977 USING ACROSS PRIORITIZATION 3739 02:11:21,977 --> 02:11:23,479 GROUPS WHEN WE TAKE A LOOK AT 3740 02:11:23,479 --> 02:11:24,580 THESE CANDIDATE THAT HAVE COME 3741 02:11:24,580 --> 02:11:26,682 IN. 3742 02:11:26,682 --> 02:11:28,750 WE ALSO PUBLISHED A REQUEST FOR 3743 02:11:28,750 --> 02:11:32,154 INFORMATION OR RFI BACK IN 3744 02:11:32,154 --> 02:11:33,155 OCTOBER THAT WILL BE OPEN 3745 02:11:33,155 --> 02:11:33,589 THROUGH FEBRUARY. 3746 02:11:33,589 --> 02:11:36,992 THIS IS AN ADDITIONAL MEANS OF 3747 02:11:36,992 --> 02:11:38,560 FOLKS SUBMITTING POTENTIAL 3748 02:11:38,560 --> 02:11:39,428 THERAPEUTICS THAT THEY'D LIKE 3749 02:11:39,428 --> 02:11:41,063 THE RECOVER TLC GROUP TO LOOK 3750 02:11:41,063 --> 02:11:42,264 AT. 3751 02:11:42,264 --> 02:11:43,932 THIS HAS ALSO BEEN A WAY FOR 3752 02:11:43,932 --> 02:11:46,668 PEOPLE TO VOLUNTEER TO 3753 02:11:46,668 --> 02:11:47,536 PARTICIPATE IN THE WORKING 3754 02:11:47,536 --> 02:11:48,837 GROUPS, AND THIS IS A PRIMARY 3755 02:11:48,837 --> 02:11:52,608 WAY THAT WE'VE BEEN DRAWING 3756 02:11:52,608 --> 02:11:56,111 MEMBERS FOR OUR INDIVIDUAL 3757 02:11:56,111 --> 02:11:57,980 PRIORITIZATION GROUPS AND 3758 02:11:57,980 --> 02:11:59,715 WORKING GROUPS FROM RESPONSES TO 3759 02:11:59,715 --> 02:12:00,415 THIS RFI. 3760 02:12:00,415 --> 02:12:01,717 WE ALSO ARE SOLICITING 3761 02:12:01,717 --> 02:12:03,018 SUGGESTIONS FOR BIOMARKER WORK 3762 02:12:03,018 --> 02:12:04,920 AS WELL AS JUST GENERAL FEEDBACK 3763 02:12:04,920 --> 02:12:06,154 FOR ANYONE THAT WASN'T ABLE TO 3764 02:12:06,154 --> 02:12:11,593 BE HEARD AT OUR WORKSHOP. 3765 02:12:11,593 --> 02:12:14,329 WHAT HAVE WE SEEN COMING THROUGH 3766 02:12:14,329 --> 02:12:15,397 THE PORTAL SO FAR? 3767 02:12:15,397 --> 02:12:16,798 THIS IS NOT QUITE UP TO DATE, 3768 02:12:16,798 --> 02:12:18,166 THIS IS A DATA POLL WE DID BACK 3769 02:12:18,166 --> 02:12:20,168 IN NOVEMBER, BUT YOU GET A SENSE 3770 02:12:20,168 --> 02:12:22,471 WE HAD AT THAT TIME 313 TOTAL 3771 02:12:22,471 --> 02:12:26,775 SUBMISSIONS FROM 232 DISTINCT 3772 02:12:26,775 --> 02:12:27,409 RESPONDENTS, THAT NUMBER HAS 3773 02:12:27,409 --> 02:12:29,411 AGAIN GONE UP, CLOSER TO 400, I 3774 02:12:29,411 --> 02:12:30,646 THINK WE'RE A LITTLE OVER 400 3775 02:12:30,646 --> 02:12:31,446 NOW. 3776 02:12:31,446 --> 02:12:33,148 AND WHAT WERE THESE 3777 02:12:33,148 --> 02:12:34,449 INTERVENTIONS THAT WERE 3778 02:12:34,449 --> 02:12:35,551 SUBMITTED? 3779 02:12:35,551 --> 02:12:38,287 PRIMARILY 70% OF THEM WERE 3780 02:12:38,287 --> 02:12:40,389 DRUGS, AND OF THOSE DRUGS, THE 3781 02:12:40,389 --> 02:12:45,761 MAJORITY OF THOSE, 345%, WERE 3782 02:12:45,761 --> 02:12:46,261 IMMUNOMODULATORY AGENTS. 3783 02:12:46,261 --> 02:12:47,296 THERE WERE ALSO A SIGNIFICANT 3784 02:12:47,296 --> 02:12:49,064 NUMBER OF NEUROLOGICAL AGENTS, 3785 02:12:49,064 --> 02:12:51,700 24%, AND THEN SOME ANTIVIRALS, 3786 02:12:51,700 --> 02:12:52,701 HOST DIRECTED AND OTHERS. 3787 02:12:52,701 --> 02:12:54,703 THIS REALLY REFLECTS, I THINK, 3788 02:12:54,703 --> 02:12:56,538 SOMETHING WE ALSO HEARD AT THE 3789 02:12:56,538 --> 02:12:57,973 WORKSHOP, WHICH WAS THE DESIRE 3790 02:12:57,973 --> 02:12:59,207 REALLY TO BE LOOKING AT 3791 02:12:59,207 --> 02:13:01,944 PHARMACOLOGIC INTERVENTIONS AS 3792 02:13:01,944 --> 02:13:04,746 OPPOSED TO THIRNLI THINGS LIKE E 3793 02:13:04,746 --> 02:13:08,951 OR OTHER LIFESTYLE MODIFICAT 3794 02:13:08,951 --> 02:13:11,587 MODIFICATIONS. 3795 02:13:11,587 --> 02:13:13,021 THEN HOW WILL WE BE APPROACHING 3796 02:13:13,021 --> 02:13:13,455 THE REVIEW? 3797 02:13:13,455 --> 02:13:16,325 WE'RE WELL ON OUR WAY TO HAVING 3798 02:13:16,325 --> 02:13:18,126 DONE SOME SORT OF CATEGORIZATION 3799 02:13:18,126 --> 02:13:19,061 AND BUCKETING OF THE AGENTS THAT 3800 02:13:19,061 --> 02:13:19,928 HAVE COME THROUGH. 3801 02:13:19,928 --> 02:13:21,296 AGAIN WE'VE COLLECTED THE NAMES 3802 02:13:21,296 --> 02:13:23,699 OF ALL VOLUNTEERS THROUGH RFI 3803 02:13:23,699 --> 02:13:25,434 AND SENT OUT INVITATIONS TO 3804 02:13:25,434 --> 02:13:26,602 POPULATE OUR PRIORITIZATION 3805 02:13:26,602 --> 02:13:27,569 GROUPS THAT WE'RE STILL IN THE 3806 02:13:27,569 --> 02:13:28,537 PROCESS, WE HAVE A NUMBER OF 3807 02:13:28,537 --> 02:13:30,172 GROUPS WE NEED TO PUT TOGETHER, 3808 02:13:30,172 --> 02:13:31,506 AND WE WERE STARTING WITH THE 3809 02:13:31,506 --> 02:13:34,476 APT VIRALS. 3810 02:13:34,476 --> 02:13:36,445 WE'VE ISSUED CDAs TO BE SIGNED 3811 02:13:36,445 --> 02:13:37,879 AND SO ON, SO WE'RE ACTUALLY 3812 02:13:37,879 --> 02:13:39,081 READY TO GO FOR OUR FIRST 3813 02:13:39,081 --> 02:13:41,183 REVIEW, OUR FIRST ROUND OF 3814 02:13:41,183 --> 02:13:42,084 ANTIVIRALS ON MONDAY. 3815 02:13:42,084 --> 02:13:43,185 SO WE'RE EXCITED TO GET STARTED 3816 02:13:43,185 --> 02:13:47,656 WITH THAT. 3817 02:13:47,656 --> 02:13:49,291 AND THEN IN TERMS OF ONGOING 3818 02:13:49,291 --> 02:13:50,292 COMMUNICATION, WE'RE REALLY 3819 02:13:50,292 --> 02:13:51,827 COMMITTED, AGAIN, TO BEING 3820 02:13:51,827 --> 02:13:52,828 TRANSPARENT AND KEEPING UP THE 3821 02:13:52,828 --> 02:13:53,095 DIALOGUE. 3822 02:13:53,095 --> 02:13:55,097 WE'RE COMMITTED TO HAVING AN 3823 02:13:55,097 --> 02:13:57,799 ANNUAL MEETING WHERE WE WILL 3824 02:13:57,799 --> 02:14:00,002 DISSEMINATE THE LATEST RESEARCH 3825 02:14:00,002 --> 02:14:00,969 AND CLINICAL FINDINGS THAT WE 3826 02:14:00,969 --> 02:14:02,437 HAVE AND REVIEW OUR OVERALL 3827 02:14:02,437 --> 02:14:04,072 PROGRESS, BUT ANNUAL MEETINGS 3828 02:14:04,072 --> 02:14:05,507 REALLY, I THINK, ARE 3829 02:14:05,507 --> 02:14:08,377 INSUFFICIENT FOR MAKING SURE 3830 02:14:08,377 --> 02:14:10,012 THAT EVERYBODY FEELS THAT THEY 3831 02:14:10,012 --> 02:14:11,647 ARE AWARE OF WHAT'S GOING ON 3832 02:14:11,647 --> 02:14:13,315 WITHIN THE RECOVER TLC 3833 02:14:13,315 --> 02:14:13,982 INITIATIVE AND HAVE AN 3834 02:14:13,982 --> 02:14:16,385 OPPORTUNITY TO PROVIDE INPUT. 3835 02:14:16,385 --> 02:14:18,787 SO WE ARE COMMITTED TO DOING 3836 02:14:18,787 --> 02:14:19,721 REGULAR WEBINARS. 3837 02:14:19,721 --> 02:14:20,789 WE HAD ONE AT THE END OF 3838 02:14:20,789 --> 02:14:22,324 NOVEMBER THAT WAS ATTENDED BY 3839 02:14:22,324 --> 02:14:24,426 OVER 800 PARTICIPANTS ONLINE. 3840 02:14:24,426 --> 02:14:26,628 WE HAVE HAD A NUMBER OF BLOG 3841 02:14:26,628 --> 02:14:28,597 POSTS AND WE'LL CONTINUE TO DO 3842 02:14:28,597 --> 02:14:29,898 BOTH BLOG POSTS AND WEBINARS ON 3843 02:14:29,898 --> 02:14:31,033 A REGULAR CADENCE. 3844 02:14:31,033 --> 02:14:33,702 WE HAVE OUR NEXT WEBINAR PLANNED 3845 02:14:33,702 --> 02:14:34,536 FOR EARLY JANUARY, AND WE ALSO 3846 02:14:34,536 --> 02:14:36,071 HAVE A PLAN FOR NEWSLETTERS TO 3847 02:14:36,071 --> 02:14:37,939 BE SHARED AND WE HAVE ONE TEED 3848 02:14:37,939 --> 02:14:40,475 UP THAT SHOULD BE COMING OUT 3849 02:14:40,475 --> 02:14:40,676 SOON. 3850 02:14:40,676 --> 02:14:41,309 AGAIN IN ORDER TO SHARE MORE UP 3851 02:14:41,309 --> 02:14:43,445 TO THE MINUTE PROGRESS WITHIN 3852 02:14:43,445 --> 02:14:45,380 THE INITIATIVE. 3853 02:14:45,380 --> 02:14:48,483 I THINK THAT MIGHT BE MY LAST 3854 02:14:48,483 --> 02:14:49,918 SLIDE, BUT -- THAT'S ALL. 3855 02:14:49,918 --> 02:14:51,787 SO I THANK YOU VERY MUCH AGAIN 3856 02:14:51,787 --> 02:14:53,255 FOR THE OPPORTUNITY TO DESCRIBE 3857 02:14:53,255 --> 02:14:54,723 THE WORK THAT WE'VE BEEN DOING 3858 02:14:54,723 --> 02:14:57,592 SO FAR, AND I'LL LEAVE TO MONICA 3859 02:14:57,592 --> 02:15:00,128 AS TO WHEN TO TAKE QUESTIONS OR 3860 02:15:00,128 --> 02:15:00,896 RECEIVE COMMENT. 3861 02:15:00,896 --> 02:15:01,997 >> OKAY. 3862 02:15:01,997 --> 02:15:02,998 WELL, WE'LL DO THAT AT THE END. 3863 02:15:02,998 --> 02:15:06,501 THANK YOU SO MUCH, SARAH, AND 3864 02:15:06,501 --> 02:15:09,905 WE'RE JUST GRATEFUL FOR YOUR 3865 02:15:09,905 --> 02:15:13,308 TEAM AND ALSO THE HELP OF 3866 02:15:13,308 --> 02:15:14,209 DR. TARA SCHWETZ AND THE PEOPLE 3867 02:15:14,209 --> 02:15:15,744 IN THE DIRECTOR'S OFFICE WHO'VE 3868 02:15:15,744 --> 02:15:19,147 ALSO HELPED FACILITATE THIS 3869 02:15:19,147 --> 02:15:21,650 REALLY IMPORTANT NEW PHASE OF 3870 02:15:21,650 --> 02:15:23,418 OUR WORK AND TO BATTLE LONG 3871 02:15:23,418 --> 02:15:23,618 COVID. 3872 02:15:23,618 --> 02:15:25,954 SO JUST A FEW COMMENTS NOW FROM 3873 02:15:25,954 --> 02:15:27,823 ME KIND OF OVERALL ABOUT LONG 3874 02:15:27,823 --> 02:15:29,758 COVID. 3875 02:15:29,758 --> 02:15:32,728 FIRST OF ALL, I'M SURE YOU ALL 3876 02:15:32,728 --> 02:15:34,062 KNOW, POST VIRAL SYNDROMES HAVE 3877 02:15:34,062 --> 02:15:35,397 ALWAYS BEEN WITH US, AND THEY'VE 3878 02:15:35,397 --> 02:15:37,599 ALWAYS BEEN DIFFICULT. 3879 02:15:37,599 --> 02:15:41,303 WE HAVE NOT BEEN ABLE TO 3880 02:15:41,303 --> 02:15:42,971 UNDERSTAND THEM, DIAGNOSE THEM, 3881 02:15:42,971 --> 02:15:46,808 TREAT THEM. 3882 02:15:46,808 --> 02:15:48,343 AND LONG COVID NOW TEACHES US 3883 02:15:48,343 --> 02:15:50,879 MANY NEW THINGS ABOUT THESE VERY 3884 02:15:50,879 --> 02:15:53,682 PREVALENT CONDITIONS. 3885 02:15:53,682 --> 02:15:56,451 MAYBE ONE OF THE MOST IMPORTANT 3886 02:15:56,451 --> 02:15:59,287 IS THAT THERE ARE -- THE COHORTS 3887 02:15:59,287 --> 02:16:00,422 THAT I'LL DESCRIBE IN A MINUTE 3888 02:16:00,422 --> 02:16:03,725 ARE HELPING US UNCOVER THE KIND 3889 02:16:03,725 --> 02:16:06,995 OF LINGERING SUBCLINICAL EFFECTS 3890 02:16:06,995 --> 02:16:08,864 THAT HAPPEN AFTER PEOPLE ARE 3891 02:16:08,864 --> 02:16:15,904 INFECTED BY VARIOUS AGENTS. 3892 02:16:15,904 --> 02:16:16,872 MANY PEOPLE ARE OUT THERE IN OUR 3893 02:16:16,872 --> 02:16:19,274 WORLD THAT HAVE ISSUES RELATED 3894 02:16:19,274 --> 02:16:23,311 TO A PRIOR INFECTION THAT ARE 3895 02:16:23,311 --> 02:16:25,213 NEVER DIAGNOSED, AND WHEN YOU 3896 02:16:25,213 --> 02:16:27,315 REALLY START TO WRAP YOUR HEAD 3897 02:16:27,315 --> 02:16:29,050 AROUND THE SUFFERING THAT THIS 3898 02:16:29,050 --> 02:16:30,352 CREATES NATIONWIDE, IT MAKES 3899 02:16:30,352 --> 02:16:34,122 SENSE THAT WE DON'T DEVOTE A 3900 02:16:34,122 --> 02:16:37,425 TREMENDOUS EFFORT TO USING THIS 3901 02:16:37,425 --> 02:16:41,830 NEW ONSET -- NEW TYPE OF DISEASE 3902 02:16:41,830 --> 02:16:45,000 AND THE OPPORTUNITY FOR 3903 02:16:45,000 --> 02:16:47,302 UNDERSTANDING ITS EFFECTS IN 3904 02:16:47,302 --> 02:16:48,737 BASIC BIOLOGY, UNPRECEDENTED 3905 02:16:48,737 --> 02:16:51,139 SCOPE AND SCALE TO RESEARCH TO 3906 02:16:51,139 --> 02:16:52,174 TRULY TACKLE THIS PROBLEM FOR 3907 02:16:52,174 --> 02:16:52,941 THE FIRST TIME. 3908 02:16:52,941 --> 02:16:54,743 OUR WORK IN LONG COVID IS REALLY 3909 02:16:54,743 --> 02:16:58,547 SETTING A NEW PARADIGM FOR HOW 3910 02:16:58,547 --> 02:16:59,848 WE THINK ABOUT RESPONSE TO A 3911 02:16:59,848 --> 02:17:00,282 CLINICAL NEED. 3912 02:17:00,282 --> 02:17:02,017 I THINK YOU CAN ALREADY SEE THAT 3913 02:17:02,017 --> 02:17:07,322 IN THE OVERALL APPROACH, SEEINGN 3914 02:17:07,322 --> 02:17:08,490 WITH RECOVER TLC. 3915 02:17:08,490 --> 02:17:08,890 OKAY. 3916 02:17:08,890 --> 02:17:10,125 PEOPLE WITH LONG COVID KNOW HOW 3917 02:17:10,125 --> 02:17:12,828 COMPLICATED THIS RESEARCH IS. 3918 02:17:12,828 --> 02:17:14,396 AND THEIR CARE PROVIDERS KNOW. 3919 02:17:14,396 --> 02:17:15,197 I DON'T THINK THE REST OF THE 3920 02:17:15,197 --> 02:17:16,498 WORLD REALLY REALIZED THIS. 3921 02:17:16,498 --> 02:17:17,732 IT'S A HIGHLY VARIABLE CONDITION 3922 02:17:17,732 --> 02:17:19,267 THAT CAN WAX AND WANE. 3923 02:17:19,267 --> 02:17:22,003 IT DIFFERS BY AGE, GENDER, 3924 02:17:22,003 --> 02:17:23,638 VACCINATION STATUS, SO MANY 3925 02:17:23,638 --> 02:17:25,273 OTHER EFFECTS IN LIFE. 3926 02:17:25,273 --> 02:17:32,113 AND WHEN IT LANDED IN OUR WORLD 3927 02:17:32,113 --> 02:17:34,516 IN EARLY 2020, WE DIDN'T HAVE A 3928 02:17:34,516 --> 02:17:35,383 CLEAR DEFINITION OF WHAT IT WAS 3929 02:17:35,383 --> 02:17:37,085 THAT COULD EVEN PROVIDE BOTH 3930 02:17:37,085 --> 02:17:40,355 CLINICIANS AND CERTAINLY THERAPY 3931 02:17:40,355 --> 02:17:42,324 DEVELOPMENTS END POINT TO 3932 02:17:42,324 --> 02:17:43,525 UNDERSTAND HOW TO DEVELOP 3933 02:17:43,525 --> 02:17:43,859 TREATMENTS. 3934 02:17:43,859 --> 02:17:47,729 WE NEEDED RESOURCES, NOT ONLY TO 3935 02:17:47,729 --> 02:17:49,898 JUST DIAGNOSE THE DISEASE BUT 3936 02:17:49,898 --> 02:17:51,433 ALSO UNDERSTAND BIOLOGY IN WAYS 3937 02:17:51,433 --> 02:17:52,901 THAT COULD LEAD TO EFFECTIVE 3938 02:17:52,901 --> 02:17:56,938 THERAPY. 3939 02:17:56,938 --> 02:17:58,640 SO WITH THAT INTRO, I WANT TO 3940 02:17:58,640 --> 02:18:02,944 FIRST NOTE THAT -- GIVE A 3941 02:18:02,944 --> 02:18:07,349 FUNDING UP TA UPDATE FOR LONG C. 3942 02:18:07,349 --> 02:18:10,318 IN 2021, CONGRESS APPROPRIATED 3943 02:18:10,318 --> 02:18:11,253 $1.15 BILLION TO SUPPORT THE 3944 02:18:11,253 --> 02:18:14,489 ESTABLISHMENT OF RECOVER, 3945 02:18:14,489 --> 02:18:16,057 RESEARCH IN COVID TO ENHANCE 3946 02:18:16,057 --> 02:18:17,826 RECOVERY, A NATIONWIDE RESEARCH 3947 02:18:17,826 --> 02:18:18,493 PROGRAM. 3948 02:18:18,493 --> 02:18:19,828 I ALSO WANT TO NOTE THAT NIH 3949 02:18:19,828 --> 02:18:22,564 RECENTLY RECEIVED AN ADDITIONAL 3950 02:18:22,564 --> 02:18:23,698 $147 MILLION TO SUPPORT OUR 3951 02:18:23,698 --> 02:18:27,402 ONGOING RECOVER EFFORTS. 3952 02:18:27,402 --> 02:18:28,470 THIS ALLOCATION IS YET IN 3953 02:18:28,470 --> 02:18:31,806 ADDITION TO THE $515 MILLION 3954 02:18:31,806 --> 02:18:33,375 SUPPORT FOR ONGOING RECOVER 3955 02:18:33,375 --> 02:18:36,444 EFFORTS. 3956 02:18:36,444 --> 02:18:39,848 SO THE $662 MILLION WILL BE 3957 02:18:39,848 --> 02:18:48,423 ALLOCATED OVER FISCAL YEARS 2025 3958 02:18:48,423 --> 02:18:51,593 TO 2029 TO SUPPORT OUR ONGOING 3959 02:18:51,593 --> 02:18:54,462 RECOVERY EFFORTS. 3960 02:18:54,462 --> 02:18:55,363 THIS ALLOCATION IS YET IN 3961 02:18:55,363 --> 02:18:57,232 ADDITION TO THE $515 MILLION TO 3962 02:18:57,232 --> 02:18:58,900 SUPPORT OUR ONGOING RECOVERY 3963 02:18:58,900 --> 02:18:59,434 EFFORTS. 3964 02:18:59,434 --> 02:19:01,069 FOR OUR ONGOING RECOVER EFFORTS 3965 02:19:01,069 --> 02:19:02,404 THIS ALLOCATION IS YET IN 3966 02:19:02,404 --> 02:19:04,139 ADDITION TO THE 515 MILL YONDZ 3967 02:19:04,139 --> 02:19:06,308 SUPPORT FOR ONGOING RECOVER 3968 02:19:06,308 --> 02:19:13,882 EFFORTS, SO THE $662 MILLION -- 3969 02:19:13,882 --> 02:19:15,150 ADDITIONAL PATHOBIOLOGY STUDIES 3970 02:19:15,150 --> 02:19:17,218 TO IDENTIFY THE BIOLOGICAL 3971 02:19:17,218 --> 02:19:17,852 MARKERS OF DISEASE. 3972 02:19:17,852 --> 02:19:18,954 RIGHT NOW IT'S A CLINICAL 3973 02:19:18,954 --> 02:19:21,957 DEFINITION OF HIGHLY VARIABLE 3974 02:19:21,957 --> 02:19:22,223 PHENOTYPE. 3975 02:19:22,223 --> 02:19:26,761 WE REALLY DO NEED A BIOLOGICAL 3976 02:19:26,761 --> 02:19:28,630 END POINT THAT WE CANNOT ONLY 3977 02:19:28,630 --> 02:19:29,731 TARGET FOR THERAPY DEVELOPMENT 3978 02:19:29,731 --> 02:19:31,066 BUT ALSO USE FOR EFFECTIVE 3979 02:19:31,066 --> 02:19:31,399 DIAGNOSIS. 3980 02:19:31,399 --> 02:19:36,438 THIS IS GOING TO BE PARTICULARLY 3981 02:19:36,438 --> 02:19:37,539 IMPORTANT AS THE COHORT OF 3982 02:19:37,539 --> 02:19:39,274 PEOPLE THAT HAVE NEVER HAD 3983 02:19:39,274 --> 02:19:41,643 COVID, WHICH ARE PROVIDING THE 3984 02:19:41,643 --> 02:19:44,579 VERY IMPORTANT COMPARATORS TO 3985 02:19:44,579 --> 02:19:47,549 UNDERSTAND THE DIFFERENCE 3986 02:19:47,549 --> 02:19:48,683 BETWEEN COVID -- BETWEEN NOT 3987 02:19:48,683 --> 02:19:51,386 LONG COVID AND LONG COVID AS 3988 02:19:51,386 --> 02:19:52,487 THIS POPULATION GETS SMALLER AND 3989 02:19:52,487 --> 02:19:54,789 SMALLER AS COVID TRULY BECOMES 3990 02:19:54,789 --> 02:19:56,057 ENDEMIC IN OUR POPULATION. 3991 02:19:56,057 --> 02:20:00,528 SO REALLY CRITICAL THAT WE FIND 3992 02:20:00,528 --> 02:20:01,096 BIOMARKERS. 3993 02:20:01,096 --> 02:20:02,564 THEN FINALLY, WE ALSO NEED TO 3994 02:20:02,564 --> 02:20:03,565 PRESERVE AND PROVIDE BROADER 3995 02:20:03,565 --> 02:20:05,734 ACCESS TO THE DATA AND 3996 02:20:05,734 --> 02:20:08,770 BIOSPECIMENS, AND MAINTAIN THE 3997 02:20:08,770 --> 02:20:09,537 RECOVERY SEARCH INFRASTRUCTURE 3998 02:20:09,537 --> 02:20:12,207 OVER THE NEXT FIVE YEARS. 3999 02:20:12,207 --> 02:20:14,309 THIS SLIDE SHOWS THE THREE MAIN 4000 02:20:14,309 --> 02:20:15,744 RECOVERY SEARCH COMPONENTS, 4001 02:20:15,744 --> 02:20:16,845 OBSERVATIONAL COHORTS, 4002 02:20:16,845 --> 02:20:20,148 PATHOBIOLOGY STUDIES, AND 4003 02:20:20,148 --> 02:20:21,349 CLINICAL TRIALS. 4004 02:20:21,349 --> 02:20:22,817 RECOVER INCLUDES A CLINICAL 4005 02:20:22,817 --> 02:20:24,452 TRIAL COORDINATING CENTER, A 4006 02:20:24,452 --> 02:20:25,754 CLINICAL SCIENCE CORE, A DATA 4007 02:20:25,754 --> 02:20:28,223 RESOURCE CORE AND A 4008 02:20:28,223 --> 02:20:28,556 BIOREPOSITORY. 4009 02:20:28,556 --> 02:20:32,060 HERE'S A SNAPSHOT OF RECOVER 4010 02:20:32,060 --> 02:20:32,927 EFFORTS SO FAR. 4011 02:20:32,927 --> 02:20:34,829 YOU AND THE COMMITTEE WILL HAVE 4012 02:20:34,829 --> 02:20:35,430 THESE SLIDES AVAILABLE TO YOU. 4013 02:20:35,430 --> 02:20:36,664 I'M NOT GOING TO GO OVER EVERY 4014 02:20:36,664 --> 02:20:38,233 ONE OF THEM, BUT YOU CAN SEE, 4015 02:20:38,233 --> 02:20:42,404 RECOVER IS THE MOST DIVERSE, 4016 02:20:42,404 --> 02:20:43,905 DEEPLY CARE TERKIZED COHORT OF 4017 02:20:43,905 --> 02:20:44,606 LONG COVID PATIENTS. 4018 02:20:44,606 --> 02:20:47,575 IT IS THE -- ALSO THE LARGEST 4019 02:20:47,575 --> 02:20:50,678 AND MOST DIVERSE COHORT OF ANY 4020 02:20:50,678 --> 02:20:54,616 POST -- THAT HAS A NEGATIVE EXAI 4021 02:20:54,616 --> 02:20:57,018 TORE GROUP FOR STUDY OF -- IN 4022 02:20:57,018 --> 02:20:58,486 REALTIME OF A POST VIRAL 4023 02:20:58,486 --> 02:21:00,355 SYNDROME. 4024 02:21:00,355 --> 02:21:01,956 HIGHLIGHTING, AGAIN, THAT WE 4025 02:21:01,956 --> 02:21:05,527 BELIEVE THIS WORK WILL HAVE 4026 02:21:05,527 --> 02:21:06,628 IMPLICATIONS BEYOND JUST THE 4027 02:21:06,628 --> 02:21:09,364 COVID ORGANISM ITSELF. 4028 02:21:09,364 --> 02:21:10,365 THOUSANDS OF RESEARCH 4029 02:21:10,365 --> 02:21:12,033 PARTICIPANTS HAVE JOINED US AS 4030 02:21:12,033 --> 02:21:13,802 PARTNERS IN THIS EFFORT. 4031 02:21:13,802 --> 02:21:15,136 AS THIS WORK MATURES, WE ARE 4032 02:21:15,136 --> 02:21:16,704 LEARNING A TREMENDOUS AMOUNT 4033 02:21:16,704 --> 02:21:17,672 CONCERNING THE NATURE AND 4034 02:21:17,672 --> 02:21:19,074 UNDERLYING CAUSES OF THIS VERY 4035 02:21:19,074 --> 02:21:22,844 COMPLEX NEW CONDITION. 4036 02:21:22,844 --> 02:21:25,046 THE FULL RECOVER COHORT INCLUDES 4037 02:21:25,046 --> 02:21:26,481 ALMOST 30,000 PARTICIPANTS 4038 02:21:26,481 --> 02:21:28,216 ACROSS THREE MAJOR GROUPS: 4039 02:21:28,216 --> 02:21:29,417 ABOUT HALF ARE ADULTS, ABOUT 4040 02:21:29,417 --> 02:21:32,087 HALF ARE CHILDREN, AND A 4041 02:21:32,087 --> 02:21:33,088 RELATIVELY SMALL NUMBER OF 4042 02:21:33,088 --> 02:21:36,024 TISSUE PATHOLOGY OR AUTOPSY 4043 02:21:36,024 --> 02:21:36,458 CASES. 4044 02:21:36,458 --> 02:21:37,792 PARTICIPANTS WERE ENROLLED WHEN 4045 02:21:37,792 --> 02:21:41,096 THEY HAD ACUTE COVID INFECTIONS, 4046 02:21:41,096 --> 02:21:44,165 WERE UNINFECTED AND 4047 02:21:44,165 --> 02:21:46,067 SEROCONFIRMED TO BE UNINFECTED, 4048 02:21:46,067 --> 02:21:49,904 OR IN THE POST-ACUTE PHASE. 4049 02:21:49,904 --> 02:21:51,873 DECEASED PARTICIPANTS WHO ARE AT 4050 02:21:51,873 --> 02:21:53,141 LEAST 18 YEARS OLD AND WERE 4051 02:21:53,141 --> 02:21:55,543 SUSPECTED OR CONFIRMED TO HAVE 4052 02:21:55,543 --> 02:21:57,178 HAD COVID WITHIN 60 DAYS OF 4053 02:21:57,178 --> 02:21:59,080 THEIR DEATH, WE HONOR THEIR 4054 02:21:59,080 --> 02:22:01,249 CONTRIBUTION TO SCIENCE WITH 4055 02:22:01,249 --> 02:22:04,419 ALLOWING US TO PURSUE THESE VERY 4056 02:22:04,419 --> 02:22:05,753 DETAILED AUTOPSIES. 4057 02:22:05,753 --> 02:22:08,523 VERY GRATEFUL TO THESE 4058 02:22:08,523 --> 02:22:09,858 INDIVIDUALS AND THEIR FAMILIES. 4059 02:22:09,858 --> 02:22:11,693 THEY WERE CONSIDERED IN THE MOST 4060 02:22:11,693 --> 02:22:13,294 ACUTE -- POST-ACUTE CATEGORY IF 4061 02:22:13,294 --> 02:22:14,829 THEY'D BEEN 30 DAYS OR MORE FROM 4062 02:22:14,829 --> 02:22:18,066 THEIR COVID ONSET -- SYMPTOM 4063 02:22:18,066 --> 02:22:18,266 ONSET. 4064 02:22:18,266 --> 02:22:20,001 THE ADULT COHORT IS FULLY 4065 02:22:20,001 --> 02:22:21,202 ENROLLED, THE PEDIATRIC COHORT 4066 02:22:21,202 --> 02:22:24,472 IS ALMOST COMPLETELY ENROLLED, 4067 02:22:24,472 --> 02:22:26,741 AND THE AUTOPSY COHORT IS ABOUT 4068 02:22:26,741 --> 02:22:30,311 60% ENROLLED. 4069 02:22:30,311 --> 02:22:32,280 THIS SLIDE OUTLINES SECURE DATA 4070 02:22:32,280 --> 02:22:34,682 NOW AVAILABLE TO AUTHORIZED 4071 02:22:34,682 --> 02:22:36,718 RESEARCHERS THROUGH THE 4072 02:22:36,718 --> 02:22:37,919 CLOUD-BASED ECOSYSTEM BIODATA 4073 02:22:37,919 --> 02:22:38,453 CATALYST. 4074 02:22:38,453 --> 02:22:39,988 IN ALL, DATA ARE AVAILABLE FOR 4075 02:22:39,988 --> 02:22:41,689 MORE THAN 15,000 ADULTS 4076 02:22:41,689 --> 02:22:45,093 INCLUDING A SUBCOHORT OF MORE 4077 02:22:45,093 --> 02:22:51,733 THAN 2,000 PREGNANT WOMEN AND 4078 02:22:51,733 --> 02:22:53,001 MORE THAN 24,000 YOUNG ADULTS, 4079 02:22:53,001 --> 02:22:54,435 CHILDREN, INFANTS AND 4080 02:22:54,435 --> 02:22:54,969 CAREGIVERS. 4081 02:22:54,969 --> 02:23:00,775 SOME INFANTS, SOME EXPOSED TO 4082 02:23:00,775 --> 02:23:01,910 COVID WHEN THEIR MOTHERS WERE 4083 02:23:01,910 --> 02:23:03,111 INFECTED WHEN THEY WERE 4084 02:23:03,111 --> 02:23:05,280 PREGNANT. 4085 02:23:05,280 --> 02:23:06,781 AND ALSO DATA FROM THEIR 4086 02:23:06,781 --> 02:23:07,215 CAREGIVERS. 4087 02:23:07,215 --> 02:23:16,724 DATA COLLECTED FROM MORE THAN 4088 02:23:16,724 --> 02:23:22,997 184,000 VISITS, WHY DO WE NEED 4089 02:23:22,997 --> 02:23:23,998 ALL THIS DATA? 4090 02:23:23,998 --> 02:23:25,200 THIS DATA IS AVAILABLE TO SPUR 4091 02:23:25,200 --> 02:23:27,101 AN INCREDIBLE, UNPRECEDENTED, WE 4092 02:23:27,101 --> 02:23:28,970 WILL NEVER HAVE IT AGAIN 4093 02:23:28,970 --> 02:23:30,939 RESOURCE FOR INNOVATION, 4094 02:23:30,939 --> 02:23:34,475 COLLABORATION, AND DISCOVERY. 4095 02:23:34,475 --> 02:23:36,010 AND TO PROVIDE A PLATFORM FOR 4096 02:23:36,010 --> 02:23:39,280 DATA SHARING AND, VERY 4097 02:23:39,280 --> 02:23:39,948 IMPORTANT, VALIDATING RESULTS AS 4098 02:23:39,948 --> 02:23:45,220 WE MOVE FORWARD. 4099 02:23:45,220 --> 02:23:47,088 THIS DATA CAN HELP PEOPLE MAKE 4100 02:23:47,088 --> 02:23:48,389 CONNECTIONS THAT WILL INFORM ALL 4101 02:23:48,389 --> 02:23:49,991 FUTURE STUDIES, PARTICULARLY 4102 02:23:49,991 --> 02:23:50,525 CLINICAL TRIALS. 4103 02:23:50,525 --> 02:23:52,160 HAVING SAMPLES AVAILABLE SHOULD 4104 02:23:52,160 --> 02:23:53,595 ENABLE FURTHER HYPOTHESIS 4105 02:23:53,595 --> 02:23:55,163 TESTING THROUGH PATHOBIOLOGY 4106 02:23:55,163 --> 02:23:56,164 STUDIES, AND THIS IS JUST THE 4107 02:23:56,164 --> 02:23:56,931 BEGINNING. 4108 02:23:56,931 --> 02:23:58,366 ADDITIONAL ADULT PEDIATRIC AND 4109 02:23:58,366 --> 02:24:01,803 AUTOPSY COHORT DATA FROM RECOVER 4110 02:24:01,803 --> 02:24:03,338 WILL CONTINUE TO BE RELEASED ON 4111 02:24:03,338 --> 02:24:06,307 AN ONGOING BASIS. 4112 02:24:06,307 --> 02:24:08,009 MORE THAN -- ABOUT PUBLICATIONS, 4113 02:24:08,009 --> 02:24:09,210 MORE THAN 50 PAPERS HAVE BEEN 4114 02:24:09,210 --> 02:24:10,378 PUBLISHED ON KEY CLINICAL 4115 02:24:10,378 --> 02:24:12,614 FINDINGS JUST BASED ON THE 4116 02:24:12,614 --> 02:24:14,849 OBSERVATIONAL COHORTS ALONE. 4117 02:24:14,849 --> 02:24:17,819 WE'VE DEVELOPED A SYMPTOM-BASED 4118 02:24:17,819 --> 02:24:22,323 OF LONG COVID IN ADULTS AND 4119 02:24:22,323 --> 02:24:22,590 CHILDREN. 4120 02:24:22,590 --> 02:24:26,694 I CANNOT EMPHASIZE STRONGLY 4121 02:24:26,694 --> 02:24:29,230 ENOUGH HOW CHALLENGING THIS WAS. 4122 02:24:29,230 --> 02:24:32,467 IT REALLY BASICALLY IS WHAT KIND 4123 02:24:32,467 --> 02:24:33,868 OF SYMPTOMS DO PEOPLE HAVE WHO 4124 02:24:33,868 --> 02:24:35,303 HAVE NEVER HAD COVID AND WHAT 4125 02:24:35,303 --> 02:24:36,604 KIND OF SYMPTOMS DO PEOPLE HAVE 4126 02:24:36,604 --> 02:24:39,741 WHO HAVE EXPERIENCED COVID OF 4127 02:24:39,741 --> 02:24:44,412 ALL THE VARIOUS SUBTYPES AND ALL 4128 02:24:44,412 --> 02:24:45,847 THE VARIOUS STAGES AFTER 4129 02:24:45,847 --> 02:24:48,683 EXPOSURE TO THE VIRUS. 4130 02:24:48,683 --> 02:24:51,753 AND REALLY, IT'S THE DIFFERENCE 4131 02:24:51,753 --> 02:24:54,122 IN CLINICAL CHARACTERISTICS. 4132 02:24:54,122 --> 02:24:55,757 DO I HAVE BRAIN FOG, DOES EVERY 4133 02:24:55,757 --> 02:24:57,892 MUSCLE IN MY BODY ACHE, DO I 4134 02:24:57,892 --> 02:25:00,295 HAVE CHRONIC FATIGUE. 4135 02:25:00,295 --> 02:25:01,396 DIFFERENCE IN SYMPTOMS BETWEEN 4136 02:25:01,396 --> 02:25:03,031 THOSE TWO POPULATIONS THAT HAS 4137 02:25:03,031 --> 02:25:05,066 LED TO THIS DIAGNOSIS. 4138 02:25:05,066 --> 02:25:08,136 WE'VE DEVELOPED THIS -- AND BY 4139 02:25:08,136 --> 02:25:09,203 THE WAY, IT'S DIFFERENT IN GRADE 4140 02:25:09,203 --> 02:25:13,508 SCHOOL KIDS, ADOLESCENTS AND 4141 02:25:13,508 --> 02:25:14,409 ADULTS, AND THIS SYMPTOM COMPLEX 4142 02:25:14,409 --> 02:25:17,045 IS DIFFERENT IN PEOPLE WHO, 4143 02:25:17,045 --> 02:25:18,780 BASED ON AGE, THEIR GENDER AND 4144 02:25:18,780 --> 02:25:20,381 WHETHER THEY'VE HAD A 4145 02:25:20,381 --> 02:25:22,116 VACCINATION, AND EVEN TO 4146 02:25:22,116 --> 02:25:23,618 SOME DEGREE WHAT VIRAL SUBGROUP 4147 02:25:23,618 --> 02:25:24,952 THEY'VE BEEN EXPOSED TO. 4148 02:25:24,952 --> 02:25:27,989 SO I HOPE I'VE ILLUSTRATED IN A 4149 02:25:27,989 --> 02:25:29,190 SNAPSHOT HERE JUST HOW 4150 02:25:29,190 --> 02:25:31,392 INCREDIBLY COMPLEX THIS IS. 4151 02:25:31,392 --> 02:25:33,561 WE'VE DEFINED THE SYMPTOMS AND 4152 02:25:33,561 --> 02:25:34,796 CONDITIONS THROUGH THESE COHORTS 4153 02:25:34,796 --> 02:25:39,434 THAT ARE SPECIFIC TO LONG COVID. 4154 02:25:39,434 --> 02:25:40,535 I'LL CALL YOUR ATTENTION TO THAT 4155 02:25:40,535 --> 02:25:44,372 IN CHILDREN, WHICH HAVE 4156 02:25:44,372 --> 02:25:45,506 PARTICULARLY PRONE TO 4157 02:25:45,506 --> 02:25:55,616 CIRCULATORY AND RE RE RE R -- WN 4158 02:25:55,616 --> 02:25:59,787 THAT VACCINATION SIGNIFICANTLY 4159 02:25:59,787 --> 02:26:01,656 DECREASES THE RESULT OF 4160 02:26:01,656 --> 02:26:02,924 DEVELOPING LONG COVID. 4161 02:26:02,924 --> 02:26:05,326 THIS IS ANOTHER THING I CANNOT 4162 02:26:05,326 --> 02:26:06,961 EMPHASIZE ENOUGH. 4163 02:26:06,961 --> 02:26:09,030 VACCINATION IS THE BEST THING WE 4164 02:26:09,030 --> 02:26:10,698 HAVE RIGHT NOW. 4165 02:26:10,698 --> 02:26:12,066 LONG COVID IS SERIOUS IN SOME 4166 02:26:12,066 --> 02:26:13,801 PEOPLE, IT IS ABSOLUTELY 4167 02:26:13,801 --> 02:26:14,802 LIFE-ALTERING, AND THE WAY TO 4168 02:26:14,802 --> 02:26:17,171 PREVENT IT IS TO RECEIVE A 4169 02:26:17,171 --> 02:26:18,473 VACCINATION AND THE VERY BEST 4170 02:26:18,473 --> 02:26:22,310 WAY TO PREVENT IT IS IF WHEN 4171 02:26:22,310 --> 02:26:23,978 THAT VACCINATION IS ADMINISTERED 4172 02:26:23,978 --> 02:26:25,880 BEFORE A PERSON EVER HAS THEIR 4173 02:26:25,880 --> 02:26:28,916 FIRST EXPOSURE TO THE VIRUS. 4174 02:26:28,916 --> 02:26:30,618 WE HAVE OBSERVED A HIGHER RISK 4175 02:26:30,618 --> 02:26:36,324 OF NEW CARDIOVASCULAR, 4176 02:26:36,324 --> 02:26:39,427 NEUROLOGIC AND ENDOCRINE AND GI 4177 02:26:39,427 --> 02:26:41,095 SYMPTOMS IN BLACK AND HISPANIC 4178 02:26:41,095 --> 02:26:42,397 PATIENTS, A DISPARITY WE DON'T 4179 02:26:42,397 --> 02:26:43,064 FULLY UNDERSTAND. 4180 02:26:43,064 --> 02:26:44,465 WE'VE IDENTIFIED SOME 4181 02:26:44,465 --> 02:26:45,433 DISTINGUISHING IMMUNE FEATURES 4182 02:26:45,433 --> 02:26:47,502 OF LONG COVID. 4183 02:26:47,502 --> 02:26:49,704 IF THIS DISEASE IS STICKING 4184 02:26:49,704 --> 02:26:51,873 AROUND, MAYBE THE IMMUNE 4185 02:26:51,873 --> 02:26:53,341 SYSTEM -- IT LOOKS LIKE THE 4186 02:26:53,341 --> 02:26:54,542 IMMUNE SYSTEM IS JUST NOT 4187 02:26:54,542 --> 02:26:56,077 EFFECTIVELY FIGHTING IT OFF. 4188 02:26:56,077 --> 02:26:57,712 ALL THIS WORK IS LEADING TO 4189 02:26:57,712 --> 02:26:58,880 IMPROVED DIAGNOSTICS, MONITORING 4190 02:26:58,880 --> 02:27:01,282 AND CARE FOR PATIENTS, BETTER 4191 02:27:01,282 --> 02:27:03,584 PREVENTIVE CARE, AND GETTING US 4192 02:27:03,584 --> 02:27:05,286 TOWARD MORE EFFECTIVE TARGETED 4193 02:27:05,286 --> 02:27:07,922 TREATMENTS. 4194 02:27:07,922 --> 02:27:10,191 JUST A LITTLE REVIEW QUICKLY 4195 02:27:10,191 --> 02:27:11,626 HERE, SOME KEY DISCOVERIES FROM 4196 02:27:11,626 --> 02:27:13,795 THE OBSERVATIONAL COHORTS. 4197 02:27:13,795 --> 02:27:15,363 PATIENT IN JAMA LAST YEAR, THE 4198 02:27:15,363 --> 02:27:17,064 FIRST STRUCTURED FRAMEWORK FOR 4199 02:27:17,064 --> 02:27:18,666 HOW WE DIAGNOSE LONG COVID IN 4200 02:27:18,666 --> 02:27:20,401 ADULTS, BASED ON SYMPTOMS. 4201 02:27:20,401 --> 02:27:21,803 AND DESCRIBES THE RISK 4202 02:27:21,803 --> 02:27:23,571 ASSOCIATED WITH THE DIFFERENT 4203 02:27:23,571 --> 02:27:24,605 STRAINS. 4204 02:27:24,605 --> 02:27:25,373 THIS FRAMEWORK HAS BEEN USED BY 4205 02:27:25,373 --> 02:27:26,574 MANY OTHER GROUPS. 4206 02:27:26,574 --> 02:27:27,942 THIS MANUSCRIPT ACTUALLY WAS THE 4207 02:27:27,942 --> 02:27:29,644 THIRD MOST REVIEWED AND THE 4208 02:27:29,644 --> 02:27:30,378 SECOND MOST DISCUSSED AND HAD 4209 02:27:30,378 --> 02:27:37,251 THE VERY HIGHEST SCORE OF ALL 4210 02:27:37,251 --> 02:27:40,621 PAPERS IN 2023 SO IT REALLY WAS 4211 02:27:40,621 --> 02:27:41,255 A GROUNDBREAKING RESULT. 4212 02:27:41,255 --> 02:27:42,557 ANOTHER MORE RECENT PAPER IN 4213 02:27:42,557 --> 02:27:46,060 JAMA PROVIDED THE FIRST 4214 02:27:46,060 --> 02:27:47,128 FRAMEWORK FOR IDENTIFYING LONG 4215 02:27:47,128 --> 02:27:48,763 COVID IN BOTH CHILDREN AND 4216 02:27:48,763 --> 02:27:49,630 ADOLESCENTS BASED ON THEIR 4217 02:27:49,630 --> 02:27:51,365 DIFFERENT TYPES OF SYMPTOMS. 4218 02:27:51,365 --> 02:27:52,633 OTHER KEY PAPERS, THE PREVALENCE 4219 02:27:52,633 --> 02:27:54,001 AND RISK FACTORS FOR PREGNANT 4220 02:27:54,001 --> 02:27:56,370 PEOPLE DEVELOPING LONG COVID 4221 02:27:56,370 --> 02:27:59,707 FOCUSED ON SOME PATHOBIOLOGY AND 4222 02:27:59,707 --> 02:28:01,576 BIOMARKER RESEARCH BY SHOWING 4223 02:28:01,576 --> 02:28:03,978 UNFORTUNATELY THAT 25 COMMON 4224 02:28:03,978 --> 02:28:06,180 BLOOD LAB TESTS ARE NOT RELIABLE 4225 02:28:06,180 --> 02:28:08,115 BIOMARKERS FOR LONG COVID. 4226 02:28:08,115 --> 02:28:09,851 IDENTIFYING CIRCULATING 4227 02:28:09,851 --> 02:28:10,818 SARS-COV-2 ANTIGENS IN THE BLOOD 4228 02:28:10,818 --> 02:28:12,220 OF PEOPLE WITH LONG COVID AFTER 4229 02:28:12,220 --> 02:28:14,088 THEY HAD AN ACUTE INFECTION THAT 4230 02:28:14,088 --> 02:28:15,723 CONTRIBUTE TO THE GROWING 4231 02:28:15,723 --> 02:28:18,793 EVIDENCE THAT VIRAL PERSISTENCE 4232 02:28:18,793 --> 02:28:20,661 MAY BE A CONTRIBUTING MECHANISM 4233 02:28:20,661 --> 02:28:21,362 TO LONG COVID. 4234 02:28:21,362 --> 02:28:24,765 AND THE MOST WELL SUPPORTED 4235 02:28:24,765 --> 02:28:27,502 HYPOTHESIS NOW IS, YOU GET A 4236 02:28:27,502 --> 02:28:31,472 COVID INFECTION, SOMEHOW YOUR 4237 02:28:31,472 --> 02:28:32,707 IMMUNE SYSTEM TRIES TO FIGHT IT 4238 02:28:32,707 --> 02:28:35,843 OFF BUT JUST IS INEFFECTIVE, AND 4239 02:28:35,843 --> 02:28:38,112 THAT LEADS TO THAT VIRUS 4240 02:28:38,112 --> 02:28:43,351 STICKING AROUND. 4241 02:28:43,351 --> 02:28:46,220 RECOVER PATHOBIOLOGY STUDIES 4242 02:28:46,220 --> 02:28:47,388 LOOK AT BIOLOGICAL MECHANISMS 4243 02:28:47,388 --> 02:28:49,123 THAT CAN BE USED TO DEVELOP NEW 4244 02:28:49,123 --> 02:28:50,324 OR MORE TARGETED TREATMENTS. 4245 02:28:50,324 --> 02:28:51,659 THE RESEARCH IS ADVANCING OUR 4246 02:28:51,659 --> 02:28:52,827 UNDERSTANDING OF SO MANY CHANGES 4247 02:28:52,827 --> 02:28:55,663 IN BODY TISSUES AND ORGANS 4248 02:28:55,663 --> 02:28:58,666 CAUSED BY THE COV2 INFECTION, 4249 02:28:58,666 --> 02:29:00,201 IDENTIFYING BIOLOGIC MARKERS FOR 4250 02:29:00,201 --> 02:29:01,636 THERAPEUTIC TARGETS BASED ON AN 4251 02:29:01,636 --> 02:29:03,137 INDIVIDUAL'S RISK FACTORS. 4252 02:29:03,137 --> 02:29:04,672 I'LL EMPHASIZE IT AGAIN, THIS IS 4253 02:29:04,672 --> 02:29:08,075 NOT -- THIS IS AN INCREDIBLY 4254 02:29:08,075 --> 02:29:12,013 DIVERSE SPECTRUM OF SYMPTOMS. 4255 02:29:12,013 --> 02:29:14,382 NOT JUST ONE THING THAT CAN 4256 02:29:14,382 --> 02:29:15,583 EASILY BE IDENTIFIED. 4257 02:29:15,583 --> 02:29:18,419 BY EXAMINING SPECIMENS SUCH AS 4258 02:29:18,419 --> 02:29:20,121 BLOOD, SALIVA AND OTHER SAMPLES 4259 02:29:20,121 --> 02:29:22,123 AND DATA COLLECTED FROM THESE 4260 02:29:22,123 --> 02:29:25,026 RECOVER COHORTS AND TRIALS, 4261 02:29:25,026 --> 02:29:26,427 PATHOBIOLOGY STUDIES ARE HELPING 4262 02:29:26,427 --> 02:29:27,962 US STAWND HOW THE VIRUS CAN 4263 02:29:27,962 --> 02:29:29,797 PERSIST IN THE BODY, THE EFFECTS 4264 02:29:29,797 --> 02:29:31,866 OF THE VIRUS ON CERTAIN ORGANS 4265 02:29:31,866 --> 02:29:33,834 LIKE RESPIRATORY, VASCULAR, THE 4266 02:29:33,834 --> 02:29:34,602 IMMUNE SYSTEM. 4267 02:29:34,602 --> 02:29:38,272 AND EXAMPLES OF RESULTS WE HAVE 4268 02:29:38,272 --> 02:29:39,473 TODAY INDICATE THAT, AS I SAID, 4269 02:29:39,473 --> 02:29:41,642 THIS MAY CAUSE LONG LASTING 4270 02:29:41,642 --> 02:29:43,711 ALTERATIONS TO THE INNATE IMMUNE 4271 02:29:43,711 --> 02:29:46,881 SYSTEM, AND CAN ALSO MAKE PEOPLE 4272 02:29:46,881 --> 02:29:48,749 WHO HAVE LONG COVID MORE 4273 02:29:48,749 --> 02:29:51,018 SUSCEPTIBLE TO A HOST OF OTHER 4274 02:29:51,018 --> 02:29:52,853 INFECTIONS. 4275 02:29:52,853 --> 02:29:56,791 AND THEN SOME LONG COVID 4276 02:29:56,791 --> 02:30:00,595 SUFFERERS APPEAR TO HAVE 4277 02:30:00,595 --> 02:30:01,996 PERSISTENT INFECTION AND ONE OF 4278 02:30:01,996 --> 02:30:03,497 OUR MAIN HYPOTHESES TODAY IS 4279 02:30:03,497 --> 02:30:06,067 THAT THEY MAY RESPOND TO MORE 4280 02:30:06,067 --> 02:30:08,669 RIGOROUS TREATMENT WITH 4281 02:30:08,669 --> 02:30:10,972 ANTIVIRAL MEDICATION. 4282 02:30:10,972 --> 02:30:13,641 RECOVER WILL -- WE WILL AWARD 4283 02:30:13,641 --> 02:30:16,210 NEARLY $18 MILLION FROM THE 4284 02:30:16,210 --> 02:30:19,113 INITIAL $1.5 BILLION TOWARD AN 4285 02:30:19,113 --> 02:30:20,548 ADDITIONAL 20 PATHOLOGY RESEARCH 4286 02:30:20,548 --> 02:30:21,582 STUDIES NOW. 4287 02:30:21,582 --> 02:30:22,550 THESE SUBAWARDS ARE IN ADDITION 4288 02:30:22,550 --> 02:30:26,387 TO MORE THAN 40 PATHOBIOLOGY 4289 02:30:26,387 --> 02:30:28,789 RESEARCH PROJECTS AWARDED IN 4290 02:30:28,789 --> 02:30:29,156 2022. 4291 02:30:29,156 --> 02:30:31,926 SO THAT ORIGINAL FUNDING FROM 4292 02:30:31,926 --> 02:30:33,995 CONGRESS IS STILL WORKING VERY 4293 02:30:33,995 --> 02:30:35,963 HARD FOR BOTH THE COHORT AND THE 4294 02:30:35,963 --> 02:30:38,666 PATHOBIOLOGY. 4295 02:30:38,666 --> 02:30:41,535 ALSO AS A RESULT OF THE INITIAL 4296 02:30:41,535 --> 02:30:44,705 WAVE OF WORK, THIS IS BEFORE 4297 02:30:44,705 --> 02:30:47,375 RECOVER TLC WAS LAUNCHED BASED 4298 02:30:47,375 --> 02:30:50,444 ON ALL THE NEW DATA, THERE WERE 4299 02:30:50,444 --> 02:30:52,780 CURRENTLY EIGHT CLINICAL TRIALS 4300 02:30:52,780 --> 02:30:55,149 UNDERWAY, TESTING 13 4301 02:30:55,149 --> 02:30:55,850 INTERVENTIONS. 4302 02:30:55,850 --> 02:30:57,518 THESE ARE FOCUSED ON FINDING 4303 02:30:57,518 --> 02:30:58,519 INTERVENTIONS NOT ONLY TO TREAT 4304 02:30:58,519 --> 02:30:59,920 THE VIRAL PERSISTENCE, WHICH HAS 4305 02:30:59,920 --> 02:31:01,856 BEEN A HYPOTHESIS SINCE DAY ONE, 4306 02:31:01,856 --> 02:31:03,691 BUT ALSO SPECIFICALLY TO HELP 4307 02:31:03,691 --> 02:31:06,861 PEOPLE RIGHT AWAY WITH COGNITIVE 4308 02:31:06,861 --> 02:31:08,896 DYSFUNCTION, POSTURAL 4309 02:31:08,896 --> 02:31:11,866 ORTHOSTATIC TACHYCARDIA SYNDROME 4310 02:31:11,866 --> 02:31:16,570 OR POTS, COMPLEX SLEEP 4311 02:31:16,570 --> 02:31:18,839 DISTURBANCES, EXERCISE 4312 02:31:18,839 --> 02:31:21,242 INTOLERANCE AND POST EXERTIONAL 4313 02:31:21,242 --> 02:31:21,676 MALAISE. 4314 02:31:21,676 --> 02:31:22,777 I'LL JUST EMPHASIZE AGAIN, THESE 4315 02:31:22,777 --> 02:31:23,310 ARE NOT NEW. 4316 02:31:23,310 --> 02:31:24,578 THESE ARE THE KINDS OF THINGS WE 4317 02:31:24,578 --> 02:31:27,982 SEE THAT OCCUR IN OTHER POST 4318 02:31:27,982 --> 02:31:29,517 VIRAL SYMPTOMS. 4319 02:31:29,517 --> 02:31:31,752 SO UPDATE ON THESE EARLIER 4320 02:31:31,752 --> 02:31:32,319 LAUNCHED TRIALS. 4321 02:31:32,319 --> 02:31:35,156 THE VITAL AND NEURO TRIALS ARE 4322 02:31:35,156 --> 02:31:36,157 FULLY ENROLLED. 4323 02:31:36,157 --> 02:31:40,828 FOLLOW-UP FOR THE NEURO TRIAL IS 4324 02:31:40,828 --> 02:31:42,363 EXPECTED IN -- WILL END THIS 4325 02:31:42,363 --> 02:31:44,231 MONTH AND FOLLOW-UP FOR THE 4326 02:31:44,231 --> 02:31:46,133 VITAL TRIAL WILL END IN 4327 02:31:46,133 --> 02:31:48,135 MARCH 2025. 4328 02:31:48,135 --> 02:31:50,337 THE AUTONOMIC, SLEEP AND 4329 02:31:50,337 --> 02:31:51,939 ENERGIZE TRIALS ARE STILL OPEN 4330 02:31:51,939 --> 02:31:54,442 TO ENROLLMENT AND EXPECTED TO 4331 02:31:54,442 --> 02:31:55,976 END ENROLLMENT LATER NEXT YEAR 4332 02:31:55,976 --> 02:32:00,014 WITH FOLLOW-UP CONTINUING INTO 4333 02:32:00,014 --> 02:32:00,214 2026. 4334 02:32:00,214 --> 02:32:01,515 SO WE LOOK FORWARD TO SEEING THE 4335 02:32:01,515 --> 02:32:03,150 RESULTS OF THESE. 4336 02:32:03,150 --> 02:32:06,654 SO TO CLOSE, I JUST WANT TO 4337 02:32:06,654 --> 02:32:10,891 STRESS THAT LONG COVID IS A 4338 02:32:10,891 --> 02:32:12,426 COMPLEX DEBILITATING CONDITION 4339 02:32:12,426 --> 02:32:14,528 THAT AFFECTS PEOPLE'S ABILITY TO 4340 02:32:14,528 --> 02:32:17,598 WORK, ATTEND SCHOOL, PARTICIPATE 4341 02:32:17,598 --> 02:32:19,400 IN THEIR REGULAR ACTIVITY, AND 4342 02:32:19,400 --> 02:32:24,739 EVEN, I THINK, WE'RE SEEING 4343 02:32:24,739 --> 02:32:26,841 EXPERIENCE TELLING US IT ALSO 4344 02:32:26,841 --> 02:32:28,209 CONTRIBUTES TO EVEN SUBCLINICAL 4345 02:32:28,209 --> 02:32:32,480 DISEASE THAT AFFECTS PEOPLE SAND 4346 02:32:32,480 --> 02:32:38,052 PART OF A TYPE OF POST 4347 02:32:38,052 --> 02:32:39,386 INFECTIOUS COMPLICATION THAT WE 4348 02:32:39,386 --> 02:32:43,057 HAVE REALLY BEEN STYMIED FOR 4349 02:32:43,057 --> 02:32:43,491 FOREVER. 4350 02:32:43,491 --> 02:32:45,359 SO, THEREFORE, WE, NIH, REMAINS 4351 02:32:45,359 --> 02:32:47,128 COMMITTED TO ALLEVIATING THE 4352 02:32:47,128 --> 02:32:48,529 SUFFERING OF SO MANY 4353 02:32:48,529 --> 02:32:50,598 INDIVIDUALS, THEIR FAMILIES AND 4354 02:32:50,598 --> 02:32:53,033 CAREGIVERS, FINDING A WAY 4355 02:32:53,033 --> 02:32:55,136 THROUGH APPLICATION OF SCIENCE, 4356 02:32:55,136 --> 02:32:58,539 BIOLOGY, DRUG DEVELOPMENT, AND 4357 02:32:58,539 --> 02:33:00,841 THERAPY DELIVERY TO REALLY END 4358 02:33:00,841 --> 02:33:02,576 SUFFERING FROM ALL OF THESE 4359 02:33:02,576 --> 02:33:03,978 DISEASES AND, IN PARTICULAR, 4360 02:33:03,978 --> 02:33:04,645 LONG COVID. 4361 02:33:04,645 --> 02:33:06,147 WE LOOK FORWARD TO FURTHER 4362 02:33:06,147 --> 02:33:08,816 ADVANCING OUR UNDERSTANDING, AND 4363 02:33:08,816 --> 02:33:10,050 ALSO ADVANCING PREVENTION AND 4364 02:33:10,050 --> 02:33:11,585 TREATMENT OF ALL OF THESE 4365 02:33:11,585 --> 02:33:12,253 SPECTRUM OF DISEASES. 4366 02:33:12,253 --> 02:33:13,721 THANK YOU SO MUCH. 4367 02:33:13,721 --> 02:33:14,855 NOW WE CAN TAKE SOME QUESTIONS 4368 02:33:14,855 --> 02:33:15,756 ABOUT RECOVER. 4369 02:33:15,756 --> 02:33:16,690 >> GREAT. 4370 02:33:16,690 --> 02:33:21,095 SO IF YOU COULD PULL DOWN THE -- 4371 02:33:21,095 --> 02:33:21,896 GREAT. 4372 02:33:21,896 --> 02:33:26,200 ANYBODY WHO HAS A QUESTION? 4373 02:33:26,200 --> 02:33:28,269 YES, GISELLE, YOU CAN START. 4374 02:33:28,269 --> 02:33:30,404 >> YES, I APOLOGIZE, I CANNOT 4375 02:33:30,404 --> 02:33:31,939 GET MY VIDEO TO TURN ON. 4376 02:33:31,939 --> 02:33:33,340 I'VE BEEN TRYING SINCE WE CAME 4377 02:33:33,340 --> 02:33:34,308 BACK FROM THE BREAK. 4378 02:33:34,308 --> 02:33:34,708 >> NOT A PROBLEM. 4379 02:33:34,708 --> 02:33:36,944 >> YES, I WISH I COULD START MY 4380 02:33:36,944 --> 02:33:37,478 VIDEO. 4381 02:33:37,478 --> 02:33:39,346 I GOT A LITTLE NOTE THAT THE 4382 02:33:39,346 --> 02:33:41,382 CO-HOST IS ASKING ME TO START IT 4383 02:33:41,382 --> 02:33:42,683 BUT FOR WHATEVER REASON, I CAN'T 4384 02:33:42,683 --> 02:33:43,083 START IT. 4385 02:33:43,083 --> 02:33:44,752 >> WE'LL TAKE EXTRAMURAL OUT. 4386 02:33:44,752 --> 02:33:45,219 DON'T WORRY. 4387 02:33:45,219 --> 02:33:46,720 >> THANK YOU. 4388 02:33:46,720 --> 02:33:51,725 >> FIRST OF WILL ALL FIRST OF A, 4389 02:33:51,725 --> 02:33:53,360 DR. MONICA, DR. READ, THANK YOU 4390 02:33:53,360 --> 02:33:54,228 FOR THESE PRESENTATIONS. 4391 02:33:54,228 --> 02:33:57,731 THIS WORK IS SO VITALLY 4392 02:33:57,731 --> 02:33:59,900 IMPORTANT. 4393 02:33:59,900 --> 02:34:03,170 MY QUESTION HAS TO DO WITH THE 4394 02:34:03,170 --> 02:34:07,441 RELATIONSHIP, IF ANY, THERE IS 4395 02:34:07,441 --> 02:34:11,879 WITH RADX UP, PARTICULARLY, 4396 02:34:11,879 --> 02:34:14,615 THERE WERE 125 SITE. 4397 02:34:14,615 --> 02:34:16,684 THAT STUDY, OR THAT INITIATIVE 4398 02:34:16,684 --> 02:34:21,355 IS CLOSING NOW AFTER FIVE YEARS, 4399 02:34:21,355 --> 02:34:25,192 AND THERE'S 125 SITES IN 4400 02:34:25,192 --> 02:34:26,827 COMMUNITIES THAT HAD MOST 4401 02:34:26,827 --> 02:34:29,763 HARD-HIT BY THE PANDEMIC. 4402 02:34:29,763 --> 02:34:31,198 THIS IS ALL IN SERVICE OF 4403 02:34:31,198 --> 02:34:33,601 ENSURING THAT ESSENTIAL WORKERS, 4404 02:34:33,601 --> 02:34:35,836 THOSE THAT WERE MOST -- THOSE 4405 02:34:35,836 --> 02:34:37,538 COMMUNITIES THAT WERE MOST 4406 02:34:37,538 --> 02:34:40,274 IMPACTED HAVE THE OPPORTUNITY TO 4407 02:34:40,274 --> 02:34:40,574 PARTICIPATE. 4408 02:34:40,574 --> 02:34:44,945 I WAS EXCITED TO HEAR ABOUT 4409 02:34:44,945 --> 02:34:47,581 ACCESSIBILITY CONSIDERATIONS, 4410 02:34:47,581 --> 02:34:50,317 BECAUSE SO MANY OF THOSE 4411 02:34:50,317 --> 02:34:52,486 INDIVIDUALS, WHEN THEY WERE 4412 02:34:52,486 --> 02:34:54,121 EXPOSED AS ESSENTIAL WORKERS OR 4413 02:34:54,121 --> 02:34:56,624 HEALTHCARE WORKERS OR 4414 02:34:56,624 --> 02:34:57,558 COMMUNITIES THAT WEREN'T ABLE TO 4415 02:34:57,558 --> 02:35:05,900 GET TESTING OR TREATMENT, HAVE 4416 02:35:05,900 --> 02:35:08,736 LIMITATIONS IN TERMS OF THEIR 4417 02:35:08,736 --> 02:35:10,237 ABILITY TO COME TO A 4418 02:35:10,237 --> 02:35:10,871 COORDINATING CENTER AND 4419 02:35:10,871 --> 02:35:14,174 PARTICIPATE IN A CLINICAL TRIAL, 4420 02:35:14,174 --> 02:35:15,576 FOR EXAMPLE. 4421 02:35:15,576 --> 02:35:16,610 SO I'M PARTICULARLY INTERESTED 4422 02:35:16,610 --> 02:35:17,945 TO THINK ABOUT AND HEAR WHAT 4423 02:35:17,945 --> 02:35:20,447 EXPECTATIONS THERE ARE IN USE OF 4424 02:35:20,447 --> 02:35:23,517 TECHNOLOGY OR OTHER WAYS TO 4425 02:35:23,517 --> 02:35:24,618 INCLUDE INDIVIDUALS SO THAT THEY 4426 02:35:24,618 --> 02:35:25,986 CAN PARTICIPATE IN A CLINICAL 4427 02:35:25,986 --> 02:35:27,721 TRIAL IF THEY WORK AN HOURLY 4428 02:35:27,721 --> 02:35:29,156 WAGE, FOR EXAMPLE, OR WORKING 4429 02:35:29,156 --> 02:35:30,324 THE NIGHT SHIFT OR WHAT HAVE 4430 02:35:30,324 --> 02:35:30,524 YOU. 4431 02:35:30,524 --> 02:35:31,992 THANK YOU. 4432 02:35:31,992 --> 02:35:33,394 >> THANK YOU SO MUCH FOR RAISING 4433 02:35:33,394 --> 02:35:34,595 THIS IMPORTANT ISSUE. 4434 02:35:34,595 --> 02:35:38,065 AND SO I HAVE TO BE REALLY VERY 4435 02:35:38,065 --> 02:35:39,033 HONEST AND TRANSPARENT ABOUT 4436 02:35:39,033 --> 02:35:41,468 THIS. 4437 02:35:41,468 --> 02:35:44,305 WE DON'T HAVE THE BUDGET THAT IS 4438 02:35:44,305 --> 02:35:48,175 GOING TO ALLOW US TO INCLUDE 4439 02:35:48,175 --> 02:35:50,477 EVERYONE WE WANT TO IN THE 4440 02:35:50,477 --> 02:35:52,246 ONGOING CLINICAL TRIALS. 4441 02:35:52,246 --> 02:35:55,149 WE JUST DON'T HAVE THAT BUDGET. 4442 02:35:55,149 --> 02:35:57,451 I CAN TELL YOU THAT EVERY EFFORT 4443 02:35:57,451 --> 02:36:01,155 IS BEING MADE, WITH A MANDATE TO 4444 02:36:01,155 --> 02:36:03,891 CONTINUE THE DIVERSITY OF THE 4445 02:36:03,891 --> 02:36:05,092 SCOPE OF INDIVIDUALS 4446 02:36:05,092 --> 02:36:06,226 PARTICIPATING IN THESE TRIALS. 4447 02:36:06,226 --> 02:36:09,096 I MEAN, THAT'S OUR CORE MANDATE 4448 02:36:09,096 --> 02:36:11,899 ACROSS ALL OF NIH, AND CERTAINLY 4449 02:36:11,899 --> 02:36:12,533 WILL CONTINUE HERE. 4450 02:36:12,533 --> 02:36:19,306 SO I CAN'T SPEAK INDIVIDUALLY TO 4451 02:36:19,306 --> 02:36:20,708 WHICH TRIAL CENTERS CAN GO 4452 02:36:20,708 --> 02:36:22,176 FORWARD BECAUSE WE'VE JUST GOT 4453 02:36:22,176 --> 02:36:23,777 AN ISSUE OF ECONOMICS THAT WE 4454 02:36:23,777 --> 02:36:25,946 HAVE TO TE DEAL WITH. 4455 02:36:25,946 --> 02:36:27,715 NOW, THAT BEING SAID, ONE OF THE 4456 02:36:27,715 --> 02:36:28,749 BRIGHT SPOTS WE'VE ALSO GOT HERE 4457 02:36:28,749 --> 02:36:29,850 IS ENGAGEMENT TO THE FOUNDATION 4458 02:36:29,850 --> 02:36:33,220 FOR THE NIH, WHICH HAS BEEN -- 4459 02:36:33,220 --> 02:36:34,955 THROUGH RECOVER TLC BEEN BROUGHT 4460 02:36:34,955 --> 02:36:35,823 INTO THIS EFFORT. 4461 02:36:35,823 --> 02:36:38,559 SO WE'RE LOOKING TO MOVE AND 4462 02:36:38,559 --> 02:36:41,695 EXPAND HOPEFULLY ON WHAT WE SEE 4463 02:36:41,695 --> 02:36:43,564 WITH PUBLIC FUNDING, AND ALSO 4464 02:36:43,564 --> 02:36:45,532 BEING ABLE TO EXPAND WITH 4465 02:36:45,532 --> 02:36:47,167 PARTICIPATION OF HOPEFULLY 4466 02:36:47,167 --> 02:36:48,902 PHARMACEUTICAL PARTNERS AND ABLE 4467 02:36:48,902 --> 02:36:50,971 TO EXPAND TESTING OF IMPORTANT 4468 02:36:50,971 --> 02:36:53,907 AGENTS. 4469 02:36:53,907 --> 02:36:54,908 SO THANK YOU FOR RAISING THIS 4470 02:36:54,908 --> 02:36:55,442 ISSUE. 4471 02:36:55,442 --> 02:36:58,045 I CAN'T TELL YOU HOW WE WISH 4472 02:36:58,045 --> 02:37:00,447 THAT WE COULD CONTINUE THE 4473 02:37:00,447 --> 02:37:01,782 BROADEST POSSIBLE ENGAGEMENT IN 4474 02:37:01,782 --> 02:37:02,216 THESE SITES. 4475 02:37:02,216 --> 02:37:04,018 THAT WILL MAKE THEM GO A LOT 4476 02:37:04,018 --> 02:37:05,285 FASTER ANYWAY AND WE NEED FAST 4477 02:37:05,285 --> 02:37:05,552 ANSWERS. 4478 02:37:05,552 --> 02:37:10,157 THANKS. 4479 02:37:10,157 --> 02:37:11,158 >> THANK YOU. 4480 02:37:11,158 --> 02:37:12,126 OTHER COMMENTS OR QUESTIONS, 4481 02:37:12,126 --> 02:37:19,333 PLEASE? 4482 02:37:19,333 --> 02:37:20,634 YES, BRIAN, PLEASE GO AHEAD. 4483 02:37:20,634 --> 02:37:22,069 >> IT'S REALLY NICE TO HEAR THE 4484 02:37:22,069 --> 02:37:23,604 UPDATE ABOUT THIS IMPORTANT 4485 02:37:23,604 --> 02:37:23,971 INITIATIVE. 4486 02:37:23,971 --> 02:37:24,805 I WONDER IF YOU COULD TALK A 4487 02:37:24,805 --> 02:37:27,608 LITTLE BIT MORE ABOUT THE ROLE 4488 02:37:27,608 --> 02:37:29,843 OF SOCIAL, BEHAVIORAL AND MENTAL 4489 02:37:29,843 --> 02:37:31,378 HEALTH SCIENCE IN THE RECOVER 4490 02:37:31,378 --> 02:37:31,678 INITIATIVE. 4491 02:37:31,678 --> 02:37:34,081 I FEEL LIKE, YOU KNOW, AS YOU 4492 02:37:34,081 --> 02:37:36,583 WERE DESCRIBING IT, IT SEEMED 4493 02:37:36,583 --> 02:37:38,185 LIKE MUCH THAT WAS DESCRIBED IS 4494 02:37:38,185 --> 02:37:40,387 FOCUSED ON PATHOBIOLOGY, 4495 02:37:40,387 --> 02:37:41,588 NEUROLOGY, PHARMACOLOGICAL 4496 02:37:41,588 --> 02:37:43,090 TREATMENTS, AND YOU KNOW, AS WE 4497 02:37:43,090 --> 02:37:44,525 UNDERSTAND LONG COVID, A LOT OF 4498 02:37:44,525 --> 02:37:46,393 THE KEY SYMPTOMS ARE 4499 02:37:46,393 --> 02:37:47,895 PATIENT-REPORTED OUTCOMES LIKE 4500 02:37:47,895 --> 02:37:49,630 FATIGUE, QUALITY OF LIFE IS 4501 02:37:49,630 --> 02:37:52,266 CERTAINLY VERY IMPORTANT FOR 4502 02:37:52,266 --> 02:37:53,967 UNDERSTANDING HOW TREATMENTS 4503 02:37:53,967 --> 02:37:54,868 IMPROVE PEOPLE WHO ARE LIVING 4504 02:37:54,868 --> 02:37:58,072 WITH THESE CONDITIONS. 4505 02:37:58,072 --> 02:37:59,373 THEN THERE'S ALSO A LOT OF 4506 02:37:59,373 --> 02:38:00,374 STRONG EVIDENCE THAT MENTAL 4507 02:38:00,374 --> 02:38:01,542 HEALTH CONDITIONS LIKE 4508 02:38:01,542 --> 02:38:03,710 DEPRESSION AND ANXIETY ARE 4509 02:38:03,710 --> 02:38:04,545 ANTECEDENTS AND SEQUELAE OF LONG 4510 02:38:04,545 --> 02:38:04,778 COVID. 4511 02:38:04,778 --> 02:38:07,514 SO I WONDER IF WE COULD TA TALKA 4512 02:38:07,514 --> 02:38:09,917 LITTLE BIT MORE ABOUT MENTAL 4513 02:38:09,917 --> 02:38:11,318 HEALTH RESEARCHERS, HEALTH 4514 02:38:11,318 --> 02:38:12,586 PSYCHOLOGISTS ARE INVOLVED IN 4515 02:38:12,586 --> 02:38:13,687 THE LEADERSHIP OF THIS 4516 02:38:13,687 --> 02:38:14,254 INITIATIVE OR THE WORKING 4517 02:38:14,254 --> 02:38:14,488 GROUPS. 4518 02:38:14,488 --> 02:38:18,959 >> SO I CAN SAY DEFINITELY THAT 4519 02:38:18,959 --> 02:38:24,164 THE COHORT DESIGNS INCLUDED AN 4520 02:38:24,164 --> 02:38:25,399 INCREDIBLY DIVERSE 4521 02:38:25,399 --> 02:38:26,266 MULTIDISCIPLINARY GROUP, BECAUSE 4522 02:38:26,266 --> 02:38:27,668 YOU HIT IT EXACTLY RIGHT, BRIAN. 4523 02:38:27,668 --> 02:38:30,070 WE HAD TO IDENTIFY -- THIS IS A 4524 02:38:30,070 --> 02:38:30,637 CLINICAL DIAGNOSIS. 4525 02:38:30,637 --> 02:38:32,139 AND YOU KNOW, HOW COULD YOU 4526 02:38:32,139 --> 02:38:35,943 POSSIBLY COME UP WITH AN 4527 02:38:35,943 --> 02:38:41,381 ADEQUATE AND, YOU KNOW, 4528 02:38:41,381 --> 02:38:44,785 APPROPRIATELY DESIGNED CLINICAL 4529 02:38:44,785 --> 02:38:46,887 DIAGNOSIS WITHOUT INVOLVEMENT OF 4530 02:38:46,887 --> 02:38:49,256 BEHAVIORAL SCIENTISTS, SOCIAL 4531 02:38:49,256 --> 02:38:51,258 SCIENCE, AND FRANKLY THOSE IN 4532 02:38:51,258 --> 02:38:56,530 THE CLINIC WHO ARE EXPERIENCED 4533 02:38:56,530 --> 02:38:58,866 IN TREATING SOME OF THESE 4534 02:38:58,866 --> 02:39:00,801 POST-INFECTIOUS SYNDROMES FOR, 4535 02:39:00,801 --> 02:39:02,769 YOU KNOW, FOR DECADES. 4536 02:39:02,769 --> 02:39:05,472 SO THAT WAS DEFINITELY IN PART 4537 02:39:05,472 --> 02:39:09,843 OF THE ORIGINAL COHORT DESIGNS. 4538 02:39:09,843 --> 02:39:12,146 AND WE HOPE TO CONTINUE TO 4539 02:39:12,146 --> 02:39:14,114 ENGAGE THAT FULL SPECTRUM OF 4540 02:39:14,114 --> 02:39:15,983 RESEARCHERS AS THE COHORTS 4541 02:39:15,983 --> 02:39:18,552 MATURE AND WE PROCEED TO 4542 02:39:18,552 --> 02:39:21,288 MAINTENANCE AND ANALYSIS. 4543 02:39:21,288 --> 02:39:22,489 I'LL JUST EMPHASIZE AGAIN THAT 4544 02:39:22,489 --> 02:39:26,360 ONE OF OUR STRUGGLES IS THAT AS 4545 02:39:26,360 --> 02:39:27,594 SOMETIMES HAPPENS WITH NIH, THE 4546 02:39:27,594 --> 02:39:29,930 FUNDING FOR THE RECOVER COHORTS 4547 02:39:29,930 --> 02:39:32,299 ARE ALL TIME-LIMITED. 4548 02:39:32,299 --> 02:39:33,734 AND SO ONE OF OUR CHALLENGES 4549 02:39:33,734 --> 02:39:35,702 HERE IS TO FIGURE OUT HOW WE ARE 4550 02:39:35,702 --> 02:39:38,872 GOING TO MAINTAIN THE TEAM THAT 4551 02:39:38,872 --> 02:39:43,010 HAS SO FAR CONTRIBUTED AS WE NOW 4552 02:39:43,010 --> 02:39:45,078 MATURE INTO THE DATA ANALYSIS 4553 02:39:45,078 --> 02:39:46,713 AND THE COHORT MAINTENANCE 4554 02:39:46,713 --> 02:39:48,682 PHASES, AS WELL AS THE CLINICAL 4555 02:39:48,682 --> 02:39:48,916 TRIALS. 4556 02:39:48,916 --> 02:39:50,551 >> THANK YOU. 4557 02:39:50,551 --> 02:39:54,688 >> IF I COULD JUST FOLLOW UP ON 4558 02:39:54,688 --> 02:39:56,790 THAT, INTERVENTION ST STUDIES TT 4559 02:39:56,790 --> 02:39:57,925 ARE BEING DONE, ARE WE 4560 02:39:57,925 --> 02:39:59,459 CONSIDERING BEHAVIORAL 4561 02:39:59,459 --> 02:39:59,793 INTERVENTIONS? 4562 02:39:59,793 --> 02:40:03,564 >> THE ORIGINAL -- THE ORIGINAL 4563 02:40:03,564 --> 02:40:05,666 SET OF STUDIES HAVE BEHAVIORAL 4564 02:40:05,666 --> 02:40:08,168 INTERVENTIONS WITHIN THEM. 4565 02:40:08,168 --> 02:40:09,870 I CAN'T GO INTO GREAT DETAILS, 4566 02:40:09,870 --> 02:40:13,607 BUT YOU WILL SEE WHEN YOU LOOK 4567 02:40:13,607 --> 02:40:14,841 AT THE -- WHAT HAPPENED IN THE 4568 02:40:14,841 --> 02:40:16,677 FIRST PLATFORM TRIALS, YOU WILL 4569 02:40:16,677 --> 02:40:18,278 SEE BEHAVIORAL INTERVENTIONS, 4570 02:40:18,278 --> 02:40:19,613 AND THEN THE STUDIES GOING 4571 02:40:19,613 --> 02:40:20,814 FORWARD, YOU SAW THE 4572 02:40:20,814 --> 02:40:22,349 PRESENTATION FROM RECOVER TLC, 4573 02:40:22,349 --> 02:40:23,951 AND SO STUDIES GOING FORWARD ARE 4574 02:40:23,951 --> 02:40:26,720 GOING TO BE -- ARE STILL BEING 4575 02:40:26,720 --> 02:40:28,889 PLANNED, AND I CERTAINLY -- 4576 02:40:28,889 --> 02:40:31,358 YOU'VE SEEN THAT IN THE INITIAL 4577 02:40:31,358 --> 02:40:32,559 RESPONSE TO THE PORTAL. 4578 02:40:32,559 --> 02:40:34,962 MOST OF WHAT WE GOT WERE DRUG 4579 02:40:34,962 --> 02:40:36,830 TRIALS, BUT STILL THERE ARE SOME 4580 02:40:36,830 --> 02:40:38,165 BEHAVIORAL INTERVENTIONS IN 4581 02:40:38,165 --> 02:40:38,365 THERE. 4582 02:40:38,365 --> 02:40:41,735 AND I KNOW THE TEAM IS GOING TO 4583 02:40:41,735 --> 02:40:42,502 HAVE, FRANKLY, DIFFICULT 4584 02:40:42,502 --> 02:40:43,670 DECISIONS TO MAKE WITH THE 4585 02:40:43,670 --> 02:40:44,905 FUNDING AVAILABLE TO DECIDE 4586 02:40:44,905 --> 02:40:46,340 WHICH ONES ARE GOING TO HAVE 4587 02:40:46,340 --> 02:40:49,843 PRIORITY GOING FORWARD. 4588 02:40:49,843 --> 02:40:50,344 >> THANK YOU. 4589 02:40:50,344 --> 02:40:51,745 >> OKAY. 4590 02:40:51,745 --> 02:40:52,212 ADDITIONAL COMMENTS OR 4591 02:40:52,212 --> 02:40:52,479 QUESTIONS? 4592 02:40:52,479 --> 02:40:54,581 I KNOW WE'RE THE ONLY THING 4593 02:40:54,581 --> 02:40:55,916 STANDING BETWEEN YOU AND YOUR 4594 02:40:55,916 --> 02:40:57,251 LUNCH, IF YOU'RE HERE ON THE 4595 02:40:57,251 --> 02:40:59,286 EAST COAST. 4596 02:40:59,286 --> 02:41:04,091 SO -- BUT -- OR PERHAPS 4597 02:41:04,091 --> 02:41:04,758 BREAKFAST. 4598 02:41:04,758 --> 02:41:11,632 OTHER COMMENTS OR QUESTIONS? 4599 02:41:11,632 --> 02:41:13,100 I THINK THE POWER OF THE MEAL IS 4600 02:41:13,100 --> 02:41:15,969 TOO GREAT. 4601 02:41:15,969 --> 02:41:16,169 OKAY. 4602 02:41:16,169 --> 02:41:17,204 ALL RIGHT. 4603 02:41:17,204 --> 02:41:20,574 SO THANK YOU ALL. 4604 02:41:20,574 --> 02:41:24,611 SO WE ARE GOING TO NOW RECONVENE 4605 02:41:24,611 --> 02:41:27,014 AT 1:15 P.M. EASTERN TIME AFTER 4606 02:41:27,014 --> 02:41:28,315 THE LUNCH BREAK, AND SO WE LOOK 4607 02:41:28,315 --> 02:41:30,150 FORWARD TO SEEING EVERYBODY BACK 4608 02:41:30,150 --> 02:41:33,561 THEN. THANKS. 4609 02:41:33,561 --> 02:41:35,429 WELCOME BACK, EVERYBODY. 4610 02:41:35,429 --> 02:41:37,064 WE'RE MOVING TO OUR AFTERNOON 4611 02:41:37,064 --> 02:41:40,601 FOR THE ACD MEETING. 4612 02:41:40,601 --> 02:41:44,839 I AM REALLY EXCITED TO BE ABLE 4613 02:41:44,839 --> 02:41:46,073 TO HIGHLIGHT TWO EARLY CAREER 4614 02:41:46,073 --> 02:41:46,707 INTRAMURAL INVESTIGATORS FOR YOU 4615 02:41:46,707 --> 02:41:49,710 ALL TODAY. 4616 02:41:49,710 --> 02:41:52,346 WE'RE GOING TO START WITH DR. 4617 02:41:52,346 --> 02:41:55,716 CAITLIN STADLER, A STADTMAN 4618 02:41:55,716 --> 02:41:58,886 INVESTIGATOR, SECTION ON 4619 02:41:58,886 --> 02:42:01,422 BIOENGINEERING IN NIBIB. 4620 02:42:01,422 --> 02:42:03,691 >> THANK YOU SO MUCH, DR. 4621 02:42:03,691 --> 02:42:03,991 BERTAGNOLLI. 4622 02:42:03,991 --> 02:42:04,925 I APPRECIATE THE INVITATION TO 4623 02:42:04,925 --> 02:42:06,026 COME AND SHARE SOME WORK WE'VE 4624 02:42:06,026 --> 02:42:09,430 BEEN DOING IN THE INTRAMURAL 4625 02:42:09,430 --> 02:42:11,765 RESEARCH PROGRAM OF NIBIB. 4626 02:42:11,765 --> 02:42:15,135 OUR WORK LIES AT THE 4627 02:42:15,135 --> 02:42:16,337 INTERSECTION OF BIOMEDICAL 4628 02:42:16,337 --> 02:42:17,771 ENGINEERING AND IMMUNOLOGY 4629 02:42:17,771 --> 02:42:19,707 REALLY FOCUSED ON TRAUMATIC 4630 02:42:19,707 --> 02:42:20,040 INJURIES. 4631 02:42:20,040 --> 02:42:22,476 AND SO WHEN WE'RE TALKING ABOUT 4632 02:42:22,476 --> 02:42:23,344 TRAUMATIC INJURIES, YOU KNOW, 4633 02:42:23,344 --> 02:42:26,113 WHAT ARE WE GENERALLY REFERRING 4634 02:42:26,113 --> 02:42:26,647 TO? 4635 02:42:26,647 --> 02:42:29,083 AND THE ANSWER IS A WIDE VARIETY 4636 02:42:29,083 --> 02:42:34,455 OF THINGS. 4637 02:42:34,455 --> 02:42:35,756 FRACTURES, HEMATOMAS, BURNS, 4638 02:42:35,756 --> 02:42:37,291 FALLS, ANYTHING THAT CAUSES LOSS 4639 02:42:37,291 --> 02:42:38,525 OF TISSUE ARCHITECTURE, AND M 4640 02:42:38,525 --> 02:42:40,261 MORE SEVERE CASES THERE ARE DOWN 4641 02:42:40,261 --> 02:42:42,429 EXTREME EFFECTS ON TISSUE HEALTH 4642 02:42:42,429 --> 02:42:45,165 FROM ISCHEMIC DAMAGE AND MUSCLE 4643 02:42:45,165 --> 02:42:46,467 WASTING FROM AN INABILITY TO 4644 02:42:46,467 --> 02:42:47,568 COMPENSATE WITH OTHER MUSCLE 4645 02:42:47,568 --> 02:42:51,205 GROUPS THAT MAY BE LOST DUE TO 4646 02:42:51,205 --> 02:42:51,939 INITIAL TRAUMA. 4647 02:42:51,939 --> 02:42:53,374 THESE PATIENTS NOT ONLY HAVE 4648 02:42:53,374 --> 02:42:56,243 ISSUES WITH THEIR KIND OF LOCAL 4649 02:42:56,243 --> 02:43:00,848 TISSUE BUT THEY ALSO HAVE ISSUES 4650 02:43:00,848 --> 02:43:06,654 WITH MORE SYSTEMIC AND I DO 4651 02:43:06,654 --> 02:43:08,522 APOLOGIZE IF I'M IN FULL SCREEN 4652 02:43:08,522 --> 02:43:09,490 PRESENTATION, HOPEFULLY YOU CAN 4653 02:43:09,490 --> 02:43:13,193 SEE FULL SCREEN NOW. 4654 02:43:13,193 --> 02:43:14,962 MY MONITOR SWITCHED ON ME. 4655 02:43:14,962 --> 02:43:16,597 I APOLOGIZE FOR THAT. 4656 02:43:16,597 --> 02:43:20,334 SO THESE PATIENTS ALSO SUFFER 4657 02:43:20,334 --> 02:43:21,936 FROM SYSTEMIC IMMUNE ACTIVATION 4658 02:43:21,936 --> 02:43:25,339 AND IMMUNOSUPPRESSION CONDITIONS 4659 02:43:25,339 --> 02:43:26,206 AS WELL. 4660 02:43:26,206 --> 02:43:30,711 AND SO TISSUE ENGINEERING AND 4661 02:43:30,711 --> 02:43:31,345 REGENERATIVE MEDICINE, OLD 4662 02:43:31,345 --> 02:43:33,480 FIELDS FORMED WITH THE GOAL OF 4663 02:43:33,480 --> 02:43:34,281 BUILDING BACK TISSUES AND 4664 02:43:34,281 --> 02:43:36,183 REPAIRING WHAT WAS LOST. 4665 02:43:36,183 --> 02:43:37,985 WHO EXACTLY ARE OUR PATIENTS 4666 02:43:37,985 --> 02:43:39,687 HERE WHEN WE'RE TALKING ABOUT 4667 02:43:39,687 --> 02:43:42,623 THESE TRAUMATIC INJURIES? 4668 02:43:42,623 --> 02:43:44,825 WE HAVE SOLDIERS, CIVILIANS IN 4669 02:43:44,825 --> 02:43:45,893 COMBAT ZONES, FARMERS, 4670 02:43:45,893 --> 02:43:47,227 MANUFACTURING PROFESSIONALS 4671 02:43:47,227 --> 02:43:49,730 WORKING WITH HEAVY MACHINERY, WE 4672 02:43:49,730 --> 02:43:52,132 HAVE INJURIES IN CIVILIANS FROM 4673 02:43:52,132 --> 02:43:53,334 EXPLOSIVES AND CAR ACCIDENTS AND 4674 02:43:53,334 --> 02:43:54,735 THEN OTHER THINGS THAT YOU MIGHT 4675 02:43:54,735 --> 02:43:57,504 NOT THINK OF AS A TRAUMATIC 4676 02:43:57,504 --> 02:44:00,007 INJURY SUCH AS CHILD BIRTH THAT 4677 02:44:00,007 --> 02:44:01,342 CAUSE SEVERE TISSUE DAMAGE. 4678 02:44:01,342 --> 02:44:04,078 AND OVERALL WHEN WE LOOK AT THE 4679 02:44:04,078 --> 02:44:04,678 POPULATION WITHIN THE UNITED 4680 02:44:04,678 --> 02:44:05,813 STATES, THESE PROBLEMS THAT 4681 02:44:05,813 --> 02:44:07,348 WE'RE DEALING WITH ARE 4682 02:44:07,348 --> 02:44:07,648 WIDESPREAD. 4683 02:44:07,648 --> 02:44:09,216 TRAUMATIC INJURY IS THE 4684 02:44:09,216 --> 02:44:10,317 LEADING -- FOURTH LEADING CAUSE 4685 02:44:10,317 --> 02:44:11,952 OF DEATH OVERALL AND LEADING 4686 02:44:11,952 --> 02:44:13,287 CAUSE OF DEATH FOR THOSE UNDER 4687 02:44:13,287 --> 02:44:15,923 45 YEARS OF AGE IN THE UNITED 4688 02:44:15,923 --> 02:44:17,891 STATES. 4689 02:44:17,891 --> 02:44:24,865 AND THIS WAS REALIZED AS A 4690 02:44:24,865 --> 02:44:26,200 PROBLEM IN 2016, EMISSION ZERO 4691 02:44:26,200 --> 02:44:36,610 WAS THE GOAL OF GETTING 4692 02:44:40,814 --> 02:44:42,683 PREVENTIBLE DEATHS DOWN BUT THEY 4693 02:44:42,683 --> 02:44:45,319 ARE HIGHER NOW. 4694 02:44:45,319 --> 02:44:46,387 WORKING IN EMERGENCY MEDICINE 4695 02:44:46,387 --> 02:44:47,988 THEY MEET PATIENTS ON THE WORST 4696 02:44:47,988 --> 02:44:49,857 DAY OF THEIR LIFE. 4697 02:44:49,857 --> 02:44:51,291 IF THEY SURVIVE THE ROAD TO 4698 02:44:51,291 --> 02:44:52,726 RECOVERY FROM TRAUMA HAS A VERY, 4699 02:44:52,726 --> 02:44:55,229 VERY LONG ROAD. 4700 02:44:55,229 --> 02:45:00,601 WE HAVE ISSUES WITH DONOR SITE 4701 02:45:00,601 --> 02:45:01,902 MORBIDITY FROM GRAPHS, LIMITED 4702 02:45:01,902 --> 02:45:03,537 AVAILABILITY OF DONOR ORGANS. 4703 02:45:03,537 --> 02:45:05,639 PEOPLE ARE AWARE OF SHORTAGES IN 4704 02:45:05,639 --> 02:45:06,507 THE UNITED STATES. 4705 02:45:06,507 --> 02:45:10,377 AS A SHEER FACT OF NUMBERS, IN 4706 02:45:10,377 --> 02:45:12,846 THE U.S. WE HAVE 24.8 MILLION 4707 02:45:12,846 --> 02:45:13,747 ACCIDENTAL TRAUMAS AND 60 4708 02:45:13,747 --> 02:45:15,816 MILLION SURGERIES WHICH ALSO 4709 02:45:15,816 --> 02:45:16,550 CAUSE TRAUMATIC INJURIES PER 4710 02:45:16,550 --> 02:45:18,852 YEAR IN THE U.S. ALONE. 4711 02:45:18,852 --> 02:45:20,854 WHEN LOOKING AT THE SURGICAL 4712 02:45:20,854 --> 02:45:24,124 REPAIR OF THESE TISSUES AFTER 4713 02:45:24,124 --> 02:45:25,325 TRAUMA, IT'S NOT JUST STITCHING 4714 02:45:25,325 --> 02:45:27,061 A PATIENT UP. 4715 02:45:27,061 --> 02:45:29,029 FREQUENTLY SURGEONS ARE USING 4716 02:45:29,029 --> 02:45:31,365 DIFFERENT MATERIALS TO HELP HEAL 4717 02:45:31,365 --> 02:45:32,066 THESE INJURIES. 4718 02:45:32,066 --> 02:45:33,667 SO, FOR EXAMPLE, THERE ARE 4719 02:45:33,667 --> 02:45:35,636 BIOLOGIC PRODUCTS FOR WOUND 4720 02:45:35,636 --> 02:45:36,303 REPAIR. 4721 02:45:36,303 --> 02:45:40,674 THIS IS A COLLAGEN BASED 4722 02:45:40,674 --> 02:45:42,843 MATERIAL, ECM, HERE IT'S APPLIED 4723 02:45:42,843 --> 02:45:46,146 TO A DIABETIC FOOT ULCER, ALSO 4724 02:45:46,146 --> 02:45:47,881 USED FOR LARGER SCALE INJURIES. 4725 02:45:47,881 --> 02:45:52,152 HERE A SOLDIER HIT WITH AN IED 4726 02:45:52,152 --> 02:45:55,656 BLAST, ON THE RIGHT THERE'S A 4727 02:45:55,656 --> 02:45:59,793 REGROWTH OF MUSCLE TISSUE AFTER 4728 02:45:59,793 --> 02:46:01,228 TREATMENT WITH ECM MATERIAL. 4729 02:46:01,228 --> 02:46:02,229 OTHER IMPLANTS ARE NOT 4730 02:46:02,229 --> 02:46:03,630 NECESSARILY MADE TO BE REPLACED 4731 02:46:03,630 --> 02:46:06,800 BY THE PATIENT'S OWN TISSUE. 4732 02:46:06,800 --> 02:46:09,103 THINGS LIKE SYNTHETIC BREAST 4733 02:46:09,103 --> 02:46:10,437 IMPLANTS, MEDICAL DEVICES FOR 4734 02:46:10,437 --> 02:46:10,804 RECONSTRUCTION. 4735 02:46:10,804 --> 02:46:13,140 SO THIS IS AN EXAMPLE OF A MORE 4736 02:46:13,140 --> 02:46:14,241 NEGATIVE IMMUNE RESPONSE AGAINST 4737 02:46:14,241 --> 02:46:16,643 THESE MEDICAL DEVICES WHERE YOU 4738 02:46:16,643 --> 02:46:19,179 GET SCAR TISSUE FORMATION AND 4739 02:46:19,179 --> 02:46:20,380 FIBROTIC ENCAPSULATION OF THE 4740 02:46:20,380 --> 02:46:21,915 DEVICE THAT'S BEEN IMPLANTED. 4741 02:46:21,915 --> 02:46:23,784 AS MENTIONED BEFORE EVEN 4742 02:46:23,784 --> 02:46:24,451 CONTROLLED SURGERIES CAUSE 4743 02:46:24,451 --> 02:46:24,885 TRAUMA. 4744 02:46:24,885 --> 02:46:26,520 WHEN WE'RE GOING TO IMPLANT 4745 02:46:26,520 --> 02:46:29,256 MEDICAL DEVICES IT'S NOT JUST IN 4746 02:46:29,256 --> 02:46:33,760 THE CONTEXT OF TRAUMATIC 4747 02:46:33,760 --> 02:46:35,496 INJURIES BUT ALL SURGICAL 4748 02:46:35,496 --> 02:46:36,263 IMPLANTATIONS AS GIVING TISSUE 4749 02:46:36,263 --> 02:46:36,563 DAMAGE. 4750 02:46:36,563 --> 02:46:37,998 WHEN WE THINK OF THESE DEVICES 4751 02:46:37,998 --> 02:46:40,534 WE NEED TO THINK OF THEM IN THE 4752 02:46:40,534 --> 02:46:43,604 CONTEXT OF DAMAGED TISSUE. 4753 02:46:43,604 --> 02:46:47,441 SO WITHIN NIBIB HERE AT NIH OUR 4754 02:46:47,441 --> 02:46:50,177 SECTION ON IMMUNOENGINEERING, 4755 02:46:50,177 --> 02:46:51,745 WE'RE ENGINEERS, IMMUNOLOGISTS, 4756 02:46:51,745 --> 02:46:52,246 BIOLOGIST, A LARGE 4757 02:46:52,246 --> 02:46:53,547 INTERDISCIPLINARY TEAM. 4758 02:46:53,547 --> 02:46:55,182 WE WORK ON FUNDAMENTAL 4759 02:46:55,182 --> 02:46:55,816 IMMUNOLOGIC DISCOVERIES TRYING 4760 02:46:55,816 --> 02:46:59,820 TO UNDERSTAND HOW THE IMMUNE 4761 02:46:59,820 --> 02:47:00,921 SYSTEM RESPONDS TO INJURY, 4762 02:47:00,921 --> 02:47:02,322 RESPONDS TO MEDICAL DEVICES THAT 4763 02:47:02,322 --> 02:47:03,323 GET IMPLANTED. 4764 02:47:03,323 --> 02:47:05,626 AND USE THAT KNOWLEDGE TO 4765 02:47:05,626 --> 02:47:06,927 DEVELOP NEW THERAPEUTICS FOR 4766 02:47:06,927 --> 02:47:08,662 MATERIALS IN TRAUMA AND 4767 02:47:08,662 --> 02:47:08,996 REGENERATION. 4768 02:47:08,996 --> 02:47:10,531 NOW, OF COURSE, ALL OF THIS IS 4769 02:47:10,531 --> 02:47:11,965 ON A BEDROCK OF CLINICAL 4770 02:47:11,965 --> 02:47:12,633 DISCOVERY AND TRANSLATION 4771 02:47:12,633 --> 02:47:15,235 BECAUSE WE WANT TO FOCUS IN ON 4772 02:47:15,235 --> 02:47:16,670 MAKING MATERIALS THAT HELP 4773 02:47:16,670 --> 02:47:17,137 PEOPLE. 4774 02:47:17,137 --> 02:47:18,438 SO I'M GOING TO CHAT A LITTLE 4775 02:47:18,438 --> 02:47:20,607 BIT ABOUT ONE OF THOSE CLINICAL 4776 02:47:20,607 --> 02:47:22,142 PROJECTS WE HAD EARLY ON, ABLE 4777 02:47:22,142 --> 02:47:23,677 TO BRANCH OFF OF SOME COVID 4778 02:47:23,677 --> 02:47:26,180 RESEARCH THAT WE DID DURING THE 4779 02:47:26,180 --> 02:47:28,382 FIRST TWO YEARS WHERE OUR LAB 4780 02:47:28,382 --> 02:47:29,349 WAS HERE. 4781 02:47:29,349 --> 02:47:31,552 AND THIS WAS A LARGE 4782 02:47:31,552 --> 02:47:32,553 MULTI-CENTER COLLABORATION WITH 4783 02:47:32,553 --> 02:47:33,754 FIVE DIFFERENT TRAUMA CENTERS IN 4784 02:47:33,754 --> 02:47:34,721 THE UNITED STATES. 4785 02:47:34,721 --> 02:47:37,457 WE WERE ABLE TO GET OFF THE 4786 02:47:37,457 --> 02:47:38,425 GROUND THIS THOUSAND-PATIENT 4787 02:47:38,425 --> 02:47:40,294 COHORT STUDY LOOKING AT HUMAN 4788 02:47:40,294 --> 02:47:41,728 IMMUNE RESPONSES TO TRAUMATIC 4789 02:47:41,728 --> 02:47:41,962 INJURY. 4790 02:47:41,962 --> 02:47:43,897 WHAT WE DID WAS WOUND UP LOOKING 4791 02:47:43,897 --> 02:47:45,899 AT THESE PATIENTS WITH A VARIETY 4792 02:47:45,899 --> 02:47:48,635 OF TRAUMA SOURCES, AND WE 4793 02:47:48,635 --> 02:47:49,570 EVALUATED 59 PROTEINS IN THEIR 4794 02:47:49,570 --> 02:47:52,372 BLOOD AT THE TIME OF ADMISSION. 4795 02:47:52,372 --> 02:47:55,008 AND WE EXCITINGLY FOUND NEW 4796 02:47:55,008 --> 02:47:56,410 TRAUMA RESPONSE PROTEINS. 4797 02:47:56,410 --> 02:47:57,678 THEY HAVE NEVER BEEN PREVIOUSLY 4798 02:47:57,678 --> 02:47:59,613 REPORTED IN THE CONTEXT OF 4799 02:47:59,613 --> 02:48:00,047 TRAUMATIC INJURY. 4800 02:48:00,047 --> 02:48:04,184 ONE THAT WAS REALLY EXCITING WAS 4801 02:48:04,184 --> 02:48:05,953 THIS PROTEIN IL-29, A RELATIVELY 4802 02:48:05,953 --> 02:48:07,254 NEW CYTOKINE, HASN'T BEEN 4803 02:48:07,254 --> 02:48:08,355 REPORTED BEFORE IN TRAUMA. 4804 02:48:08,355 --> 02:48:09,890 WHAT WAS EVEN MORE INTERESTING 4805 02:48:09,890 --> 02:48:12,192 WAS IT WAS ACTUALLY PREDICTIVE 4806 02:48:12,192 --> 02:48:15,896 OF SURVIVAL. 4807 02:48:15,896 --> 02:48:17,864 IF WE GO THROUGH THOSE PROTEINS 4808 02:48:17,864 --> 02:48:20,300 AND DATA, USING MACHINE LEARNING 4809 02:48:20,300 --> 02:48:26,106 AND BASIC ALGEBRA WE CAN DEVELOP 4810 02:48:26,106 --> 02:48:27,541 NEW EQUATIONS TO PREDICT 4811 02:48:27,541 --> 02:48:27,941 SURVIVAL. 4812 02:48:27,941 --> 02:48:32,446 THIS IS AN EXAMPLE, VIPER, IN 4813 02:48:32,446 --> 02:48:34,448 REVISION, SO NEW DATA AND WE'RE 4814 02:48:34,448 --> 02:48:35,849 EXCITED ABOUT LEARNING FROM THE 4815 02:48:35,849 --> 02:48:37,050 BIOLOGY OF THESE PROTEINS AND 4816 02:48:37,050 --> 02:48:38,452 THEN THE FACT THIS MIGHT BE ABLE 4817 02:48:38,452 --> 02:48:41,555 TO BE USED AS A DIAGNOSTIC. 4818 02:48:41,555 --> 02:48:44,524 AS I MENTIONED BEFORE, TRAUMA 4819 02:48:44,524 --> 02:48:45,726 AFFECTS A PATIENT SYSTEMICALLY, 4820 02:48:45,726 --> 02:48:48,462 ALSO WITHIN THAT LOCAL INJURED 4821 02:48:48,462 --> 02:48:48,762 TISSUE. 4822 02:48:48,762 --> 02:48:50,864 CLINICAL WORK WAS LOOKING AT 4823 02:48:50,864 --> 02:48:51,965 SYSTEMIC, AT THE PERIPHERAL 4824 02:48:51,965 --> 02:48:52,432 BLOOD. 4825 02:48:52,432 --> 02:48:54,268 BUT WE REALLY DO NEED TO ZOOM 4826 02:48:54,268 --> 02:48:56,236 INTO THAT LOCAL TISSUE TO START 4827 02:48:56,236 --> 02:48:57,871 LEARNING ON HOW TO RECONSTRUCT 4828 02:48:57,871 --> 02:48:58,038 IT. 4829 02:48:58,038 --> 02:48:59,506 AND SO THIS IS WHERE ANOTHER SET 4830 02:48:59,506 --> 02:49:04,111 OF OUR GROUP, WHERE WE WORK ON 4831 02:49:04,111 --> 02:49:05,746 PRE-CLINICAL MODELS COMES INTO 4832 02:49:05,746 --> 02:49:06,847 PLAY STUDYING IN DETAIL WHAT 4833 02:49:06,847 --> 02:49:10,550 IMMUNE CELLS ARE DOING IN THAT 4834 02:49:10,550 --> 02:49:10,784 INJURY. 4835 02:49:10,784 --> 02:49:13,320 SO WE FOCUS IN ON SKELETAL 4836 02:49:13,320 --> 02:49:16,390 MUSCLES, TISSUE WE WORK ON, SO 4837 02:49:16,390 --> 02:49:18,659 HERE IS A SCHEMATIC OF ALL OF 4838 02:49:18,659 --> 02:49:21,395 THE -- A BUNCH OF IMMUNE CELLS 4839 02:49:21,395 --> 02:49:22,796 INVOLVED IN TRAUMATIC MUSCLE 4840 02:49:22,796 --> 02:49:25,666 INJURY AND REPAIR. 4841 02:49:25,666 --> 02:49:28,201 WE HAVE EARLY ON INFLAMMATORY 4842 02:49:28,201 --> 02:49:30,470 SIGNALS LIKE THIS PROTEIN 4843 02:49:30,470 --> 02:49:32,673 INTERFERON GAMMA CAN STIMULATE 4844 02:49:32,673 --> 02:49:33,640 STEM CELL PROLIFERATION TO BUILD 4845 02:49:33,640 --> 02:49:34,341 NEW TISSUE. 4846 02:49:34,341 --> 02:49:37,177 DOWN THE LINE THERE'S A SWITCH 4847 02:49:37,177 --> 02:49:41,248 IN IMMUNE RESPONSES WHERE THIS 4848 02:49:41,248 --> 02:49:42,983 HEADS TOWARD A REGULATORY IMMUNE 4849 02:49:42,983 --> 02:49:44,951 RESPONSE, DIFFERENT IMMUNE CUES 4850 02:49:44,951 --> 02:49:48,989 WITH SIGNAL STEM CELLS TO FUSE 4851 02:49:48,989 --> 02:49:55,562 INTO MYOTUBES AND FORM MUSCLE 4852 02:49:55,562 --> 02:49:55,962 FIBER. 4853 02:49:55,962 --> 02:49:57,097 ONE THING THAT WAS BOTHERING US 4854 02:49:57,097 --> 02:49:58,865 EARLY ON WHEN YOU THINK OF 4855 02:49:58,865 --> 02:50:01,601 TRAUMATIC INJURY THERE'S A 4856 02:50:01,601 --> 02:50:02,469 MASSIVE DISTURBANCE IN 4857 02:50:02,469 --> 02:50:03,170 HOMEOSTASIS. 4858 02:50:03,170 --> 02:50:05,872 WE HAVE ALL SORTS OF THINGS IN 4859 02:50:05,872 --> 02:50:06,073 THERE. 4860 02:50:06,073 --> 02:50:06,973 BACTERIA, DEBRIS, PROTEINS ON 4861 02:50:06,973 --> 02:50:07,941 THE OUTSIDE OF CELLS THAT SHOULD 4862 02:50:07,941 --> 02:50:09,343 BE ON THE INSIDE. 4863 02:50:09,343 --> 02:50:11,745 AND SO JUST THINKING ABOUT THE 4864 02:50:11,745 --> 02:50:13,947 BIOLOGY WE HAVE THIS PERSISTENT 4865 02:50:13,947 --> 02:50:15,816 INFLAMMATION THAT GOES ON FOR 4866 02:50:15,816 --> 02:50:16,049 MONTHS. 4867 02:50:16,049 --> 02:50:19,619 HOW DO WE NOT GET AUTOIMMUNITY, 4868 02:50:19,619 --> 02:50:21,621 HOW HAVE OUR BODIES DEVELOPED 4869 02:50:21,621 --> 02:50:23,824 WAYS TO PREVENT THIS AND COULD 4870 02:50:23,824 --> 02:50:24,691 WE LEVERAGE FOR THERAPEUTICS? 4871 02:50:24,691 --> 02:50:26,560 WE GO INTO THE LABORATORY WE 4872 02:50:26,560 --> 02:50:30,063 START LOOKING AT OUR VOLUMETRIC 4873 02:50:30,063 --> 02:50:31,398 MUSCLE LOSS VML MODEL TO ANSWER 4874 02:50:31,398 --> 02:50:32,666 THESE QUESTIONS. 4875 02:50:32,666 --> 02:50:35,869 THIS IS A SURGICAL EXCISION 4876 02:50:35,869 --> 02:50:38,905 MODEL OF SKELETAL MUSCLE INJURY. 4877 02:50:38,905 --> 02:50:41,007 WE USE TWO POLLS OF IMMUNE 4878 02:50:41,007 --> 02:50:42,209 RESPONSE TO BIOMATERIALS. 4879 02:50:42,209 --> 02:50:44,411 ONE BEING GOOD MATERIAL WHERE 4880 02:50:44,411 --> 02:50:46,480 OUR PRO HEALING MATERIAL THAT 4881 02:50:46,480 --> 02:50:48,248 ECM I MENTIONED PREVIOUSLY USED 4882 02:50:48,248 --> 02:50:49,316 CLINICALLY THAT HELPS HEAL THE 4883 02:50:49,316 --> 02:50:49,649 WOUND. 4884 02:50:49,649 --> 02:50:52,953 ON THE OTHER SIDE WE IMPLANT 4885 02:50:52,953 --> 02:50:54,688 POLYETHYLENE, AND SO THIS IS OUR 4886 02:50:54,688 --> 02:50:55,589 BAD MATERIAL. 4887 02:50:55,589 --> 02:50:56,656 IT'S WONDERFUL WHEN IT'S SOLID 4888 02:50:56,656 --> 02:50:59,092 AND TOGETHER IN A MEDICAL DEVICE 4889 02:50:59,092 --> 02:51:00,193 BUT WHEN YOU GET TINY WEAR 4890 02:51:00,193 --> 02:51:02,596 PARTICLES YOU HAVE LOTS OF 4891 02:51:02,596 --> 02:51:03,130 INFLAMMATION, FIBROSIS, 4892 02:51:03,130 --> 02:51:03,430 SCARRING. 4893 02:51:03,430 --> 02:51:05,565 IF WE CAN UNDERSTAND WHAT MAKES 4894 02:51:05,565 --> 02:51:07,401 THE GOOD GOOD AND WHAT MAKES THE 4895 02:51:07,401 --> 02:51:09,803 BAD BAD, WE CAN START TO TRY TO 4896 02:51:09,803 --> 02:51:11,238 IDENTIFY THESE TARGETS FOR 4897 02:51:11,238 --> 02:51:11,772 THERAPEUTICS. 4898 02:51:11,772 --> 02:51:13,740 WE STARTED OUT WITH A REALLY 4899 02:51:13,740 --> 02:51:15,041 STRAIGHTFORWARD QUESTION. 4900 02:51:15,041 --> 02:51:17,811 WHAT HAPPENS TO WOUNDS WITHOUT 4901 02:51:17,811 --> 02:51:18,712 IMMUNOLOGIC SELF-TOLERANCE? 4902 02:51:18,712 --> 02:51:20,313 THIS MEANS WHAT HAPPENS IN CASES 4903 02:51:20,313 --> 02:51:21,648 OF KNOWN AUTOIMMUNITY. 4904 02:51:21,648 --> 02:51:26,853 SO WHEN WE LOOK INSIDE THESE 4905 02:51:26,853 --> 02:51:28,722 MICE THAT LACK THIS PROTEIN, IT 4906 02:51:28,722 --> 02:51:30,290 IS NEEDED FOR THIS PROCESS OF 4907 02:51:30,290 --> 02:51:32,125 TELLING OUR BODY NOT TO ATTACK 4908 02:51:32,125 --> 02:51:32,492 ITSELF. 4909 02:51:32,492 --> 02:51:34,127 WHEN THIS PROTEIN IS GONE WE 4910 02:51:34,127 --> 02:51:35,429 HAVE AUTOIMMUNITY. 4911 02:51:35,429 --> 02:51:41,468 SO LET'S LOOK INSIDE THE AIR 4912 02:51:41,468 --> 02:51:41,902 KNOCKOUT MICE. 4913 02:51:41,902 --> 02:51:45,005 WILD TYPE ON LEFT, PINK IS 4914 02:51:45,005 --> 02:51:47,407 MUSCLE TISSUE AT THE TOP OF THE 4915 02:51:47,407 --> 02:51:49,709 IMAGE, IMPLANTED WITH THAT MORE 4916 02:51:49,709 --> 02:51:50,777 PRO-INFLAMMATORY MATERIAL. 4917 02:51:50,777 --> 02:51:53,113 WE SEE A REALLY STRONG AND 4918 02:51:53,113 --> 02:51:53,780 ROBUST INFLAMMATION. 4919 02:51:53,780 --> 02:51:56,850 HOWEVER IF WE LOOK AT IMAGES ON 4920 02:51:56,850 --> 02:51:59,586 THE RIGHT SIDE WE CAN SEE IN 4921 02:51:59,586 --> 02:52:00,353 AUTOIMMUNE MICE MASSIVELY 4922 02:52:00,353 --> 02:52:02,088 EXPANDED IN PRESENCE OF THIS 4923 02:52:02,088 --> 02:52:02,556 PLASTIC. 4924 02:52:02,556 --> 02:52:05,392 AND THAT'S CONFIRMED WITH THE CD 4925 02:52:05,392 --> 02:52:08,995 45 IMMUNE MARKER BELOW. 4926 02:52:08,995 --> 02:52:15,001 SO CONCLUSION FROM THAT 4927 02:52:15,001 --> 02:52:16,203 EXPERIMENT IMMUNE CELLS 4928 02:52:16,203 --> 02:52:17,504 TOLERATE, CRITICAL IN MATERIAL 4929 02:52:17,504 --> 02:52:18,038 IMPLANTATION. 4930 02:52:18,038 --> 02:52:20,373 DIGGING FURTHER WHAT ARE SOME 4931 02:52:20,373 --> 02:52:23,310 MECHANISMS OF MAINTAINING THIS 4932 02:52:23,310 --> 02:52:24,411 IMMUNOLOGIC TOLERANCE IN, SAY, 4933 02:52:24,411 --> 02:52:24,711 NORMAL MICE. 4934 02:52:24,711 --> 02:52:27,013 THIS IS A PAPER WE HAD PUBLISHED 4935 02:52:27,013 --> 02:52:27,781 RECENTLY. 4936 02:52:27,781 --> 02:52:33,520 WE FOCUSED ON THIS IMMUNE CELL, 4937 02:52:33,520 --> 02:52:36,022 KNOWN TO HELP PROMOTE THIS CELL 4938 02:52:36,022 --> 02:52:37,324 TOLERANCE IN THE LITERATURE. 4939 02:52:37,324 --> 02:52:39,092 WHEN WE LOOKED AT THE MODEL WE 4940 02:52:39,092 --> 02:52:42,128 WERE EXCITED TO SEE WITH THE PRO 4941 02:52:42,128 --> 02:52:44,130 HEALING MATERIAL WE SAW 4942 02:52:44,130 --> 02:52:45,332 ENRICHMENT OF THIS IMMUNE CELL 4943 02:52:45,332 --> 02:52:47,534 TYPE FOR THIS TOP RIGHT CORNER 4944 02:52:47,534 --> 02:52:49,703 OF THE GRAPH IN TEAL. 4945 02:52:49,703 --> 02:52:51,204 IN THAT PRO HEALING MATERIAL. 4946 02:52:51,204 --> 02:52:54,107 WE DIDN'T GET THE SAME 4947 02:52:54,107 --> 02:52:55,075 ENRICHMENT WITH THE 4948 02:52:55,075 --> 02:52:55,876 PRO-INFLAMMATORY MATERIAL. 4949 02:52:55,876 --> 02:52:58,678 LOOKING DOWN THE LINE WE SAW 4950 02:52:58,678 --> 02:53:00,981 THESE CDC 1s COULD AFFECT 4951 02:53:00,981 --> 02:53:02,082 HELPER T-CELL ACTIVATION WHICH 4952 02:53:02,082 --> 02:53:04,618 IS KNOWN TO BE IMPORTANT IN 4953 02:53:04,618 --> 02:53:06,920 MUSCLE REGENERATION. 4954 02:53:06,920 --> 02:53:10,323 AND THEN ALSO M2 MACRO MAJOR 4955 02:53:10,323 --> 02:53:11,424 POLARIZATION IMPORTANT IN 4956 02:53:11,424 --> 02:53:12,626 REGENERATION AND ALSO REMODELING 4957 02:53:12,626 --> 02:53:14,461 OF THAT SCAFFOLD INTO NEW 4958 02:53:14,461 --> 02:53:14,995 TISSUE. 4959 02:53:14,995 --> 02:53:16,897 THAT BEING SAID WHEN WE LOOK AT 4960 02:53:16,897 --> 02:53:18,532 THE TISSUE ITSELF IN MICE THAT 4961 02:53:18,532 --> 02:53:20,934 DON'T HAVE THESE CDC 1s, WE 4962 02:53:20,934 --> 02:53:23,236 SEE IMBALANCES IN STEM CELL 4963 02:53:23,236 --> 02:53:23,570 DIFFERENTIATE. 4964 02:53:23,570 --> 02:53:29,142 SO WE LACK THESE CELLS, WE HAVE 4965 02:53:29,142 --> 02:53:30,677 ISSUES WITH MUSCLE DEVELOPMENT, 4966 02:53:30,677 --> 02:53:31,678 TISSUE CALCIFICATIONS. 4967 02:53:31,678 --> 02:53:33,413 STEM CELLS AREN'T GETTING RIGHT 4968 02:53:33,413 --> 02:53:34,714 IMMUNE CUES TO DEVELOP INTO 4969 02:53:34,714 --> 02:53:37,017 TISSUE THEY NEED TO BE. 4970 02:53:37,017 --> 02:53:39,319 SO NOW WE LOOK BEFOREHAND AND 4971 02:53:39,319 --> 02:53:40,520 SEE WHAT IS MAKING THESE CELLS 4972 02:53:40,520 --> 02:53:41,988 COME IN. 4973 02:53:41,988 --> 02:53:43,823 WE TOOK SOME INSPIRATION FROM 4974 02:53:43,823 --> 02:53:45,358 CANCER LITERATURE THAT SHOWED 4975 02:53:45,358 --> 02:53:51,598 NATURAL KILLER CELLS COULD 4976 02:53:51,598 --> 02:53:53,266 RECRUIT CD 1, WHY NOT WOUNDS, 4977 02:53:53,266 --> 02:53:54,901 THE MECHANISM IS EXACTLY THE 4978 02:53:54,901 --> 02:53:55,101 SAME. 4979 02:53:55,101 --> 02:53:56,970 WE SEE THESE NATURAL KILLER 4980 02:53:56,970 --> 02:54:00,240 CELLS WHEN STIMULATED WITH 4981 02:54:00,240 --> 02:54:07,380 SIGNALS OF TISSUE DAMAGE, 4982 02:54:07,380 --> 02:54:08,615 UPREGULATES. 4983 02:54:08,615 --> 02:54:13,954 WE'VE IDENTIFIED A PATHWAY FOR 4984 02:54:13,954 --> 02:54:15,155 SELF-TOLERANCE AND IMMUNOREGULAR 4985 02:54:15,155 --> 02:54:16,423 NATION, EXCITED TO INVESTIGATE 4986 02:54:16,423 --> 02:54:18,224 NEW PATHWAYS. 4987 02:54:18,224 --> 02:54:19,392 SO LOOKING FAR FORWARD IN THE 4988 02:54:19,392 --> 02:54:21,094 FUTURE I'M STILL EARLY CAREER, 4989 02:54:21,094 --> 02:54:23,129 I'VE BEEN HERE FIVE YEARS, VERY 4990 02:54:23,129 --> 02:54:25,565 EXCITED AS TO THE WAY THAT THIS 4991 02:54:25,565 --> 02:54:27,334 FIELD AS A WHOLE, NOT JUST OUR 4992 02:54:27,334 --> 02:54:29,102 LAB BUT OTHERS WORKING IN IT 4993 02:54:29,102 --> 02:54:30,270 COULD AFFECT MEDICINE. 4994 02:54:30,270 --> 02:54:31,504 THIS WILL IMPROVE OUR 4995 02:54:31,504 --> 02:54:33,340 UNDERSTANDING OF HOW THE IMMUNE 4996 02:54:33,340 --> 02:54:35,008 SYSTEM RESPONDS TO TRAUMATIC 4997 02:54:35,008 --> 02:54:36,743 INJURY, GENERATING NEW 4998 02:54:36,743 --> 02:54:38,612 PREDICTORS AND DIAGNOSTICS FOR 4999 02:54:38,612 --> 02:54:41,348 PATIENT SURVIVAL, NEW MEDICAL 5000 02:54:41,348 --> 02:54:44,517 DEVICES, MEDICAL DEVICE CODING 5001 02:54:44,517 --> 02:54:54,961 TO EXTEND LIFETIME OF DEVICES. 5002 02:54:54,961 --> 02:54:56,730 AND LEARNING ABOUT WOUND HEALING 5003 02:54:56,730 --> 02:54:58,999 USING THIS KNOWLEDGE FOR OTHER 5004 02:54:58,999 --> 02:55:00,333 FIELDS SUCH AS AUTOIMMUNE 5005 02:55:00,333 --> 02:55:07,807 CONDITIONS, PLACES WE MIGHT BE 5006 02:55:07,807 --> 02:55:09,643 EXPOSED TO PLASTICS, 5007 02:55:09,643 --> 02:55:11,645 MICROPLASTICS ARE DISCUSSED NOW. 5008 02:55:11,645 --> 02:55:14,114 WE HAVE A BROAD COLLABORATION, 5009 02:55:14,114 --> 02:55:15,415 MASSIVE -- THANKS TO EVERYBODY 5010 02:55:15,415 --> 02:55:16,650 WE COLLABORATE WITH, WE'RE 5011 02:55:16,650 --> 02:55:19,653 EXCITED TO WORK ACROSS NIH 5012 02:55:19,653 --> 02:55:20,387 INTRAMURAL RESEARCH PROGRAMS, 5013 02:55:20,387 --> 02:55:22,455 DEPARTMENT OF DEFENSE, ALSO OUR 5014 02:55:22,455 --> 02:55:23,590 ACADEMIC COLLABORATORS. 5015 02:55:23,590 --> 02:55:25,091 WITH THAT I'D LIKE TO THANK 5016 02:55:25,091 --> 02:55:27,160 EVERYONE IN MY LABORATORY AS 5017 02:55:27,160 --> 02:55:29,362 WELL AS OUR EXTERNAL 5018 02:55:29,362 --> 02:55:29,996 COLLABORATIONS, COLLABORATORS, 5019 02:55:29,996 --> 02:55:31,231 TRAUMA PATIENTS AND THEIR 5020 02:55:31,231 --> 02:55:32,532 FAMILIES, OF COURSE THE FUNDING 5021 02:55:32,532 --> 02:55:34,934 THAT WAS PROVIDED FROM THE NIBIB 5022 02:55:34,934 --> 02:55:35,835 INTRAMURAL RESEARCH PROGRAM. 5023 02:55:35,835 --> 02:55:37,337 I'M HAPPY TO TAKE ANY QUESTIONS 5024 02:55:37,337 --> 02:55:39,539 WHEN THE TIME PERMITS. 5025 02:55:39,539 --> 02:55:39,973 THANK YOU. 5026 02:55:39,973 --> 02:55:41,408 >> WELL, THANK YOU. 5027 02:55:41,408 --> 02:55:43,343 WE HAVE LITERALLY TIME FOR ONE 5028 02:55:43,343 --> 02:55:45,011 OR MAYBE TWO VERY QUICK 5029 02:55:45,011 --> 02:55:45,278 QUESTIONS. 5030 02:55:45,278 --> 02:55:48,081 MONICA, DID YOU WANT TO START? 5031 02:55:48,081 --> 02:55:49,649 >> GO AHEAD. 5032 02:55:49,649 --> 02:55:53,253 >> ANYBODY HAVE A QUICK 5033 02:55:53,253 --> 02:55:53,553 QUESTION? 5034 02:55:53,553 --> 02:55:59,926 WE'RE STRAINED FOR TIME HERE. 5035 02:55:59,926 --> 02:56:00,727 >> I'LL GO QUICK. 5036 02:56:00,727 --> 02:56:02,896 THIS IS THE ADVISORY BOARD TO 5037 02:56:02,896 --> 02:56:06,700 THE COMMITTEE TO THE DIRECTOR. 5038 02:56:06,700 --> 02:56:08,668 ANY THOUGHTS YOU HAVE ABOUT 5039 02:56:08,668 --> 02:56:09,903 BEING A JUNIOR INVESTIGATOR AND 5040 02:56:09,903 --> 02:56:13,807 KIND OF THE ROLE AT NIH? 5041 02:56:13,807 --> 02:56:16,609 >> I'D SAY BEING A JUNIOR 5042 02:56:16,609 --> 02:56:22,282 INVESTIGATOR HERE, ONE THING 5043 02:56:22,282 --> 02:56:23,149 I'VE ENJOYED IS DOING 5044 02:56:23,149 --> 02:56:24,117 HYPOTHESIS-DRIVEN RESEARCH, 5045 02:56:24,117 --> 02:56:24,918 EXCITING NEW DIRECTIONS WHERE I 5046 02:56:24,918 --> 02:56:26,319 CAN DO THE SCIENCE AND SHOW THAT 5047 02:56:26,319 --> 02:56:28,822 I WAS ABLE TO DO IT AS OPPOSED 5048 02:56:28,822 --> 02:56:31,558 TO, YOU KNOW, THE GRANT-BASED 5049 02:56:31,558 --> 02:56:32,892 MECHANISM ON THE OUTSIDE AND 5050 02:56:32,892 --> 02:56:35,528 THEN OF COURSE WE'RE WORKING 5051 02:56:35,528 --> 02:56:37,597 WITH, YOU KNOW, FUNGAL DISEASE 5052 02:56:37,597 --> 02:56:39,899 RESEARCHERS, WITH TRAUMA 5053 02:56:39,899 --> 02:56:43,002 SURGEONS, WORKING WITH CANCER 5054 02:56:43,002 --> 02:56:44,204 RESEARCHERS, BASIC 5055 02:56:44,204 --> 02:56:45,038 IMMUNOLOGISTS, AND NOT BEING 5056 02:56:45,038 --> 02:56:47,040 SILOED WITHIN FIELDS I THINK HAS 5057 02:56:47,040 --> 02:56:48,241 BEEN VERY, VERY HELPFUL IN TERMS 5058 02:56:48,241 --> 02:56:50,643 OF THE SCIENCE THAT WE DO. 5059 02:56:50,643 --> 02:56:52,712 AND SO THOSE TWO THINGS COMBINED 5060 02:56:52,712 --> 02:56:54,681 BEING ABLE TO DO THE SCIENCE 5061 02:56:54,681 --> 02:56:55,782 THAT, YOU KNOW, WE THINK NEEDS 5062 02:56:55,782 --> 02:56:58,651 TO BE DONE AND THEN HAVING THE 5063 02:56:58,651 --> 02:56:59,953 INTERDISCIPLINARY COLLABORATION 5064 02:56:59,953 --> 02:57:01,921 HAS BEEN REALLY WONDERFUL. 5065 02:57:01,921 --> 02:57:02,288 >> EXCELLENT. 5066 02:57:02,288 --> 02:57:03,556 THAT'S WHAT WE'RE TRYING TO 5067 02:57:03,556 --> 02:57:03,890 ACHIEVE. 5068 02:57:03,890 --> 02:57:04,891 THANK YOU SO MUCH. 5069 02:57:04,891 --> 02:57:07,727 THANK YOU FOR BEING HERE. 5070 02:57:07,727 --> 02:57:09,162 OKAY. 5071 02:57:09,162 --> 02:57:14,400 NEXT, DR. KEENAN WALKER, WHO AN 5072 02:57:14,400 --> 02:57:16,703 NIH DISTINGUISHED SCHOLAR, 5073 02:57:16,703 --> 02:57:18,271 MULTI-MODAL IMAGING OF 5074 02:57:18,271 --> 02:57:19,639 NEURODEGENERATIVE DISEASE UNIT 5075 02:57:19,639 --> 02:57:22,509 IN THE NATIONAL INSTITUTE OF 5076 02:57:22,509 --> 02:57:23,476 AGING. 5077 02:57:23,476 --> 02:57:24,444 DR. WALKER. 5078 02:57:24,444 --> 02:57:24,711 >> OKAY. 5079 02:57:24,711 --> 02:57:27,647 FIRST, THANK YOU FOR HAVING ME. 5080 02:57:27,647 --> 02:57:28,181 HOPEFULLY YOU'RE SEEING MY 5081 02:57:28,181 --> 02:57:29,616 SCREEN, THE RIGHT SCREEN AND CAN 5082 02:57:29,616 --> 02:57:32,886 HEAR ME WELL. 5083 02:57:32,886 --> 02:57:33,686 >> GOOD. 5084 02:57:33,686 --> 02:57:38,024 >> AWESOME. 5085 02:57:38,024 --> 02:57:39,559 I'M KEENAN WALKER, NIA. 5086 02:57:39,559 --> 02:57:42,395 I'VE BEEN AT NIA FOR ABOUT FOUR 5087 02:57:42,395 --> 02:57:42,595 YEARS. 5088 02:57:42,595 --> 02:57:45,932 I'M GOING TO TALK ABOUT 5089 02:57:45,932 --> 02:57:47,467 UNDERSTANDING THIS LINK BETWEEN 5090 02:57:47,467 --> 02:57:49,969 INFECTION AND DEMENTIA RISK AND 5091 02:57:49,969 --> 02:57:52,505 UNDERSTANDING THE MOLECULAR 5092 02:57:52,505 --> 02:57:53,406 CONNECTION THERE. 5093 02:57:53,406 --> 02:57:55,141 SO, I'LL FOCUS FIRST TO GET 5094 02:57:55,141 --> 02:57:56,576 EVERYONE ON THE SAME PAGE ON 5095 02:57:56,576 --> 02:57:58,111 ALZHEIMER'S DISEASE WHICH WE 5096 02:57:58,111 --> 02:57:59,112 KNOW AFFECTS OVER 10% OF 5097 02:57:59,112 --> 02:58:01,915 INDIVIDUALS IN THE U.S., OVER 5098 02:58:01,915 --> 02:58:02,148 AGE 65. 5099 02:58:02,148 --> 02:58:04,117 IT'S THE MOST COMMON FORM OF 5100 02:58:04,117 --> 02:58:04,617 DEMENTIA. 5101 02:58:04,617 --> 02:58:06,886 THERE'S MANY FORMS OF DEMENTIA 5102 02:58:06,886 --> 02:58:09,255 BUT ALZHEIMER'S DISEASE PRESENTS 5103 02:58:09,255 --> 02:58:11,558 2/3, IT'S CHARACTERIZED BY 5104 02:58:11,558 --> 02:58:13,226 BIOLOGICALLY BY EXTRACELLULAR 5105 02:58:13,226 --> 02:58:14,427 AMYLOID PLACENTAL PERFUSION, 5106 02:58:14,427 --> 02:58:16,262 INTRACELLULAR TANGLES, AND A 5107 02:58:16,262 --> 02:58:19,232 HOST OF OTHER NEUROBIOLOGIC 5108 02:58:19,232 --> 02:58:20,600 PROCESSES LIKE MICROGLIAL 5109 02:58:20,600 --> 02:58:21,634 ACTIVATION, NEUROINFLAMMATION. 5110 02:58:21,634 --> 02:58:24,037 BUT THERE'S ALSO OTHER THINGS 5111 02:58:24,037 --> 02:58:26,039 THAT INFLUENCE DEMENTIA RISK OR 5112 02:58:26,039 --> 02:58:27,707 ALZHEIMER'S DISEASE RISK. 5113 02:58:27,707 --> 02:58:28,541 FOR EXAMPLE, SYSTEMIC HEALTH 5114 02:58:28,541 --> 02:58:30,176 CONDITIONS, THESE ARE CONDITIONS 5115 02:58:30,176 --> 02:58:33,146 THAT OCCUR OUTSIDE THE CENTRAL 5116 02:58:33,146 --> 02:58:36,449 NERVOUS SYSTEM, LIKE DIABETES, 5117 02:58:36,449 --> 02:58:37,317 HYPERTENSION, SYSTEMIC 5118 02:58:37,317 --> 02:58:42,655 INFLAMMATORY OR METABOLIC 5119 02:58:42,655 --> 02:58:44,290 CONDITIONS, EPIDEMIOLOGIC, 5120 02:58:44,290 --> 02:58:44,791 TRANSLATIONAL RESEARCH 5121 02:58:44,791 --> 02:58:46,492 DEMONSTRATE INCREASED RISK FOR 5122 02:58:46,492 --> 02:58:47,794 DEMENTIA AND ALZHEIMER'S, 5123 02:58:47,794 --> 02:58:48,127 SPECIFICALLY. 5124 02:58:48,127 --> 02:58:50,630 AND WHAT OF THE LARGE 5125 02:58:50,630 --> 02:58:52,632 CATEGORIES, WHAT WE STUDY IN THE 5126 02:58:52,632 --> 02:58:54,567 MIND UNIT, EFFECT OF ONE SUCH 5127 02:58:54,567 --> 02:58:58,304 CONDITION OR TYPE OF CONDITION, 5128 02:58:58,304 --> 02:58:59,639 THAT'S AFFECTING THE IMMUNE 5129 02:58:59,639 --> 02:59:01,274 SYSTEM, OUTSIDE THE CENTRAL 5130 02:59:01,274 --> 02:59:02,809 NERVOUS SYSTEM. 5131 02:59:02,809 --> 02:59:03,676 AND OUR HYPOTHESIS, THERE'S BEEN 5132 02:59:03,676 --> 02:59:07,413 QUITE A BIT OF WORK TO SHOW THAT 5133 02:59:07,413 --> 02:59:08,815 PERIPHERAL IMMUNE FUNCTION AND 5134 02:59:08,815 --> 02:59:10,250 DYSFUNCTION CAN INFLUENCE ONE'S 5135 02:59:10,250 --> 02:59:12,919 RISK FOR ALZHEIMER'S DISEASE. 5136 02:59:12,919 --> 02:59:15,388 I LIKE TO CLASSIFY PERIPHERAL 5137 02:59:15,388 --> 02:59:16,689 IMMUNITY INTO TWO DIFFERENT 5138 02:59:16,689 --> 02:59:18,691 CATEGORIES IN TERMS OF 5139 02:59:18,691 --> 02:59:19,259 INFLAMMATORY INSULTS. 5140 02:59:19,259 --> 02:59:21,628 SO, ON THE LEFT WE HAVE CHRONIC 5141 02:59:21,628 --> 02:59:23,930 IMMUNE ACTIVATION WHICH COMES 5142 02:59:23,930 --> 02:59:25,465 FROM ELECTRONIC AUTOIMMUNE 5143 02:59:25,465 --> 02:59:26,566 CONDITIONS, CHRONIC INFECTION, 5144 02:59:26,566 --> 02:59:27,000 LIFESTYLE CHOICES. 5145 02:59:27,000 --> 02:59:29,502 AND ON THE RIGHT WE HAVE ACUTE 5146 02:59:29,502 --> 02:59:31,471 INFLAMMATORY CONDITIONS THAT 5147 02:59:31,471 --> 02:59:33,873 COME FROM TISSUE INJURY, ACUTE 5148 02:59:33,873 --> 02:59:35,541 INFECTION, CRITICAL ILLNESS, FOR 5149 02:59:35,541 --> 02:59:35,775 EXAMPLE. 5150 02:59:35,775 --> 02:59:38,044 AND THE THING THAT THESE TWO 5151 02:59:38,044 --> 02:59:40,446 TYPES OF IMMUNE INSULTS HAVE IN 5152 02:59:40,446 --> 02:59:45,051 COMMON IS THAT THEY UPREGULATE 5153 02:59:45,051 --> 02:59:46,019 INFLAMMATORY MEDIATORS, MAKING 5154 02:59:46,019 --> 02:59:49,522 THE WAY FROM TISSUE INTO 5155 02:59:49,522 --> 02:59:51,524 CIRCULATION AND THEN CAN 5156 02:59:51,524 --> 02:59:52,825 INFLUENCE TARGET CELLS WITHIN 5157 02:59:52,825 --> 02:59:54,961 THE BRAIN THROUGH VARIOUS 5158 02:59:54,961 --> 02:59:56,562 CONDUITS, THROUGH THE 5159 02:59:56,562 --> 03:00:00,433 BLOOD-BRAIN BARRIER FOR EXAMPLE, 5160 03:00:00,433 --> 03:00:01,034 FORWARD PLEXUS, SIGNALING VIA 5161 03:00:01,034 --> 03:00:05,471 THE AFFERENT VAGAL NERVE 5162 03:00:05,471 --> 03:00:05,805 SIGNALING. 5163 03:00:05,805 --> 03:00:08,308 THESE INFLAMMATORY PROTEINS IN 5164 03:00:08,308 --> 03:00:09,309 CIRCULATION IN BLOOD EXERT QUITE 5165 03:00:09,309 --> 03:00:12,378 A BIT OF EFFECT ON BRAIN 5166 03:00:12,378 --> 03:00:12,645 FUNCTION. 5167 03:00:12,645 --> 03:00:16,416 AND THIS IS REALLY FOR US THE 5168 03:00:16,416 --> 03:00:20,887 FOREFRONT WITH THE COVID-19 5169 03:00:20,887 --> 03:00:21,321 PANDEMIC. 5170 03:00:21,321 --> 03:00:24,624 IT'S BEEN WIDELY ACCEPTED THAT 5171 03:00:24,624 --> 03:00:26,592 INFECTION OR ACUTE INFLAMMATORY 5172 03:00:26,592 --> 03:00:28,294 INSULT CAN HAVE LONG-TERM 5173 03:00:28,294 --> 03:00:30,296 EFFECTS ON BRAIN HEALTH AND HAVE 5174 03:00:30,296 --> 03:00:31,097 BEEN ASSOCIATED WITH DEMENTIA 5175 03:00:31,097 --> 03:00:33,499 RISK IN THE PAST. 5176 03:00:33,499 --> 03:00:35,468 BUT I THINK IT'S BECOME VERY 5177 03:00:35,468 --> 03:00:38,972 WELL RECOGNIZED EVER SINCE COVID 5178 03:00:38,972 --> 03:00:41,374 AND IT'S THOUGHT TO BE WHAT 5179 03:00:41,374 --> 03:00:42,942 UNDERLIES A LOT OF 5180 03:00:42,942 --> 03:00:44,344 MANIFESTATIONS OF LONG COVID, 5181 03:00:44,344 --> 03:00:46,612 PARTICULARLY THAT AFFECTS BRAIN 5182 03:00:46,612 --> 03:00:47,780 HEALTH, COGNITION, DEMENTIA 5183 03:00:47,780 --> 03:00:49,716 RISK, PSYCHIATRIC CONDITIONS, ET 5184 03:00:49,716 --> 03:00:50,049 CETERA. 5185 03:00:50,049 --> 03:00:52,318 SO WE SET OUT TO REALLY 5186 03:00:52,318 --> 03:00:55,588 UNDERSTAND THE MOLECULAR LENGTH 5187 03:00:55,588 --> 03:00:58,391 BETWEEN INFECTION AND COGNITIVE 5188 03:00:58,391 --> 03:01:00,860 DECLINE AND DEMENTIA RISK NOT IN 5189 03:01:00,860 --> 03:01:02,395 COVID SPECIFICALLY BUT ACROSS 5190 03:01:02,395 --> 03:01:04,564 INFECTIONS BECAUSE WE THINK 5191 03:01:04,564 --> 03:01:08,167 THERE'S MORE SIMILARITIES ACROSS 5192 03:01:08,167 --> 03:01:10,436 INFECTIONS DRIVING THIS 5193 03:01:10,436 --> 03:01:11,337 MECHANISM THAN THERE ARE 5194 03:01:11,337 --> 03:01:11,771 DIFFERENCES. 5195 03:01:11,771 --> 03:01:17,577 SO THIS WAS A PAPER THAT WAS 5196 03:01:17,577 --> 03:01:19,779 PUBLISHED BY MICHAEL DUGGAN, MY 5197 03:01:19,779 --> 03:01:21,981 POSTDOC, THIS CAME OUT IN NATURE 5198 03:01:21,981 --> 03:01:22,181 AGING. 5199 03:01:22,181 --> 03:01:24,784 WE TRIED TO TEST THIS HYPOTHESIS 5200 03:01:24,784 --> 03:01:25,785 THAT'S ILLUSTRATED IN THE 5201 03:01:25,785 --> 03:01:27,787 DIAGRAM AT THE BOTTOM. 5202 03:01:27,787 --> 03:01:29,422 WHEN WE HAVE INFECTION, THE IDEA 5203 03:01:29,422 --> 03:01:31,824 IS THAT INFECTION IS ASSOCIATED 5204 03:01:31,824 --> 03:01:34,794 WITH ABNORMAL EXPRESSION OF 5205 03:01:34,794 --> 03:01:38,431 PROTEINS IN CIRCULATION. 5206 03:01:38,431 --> 03:01:40,066 THESE PROTEINS ARE EMERGING FROM 5207 03:01:40,066 --> 03:01:41,501 TISSUES ACROSS THE BODY. 5208 03:01:41,501 --> 03:01:43,669 ONCE THEY GET IN CIRCULATION THE 5209 03:01:43,669 --> 03:01:45,872 IDEA IS THEY CAN INFLUENCE 5210 03:01:45,872 --> 03:01:48,141 MOLECULAR CHANGES WITHIN THE 5211 03:01:48,141 --> 03:01:49,509 BRAIN TO VARIOUS CONDUITS, AS 5212 03:01:49,509 --> 03:01:52,011 MENTIONED BEFORE. 5213 03:01:52,011 --> 03:02:02,555 SOME OF THESE INCLUDE HALLMARKS 5214 03:02:08,494 --> 03:02:09,095 OF ALZHEIMER'S, ACCELERATING TO 5215 03:02:09,095 --> 03:02:09,896 DEMENTIA RISK. 5216 03:02:09,896 --> 03:02:14,000 WE TRIED TO TEST MOST OF THE 5217 03:02:14,000 --> 03:02:15,668 CONNECTIONS IN THIS CAUSAL OR 5218 03:02:15,668 --> 03:02:17,203 MECHANISTIC CHAIN HERE. 5219 03:02:17,203 --> 03:02:20,406 WE STARTED BY LOOKING AT THIS 5220 03:02:20,406 --> 03:02:22,141 RELATIONSHIP BETWEEN PAST 5221 03:02:22,141 --> 03:02:23,142 INFECTION AND NEURODEGENERATION. 5222 03:02:23,142 --> 03:02:26,846 AND TO DO THIS WE USED DAD FROM 5223 03:02:26,846 --> 03:02:28,815 LEGISLATURE LONGITUDINAL STUDY 5224 03:02:28,815 --> 03:02:31,684 OF AGE, CONDUCTED OUT OF THE NIA 5225 03:02:31,684 --> 03:02:32,885 INTRAMURAL RESEARCH PROGRAM AND 5226 03:02:32,885 --> 03:02:35,288 ONE OF THE LONGEST RUNNING AGING 5227 03:02:35,288 --> 03:02:37,056 COHORT STUDIES IN THE UNITED 5228 03:02:37,056 --> 03:02:38,758 STATES, STARTED BACK IN THE 5229 03:02:38,758 --> 03:02:40,226 40s OR 50s I BELIEVE. 5230 03:02:40,226 --> 03:02:44,063 WHAT WE DID WAS LOOKED AT 5231 03:02:44,063 --> 03:02:45,898 HISTORY OF INFECTION IN RELATION 5232 03:02:45,898 --> 03:02:48,434 TO BRAIN VOLUME LOSS BECAUSE WE 5233 03:02:48,434 --> 03:02:50,536 HAVE QUITE A BIT OF BRAIN VOLUME 5234 03:02:50,536 --> 03:02:53,139 DATA AND COGNITIVE DATA. 5235 03:02:53,139 --> 03:02:54,774 WHAT WE FOUND WAS THAT PEOPLE 5236 03:02:54,774 --> 03:02:58,377 WITH HISTORY OF CERTAIN SET OF 5237 03:02:58,377 --> 03:03:00,146 INFECTIONS TEND TO SHOW GREATER 5238 03:03:00,146 --> 03:03:03,216 BRAIN ATROPHY IN SUBSEQUENT 5239 03:03:03,216 --> 03:03:03,683 YEARS. 5240 03:03:03,683 --> 03:03:06,385 SO RESULTS FROM INFLUENZA, SKIN 5241 03:03:06,385 --> 03:03:10,123 INFECTION, TWO OF SEVERAL TYPES 5242 03:03:10,123 --> 03:03:13,392 WE LOOKED AT. 5243 03:03:13,392 --> 03:03:16,996 WITH INFLUENZA THOSE INDIVIDUALS 5244 03:03:16,996 --> 03:03:19,665 DO SHOW GREATER VOLUME LOSS IN 5245 03:03:19,665 --> 03:03:20,967 TEMPORAL REGIONS AND OCCIPITAL 5246 03:03:20,967 --> 03:03:21,267 REGIONS. 5247 03:03:21,267 --> 03:03:22,401 THOSE WITH HISTORY OF SKIN 5248 03:03:22,401 --> 03:03:24,837 INFECTIONS TEND TO HAVE GREATER 5249 03:03:24,837 --> 03:03:26,439 VOLUME LOSS IN TOTAL BRAIN 5250 03:03:26,439 --> 03:03:27,874 VOLUME AND TOTAL GRAY MATTER. 5251 03:03:27,874 --> 03:03:31,077 OVERALL YOU SEE THE TREND ACROSS 5252 03:03:31,077 --> 03:03:32,812 VARIOUS BRAIN REGIONS FOR 5253 03:03:32,812 --> 03:03:34,780 DECREMENT AND VOLUME WITH TIME 5254 03:03:34,780 --> 03:03:35,148 POST-INFECTION. 5255 03:03:35,148 --> 03:03:38,317 THIS CAN BE MANY YEARS 5256 03:03:38,317 --> 03:03:39,485 POST-INFECTION. 5257 03:03:39,485 --> 03:03:41,721 THE AVERAGE DURATION BETWEEN THE 5258 03:03:41,721 --> 03:03:42,688 ASCERTAINMENT OF INFECTION AND 5259 03:03:42,688 --> 03:03:44,657 WHEN WE STARTED LOOKING AT BRAIN 5260 03:03:44,657 --> 03:03:46,726 VOLUME LOSS ON MRI WAS OVER TEN 5261 03:03:46,726 --> 03:03:46,959 YEARS. 5262 03:03:46,959 --> 03:03:49,695 SO THESE ARE REMOTE INFECTIONS. 5263 03:03:49,695 --> 03:03:52,431 THESE ARE INFECTIONS SEVERE 5264 03:03:52,431 --> 03:03:57,270 ENOUGH TO BE CLASSIFIED IN ICD-9 5265 03:03:57,270 --> 03:03:58,905 CODES, IMPORTANT CAVEAT. 5266 03:03:58,905 --> 03:04:00,773 THIS HAS EXPANDED BEYOND SKIN 5267 03:04:00,773 --> 03:04:01,107 INFECTIONS. 5268 03:04:01,107 --> 03:04:03,176 HERE ARE A NUMBER OF OTHER -- WE 5269 03:04:03,176 --> 03:04:06,779 LOOKED AT 15 IN TOTAL, AT LEAST 5270 03:04:06,779 --> 03:04:08,214 SIX SHOWED ASSOCIATION WITH 5271 03:04:08,214 --> 03:04:11,150 SUBSEQUENT BRAIN VOLUME LOSS. 5272 03:04:11,150 --> 03:04:13,152 INCLUDING HERPES VIRUS, VIRAL 5273 03:04:13,152 --> 03:04:14,587 INFECTIONS, UPPER AND LOWER 5274 03:04:14,587 --> 03:04:15,788 RESPIRATORY TRACT INFECTIONS. 5275 03:04:15,788 --> 03:04:18,424 SO, WE TOOK THESE SIX INFECTIONS 5276 03:04:18,424 --> 03:04:20,159 AFTER SHOWING ASSOCIATION WITH 5277 03:04:20,159 --> 03:04:21,460 VOLUME LOSS, AND THEN WE ASKED 5278 03:04:21,460 --> 03:04:25,198 WHETHER OR NOT THEY WERE 5279 03:04:25,198 --> 03:04:26,732 ASSOCIATED WITH SUBSEQUENT 5280 03:04:26,732 --> 03:04:27,099 DEMENTIA. 5281 03:04:27,099 --> 03:04:30,002 THE EXPRESSION OR END STAGE OF 5282 03:04:30,002 --> 03:04:30,870 VOLUME LOSS. 5283 03:04:30,870 --> 03:04:34,373 WE DID THIS IN A LARGER COHORT. 5284 03:04:34,373 --> 03:04:38,411 WE WORKED WITH THE U.K. BIOBANK, 5285 03:04:38,411 --> 03:04:39,312 MULTI-COHORT CONSORTIA IN 5286 03:04:39,312 --> 03:04:44,217 FINLAND, WERE ABLE TO USE ICD-9 5287 03:04:44,217 --> 03:04:46,085 AND ICD-10 CODE TO RELATE 5288 03:04:46,085 --> 03:04:49,088 INFECTION GROUPINGS TO DEMENTIA 5289 03:04:49,088 --> 03:04:52,225 RISK OVER SUBSEQUENT 10 TO 15 5290 03:04:52,225 --> 03:04:53,859 YEARS AND SAW INFLUENZA AND ALL 5291 03:04:53,859 --> 03:04:56,495 BUT ONE ASSOCIATED WITH 5292 03:04:56,495 --> 03:04:58,764 INCREASED RISK FOR ALL-CAUSE 5293 03:04:58,764 --> 03:05:01,934 DEMENTIA IN THE SUBSEQUENT U.K. 5294 03:05:01,934 --> 03:05:04,437 BIOBANK, 16 YEARS OF FOLLOW-UP. 5295 03:05:04,437 --> 03:05:06,572 WE WERE ABLE TO LOOK AT 5296 03:05:06,572 --> 03:05:08,074 ALZHEIMER'S DISEASE AND VASCULAR 5297 03:05:08,074 --> 03:05:10,443 DEMENTIA SPECIFICALLY, AND IN 5298 03:05:10,443 --> 03:05:12,778 SOME CASES SOME INFECTIONS 5299 03:05:12,778 --> 03:05:15,181 ACTUALLY SHOWED GREATER OR WERE 5300 03:05:15,181 --> 03:05:20,920 SOME GREATER RISK FACTORS FOR 5301 03:05:20,920 --> 03:05:22,321 VASCULAR DEPARTMENT THAN 5302 03:05:22,321 --> 03:05:23,656 ALZHEIMER'S, WHICH WAS 5303 03:05:23,656 --> 03:05:24,957 INTERESTING. 5304 03:05:24,957 --> 03:05:32,298 WE SAW SOMETHING SIMILAR IN THE 5305 03:05:32,298 --> 03:05:32,898 FINNISH MULTI-COHORT, EFFECTS 5306 03:05:32,898 --> 03:05:34,700 ATTENUATED, WORKING WITH HALF A 5307 03:05:34,700 --> 03:05:36,569 SAMPLE SIZE AS WELL. 5308 03:05:36,569 --> 03:05:38,004 AFTER ESTABLISHING THIS SET OF 5309 03:05:38,004 --> 03:05:39,105 SIX INFECTIONS IS ASSOCIATED 5310 03:05:39,105 --> 03:05:44,143 WITH VOLUME LOSS AND DEMENTIA 5311 03:05:44,143 --> 03:05:46,779 RISK, WE TO CHARACTERIZE THE 5312 03:05:46,779 --> 03:05:47,947 PROTEOMIC SIGNATURE THAT 5313 03:05:47,947 --> 03:05:50,750 UNDERLIES THESE INFECTIONS. 5314 03:05:50,750 --> 03:05:58,491 WE USED A PLATFORM CALLED 5315 03:05:58,491 --> 03:06:00,426 SOMASCAN, 7,000 PROTEINS, IN THE 5316 03:06:00,426 --> 03:06:02,895 BALTIMORE LONGITUDINAL STUDY OF 5317 03:06:02,895 --> 03:06:03,095 AGING. 5318 03:06:03,095 --> 03:06:06,032 OF THE 7,000 PROTEINS WE FOUND 5319 03:06:06,032 --> 03:06:08,200 900 WERE IMMUNE RELATED. 5320 03:06:08,200 --> 03:06:10,403 WE FOCUSED ON THESE 900 IMMUNE 5321 03:06:10,403 --> 03:06:11,504 PROTEINS AND FOUND THAT PEOPLE 5322 03:06:11,504 --> 03:06:13,973 WITH HISTORY OF THE INFECTIONS 5323 03:06:13,973 --> 03:06:17,510 THAT WE HAD BEEN FOCUSING ON DID 5324 03:06:17,510 --> 03:06:19,245 HAVE THIS DIFFERENTIAL 5325 03:06:19,245 --> 03:06:21,714 EXPRESSION IN THEIR BLOOD 5326 03:06:21,714 --> 03:06:22,114 PROTEOME. 5327 03:06:22,114 --> 03:06:25,418 WHAT'S HIGHLIGHTED HERE ARE A 5328 03:06:25,418 --> 03:06:27,486 SET OF PROTEINS DIFFERENTIALLY 5329 03:06:27,486 --> 03:06:31,023 EXPRESSED, THOSE WITH REMOTE 5330 03:06:31,023 --> 03:06:33,759 HISTORY OF SKIN INFECTION ON THE 5331 03:06:33,759 --> 03:06:36,429 RIGHT, YOU MIGHT RECOGNIZE THE 5332 03:06:36,429 --> 03:06:38,764 PROTEINS, SOME HAVE ALREADY BEEN 5333 03:06:38,764 --> 03:06:42,935 IMPLICATED IN DEMENTIA 5334 03:06:42,935 --> 03:06:44,070 PREVIOUSLY. 5335 03:06:44,070 --> 03:06:46,339 WE SEE ApoE TREND HERE 5336 03:06:46,339 --> 03:06:50,276 SOMEWHERE, AND WE DID THIS FOR 5337 03:06:50,276 --> 03:06:51,811 BROADER SET OF INFECTIONS AND 5338 03:06:51,811 --> 03:06:59,018 SAW FOR EACH THERE WAS PROTEOMIC 5339 03:06:59,018 --> 03:07:00,186 SIGNATURE, SOME DEGREE OF 5340 03:07:00,186 --> 03:07:02,088 OVERLAP BUT A LOT OF 5341 03:07:02,088 --> 03:07:03,422 INFECTION-SPECIFIC PROTEINS AS 5342 03:07:03,422 --> 03:07:03,956 WELL. 5343 03:07:03,956 --> 03:07:07,360 A LOT OF UNIQUENESS THERE. 5344 03:07:07,360 --> 03:07:08,127 AND DUPLICATES ARE HIGHLIGHTED 5345 03:07:08,127 --> 03:07:14,133 IN THE HEAT MAP ON THE RIGHT. 5346 03:07:14,133 --> 03:07:14,667 AFTER ESTABLISHING 5347 03:07:14,667 --> 03:07:16,869 INFECTION-RELATED PROTEINS SET 5348 03:07:16,869 --> 03:07:19,805 OUT TO FIND MOLECULAR MEDIATORS. 5349 03:07:19,805 --> 03:07:21,173 SO THEY HAD TO MEET CRITERIA. 5350 03:07:21,173 --> 03:07:24,643 ONE WAS THEY HAD TO BE 5351 03:07:24,643 --> 03:07:25,144 DIFFERENTIALLY EXPRESSED 5352 03:07:25,144 --> 03:07:25,578 POST-INFECTION. 5353 03:07:25,578 --> 03:07:28,347 SECOND WAS THEY HAD TO BE 5354 03:07:28,347 --> 03:07:29,648 PREDICTIVE OR ASSOCIATED WITH 5355 03:07:29,648 --> 03:07:31,550 SUBSEQUENT BRAIN VOLUME LOSS OR 5356 03:07:31,550 --> 03:07:34,954 BRAIN ATROPHY. 5357 03:07:34,954 --> 03:07:38,124 SO, WE THOUGHT THAT THIS -- IF 5358 03:07:38,124 --> 03:07:39,992 THEY MET THE CRITERIA THEY WERE 5359 03:07:39,992 --> 03:07:41,961 POTENTIAL CANDIDATES FOR BEING 5360 03:07:41,961 --> 03:07:43,262 INTERMEDIARIES BETWEEN INFECTION 5361 03:07:43,262 --> 03:07:44,797 AND BRAIN VOLUME LOSS AND 5362 03:07:44,797 --> 03:07:47,867 SUBSEQUENT DEMENTIA RISK. 5363 03:07:47,867 --> 03:07:55,007 SO WE THEN RELATED PROTEINS TO 5364 03:07:55,007 --> 03:07:55,975 MOLECULAR MEASURES OF 5365 03:07:55,975 --> 03:07:57,076 ALZHEIMER'S AND DEGENERATION. 5366 03:07:57,076 --> 03:07:59,812 WE'LL GO BACK TO INFLUENZA AS AN 5367 03:07:59,812 --> 03:08:00,679 EXAMPLE. 5368 03:08:00,679 --> 03:08:03,549 SO WHAT YOU'RE SEEING IN THE 5369 03:08:03,549 --> 03:08:06,819 PLOT, TOP RIGHT, ARE THE VARIOUS 5370 03:08:06,819 --> 03:08:09,889 PROTEINS, WHAT WE'RE CALLING 5371 03:08:09,889 --> 03:08:10,423 CANDIDATE PROTEINS BOTH 5372 03:08:10,423 --> 03:08:12,525 ASSOCIATED WITH HISTORY OF 5373 03:08:12,525 --> 03:08:14,727 INFECTION AND WITH SUBSEQUENT 5374 03:08:14,727 --> 03:08:18,330 BRAIN VOLUME CHANGES. 5375 03:08:18,330 --> 03:08:21,167 SO TOP LEFT ARE PATHOGENIC 5376 03:08:21,167 --> 03:08:22,835 PROTEINS, UPREGULATED IN PEOPLE 5377 03:08:22,835 --> 03:08:24,470 WITH HISTORY OF INFLUENZA AND 5378 03:08:24,470 --> 03:08:27,173 ASSOCIATED WITH FUTURE BRAIN 5379 03:08:27,173 --> 03:08:28,841 VOLUME LOSS. 5380 03:08:28,841 --> 03:08:32,678 BOTTOM RIGHT PROTECTIVE PROTEINS 5381 03:08:32,678 --> 03:08:35,514 DO YOU REGULATED POST-INFLUENZA 5382 03:08:35,514 --> 03:08:36,415 AND THEMSELVES ASSOCIATED WITH 5383 03:08:36,415 --> 03:08:38,884 STABLE BRAIN VOLUME OVER TIME 5384 03:08:38,884 --> 03:08:43,722 AND TOOK PROTEINS FROM BOTH 5385 03:08:43,722 --> 03:08:45,124 QUADRANTS, AND LOOKED AT 5386 03:08:45,124 --> 03:08:49,495 RELATIONSHIP TO MOLECULAR 5387 03:08:49,495 --> 03:08:54,700 MEASURES OF ALZHEIMER'S DISEASE. 5388 03:08:54,700 --> 03:08:58,471 AND NON-SPECIFIC MEASURES AS 5389 03:08:58,471 --> 03:08:58,737 WELL. 5390 03:08:58,737 --> 03:09:01,140 THE PROTECTIVE PROTEINS ACTUALLY 5391 03:09:01,140 --> 03:09:02,641 DOWNREGULATED POST-INFECTION AND 5392 03:09:02,641 --> 03:09:04,577 BUT THEMSELVES SEEMED TO BE 5393 03:09:04,577 --> 03:09:06,545 ASSOCIATED WITH STABLE BRAIN 5394 03:09:06,545 --> 03:09:08,314 VOLUME ACTUALLY SHOWED STRONG 5395 03:09:08,314 --> 03:09:09,815 RELATIONSHIPS WITH BOTH 5396 03:09:09,815 --> 03:09:10,916 ALZHEIMER'S DISEASE SPECIFIC 5397 03:09:10,916 --> 03:09:16,155 MARKERS WHERE WE HAVE PROTECTIVE 5398 03:09:16,155 --> 03:09:19,558 PROTEINS ASSOCIATED WITH LOWER 5399 03:09:19,558 --> 03:09:26,232 P-TAU AND IN PLASMA SUGGESTIVE 5400 03:09:26,232 --> 03:09:28,868 OF LOWER CORTICAL AMYLOID. 5401 03:09:28,868 --> 03:09:29,702 PATHOGENIC SIDE NOT AS 5402 03:09:29,702 --> 03:09:31,470 CONSISTENT IN TERMS OF 5403 03:09:31,470 --> 03:09:32,571 RELATIONSHIP WITH MOLECULAR 5404 03:09:32,571 --> 03:09:32,805 CHANGES. 5405 03:09:32,805 --> 03:09:35,207 AND THAT WAS THE SAME FOR SKIN 5406 03:09:35,207 --> 03:09:39,912 INFECTION WHERE WE SEE MUCH MORE 5407 03:09:39,912 --> 03:09:41,680 CANDIDATES BUT TWO PATHOGENIC 5408 03:09:41,680 --> 03:09:43,983 AND ONE PROTECTIVE PROTEIN. 5409 03:09:43,983 --> 03:09:45,784 WE SEE INTERESTING DISCORDANCE 5410 03:09:45,784 --> 03:09:48,020 INCLUDING FOR IL-18 YEAR WHERE 5411 03:09:48,020 --> 03:09:50,523 IT'S ASSOCIATED WITH HISTORY OF 5412 03:09:50,523 --> 03:09:52,725 INFECTION BUT ALSO AT THE SAME 5413 03:09:52,725 --> 03:09:54,159 TIME ASSOCIATED WITH STABLE 5414 03:09:54,159 --> 03:09:55,027 BRAIN VOLUME OVER TIME. 5415 03:09:55,027 --> 03:09:59,965 DIDN'T KNOW WHAT TO MAKE OF 5416 03:09:59,965 --> 03:10:05,137 THOSE TWO IN THE DIAGONAL. 5417 03:10:05,137 --> 03:10:06,539 YES, THIS PARADIGM WAS APPLIED 5418 03:10:06,539 --> 03:10:08,941 TO EACH OF OUR INFECTIONS. 5419 03:10:08,941 --> 03:10:10,576 AND ONCE WE HAD A FULL SET OF 5420 03:10:10,576 --> 03:10:13,646 CANDIDATE PROTEINS WERE ABLE TO 5421 03:10:13,646 --> 03:10:17,816 APPLY TECHNIQUE CALLED TWO 5422 03:10:17,816 --> 03:10:18,484 SAMPLE MENDELIAN RANDOMIZATION, 5423 03:10:18,484 --> 03:10:19,685 TRYING TO ADDRESS THE CAUSAL 5424 03:10:19,685 --> 03:10:22,721 QUESTION WHETHER OR NOT THE 5425 03:10:22,721 --> 03:10:24,423 PROTEINS ARE MECHANISTICALLY 5426 03:10:24,423 --> 03:10:25,457 RELEVANT IN BRAIN ATROPHY. 5427 03:10:25,457 --> 03:10:27,860 SO WE WERE ABLE TO REALLY USE 5428 03:10:27,860 --> 03:10:32,898 OBSERVATIONAL DATA AND LOOK AT 5429 03:10:32,898 --> 03:10:35,334 THE GENETIC OVERLAP LIKE CODING 5430 03:10:35,334 --> 03:10:37,736 EXPRESSION AND VARIANTS THAT 5431 03:10:37,736 --> 03:10:40,139 INCREASED RISK FOR BRAIN ATROPHY 5432 03:10:40,139 --> 03:10:42,308 AND BASED ON THAT OVERLAP WERE 5433 03:10:42,308 --> 03:10:45,945 ABLE TO INFER THESE CAUSAL LINKS 5434 03:10:45,945 --> 03:10:47,012 BETWEEN SEVERAL PROTEINS AND 5435 03:10:47,012 --> 03:10:49,415 BRAIN ATROPHY THAT WE THINK 5436 03:10:49,415 --> 03:10:51,517 UNDERLIES DEMENTIA RISK. 5437 03:10:51,517 --> 03:10:52,618 ESPECIALLY FOR SKIN SUBCUTANEOUS 5438 03:10:52,618 --> 03:10:55,354 AND INFLUENZA PROTEINS WHERE WE 5439 03:10:55,354 --> 03:10:58,424 SAW EVIDENCE OF CAUSALITY AND 5440 03:10:58,424 --> 03:11:01,126 FOR A NUMBER DIDN'T SEE 5441 03:11:01,126 --> 03:11:01,393 EVIDENCE. 5442 03:11:01,393 --> 03:11:05,331 THEY MAY JUST BE ASSOCIATIVE OR 5443 03:11:05,331 --> 03:11:07,499 REPRESENT BIOMARKERS RATHER THAN 5444 03:11:07,499 --> 03:11:07,933 MECHANISTIC TARGETS. 5445 03:11:07,933 --> 03:11:08,801 WE PULL THIS TOGETHER. 5446 03:11:08,801 --> 03:11:10,469 WE HAVE A NUMBER OF CANDIDATE 5447 03:11:10,469 --> 03:11:12,004 PROTEINS THAT ARE BOTH 5448 03:11:12,004 --> 03:11:14,940 ASSOCIATED WITH HISTORY OF 5449 03:11:14,940 --> 03:11:15,908 CERTAIN INFECTIONS AND 5450 03:11:15,908 --> 03:11:16,909 PREDICTIVE OF FUTURE BRAIN 5451 03:11:16,909 --> 03:11:18,243 VOLUME LOSS AND COULD PUT IT 5452 03:11:18,243 --> 03:11:21,947 TOGETHER IN THIS SORT OF PATHWAY 5453 03:11:21,947 --> 03:11:23,916 WHERE WE HAVE INFECTION LEADING 5454 03:11:23,916 --> 03:11:25,684 TO UPREGULATION OF PATHOGENIC 5455 03:11:25,684 --> 03:11:28,153 PROTEINS AND DOWNREGULATION OF 5456 03:11:28,153 --> 03:11:28,721 PROTECTIVE PROTEINS. 5457 03:11:28,721 --> 03:11:31,557 WE SAW STRONG EVIDENCE HERE FOR 5458 03:11:31,557 --> 03:11:32,224 THIS DOWNREGULATION AND 5459 03:11:32,224 --> 03:11:33,626 PROTECTIVE PROTEINS BEING 5460 03:11:33,626 --> 03:11:35,728 ASSOCIATED WITH GREATER AMYLOID 5461 03:11:35,728 --> 03:11:37,796 AND TAU, ALZHEIMER'S DISEASE 5462 03:11:37,796 --> 03:11:38,664 HALLMARKS, AND KNOW 5463 03:11:38,664 --> 03:11:39,865 DOWNREGULATION AND PROTECTIVE 5464 03:11:39,865 --> 03:11:44,436 PROTEINS IS ALSO ASSOCIATED WITH 5465 03:11:44,436 --> 03:11:45,371 ATROPHY. 5466 03:11:45,371 --> 03:11:46,438 PATHOGENIC PROTEINS, LESS CLEAR, 5467 03:11:46,438 --> 03:11:47,640 ASSOCIATED WITH BRAIN ACTIVITY 5468 03:11:47,640 --> 03:11:50,042 WHEN HIGHER BUT DOESN'T SEEM TO 5469 03:11:50,042 --> 03:11:50,743 BE THROUGH ALZHEIMER'S-SPECIFIC 5470 03:11:50,743 --> 03:11:52,911 PATHWAY BECAUSE WE DIDN'T SEE 5471 03:11:52,911 --> 03:11:55,314 ANY CONSISTENT RELATIONSHIP WITH 5472 03:11:55,314 --> 03:11:57,716 AMYLOID OR P TAU. 5473 03:11:57,716 --> 03:11:59,284 GOING BACK TO WHERE WE STARTED 5474 03:11:59,284 --> 03:12:02,755 WE HAVE A SET OF PROTEINS IN RED 5475 03:12:02,755 --> 03:12:06,125 HERE THAT WERE IDENTIFIED AS 5476 03:12:06,125 --> 03:12:11,063 POTENTIALLY CAUSAL AND, WELL, 5477 03:12:11,063 --> 03:12:11,597 MECHANISTIC MEDIATORS IN 5478 03:12:11,597 --> 03:12:14,600 INFECTION TO DEMENTIA INCLUDING 5479 03:12:14,600 --> 03:12:15,501 CYTOKINES, PATTERN RECOGNITION 5480 03:12:15,501 --> 03:12:17,569 RECEPTORS, CHEMOKINES AS WELL. 5481 03:12:17,569 --> 03:12:18,971 BUT WE'RE FOLLOWING UP WITH 5482 03:12:18,971 --> 03:12:20,939 THESE SPECIFIC PROTEINS TO TRY 5483 03:12:20,939 --> 03:12:22,775 TO REALLY UNDERSTAND WHAT THEY 5484 03:12:22,775 --> 03:12:33,185 MAY BE DOING TO THE CNS. 5485 03:12:34,820 --> 03:12:35,287 THERE'S ONE ALTERNATIVE 5486 03:12:35,287 --> 03:12:37,589 HYPOTHESIS THAT WE HAVE. 5487 03:12:37,589 --> 03:12:40,225 THIS WAS PROMPTED BY WHAT WE SAW 5488 03:12:40,225 --> 03:12:41,226 WITH PROTECTIVE PROTEINS BUT 5489 03:12:41,226 --> 03:12:43,495 THINK IT'S ALSO POSSIBLE THAT 5490 03:12:43,495 --> 03:12:44,830 THERE'S AN IMMUNE TRAIT THAT MIX 5491 03:12:44,830 --> 03:12:46,799 ONE MORE SUSCEPTIBLE TO 5492 03:12:46,799 --> 03:12:48,867 INFECTION AND MORE SUSCEPTIBLE 5493 03:12:48,867 --> 03:12:50,536 TO DEMENTIA. 5494 03:12:50,536 --> 03:12:52,771 AND THAT THE PROTEIN SIGNATURE 5495 03:12:52,771 --> 03:12:54,907 WE SEE IS AN EXPRESSION OF THAT 5496 03:12:54,907 --> 03:12:57,976 IMMUNE TRAIT SO YOU CAN IMAGINE, 5497 03:12:57,976 --> 03:13:00,045 YOU KNOW, SOMEONE WHOSE 5498 03:13:00,045 --> 03:13:02,548 MACROPHAGE MAYBE AREN'T AS 5499 03:13:02,548 --> 03:13:06,552 EFFECTIVE ALSO THE SAME PERSON 5500 03:13:06,552 --> 03:13:16,862 WHOSE MICROGLIA ARE LESS 5501 03:13:16,862 --> 03:13:20,432 SUSCEPTIBLE TO AMYLOID PLAQUES, 5502 03:13:20,432 --> 03:13:22,901 BOTH COULD BE POTENTIAL 5503 03:13:22,901 --> 03:13:23,435 EXPLANATIONS. 5504 03:13:23,435 --> 03:13:25,170 THANK YOU FOR LISTENING. 5505 03:13:25,170 --> 03:13:27,806 I WANT TO THANK -- SPECIAL 5506 03:13:27,806 --> 03:13:31,443 THANKS TO MICHAEL DUGGAN WHO LED 5507 03:13:31,443 --> 03:13:32,211 THIS HERCULEAN UNDERTAKING AND 5508 03:13:32,211 --> 03:13:39,017 THE REST OF THE COLLABORATORS AT 5509 03:13:39,017 --> 03:13:42,755 MY LAB, AND OF COURSE THE 5510 03:13:42,755 --> 03:13:44,490 FUNDING AND FOLKS AT NIA, GREAT 5511 03:13:44,490 --> 03:13:45,124 MENTORS AND COLLEAGUES. 5512 03:13:45,124 --> 03:13:46,024 THANK YOU. 5513 03:13:46,024 --> 03:13:48,260 I'M HAPPY TO TAKE QUESTIONS IF 5514 03:13:48,260 --> 03:13:49,628 THERE'S TIME. 5515 03:13:49,628 --> 03:13:49,962 >> THERE IS. 5516 03:13:49,962 --> 03:13:50,829 GREAT, THANK YOU. 5517 03:13:50,829 --> 03:13:54,967 IF WE COULD PULL UP THE FULL 5518 03:13:54,967 --> 03:13:56,835 GROUP OF FOLKS ON THE SCREEN. 5519 03:13:56,835 --> 03:14:01,340 YES, RUSS, LET'S START WITH YOU. 5520 03:14:01,340 --> 03:14:02,775 >> DR. WALKER, WONDERFUL 5521 03:14:02,775 --> 03:14:04,276 PRESENTATION, OBVIOUSLY HUGE 5522 03:14:04,276 --> 03:14:06,478 PUBLIC HEALTH PROBLEM AND 5523 03:14:06,478 --> 03:14:07,679 DISEASE WHERE WE HAVE SOME 5524 03:14:07,679 --> 03:14:11,316 PATHOLOGIC CLUES BUT NOT A LOT 5525 03:14:11,316 --> 03:14:12,484 OF MECHANISTIC CLUES, INTRIGUING 5526 03:14:12,484 --> 03:14:13,719 HYPOTHESIS. 5527 03:14:13,719 --> 03:14:14,553 TWO QUESTIONS. 5528 03:14:14,553 --> 03:14:19,625 ONE IS ONE OF THE CHALLENGES 5529 03:14:19,625 --> 03:14:21,627 WITH BIG DATA LIKE LONGITUDINAL 5530 03:14:21,627 --> 03:14:24,997 STUDY AT HOPKINS IS SPECIFICS TO 5531 03:14:24,997 --> 03:14:26,732 THAT STUDY POPULATION AND HOW 5532 03:14:26,732 --> 03:14:31,436 EASILY THESE FINDINGS CAN BE 5533 03:14:31,436 --> 03:14:31,937 TRANSLATED ACROSS OTHER 5534 03:14:31,937 --> 03:14:32,437 POPULATIONS. 5535 03:14:32,437 --> 03:14:34,706 U.K. BIOBANK IS A USEFUL 5536 03:14:34,706 --> 03:14:35,607 RESOURCE BUT HAS LIMITATIONS IN 5537 03:14:35,607 --> 03:14:37,776 TERMS OF QUALITY OF DATA AND 5538 03:14:37,776 --> 03:14:39,111 OBVIOUSLY THAT'S A DIFFERENT 5539 03:14:39,111 --> 03:14:40,412 POPULATION AS WELL. 5540 03:14:40,412 --> 03:14:44,883 HAVE YOU LOOKED AT, FOR EXAMPLE, 5541 03:14:44,883 --> 03:14:47,019 OTHER NIH-FUNDED CONSORTIA, I'M 5542 03:14:47,019 --> 03:14:48,120 THINKING SPECIFICALLY OF ADULT 5543 03:14:48,120 --> 03:14:51,824 CHANGES IN THOUGHT STUDY, WHICH 5544 03:14:51,824 --> 03:14:52,591 IS LONGITUDINAL PROSPECTIVE 5545 03:14:52,591 --> 03:14:53,692 STUDY OF PEOPLE WHO DEVELOP 5546 03:14:53,692 --> 03:14:56,461 DEMENTIA TO SEE WHETHER YOUR 5547 03:14:56,461 --> 03:14:58,297 RESULTS ON PRIOR INFECTION 5548 03:14:58,297 --> 03:14:58,697 REPLICATE THERE? 5549 03:14:58,697 --> 03:15:01,800 >> WE HAVEN'T LOOKED AT THAT 5550 03:15:01,800 --> 03:15:03,202 STUDY SPECIFICALLY BUT WORK 5551 03:15:03,202 --> 03:15:04,636 ACROSS COHORTS QUITE OFTEN. 5552 03:15:04,636 --> 03:15:06,371 IT'S ALMOST, YOU KNOW, THE RULE 5553 03:15:06,371 --> 03:15:09,541 RATHER THAN THE EXCEPTION. 5554 03:15:09,541 --> 03:15:14,246 ACTUALLY OUR USE OF PROTEOMICS 5555 03:15:14,246 --> 03:15:16,215 AND THE COHORT ADAPTION HAS MADE 5556 03:15:16,215 --> 03:15:17,316 IT EASY. 5557 03:15:17,316 --> 03:15:19,284 WE FIND A PROTEIN WE THINK IS 5558 03:15:19,284 --> 03:15:20,986 RELATED IN ONE COHORT AND A LOT 5559 03:15:20,986 --> 03:15:31,096 OF COHORTS HAVE THE SAME EXACT 5560 03:15:31,096 --> 03:15:34,366 PROTEOMIC PLATFORM, WE HAVE 5561 03:15:34,366 --> 03:15:35,701 REPLICATED INFECTION ASSOCIATION 5562 03:15:35,701 --> 03:15:46,078 WITH DEMENTIA IN THE U.K. 5563 03:15:46,078 --> 03:15:48,280 BIOBANK, BUT, YEAH, IT'S A GREAT 5564 03:15:48,280 --> 03:15:49,615 POINT. 5565 03:15:49,615 --> 03:15:52,351 U.K. BIOBANK IS MASSIVE AND 5566 03:15:52,351 --> 03:15:53,418 EXTREMELY HELPFUL. 5567 03:15:53,418 --> 03:15:55,954 BUT I THINK GENERALIZABILITY IS 5568 03:15:55,954 --> 03:15:57,623 ALWAYS A QUESTION. 5569 03:15:57,623 --> 03:15:58,790 >> YEAH, I THINK THE BROADER 5570 03:15:58,790 --> 03:16:01,326 CONCERN FOR THIS GROUP IS WHERE 5571 03:16:01,326 --> 03:16:03,829 YOU DO HAVE SO MUCH EMPHASIS 5572 03:16:03,829 --> 03:16:05,697 WITH CONGRESSIONAL EARMARKS FOR 5573 03:16:05,697 --> 03:16:07,499 ALZHEIMER'S RESEARCH AND SUCH A 5574 03:16:07,499 --> 03:16:08,533 RICH RESEARCH ENVIRONMENT, THERE 5575 03:16:08,533 --> 03:16:12,938 ARE A LOT OF OPPORTUNITIES FOR 5576 03:16:12,938 --> 03:16:14,373 REPLICATION AND CONFIRMATION AND 5577 03:16:14,373 --> 03:16:16,308 SYNERGY WHICH I DON'T SENSE ARE 5578 03:16:16,308 --> 03:16:19,311 FULLY MINED AT THIS POINT. 5579 03:16:19,311 --> 03:16:20,279 SOMETIMES THERE'S NOT EVEN 5580 03:16:20,279 --> 03:16:21,246 RECOGNITION OF WHAT'S OUT THERE 5581 03:16:21,246 --> 03:16:24,549 IN TERMS OF OTHER DATASETS AND I 5582 03:16:24,549 --> 03:16:26,752 WONDER IF THAT'S SOMETHING THERE 5583 03:16:26,752 --> 03:16:28,253 WOULD BE A MECHANISM FOR 5584 03:16:28,253 --> 03:16:29,454 IMPROVING IN THE FUTURE SO THAT 5585 03:16:29,454 --> 03:16:31,657 WHEN YOU HAVE A FINDING LIKE 5586 03:16:31,657 --> 03:16:34,293 PRIOR INFECTION INCREASES RISK 5587 03:16:34,293 --> 03:16:37,462 YOU CAN REVALIDATE WITH 5588 03:16:37,462 --> 03:16:43,135 NIH-GENERATED DATA RAPIDLY. 5589 03:16:43,135 --> 03:16:45,337 >> YEAH, THERE DEFINITELY IS. 5590 03:16:45,337 --> 03:16:47,072 THERE'S CONSORTIA BUILT AROUND 5591 03:16:47,072 --> 03:16:49,942 FOLKS, YOU KNOW, COHORTS, 5592 03:16:49,942 --> 03:16:53,545 NIH-FUNDED AND OTHERWISE, WITH 5593 03:16:53,545 --> 03:16:54,646 PROTEOMIC DATA INTERESTED IN 5594 03:16:54,646 --> 03:16:55,847 AGE-RELATED OUTCOMES. 5595 03:16:55,847 --> 03:16:57,783 THERE'S ONE FUNDED BY, WELL, 5596 03:16:57,783 --> 03:17:01,653 BEING SPONSORED BY VARIOUS 5597 03:17:01,653 --> 03:17:03,956 ORGANIZATIONS BUT REALLY POOL IN 5598 03:17:03,956 --> 03:17:06,992 DATA FROM NIH-FUNDED STUDIES, 5599 03:17:06,992 --> 03:17:10,062 AND THEY WILL SOMETIMES EMBARGO 5600 03:17:10,062 --> 03:17:15,100 FOR A YEAR AND OPEN TO THE REST 5601 03:17:15,100 --> 03:17:17,302 OF THE COMMUNITY AND THE ARAC 5602 03:17:17,302 --> 03:17:20,372 STUDY, TWO STUDIES WITH A 5603 03:17:20,372 --> 03:17:21,573 SIZEABLE RULEIN, WE CONTRIBUTED 5604 03:17:21,573 --> 03:17:31,883 DATA BUT OFTEN WE FIND THE 5605 03:17:31,883 --> 03:17:35,620 DIRECT INVESTIGATOR TO 5606 03:17:35,620 --> 03:17:36,588 INVESTIGATOR RELATIONSHIP, 5607 03:17:36,588 --> 03:17:38,557 TAPPING THOSE, ACROSS COHORTS IN 5608 03:17:38,557 --> 03:17:39,224 WEEKS. 5609 03:17:39,224 --> 03:17:40,659 SO IT IS ESPECIALLY WHEN WE'RE 5610 03:17:40,659 --> 03:17:42,861 ALL TALKING ABOUT THE SAME 5611 03:17:42,861 --> 03:17:44,730 PREDICTORS, IT CAN HAPPEN 5612 03:17:44,730 --> 03:17:45,464 QUICKLY. 5613 03:17:45,464 --> 03:17:47,132 JOURNALS REQUIRE IT ESSENTIALLY, 5614 03:17:47,132 --> 03:17:49,334 THIS REPLICATION. 5615 03:17:49,334 --> 03:17:51,503 >> THE SECOND QUESTION IS THE 5616 03:17:51,503 --> 03:17:58,944 SAME ON A DIFFERENT AXIS, 5617 03:17:58,944 --> 03:18:00,579 TALKING ABOUT NEURODEGENERATION, 5618 03:18:00,579 --> 03:18:03,348 ALMOST SYNONYMOUS WITH AGE 5619 03:18:03,348 --> 03:18:05,317 RELATED DEMENTIA, BUT THERE'S 5620 03:18:05,317 --> 03:18:06,618 AGE RELATED MACULAR DEGENERATION 5621 03:18:06,618 --> 03:18:08,587 AND GLAUCOMA, CAN SUBSTANTIAL 5622 03:18:08,587 --> 03:18:09,988 PUBLIC HEALTH MORBIDITY. 5623 03:18:09,988 --> 03:18:12,958 DO YOUR FINDINGS HOLD UP WITH 5624 03:18:12,958 --> 03:18:15,460 OTHER NEURODEGENERATIVE DISEASES 5625 03:18:15,460 --> 03:18:16,728 THAN NON-DEMENTIA? 5626 03:18:16,728 --> 03:18:22,367 >> I HAVEN'T LOOKED, TO BE 5627 03:18:22,367 --> 03:18:23,902 HONEST. 5628 03:18:23,902 --> 03:18:29,608 I THINK -- THE FIRST WE'VE GONE 5629 03:18:29,608 --> 03:18:31,910 BEYOND TRADITIONAL CONDITIONS IS 5630 03:18:31,910 --> 03:18:32,644 MULTIPLE SCLEROSIS, MY LAB 5631 03:18:32,644 --> 03:18:33,879 DOESN'T FOCUS ON ANYTHING BELOW 5632 03:18:33,879 --> 03:18:38,483 THE NECK WHEN IT COMES TO 5633 03:18:38,483 --> 03:18:39,017 OUTCOMES. 5634 03:18:39,017 --> 03:18:40,218 >> EYES ARE STILL ABOVE THE 5635 03:18:40,218 --> 03:18:40,652 NECK. 5636 03:18:40,652 --> 03:18:42,854 I THINK THERE'S A GREAT 5637 03:18:42,854 --> 03:18:43,822 OPPORTUNITY THERE BECAUSE THESE 5638 03:18:43,822 --> 03:18:45,157 ARE, AGAIN, DATASETS THAT ARE 5639 03:18:45,157 --> 03:18:47,492 SORT OF SHOVEL READY TO ASK THE 5640 03:18:47,492 --> 03:18:50,162 QUESTION OF WHETHER THE SAME 5641 03:18:50,162 --> 03:18:53,932 RISK FACTORS AND EVEN PROTEOMIC 5642 03:18:53,932 --> 03:18:57,069 PROFILES ARE PREDICTIVE OF OTHER 5643 03:18:57,069 --> 03:18:58,270 NEURODEGENERAL DISEASES. 5644 03:18:58,270 --> 03:19:00,605 MACULAR DEGENERATION IS A HIGHER 5645 03:19:00,605 --> 03:19:02,240 PREDICTOR OF DEVELOPING DEMENTIA 5646 03:19:02,240 --> 03:19:08,180 THAN APO 4 ALLELE, SO THERE MAY 5647 03:19:08,180 --> 03:19:10,449 BE AN OPPORTUNITY TO EXTEND YOUR 5648 03:19:10,449 --> 03:19:13,518 STUDIES INTO A BROADER GROUP OF 5649 03:19:13,518 --> 03:19:14,686 DISEASES. 5650 03:19:14,686 --> 03:19:15,020 >> RIGHT. 5651 03:19:15,020 --> 03:19:17,589 NO, THAT'S AN IMPORTANT POINT. 5652 03:19:17,589 --> 03:19:17,889 >> GREAT. 5653 03:19:17,889 --> 03:19:21,193 THANK YOU VERY MUCH FOR THOSE 5654 03:19:21,193 --> 03:19:23,028 QUESTIONS. 5655 03:19:23,028 --> 03:19:25,464 LUCILA, YOU'RE NEXT PLEASE. 5656 03:19:25,464 --> 03:19:28,266 >> JUST BRIEFLY, I THINK YOU 5657 03:19:28,266 --> 03:19:29,601 COULD EXPLORE THE "ALL OF US" 5658 03:19:29,601 --> 03:19:36,741 PROGRAM DATA AS WELL AS THE 5659 03:19:36,741 --> 03:19:38,043 VETERANS PROGRAM, VETERANS AGING 5660 03:19:38,043 --> 03:19:43,315 COHORT AS WELL AT LEAST ON 5661 03:19:43,315 --> 03:19:44,416 ASSOCIATION AND MOST NOTABLY 5662 03:19:44,416 --> 03:19:47,018 BECAUSE DIVERSITY OF THOSE 5663 03:19:47,018 --> 03:19:50,422 COHORTS IS, YOU KNOW, SEVERAL 5664 03:19:50,422 --> 03:19:53,258 TIMES MORE THAN FINLAND OR U.K. 5665 03:19:53,258 --> 03:19:54,192 BIOBANK COHORTS SO WOULD BE 5666 03:19:54,192 --> 03:19:55,594 INTERESTING TO SEE. 5667 03:19:55,594 --> 03:19:58,330 >> YEAH, MILLION VETERANS, WE'RE 5668 03:19:58,330 --> 03:20:03,135 MAKING INROADS THERE WITH 5669 03:20:03,135 --> 03:20:05,237 COLLABORATOR, PARTICULARLY WITH 5670 03:20:05,237 --> 03:20:07,172 RESPECT TO VACCINATION AND 5671 03:20:07,172 --> 03:20:11,776 EFFECT ON DEMENTIA RISK, SO THAT 5672 03:20:11,776 --> 03:20:12,978 IS SOMETHING WE'RE PURSUING, 5673 03:20:12,978 --> 03:20:14,412 IT'S A RICH RESOURCE. 5674 03:20:14,412 --> 03:20:17,883 I WOULD LOVE TO GET MORE OUT OF 5675 03:20:17,883 --> 03:20:19,751 "ALL OF US" FOR THE QUESTIONS WE 5676 03:20:19,751 --> 03:20:21,219 ARE TRYING TO ADDRESS. 5677 03:20:21,219 --> 03:20:24,055 AND I THINK A LOT OF IT, I THINK 5678 03:20:24,055 --> 03:20:25,557 MAYBE SPECIFIC FOR OTHER 5679 03:20:25,557 --> 03:20:27,125 DEMENTIA RESEARCHERS, IT COMES 5680 03:20:27,125 --> 03:20:29,494 DOWN TO THE OUTCOME. 5681 03:20:29,494 --> 03:20:31,796 LIKE ONES LIKE DEMENTIA, THE 5682 03:20:31,796 --> 03:20:34,199 PHENOTYPE IS WELL ESTABLISHED, 5683 03:20:34,199 --> 03:20:35,634 AND VALIDATED, WHETHER THROUGH 5684 03:20:35,634 --> 03:20:38,570 MEDICAL RECORDS OR SOME OTHER 5685 03:20:38,570 --> 03:20:39,037 ADJUDICATION. 5686 03:20:39,037 --> 03:20:42,874 PEOPLE WILL USE THE HECK OUT OF 5687 03:20:42,874 --> 03:20:43,041 IT. 5688 03:20:43,041 --> 03:20:47,245 BUT UNTIL THAT GETS ESTABLISHED, 5689 03:20:47,245 --> 03:20:48,980 THERE'S PAPERS ON IT, THAT AT 5690 03:20:48,980 --> 03:20:50,315 LEAST FOR ME IS WHAT'S HOLDING 5691 03:20:50,315 --> 03:20:57,122 UP OUR USE OF THAT COHORT, 5692 03:20:57,122 --> 03:20:59,524 ADJUDICATING OUTCOMES WE'RE MOST 5693 03:20:59,524 --> 03:20:59,858 INTERESTED IN. 5694 03:20:59,858 --> 03:21:03,562 >> WELL, THANK YOU SO MUCH, DR. 5695 03:21:03,562 --> 03:21:03,795 WALKER. 5696 03:21:03,795 --> 03:21:04,396 HEY, ALSO, INCIDENTALLY, THANK 5697 03:21:04,396 --> 03:21:07,632 YOU SO MUCH FOR MAKING SUCH A 5698 03:21:07,632 --> 03:21:10,368 GREAT CASE FOR ALL THE UPGRADES 5699 03:21:10,368 --> 03:21:11,469 AND NEW WORK AND INFRASTRUCTURE 5700 03:21:11,469 --> 03:21:14,206 WE REALLY WANT TO SEE AT THE 5701 03:21:14,206 --> 03:21:16,408 NATIONAL LIBRARY OF MEDICINE TO 5702 03:21:16,408 --> 03:21:18,376 ALLOW RESEARCHERS LIKE YOU AND 5703 03:21:18,376 --> 03:21:22,314 EVERYBODY ACCESS TO NOT ONLY 5704 03:21:22,314 --> 03:21:23,515 UNDERSTANDING THESE DATASETS 5705 03:21:23,515 --> 03:21:24,015 EXIST, YOU'RE OBVIOUSLY 5706 03:21:24,015 --> 03:21:26,117 KNOWLEDGEABLE IN THE FIELD BUT 5707 03:21:26,117 --> 03:21:27,786 WHAT ABOUT SOME OUTSTANDING 5708 03:21:27,786 --> 03:21:29,454 PERSON, NOT ONLY THAT DATASETS 5709 03:21:29,454 --> 03:21:30,622 EXIST BUT ESPECIALLY IN THE 5710 03:21:30,622 --> 03:21:34,459 CLINICAL CARE ENVIRONMENT, WE 5711 03:21:34,459 --> 03:21:36,194 HAVE THE PHENOTYPES 5712 03:21:36,194 --> 03:21:36,828 CHARACTERIZED CLINICALLY 5713 03:21:36,828 --> 03:21:38,697 MEANINGFUL COHORTS, YOU JUST 5714 03:21:38,697 --> 03:21:40,131 GAVE A GREAT EXAMPLE OF 5715 03:21:40,131 --> 03:21:41,166 SOMETHING WE'RE ALSO STRIVING 5716 03:21:41,166 --> 03:21:41,333 FOR. 5717 03:21:41,333 --> 03:21:43,301 THANK YOU SO MUCH. 5718 03:21:43,301 --> 03:21:46,471 I THINK NOW WE NEED TO MOVE ON. 5719 03:21:46,471 --> 03:21:46,705 CORRECT? 5720 03:21:46,705 --> 03:21:48,873 >> YEAH, JUST ABOUT ON TIME. 5721 03:21:48,873 --> 03:21:53,278 I SEE MARIE JOINED US. 5722 03:21:53,278 --> 03:21:53,578 >> GREAT. 5723 03:21:53,578 --> 03:21:55,247 DR. MARIE BERNARD IS GOING TO 5724 03:21:55,247 --> 03:21:57,649 GIVE A REPORT BACK TO YOU ON THE 5725 03:21:57,649 --> 03:22:01,386 ACD WORKING GROUP ON DIVERSITY. 5726 03:22:01,386 --> 03:22:02,487 >> GOOD AFTERNOON, EVERYONE. 5727 03:22:02,487 --> 03:22:06,858 HOPEFULLY YOU CAN SEE MY FIRST 5728 03:22:06,858 --> 03:22:07,826 SCREEN FOR COSWD UPDATE. 5729 03:22:07,826 --> 03:22:09,494 THIS IS WHAT WE TALKED ABOUT, 5730 03:22:09,494 --> 03:22:10,795 ADVISORY COMMITTEE TO THE 5731 03:22:10,795 --> 03:22:13,098 DIRECTOR WORKING GROUP ON 5732 03:22:13,098 --> 03:22:15,267 DIVERSITY MEETING YESTERDAY. 5733 03:22:15,267 --> 03:22:16,501 PEOPLE INDULGED ME WITH THE 5734 03:22:16,501 --> 03:22:17,569 OPPORTUNITY TO REVIEW WHAT WE'VE 5735 03:22:17,569 --> 03:22:18,870 DONE IN THE LAST FOUR YEARS 5736 03:22:18,870 --> 03:22:22,374 SINCE I HAVE BEEN THE COSWD. 5737 03:22:22,374 --> 03:22:24,409 WHAT WE TALKED ABOUT WAS RECENT 5738 03:22:24,409 --> 03:22:24,643 HISTORY. 5739 03:22:24,643 --> 03:22:26,878 I WAS PRIVILEGED TO BE ASKED TO 5740 03:22:26,878 --> 03:22:29,281 BE THE ACTING COSWD IN OCTOBER 5741 03:22:29,281 --> 03:22:30,248 2020. 5742 03:22:30,248 --> 03:22:34,019 I WAS SELECTED TO BE THE 5743 03:22:34,019 --> 03:22:36,121 PERMANENT COSWD AFTER NATIONAL 5744 03:22:36,121 --> 03:22:37,322 SEARCH IN MAY OF 2021. 5745 03:22:37,322 --> 03:22:39,291 SO WE'LL TALK ABOUT THAT. 5746 03:22:39,291 --> 03:22:42,227 WE'LL TALK ABOUT THE EVIDENCE 5747 03:22:42,227 --> 03:22:44,663 CASE FOR SCIENTIFIC WORKFORCE 5748 03:22:44,663 --> 03:22:45,664 DIVERSITY BECAUSE THAT'S WHAT 5749 03:22:45,664 --> 03:22:48,366 MOTIVATES EVERYTHING THAT WE DO. 5750 03:22:48,366 --> 03:22:51,670 AND THEN HOW YOU FOSTER 5751 03:22:51,670 --> 03:22:53,872 SCIENTIFIC WORKFORCE DIVERSITY, 5752 03:22:53,872 --> 03:22:55,407 IN PARTICULAR THE KEY BUILDING 5753 03:22:55,407 --> 03:22:58,877 BLOCKS OF OUR STRATEGIC PLAN, 5754 03:22:58,877 --> 03:22:59,811 BUILDING EVIDENCE, DISSEMINATING 5755 03:22:59,811 --> 03:23:01,513 IT, ACTING ON IT. 5756 03:23:01,513 --> 03:23:03,715 AND A BRIEF DISCUSSION ABOUT THE 5757 03:23:03,715 --> 03:23:05,684 WAY FORWARD. 5758 03:23:05,684 --> 03:23:08,987 SO AS I SAID, I WAS DEPUTY 5759 03:23:08,987 --> 03:23:17,529 DIRECTOR OF NATIONAL INTUT ON 5760 03:23:17,529 --> 03:23:20,165 AGING 2008 TO FALL OF 2020 ASKED 5761 03:23:20,165 --> 03:23:24,402 TO STEP IN AS ACTING COSWD. 5762 03:23:24,402 --> 03:23:25,770 DR. HANNAH VALANTINE DID A 5763 03:23:25,770 --> 03:23:27,072 BEAUTIFUL JOB DEVELOPING A 5764 03:23:27,072 --> 03:23:28,807 FOUNDATION FROM WHICH WE COULD 5765 03:23:28,807 --> 03:23:29,074 WORK. 5766 03:23:29,074 --> 03:23:30,775 WHEN IT CAME TIME FOR THE 5767 03:23:30,775 --> 03:23:35,280 NATIONAL SEARCH IN JANUARY I 5768 03:23:35,280 --> 03:23:36,147 SUBMITTED MY APPLICATION, I KNOW 5769 03:23:36,147 --> 03:23:37,615 A LOT OF GOOD PEOPLE APPLIED, I 5770 03:23:37,615 --> 03:23:39,351 WITH AS THRILLED TO HAVE BEEN 5771 03:23:39,351 --> 03:23:39,617 SELECTED. 5772 03:23:39,617 --> 03:23:42,187 WHAT I SAID IN MY APPLICATION 5773 03:23:42,187 --> 03:23:44,055 WAS THAT A GUIDING PRINCIPLE 5774 03:23:44,055 --> 03:23:45,390 WOULD BE THIS AFRICAN PROVERBS 5775 03:23:45,390 --> 03:23:47,459 IF YOU WANT TO GO FAST GO ALONE. 5776 03:23:47,459 --> 03:23:50,395 IF YOU WANT TO GO FAR, GO 5777 03:23:50,395 --> 03:23:50,862 TOGETHER. 5778 03:23:50,862 --> 03:23:54,332 I TALKED ABOUT THE FACT THE 5779 03:23:54,332 --> 03:23:59,704 MISSION OF THE COSWD OFFICE WAS 5780 03:23:59,704 --> 03:24:01,639 LIKE HAVING AN APPLE 50 TIMES 5781 03:24:01,639 --> 03:24:03,942 LARGER ON THE BACK OF AN ANT, 5782 03:24:03,942 --> 03:24:05,076 VERY FEW STAFF MEMBERS IN THE 5783 03:24:05,076 --> 03:24:09,314 OFFICE, YET THE GOAL IS TO MAKE 5784 03:24:09,314 --> 03:24:10,415 SURE THAT THIS BROAD 5785 03:24:10,415 --> 03:24:12,384 PARTICIPATION IN THE GENERATION 5786 03:24:12,384 --> 03:24:13,685 AND EXECUTION OF SCIENCE BECAUSE 5787 03:24:13,685 --> 03:24:16,888 OF THE DATA THAT I'LL BE SHOWING 5788 03:24:16,888 --> 03:24:18,156 SHORTLY THAT THAT PROMOTES 5789 03:24:18,156 --> 03:24:19,157 CREATIVITY AND INNOVATION. 5790 03:24:19,157 --> 03:24:22,127 I ALSO TALKED ABOUT THE FACT 5791 03:24:22,127 --> 03:24:23,762 THAT WE COULD CATALYZE THINGS, 5792 03:24:23,762 --> 03:24:25,597 WE COULD LEVERAGE THINGS. 5793 03:24:25,597 --> 03:24:27,065 BUT WE'RE PARTICULARLY 5794 03:24:27,065 --> 03:24:30,001 PRIVILEGED TO HAVE A LOT OF 5795 03:24:30,001 --> 03:24:31,536 ALLIES TO HELP CARRYING THAT 5796 03:24:31,536 --> 03:24:33,271 APPLE FORWARD. 5797 03:24:33,271 --> 03:24:39,344 WE WRITTEN ABOUT THIS IN -- 5798 03:24:39,344 --> 03:24:44,015 >> MARIE, YOU'RE ON MUTE. 5799 03:24:44,015 --> 03:24:45,350 >> ACCIDENTALLY HIT MUTE, YES. 5800 03:24:45,350 --> 03:24:53,091 >> MARIE, YOU'RE ON MUTE. 5801 03:24:53,091 --> 03:24:55,059 >> HOPEFULLY NOW YOU CAN HEAR 5802 03:24:55,059 --> 03:24:56,094 ME. 5803 03:24:56,094 --> 03:24:56,828 >> YES. 5804 03:24:56,828 --> 03:24:57,829 >> OKAY. 5805 03:24:57,829 --> 03:24:59,898 SO WE'VE TALKED ABOUT THIS. 5806 03:24:59,898 --> 03:25:01,766 WE HAVE A NATURE MEDICINE 5807 03:25:01,766 --> 03:25:04,702 PUBLICATION FROM NOW THREE YEARS 5808 03:25:04,702 --> 03:25:07,338 AGO WITH LARRY TABAK, ALFRED 5809 03:25:07,338 --> 03:25:12,377 JOHNSON OUR DEPUTY DIRECTOR OF 5810 03:25:12,377 --> 03:25:13,144 MANAGEMENT, OUR THEN-DIRECTOR OF 5811 03:25:13,144 --> 03:25:15,313 OFFICE OF EQUITY DIVERSITY AND 5812 03:25:15,313 --> 03:25:16,948 INCLUSION TALKING ABOUT HOW 5813 03:25:16,948 --> 03:25:19,250 IMPORTANT IT IS TO GET DIVERSE 5814 03:25:19,250 --> 03:25:20,585 PERSPECTIVES AROUND THE TABLE TO 5815 03:25:20,585 --> 03:25:22,320 PROMOTE THE SCIENCE. 5816 03:25:22,320 --> 03:25:26,891 WE TALK ABOUT THE FACT THAT THE 5817 03:25:26,891 --> 03:25:28,026 SORTS OF PROBLEMS WE NEED TO 5818 03:25:28,026 --> 03:25:29,594 SOLVE IN BIOMEDICAL AND 5819 03:25:29,594 --> 03:25:30,995 BEHAVIORAL RESEARCH ARE LIKE 5820 03:25:30,995 --> 03:25:35,400 TRYING TO DESCRIBE AN ELEPHANT 5821 03:25:35,400 --> 03:25:35,700 SIGHTLESSLY. 5822 03:25:35,700 --> 03:25:36,501 THERE ARE HUGE PROBLEMS. 5823 03:25:36,501 --> 03:25:40,638 YOU NEED TO COME AT THEM WITH 5824 03:25:40,638 --> 03:25:41,739 DIFFERENT PERSPECTIVES. 5825 03:25:41,739 --> 03:25:42,607 WHAT INFORMS THOSE? 5826 03:25:42,607 --> 03:25:43,508 LOTS OF THINGS. 5827 03:25:43,508 --> 03:25:47,679 HOW YOU GREW UP, WHERE YOU GREW 5828 03:25:47,679 --> 03:25:49,747 UP, RURAL, URBAN, SES AS YOU 5829 03:25:49,747 --> 03:25:51,816 GREW UP, YOUR DISABILITY STATUS, 5830 03:25:51,816 --> 03:25:54,118 YOUR SEX, YOUR RACE, YOUR 5831 03:25:54,118 --> 03:25:54,886 ETHNICITY. 5832 03:25:54,886 --> 03:25:56,321 LOTS OF OTHER THINGS THAT MAKE 5833 03:25:56,321 --> 03:25:58,823 YOU THE UNIQUE PERSON THAT YOU 5834 03:25:58,823 --> 03:26:00,692 ARE AND BRINGING YOUR UNIQUE 5835 03:26:00,692 --> 03:26:00,992 PERSPECTIVE. 5836 03:26:00,992 --> 03:26:03,661 WE NEED A LOT OF UNIQUE 5837 03:26:03,661 --> 03:26:04,963 PERSPECTIVES AT THE TABLE TO GET 5838 03:26:04,963 --> 03:26:05,830 THE BEST SCIENCE. 5839 03:26:05,830 --> 03:26:07,265 IT'S NOT JUST A HYPOTHETICAL. 5840 03:26:07,265 --> 03:26:09,100 IT IS SOMETHING THAT'S BEEN 5841 03:26:09,100 --> 03:26:10,768 REALLY WELL DEMONSTRATED IN THE 5842 03:26:10,768 --> 03:26:15,607 BUSINESS LITERATURE AND IS A 5843 03:26:15,607 --> 03:26:16,441 BURGEONING LITERATURE IN 5844 03:26:16,441 --> 03:26:22,547 SCIENCE, ONE OF THE BEST 5845 03:26:22,547 --> 03:26:24,148 BUSINESS STUDIES TALKS ABOUT 5846 03:26:24,148 --> 03:26:25,783 TRADERS, HOMOGENUS VERSUS MIXED, 5847 03:26:25,783 --> 03:26:27,218 THE RETURN ON INVESTMENT IS 5848 03:26:27,218 --> 03:26:28,520 GREATER WITH THAT MIXED GROUP 5849 03:26:28,520 --> 03:26:35,426 BECAUSE YOU HAVE DIFFERENT 5850 03:26:35,426 --> 03:26:36,427 VIEWPOINTS. 5851 03:26:36,427 --> 03:26:37,495 FROM SCIENTIFIC PERSPECTIVE 5852 03:26:37,495 --> 03:26:39,464 THERE'S STUDIES LIKE CLASSIC 5853 03:26:39,464 --> 03:26:43,935 ARTICLE BY FREEMAN AND WANG FROM 5854 03:26:43,935 --> 03:26:48,106 2015 LOOKING AT 2.5 MILLION 5855 03:26:48,106 --> 03:26:49,774 ARTICLES IN THE LITERATURE TO 5856 03:26:49,774 --> 03:26:56,414 DETERMINE WHETHER A DIVERSE TEAM 5857 03:26:56,414 --> 03:27:02,020 VERSUS HOMOGENOUS TEAM LED TO 5858 03:27:02,020 --> 03:27:03,855 MORE IMPACTFUL PAPERS. 5859 03:27:03,855 --> 03:27:04,956 THEY LOOKED BASED UPON 5860 03:27:04,956 --> 03:27:07,825 GEOGRAPHIC LOCATION, HOW MUCH 5861 03:27:07,825 --> 03:27:10,328 INFORMATION WAS CITED, ETHNIC 5862 03:27:10,328 --> 03:27:11,429 BACKGROUND AS BEST ASSESSED 5863 03:27:11,429 --> 03:27:13,731 LOOKING AT LAST NAMES. 5864 03:27:13,731 --> 03:27:14,599 THERE'S AN ALGORITHM 5865 03:27:14,599 --> 03:27:15,833 COMPUTER-DRIVEN THAT MADE THAT 5866 03:27:15,833 --> 03:27:18,870 ASSESSMENT, NOT A PERFECT TOOL 5867 03:27:18,870 --> 03:27:20,438 BUT CONSISTENTLY APPLIED. 5868 03:27:20,438 --> 03:27:23,608 AND THEY FOUND THAT THE MORE 5869 03:27:23,608 --> 03:27:26,444 DIVERSE THE TEAM, YES, THE 5870 03:27:26,444 --> 03:27:27,412 HIGHER OF IMPACT FACTOR OF 5871 03:27:27,412 --> 03:27:29,981 JOURNAL IN WHICH THE PAPER IS 5872 03:27:29,981 --> 03:27:32,250 PUBLISHED AND MORE FREQUENTLY 5873 03:27:32,250 --> 03:27:34,586 THE PAPER IS CITED. 5874 03:27:34,586 --> 03:27:38,723 THERE'S A LOVELY STUDY IN 2020 5875 03:27:38,723 --> 03:27:49,267 HANES AND COLLEAGUES LOOKING AT 5876 03:27:50,201 --> 03:27:51,903 ORNITHOLOGY, WITH BIRD SONG. 5877 03:27:51,903 --> 03:27:54,172 THERE WAS A DOMINANT PARADIGM 5878 03:27:54,172 --> 03:27:58,443 BUT LOOKING CAREFULLY BASED UPON 5879 03:27:58,443 --> 03:28:01,112 MALE-DOMINATED FIELD, MALE 5880 03:28:01,112 --> 03:28:01,446 BIRDS. 5881 03:28:01,446 --> 03:28:04,515 AND FEMALES JOINED THE RANKS, 5882 03:28:04,515 --> 03:28:05,817 THEY LOOKED MORE WIDELY AT MALE 5883 03:28:05,817 --> 03:28:09,988 AND FEMALE BIRDS AND THAT 5884 03:28:09,988 --> 03:28:11,289 DOMINANT PARADIGM FELL. 5885 03:28:11,289 --> 03:28:13,091 REALLY SURPRISING EXAMPLE OF 5886 03:28:13,091 --> 03:28:15,593 BENEFITS OF DIVERSE 5887 03:28:15,593 --> 03:28:16,027 PERSPECTIVES. 5888 03:28:16,027 --> 03:28:17,662 THEN THERE'S A STUDY A COUPLE 5889 03:28:17,662 --> 03:28:20,732 YEARS AGO THAT LOOKED AT NOW 5890 03:28:20,732 --> 03:28:21,933 SOME 5 MILLION ARTICLES. 5891 03:28:21,933 --> 03:28:24,435 WHEN I TALK ABOUT DIVERSITY, I 5892 03:28:24,435 --> 03:28:28,039 TALK ABOUT THE FACT THAT IT'S 5893 03:28:28,039 --> 03:28:28,640 DISABILITY STATUS, GEOGRAPHY, 5894 03:28:28,640 --> 03:28:30,475 SES, THOSE THINGS ARE MORE 5895 03:28:30,475 --> 03:28:32,210 DIFFICULT TO MEASURE. 5896 03:28:32,210 --> 03:28:33,578 THE THINGS EASIER TO MEASURE, 5897 03:28:33,578 --> 03:28:36,247 THAT GET REPORTED THUS FAR, 5898 03:28:36,247 --> 03:28:37,248 THINGS LIKE SEX, RACE, 5899 03:28:37,248 --> 03:28:37,582 ETHNICITY. 5900 03:28:37,582 --> 03:28:40,685 SO IN THIS STUDY THEY LOOKED AT 5901 03:28:40,685 --> 03:28:44,589 WHO PUBLISHED WHAT BY SEX, RACE, 5902 03:28:44,589 --> 03:28:45,289 ETHNICITY. 5903 03:28:45,289 --> 03:28:46,357 AFRICAN AMERICAN MALE, 5904 03:28:46,357 --> 03:28:50,962 NON-HISPANIC WHITE MALE, ASIAN 5905 03:28:50,962 --> 03:28:52,930 MALES, LATINOS, ASIAN FEMALES, 5906 03:28:52,930 --> 03:28:53,431 LATINAS. 5907 03:28:53,431 --> 03:28:54,465 AFRICAN AMERICAN AND WHITE 5908 03:28:54,465 --> 03:28:55,199 FEMALES. 5909 03:28:55,199 --> 03:28:57,869 WHAT THEY FOUND WAS THAT THE 5910 03:28:57,869 --> 03:28:59,704 WOMEN TENDED TO PUBLISH MORE IN 5911 03:28:59,704 --> 03:29:02,774 THE ARTS AND HEALTH SCIENCES, 5912 03:29:02,774 --> 03:29:05,943 MUCH LESS IN ENGINEERING 5913 03:29:05,943 --> 03:29:07,745 TECHNOLOGY, PHYSICS. 5914 03:29:07,745 --> 03:29:09,347 ALMOST EXACT REVERSE FOR MEN. 5915 03:29:09,347 --> 03:29:10,415 THEY FOUND THE WOMEN PUBLISHED 5916 03:29:10,415 --> 03:29:13,718 LESS THAN THE MEN, WHICH IS A 5917 03:29:13,718 --> 03:29:15,820 KNOWN PHENOMENON BUT LED TO 5918 03:29:15,820 --> 03:29:17,789 CONCLUSION IF THERE WERE GREATER 5919 03:29:17,789 --> 03:29:18,856 PARITY IN PUBLISHING THERE WOULD 5920 03:29:18,856 --> 03:29:20,425 BE A DIFFERENT BODY OF 5921 03:29:20,425 --> 03:29:21,292 SCIENTIFIC KNOWLEDGE THAT WE 5922 03:29:21,292 --> 03:29:23,027 WOULD BE LOOKING AT. 5923 03:29:23,027 --> 03:29:25,897 AGAIN, SPEAKING TO THIS ISSUE OF 5924 03:29:25,897 --> 03:29:27,265 HAVING DIVERSE PERSPECTIVES AND 5925 03:29:27,265 --> 03:29:30,501 APPROACHES TO GET TO THE 5926 03:29:30,501 --> 03:29:32,136 GREATEST CREATIVITY AND 5927 03:29:32,136 --> 03:29:32,437 INNOVATION. 5928 03:29:32,437 --> 03:29:34,539 WE ADDRESSED THIS IN THE 5929 03:29:34,539 --> 03:29:35,206 SCIENTIFIC WORKFORCE DIVERSITY 5930 03:29:35,206 --> 03:29:37,508 SEMINAR THAT WE HAD IN MAY OF 5931 03:29:37,508 --> 03:29:37,909 2022. 5932 03:29:37,909 --> 03:29:39,310 WE STARTED DOING THESE IN 5933 03:29:39,310 --> 03:29:41,779 SEPTEMBER OF 21 TO ASK A 5934 03:29:41,779 --> 03:29:42,847 QUESTION EACH TIME. 5935 03:29:42,847 --> 03:29:45,049 THE QUESTION AT THAT MAY SEMINAR 5936 03:29:45,049 --> 03:29:48,419 IS HOW DOES DIVERSITY IMPACT 5937 03:29:48,419 --> 03:29:48,653 SCIENCE. 5938 03:29:48,653 --> 03:29:58,296 WE WERE REALLY HONORED TO HAVE 5939 03:29:58,296 --> 03:30:02,567 DR. ISLER, DOCTORS S 5940 03:30:02,567 --> 03:30:13,077 MITH-D.O.E.RR, JENNIFER KUAN, 5941 03:30:13,778 --> 03:30:16,447 SANTANGELO AND SHIRLEY TILGHMAN 5942 03:30:16,447 --> 03:30:17,215 GAVE CLOSING REMARKS, FOCUSING 5943 03:30:17,215 --> 03:30:19,016 ON THE MOST RECENT EVIDENCE. 5944 03:30:19,016 --> 03:30:22,587 I WOULD ENCOURAGE YOU TO GO TO 5945 03:30:22,587 --> 03:30:25,890 THE URLs LISTED THERE, ONE 5946 03:30:25,890 --> 03:30:27,158 PROVIDES PROCEEDINGS FROM THE 5947 03:30:27,158 --> 03:30:29,393 SEMINAR, AND THE OTHER IS THE 5948 03:30:29,393 --> 03:30:30,762 PROCEEDINGS ON THE NLM BOOKSHELF 5949 03:30:30,762 --> 03:30:33,898 WHICH CAN ALSO BE FOUND IN 5950 03:30:33,898 --> 03:30:34,132 PubMed. 5951 03:30:34,132 --> 03:30:35,666 BUT AGAIN LOOKING AT THE 5952 03:30:35,666 --> 03:30:37,268 EVIDENCE THAT IS WHAT'S 5953 03:30:37,268 --> 03:30:47,845 MOTIVATED THE THINGS WE'VE DONE 5954 03:30:50,081 --> 03:30:52,116 JANINE CLAYTON, AND OTHERS WROTE 5955 03:30:52,116 --> 03:30:52,550 ABOUT THIS IN NATURE 5956 03:30:52,550 --> 03:30:53,684 COMMUNICATIONS, WHAT IS THE 5957 03:30:53,684 --> 03:30:55,620 EVIDENCE, HOW DO YOU ACT ON 5958 03:30:55,620 --> 03:30:55,820 THIS? 5959 03:30:55,820 --> 03:30:59,023 IT'S CLEAR IF YOU'RE GOING TO 5960 03:30:59,023 --> 03:31:00,558 GET THAT BROAD PARTICIPATION, 5961 03:31:00,558 --> 03:31:02,093 DIVERSITY OF PERCEPTION AND 5962 03:31:02,093 --> 03:31:04,095 APPROACHES YOU HAVE TO BE 5963 03:31:04,095 --> 03:31:05,930 INCLUSIVE, HAVE INCLUSIVE 5964 03:31:05,930 --> 03:31:06,230 EXCELLENCE. 5965 03:31:06,230 --> 03:31:07,899 AND THERE'S NO ONE THING THAT 5966 03:31:07,899 --> 03:31:11,402 YOU CAN DO TO ACCOMPLISH THIS. 5967 03:31:11,402 --> 03:31:12,737 THERE ARE MULTIPLE THINGS. 5968 03:31:12,737 --> 03:31:23,080 WE DO NEED TO HAVE 5969 03:31:25,383 --> 03:31:26,984 DEMONSTRATABLE SUPPORT, FRANCIS 5970 03:31:26,984 --> 03:31:30,121 COLLINS, LARRY TABAK, MONICA 5971 03:31:30,121 --> 03:31:31,756 BERTAGNOLLI, I.C. DIRECTORS, 5972 03:31:31,756 --> 03:31:32,857 EVERYONE HAS BEEN ORIENTED TO 5973 03:31:32,857 --> 03:31:35,059 MAKING SURE WE HAVE A CULTURE OF 5974 03:31:35,059 --> 03:31:36,928 INCLUSION SO THAT EVERYONE 5975 03:31:36,928 --> 03:31:39,430 RECOGNIZES THEIR VALUE AND THE 5976 03:31:39,430 --> 03:31:40,631 THINGS THEY CAN CONTRIBUTE TO 5977 03:31:40,631 --> 03:31:42,934 MAKE FOR BETTER SCIENCE. 5978 03:31:42,934 --> 03:31:46,137 THAT'S GENERALIZABLE TO EVERYONE 5979 03:31:46,137 --> 03:31:49,607 IN THE COUNTRY. 5980 03:31:49,607 --> 03:31:50,408 ACTION ORIENTED ACCOUNTABILITY, 5981 03:31:50,408 --> 03:31:52,143 A NUMBER OF THINGS HAVE BEEN 5982 03:31:52,143 --> 03:31:54,445 GENERATED TO ALLOW FOR THAT. 5983 03:31:54,445 --> 03:31:57,148 SOME WE DIRECTLY GENERATED, SOME 5984 03:31:57,148 --> 03:31:58,149 WE'VE LEVERAGED AND CATALYZED. 5985 03:31:58,149 --> 03:31:59,784 WE NEED TO USE THE BEST 5986 03:31:59,784 --> 03:32:01,319 PRACTICES THAT ARE OUT THERE AND 5987 03:32:01,319 --> 03:32:02,987 WE'VE BEEN ABOUT THE BUSINESS OF 5988 03:32:02,987 --> 03:32:05,923 TRYING TO IDENTIFY THOSE BEST 5989 03:32:05,923 --> 03:32:07,358 PRACTICES AND DISSEMINATING 5990 03:32:07,358 --> 03:32:08,326 INFORMATION ABOUT THAT. 5991 03:32:08,326 --> 03:32:11,062 AND YET THIS WAS WRITTEN ABOUT 5992 03:32:11,062 --> 03:32:13,064 SUPPORTING WOMEN IN SCIENCE BUT 5993 03:32:13,064 --> 03:32:14,398 THIS ISSUE OF ENHANCED 5994 03:32:14,398 --> 03:32:15,900 FLEXIBILITY OPTIONS WE TALKED 5995 03:32:15,900 --> 03:32:19,737 ABOUT IN THIS ARTICLE ARE 5996 03:32:19,737 --> 03:32:22,540 APPLICABLE BROADLY FOR GROUPS OF 5997 03:32:22,540 --> 03:32:23,674 SCIENTISTS NOT WELL REPRESENTED 5998 03:32:23,674 --> 03:32:24,876 IN BIOMEDICAL AND BEHAVIORAL 5999 03:32:24,876 --> 03:32:25,643 RESEARCH. 6000 03:32:25,643 --> 03:32:27,778 MANY TIMES PEOPLE MAY COME FROM 6001 03:32:27,778 --> 03:32:28,913 SOCIOECONOMIC BACK GROUND WHERE 6002 03:32:28,913 --> 03:32:32,416 THEY DON'T HAVE THE FUNDS FOR 6003 03:32:32,416 --> 03:32:33,517 BROAD CHILD CARE OR OLDER ADULT 6004 03:32:33,517 --> 03:32:35,052 CARE OR HAVE LOTS OF OTHER 6005 03:32:35,052 --> 03:32:37,321 DEMANDS THAT ARE PLACED UPON 6006 03:32:37,321 --> 03:32:39,490 THEM AND THUS WILL NOT HAVE THAT 6007 03:32:39,490 --> 03:32:42,894 LINEAR PATH TO BECOME ALL ONE 6008 03:32:42,894 --> 03:32:44,562 FUNDED RESEARCHER AND WE NEED 6009 03:32:44,562 --> 03:32:46,297 FLEXIBILITY AND OPTIONS TO TAKE 6010 03:32:46,297 --> 03:32:49,800 ADVANTAGE OF THOSE TALENTS AS 6011 03:32:49,800 --> 03:32:50,701 WELL. 6012 03:32:50,701 --> 03:32:55,206 SO, AS I SAID, I WAS SELECTED 6013 03:32:55,206 --> 03:32:59,377 AFTER A COMPETITIVE PROCESS AS 6014 03:32:59,377 --> 03:33:03,814 THE COSWD MAY 31 OF 2021 AFTER 6015 03:33:03,814 --> 03:33:05,016 NINE MONTHS IN ACTING ROLE THUS 6016 03:33:05,016 --> 03:33:07,285 ABLE TO HIT THE GROUND RUNNING, 6017 03:33:07,285 --> 03:33:10,554 PUT OUT A STRATEGIC PLAN FOR 22 6018 03:33:10,554 --> 03:33:12,590 TO 26 BY MARCH OF 2022. 6019 03:33:12,590 --> 03:33:16,861 WE RECENTLY PUT OUT A MID-TERM 6020 03:33:16,861 --> 03:33:18,262 PROGRESS REPORT, WE'RE HALFWAY 6021 03:33:18,262 --> 03:33:20,364 THROUGH THAT TIME PERIOD. 6022 03:33:20,364 --> 03:33:23,000 WE TALKED WITHIN THAT STRATEGIC 6023 03:33:23,000 --> 03:33:26,037 PLAN ABOUT A VISION TO ENABLE 6024 03:33:26,037 --> 03:33:26,904 NIH AND NIH-FUNDED INSTITUTIONS 6025 03:33:26,904 --> 03:33:30,074 TO BENEFIT FROM THE NATION'S 6026 03:33:30,074 --> 03:33:31,409 FULL RANGE OF TALENT. 6027 03:33:31,409 --> 03:33:34,445 IF WE DON'T DO THAT WE'RE GOING 6028 03:33:34,445 --> 03:33:36,781 TO LOSE OUR LEADERSHIP ROLE 6029 03:33:36,781 --> 03:33:39,383 WORLDWIDE IN SCIENCE, FORCES 6030 03:33:39,383 --> 03:33:40,384 CREATIVITY AND INNOVATION, NOT 6031 03:33:40,384 --> 03:33:42,320 JUST FOR THE SAKE OF BEING GOOD 6032 03:33:42,320 --> 03:33:42,553 GUYS. 6033 03:33:42,553 --> 03:33:46,157 WE WANT TO HAVE THE BEST 6034 03:33:46,157 --> 03:33:46,691 SCIENCE. 6035 03:33:46,691 --> 03:33:49,126 OUR MISSION TO BE THE NIH 6036 03:33:49,126 --> 03:33:52,430 THOUGHT LEADER IN THE SCIENTIFIC 6037 03:33:52,430 --> 03:33:53,264 WORKFORCE DIFFUSING 6038 03:33:53,264 --> 03:34:00,204 EVIDENCE-BASED APPROACHES TO 6039 03:34:00,204 --> 03:34:01,672 CATALYZE CULTURES OF INCLUSIVE 6040 03:34:01,672 --> 03:34:04,775 EVIDENCE USING NIH AS A TEST 6041 03:34:04,775 --> 03:34:05,977 BED, DISSEMINATING EVIDENCE 6042 03:34:05,977 --> 03:34:09,246 ACROSS THE ECOSYSTEM AND ACTING 6043 03:34:09,246 --> 03:34:11,115 ON THE EVIDENCE. 6044 03:34:11,115 --> 03:34:12,450 HIGHLIGHTS, A FEW EXAMPLES, 6045 03:34:12,450 --> 03:34:16,454 PARTICULARLY IN TERMS OF 6046 03:34:16,454 --> 03:34:17,688 BUILDING EVIDENCE, WE WERE 6047 03:34:17,688 --> 03:34:20,091 PRIVILEGED TO LEAD THE SUBGROUP 6048 03:34:20,091 --> 03:34:20,958 ON INDIVIDUALS WITH 6049 03:34:20,958 --> 03:34:21,859 DISABILITIES, WHICH WAS A 6050 03:34:21,859 --> 03:34:24,195 SUBGROUP OF ADVISORY COMMITTEES 6051 03:34:24,195 --> 03:34:25,830 TO THE DIRECTOR OF DIVERSITY. 6052 03:34:25,830 --> 03:34:27,465 YOU'LL HEAR MORE ABOUT OUTCOMES 6053 03:34:27,465 --> 03:34:30,968 FROM THIS BUT AGAIN THIS ROLE OF 6054 03:34:30,968 --> 03:34:35,139 CATALYZING MY TEAM SPENT A SOLID 6055 03:34:35,139 --> 03:34:36,574 YEAR FOSTERING CONVERSATIONS 6056 03:34:36,574 --> 03:34:38,209 AMONG THIS SUBJECT MATTER EXPECT 6057 03:34:38,209 --> 03:34:41,178 GROUP, THIS WAS ON THE SUBJECT 6058 03:34:41,178 --> 03:34:43,781 GROUP HELPING TO CRAFT 6059 03:34:43,781 --> 03:34:45,883 SUGGESTIONS FOR NIH THAT WERE 6060 03:34:45,883 --> 03:34:47,184 TANGIBLE AND ACTIONABLE. 6061 03:34:47,184 --> 03:34:49,954 THAT LED TO A PRESENTATION TO 6062 03:34:49,954 --> 03:34:53,924 THE ACD NOW TWO YEARS AGO WHICH 6063 03:34:53,924 --> 03:34:58,029 GOT ADOPTED AS A SET OF 6064 03:34:58,029 --> 03:35:00,765 RECOMMENDATIONS, MULTIPLE 6065 03:35:00,765 --> 03:35:02,133 RECOMMENDATIONS, AS DR. 6066 03:35:02,133 --> 03:35:03,667 BERTAGNOLLI MENTIONED, 6067 03:35:03,667 --> 03:35:04,935 RECONSIDERATION OF THE NIH 6068 03:35:04,935 --> 03:35:09,407 MISSION, THAT PROCESS IS 6069 03:35:09,407 --> 03:35:09,940 ONGOING. 6070 03:35:09,940 --> 03:35:12,043 DR. SCHWETZ ELABORATED UPON. 6071 03:35:12,043 --> 03:35:12,943 THERE'S A RECOMMENDATION 6072 03:35:12,943 --> 03:35:15,646 DISABLED POPULATIONS BE NAMED A 6073 03:35:15,646 --> 03:35:16,981 HEALTH DISPARITIES POPULATION. 6074 03:35:16,981 --> 03:35:27,024 THAT FOLLOWING AUGUST THE 6075 03:35:27,024 --> 03:35:28,993 DIRECTORS WHO COULD DECLARE 6076 03:35:28,993 --> 03:35:32,296 HEALTH DISPARITY POPULATIONS DID 6077 03:35:32,296 --> 03:35:35,699 SO FOR DISABLED POPULATIONS. 6078 03:35:35,699 --> 03:35:37,101 THERE WAS NOT SPECIFIC 6079 03:35:37,101 --> 03:35:38,736 RECOMMENDATION BUT THIS NEEDED 6080 03:35:38,736 --> 03:35:40,571 TO BE SYNERGIZED WITH THE 6081 03:35:40,571 --> 03:35:45,309 STRATEGIC PLAN IN MARCH OF 2023 6082 03:35:45,309 --> 03:35:46,777 AND IS ONGOING. 6083 03:35:46,777 --> 03:35:49,046 IT WAS CLEAR CERTAINLY TO ME 6084 03:35:49,046 --> 03:35:50,881 LISTENING TO THE DISCUSSIONS OF 6085 03:35:50,881 --> 03:35:52,450 THIS SUBJECT MATTER EXPERT GROUP 6086 03:35:52,450 --> 03:35:54,418 THAT WE NEEDED TO HAVE AN 6087 03:35:54,418 --> 03:35:55,953 ASSESSMENT OF THE NIH 6088 03:35:55,953 --> 03:35:57,788 DISABILITIES RESEARCH PORTFOLIO. 6089 03:35:57,788 --> 03:36:02,059 I'M GRATEFUL THAT THE DIVISIONAL 6090 03:36:02,059 --> 03:36:03,794 PROGRAM COORDINATION AND 6091 03:36:03,794 --> 03:36:04,862 RESEARCH AND STRATEGIC PLANNING 6092 03:36:04,862 --> 03:36:09,834 OR DPCPSI IS IN THE PROCESS OF 6093 03:36:09,834 --> 03:36:13,104 DOING EXACTLY THAT. 6094 03:36:13,104 --> 03:36:14,638 WE ARE STARTED ON BUILDING 6095 03:36:14,638 --> 03:36:16,941 SOMETHING WE CALL ENGAGEMENT AND 6096 03:36:16,941 --> 03:36:23,080 ACCESS FOR RESEARCH ACTIVE 6097 03:36:23,080 --> 03:36:26,851 INSTITUTIONS, THIS CAME FROM NIH 6098 03:36:26,851 --> 03:36:29,120 INITIATIVE RECOGNIZED THAT THERE 6099 03:36:29,120 --> 03:36:30,988 ARE SCIENTISTS OFTEN FROM GROUPS 6100 03:36:30,988 --> 03:36:32,857 NOT WELL REPRESENTED IN 6101 03:36:32,857 --> 03:36:33,924 BIOMEDICAL AND BEHAVIORAL 6102 03:36:33,924 --> 03:36:36,227 RESEARCH WHO GOT THEIR INITIAL 6103 03:36:36,227 --> 03:36:38,963 TRAINING AT INSTITUTIONS THAT 6104 03:36:38,963 --> 03:36:41,732 ARE DEFINED AS RESEARCH ACTIVE 6105 03:36:41,732 --> 03:36:42,500 INSTITUTIONS. 6106 03:36:42,500 --> 03:36:43,334 INSTITUTIONS THAT AWARD DEGREES 6107 03:36:43,334 --> 03:36:46,704 IN THE HEALTH PROFESSIONS OR 6108 03:36:46,704 --> 03:36:48,672 SCIENCE RELATED TO HEALTH AND 6109 03:36:48,672 --> 03:36:49,640 STEM FIELDS BUT DO NOT ENJOY 6110 03:36:49,640 --> 03:36:52,443 MUCH IN THE WAY OF NIH FUNDING. 6111 03:36:52,443 --> 03:36:54,311 WE'RE SAYING NO MORE THAN $25 6112 03:36:54,311 --> 03:36:56,747 MILLION PER YEAR AVERAGE COST OF 6113 03:36:56,747 --> 03:36:59,917 NIH RESEARCH PROJECT GRANT 6114 03:36:59,917 --> 03:37:00,484 FUNDING. 6115 03:37:00,484 --> 03:37:02,753 THE ISSUE WAS HAD THERE BEEN 6116 03:37:02,753 --> 03:37:04,288 MORE AS THEY GOT STARTED THAT 6117 03:37:04,288 --> 03:37:06,490 THEIR CAREER MIGHT HAVE BEEN 6118 03:37:06,490 --> 03:37:08,325 ACCELERATED, AND FOR COLLEAGUES 6119 03:37:08,325 --> 03:37:10,294 WHO DID NOT END UP PERSEVERING 6120 03:37:10,294 --> 03:37:12,930 WHO WENT INTO OTHER FIELDS THEY 6121 03:37:12,930 --> 03:37:16,233 MIGHT HAVE BEEN MORE INSPIRED 6122 03:37:16,233 --> 03:37:18,202 HAD THERE BEEN MORE IN THE WAY 6123 03:37:18,202 --> 03:37:19,937 OF NIH FUNDING. 6124 03:37:19,937 --> 03:37:23,007 SO WE, THE COSWD TEAM, AFTER A 6125 03:37:23,007 --> 03:37:24,308 LOT OF DELIBERATIONS INTERNALLY 6126 03:37:24,308 --> 03:37:28,913 TOOK THIS ON ON BEHALF OF NIH TO 6127 03:37:28,913 --> 03:37:31,782 BE RESPONSIVE TO FEEDBACK THAT 6128 03:37:31,782 --> 03:37:36,153 THESE INSTITUTIONS FOUND THIS 6129 03:37:36,153 --> 03:37:41,525 VERY DIFFICULT TO ACCESS, 6130 03:37:41,525 --> 03:37:46,664 SYSTEMS WERE COME LATED, I'VE 6131 03:37:46,664 --> 03:37:48,332 HEARD THE TERM "ARCANE," 6132 03:37:48,332 --> 03:37:50,267 DIFFICULT TO TALK TO ANYONE, 6133 03:37:50,267 --> 03:37:52,236 PROGRAM OFFICER IS HARD TO 6134 03:37:52,236 --> 03:37:54,405 REACH, MUCH LESS NIH LEADERSHIP. 6135 03:37:54,405 --> 03:37:56,707 WE'VE BEEN WORKING A GOOD YEAR, 6136 03:37:56,707 --> 03:37:58,709 MORE THAN A NOW, ANNOUNCED IN 6137 03:37:58,709 --> 03:38:02,546 OCTOBER OF 2023 I BELIEVE IT 6138 03:38:02,546 --> 03:38:05,382 WAS, THIS INITIATIVE, ADVISORY 6139 03:38:05,382 --> 03:38:07,551 COMMITTEE WORKING GROUP FOR 6140 03:38:07,551 --> 03:38:11,622 LEADERSHIP AND MEMBERS OF CENTER 6141 03:38:11,622 --> 03:38:14,892 FOR SCIENTIFIC REVIEW, MINORITY 6142 03:38:14,892 --> 03:38:16,527 HEALTH, OFFICE OF ACQUISITION 6143 03:38:16,527 --> 03:38:18,062 AND LOGISTICS MANAGEMENT AND 6144 03:38:18,062 --> 03:38:19,163 EXTRAMURAL RESEARCH, REALLY ALL 6145 03:38:19,163 --> 03:38:22,099 OF THE NIH INSTITUTES AND 6146 03:38:22,099 --> 03:38:23,734 CENTERS HAD BEEN SUPPORTING THIS 6147 03:38:23,734 --> 03:38:26,370 INITIATIVE FOR US. 6148 03:38:26,370 --> 03:38:29,773 THE INTENT IS TO BECOME A 6149 03:38:29,773 --> 03:38:31,742 ONE-STOP SHOP FOR LEADERSHIP AND 6150 03:38:31,742 --> 03:38:34,044 FACULTY AT THESE INSTITUTIONS 6151 03:38:34,044 --> 03:38:36,647 WHERE IT'S EASY TO NAVIGATE WHAT 6152 03:38:36,647 --> 03:38:38,082 IS AVAILABLE AT NIH AND TO 6153 03:38:38,082 --> 03:38:39,950 IDENTIFY WHAT IS MOST 6154 03:38:39,950 --> 03:38:42,987 APPROPRIATE FOR THEM. 6155 03:38:42,987 --> 03:38:45,956 SO WE HAVE A WEBSITE THAT'S 6156 03:38:45,956 --> 03:38:47,391 EVOLVING, A NEWSLETTER THAT 6157 03:38:47,391 --> 03:38:48,692 PROVIDES INFORMATION ABOUT 6158 03:38:48,692 --> 03:38:50,361 RESEARCH GRANT PROCESSES, NOTICE 6159 03:38:50,361 --> 03:38:51,962 OF FUNDING OPPORTUNITY, ET 6160 03:38:51,962 --> 03:38:52,196 CETERA. 6161 03:38:52,196 --> 03:38:58,002 HERE IS A SCREEN SHOT OF THE 6162 03:38:58,002 --> 03:38:59,303 WEBSITE. 6163 03:38:59,303 --> 03:39:01,739 AND A QR CODE TO GET THERE, EVER 6164 03:39:01,739 --> 03:39:02,439 EVOLVING. 6165 03:39:02,439 --> 03:39:05,009 IT'S MEANT TO BE THAT EASY PLACE 6166 03:39:05,009 --> 03:39:06,010 FOR ACCESS. 6167 03:39:06,010 --> 03:39:09,179 WE ALSO HAVE A NEWSLETTER, FIRST 6168 03:39:09,179 --> 03:39:12,783 NEWSLETTER OUT IN JULY. 6169 03:39:12,783 --> 03:39:15,519 I'LL SAY WE'VE LEARNED THAT 6170 03:39:15,519 --> 03:39:16,153 BEAUTIFUL LONG NEWSLETTERS SUCH 6171 03:39:16,153 --> 03:39:18,355 AS WE SENT OUT ARE NOT 6172 03:39:18,355 --> 03:39:19,356 NECESSARILY HELPFUL TO THE 6173 03:39:19,356 --> 03:39:22,426 FACULTY, THE TARGET HERE. 6174 03:39:22,426 --> 03:39:24,061 WE'RE NOW DOING A NEWS BLAST 6175 03:39:24,061 --> 03:39:34,638 SECOND AND AND FOURTH TUESDAY F 6176 03:39:34,972 --> 03:39:36,440 EACH MONTH. 6177 03:39:36,440 --> 03:39:37,641 WE HAVE ANOTHER COMPONENT. 6178 03:39:37,641 --> 03:39:39,510 WE WEREN'T CERTAIN IF WE BUILT 6179 03:39:39,510 --> 03:39:41,779 IT THEY WOULD COME SO THE INTENT 6180 03:39:41,779 --> 03:39:47,284 HERE WAS TO ENGAGE WITH 6181 03:39:47,284 --> 03:39:49,987 INSTITUTIONS THAT MEET OUR 6182 03:39:49,987 --> 03:39:51,522 DEFINITIONS OF RAI TO BETTER 6183 03:39:51,522 --> 03:39:53,090 UNDERSTAND AND BETTER CONNECT 6184 03:39:53,090 --> 03:39:54,725 THEIR FACULTY WITH RESOURCES. 6185 03:39:54,725 --> 03:39:56,894 WE STARTED OFF WITH THOSE 6186 03:39:56,894 --> 03:39:58,529 INSTITUTIONS THAT HAVE HAD SOME 6187 03:39:58,529 --> 03:40:01,832 FUNDING BUT NOT MORE THAN THAT 6188 03:40:01,832 --> 03:40:03,467 $25 MILLION AVERAGE RPG GRANT 6189 03:40:03,467 --> 03:40:05,369 FUNDING FOR PRIOR THREE YEARS. 6190 03:40:05,369 --> 03:40:07,638 GOING THROUGH A PROCESS OF 6191 03:40:07,638 --> 03:40:11,241 TRYING TO IDENTIFY ELIGIBLE 6192 03:40:11,241 --> 03:40:12,776 INSTITUTIONS WE IDENTIFIED ABOUT 6193 03:40:12,776 --> 03:40:15,145 115 OR SO, WROTE TO THE 6194 03:40:15,145 --> 03:40:16,280 PRESIDENT AND SENIOR VICE 6195 03:40:16,280 --> 03:40:17,715 PRESIDENT FOR RESEARCH AT THOSE 6196 03:40:17,715 --> 03:40:21,085 INSTITUTIONS, WOULD YOU LIKE TO 6197 03:40:21,085 --> 03:40:21,418 ENGAGE? 6198 03:40:21,418 --> 03:40:23,287 OUR THOUGHT WAS WE WOULD 6199 03:40:23,287 --> 03:40:25,155 PROBABLY GET 20 INSTITUTIONS TO 6200 03:40:25,155 --> 03:40:27,124 VOLUNTEER AND WOULD WORK 6201 03:40:27,124 --> 03:40:30,060 INTENSIVELY WITH 12. 6202 03:40:30,060 --> 03:40:33,597 WE GOT 50+ REALLY ENTHUSIASTIC 6203 03:40:33,597 --> 03:40:33,897 VOLUNTEERS. 6204 03:40:33,897 --> 03:40:35,332 AND DECIDED THAT WE WILL WORK 6205 03:40:35,332 --> 03:40:37,968 WITH ALL OF THEM BECAUSE THERE 6206 03:40:37,968 --> 03:40:41,705 WAS SUCH ENTHUSIASM THERE. 6207 03:40:41,705 --> 03:40:46,844 THE VOLUNTEER INSTITUTIONS ARE 6208 03:40:46,844 --> 03:40:49,680 FROM RURAL, IDeAS, HISTORICAL 6209 03:40:49,680 --> 03:40:51,648 BLACK COLLEGES AND OTHER 6210 03:40:51,648 --> 03:40:52,383 MINORITY-SERVING INSTITUTIONS, 6211 03:40:52,383 --> 03:40:55,285 KEEPS WITH THE CHIPS IN SCIENCE 6212 03:40:55,285 --> 03:40:56,253 ACT, NOT MORE THAN $25 MILLION 6213 03:40:56,253 --> 03:40:57,788 AVERAGE IN FUNDING. 6214 03:40:57,788 --> 03:40:59,423 OTHER INSTITUTIONS MAY NOT HAVE 6215 03:40:59,423 --> 03:41:03,360 HAD ANY NIH FUNDINGS TO WHOM WE 6216 03:41:03,360 --> 03:41:06,096 NEED TO MAKE OUTREACH. 6217 03:41:06,096 --> 03:41:07,631 WE'RE STARTING SMALL TO FIGURE 6218 03:41:07,631 --> 03:41:09,066 OUT HOW TO GENERALIZE BEYOND 6219 03:41:09,066 --> 03:41:09,400 THAT. 6220 03:41:09,400 --> 03:41:11,368 WHAT WE'RE DOING IN THIS 6221 03:41:11,368 --> 03:41:13,537 ENGAGEMENT IS FOCUSING ON THIS 6222 03:41:13,537 --> 03:41:15,639 PORTION OF THE GRANT LIFE CYCLE. 6223 03:41:15,639 --> 03:41:18,842 THERE'S A LOT TO GETTING A GRANT 6224 03:41:18,842 --> 03:41:20,144 SUBMITTED AND FUNDED. 6225 03:41:20,144 --> 03:41:22,212 YOU HAVE TO CONCEIVE OF THE 6226 03:41:22,212 --> 03:41:24,782 NOTION, FIND YOUR COLLABORATORS, 6227 03:41:24,782 --> 03:41:27,684 DEVELOP YOUR ABSTRACT AND AIMS. 6228 03:41:27,684 --> 03:41:30,621 THE PART WE'RE FOCUSING ON ONCE 6229 03:41:30,621 --> 03:41:33,791 THAT ABSTRACT AND AIMS DOCUMENT 6230 03:41:33,791 --> 03:41:36,427 IS DEVELOPED, GETTING THE 6231 03:41:36,427 --> 03:41:36,994 FACULTY MEMBER APPROPRIATELY 6232 03:41:36,994 --> 03:41:37,995 MATCHED TO INSTITUTE OR CENTER 6233 03:41:37,995 --> 03:41:44,835 AND HAVE A CONVERSATION WITH THE 6234 03:41:44,835 --> 03:41:48,539 PROGRAM OFFICER WHOSE PORTFOLIO 6235 03:41:48,539 --> 03:41:50,340 MIGHT OVERLAP WITH TO HAVE A 6236 03:41:50,340 --> 03:41:50,674 CONVERSATION. 6237 03:41:50,674 --> 03:41:51,442 PEOPLE CAN READ WHATEVER THEY 6238 03:41:51,442 --> 03:41:53,076 WANT INTO IT SO HAVING THAT 6239 03:41:53,076 --> 03:41:56,480 CONVERSATION IS REALLY 6240 03:41:56,480 --> 03:41:57,548 IMPORTANT. 6241 03:41:57,548 --> 03:41:59,550 AND HAVING CONVERSATION ABOUT 6242 03:41:59,550 --> 03:42:01,852 SCIENTIFIC REVIEW GROUP, OTHER 6243 03:42:01,852 --> 03:42:03,287 I.C.s, SOMETIMES ONE MAY HAVE 6244 03:42:03,287 --> 03:42:07,090 A MORE GENEROUS FUNDING LINE 6245 03:42:07,090 --> 03:42:08,725 THAN ANOTHER. 6246 03:42:08,725 --> 03:42:10,727 WE'RE NOT LOOKING AT APPLICATION 6247 03:42:10,727 --> 03:42:11,462 FOLLOW-UP FEEDBACK OR 6248 03:42:11,462 --> 03:42:13,931 RESUBMISSION, JUST THIS PART OF 6249 03:42:13,931 --> 03:42:17,701 IT, WHICH CAN BE REALLY PIVOTAL 6250 03:42:17,701 --> 03:42:21,972 TO THE SUCCESS OF RESEARCHER. 6251 03:42:21,972 --> 03:42:25,709 WE AS I SAID ARE MAKING OUTREACH 6252 03:42:25,709 --> 03:42:30,414 TO BE MORE PRECISE 52 6253 03:42:30,414 --> 03:42:31,482 INTUITIONS. 6254 03:42:31,482 --> 03:42:38,822 WE MET WITH THE PRESIDENT AND 6255 03:42:38,822 --> 03:42:40,157 RESEARCHERS THIS PAST SPRING, 6256 03:42:40,157 --> 03:42:41,592 DOING ANOTHER 15 INSTITUTIONS 6257 03:42:41,592 --> 03:42:44,995 NOW, FINISHED A MEETING WITH THE 6258 03:42:44,995 --> 03:42:46,697 INSTITUTIONS USUALLY AN HOUR AND 6259 03:42:46,697 --> 03:42:48,265 15 MINUTES PERIOD OF TIME AND 6260 03:42:48,265 --> 03:42:50,901 WE'RE GOING THROUGH THE PROCESS 6261 03:42:50,901 --> 03:42:52,536 OF MATCHING THEM WITH I.C. AND 6262 03:42:52,536 --> 03:42:58,008 PROGRAM OFFICER AND DOING A WARM 6263 03:42:58,008 --> 03:42:58,909 HANDOFF, E-MAIL INTRODUCTION, 6264 03:42:58,909 --> 03:43:02,045 FACULTY MEMBER, PROGRAM OFFICER. 6265 03:43:02,045 --> 03:43:06,049 THE GOAL TO DO REMAINING 6266 03:43:06,049 --> 03:43:07,317 INSTITUTIONS THIS SPRING, 6267 03:43:07,317 --> 03:43:10,020 APPROXIMATELY FEBRUARY TO JULY. 6268 03:43:10,020 --> 03:43:14,658 WE STARTED OFF BASED ON 6269 03:43:14,658 --> 03:43:19,429 GEOGRAPHY, DIVERSITY, WE FOUND 6270 03:43:19,429 --> 03:43:21,431 THAT THERE'S SQUISHINESS, SOME 6271 03:43:21,431 --> 03:43:24,167 WAVE 1 BECAME WAVE 2, SOME 2 6272 03:43:24,167 --> 03:43:26,036 MOVE TO 3, ALL SORTS OF THINGS 6273 03:43:26,036 --> 03:43:28,205 HAPPENED BUT WE WORK WITH THEM. 6274 03:43:28,205 --> 03:43:30,407 THESE ARE THE INSTITUTIONS 6275 03:43:30,407 --> 03:43:32,709 INVOLVED WITH WAVE 1. 6276 03:43:32,709 --> 03:43:34,778 THIS INCLUDES SIX HISTORICALLY 6277 03:43:34,778 --> 03:43:36,647 BLACK COLLEGES AND UNIVERSITIES, 6278 03:43:36,647 --> 03:43:39,049 FOUR RURAL INSTITUTIONS IN 6279 03:43:39,049 --> 03:43:39,616 IDeA STATES. 6280 03:43:39,616 --> 03:43:45,389 AND THIS IS THE OUTCOME OF MAT. 6281 03:43:45,389 --> 03:43:48,125 OUR TEAM MATCHED THEM TO AN 6282 03:43:48,125 --> 03:43:49,126 INSTITUTE OR CENTER AND A 6283 03:43:49,126 --> 03:43:50,093 PROGRAM OFFICER. 6284 03:43:50,093 --> 03:43:55,499 WE DID A PRETTY GOOD JOB OF 6285 03:43:55,499 --> 03:43:57,668 MATCHING, 75% OF THE TIME TO SAY 6286 03:43:57,668 --> 03:43:59,636 IS THIS APPROPRIATE MATCH THEY 6287 03:43:59,636 --> 03:44:00,137 AGREED. 6288 03:44:00,137 --> 03:44:02,272 BUT WE DIDN'T DO AS WELL IN 6289 03:44:02,272 --> 03:44:04,341 MATCHING TO THE PROGRAM OFFICER 6290 03:44:04,341 --> 03:44:08,278 IN ONLY 58% OF THE TIME WAS THAT 6291 03:44:08,278 --> 03:44:09,947 AN APPROPRIATE MATCH, FROM THE 6292 03:44:09,947 --> 03:44:11,381 VIEWPOINT OF LEADERSHIP. 6293 03:44:11,381 --> 03:44:14,751 SOMETIMES PROGRAM OFFICERS HAD 6294 03:44:14,751 --> 03:44:15,519 CHANGED PORTFOLIOS, LEAVE, ALL 6295 03:44:15,519 --> 03:44:17,054 SORTS OF THINGS. 6296 03:44:17,054 --> 03:44:19,690 ANOTHER FACT WE THOUGHT PERHAPS 6297 03:44:19,690 --> 03:44:21,458 THAT THE SCIENTISTS KNOW THEIR 6298 03:44:21,458 --> 03:44:22,793 SCIENCE BETTER THAN WE DO AND 6299 03:44:22,793 --> 03:44:24,928 MAYBE THEY NEED TO BE DOING THE 6300 03:44:24,928 --> 03:44:26,363 MATCHING SO THAT'S SOMETHING 6301 03:44:26,363 --> 03:44:28,332 THAT'S BEEN CHANGED TO WAVE 2 6302 03:44:28,332 --> 03:44:29,800 THAT WE'RE HAVING THE FACULTY DO 6303 03:44:29,800 --> 03:44:31,935 THE INITIAL MATCHING RATHER THAN 6304 03:44:31,935 --> 03:44:35,939 OUR TEAM TO SEE WHETHER THAT PO 6305 03:44:35,939 --> 03:44:38,208 MATCH TURNS OUT TO BE BETTER. 6306 03:44:38,208 --> 03:44:40,277 WAVE 1 THE INTENT WAS TO MAKE 6307 03:44:40,277 --> 03:44:42,045 SURE THE FACULTY HAD MORE THAN 6308 03:44:42,045 --> 03:44:45,449 ONE CONNECTION TO AN I.C. 6309 03:44:45,449 --> 03:44:46,783 BECAUSE, AGAIN, SOMETIMES IT'S 6310 03:44:46,783 --> 03:44:49,386 AMAZING HOW MANY I.C.s HAVE 6311 03:44:49,386 --> 03:44:51,355 SIMILAR INTERESTS AND HOW 6312 03:44:51,355 --> 03:44:52,656 DIFFERENT THE OPPORTUNITIES FOR 6313 03:44:52,656 --> 03:44:55,292 FUNDING MIGHT BE FOR I.C.s. 6314 03:44:55,292 --> 03:44:57,594 AND WE WERE VERY PLEASED THAT AT 6315 03:44:57,594 --> 03:44:59,763 LEAST 65% OF THE FACULTY WERE 6316 03:44:59,763 --> 03:45:04,701 ABLE TO HAVE TWO OR MORE 6317 03:45:04,701 --> 03:45:05,002 CONNECTIONS. 6318 03:45:05,002 --> 03:45:07,537 WHAT DID WE LEARN? 6319 03:45:07,537 --> 03:45:11,341 WE LEARNED THESE INSTITUTIONS 6320 03:45:11,341 --> 03:45:16,179 ALL HAD UNIQUE STRENGTHS TO BE 6321 03:45:16,179 --> 03:45:18,915 LEVERAGED FOR POTENTIAL GRANT 6322 03:45:18,915 --> 03:45:19,483 APPLICATIONS, NSF FUNDING, 6323 03:45:19,483 --> 03:45:20,350 DoD, DEPARTMENT OF 6324 03:45:20,350 --> 03:45:23,186 AGRICULTURE, SOME INFRASTRUCTURE 6325 03:45:23,186 --> 03:45:26,490 FUNDING FROM NIH, SOME HAD 6326 03:45:26,490 --> 03:45:28,125 PHILANTHROPIC SUPPORT FOR THEIR 6327 03:45:28,125 --> 03:45:29,292 OFFICE OF SCIENCE SPONSORED 6328 03:45:29,292 --> 03:45:30,661 RESEARCH BUT ALL THAT STRENGTHS, 6329 03:45:30,661 --> 03:45:32,929 WHICH IS WONDERFUL AND THEY 6330 03:45:32,929 --> 03:45:33,830 BRING DIFFERENT PERSPECTIVES TO 6331 03:45:33,830 --> 03:45:36,566 THE SCIENCE OF NIH. 6332 03:45:36,566 --> 03:45:39,736 BECAUSE WE WERE LOOKING FOR 6333 03:45:39,736 --> 03:45:43,140 PEOPLE WHO HAD AN ABSTRACT 6334 03:45:43,140 --> 03:45:44,875 SPECIFIC AIM, FAIRLY 6335 03:45:44,875 --> 03:45:46,643 SOPHISTICATED, PRETTY UNIFORMLY 6336 03:45:46,643 --> 03:45:48,145 TURNED IN ABSTRACTS REALLY WELL 6337 03:45:48,145 --> 03:45:48,612 WRITTEN. 6338 03:45:48,612 --> 03:45:55,819 AND NOT EVEN A HANDFUL SUBMITTED 6339 03:45:55,819 --> 03:45:57,487 ABSTRACTS AND AIMS BUT HAD A 6340 03:45:57,487 --> 03:45:58,255 CONVERSATION WITH SOMEONE FROM 6341 03:45:58,255 --> 03:46:00,223 THE I.C. TO GET A BETTER 6342 03:46:00,223 --> 03:46:04,695 UNDERSTANDING HOW TO GO FORWARD. 6343 03:46:04,695 --> 03:46:06,329 UNLESS FACULTY WERE BEYOND EARLY 6344 03:46:06,329 --> 03:46:07,631 CAREER STAGE. 6345 03:46:07,631 --> 03:46:11,568 WHAT WE LEARNED AT END OF WAVE 6346 03:46:11,568 --> 03:46:13,537 1, CONVENING IN AUGUST, WHAT 6347 03:46:13,537 --> 03:46:16,039 COULD BE DONE BETTER, GIVING 6348 03:46:16,039 --> 03:46:18,809 THEM A CHANCE TO HAVE INTERNAL 6349 03:46:18,809 --> 03:46:21,078 NETWORKING AND NETWORK WITH OUR 6350 03:46:21,078 --> 03:46:22,479 NIH STAFF WHO WERE INVOLVED WITH 6351 03:46:22,479 --> 03:46:23,613 THE ADVISORY COMMITTEE, THEY 6352 03:46:23,613 --> 03:46:25,415 WERE REALLY GRATEFUL FOR THE 6353 03:46:25,415 --> 03:46:26,783 CONNECTIONS WITH THE PROGRAM 6354 03:46:26,783 --> 03:46:27,017 OFFICER. 6355 03:46:27,017 --> 03:46:30,754 SOME NOT REALIZING YOU COULD 6356 03:46:30,754 --> 03:46:33,623 MAKE SUCH OUTREACH. 6357 03:46:33,623 --> 03:46:35,525 AND THEY -- IN THE MAJORITY OF 6358 03:46:35,525 --> 03:46:38,562 CASES FOUND THE PROGRAM OFFICER 6359 03:46:38,562 --> 03:46:41,932 WAS HELPFUL, 73 OUT OF 74. 6360 03:46:41,932 --> 03:46:42,999 THERE'S ALWAYS A CURMUDGEON IN 6361 03:46:42,999 --> 03:46:44,334 THE GROUP BUT THAT'S OKAY. 6362 03:46:44,334 --> 03:46:46,837 WE HEARD THESE FOLKS ARE REALLY 6363 03:46:46,837 --> 03:46:48,605 BUSY, MANY WITH HEAVY TEACHING 6364 03:46:48,605 --> 03:46:52,209 LOADS, ET CETERA, THEREFORE THEY 6365 03:46:52,209 --> 03:46:53,009 APPRECIATE INFORMATION PACKAGED 6366 03:46:53,009 --> 03:46:55,712 AND DELIVERED TO THEM. 6367 03:46:55,712 --> 03:47:06,189 THAT LED TO EARA NEWS BLAST. 6368 03:47:07,157 --> 03:47:09,392 THESE ARE INSTITUTIONS INVOLVED 6369 03:47:09,392 --> 03:47:12,996 IN WAVE 2, INCLUDING THREE 6370 03:47:12,996 --> 03:47:13,330 HBCUs. 6371 03:47:13,330 --> 03:47:15,398 WE'RE IN THE MIDDLE OF THE 6372 03:47:15,398 --> 03:47:16,066 PROCESS. 6373 03:47:16,066 --> 03:47:18,235 WE'VE MET WITH ALL, HAVE GOTTEN 6374 03:47:18,235 --> 03:47:19,870 ABSTRACT OF AIMS FROM THE 6375 03:47:19,870 --> 03:47:21,304 FACULTY NOW, CONFIRMING WITH THE 6376 03:47:21,304 --> 03:47:24,141 LEADERSHIP OF I.C.s THE 6377 03:47:24,141 --> 03:47:26,476 MATCHES ARE APPROPRIATE. 6378 03:47:26,476 --> 03:47:30,180 IN THIS CASE WE TAUGHT THEM TO 6379 03:47:30,180 --> 03:47:32,549 DO THEIR OWN MATCHES, I'LL 6380 03:47:32,549 --> 03:47:35,085 ELABORATE IN JUST A MOMENT. 6381 03:47:35,085 --> 03:47:39,022 WE SENT IT TO I.C. LEADERSHIP. 6382 03:47:39,022 --> 03:47:40,891 THIS IS DIFFERENT. 6383 03:47:40,891 --> 03:47:43,794 IN PURPLE YOU SEE WE HAVE THE 6384 03:47:43,794 --> 03:47:44,961 INITIAL CALL AND TRAIN THEM 6385 03:47:44,961 --> 03:47:47,831 DURING THAT CALL TO USE THE NIH 6386 03:47:47,831 --> 03:47:48,932 TOOL MATCHMAKER. 6387 03:47:48,932 --> 03:47:51,768 IT'S A GREAT TOOL FOR TRYING TO 6388 03:47:51,768 --> 03:47:56,139 FIGURE OUT WHAT I.C., WHAT 6389 03:47:56,139 --> 03:47:57,040 PROGRAM OFFICER, WHAT GROUP, 6390 03:47:57,040 --> 03:47:59,442 HELP THEM TO BE REALLY ADEPT AT 6391 03:47:59,442 --> 03:48:01,845 USING IT WAS THE INTENT HERE. 6392 03:48:01,845 --> 03:48:04,381 THEY THEN WERE SENT OUT TO 6393 03:48:04,381 --> 03:48:05,782 IDENTIFY THEIR OWN MATCHES TO 6394 03:48:05,782 --> 03:48:06,983 SUBMIT THAT INFORMATION TO US 6395 03:48:06,983 --> 03:48:08,318 WITHIN A COUPLE WEEKS. 6396 03:48:08,318 --> 03:48:10,821 WE HAVE TEAM MEMBERS AVAILABLE 6397 03:48:10,821 --> 03:48:13,790 TO PROVIDE THEM TECHNICAL 6398 03:48:13,790 --> 03:48:14,291 ASSISTANCE. 6399 03:48:14,291 --> 03:48:16,726 AND THEN THERE WAS A FOLLOW-UP 6400 03:48:16,726 --> 03:48:19,062 E-MAIL THAT WENT TO I.C. 6401 03:48:19,062 --> 03:48:21,665 LEADERSHIP TO ASK DOES THIS 6402 03:48:21,665 --> 03:48:23,099 APPEAR TO BE APPROPRIATE, THEN 6403 03:48:23,099 --> 03:48:24,534 THERE WAS E-MAIL CONNECTION DONE 6404 03:48:24,534 --> 03:48:26,069 BETWEEN THE FACULTY MEMBER AND 6405 03:48:26,069 --> 03:48:28,905 THE PROGRAM OFFICER AFTER WE HAD 6406 03:48:28,905 --> 03:48:30,540 CONFIRMATION THAT THE CONNECTION 6407 03:48:30,540 --> 03:48:31,641 WAS APPROPRIATE. 6408 03:48:31,641 --> 03:48:33,643 TEAM DID A COUPLE FOLLOW-UPS, 6409 03:48:33,643 --> 03:48:35,078 THEY WILL BE DOING A COUPLE 6410 03:48:35,078 --> 03:48:36,913 FOLLOW-UPS AS THEY DID WITH WAVE 6411 03:48:36,913 --> 03:48:39,883 1 TO MAKE SURE ANY PROBLEMS THAT 6412 03:48:39,883 --> 03:48:42,953 MAY HAVE OCCURRED WE'VE MADE 6413 03:48:42,953 --> 03:48:44,421 SOME INTERVENTIONS, AND THERE 6414 03:48:44,421 --> 03:48:45,488 WILL BE ANOTHER VIRTUAL 6415 03:48:45,488 --> 03:48:47,524 CONVENING EARLY MARCH TO SEE HOW 6416 03:48:47,524 --> 03:48:48,625 THINGS WENT FOR WAVE 2 FACULTY 6417 03:48:48,625 --> 03:48:51,394 AND TO GIVE THEM A CHANCE TO 6418 03:48:51,394 --> 03:48:54,564 NETWORK AMONG THEM SELVES AND 6419 03:48:54,564 --> 03:48:56,433 NIH STAFF WITH THE IDEA WHATEVER 6420 03:48:56,433 --> 03:48:58,401 LESSONS LEARNED FROM THAT BEING 6421 03:48:58,401 --> 03:49:05,809 APPLICABLE TO THE WAVE 3 FOLKS. 6422 03:49:05,809 --> 03:49:08,111 AND AFTER ALL THREE PRESUMABLY 6423 03:49:08,111 --> 03:49:09,212 I'LL BE RETIRED BUT PRESUMABLY A 6424 03:49:09,212 --> 03:49:13,149 CHANCE TO STEP BACK AND SEE WHAT 6425 03:49:13,149 --> 03:49:13,917 ARE GENERALIZABLE PRINCIPLES 6426 03:49:13,917 --> 03:49:16,553 FROM THAT CAN BE USED WITH 6427 03:49:16,553 --> 03:49:17,721 OTHERS. 6428 03:49:17,721 --> 03:49:20,423 THIS IS A MAP THAT SHOWS THE 6429 03:49:20,423 --> 03:49:23,493 LOCATION OF ALL THE TARGETED 6430 03:49:23,493 --> 03:49:26,596 INSTITUTIONS, SPRING OF 2024 IS 6431 03:49:26,596 --> 03:49:35,906 WAVE 1 INSTITUTIONS, WINTER 2025 6432 03:49:35,906 --> 03:49:37,107 WAVE 2 INSTITUTIONS, SUMMER 2025 6433 03:49:37,107 --> 03:49:37,974 WAVE THREE. 6434 03:49:37,974 --> 03:49:39,643 THINGS MOVE AROUND. 6435 03:49:39,643 --> 03:49:40,877 UNTIL IT'S ABSOLUTELY CONFIRMED 6436 03:49:40,877 --> 03:49:43,880 WHAT THE WAVE 3 INSTITUTIONS ARE 6437 03:49:43,880 --> 03:49:45,515 THAT IS NOT SHARED. 6438 03:49:45,515 --> 03:49:47,417 THAT'S BEEN A BIG EFFORT, 6439 03:49:47,417 --> 03:49:50,253 BUILDING THAT IS GOING TO GROW 6440 03:49:50,253 --> 03:49:52,055 AND EXPAND. 6441 03:49:52,055 --> 03:49:54,357 BECAUSE IT'S REALLY IMPORTANT 6442 03:49:54,357 --> 03:49:57,727 TO, AGAIN, BRING IN DIFFERENT 6443 03:49:57,727 --> 03:50:01,564 PERSPECTIVES AND NOT THE USUAL 6444 03:50:01,564 --> 03:50:03,533 SUSPECTS ADDRESSING QUESTIONS OF 6445 03:50:03,533 --> 03:50:05,402 BIOMEDICAL AND BEHAVIORAL 6446 03:50:05,402 --> 03:50:05,735 RESEARCH. 6447 03:50:05,735 --> 03:50:07,904 WE WORK ON DISSEMINATING 6448 03:50:07,904 --> 03:50:08,171 EVIDENCE. 6449 03:50:08,171 --> 03:50:09,673 WE'VE HAD BLOGS. 6450 03:50:09,673 --> 03:50:12,943 WE HAVE SCIENTIFIC DIVERSITY 6451 03:50:12,943 --> 03:50:13,810 WORKFORCE SEMINAR SERIES. 6452 03:50:13,810 --> 03:50:17,113 I'D LIKE TO POINT OUT THAT, 6453 03:50:17,113 --> 03:50:18,882 AGAIN, SEMINAR SERIES 6454 03:50:18,882 --> 03:50:21,418 INFORMATION IS ON NLM BOOKSHELF. 6455 03:50:21,418 --> 03:50:24,120 IT CAN BE SEARCHED BY 6456 03:50:24,120 --> 03:50:24,487 PubMed. 6457 03:50:24,487 --> 03:50:25,889 IT BRINGS TOGETHER RELATED 6458 03:50:25,889 --> 03:50:28,825 EVIDENCE FROM EACH ONE OF THESE 6459 03:50:28,825 --> 03:50:31,361 SEMINARS, A TOTAL OF 12 OR 15 OF 6460 03:50:31,361 --> 03:50:36,499 THEM, WITH LOTS OF REFERENCES. 6461 03:50:36,499 --> 03:50:38,601 WE'RE HONORED TO HELP CO-LEAD 6462 03:50:38,601 --> 03:50:42,872 THE DEVELOPMENT OF THE NIH-WIDE 6463 03:50:42,872 --> 03:50:44,407 DEIA STRATEGIC PLAN. 6464 03:50:44,407 --> 03:50:47,010 THIS IS SOMETHING A MANDATE OF 6465 03:50:47,010 --> 03:50:51,214 THE BIDEN ADMINISTRATION, 6466 03:50:51,214 --> 03:50:53,950 EXECUTIVE ORDER, HOWEVER WAS 6467 03:50:53,950 --> 03:50:54,951 DEVELOPED TWO DIFFERENT 6468 03:50:54,951 --> 03:50:56,586 MANDATES, NOT ONLY EXECUTIVE 6469 03:50:56,586 --> 03:50:59,422 ORDER BUT ALSO LANGUAGE FROM THE 6470 03:50:59,422 --> 03:51:06,563 FISCAL YEAR 21 21 NIH BUDGET TO 6471 03:51:06,563 --> 03:51:08,298 ASSURE A DIVERSITY OF RESEARCH 6472 03:51:08,298 --> 03:51:10,500 WITH NIH-FUNDED RESEARCH SO YOU 6473 03:51:10,500 --> 03:51:12,068 SEE PARTICULARLY IN OBJECTIVE 3 6474 03:51:12,068 --> 03:51:16,639 OF THIS PLAN ATTENTION TO THAT 6475 03:51:16,639 --> 03:51:18,174 ISSUE. 6476 03:51:18,174 --> 03:51:22,245 WE'RE REALLY GRATEFUL TO ALL 6477 03:51:22,245 --> 03:51:24,514 100+ NIHers WHO CONTRIBUTED TO 6478 03:51:24,514 --> 03:51:26,282 THE DEVELOPMENT OF PLAN AND 6479 03:51:26,282 --> 03:51:28,251 COLLEAGUES AT EDI LEADING 6480 03:51:28,251 --> 03:51:29,452 IMPLEMENTATION OF IT. 6481 03:51:29,452 --> 03:51:31,421 WHAT DOES THE FUTURE HOLD? 6482 03:51:31,421 --> 03:51:33,523 AS OF DECEMBER 31 I WILL BE 6483 03:51:33,523 --> 03:51:33,857 RETIRED. 6484 03:51:33,857 --> 03:51:36,126 WATCHING FROM A DISTANCE. 6485 03:51:36,126 --> 03:51:38,661 BUT I THINK THAT THERE WILL BE 6486 03:51:38,661 --> 03:51:41,831 AN OPPORTUNITY GOING FORWARD TO 6487 03:51:41,831 --> 03:51:45,101 MORE BROADLY APPLICABLE 6488 03:51:45,101 --> 03:51:45,668 EVIDENCE-BASED INITIATIVES. 6489 03:51:45,668 --> 03:51:46,970 WHAT HAS BEEN DEVELOPED HAS BEEN 6490 03:51:46,970 --> 03:51:48,004 BROADLY APPLICABLE. 6491 03:51:48,004 --> 03:51:48,838 WE DON'T TARGET A PARTICULAR 6492 03:51:48,838 --> 03:51:49,906 TYPE OF INDIVIDUAL. 6493 03:51:49,906 --> 03:51:53,410 WE THINK OF THINGS BROADLY. 6494 03:51:53,410 --> 03:51:55,712 WELL, OKAY, WE'RE TARGETING WITH 6495 03:51:55,712 --> 03:51:56,946 THE RAI INITIATIVE INSTITUTIONS 6496 03:51:56,946 --> 03:51:59,349 THAT HAVE NOT HAD MUCH IN THE 6497 03:51:59,349 --> 03:52:04,954 WAY OF NIH FUNDING. 6498 03:52:04,954 --> 03:52:07,791 BUT INITIATIVES ARE BROADLY 6499 03:52:07,791 --> 03:52:08,224 APPLICABLE. 6500 03:52:08,224 --> 03:52:13,263 A RISING TIDE LIFTS ALL BOATS IS 6501 03:52:13,263 --> 03:52:13,696 APROPO. 6502 03:52:13,696 --> 03:52:15,331 I'LL CLOSE BY SAYING WHAT I SAID 6503 03:52:15,331 --> 03:52:16,766 WHEN I APPLIED FOR THE JOB. 6504 03:52:16,766 --> 03:52:18,535 IF YOU WANT TO GO FAST, GO 6505 03:52:18,535 --> 03:52:19,035 ALONE. 6506 03:52:19,035 --> 03:52:21,137 IF YOU WANT TO GO FAR, YOU GO 6507 03:52:21,137 --> 03:52:21,404 TOGETHER. 6508 03:52:21,404 --> 03:52:24,741 WE'VE BEEN ABLE TO GO REALLY FAR 6509 03:52:24,741 --> 03:52:26,709 THANKS TO THE SUPPORT OF MANY, 6510 03:52:26,709 --> 03:52:27,277 MANY, MANY INDIVIDUALS. 6511 03:52:27,277 --> 03:52:30,680 I WOULD LIKE TO PARTICULARLY 6512 03:52:30,680 --> 03:52:31,781 THANK MONICA BERTAGNOLLI AND 6513 03:52:31,781 --> 03:52:34,951 LARRY TABAK WHO HAVE BEEN 6514 03:52:34,951 --> 03:52:37,220 STEADFAST IN THEIR SUPPORT. 6515 03:52:37,220 --> 03:52:41,291 ALL OF I.C. DIRECTORS, ADVISORY 6516 03:52:41,291 --> 03:52:44,461 COMMITTEE, CHAIR AND WORKING 6517 03:52:44,461 --> 03:52:46,763 GROUP ON DIVERSITY, INTERNAL 6518 03:52:46,763 --> 03:52:48,598 GROUPS WORKING WITH US TO MOVE 6519 03:52:48,598 --> 03:52:49,032 THINGS FORWARD. 6520 03:52:49,032 --> 03:52:52,102 ALL I CAN SAY IS MANY THANKS TO 6521 03:52:52,102 --> 03:52:52,335 ALL. 6522 03:52:52,335 --> 03:52:53,670 IT'S BEEN A REALLY WONDERFUL 6523 03:52:53,670 --> 03:52:54,737 FOUR YEARS. 6524 03:52:54,737 --> 03:52:57,240 THANK YOU. 6525 03:52:57,240 --> 03:52:59,109 >> WOW, THANK YOU SO MUCH, 6526 03:52:59,109 --> 03:52:59,876 MARIE. 6527 03:52:59,876 --> 03:53:02,378 LET ME JUST SAY THANK YOU FOR 6528 03:53:02,378 --> 03:53:06,850 ALL YOU'VE DONE TO ELEVATE OUR 6529 03:53:06,850 --> 03:53:09,786 SCIENTIFIC EXCELLENCE ACROSS THE 6530 03:53:09,786 --> 03:53:11,721 BOARD TO EMPOWER A WORKFORCE WE 6531 03:53:11,721 --> 03:53:14,757 REALLY NEED TO SEE AND TO REALLY 6532 03:53:14,757 --> 03:53:17,160 MAKE IT POSSIBLE FOR SO MANY 6533 03:53:17,160 --> 03:53:20,430 MORE PEOPLE THAT HAVE SO MUCH TO 6534 03:53:20,430 --> 03:53:21,164 CONTRIBUTE TO PARTICIPATE IN OUR 6535 03:53:21,164 --> 03:53:22,532 IMPORTANT WORK. 6536 03:53:22,532 --> 03:53:24,400 THIS IS OPEN FOR QUESTIONS FROM 6537 03:53:24,400 --> 03:53:25,335 THE TEAM. 6538 03:53:25,335 --> 03:53:28,738 WE HAVE ABOUT 15 MINUTES. 6539 03:53:28,738 --> 03:53:34,777 6540 03:53:34,777 --> 03:53:37,981 6541 03:53:37,981 --> 03:53:39,182 >> ANY COMMENTS OR QUESTIONS 6542 03:53:39,182 --> 03:53:41,251 FROM FOLKS? 6543 03:53:41,251 --> 03:53:43,319 6544 03:53:43,319 --> 03:53:46,756 >> MY ONLY COMMENT IS WOW, WHAT 6545 03:53:46,756 --> 03:53:49,392 A TOUR DE FORCE THROUGH AN 6546 03:53:49,392 --> 03:53:54,531 EVIDENCE-BASED A APPROACH. 6547 03:53:54,531 --> 03:53:56,799 THANK YOU FOR THE YEARS OF 6548 03:53:56,799 --> 03:53:58,434 SERVICE, YOUR LEADERSHIP THROUGH 6549 03:53:58,434 --> 03:54:01,871 NIA, NOW IN THIS WORK AROUND 6550 03:54:01,871 --> 03:54:02,372 WORKFORCE DIVERSITY. 6551 03:54:02,372 --> 03:54:04,574 THANK YOU AND APPRECIATE YOU. 6552 03:54:04,574 --> 03:54:05,909 VERY LARGE SHOES TO FILL. 6553 03:54:05,909 --> 03:54:10,346 >> THANK YOU SO MUCH. 6554 03:54:10,346 --> 03:54:11,347 >> OTHER COMMENTS OR QUESTIONS 6555 03:54:11,347 --> 03:54:16,052 THAT PEOPLE MAY HAVE? 6556 03:54:16,052 --> 03:54:16,619 6557 03:54:16,619 --> 03:54:16,886 YES, RUSS? 6558 03:54:16,886 --> 03:54:20,790 >> DR. BERNARD, LET ME ALSO 6559 03:54:20,790 --> 03:54:21,658 ECHO DEEP APPRECIATION. 6560 03:54:21,658 --> 03:54:24,093 I'VE WATCHED YOUR WORK ON 6561 03:54:24,093 --> 03:54:25,929 COUNCIL OF COUNCILS AS WELL. 6562 03:54:25,929 --> 03:54:27,697 CLEARLY YOUR IMPACT ON NIH AS A 6563 03:54:27,697 --> 03:54:30,400 WHOLE IN THE SCIENTIFIC 6564 03:54:30,400 --> 03:54:32,402 ESTABLISHMENT IS PROFOUND. 6565 03:54:32,402 --> 03:54:33,269 THE QUESTIONS, WHAT ADVICE ARE 6566 03:54:33,269 --> 03:54:35,004 YOU GOING TO GIVE YOUR 6567 03:54:35,004 --> 03:54:36,639 SUCCESSOR? 6568 03:54:36,639 --> 03:54:38,875 WHAT IS THE BIGGEST TASK YOU SEE 6569 03:54:38,875 --> 03:54:44,013 BEFORE YOU RIGHT NOW AS WE MOVE 6570 03:54:44,013 --> 03:54:46,950 INTO THE POST-ERA OF YOUR 6571 03:54:46,950 --> 03:54:47,250 LEADERSHIP? 6572 03:54:47,250 --> 03:54:48,384 >> GOOD QUESTION. 6573 03:54:48,384 --> 03:54:53,656 WHAT I SEE IS A LOT OF DIFFERENT 6574 03:54:53,656 --> 03:54:55,391 PEOPLE BEING INVOLVED AND 6575 03:54:55,391 --> 03:54:56,926 RESPONSIBLE FOR MAKING SURE THAT 6576 03:54:56,926 --> 03:54:58,795 THERE'S BROAD PARTICIPATION IN 6577 03:54:58,795 --> 03:54:59,128 SCIENCE. 6578 03:54:59,128 --> 03:55:01,831 AND WHAT I WOULD SAY TO EVERY 6579 03:55:01,831 --> 03:55:03,399 ONE OF THEM IS THAT THEY SHOULD 6580 03:55:03,399 --> 03:55:05,335 BE VERY, VERY PROUD OF THE WORK 6581 03:55:05,335 --> 03:55:06,336 THEY ARE DOING. 6582 03:55:06,336 --> 03:55:07,537 AND THE FACT THAT THEY HAD THE 6583 03:55:07,537 --> 03:55:10,974 CHANCE TO DO IT HERE AT NIH, YOU 6584 03:55:10,974 --> 03:55:13,810 KNOW, BEST PLACE IN THE WORLD TO 6585 03:55:13,810 --> 03:55:16,412 GENERATE KNOWLEDGE AND SCIENCE. 6586 03:55:16,412 --> 03:55:17,180 AND DR. BERTAGNOLLI KEEPS 6587 03:55:17,180 --> 03:55:19,048 SAYING, INTENT IS FOR WHAT WE 6588 03:55:19,048 --> 03:55:21,451 DEVELOP TO BE APPLICABLE TO ALL. 6589 03:55:21,451 --> 03:55:24,053 SO THEIR JOB IS TO MAKE SURE 6590 03:55:24,053 --> 03:55:24,687 THAT HAPPENS. 6591 03:55:24,687 --> 03:55:27,490 AND THAT BEGINNINGS WITH MAKING 6592 03:55:27,490 --> 03:55:30,093 SURE YOU HAVE THE BEST IN THE 6593 03:55:30,093 --> 03:55:31,561 WAY OF IDEATION, THAT'S BROAD 6594 03:55:31,561 --> 03:55:31,928 PARTICIPATION. 6595 03:55:31,928 --> 03:55:34,697 KEEP UP THE GOOD WORK. 6596 03:55:34,697 --> 03:55:36,699 KEEP DOING WHAT YOU'RE DOING IN 6597 03:55:36,699 --> 03:55:38,968 TERMS OF MAKING SURE THAT YOU'RE 6598 03:55:38,968 --> 03:55:40,937 THINKING DIFFERENTLY AND THAT 6599 03:55:40,937 --> 03:55:43,039 YOU'RE LISTENING TO SOMETHING 6600 03:55:43,039 --> 03:55:45,208 THAT YOU DIDN'T THINK ABOUT. 6601 03:55:45,208 --> 03:55:48,177 YOU KNOW, THE STUDY OF 6602 03:55:48,177 --> 03:55:52,882 ORNITHOLOGY WHERE THEY HAD MORE 6603 03:55:52,882 --> 03:55:54,884 WOMEN COME IN, SUBVERTED 6604 03:55:54,884 --> 03:55:55,551 DOMINANT PARADIGM. 6605 03:55:55,551 --> 03:55:56,986 SOMETIMES YOU PERSON WHO BRINGS 6606 03:55:56,986 --> 03:55:57,820 SOMETHING FORWARD YOU DIDN'T 6607 03:55:57,820 --> 03:55:58,488 EXPECT THAT'S THE PERSON THAT 6608 03:55:58,488 --> 03:56:00,023 COMES UP WITH THE ANSWER BUT 6609 03:56:00,023 --> 03:56:02,558 THAT CAN SOMETIMES BE THE CASE. 6610 03:56:02,558 --> 03:56:03,993 TO REMEMBER THAT, TO REMEMBER 6611 03:56:03,993 --> 03:56:07,063 THE MISSION THAT WE HAVE AT NIH, 6612 03:56:07,063 --> 03:56:08,731 KEEP WORKING TOWARDS THAT IS 6613 03:56:08,731 --> 03:56:10,667 WHAT I WOULD ENCOURAGE ALL OF 6614 03:56:10,667 --> 03:56:14,604 THE FOLKS WHO HAVE BEEN 6615 03:56:14,604 --> 03:56:16,172 INVOLVED, NOT JUST ONE. 6616 03:56:16,172 --> 03:56:17,807 >> THANK YOU. 6617 03:56:17,807 --> 03:56:22,512 OTHER COMMENTS? 6618 03:56:22,512 --> 03:56:27,884 YES, GO AHEAD. 6619 03:56:27,884 --> 03:56:29,085 >> I WANT TO SAY I THINK THIS IS 6620 03:56:29,085 --> 03:56:31,921 A REALLY IMPORTANT AREA AND I 6621 03:56:31,921 --> 03:56:34,657 THINK THAT AT THIS TIME RECENTLY 6622 03:56:34,657 --> 03:56:35,958 WE'VE SEEN DIFFERENT 6623 03:56:35,958 --> 03:56:36,592 UNIVERSITIES, DIFFERENT 6624 03:56:36,592 --> 03:56:38,528 PROGRAMS, GETTING RID OF THEIR 6625 03:56:38,528 --> 03:56:40,930 DIVERSITY INITIATIVES AND I WANT 6626 03:56:40,930 --> 03:56:44,033 TO SAY IT'S INCREDIBLY IMPORTANT 6627 03:56:44,033 --> 03:56:48,404 THAT WE KEEP MOVING THIS NEEDLE 6628 03:56:48,404 --> 03:56:48,638 FORWARD. 6629 03:56:48,638 --> 03:56:52,442 IT'S A SLOW PROCESS. 6630 03:56:52,442 --> 03:56:55,478 I JUST GRADUATED MY FIRST 6631 03:56:55,478 --> 03:56:56,713 STUDENT, MY FIRST UNDERGRADUATE 6632 03:56:56,713 --> 03:57:00,350 JUST GRADUATED WITH A DOCTORAL 6633 03:57:00,350 --> 03:57:01,117 DISSERTATION YESTERDAY SO 17 6634 03:57:01,117 --> 03:57:04,620 YEARS LATER, SO IT TAKES A WHILE 6635 03:57:04,620 --> 03:57:05,722 TO BUILD THESE FOLKS. 6636 03:57:05,722 --> 03:57:07,457 IT'S A LOT OF EFFORT. 6637 03:57:07,457 --> 03:57:09,759 WE HAVE TO BE PERSISTENT WE 6638 03:57:09,759 --> 03:57:11,594 DON'T LOSE ANY MOMENTUM THERE. 6639 03:57:11,594 --> 03:57:13,363 ONE OF THE THINGS I WAS GOING TO 6640 03:57:13,363 --> 03:57:16,099 SUGGEST AND THEN YOU WENT RIGHT 6641 03:57:16,099 --> 03:57:18,835 INTO IT WAS IMPORTANCE OF 6642 03:57:18,835 --> 03:57:20,403 COMMUNICATING WHAT THE EFFECT OF 6643 03:57:20,403 --> 03:57:22,138 DIVERSITY IS. 6644 03:57:22,138 --> 03:57:26,709 WHAT THE MEANING IS BEYOND 6645 03:57:26,709 --> 03:57:29,379 SIMPLIFYING, YOU KNOW, AMERICANS 6646 03:57:29,379 --> 03:57:33,316 HAVE A TENDENCY TO SIMPLIFY, 6647 03:57:33,316 --> 03:57:34,283 IT'S NOT. 6648 03:57:34,283 --> 03:57:35,618 DIVERSITY OF IDEAS, DIVERSITY OF 6649 03:57:35,618 --> 03:57:39,021 OPPORTUNITY, OPPORTUNITY IS THE 6650 03:57:39,021 --> 03:57:43,493 ONE KEY TO GETTING PEOPLE -- 6651 03:57:43,493 --> 03:57:44,260 GETTING DIFFERENT AGENCIES 6652 03:57:44,260 --> 03:57:44,927 DIVERSE. 6653 03:57:44,927 --> 03:57:46,462 WE HAVE TO CREATE AS MANY 6654 03:57:46,462 --> 03:57:47,663 OPPORTUNITIES AS WE CAN. 6655 03:57:47,663 --> 03:57:49,632 I APPRECIATE YOUR WORK DOING 6656 03:57:49,632 --> 03:57:49,832 THAT. 6657 03:57:49,832 --> 03:57:54,003 SO, THANK YOU FOR THAT. 6658 03:57:54,003 --> 03:57:55,972 I REALLY APPRECIATE IT. 6659 03:57:55,972 --> 03:58:01,244 >> I'M EXCITED ABOUT THE THE WK 6660 03:58:01,244 --> 03:58:02,545 CONTINUING WITH THE EARA 6661 03:58:02,545 --> 03:58:02,845 INITIATIVES. 6662 03:58:02,845 --> 03:58:04,547 THAT'S GOING TO BE REALLY 6663 03:58:04,547 --> 03:58:06,382 IMPORTANT TO MAKING SURE DIVERSE 6664 03:58:06,382 --> 03:58:07,250 VOICES ARE THERE. 6665 03:58:07,250 --> 03:58:09,118 I GREW UP IN OKLAHOMA. 6666 03:58:09,118 --> 03:58:10,887 I SPENT SOME TIME AS A FACULTY 6667 03:58:10,887 --> 03:58:15,024 MEMBER AT UNIVERSITY OF OKLAHOMA 6668 03:58:15,024 --> 03:58:16,993 COLLEGE OF MEDICINE. 6669 03:58:16,993 --> 03:58:19,962 AND THERE'S SUCH GREAT -- WE HAD 6670 03:58:19,962 --> 03:58:21,330 SUCH BRIGHT STUDENTS THERE AT 6671 03:58:21,330 --> 03:58:22,698 UNIVERSITY OF OKLAHOMA COLLEGE 6672 03:58:22,698 --> 03:58:23,232 OF MEDICINE. 6673 03:58:23,232 --> 03:58:25,968 AND I THINK WE NEED CAPTURE THAT 6674 03:58:25,968 --> 03:58:26,202 TALENT. 6675 03:58:26,202 --> 03:58:28,571 IT'S ALL OVER THE COUNTRY. 6676 03:58:28,571 --> 03:58:29,806 WE DON'T NECESSARILY MAKE AS 6677 03:58:29,806 --> 03:58:37,880 MUCH CONTACT AS WE NEED IN THOSE 6678 03:58:37,880 --> 03:58:38,147 SETTINGS. 6679 03:58:38,147 --> 03:58:40,283 >> AS MARIE KNOWS, I'M A PROUD 6680 03:58:40,283 --> 03:58:42,718 GRADUATE OF CITY COLLEGE OF NEW 6681 03:58:42,718 --> 03:58:43,019 YORK. 6682 03:58:43,019 --> 03:58:44,687 SO, YOU KNOW, IT CAN HAPPEN. 6683 03:58:44,687 --> 03:58:47,690 YOU CAN GO TO PLACES THAT AT 6684 03:58:47,690 --> 03:58:50,359 LEAST AT THE TIME WERE A BIT 6685 03:58:50,359 --> 03:58:52,995 UNDERRESOURCED RELATIVE TO THEIR 6686 03:58:52,995 --> 03:58:53,596 NEIGHBORING INSTITUTIONS, OF 6687 03:58:53,596 --> 03:58:55,965 WHICH THERE ARE MANY. 6688 03:58:55,965 --> 03:59:00,903 BUT, YOU KNOW, I THINK THE EARA 6689 03:59:00,903 --> 03:59:04,474 PROGRAM IS INCREDIBLY IMPORTANT. 6690 03:59:04,474 --> 03:59:05,741 AND THE OUTREACH, YOU KNOW, THAT 6691 03:59:05,741 --> 03:59:08,678 I'VE HAD THE PRIVILEGE OF DOING, 6692 03:59:08,678 --> 03:59:09,479 TRAVELING AROUND THE COUNTRY, 6693 03:59:09,479 --> 03:59:11,981 BECAUSE I DO TEND TO GO TO 6694 03:59:11,981 --> 03:59:16,419 SCHOOLS THAT ARE A BIT MORE 6695 03:59:16,419 --> 03:59:17,753 UNDERRESOURCED THAN OTHERS, I 6696 03:59:17,753 --> 03:59:22,358 ALWAYS FIND AMAZING PEOPLE TO 6697 03:59:22,358 --> 03:59:23,226 INTERACT WITH. 6698 03:59:23,226 --> 03:59:24,760 AND JUST SOMETIMES IT JUST 6699 03:59:24,760 --> 03:59:27,797 REQUIRES A BIT OF ENCOURAGEMENT 6700 03:59:27,797 --> 03:59:28,931 BECAUSE UNFORTUNATELY, YOU KNOW, 6701 03:59:28,931 --> 03:59:32,001 THE SYSTEM CAN BE DAUNTING IF 6702 03:59:32,001 --> 03:59:34,737 YOU DON'T HAVE FOLKS AT YOUR 6703 03:59:34,737 --> 03:59:36,272 INSTITUTION WHO HAVE 6704 03:59:36,272 --> 03:59:37,473 SUCCESSFULLY NAVIGATED IT. 6705 03:59:37,473 --> 03:59:39,709 AND I THINK THE EARA PROGRAM IS 6706 03:59:39,709 --> 03:59:42,845 GOING TO FILL AND IS BEGINNING 6707 03:59:42,845 --> 03:59:45,781 TO ALREADY FILL THAT GAP, THAT 6708 03:59:45,781 --> 03:59:48,618 VOID, AND SO WE'RE REALLY JUST 6709 03:59:48,618 --> 03:59:51,921 DELIGHTED AT THE UPTAKE OF THAT 6710 03:59:51,921 --> 03:59:54,423 PROGRAM AND OUR HOPE IS TO 6711 03:59:54,423 --> 03:59:57,293 CONTINUE THIS AND EXPAND UPON 6712 03:59:57,293 --> 03:59:58,327 IT. 6713 03:59:58,327 --> 04:00:00,897 YOU KNOW, MARIE OUTLINED HOW 6714 04:00:00,897 --> 04:00:01,998 THAT COULD HAPPEN. 6715 04:00:01,998 --> 04:00:05,601 OTHER COMMENTS OR QUESTIONS? 6716 04:00:05,601 --> 04:00:07,770 >> I CAN ADD A QUICK ONE. 6717 04:00:07,770 --> 04:00:12,975 AND THAT IS, YOU KNOW, DEIA, THE 6718 04:00:12,975 --> 04:00:13,809 ACCESSIBILITY PART TOO IS, YOU 6719 04:00:13,809 --> 04:00:16,045 KNOW, SOMETHING THAT I THINK 6720 04:00:16,045 --> 04:00:21,183 MARIE IS ALSO CHAMPIONING SO 6721 04:00:21,183 --> 04:00:22,618 MUCH. 6722 04:00:22,618 --> 04:00:23,586 ABOUT BRINGING THE BEST MINDS. 6723 04:00:23,586 --> 04:00:25,688 WE LIVE IN A WORLD WITH A LOT OF 6724 04:00:25,688 --> 04:00:26,989 TECHNOLOGY, A LOT OF POTENTIAL 6725 04:00:26,989 --> 04:00:29,525 TO OPEN DOORS TO PEOPLE, TO 6726 04:00:29,525 --> 04:00:31,227 THESE BRILLIANT MINDS WE WANT TO 6727 04:00:31,227 --> 04:00:34,330 ENGAGE IN WAYS WE HAVEN'T HAD 6728 04:00:34,330 --> 04:00:34,664 BEFORE. 6729 04:00:34,664 --> 04:00:36,632 I REALLY THINK AT APPLYING THAT 6730 04:00:36,632 --> 04:00:41,871 NOT ONLY TO AS OUR RESEARCH AIM 6731 04:00:41,871 --> 04:00:44,173 TO IMPROVE PEOPLE'S LIVES, 6732 04:00:44,173 --> 04:00:46,142 ALLOWING THEM TO LEAVE FULLER 6733 04:00:46,142 --> 04:00:47,777 AND MORE ACTIVE LIVES, IT'S 6734 04:00:47,777 --> 04:00:52,815 SOMETHING WE ASPIRE TO FOR 6735 04:00:52,815 --> 04:00:55,017 IMPROVING PEOPLE'S ABILITY TO 6736 04:00:55,017 --> 04:00:55,918 CONTRIBUTE TO BIOMEDICAL 6737 04:00:55,918 --> 04:00:56,352 RESEARCH. 6738 04:00:56,352 --> 04:01:00,189 AND THAT ONE IS ALSO GOING TO BE 6739 04:01:00,189 --> 04:01:03,693 REALLY STRONG GOING FORWARD. 6740 04:01:03,693 --> 04:01:03,893 OKAY. 6741 04:01:03,893 --> 04:01:08,064 LAST CALL. 6742 04:01:08,064 --> 04:01:11,901 IF THAT'S WE'LL TAKE A COFFEE 6743 04:01:11,901 --> 04:01:17,673 BREAK I THINK. 6744 04:01:17,673 --> 04:01:20,009 6745 04:01:20,009 --> 04:01:23,613 >> OH, GO AHEAD. 6746 04:01:23,613 --> 04:01:26,315 >> I'LL EXPRESS MY SENTIMENTS, 6747 04:01:26,315 --> 04:01:26,782 DR. BERNARD. 6748 04:01:26,782 --> 04:01:29,385 I'D LIKE TO EXPAND TO THE GROUP 6749 04:01:29,385 --> 04:01:30,052 HERE. 6750 04:01:30,052 --> 04:01:34,423 I'M VERY THANKFUL FOR THE WORK 6751 04:01:34,423 --> 04:01:37,393 YOU'VE DONE, DR. BERNARD. 6752 04:01:37,393 --> 04:01:39,862 TWO ISSUES ARE CLOSE AND DEAR TO 6753 04:01:39,862 --> 04:01:41,530 ME PERSONALLY. 6754 04:01:41,530 --> 04:01:45,568 AS A PROFESSIONALS IN TERMS OF 6755 04:01:45,568 --> 04:01:49,205 ENSURING INCLUSION AS RELATES TO 6756 04:01:49,205 --> 04:01:50,640 RESEARCH, ACTIVE INSTITUTIONS, 6757 04:01:50,640 --> 04:01:57,480 MINORITY SEARCHING INSTITUTIONS 6758 04:01:57,480 --> 04:02:01,150 SUCH AS HBCUs, OF COURSE A 6759 04:02:01,150 --> 04:02:03,552 STALWART IN TERMS OF PUSHING AN 6760 04:02:03,552 --> 04:02:11,427 AGENDA FOR -- FORWARD FOR PEOPE 6761 04:02:11,427 --> 04:02:14,697 WITH DISABILITIES, SCIENTIFIC 6762 04:02:14,697 --> 04:02:16,932 WORKFORCE, CONTRIBUTING TO A 6763 04:02:16,932 --> 04:02:18,768 BROADER SCIENTIFIC WORK FORCE 6764 04:02:18,768 --> 04:02:21,303 AND ACTIVATION OF A VULNERABLE 6765 04:02:21,303 --> 04:02:22,605 POPULATION AND PERSONS WITH 6766 04:02:22,605 --> 04:02:26,475 DISABILITY NOT IDENTIFIED AS A 6767 04:02:26,475 --> 04:02:27,777 HEALTH DISPARITY GROUP 6768 04:02:27,777 --> 04:02:31,080 POPULATION WITHIN NIH AND OF 6769 04:02:31,080 --> 04:02:32,515 COURSE THIS IS A PARADIGM SHIFT 6770 04:02:32,515 --> 04:02:35,551 IN TERMS OF A POPULATION THAT 6771 04:02:35,551 --> 04:02:38,087 NIH TARGET, IN TERMS OF 6772 04:02:38,087 --> 04:02:39,488 IMPROVING SELF-CARE FOR THOSE 6773 04:02:39,488 --> 04:02:40,256 INDIVIDUALS. 6774 04:02:40,256 --> 04:02:42,892 SO I WANT TO THANK YOU AGAIN FOR 6775 04:02:42,892 --> 04:02:46,696 ALL THAT YOU'VE DONE FOR THE 6776 04:02:46,696 --> 04:02:48,030 FIELD, BIOMEDICAL AND BEHAVIORAL 6777 04:02:48,030 --> 04:02:51,534 FIELDS, AND FOR THE SCIENTISTS 6778 04:02:51,534 --> 04:02:57,773 IN THE FIELD, PARTICULARLY THOSE 6779 04:02:57,773 --> 04:02:58,307 WITH DISABILITIES. 6780 04:02:58,307 --> 04:03:00,376 WE WISH YOU A RESTFUL 6781 04:03:00,376 --> 04:03:05,181 RETIREMENT, I'M SURE YOUR LEGACY 6782 04:03:05,181 --> 04:03:06,382 WILL BE EXTENDED FORWARD FOR 6783 04:03:06,382 --> 04:03:07,383 YEARS TO COME. 6784 04:03:07,383 --> 04:03:10,352 >> THANK YOU SO MUCH. 6785 04:03:10,352 --> 04:03:11,120 >> HEAR, HEAR. 6786 04:03:11,120 --> 04:03:13,956 THANK YOU, COREY. 6787 04:03:13,956 --> 04:03:16,025 >> ONE LAST STATEMENT EVERY 6788 04:03:16,025 --> 04:03:18,194 OPPORTUNITY THAT YOU HAVE AT NIH 6789 04:03:18,194 --> 04:03:20,730 TO OPEN YOUR DOORS AND BRING 6790 04:03:20,730 --> 04:03:25,468 YOUNG PEOPLE IN FROM ZERO TO 6791 04:03:25,468 --> 04:03:27,203 WHATEVER, EVEN AN AFTERNOON, A 6792 04:03:27,203 --> 04:03:29,305 DAY, THE STUDENT I WAS JUST 6793 04:03:29,305 --> 04:03:33,509 SPEAKING ABOUT DID A FELLOWSHIP 6794 04:03:33,509 --> 04:03:37,480 AT NIH. 6795 04:03:37,480 --> 04:03:38,047 A LONG-TERM FELLOWSHIP. 6796 04:03:38,047 --> 04:03:42,752 I HAVE A LIST OF FOLKS WHO HAVE 6797 04:03:42,752 --> 04:03:45,054 DONE A PROGRAM, EVEN A ONE-WEEK 6798 04:03:45,054 --> 04:03:46,288 SUMMER SEMINAR THERE. 6799 04:03:46,288 --> 04:03:48,257 IT MAKES SUCH A HUGE IMPACT ON 6800 04:03:48,257 --> 04:03:49,024 THEM. 6801 04:03:49,024 --> 04:03:50,659 I THINK IT'S REALLY IMPORTANT. 6802 04:03:50,659 --> 04:03:55,030 AND THEY END UP IN PLACES, LABS 6803 04:03:55,030 --> 04:03:56,599 THEY NEVER KNEW THEY WOULD EVER 6804 04:03:56,599 --> 04:03:58,134 BE ABLE TO BE IN. 6805 04:03:58,134 --> 04:04:00,102 THANK YOU AND PLEASE KEEP YOUR 6806 04:04:00,102 --> 04:04:01,670 EYE AND OPEN AS MANY DOORS AS 6807 04:04:01,670 --> 04:04:02,505 YOU CAN. 6808 04:04:02,505 --> 04:04:05,107 THANK YOU. 6809 04:04:05,107 --> 04:04:07,743 6810 04:04:07,743 --> 04:04:08,377 >> OKAY. 6811 04:04:08,377 --> 04:04:09,612 >> WE WILL RECONVENE AT 3:00 6812 04:04:09,612 --> 04:04:13,215 PLEASE. 6813 04:04:13,215 --> 04:04:14,750 WE'LL TAKE A LITTLE BREAK, 6814 04:04:14,750 --> 04:04:16,952 COFFEE TIME I GUESS FOR SOME OF 6815 04:04:16,952 --> 04:04:17,753 YOU. 6816 04:04:17,753 --> 04:04:19,121 AND 3:00 WE'LL RECONVENE. 6817 04:04:19,121 --> 04:04:22,538 THANK YOU. 6818 04:04:22,538 --> 04:04:33,477 WELCOME BACK, EVERYBODY. 6819 04:04:33,477 --> 04:04:36,546 WE'RE GOING TO START WITH KEVIN 6820 04:04:36,546 --> 04:04:38,749 WILLIAMS, DIRECTOR OF THE OFFICE 6821 04:04:38,749 --> 04:04:41,051 OF EQUITY, DIVERSITY, INCLUSION. 6822 04:04:41,051 --> 04:04:42,686 KEVIN, ALL YOURS. 6823 04:04:42,686 --> 04:04:43,053 >> EXCELLENT. 6824 04:04:43,053 --> 04:04:45,622 GOOD AFTERNOON TO THE NIH 6825 04:04:45,622 --> 04:04:47,724 DIRECTOR, DR. BERTAGNOLLI, 6826 04:04:47,724 --> 04:04:49,593 SENIOR LEADERS AT THE NIH, 6827 04:04:49,593 --> 04:04:51,161 STAFF, MEMBERS OF THE ADVISORY 6828 04:04:51,161 --> 04:04:52,562 COMMITTEE TO THE DIRECTOR. 6829 04:04:52,562 --> 04:04:54,097 THANK YOU FOR INVITING ME TODAY 6830 04:04:54,097 --> 04:04:57,934 TO GIVE YOU AN UPDATE ON THE 6831 04:04:57,934 --> 04:04:59,736 ONGOING ACTIVITIES OF THE 6832 04:04:59,736 --> 04:05:03,607 DISABILITY SUBCOMMITTEE. 6833 04:05:03,607 --> 04:05:05,375 NEXT SLIDE PLEASE. 6834 04:05:05,375 --> 04:05:08,078 OUR SUBGROUP HAS SPECIFIC ROLES 6835 04:05:08,078 --> 04:05:11,248 IN PROJECTS WHICH FOCUS ON 6836 04:05:11,248 --> 04:05:14,017 ACCESSIBILITY AS A PRIMARY 6837 04:05:14,017 --> 04:05:14,651 ACTIVITY. 6838 04:05:14,651 --> 04:05:16,086 THIS INCLUDES OUTREACH TO 6839 04:05:16,086 --> 04:05:18,055 INTERNAL GROUPS SUCH AS 6840 04:05:18,055 --> 04:05:20,691 ENGAGEMENT AND EMPLOYMENT 6841 04:05:20,691 --> 04:05:22,793 INTEREST GROUPS. TO GET INPUT 6842 04:05:22,793 --> 04:05:25,529 AND FEEDBACK ON ACCESSIBILITY OF 6843 04:05:25,529 --> 04:05:26,930 NIH PROGRAMS AND POLICIES, 6844 04:05:26,930 --> 04:05:29,466 REVIEW OF POLICIES FOR 6845 04:05:29,466 --> 04:05:31,034 DISCRIMINATORY LANGUAGE, AND 6846 04:05:31,034 --> 04:05:33,503 REFERENCES FOR STYLE GUIDES. 6847 04:05:33,503 --> 04:05:35,972 COMPLIANCE REVIEWS FOR EXISTING 6848 04:05:35,972 --> 04:05:37,574 LAWS, IDENTIFICATION OF 6849 04:05:37,574 --> 04:05:38,408 TRAINING, BUILDING OF RESOURCES 6850 04:05:38,408 --> 04:05:43,347 FOR THE OFFICE OF HUMAN 6851 04:05:43,347 --> 04:05:45,048 RESOURCES AND MY OFFICE, OFFICE 6852 04:05:45,048 --> 04:05:46,616 OF DIVERSITY, EQUITY, AND 6853 04:05:46,616 --> 04:05:46,950 INCLUSION. 6854 04:05:46,950 --> 04:05:49,252 WE'LL COORDINATE WITH AND ACT AS 6855 04:05:49,252 --> 04:05:50,687 RESOURCE FOR OTHER OFFICES 6856 04:05:50,687 --> 04:05:54,157 WITHIN THE NIH THAT ARE LEADING 6857 04:05:54,157 --> 04:05:57,227 ACCESSIBILITY EFFORTS. 6858 04:05:57,227 --> 04:05:58,328 NEXT SLIDE PLEASE. 6859 04:05:58,328 --> 04:06:00,163 I HAVE THE LUXURY OF BEING 6860 04:06:00,163 --> 04:06:04,668 JOINED BY TWO OTHER CO-CHAIRS ON 6861 04:06:04,668 --> 04:06:05,702 THIS SUBCOMMITTEE. 6862 04:06:05,702 --> 04:06:09,272 THE EXECUTIVE OFFICER AT THE 6863 04:06:09,272 --> 04:06:14,111 NATIONAL HUMAN GENOME RESEARCH 6864 04:06:14,111 --> 04:06:15,879 INSTITUTE, HELEN, AND DR. ALISON 6865 04:06:15,879 --> 04:06:18,582 CERNICH, FROM THE EUNICE KENNEDY 6866 04:06:18,582 --> 04:06:19,182 SHRIVER NATIONAL INSTITUTE OF 6867 04:06:19,182 --> 04:06:21,852 CHILD HEALTH AND HUMAN 6868 04:06:21,852 --> 04:06:22,452 DEVELOPMENT. 6869 04:06:22,452 --> 04:06:24,821 WE STARTED TO ORGANIZE OUR 6870 04:06:24,821 --> 04:06:26,590 SUBCOMMITTEE INTO THREE WORK 6871 04:06:26,590 --> 04:06:29,226 STREAMS, THE FIRST IS TRAINING 6872 04:06:29,226 --> 04:06:31,995 AND EDUCATION WHICH IS ASSESSING 6873 04:06:31,995 --> 04:06:33,630 CURRENT TRAININGS AND MAKING 6874 04:06:33,630 --> 04:06:34,631 RECOMMENDATIONS AND DEVELOPING 6875 04:06:34,631 --> 04:06:38,034 NEW TRAININGS RELATED TO 6876 04:06:38,034 --> 04:06:38,702 ACCESSIBILITY. 6877 04:06:38,702 --> 04:06:43,173 THE SECOND SUBCOMMITTEE IS THE 6878 04:06:43,173 --> 04:06:46,109 WORKPLACE ACCESSIBILITY GROUP, 6879 04:06:46,109 --> 04:06:48,645 WHICH EXAMINES ACCESSIBILITY OF 6880 04:06:48,645 --> 04:06:52,816 PHYSICAL WORKSPACES AND DIGITAL 6881 04:06:52,816 --> 04:06:54,885 ACCESSIBILITY OF NIH IN MAKING 6882 04:06:54,885 --> 04:06:55,252 RECOMMENDATIONS. 6883 04:06:55,252 --> 04:06:58,755 THIRD GROUP, THAT I LEAD, 6884 04:06:58,755 --> 04:07:02,592 FOCUSES ON DATA, POLICIES, 6885 04:07:02,592 --> 04:07:03,693 PROCEDURES, WE'VE BEEN 6886 04:07:03,693 --> 04:07:04,661 EVALUATING CURRENT DATA 6887 04:07:04,661 --> 04:07:06,530 PROCESSES AND OTHER PROCESSES 6888 04:07:06,530 --> 04:07:10,700 AND PROCEDURES RELATED TO 6889 04:07:10,700 --> 04:07:11,401 ACCESSIBILITY. 6890 04:07:11,401 --> 04:07:13,637 EACH CO-CHAIR LEADS ONE WORK 6891 04:07:13,637 --> 04:07:14,171 STREAM. 6892 04:07:14,171 --> 04:07:18,575 WE HAVE A VERY ENGAGED 6893 04:07:18,575 --> 04:07:21,545 PRO-ACTIVE SUBCOMMITTEE OF 6894 04:07:21,545 --> 04:07:23,146 VOLUNTEERS, APPROXIMATELY 15 6895 04:07:23,146 --> 04:07:24,614 FROM ACROSS NIH TO MOVE THE WORK 6896 04:07:24,614 --> 04:07:27,150 IN EACH OF THE THREE WORK 6897 04:07:27,150 --> 04:07:28,885 STREAMS FORWARD. 6898 04:07:28,885 --> 04:07:30,620 THE SUBCOMMITTEE INCLUDES 6899 04:07:30,620 --> 04:07:32,622 REPRESENTATIVES WITH LIVED 6900 04:07:32,622 --> 04:07:36,326 EXPERIENCES AND DISABILITY 6901 04:07:36,326 --> 04:07:38,728 EXPERTISE TO ENSURE WE'RE 6902 04:07:38,728 --> 04:07:39,930 INCLUSIVE OF PERSPECTIVES AND IN 6903 04:07:39,930 --> 04:07:42,432 DEPTH UNDERSTANDING OF WHAT THE 6904 04:07:42,432 --> 04:07:43,867 ISSUES ARE. 6905 04:07:43,867 --> 04:07:45,702 WE ARE VERY, VERY EXCITED ABOUT 6906 04:07:45,702 --> 04:07:49,339 THE LEVEL OF PROGRESS THAT WE'VE 6907 04:07:49,339 --> 04:07:51,241 MADE SINCE LAUNCHING 6908 04:07:51,241 --> 04:07:58,415 SUBCOMMITTEE IN FEBRUARY, AND SO 6909 04:07:58,415 --> 04:07:59,850 I WOULD SAY WE WERE REMARKING 6910 04:07:59,850 --> 04:08:03,453 HOW MUCH JOY IT'S BEEN TO FOCUS 6911 04:08:03,453 --> 04:08:06,523 ON THIS PARTICULAR WORK. 6912 04:08:06,523 --> 04:08:08,058 NEXT SLIDE PLEASE. 6913 04:08:08,058 --> 04:08:10,994 HERE WE HAVE HIGHLIGHTED JUST A 6914 04:08:10,994 --> 04:08:12,562 FEW ACCOMPLISHMENTS FROM EACH 6915 04:08:12,562 --> 04:08:14,097 GROUP TO DATE. 6916 04:08:14,097 --> 04:08:15,732 PLEASE UNDERSTAND THAT THESE DO 6917 04:08:15,732 --> 04:08:17,801 NOT FULLY ENCOMPASS EVERYTHING 6918 04:08:17,801 --> 04:08:20,504 THAT THE SUBCOMMITTEE IS DOING 6919 04:08:20,504 --> 04:08:23,273 TO ENHANCE ACCESSIBILITY AT NIH. 6920 04:08:23,273 --> 04:08:26,209 WITH REGARD TO THE TRAINING AND 6921 04:08:26,209 --> 04:08:27,611 EDUCATION GROUP, THE GROUP HAS 6922 04:08:27,611 --> 04:08:30,480 COLLABORATED WITH THE OFFICE OF 6923 04:08:30,480 --> 04:08:32,682 EXTRAMURAL RESEARCH TO CREATE AN 6924 04:08:32,682 --> 04:08:34,217 ONLINE RESOURCE FOR RESEARCHERS 6925 04:08:34,217 --> 04:08:37,954 WITH DISABILITIES THAT WE HOPE 6926 04:08:37,954 --> 04:08:38,922 WILL LAUNCH SOON. 6927 04:08:38,922 --> 04:08:40,357 ANOTHER CONSULTATION WITH OFFICE 6928 04:08:40,357 --> 04:08:43,960 OF EXTRAMURAL RESEARCH FOCUSES 6929 04:08:43,960 --> 04:08:50,500 ON ACCESSIBILITY OF ONLINE 6930 04:08:50,500 --> 04:08:52,502 SYSTEMS, USE OF INCLUSIVE 6931 04:08:52,502 --> 04:08:53,503 LANGUAGE. 6932 04:08:53,503 --> 04:08:56,039 FOR THE WORKPLACE ACCESSIBILITY 6933 04:08:56,039 --> 04:08:59,376 GROUP, THEY HAVE DEVELOPED A NOT 6934 04:08:59,376 --> 04:09:01,378 ACCESSIBLE REPORTED CAMPAIGN TO 6935 04:09:01,378 --> 04:09:03,780 HELP IDENTIFY PHYSICAL SPACES 6936 04:09:03,780 --> 04:09:06,850 THAT NEED ENHANCED 6937 04:09:06,850 --> 04:09:07,183 ACCESSIBILITY. 6938 04:09:07,183 --> 04:09:09,819 THE CAMPAIGN CURRENTLY USES QR 6939 04:09:09,819 --> 04:09:10,720 CODE POSTED ACROSS THE NIH 6940 04:09:10,720 --> 04:09:13,557 CAMPUS BUT THE CAMPAIGN IS 6941 04:09:13,557 --> 04:09:16,192 LOOKING FOR WAYS TO INCREASE 6942 04:09:16,192 --> 04:09:18,828 ACCESSIBILITY. 6943 04:09:18,828 --> 04:09:20,463 THE GROUP ALSO EXAMINED 6944 04:09:20,463 --> 04:09:21,565 ACCESSIBILITY OF CONFERENCE 6945 04:09:21,565 --> 04:09:22,866 FACILITY ON BETHESDA MAIN CAMPUS 6946 04:09:22,866 --> 04:09:25,802 AND IS DEVELOPING A GUIDE TO 6947 04:09:25,802 --> 04:09:27,571 HOST ACCESSIBLE EVENTS FOR USE 6948 04:09:27,571 --> 04:09:28,972 ACROSS NIH. 6949 04:09:28,972 --> 04:09:31,708 WE HOPE TO PILOT THE GUIDE SOON. 6950 04:09:31,708 --> 04:09:34,778 WITH REGARD TO MY PARTICULAR 6951 04:09:34,778 --> 04:09:37,414 GROUP, WE HAVE REVISED A 6952 04:09:37,414 --> 04:09:39,382 COMPREHENSIVE DATA POLICY TO 6953 04:09:39,382 --> 04:09:42,886 PROMOTE TRANSPARENCY AND 6954 04:09:42,886 --> 04:09:44,187 INDIVIDUAL PRIVACY PROTECTIONS 6955 04:09:44,187 --> 04:09:46,056 FOR NIH EMPLOYEE WORKFORCE DATA. 6956 04:09:46,056 --> 04:09:48,892 IN ADDITION THE GROUP IS 6957 04:09:48,892 --> 04:09:51,528 CURRENTLY REVIEWING AND UPDATING 6958 04:09:51,528 --> 04:09:53,930 REASONABLE ACCOMMODATIONS POLICY 6959 04:09:53,930 --> 04:09:55,565 AND PROCEDURES TO INCREASE 6960 04:09:55,565 --> 04:09:57,667 INCLUSIVITY OF WORKPLACE 6961 04:09:57,667 --> 04:09:59,536 PRACTICES AND TO STREAMLINE 6962 04:09:59,536 --> 04:10:02,372 PROCESSES AT THE NIH. 6963 04:10:02,372 --> 04:10:03,239 NEXT SLIDE PLEASE. 6964 04:10:03,239 --> 04:10:05,008 WITH REGARD TO THE FUTURE WE 6965 04:10:05,008 --> 04:10:08,044 HOPE TO CONTINUE THE GREAT WORK 6966 04:10:08,044 --> 04:10:09,045 OF THIS SUBCOMMITTEE. 6967 04:10:09,045 --> 04:10:10,981 WE'LL CONTINUE WORKING ON SOME 6968 04:10:10,981 --> 04:10:13,984 OF THE ITEMS I HAVE ALREADY 6969 04:10:13,984 --> 04:10:16,152 HIGHLIGHTED ABOVE RELATED TO 6970 04:10:16,152 --> 04:10:17,787 PHYSICAL AND DIGITAL 6971 04:10:17,787 --> 04:10:19,789 ACCESSIBILITY AT THE NIH. 6972 04:10:19,789 --> 04:10:22,826 WE'LL CONTINUE TO COLLABORATE 6973 04:10:22,826 --> 04:10:24,594 WITH OUR KEY PARTNERS AND 6974 04:10:24,594 --> 04:10:27,130 CUSTOMERS ACROSS NIH TO CREATE 6975 04:10:27,130 --> 04:10:32,369 NEW RESOURCES, FOR THE BUSINESS 6976 04:10:32,369 --> 04:10:33,770 DISABILITY COMMUNITY AND IMPROVE 6977 04:10:33,770 --> 04:10:37,507 EXISTING NIH SYSTEMS. 6978 04:10:37,507 --> 04:10:40,110 WE ALSO PLAN TO CONTINUE WORK 6979 04:10:40,110 --> 04:10:41,478 EXAMINING NIH POLICIES AND 6980 04:10:41,478 --> 04:10:44,314 PROCEDURES TO ENSURE THAT THE 6981 04:10:44,314 --> 04:10:45,382 WORKFORCE DATA REMAINS SECURE 6982 04:10:45,382 --> 04:10:47,917 BUT AT THE SAME TIME WOULD ALLOW 6983 04:10:47,917 --> 04:10:51,087 US TO USE THOSE DATA IN AN 6984 04:10:51,087 --> 04:10:54,257 ACTIONABLE WAY TO IMPROVE OUR 6985 04:10:54,257 --> 04:10:55,225 PROGRAMS AND OVERALL 6986 04:10:55,225 --> 04:10:58,862 ACCESSIBILITY OF NIH. 6987 04:10:58,862 --> 04:10:59,763 THIS WILL IMPROVE WORKPLACE 6988 04:10:59,763 --> 04:11:01,264 EXPERIENCE OF ALL OF OUR 6989 04:11:01,264 --> 04:11:05,635 EMPLOYEES AND OUR VISITORS TO 6990 04:11:05,635 --> 04:11:05,969 OUR CAMPUS. 6991 04:11:05,969 --> 04:11:07,504 NEXT SLIDE PLEASE. 6992 04:11:07,504 --> 04:11:09,806 I WILL STOP THERE. 6993 04:11:09,806 --> 04:11:11,641 THIS HAS ALWAYS BEEN AN EXCITING 6994 04:11:11,641 --> 04:11:13,243 SPACE TO BE WORKING IN. 6995 04:11:13,243 --> 04:11:18,548 AND I JUST WANT TO REITERATE HOW 6996 04:11:18,548 --> 04:11:20,083 MUCH EXCITEMENT WE BRING TO EACH 6997 04:11:20,083 --> 04:11:21,651 OF THE MEETINGS AND TO THE WORK 6998 04:11:21,651 --> 04:11:23,620 THAT WE'RE DOING IN THIS SPACE. 6999 04:11:23,620 --> 04:11:30,093 I BELIEVE WE WILL BE TAKING 7000 04:11:30,093 --> 04:11:33,363 QUESTIONS AT THE END SO I'LL 7001 04:11:33,363 --> 04:11:36,099 TURN IT OVER TO ADAM POLITIS. 7002 04:11:36,099 --> 04:11:39,269 >> LET ME INTRODUCE ADAM 7003 04:11:39,269 --> 04:11:39,602 QUICKLY. 7004 04:11:39,602 --> 04:11:41,237 YOU, NOT ADAM. 7005 04:11:41,237 --> 04:11:47,811 OKAY, I'LL INTRODUCE YOU TO DR. 7006 04:11:47,811 --> 04:11:49,879 TARA SCHWETZ, DEPUTY DIRECTOR 7007 04:11:49,879 --> 04:11:50,880 FOR PROGRAM COORDINATION, 7008 04:11:50,880 --> 04:11:51,948 PLANNING, STRATEGIC INITIATIVES 7009 04:11:51,948 --> 04:11:52,849 AT NIH. 7010 04:11:52,849 --> 04:11:53,583 >> THANK YOU. 7011 04:11:53,583 --> 04:11:57,520 NEXT SLIDE TO GET OURS CUED UP. 7012 04:11:57,520 --> 04:11:58,488 GOOD AFTERNOON. 7013 04:11:58,488 --> 04:12:01,491 I GUESS EVERYONE IS NOW IN 7014 04:12:01,491 --> 04:12:01,758 AFTERNOON. 7015 04:12:01,758 --> 04:12:02,892 TODAY WE'RE GOING TO TALK ABOUT 7016 04:12:02,892 --> 04:12:05,095 SOME OF THE MORE RESEARCH 7017 04:12:05,095 --> 04:12:07,831 FOCUSED ACTIVITIES THAT WE HAVE 7018 04:12:07,831 --> 04:12:10,467 TAKEN TO PROMOTE DISABILITY 7019 04:12:10,467 --> 04:12:12,235 INCLUSION AND ADVANCE THE 7020 04:12:12,235 --> 04:12:13,203 DISABILITY-RELATED HEALTH 7021 04:12:13,203 --> 04:12:15,505 DISPARITIES RESEARCH PORTFOLIO 7022 04:12:15,505 --> 04:12:17,373 AT NIH. 7023 04:12:17,373 --> 04:12:19,776 AND ALSO SHARE ABOUT SOME OF OUR 7024 04:12:19,776 --> 04:12:20,310 PLANNED EFFORTS. 7025 04:12:20,310 --> 04:12:24,147 IF YOU COULD GO TO THE NEXT 7026 04:12:24,147 --> 04:12:24,347 SLIDE. 7027 04:12:24,347 --> 04:12:26,983 SOME OF YOU MAY BE AWARE BUT 7028 04:12:26,983 --> 04:12:28,885 MORE THAN ONE IN FOUR ADULTS IN 7029 04:12:28,885 --> 04:12:31,387 THE UNITED STATES HAVE A 7030 04:12:31,387 --> 04:12:31,921 DISABILITY. 7031 04:12:31,921 --> 04:12:34,891 SO, I WANT TO REPEAT THAT AND 7032 04:12:34,891 --> 04:12:35,225 EMPHASIZE. 7033 04:12:35,225 --> 04:12:37,060 THAT'S ONE IN FOUR. 7034 04:12:37,060 --> 04:12:38,595 OF COURSE, PEOPLE WITH 7035 04:12:38,595 --> 04:12:40,697 DISABILITIES LEAD RICH AND FULL 7036 04:12:40,697 --> 04:12:42,532 LIVES, BUT MANY EXPERIENCE A 7037 04:12:42,532 --> 04:12:44,601 RANGE OF HEALTH CONDITIONS. 7038 04:12:44,601 --> 04:12:46,302 AND NIH IS COMMITTED TO 7039 04:12:46,302 --> 04:12:47,670 IMPROVING THE HEALTH AND 7040 04:12:47,670 --> 04:12:49,672 WELL-BEING OF PEOPLE WITH 7041 04:12:49,672 --> 04:12:50,039 DISABILITIES. 7042 04:12:50,039 --> 04:12:52,642 WE'VE GOT A LONG HISTORY OF 7043 04:12:52,642 --> 04:12:54,344 SUPPORTING DISABILITY RESEARCH. 7044 04:12:54,344 --> 04:12:56,446 BUT RECOGNIZE THAT A LOT OF WORK 7045 04:12:56,446 --> 04:13:04,120 STILL REMAINS TO HELPFULLY 7046 04:13:04,120 --> 04:13:04,788 -- TO 7047 04:13:04,788 --> 04:13:06,055 FULLY UNDERSTAND. 7048 04:13:06,055 --> 04:13:10,160 AS WAS MENTIONED EARLIER BACK IN 7049 04:13:10,160 --> 04:13:11,461 DECEMBER OF 2022, ADVISORY 7050 04:13:11,461 --> 04:13:21,971 COMMITTEE TO WORKING GROUP ON 7051 04:13:22,906 --> 04:13:24,474 DIVERSITY SUBGROUP PROVIDED 7052 04:13:24,474 --> 04:13:25,208 RECOMMENDATIONS ON PROMOTING 7053 04:13:25,208 --> 04:13:26,543 DISABILITY INCLUSION. 7054 04:13:26,543 --> 04:13:27,343 WE ESTABLISHED INTERNAL 7055 04:13:27,343 --> 04:13:28,144 DISABILITY SUBCOMMITTEE THAT YOU 7056 04:13:28,144 --> 04:13:31,281 JUST HEARD A LITTLE BIT ABOUT 7057 04:13:31,281 --> 04:13:32,348 FROM KEVIN. 7058 04:13:32,348 --> 04:13:34,918 AND AS DR. BERTAGNOLLI MENTIONED 7059 04:13:34,918 --> 04:13:36,953 THIS MORNING, NIH HAS ALSO 7060 04:13:36,953 --> 04:13:39,022 ISSUED A REQUEST FOR INFORMATION 7061 04:13:39,022 --> 04:13:41,791 SEEKING EXTERNAL AND INTERNAL 7062 04:13:41,791 --> 04:13:43,860 INPUT ON PROPOSED REVISIONS TO 7063 04:13:43,860 --> 04:13:46,162 THE MISSION STATEMENT, INCLUDED 7064 04:13:46,162 --> 04:13:48,131 A RECOMMENDATION THAT NIH REDUCE 7065 04:13:48,131 --> 04:13:49,999 DISABILITY FROM ITS MISSION 7066 04:13:49,999 --> 04:13:50,366 STATEMENT. 7067 04:13:50,366 --> 04:13:52,535 NEXT STEPS ARE BEING CONSIDERED, 7068 04:13:52,535 --> 04:13:54,470 OF COURSE ADDITIONAL COMMUNITY 7069 04:13:54,470 --> 04:13:56,906 ENGAGEMENT PLANNED WITH THAT 7070 04:13:56,906 --> 04:13:57,574 EFFORT. 7071 04:13:57,574 --> 04:13:58,975 LAST SEPTEMBER THE DIRECTOR OF 7072 04:13:58,975 --> 04:14:00,176 THE NATIONAL INSTITUTE ON 7073 04:14:00,176 --> 04:14:02,912 MINORITY HEALTH AND HEALTH 7074 04:14:02,912 --> 04:14:07,350 DISPARITIES DESIGNATED PEOPLE 7075 04:14:07,350 --> 04:14:08,551 WITH DISABILITIES AS A HEALTH 7076 04:14:08,551 --> 04:14:09,385 DISPARITY POPULATION ELEVATING 7077 04:14:09,385 --> 04:14:13,723 THE NEED FOR RESEARCH TO BETTER 7078 04:14:13,723 --> 04:14:14,591 UNDERSTAND COMPLEXITIES THAT 7079 04:14:14,591 --> 04:14:16,459 LEAD TO HEALTH OUTCOMES FOR 7080 04:14:16,459 --> 04:14:18,228 PEOPLE WITH DISABILITIES. 7081 04:14:18,228 --> 04:14:20,830 AND WE KNOW THAT THE SUCCESS OF 7082 04:14:20,830 --> 04:14:23,132 THESE AND MANY OTHER EFFORTS 7083 04:14:23,132 --> 04:14:25,535 WILL REQUIRE A WELL COORDINATED 7084 04:14:25,535 --> 04:14:27,203 APPROACH THAT INCLUDES PEOPLE 7085 04:14:27,203 --> 04:14:29,706 AND INPUT FROM ACROSS NIH, ALSO 7086 04:14:29,706 --> 04:14:32,108 ACROSS THE COMMUNITY MORE 7087 04:14:32,108 --> 04:14:32,508 BROADLY. 7088 04:14:32,508 --> 04:14:34,944 SO IF YOU COULD GO TO THE NEXT 7089 04:14:34,944 --> 04:14:35,144 SLIDE. 7090 04:14:35,144 --> 04:14:38,147 SO, WE BROUGHT ON A TEAM OF 7091 04:14:38,147 --> 04:14:39,549 DISABILITY RESEARCH AND POLICY 7092 04:14:39,549 --> 04:14:42,085 EXPERTS, INCLUDING THOSE WITH 7093 04:14:42,085 --> 04:14:44,687 LIVED EXPERIENCE, TO HELP US 7094 04:14:44,687 --> 04:14:47,090 SPEAR HEAD DIFFERENT NIH-WIDE 7095 04:14:47,090 --> 04:14:48,958 DISCUSSIONS ON DISABILITY 7096 04:14:48,958 --> 04:14:49,292 RESEARCH. 7097 04:14:49,292 --> 04:14:52,262 AND WE'RE WORKING WITH A NUMBER 7098 04:14:52,262 --> 04:14:55,732 OF PEOPLE FROM ACROSS NIH, 7099 04:14:55,732 --> 04:14:57,834 OFFICE OF PORTFOLIO ANALYSIS, 7100 04:14:57,834 --> 04:15:00,003 EXTRAMURAL RESEARCH, AND NIMHD 7101 04:15:00,003 --> 04:15:01,537 AND SEVERAL OTHERS, AS THE FIRST 7102 04:15:01,537 --> 04:15:03,840 STEP TO TAKE A MORE 7103 04:15:03,840 --> 04:15:05,174 COMPREHENSIVE LOOK AT OUR 7104 04:15:05,174 --> 04:15:06,576 PORTFOLIO IN THIS SPACE. 7105 04:15:06,576 --> 04:15:08,344 AND WE'RE STILL WORKING THROUGH 7106 04:15:08,344 --> 04:15:13,182 SOME OF THE VARIOUS ASPECTS OF 7107 04:15:13,182 --> 04:15:13,383 THIS. 7108 04:15:13,383 --> 04:15:14,717 BUT AS ONE MECHANISM TO SHARE 7109 04:15:14,717 --> 04:15:19,322 WHAT WE'RE DOING WE ALSO CREATED 7110 04:15:19,322 --> 04:15:21,491 A DISABILITY RESEARCH WEB PAGE, 7111 04:15:21,491 --> 04:15:23,026 SERVES AS A CENTRAL LANDING 7112 04:15:23,026 --> 04:15:25,762 POINT FOR INFORMATION ABOUT 7113 04:15:25,762 --> 04:15:28,164 CROSS-AGENCY ACTIVITIES THAT WE 7114 04:15:28,164 --> 04:15:29,732 ARE LAUNCHING. 7115 04:15:29,732 --> 04:15:34,304 AND WE ALSO ESTABLISHED AN 7116 04:15:34,304 --> 04:15:35,738 INTERNAL NIH DISABILITY RESEARCH 7117 04:15:35,738 --> 04:15:37,273 COORDINATING COMMITTEE. 7118 04:15:37,273 --> 04:15:38,675 NEXT SLIDE. 7119 04:15:38,675 --> 04:15:41,311 THIS COMMITTEE IS AN NIH WIDE 7120 04:15:41,311 --> 04:15:42,145 FORUM, ACTUALLY SKIP AHEAD TO 7121 04:15:42,145 --> 04:15:46,916 THE NEXT ONE IF YOU WILL. 7122 04:15:46,916 --> 04:15:47,383 THANKS. 7123 04:15:47,383 --> 04:15:48,885 THIS COMMITTEE WILL SERVE AS AN 7124 04:15:48,885 --> 04:15:50,720 OPPORTUNITY FOR US TO DISCUSS 7125 04:15:50,720 --> 04:15:53,389 ALL THE VARIOUS DIFFERENT HEALTH 7126 04:15:53,389 --> 04:15:54,357 ISSUES THAT FACE DISABILITY 7127 04:15:54,357 --> 04:15:54,657 COMMUNITIES. 7128 04:15:54,657 --> 04:15:57,226 AND IT'S GOING TO SERVE AS A 7129 04:15:57,226 --> 04:15:58,628 CATALYST FOR DEVELOPING RESEARCH 7130 04:15:58,628 --> 04:16:00,029 TO ADDRESS THOSE ISSUES. 7131 04:16:00,029 --> 04:16:02,031 ALSO HELP US AS WE CONSIDER 7132 04:16:02,031 --> 04:16:02,899 RESEARCH TRAINING AND CAREER 7133 04:16:02,899 --> 04:16:04,334 DEVELOPMENT ISSUES THAT ARE 7134 04:16:04,334 --> 04:16:06,302 FOCUSED ON PEOPLE WITH 7135 04:16:06,302 --> 04:16:07,070 DISABILITIES. 7136 04:16:07,070 --> 04:16:09,505 SO, THIS GROUP WAS FORMED A FEW 7137 04:16:09,505 --> 04:16:12,308 MONTHS AGO AND THEY HAVE REALLY 7138 04:16:12,308 --> 04:16:14,744 BEEN TREMENDOUS AND ALSO 7139 04:16:14,744 --> 04:16:15,611 TREMENDOUSLY BUSY. 7140 04:16:15,611 --> 04:16:18,348 GO TO THE NEXT SLIDE. 7141 04:16:18,348 --> 04:16:20,183 BECAUSE THEY HAD AN INITIAL 7142 04:16:20,183 --> 04:16:20,383 TASK. 7143 04:16:20,383 --> 04:16:21,718 AND REALLY ONE OF THE THINGS WE 7144 04:16:21,718 --> 04:16:23,252 ASKED THEM TO DO RIGHT OFF THE 7145 04:16:23,252 --> 04:16:26,422 BAT WAS TO DEVELOP AN NIH 7146 04:16:26,422 --> 04:16:27,623 STRATEGIC PLAN FOR DISABILITY 7147 04:16:27,623 --> 04:16:27,890 RESEARCH. 7148 04:16:27,890 --> 04:16:30,026 AND OF COURSE DOWN THE ROAD ONCE 7149 04:16:30,026 --> 04:16:31,995 THIS PLAN IS TOGETHER THERE WILL 7150 04:16:31,995 --> 04:16:34,764 BE A GROUP TO FACILITATE ITS 7151 04:16:34,764 --> 04:16:35,131 IMPLEMENTATION. 7152 04:16:35,131 --> 04:16:37,066 BUT IN ADDITION TO THE PLAN, IT 7153 04:16:37,066 --> 04:16:38,468 IS A COORDINATING BODY. 7154 04:16:38,468 --> 04:16:41,337 SO IT'S GOING TO IDENTIFY AND 7155 04:16:41,337 --> 04:16:43,840 FOSTER COLLABORATIONS AND OTHER 7156 04:16:43,840 --> 04:16:46,709 ACTIVITIES RELATED TO DISABILITY 7157 04:16:46,709 --> 04:16:48,878 RESEARCH, THINGS LIKE TRAINING 7158 04:16:48,878 --> 04:16:51,080 ACTIVITIES, MANY OTHERS. 7159 04:16:51,080 --> 04:16:53,416 AND THEY ARE LOOKING THROUGH THE 7160 04:16:53,416 --> 04:16:55,018 CROSS-AGENCY LENS, ACROSS ALL OF 7161 04:16:55,018 --> 04:16:57,086 NIH, AND HOW WE CAN PARTNER 7162 04:16:57,086 --> 04:16:58,388 TOGETHER AND WORK TOGETHER, BUT 7163 04:16:58,388 --> 04:17:00,123 ALSO HOW WE INTERSECT WITH AN 7164 04:17:00,123 --> 04:17:03,426 INTERACT WITH OTHER FEDERAL 7165 04:17:03,426 --> 04:17:06,162 AGENCIES AND OTHER 7166 04:17:06,162 --> 04:17:06,629 ORGANIZATIONS. 7167 04:17:06,629 --> 04:17:07,697 NEXT SLIDE. 7168 04:17:07,697 --> 04:17:10,333 I'M REALLY GRATEFUL THAT IT IS 7169 04:17:10,333 --> 04:17:16,105 BEING SPEARHEADED BY THREE 7170 04:17:16,105 --> 04:17:17,206 CO-CHAIRS FROM NIMHD, NICHD, AND 7171 04:17:17,206 --> 04:17:22,245 SOMEONE ON MY TEAM FROM THE 7172 04:17:22,245 --> 04:17:24,113 O.D., COMPOSED OF 69 MEMBERS 7173 04:17:24,113 --> 04:17:24,881 REPRESENTING VIRTUALLY ALL 7174 04:17:24,881 --> 04:17:26,749 INSTITUTES AND CENTERS ACROSS 7175 04:17:26,749 --> 04:17:27,150 NIH. 7176 04:17:27,150 --> 04:17:35,058 THIS ALSO -- A SHOUT OUT FOR THE 7177 04:17:35,058 --> 04:17:37,260 EXEC SEC FOR THAT GROUP, TAKING 7178 04:17:37,260 --> 04:17:40,096 ON THE BIG LIFT OF COORDINATING 7179 04:17:40,096 --> 04:17:41,064 THIS DEVELOPMENT OF THE 7180 04:17:41,064 --> 04:17:41,964 STRATEGIC PLAN. 7181 04:17:41,964 --> 04:17:44,033 GO TO THE NEXT SLIDE. 7182 04:17:44,033 --> 04:17:47,670 ALSO JUST WANT TO MENTION THE 7183 04:17:47,670 --> 04:17:48,971 WRITING TEAM BRIEFLY WHO HAS 7184 04:17:48,971 --> 04:17:51,240 STEPPED UP TO COMMIT TO DRAFTING 7185 04:17:51,240 --> 04:17:52,675 THE STRATEGIC PLAN AND REALLY 7186 04:17:52,675 --> 04:17:55,645 GRATEFUL FOR ALL OF THEIR 7187 04:17:55,645 --> 04:17:58,181 EFFORTS, AS THAT IS REALLY FULLY 7188 04:17:58,181 --> 04:17:59,682 UNDERWAY AT THIS MOMENT. 7189 04:17:59,682 --> 04:18:01,451 GO TO THE NEXT SLIDE. 7190 04:18:01,451 --> 04:18:04,487 SO IN ADDITION TO OUR INTERNAL 7191 04:18:04,487 --> 04:18:07,123 EXPERTS, WE'RE ALSO -- WE ALSO 7192 04:18:07,123 --> 04:18:10,226 RECOGNIZE HOW CRITICAL IT IS TO 7193 04:18:10,226 --> 04:18:11,527 MEANINGFULLY ENGAGE WITH THE 7194 04:18:11,527 --> 04:18:12,428 COMMUNITY. 7195 04:18:12,428 --> 04:18:15,031 AND TO OPEN A DIALOGUE, IN 7196 04:18:15,031 --> 04:18:19,669 PARTICULAR AS WE'RE IN PLANNING 7197 04:18:19,669 --> 04:18:19,869 PHASE. 7198 04:18:19,869 --> 04:18:21,504 NEXT SLIDE. 7199 04:18:21,504 --> 04:18:23,806 SO IN DOING SO WE'RE AIMING TO 7200 04:18:23,806 --> 04:18:27,310 BUILD TRUST, HELP US UNDERSTAND 7201 04:18:27,310 --> 04:18:28,411 THE COMMUNITY'S CONCERNS, NEEDS, 7202 04:18:28,411 --> 04:18:29,278 PERSPECTIVES. 7203 04:18:29,278 --> 04:18:31,814 WE ALSO HOPE TO RAISE AWARENESS 7204 04:18:31,814 --> 04:18:34,450 ABOUT THE STRATEGIC PLANNING 7205 04:18:34,450 --> 04:18:36,285 PROCESS. 7206 04:18:36,285 --> 04:18:39,255 AND HAVE A MECHANISM TO, YOU 7207 04:18:39,255 --> 04:18:40,389 KNOW, PROMOTE PARTICIPATION. 7208 04:18:40,389 --> 04:18:41,891 OF COURSE IT GIVES US A WAY TO 7209 04:18:41,891 --> 04:18:44,227 GATHER A RANGE OF CRITICAL 7210 04:18:44,227 --> 04:18:45,595 FEEDBACK THAT'S GOING TO HELP 7211 04:18:45,595 --> 04:18:48,664 AND HAS HELPED SHAPE THE 7212 04:18:48,664 --> 04:18:51,400 STRATEGIC PLAN FRAMEWORK. 7213 04:18:51,400 --> 04:18:53,035 NEXT SLIDE. 7214 04:18:53,035 --> 04:18:54,670 SO, FROM LATE OCTOBER TO 7215 04:18:54,670 --> 04:18:57,640 NOVEMBER WE'VE BEEN REALLY BUSY. 7216 04:18:57,640 --> 04:19:01,043 WE HOSTED SIX VIRTUAL COMMUNITY 7217 04:19:01,043 --> 04:19:02,345 ROUNDTABLE DISCUSSIONS TO INFORM 7218 04:19:02,345 --> 04:19:03,679 THE DEVELOPMENT OF THIS 7219 04:19:03,679 --> 04:19:05,882 STRATEGIC PLAN FRAMEWORK. 7220 04:19:05,882 --> 04:19:07,717 AND WE INVITED PANELISTS FOR 7221 04:19:07,717 --> 04:19:08,918 THESE ROUNDTABLES THAT 7222 04:19:08,918 --> 04:19:11,020 REPRESENTED A REALLY LARGE RANGE 7223 04:19:11,020 --> 04:19:12,788 OF INTERESTED GROUPS. 7224 04:19:12,788 --> 04:19:15,291 WE HAD RESEARCHERS, PEOPLE WITH 7225 04:19:15,291 --> 04:19:17,026 LIVED EXPERIENCE WITH 7226 04:19:17,026 --> 04:19:18,461 DISABILITIES, HAD CLINICIANS, 7227 04:19:18,461 --> 04:19:22,532 PROFESSIONAL ASSOCIATIONS, AND 7228 04:19:22,532 --> 04:19:23,432 ADVOCACY ORGANIZATIONS. 7229 04:19:23,432 --> 04:19:24,500 NEXT SLIDE. 7230 04:19:24,500 --> 04:19:27,870 AND THEY ALL PROVIDED REALLY 7231 04:19:27,870 --> 04:19:28,638 INCREDIBLE THOUGHTFUL FEEDBACK 7232 04:19:28,638 --> 04:19:31,140 ON A SERIES OF QUESTIONS THAT WE 7233 04:19:31,140 --> 04:19:32,041 POSED TO THEM. 7234 04:19:32,041 --> 04:19:34,210 SO THEY ARE LISTED HERE. 7235 04:19:34,210 --> 04:19:36,078 WE STARTED WITH THREE BROAD HIGH 7236 04:19:36,078 --> 04:19:37,513 LEVEL QUESTIONS. 7237 04:19:37,513 --> 04:19:39,048 WHAT ARE THE SCIENTIFIC 7238 04:19:39,048 --> 04:19:39,849 OPPORTUNITIES AND CHALLENGES 7239 04:19:39,849 --> 04:19:42,418 THAT WE SHOULD BE ADDRESSING? 7240 04:19:42,418 --> 04:19:44,053 HOW CAN WE ENCOURAGE AND CLEAR 7241 04:19:44,053 --> 04:19:45,821 THE WAY FOR NEW INVESTIGATORS TO 7242 04:19:45,821 --> 04:19:47,123 COME INTO THE FIELD? 7243 04:19:47,123 --> 04:19:49,859 AND HOW CAN WE IMPROVE INCLUSION 7244 04:19:49,859 --> 04:19:52,228 OF INDIVIDUALS WITH DISABILITIES 7245 04:19:52,228 --> 04:19:53,296 IN CLINICAL RESEARCH? 7246 04:19:53,296 --> 04:19:55,831 WE HEARD A NUMBER OF GREAT 7247 04:19:55,831 --> 04:19:56,132 SUGGESTIONS. 7248 04:19:56,132 --> 04:19:58,367 I'M NOT GOING THROUGH ALL. 7249 04:19:58,367 --> 04:19:59,769 WE'LL HAVE THAT INFORMATION 7250 04:19:59,769 --> 04:20:01,404 THAT'S AVAILABLE AND POSTED ON 7251 04:20:01,404 --> 04:20:01,737 THE WEBSITE. 7252 04:20:01,737 --> 04:20:03,272 I WANTED TO HIGHLIGHT TWO 7253 04:20:03,272 --> 04:20:06,976 EXAMPLES OF SOME FEEDBACK WE 7254 04:20:06,976 --> 04:20:07,310 GOT. 7255 04:20:07,310 --> 04:20:08,978 WE HEARD OVER AND OVER AGAIN THE 7256 04:20:08,978 --> 04:20:11,280 NEED FOR GENUINE AND MEANINGFUL 7257 04:20:11,280 --> 04:20:13,449 PARTICIPATION OF PEOPLE WITH 7258 04:20:13,449 --> 04:20:15,318 DISABILITIES IN RESEARCH. 7259 04:20:15,318 --> 04:20:16,719 AND THAT'S NEEDED THROUGHOUT ALL 7260 04:20:16,719 --> 04:20:19,088 STAGES OF THE RESEARCH PROCESS. 7261 04:20:19,088 --> 04:20:22,091 THE OTHER THING I'LL MENTION IS 7262 04:20:22,091 --> 04:20:24,827 JUST THAT THERE IS A PUSH FOR 7263 04:20:24,827 --> 04:20:26,596 RESEARCH THAT AIMS TO IMPROVE 7264 04:20:26,596 --> 04:20:29,765 THE QUALITY OF LIFE OF 7265 04:20:29,765 --> 04:20:31,067 INDIVIDUALS WITH DISABILITIES, 7266 04:20:31,067 --> 04:20:32,368 AND THAT HELPS SUPPORT THEM 7267 04:20:32,368 --> 04:20:33,569 MEETING DEMANDS OF THEIR 7268 04:20:33,569 --> 04:20:36,305 ENVIRONMENT IN WHICH THEY LIVE. 7269 04:20:36,305 --> 04:20:39,041 AND WE HAD A NUMBER OF PEOPLE, I 7270 04:20:39,041 --> 04:20:41,877 FORGET THE TOTAL NOW, BUT I FEEL 7271 04:20:41,877 --> 04:20:44,747 LIKE WE HAD AT LEAST 60 PEOPLE 7272 04:20:44,747 --> 04:20:46,716 WHO PARTICIPATED AS PANELISTS IN 7273 04:20:46,716 --> 04:20:48,050 THESE ROUNDTABLES AND I'M 7274 04:20:48,050 --> 04:20:50,553 GRATEFUL TO THEM FOR SHARING 7275 04:20:50,553 --> 04:20:52,521 PERSPECTIVES AND PROVIDING SO 7276 04:20:52,521 --> 04:20:54,390 MANY THOUGHTFUL INSIGHTS AND 7277 04:20:54,390 --> 04:20:57,960 WE'VE INCORPORATED THEM INTO OUR 7278 04:20:57,960 --> 04:21:00,930 STRATEGIC PLANNING EFFORT. 7279 04:21:00,930 --> 04:21:02,164 NEXT SLIDE. 7280 04:21:02,164 --> 04:21:05,534 SO AFTER WRAPPING UP ALL OF 7281 04:21:05,534 --> 04:21:07,637 THOSE ROUNDTABLES, WE HELD A 7282 04:21:07,637 --> 04:21:09,038 CAPSTONE EVENT, A TOWN HALL A 7283 04:21:09,038 --> 04:21:10,906 COUPLE WEEKS AGO. 7284 04:21:10,906 --> 04:21:12,775 AND IT HIGHLIGHTED NIH'S 7285 04:21:12,775 --> 04:21:19,215 COMMITMENT TO ADVANCING HEALTH 7286 04:21:19,215 --> 04:21:22,718 AND WELL-BEING OF PEOPLE WITH 7287 04:21:22,718 --> 04:21:23,052 DISABILITIES. 7288 04:21:23,052 --> 04:21:30,259 DR. BERTAGNOLLI AND PEREZ-STABLE 7289 04:21:30,259 --> 04:21:31,394 AND CERNICH PARTICIPATED. 7290 04:21:31,394 --> 04:21:32,928 WE PROVIDED A PREVIEW OF THE 7291 04:21:32,928 --> 04:21:34,664 DRAFT FRAMEWORK OF THE NIH 7292 04:21:34,664 --> 04:21:36,299 STRATEGIC PLAN FOR DISABILITY 7293 04:21:36,299 --> 04:21:37,066 HEALTH RESEARCH WHICH YOU'LL 7294 04:21:37,066 --> 04:21:39,468 HEAR ABOUT IN A MOMENT, AND THEN 7295 04:21:39,468 --> 04:21:42,004 ANSWERED A VARIETY OF QUESTIONS. 7296 04:21:42,004 --> 04:21:44,106 AND IF YOU'RE INTERESTED THERE'S 7297 04:21:44,106 --> 04:21:45,174 MORE INFORMATION THAT CAN BE 7298 04:21:45,174 --> 04:21:47,810 FOUND AT THE DPCPSI WEBSITE. 7299 04:21:47,810 --> 04:21:49,245 SO GO TO THE NEXT SLIDE. 7300 04:21:49,245 --> 04:21:51,314 THE FINAL THING I'LL SAY BEFORE 7301 04:21:51,314 --> 04:21:53,582 TURNING IT OVER TO ADAM, TO HELP 7302 04:21:53,582 --> 04:21:56,018 PUT THIS ALL IN PERSPECTIVE, 7303 04:21:56,018 --> 04:21:59,322 WHAT WE'VE DONE AND WHERE WE'RE 7304 04:21:59,322 --> 04:22:02,958 HEADED, AND THIS TIMELINE HAS 7305 04:22:02,958 --> 04:22:05,027 IMAGES OF INDIVIDUALS WITH 7306 04:22:05,027 --> 04:22:06,562 DISABILITIES, VISIBLE AND 7307 04:22:06,562 --> 04:22:07,263 INVISIBLE. 7308 04:22:07,263 --> 04:22:08,531 IT OUTLINES THE VARIOUS 7309 04:22:08,531 --> 04:22:10,166 ACTIVITIES THAT I JUST 7310 04:22:10,166 --> 04:22:10,599 DESCRIBED. 7311 04:22:10,599 --> 04:22:13,002 BUT AS WE WERE LOOKING FORWARD 7312 04:22:13,002 --> 04:22:15,304 TO WANT TO POINT OUT A FEW 7313 04:22:15,304 --> 04:22:15,638 THINGS. 7314 04:22:15,638 --> 04:22:17,606 OVER THE IN NEXT FEW MONTHS 7315 04:22:17,606 --> 04:22:19,141 WE'RE GOING TO ANALYZE THE 7316 04:22:19,141 --> 04:22:22,411 RESULTS FROM AN RFI THAT SHOULD 7317 04:22:22,411 --> 04:22:23,312 BE GOING OUT TODAY. 7318 04:22:23,312 --> 04:22:26,048 I THINK IT'S PROBABLY OUT AT 7319 04:22:26,048 --> 04:22:26,816 THIS MOMENT. 7320 04:22:26,816 --> 04:22:28,651 AND INCORPORATE THE FEEDBACK 7321 04:22:28,651 --> 04:22:31,387 THAT WE GOT INTO THE STRATEGIC 7322 04:22:31,387 --> 04:22:31,721 PLAN. 7323 04:22:31,721 --> 04:22:34,490 WE ALSO MAY BE HOLDING 7324 04:22:34,490 --> 04:22:35,324 ADDITIONAL ENGAGEMENT ACTIVITIES 7325 04:22:35,324 --> 04:22:36,525 AS NEEDED. 7326 04:22:36,525 --> 04:22:40,396 AND OUR GOAL IS TO RELEASE THE 7327 04:22:40,396 --> 04:22:42,131 PLAN NEXT SUMMER, SUMMER OF 7328 04:22:42,131 --> 04:22:42,331 2025. 7329 04:22:42,331 --> 04:22:44,867 WITH THAT I'LL TURN IT OVER TO 7330 04:22:44,867 --> 04:22:46,936 ADAM POLITIS WHO WILL RUN 7331 04:22:46,936 --> 04:22:48,604 THROUGH THE STRATEGIC PLAN 7332 04:22:48,604 --> 04:22:51,073 FRAMEWORK WE PUT TOGETHER. 7333 04:22:51,073 --> 04:22:53,275 >> THANK YOU VERY MUCH, DR. 7334 04:22:53,275 --> 04:22:53,509 SCHWETZ. 7335 04:22:53,509 --> 04:22:56,245 GOOD AFTERNOON, EVERYONE. 7336 04:22:56,245 --> 04:22:57,113 NEXT SLIDE PLEASE. 7337 04:22:57,113 --> 04:23:01,717 WE CAN GO TO THE NEXT ONE. 7338 04:23:01,717 --> 04:23:03,686 SO DR. SCHWETZ MENTIONED THE 7339 04:23:03,686 --> 04:23:05,121 DRAFT STRATEGIC PLAN FRAMEWORK 7340 04:23:05,121 --> 04:23:08,090 WAS DEVELOPED BY THE RESEARCH 7341 04:23:08,090 --> 04:23:09,291 COORDINATING COMMITTEE, DRCC FOR 7342 04:23:09,291 --> 04:23:09,825 SHORT. 7343 04:23:09,825 --> 04:23:11,293 WHICH HAS BROAD REPRESENTATION 7344 04:23:11,293 --> 04:23:16,499 FROM ACROSS NIH MANY INSTITUTES, 7345 04:23:16,499 --> 04:23:17,400 CENTERS, OFFICES, CONSIDERABLE 7346 04:23:17,400 --> 04:23:18,501 ASPECTS IN DISABILITY RESEARCH, 7347 04:23:18,501 --> 04:23:19,702 INCLUDING MANY WITH LIVED 7348 04:23:19,702 --> 04:23:23,739 EXPERIENCE WITH DISABILITY. 7349 04:23:23,739 --> 04:23:25,808 THE DRCC UTILIZED EXPERTISE TO 7350 04:23:25,808 --> 04:23:27,777 DEVELOP DRAFT FRAMEWORK AND 7351 04:23:27,777 --> 04:23:29,011 FEEDBACK BY MANY INDIVIDUALS AND 7352 04:23:29,011 --> 04:23:29,979 ORGANIZATIONS WHO PARTICIPATED 7353 04:23:29,979 --> 04:23:32,581 IN THE COMMUNITY ENGAGEMENT 7354 04:23:32,581 --> 04:23:33,048 EVENTS. 7355 04:23:33,048 --> 04:23:34,683 THE DRCC RECOGNIZES PEOPLE WITH 7356 04:23:34,683 --> 04:23:37,420 DISABILITIES MAY EXPERIENCE A 7357 04:23:37,420 --> 04:23:39,855 RAIN OF MEDICAL CONDITIONS, AS 7358 04:23:39,855 --> 04:23:40,756 WELL AS NON-MEDICAL FACTORS IN 7359 04:23:40,756 --> 04:23:42,491 THE ENVIRONMENT THAT LEAD TO 7360 04:23:42,491 --> 04:23:46,295 POOR HEALTH OUTCOMES SUCH AS 7361 04:23:46,295 --> 04:23:47,096 DISCRIMINATION, INACCESSIBLE 7362 04:23:47,096 --> 04:23:47,530 FACILITIES. 7363 04:23:47,530 --> 04:23:48,631 RESEARCH THAT SEEKS TO 7364 04:23:48,631 --> 04:23:49,698 UNDERSTAND AND ADDRESS EFFECTS 7365 04:23:49,698 --> 04:23:51,133 OF BOTH MEDICAL OR HEALTH 7366 04:23:51,133 --> 04:23:54,203 CONDITIONS AS WELL AS SOCIAL AND 7367 04:23:54,203 --> 04:23:54,804 ENVIRONMENTAL FACTORS ON THE 7368 04:23:54,804 --> 04:23:59,542 HEALTH AND WELL-BEING OF PEOPLE 7369 04:23:59,542 --> 04:24:00,142 WITH DISABILITIES, DISABILITY 7370 04:24:00,142 --> 04:24:01,310 HEALTH RESEARCH, THE TITLE FOR 7371 04:24:01,310 --> 04:24:02,545 THE STRATEGIC PLAN MOVING 7372 04:24:02,545 --> 04:24:09,852 FORWARD WOULD BE NIH STRATEGIC 7373 04:24:09,852 --> 04:24:15,758 PLAN FOR DISABILITY HEALTH 7374 04:24:15,758 --> 04:24:16,091 RESEARCH. 7375 04:24:16,091 --> 04:24:19,462 FIRST CROSS-CUTTING THEMES THAT 7376 04:24:19,462 --> 04:24:21,130 CUT ACROSS GOALS. 7377 04:24:21,130 --> 04:24:22,331 STRATEGIC GOALS THEMSELVES, OVER 7378 04:24:22,331 --> 04:24:25,768 A FIVE YEARS PERIOD BEGINNING IN 7379 04:24:25,768 --> 04:24:27,503 FY 2016 AND POTENTIAL 7380 04:24:27,503 --> 04:24:29,305 OPPORTUNITIES THAT COULD BE 7381 04:24:29,305 --> 04:24:31,974 TAKEN TO ACHIEVE STRATEGIC 7382 04:24:31,974 --> 04:24:32,575 GOALS. 7383 04:24:32,575 --> 04:24:34,343 NEXT SLIDE PLEASE. 7384 04:24:34,343 --> 04:24:35,411 CROSS-CUTTING THEMES INCLUDED IN 7385 04:24:35,411 --> 04:24:38,481 THE DRAFT FRAMEWORK WITH PUBLIC 7386 04:24:38,481 --> 04:24:41,116 PARTICIPATION AND COMMUNITY 7387 04:24:41,116 --> 04:24:42,184 ENGAGEMENT, ACCESSIBILITY, 7388 04:24:42,184 --> 04:24:43,619 COMPLEXITY AND HETEROGENEITY, 7389 04:24:43,619 --> 04:24:44,453 DYNAMICS OF DISABILITY. 7390 04:24:44,453 --> 04:24:47,323 THE PUBLIC PARTICIPATION AND 7391 04:24:47,323 --> 04:24:48,557 COMMUNITY ENGAGEMENT THEME 7392 04:24:48,557 --> 04:24:49,525 EMPHASIZES BIOMEDICAL AND 7393 04:24:49,525 --> 04:24:50,326 BEHAVIORAL RESEARCH COMMUNITY 7394 04:24:50,326 --> 04:24:52,394 SHOULD INVOLVE PEOPLE WITH 7395 04:24:52,394 --> 04:24:53,896 DISABILITIES IN IDENTIFYING 7396 04:24:53,896 --> 04:24:55,431 RESEARCH PRIORITIES AND BUILD 7397 04:24:55,431 --> 04:24:56,765 TRUST-BASED LONG-TERM AND 7398 04:24:56,765 --> 04:24:58,734 TWO-WAY RELATIONSHIPS WITH 7399 04:24:58,734 --> 04:24:59,602 DISABILITY COMMUNITIES. 7400 04:24:59,602 --> 04:25:01,737 ACCESSIBILITY THEME SPACE THAT 7401 04:25:01,737 --> 04:25:03,472 RESEARCH AND HEALTH CARE 7402 04:25:03,472 --> 04:25:04,106 FACILITIES, EQUIPMENT, 7403 04:25:04,106 --> 04:25:06,008 TECHNOLOGY AND INFORMATION MUST 7404 04:25:06,008 --> 04:25:07,977 BE ACCESSIBLE SO ALL PEOPLE 7405 04:25:07,977 --> 04:25:09,211 INCLUDING PEOPLE WITH 7406 04:25:09,211 --> 04:25:13,015 DISABILITIES CAN FULLY USE THEM. 7407 04:25:13,015 --> 04:25:14,550 THE COMPLEXITY AND HETEROGENEITY 7408 04:25:14,550 --> 04:25:18,220 THEME HIGHLIGHTS DISABILITY IS 7409 04:25:18,220 --> 04:25:20,155 NOT MONOLITHTIC, THEY ARE 7410 04:25:20,155 --> 04:25:21,657 MULTI-FACETED WITH A WIDE RANGE 7411 04:25:21,657 --> 04:25:22,358 OF EXPERIENCES. 7412 04:25:22,358 --> 04:25:24,293 THIS MUST BE ACKNOWLEDGED IN 7413 04:25:24,293 --> 04:25:26,061 ORDER TO CONDUCT MEANINGFUL 7414 04:25:26,061 --> 04:25:27,930 RESEARCH AND COMMUNITY 7415 04:25:27,930 --> 04:25:28,898 ENGAGEMENT. 7416 04:25:28,898 --> 04:25:30,900 FINALLY, THE DYNAMICS OF 7417 04:25:30,900 --> 04:25:32,401 DISABILITY THEME HIGHLIGHTS 7418 04:25:32,401 --> 04:25:34,403 DISABILITY IS DYNAMIC PROCESS 7419 04:25:34,403 --> 04:25:36,038 INVOLVING INTERACTION OF MEDICAL 7420 04:25:36,038 --> 04:25:37,139 CONDITIONS THAT MAY FLUCTUATE 7421 04:25:37,139 --> 04:25:39,775 OVER TIME WITH VARIABLE 7422 04:25:39,775 --> 04:25:40,609 BEHAVIORAL, SOCIOCULTURAL AND 7423 04:25:40,609 --> 04:25:41,977 ENVIRONMENTAL FACTORS. 7424 04:25:41,977 --> 04:25:43,812 WHEN CONDUCTING RESEARCH THESE 7425 04:25:43,812 --> 04:25:45,347 SHOULD BE INCORPORATED INTO 7426 04:25:45,347 --> 04:25:47,917 RESEARCH DESIGNS, METHODS, 7427 04:25:47,917 --> 04:25:48,851 MEASURES. 7428 04:25:48,851 --> 04:25:50,486 NEXT SLIDE PLEASE. 7429 04:25:50,486 --> 04:25:51,987 THE DRAFT FRAMEWORK INCLUDES 7430 04:25:51,987 --> 04:25:53,756 FOUR STRATEGIC GOALS. 7431 04:25:53,756 --> 04:25:56,058 FIRST GOAL TO SUPPORT HIGH 7432 04:25:56,058 --> 04:25:56,725 QUALITY INNOVATIVE IMPACTFUL 7433 04:25:56,725 --> 04:25:57,927 RESEARCH TO IMPROVE HEALTH AN 7434 04:25:57,927 --> 04:25:59,795 WELL-BEING OF PEOPLE WITH 7435 04:25:59,795 --> 04:26:01,530 DISABILITIES OF ALL AGES. 7436 04:26:01,530 --> 04:26:03,299 SECOND GOAL TO BUILD MEANINGFUL 7437 04:26:03,299 --> 04:26:04,500 INTERNAL AND EXTERNAL 7438 04:26:04,500 --> 04:26:06,235 PARTNERSHIPS TO PROMOTE 7439 04:26:06,235 --> 04:26:07,770 DISABILITY HEALTH RESEARCH. 7440 04:26:07,770 --> 04:26:08,871 THIRD GOAL PROMOTE ENGAGEMENT 7441 04:26:08,871 --> 04:26:11,807 AND INCLUSION OF PEOPLE WITH 7442 04:26:11,807 --> 04:26:14,977 DISABILITIES IN THE BIOMEDICAL 7443 04:26:14,977 --> 04:26:16,645 AND BEHAVIORAL RESEARCH 7444 04:26:16,645 --> 04:26:16,912 ECOSYSTEM. 7445 04:26:16,912 --> 04:26:18,914 FOURTH TO DEVELOP A WORK FORCE 7446 04:26:18,914 --> 04:26:20,916 THAT INCLUDES RESEARCHERS WITH 7447 04:26:20,916 --> 04:26:22,551 DISABILITIES AND TRAINED IN 7448 04:26:22,551 --> 04:26:25,621 DISABILITY HEALTH RESEARCH. 7449 04:26:25,621 --> 04:26:26,789 NEXT SLIDE PLEASE. 7450 04:26:26,789 --> 04:26:28,991 WITH REGARDS TO GOAL 1, WE KNOW 7451 04:26:28,991 --> 04:26:30,326 THAT KNOWLEDGE GAPS EXIST 7452 04:26:30,326 --> 04:26:31,827 REGARDING HEALTH AND WELL-BEING 7453 04:26:31,827 --> 04:26:33,696 OF PEOPLE WITH DISABILITIES. 7454 04:26:33,696 --> 04:26:34,930 RESEARCH IS NEEDED TO FURTHER 7455 04:26:34,930 --> 04:26:36,966 ENSURE AND ADDRESS HEALTH NEEDS 7456 04:26:36,966 --> 04:26:38,167 OF PEOPLE WITH DISABILITIES 7457 04:26:38,167 --> 04:26:39,602 ACROSS THE LIFESPAN. 7458 04:26:39,602 --> 04:26:40,703 SUPPORT FOR DEVELOPING RESOURCES 7459 04:26:40,703 --> 04:26:41,770 AND INFRASTRUCTURE IS ALSO 7460 04:26:41,770 --> 04:26:45,708 NEEDED TO ADVANCE THE STUDY OF 7461 04:26:45,708 --> 04:26:46,709 DISABILITY HEALTH. 7462 04:26:46,709 --> 04:26:47,943 NEXT SLIDE PLEASE. 7463 04:26:47,943 --> 04:26:49,778 TO ACHIEVE GOAL 1 THERE ARE A 7464 04:26:49,778 --> 04:26:52,081 RANGE OF ACTIONS THAT COULD BE 7465 04:26:52,081 --> 04:26:52,281 TAKEN. 7466 04:26:52,281 --> 04:26:53,482 WE HIGHLIGHT SEVERAL POTENTIAL 7467 04:26:53,482 --> 04:26:54,350 OPPORTUNITIES AS EXAMPLES. 7468 04:26:54,350 --> 04:26:56,051 THE FIRST IS TO DEVELOP MEASURES 7469 04:26:56,051 --> 04:26:57,686 OF DISABILITY THAT COULD EASILY 7470 04:26:57,686 --> 04:27:00,623 BE COLLECTED WITH OTHER 7471 04:27:00,623 --> 04:27:01,857 DEMOGRAPHIC DATA. 7472 04:27:01,857 --> 04:27:03,359 WITHOUT ADEQUATE DATA, EFFORTS 7473 04:27:03,359 --> 04:27:04,893 TO IDENTIFY HEALTH AND HEALTH 7474 04:27:04,893 --> 04:27:06,028 CARE DISPARITIES EXPERIENCED BY 7475 04:27:06,028 --> 04:27:08,097 PEOPLE WITH DISABILITIES ARE 7476 04:27:08,097 --> 04:27:08,964 HINDERED. 7477 04:27:08,964 --> 04:27:09,865 ANOTHER OPPORTUNITY TO TRACK 7478 04:27:09,865 --> 04:27:12,468 LONGITUDINAL HEALTH OUTCOMES OF 7479 04:27:12,468 --> 04:27:13,802 PEOPLE WITH DISABILITIES, 7480 04:27:13,802 --> 04:27:14,570 EXAMINING MEDICAL AND 7481 04:27:14,570 --> 04:27:15,904 NON-MEDICAL FACTORS THAT 7482 04:27:15,904 --> 04:27:19,174 CONTRIBUTE TO HEALTH OUTCOMES. 7483 04:27:19,174 --> 04:27:20,376 NIH COULD ENCOURAGE RESEARCH TO 7484 04:27:20,376 --> 04:27:21,944 DEVELOP INTERVENTIONS TO ADDRESS 7485 04:27:21,944 --> 04:27:23,679 HEALTH AND HEALTH CARE 7486 04:27:23,679 --> 04:27:25,748 DISPARITIES BY PEOPLE WITH 7487 04:27:25,748 --> 04:27:26,649 DISABILITIES. 7488 04:27:26,649 --> 04:27:30,819 FINALLY PROMOTE DEVELOPMENT OF 7489 04:27:30,819 --> 04:27:34,123 TECHNOLOGIES LEVERAGE EXISTING 7490 04:27:34,123 --> 04:27:34,790 TECHNOLOGIES. 7491 04:27:34,790 --> 04:27:35,858 GOAL 2 WE RECOGNIZE GENUINE 7492 04:27:35,858 --> 04:27:36,959 PARTNERSHIPS ARE NEEDED TO 7493 04:27:36,959 --> 04:27:38,293 ADVANCE RESEARCH ON THE HEALTH 7494 04:27:38,293 --> 04:27:40,562 AND WELL-BEING OF PEOPLE WITH 7495 04:27:40,562 --> 04:27:41,230 DISABILITIES INCLUDING 7496 04:27:41,230 --> 04:27:43,198 PARTNERSHIPS AMONG NIH 7497 04:27:43,198 --> 04:27:46,702 INSTITUTES AND CENTERS AND OTHER 7498 04:27:46,702 --> 04:27:50,639 FEDERAL AGENCIES AND BETWEEN NIH 7499 04:27:50,639 --> 04:27:51,340 AND EXTRAMURAL COMMUNITY 7500 04:27:51,340 --> 04:27:54,610 INCLUDING PEOPLE WITH LIVED 7501 04:27:54,610 --> 04:27:55,477 EXPERIENCES, BY UTILIZING 7502 04:27:55,477 --> 04:27:56,478 SKILLS, EXPERTISE AND PARTNERS 7503 04:27:56,478 --> 04:27:58,647 INTERNAL AND EXTERNAL TO NIH. 7504 04:27:58,647 --> 04:28:00,282 NIH-SUPPORTED RESEARCH CAN BE 7505 04:28:00,282 --> 04:28:03,252 ENHANCED AND COMMUNICATED MORE 7506 04:28:03,252 --> 04:28:04,586 EFFECTIVELY. 7507 04:28:04,586 --> 04:28:05,888 NEXT SLIDE PLEASE. 7508 04:28:05,888 --> 04:28:09,625 TO ACHIEVE GOAL 2 SOME POTENTIAL 7509 04:28:09,625 --> 04:28:10,092 OPPORTUNITIES INCLUDE 7510 04:28:10,092 --> 04:28:11,593 DESIGNATING CENTRAL POINT OF 7511 04:28:11,593 --> 04:28:13,328 CONTACT FOR DISABILITY HEALTH 7512 04:28:13,328 --> 04:28:14,863 RESEARCH AND NIH TO FACILITATE 7513 04:28:14,863 --> 04:28:16,832 AND STREAMLINE ENGAGEMENT WITH 7514 04:28:16,832 --> 04:28:19,034 THE PUBLIC, PARTNERING WITH NIH 7515 04:28:19,034 --> 04:28:21,103 INSTITUTES, CENTERS, OFFICES AND 7516 04:28:21,103 --> 04:28:22,071 COMMUNITY ORGANIZATIONS TO 7517 04:28:22,071 --> 04:28:23,439 DEVELOP DISABILITY HEALTH 7518 04:28:23,439 --> 04:28:26,141 RESEARCH EVENTS, OBTAIN INPUT ON 7519 04:28:26,141 --> 04:28:28,777 RESEARCH TOPICS, COMMUNICATE AND 7520 04:28:28,777 --> 04:28:30,312 DISSEMINATE RESEARCH FINDINGS. 7521 04:28:30,312 --> 04:28:33,482 ALSO EXPANDING COLLABORATIONS 7522 04:28:33,482 --> 04:28:36,118 WITH OTHER FEDERAL AGENCIES THAT 7523 04:28:36,118 --> 04:28:37,953 HAVE EXPERTISE AN CONDUCTING 7524 04:28:37,953 --> 04:28:39,722 OUTREACH TO INCREASE AWARENESS 7525 04:28:39,722 --> 04:28:41,356 OF INITIATIVES AT NIH IN ORDER 7526 04:28:41,356 --> 04:28:42,791 TO INCREASE NUMBER OF 7527 04:28:42,791 --> 04:28:45,060 APPLICATIONS TO THESE 7528 04:28:45,060 --> 04:28:47,463 INITIATIVES. 7529 04:28:47,463 --> 04:28:49,098 NEXT SLIDE PLEASE. 7530 04:28:49,098 --> 04:28:52,067 GOAL 3 WE BELIEVE MEANINGFUL 7531 04:28:52,067 --> 04:28:53,702 PARTICIPATION IN THE RESEARCH 7532 04:28:53,702 --> 04:28:54,803 PROCESS IS VITAL INCLUDING 7533 04:28:54,803 --> 04:28:57,773 ENGAGEMENT AT ALL STAGES OF THE 7534 04:28:57,773 --> 04:28:58,874 SCIENTIFIC PROCESS FROM 7535 04:28:58,874 --> 04:29:00,943 IDENTIFYING RESEARCH PRIORITIES 7536 04:29:00,943 --> 04:29:02,344 TO DESIGNING, REVIEWING, 7537 04:29:02,344 --> 04:29:02,945 CONDUCTING, COMMUNICATING 7538 04:29:02,945 --> 04:29:04,113 RESULTS OF STUDIES. 7539 04:29:04,113 --> 04:29:06,515 IN ADDITION, WE NEED TO PREVENT 7540 04:29:06,515 --> 04:29:07,149 UNNECESSARY EXCLUSION OF PEOPLE 7541 04:29:07,149 --> 04:29:14,957 WITH DISABILITIES, IN RESEARCH 7542 04:29:14,957 --> 04:29:18,260 STUDIES, STRENGTHENING 7543 04:29:18,260 --> 04:29:19,561 SIGNIFICANCE AND GENERALIZABLE. 7544 04:29:19,561 --> 04:29:21,864 WE NEED TO PROMOTE COLLECTION OF 7545 04:29:21,864 --> 04:29:23,265 DATA IN NIH FUNDED RESEARCH, 7546 04:29:23,265 --> 04:29:32,107 DONE IN A SAFE, SECURITY, 7547 04:29:32,107 --> 04:29:33,442 NON-STIGMATIZING MANNER. 7548 04:29:33,442 --> 04:29:34,676 NEXT SLIDE PLEASE. 7549 04:29:34,676 --> 04:29:37,646 TO ACHIEVE GOAL 3 WE HIGHLIGHT 7550 04:29:37,646 --> 04:29:38,580 SEVERAL OPPORTUNITIES. 7551 04:29:38,580 --> 04:29:40,783 FIRST TO INCLUDE PEOPLE WITH 7552 04:29:40,783 --> 04:29:42,084 LIVED EXPERIENCE WITH DISABILITY 7553 04:29:42,084 --> 04:29:45,154 IN ALL STAGES OF THE PROCESS. 7554 04:29:45,154 --> 04:29:46,021 ANOTHER OPPORTUNITY TO ENCOURAGE 7555 04:29:46,021 --> 04:29:48,223 DATA COLLECTION IN ALL 7556 04:29:48,223 --> 04:29:49,958 NIH-SUPPORTED RESEARCH. 7557 04:29:49,958 --> 04:29:51,393 NIH AND NIH-SUPPORTED 7558 04:29:51,393 --> 04:29:52,494 INVESTIGATORS COULD DEVELOP 7559 04:29:52,494 --> 04:29:57,733 ACCESSIBILITY TOOL KITS FOR 7560 04:29:57,733 --> 04:29:59,034 CLINICAL RESEARCH. 7561 04:29:59,034 --> 04:30:00,803 INACCESSIBLE FACILITIES ARE 7562 04:30:00,803 --> 04:30:03,205 BARRIERS AS PARTICIPANTS IN 7563 04:30:03,205 --> 04:30:03,672 STUDIES. 7564 04:30:03,672 --> 04:30:08,577 FINALLY, FOR HEALTH CONDITIONS, 7565 04:30:08,577 --> 04:30:11,280 NIH COULD SUPPORT DEVELOPMENT, 7566 04:30:11,280 --> 04:30:12,815 ADAPTATION FOR PEOPLE WITH 7567 04:30:12,815 --> 04:30:15,217 DISABILITIES EXPERIENCING THESE 7568 04:30:15,217 --> 04:30:17,219 CONDITIONS. 7569 04:30:17,219 --> 04:30:18,520 NEXT SLIDE PLEASE. 7570 04:30:18,520 --> 04:30:22,324 LAST GOAL WE HIGHLIGHT RESEARCH 7571 04:30:22,324 --> 04:30:23,859 WITH DISABILITIES ARE OVERLOOKED 7572 04:30:23,859 --> 04:30:25,294 RESEARCHERS WITH VALUABLE 7573 04:30:25,294 --> 04:30:25,627 PERSPECTIVES. 7574 04:30:25,627 --> 04:30:28,230 SHOULD BE PROVIDED WITH SUPPORTS 7575 04:30:28,230 --> 04:30:30,098 AND ACCOMMODATIONS IN ORDER TO 7576 04:30:30,098 --> 04:30:31,300 BE SUCCESSFUL IN RESEARCH 7577 04:30:31,300 --> 04:30:31,767 CAREERS. 7578 04:30:31,767 --> 04:30:33,402 IN ADDITION FOR BOTH RESEARCHERS 7579 04:30:33,402 --> 04:30:36,672 AND CLINICIANS WITH AND WITHOUT 7580 04:30:36,672 --> 04:30:37,639 DISABILITIES PROVIDING TRAINING 7581 04:30:37,639 --> 04:30:39,741 AND DISABILITY HEALTH RESEARCH 7582 04:30:39,741 --> 04:30:42,477 WILL ACCELERATE IMPROVEMENT IN 7583 04:30:42,477 --> 04:30:44,279 HEALTH CARE FOR DISABILITY 7584 04:30:44,279 --> 04:30:44,680 POPULATIONS. 7585 04:30:44,680 --> 04:30:46,114 NEXT SLIDE PLEASE. 7586 04:30:46,114 --> 04:30:48,750 POTENTIAL OPPORTUNITIES FOR LAST 7587 04:30:48,750 --> 04:30:49,384 GOAL INCLUDE SUPPORTING 7588 04:30:49,384 --> 04:30:51,386 RESEARCHERS WITH ALL TYPES OF 7589 04:30:51,386 --> 04:30:52,120 DISABILITIES THROUGHOUT CAREERS, 7590 04:30:52,120 --> 04:30:54,556 SO THEY CAN ADVANCE RESEARCH IN 7591 04:30:54,556 --> 04:31:00,796 BIOMEDICAL AND BEE SCIENCES, 7592 04:31:00,796 --> 04:31:09,004 DEVELOPING AND PROMOTING 7593 04:31:09,004 --> 04:31:10,105 INSTITUTIONAL TRAINING, 7594 04:31:10,105 --> 04:31:11,406 INCREASING COMPETENCY AND 7595 04:31:11,406 --> 04:31:12,608 REPRESENTATION IN VARIOUS 7596 04:31:12,608 --> 04:31:14,176 RESEARCH AND RESEARCH 7597 04:31:14,176 --> 04:31:16,912 ADMINISTRATION ROLES. 7598 04:31:16,912 --> 04:31:18,647 FINALLY SUPPORTING STAFF, 7599 04:31:18,647 --> 04:31:19,748 EMPLOYERS, SUPERVISORS TO 7600 04:31:19,748 --> 04:31:20,616 IMPLEMENT INCLUSIVE DESIGN 7601 04:31:20,616 --> 04:31:21,383 PRACTICES AND ENSURE 7602 04:31:21,383 --> 04:31:24,887 ACCESSIBILITY OF EVENTS AND 7603 04:31:24,887 --> 04:31:26,188 WORKPLACES. 7604 04:31:26,188 --> 04:31:26,989 NEXT SLIDE PLEASE. 7605 04:31:26,989 --> 04:31:31,360 AND NEXT SLIDE. 7606 04:31:31,360 --> 04:31:33,762 SO TO OBTAIN INPUT AND FEEDBACK 7607 04:31:33,762 --> 04:31:37,366 ON DRAFT STRATEGIC PLAN 7608 04:31:37,366 --> 04:31:39,534 FRAMEWORK TODAY NIH ISSUED THIS 7609 04:31:39,534 --> 04:31:43,405 RFI, OPEN FOR 90 DAYS, CLOSES ON 7610 04:31:43,405 --> 04:31:44,940 MARCH 12, 2025. 7611 04:31:44,940 --> 04:31:45,574 IT PROVIDES BACKGROUND ON DAY 7612 04:31:45,574 --> 04:31:50,279 CARE CENTERS AND -- PROVIDES 7613 04:31:50,279 --> 04:31:52,147 BACKGROUND ON DISABILITY, 7614 04:31:52,147 --> 04:31:54,016 INCLUDES A DRAFT FRAMEWORK, AND 7615 04:31:54,016 --> 04:31:55,083 INSTRUCTIONS HOW TO PROVIDE 7616 04:31:55,083 --> 04:31:55,517 FEEDBACK. 7617 04:31:55,517 --> 04:32:00,889 NIH IS INTERESTED IN FEEDBACK ON 7618 04:32:00,889 --> 04:32:02,524 FRAMEWORK AND WHETHER ADDITIONAL 7619 04:32:02,524 --> 04:32:04,192 THEMES TO BE CONSIDERED, 7620 04:32:04,192 --> 04:32:06,361 APPROPRIATENESS OF GOALS AND 7621 04:32:06,361 --> 04:32:11,600 OPPORTUNITIES INCLUDING 7622 04:32:11,600 --> 04:32:14,036 POTENTIAL BENEFITS, DRAW BACKS 7623 04:32:14,036 --> 04:32:15,570 OR CHALLENGES, SUGGESTSES TO 7624 04:32:15,570 --> 04:32:16,538 MEASURE PROGRESS, AND 7625 04:32:16,538 --> 04:32:18,507 SUGGESTIONS FOR WAYS NIH CAN 7626 04:32:18,507 --> 04:32:20,809 SHARE STRATEGIC PLAN AND 7627 04:32:20,809 --> 04:32:23,111 COMMUNICATE PROGRESS, SUCCESS, 7628 04:32:23,111 --> 04:32:23,345 IMPACT. 7629 04:32:23,345 --> 04:32:27,683 RFI WILL BE DISSEMINATED VIA 7630 04:32:27,683 --> 04:32:32,854 MULTIPLE CHANNELS, LISTED IN THE 7631 04:32:32,854 --> 04:32:34,523 GUIDE, SOCIAL MEDIA, E-MAILS AND 7632 04:32:34,523 --> 04:32:36,925 TOWN HALLS, CURRENTLY LISTED ON 7633 04:32:36,925 --> 04:32:37,893 DPCPSI DISABILITY RESEARCH 7634 04:32:37,893 --> 04:32:38,126 WEBSITE. 7635 04:32:38,126 --> 04:32:40,295 WE LOOK FORWARD TO YOUR INPUT 7636 04:32:40,295 --> 04:32:44,666 AND FEEDBACK AND HOPE YOU'LL 7637 04:32:44,666 --> 04:32:45,534 SHARE THE RFI. 7638 04:32:45,534 --> 04:32:49,171 I'LL HAND IT BACK TO DR. 7639 04:32:49,171 --> 04:32:49,404 SCHWETZ. 7640 04:32:49,404 --> 04:32:50,472 >> YES, PLEASE DO DISTRIBUTE 7641 04:32:50,472 --> 04:32:51,473 THAT WIDELY. 7642 04:32:51,473 --> 04:32:53,108 YOU ALL SHOULD BE GETTING AN 7643 04:32:53,108 --> 04:32:56,078 E-MAIL FROM ME IN A FEW MINUTES 7644 04:32:56,078 --> 04:32:58,914 WITH INFORMATION AND LINK. 7645 04:32:58,914 --> 04:33:02,084 I DID WANT TO MENTION ONE MORE 7646 04:33:02,084 --> 04:33:02,751 ACTIVITY. 7647 04:33:02,751 --> 04:33:05,721 I HOPE MANY OF YOU ARE FAMILIAR 7648 04:33:05,721 --> 04:33:06,989 WITH THE NIH COUNCIL OF 7649 04:33:06,989 --> 04:33:07,656 COUNCILS. 7650 04:33:07,656 --> 04:33:10,926 RUSS IS BECAUSE HE'S ON IT. 7651 04:33:10,926 --> 04:33:14,663 IT IS AN ADVISORY COMMITTEE ON 7652 04:33:14,663 --> 04:33:15,964 MATTERS RELATING TO DPCPSI. 7653 04:33:15,964 --> 04:33:19,034 AND AT THE LAST MEETING BACK IN 7654 04:33:19,034 --> 04:33:20,235 SEPTEMBER WE DISCUSSED SOME OF 7655 04:33:20,235 --> 04:33:23,271 THE EFFORTS YOU ALL JUST HEARD 7656 04:33:23,271 --> 04:33:25,974 ABOUT TODAY AND RAISED IDEA OF 7657 04:33:25,974 --> 04:33:27,009 ESTABLISHING A STANDING COUNCIL 7658 04:33:27,009 --> 04:33:28,210 OF COUNCILS DISABILITY RESEARCH 7659 04:33:28,210 --> 04:33:30,946 WORKING GROUP. 7660 04:33:30,946 --> 04:33:31,613 NEXT SLIDE. 7661 04:33:31,613 --> 04:33:35,017 SO THIS GROUP IS GOING TO 7662 04:33:35,017 --> 04:33:36,184 PROVIDE INPUT ON ACTIVITIES TO 7663 04:33:36,184 --> 04:33:39,721 HELP US GROW THE FIELD, THINK 7664 04:33:39,721 --> 04:33:42,457 ABOUT PRIOR SCIENTIFIC AREAS, 7665 04:33:42,457 --> 04:33:44,860 PARTICULARLY AS WE THINK ABOUT A 7666 04:33:44,860 --> 04:33:46,628 WHOLE OF NIH FOCUS. 7667 04:33:46,628 --> 04:33:48,697 AND WEIGH IN ON STRATEGIES TO 7668 04:33:48,697 --> 04:33:50,665 INCREASE THE WORKFORCE OF 7669 04:33:50,665 --> 04:33:51,666 INVESTIGATORS WITH DISABILITIES. 7670 04:33:51,666 --> 04:33:56,571 THE GROUP IS ALSO GOING TO HELP 7671 04:33:56,571 --> 04:33:59,274 US CONSIDER OPTIMIZING OUTREACH 7672 04:33:59,274 --> 04:34:00,375 TO DISABILITY COMMUNITIES, A 7673 04:34:00,375 --> 04:34:02,778 CRUCIAL AND CRITICAL PART OF THE 7674 04:34:02,778 --> 04:34:03,145 PROCESS. 7675 04:34:03,145 --> 04:34:05,347 SO WE HAVEN'T YET FORMALLY 7676 04:34:05,347 --> 04:34:07,616 KICKED THIS OFF BUT WILL BE 7677 04:34:07,616 --> 04:34:09,351 DOING SO SOON AND KIND OF 7678 04:34:09,351 --> 04:34:11,219 LOOKING FORWARD I GUESS MORE TO 7679 04:34:11,219 --> 04:34:12,254 SOME OF THE ACTIVITIES THAT ARE 7680 04:34:12,254 --> 04:34:14,723 GOING TO COME OUT OF THAT 7681 04:34:14,723 --> 04:34:15,590 GROUP'S EFFORT. 7682 04:34:15,590 --> 04:34:18,994 SO WITH THAT I THINK WE'LL TAKE 7683 04:34:18,994 --> 04:34:22,731 QUESTIONS AND OPEN IT UP OR TURN 7684 04:34:22,731 --> 04:34:23,932 IT BACK. 7685 04:34:23,932 --> 04:34:24,499 >> GREAT. 7686 04:34:24,499 --> 04:34:26,034 IF WE COULD PULL DOWN THE SLIDES 7687 04:34:26,034 --> 04:34:29,971 PLEASE AND SEE EVERYBODY. 7688 04:34:29,971 --> 04:34:35,177 ANY COMMENTS OR QUESTIONS? 7689 04:34:35,177 --> 04:34:36,411 7690 04:34:36,411 --> 04:34:39,948 YES, PLEASE, COREY, YOU'RE UP 7691 04:34:39,948 --> 04:34:41,917 FIRST. 7692 04:34:41,917 --> 04:34:43,552 >> YES, I'M ASTOUNDED IN TERMS 7693 04:34:43,552 --> 04:34:45,987 OF GREAT WORK AND PROGRESS THAT 7694 04:34:45,987 --> 04:34:49,257 NIH CONTINUES TO MAKE IN THIS 7695 04:34:49,257 --> 04:34:50,859 PARTICULAR SPACE OF DISABILITY. 7696 04:34:50,859 --> 04:34:54,963 YOU ALL HAVE A LOT OF GREAT WORK 7697 04:34:54,963 --> 04:34:57,165 GOING ON THAT, AGAIN, INCLUDES 7698 04:34:57,165 --> 04:35:00,102 INPUT FROM PEOPLE WITH 7699 04:35:00,102 --> 04:35:01,937 DISABILITIES AND OVER IN THE 7700 04:35:01,937 --> 04:35:05,140 DISABILITY COMMUNITY. 7701 04:35:05,140 --> 04:35:08,076 I THINK THE STRATEGIC PLAN IN 7702 04:35:08,076 --> 04:35:11,379 HEALTH RESEARCH IS JUST A 7703 04:35:11,379 --> 04:35:12,481 VISIONARY IDEA THAT HOPEFULLY 7704 04:35:12,481 --> 04:35:15,450 WILL SERVE AS A GUIDE POST FOR 7705 04:35:15,450 --> 04:35:18,787 THE AGENCY IN YEARS TO COME, IN 7706 04:35:18,787 --> 04:35:21,823 TERMS OF ADVANCING DISABILITY IN 7707 04:35:21,823 --> 04:35:23,592 THE NIH CULTURE. 7708 04:35:23,592 --> 04:35:27,863 WE HAVE A COUPLE OF POINTS OR 7709 04:35:27,863 --> 04:35:28,964 QUESTIONS, PER SE. 7710 04:35:28,964 --> 04:35:33,001 SO MY FIRST QUESTION IS IN TERMS 7711 04:35:33,001 --> 04:35:37,072 OF GOAL NUMBER 3 IN THE DRAFT 7712 04:35:37,072 --> 04:35:39,241 STRATEGIC PLAN AROUND PROMOTING 7713 04:35:39,241 --> 04:35:42,310 PEOPLE WITH DISABILITIES, ONE OF 7714 04:35:42,310 --> 04:35:45,814 THE THINGS THAT HAS COME UP TO 7715 04:35:45,814 --> 04:35:49,951 ME IN TERMS OF ENSURING SAFETY, 7716 04:35:49,951 --> 04:35:57,759 IF YOU WILL, OR ENSURING THAT 7717 04:35:57,759 --> 04:36:04,599 PEOPLE ARE WILLING TO DISCLOSE 7718 04:36:04,599 --> 04:36:08,770 THEIR DISABILITY IS POTENTIAL 7719 04:36:08,770 --> 04:36:11,706 FOR NEGATIVE RAMIFICATIONS, NOT 7720 04:36:11,706 --> 04:36:15,544 JUST WITHIN NIH BUT ACROSS 7721 04:36:15,544 --> 04:36:17,712 COLLEGE CAMPUSES, ACROSS 7722 04:36:17,712 --> 04:36:19,915 RESEARCH INSTITUTES, WHERE 7723 04:36:19,915 --> 04:36:21,616 INDIVIDUALS WHO HAVE PARTICULAR 7724 04:36:21,616 --> 04:36:25,020 DISABILITIES AND WHO FEEL THAT 7725 04:36:25,020 --> 04:36:28,557 THE DISCLOSURE MIGHT HAVE 7726 04:36:28,557 --> 04:36:33,395 NEGATIVE IMPLICATIONS ESPECIALLY 7727 04:36:33,395 --> 04:36:39,201 WITHIN THE INTELLECTUAL REALM OF 7728 04:36:39,201 --> 04:36:41,703 SCIENCE, WHERE ONE'S ABILITY TO 7729 04:36:41,703 --> 04:36:44,472 SYNTHESIZE INFORMATION, ONE'S 7730 04:36:44,472 --> 04:36:47,209 ACADEMIC PROWESS IS HELD AT THE 7731 04:36:47,209 --> 04:36:52,914 HIGHEST LEVEL, SOME INDIVIDUALS 7732 04:36:52,914 --> 04:37:00,121 WITH DISABILITIES WHO MAY 7733 04:37:00,121 --> 04:37:04,192 HAVE -- MAY BE CONSCIOUS OF 7734 04:37:04,192 --> 04:37:05,093 SHARING THEIR DISABILITY STATUS 7735 04:37:05,093 --> 04:37:06,461 IN THIS REGARD SO ONE OF THE 7736 04:37:06,461 --> 04:37:10,632 QUESTIONS IS HOW DO WE AND HOW 7737 04:37:10,632 --> 04:37:13,702 DOES NIH PROMOTE A CULTURE IN 7738 04:37:13,702 --> 04:37:16,004 WHICH INDIVIDUALS WHO MAY NEED 7739 04:37:16,004 --> 04:37:18,740 SUPPORT, WHO MAY HAVE INVISIBLE 7740 04:37:18,740 --> 04:37:20,842 DISABILITIES, AND WHO MAY NEED 7741 04:37:20,842 --> 04:37:23,778 SUPPORT, WHO MAY HAVE 7742 04:37:23,778 --> 04:37:24,679 DISABILITIES THAT OTHER 7743 04:37:24,679 --> 04:37:30,585 SCIENTISTS MAY LOOK UPON THESE 7744 04:37:30,585 --> 04:37:32,887 AS A NEGATIVE, SO HOW WOULD WE 7745 04:37:32,887 --> 04:37:36,691 PROMOTE THOSE INDIVIDUALS TO 7746 04:37:36,691 --> 04:37:40,195 ACTUALLY DISCLOSE, TO ACTUALLY 7747 04:37:40,195 --> 04:37:40,795 REQUEST ACCOMMODATIONS, THAT 7748 04:37:40,795 --> 04:37:43,398 THEY MAY NEED TO BE SUCCESSFUL, 7749 04:37:43,398 --> 04:37:47,535 INTRAMURALLY, IN THE NIH, AS 7750 04:37:47,535 --> 04:37:53,008 WELL AS EXTRAMURALLY, 7751 04:37:53,008 --> 04:37:54,109 EXTERNALLY, THOSE RESEARCHERS AT 7752 04:37:54,109 --> 04:37:58,046 INCORPORATION TUITION -- 7753 04:37:58,046 --> 04:37:59,481 INSTITUTIONS AROUND THE COUNTRY. 7754 04:37:59,481 --> 04:38:02,550 I ASKED THE QUESTION AROUND LACK 7755 04:38:02,550 --> 04:38:05,287 OF DATA AT ONE OF THE ICD 7756 04:38:05,287 --> 04:38:09,224 MEETINGS, LACK OF DATA FOR 7757 04:38:09,224 --> 04:38:10,825 INDIVIDUALS WITH DISABILITIES 7758 04:38:10,825 --> 04:38:11,826 AND GRANT PROCUREMENT. 7759 04:38:11,826 --> 04:38:15,997 AND ONE OF THE RESPONSES IN 7760 04:38:15,997 --> 04:38:19,067 TERMS OF THAT QUESTION HAD TO DO 7761 04:38:19,067 --> 04:38:20,468 WITH INDIVIDUALS -- HAD TO DO 7762 04:38:20,468 --> 04:38:23,305 WITH NIH NOT REALLY BEING ABLE 7763 04:38:23,305 --> 04:38:25,607 TO IDENTIFY THE MEMBER OF 7764 04:38:25,607 --> 04:38:27,475 RESEARCH SCIENTISTS THAT 7765 04:38:27,475 --> 04:38:28,576 ACTUALLY HAVE DISABILITIES. 7766 04:38:28,576 --> 04:38:32,280 SO I'VE SAID A LOT BUT THE 7767 04:38:32,280 --> 04:38:34,049 QUESTION IS WHAT SORTS OF WAYS 7768 04:38:34,049 --> 04:38:37,652 DOES NIH HAVE IN MIND IN TERMS 7769 04:38:37,652 --> 04:38:40,522 OF STRATEGIC PLANNING TO REALLY 7770 04:38:40,522 --> 04:38:43,558 BE ABLE TO ENHANCE THE CULTURE 7771 04:38:43,558 --> 04:38:48,697 WHICH INDIVIDUALS WITH 7772 04:38:48,697 --> 04:38:49,497 DISABILITY, HIDDEN DISABILITIES, 7773 04:38:49,497 --> 04:38:52,334 TO DISCLOSE THEY HAVE A 7774 04:38:52,334 --> 04:38:53,668 DISABILITY AND FEEL LIKE THEY 7775 04:38:53,668 --> 04:38:57,505 CAN GET SUPPORT AND 7776 04:38:57,505 --> 04:39:03,211 ACCOMMODATIONS AND WOULD NOT BE 7777 04:39:03,211 --> 04:39:03,745 NEGATIVELY IMPLICATED FOR 7778 04:39:03,745 --> 04:39:13,955 DISCLOSING. 7779 04:39:15,557 --> 04:39:16,825 >> ELIZABETH, DO YOU WANT TO 7780 04:39:16,825 --> 04:39:19,861 JUMP IN ON THIS ONE? 7781 04:39:19,861 --> 04:39:23,264 >> I JUST WANTED TO REITERATE 7782 04:39:23,264 --> 04:39:25,533 THE SAME THING, THAT COREY SAID 7783 04:39:25,533 --> 04:39:26,601 IS IMPORTANT. 7784 04:39:26,601 --> 04:39:30,705 I'VE SEEN IN MY LAB FIRST HAND 7785 04:39:30,705 --> 04:39:33,475 OUR ABILITY TO USE NON-NIH 7786 04:39:33,475 --> 04:39:34,876 DISCRETIONARY FUNDS TO HAVE 7787 04:39:34,876 --> 04:39:38,279 ACCOMMODATIONS FOR ONE TECH THAT 7788 04:39:38,279 --> 04:39:39,581 WAS HEARING IMPAIRED, AND, YOU 7789 04:39:39,581 --> 04:39:45,186 KNOW, PROVIDING ZOOM MEETINGS 7790 04:39:45,186 --> 04:39:46,054 AND BUY MICROPHONES. 7791 04:39:46,054 --> 04:39:48,123 WHEN WE STARTED DOING THIS, 7792 04:39:48,123 --> 04:39:49,324 WHICH HADN'T OCCURRED TO ME 7793 04:39:49,324 --> 04:39:51,025 BEFORE, IN THE LAST YEAR HE WAS 7794 04:39:51,025 --> 04:39:58,299 IN THE LAB IT WAS INCREDIBLE HOW 7795 04:39:58,299 --> 04:40:00,502 HIS PERSONALITY AND PRODUCTIVITY 7796 04:40:00,502 --> 04:40:02,137 CHANGED, HE'S IN UCSF NOW 7797 04:40:02,137 --> 04:40:04,506 MEDICAL SCHOOL NOW, THEY SAID NO 7798 04:40:04,506 --> 04:40:06,040 TO THESE THINGS. 7799 04:40:06,040 --> 04:40:08,910 THEY DIDN'T ALLOW US TO NIH 7800 04:40:08,910 --> 04:40:11,413 FUNDS, SO THIS MAY BE A SMALL 7801 04:40:11,413 --> 04:40:13,715 CHANGE, WELL, IT'S NEVER SMALL, 7802 04:40:13,715 --> 04:40:15,483 BUT REALLY CHANGES THE LIVES OF 7803 04:40:15,483 --> 04:40:17,118 PEOPLE WITH DISABILITIES. 7804 04:40:17,118 --> 04:40:19,654 IT'S INCLUSIVE. 7805 04:40:19,654 --> 04:40:20,922 IT'S IMPORTANT. 7806 04:40:20,922 --> 04:40:23,691 AND AS I SAID, I'VE SEEN TWO 7807 04:40:23,691 --> 04:40:24,559 CASES, BOTH HEARING 7808 04:40:24,559 --> 04:40:28,062 DISABILITIES, ONE IN MY LAB AND 7809 04:40:28,062 --> 04:40:28,530 EFFECT WAS INCREDIBLE. 7810 04:40:28,530 --> 04:40:30,565 I THINK CORY IS RIGHT, IT WOULD 7811 04:40:30,565 --> 04:40:32,066 BE IMPORTANT TO THINK ABOUT 7812 04:40:32,066 --> 04:40:35,270 SPECIFIC CHANGES AND THINGS THAT 7813 04:40:35,270 --> 04:40:39,007 WILL ALLOW THE SCIENTIFIC 7814 04:40:39,007 --> 04:40:45,780 WORKFORCE TO SUPPORT THESE 7815 04:40:45,780 --> 04:40:46,314 WONDERFUL INDIVIDUALS. 7816 04:40:46,314 --> 04:40:48,183 >> A COUPLE THINGS TUCKED INTO 7817 04:40:48,183 --> 04:40:48,850 THAT. 7818 04:40:48,850 --> 04:40:50,718 I WOULD JUST SAY GENERALLY, 7819 04:40:50,718 --> 04:40:52,120 COREY, YOU'RE ABSOLUTELY RIGHT. 7820 04:40:52,120 --> 04:40:53,988 THERE'S A LOT OF VARIABILITY IN 7821 04:40:53,988 --> 04:40:57,826 THE COMFORT LEVEL PEOPLE HAVE, 7822 04:40:57,826 --> 04:41:00,995 WHETHER OR NOT THEY HAVE A 7823 04:41:00,995 --> 04:41:01,329 DISABILITY. 7824 04:41:01,329 --> 04:41:04,165 WE MAY BE EVEN SEEING A LITTLE 7825 04:41:04,165 --> 04:41:05,600 BIT OF GENERATIONAL DIFFERENCES 7826 04:41:05,600 --> 04:41:08,102 WITH THAT COMFORT LEVEL AS WELL. 7827 04:41:08,102 --> 04:41:09,737 AND OF COURSE ONE OF THE THINGS 7828 04:41:09,737 --> 04:41:11,639 THAT THE GROUP HAS BEEN TALKING 7829 04:41:11,639 --> 04:41:13,808 ABOUT AND WILL CONTINUE TO TALK 7830 04:41:13,808 --> 04:41:15,243 ABOUT AND FIGURE OUT WAYS TO 7831 04:41:15,243 --> 04:41:19,714 ADDRESS THIS IS HOW WE CAN 7832 04:41:19,714 --> 04:41:22,350 INCREASE THE DATA THAT WE HAVE 7833 04:41:22,350 --> 04:41:24,419 ON THE FOLKS THAT WE'RE FUNDING 7834 04:41:24,419 --> 04:41:26,654 AND PART OF THAT AS YOU'VE 7835 04:41:26,654 --> 04:41:29,023 INDICATED IS KIND OF PROMOTING 7836 04:41:29,023 --> 04:41:32,060 THAT CULTURE WHERE PEOPLE FEEL 7837 04:41:32,060 --> 04:41:33,728 COMFORTABLE WITH DISCLOSING THAT 7838 04:41:33,728 --> 04:41:35,363 INFORMATION, YOU KNOW, 7839 04:41:35,363 --> 04:41:35,797 PRIVATELY. 7840 04:41:35,797 --> 04:41:37,799 THE OTHER THING I WOULD JUST 7841 04:41:37,799 --> 04:41:41,436 POINT OUT IN TERMS OF THE 7842 04:41:41,436 --> 04:41:43,304 STATEMENT MADE, THERE'S AN 7843 04:41:43,304 --> 04:41:45,707 OPPORTUNITY TO APPLY FOR 7844 04:41:45,707 --> 04:41:47,442 SUPPLEMENTS FOR ACCOMMODATIONS 7845 04:41:47,442 --> 04:41:50,144 SO IT'S NOT THAT THERE AREN'T 7846 04:41:50,144 --> 04:41:53,781 RESTRICTIONS THERE. 7847 04:41:53,781 --> 04:41:55,416 THERE'S PATHWAYS, MECHANISMS FOR 7848 04:41:55,416 --> 04:41:55,617 THAT. 7849 04:41:55,617 --> 04:41:58,052 MAYBE WE COULD DO A BETTER JOB 7850 04:41:58,052 --> 04:41:59,921 RAISING AWARENESS SO PEOPLE 7851 04:41:59,921 --> 04:42:01,122 UNDERSTAND WHAT IS AVAILABLE. 7852 04:42:01,122 --> 04:42:04,192 I DON'T KNOW IF ADAM WANTS TO 7853 04:42:04,192 --> 04:42:07,028 WEIGH IN OR KEVIN, TALKING ABOUT 7854 04:42:07,028 --> 04:42:10,865 THE INTERNAL OF COURSE. 7855 04:42:10,865 --> 04:42:11,332 >> YEAH, THANK YOU. 7856 04:42:11,332 --> 04:42:13,835 TO HIGHLIGHT THIS IS A CULTURAL 7857 04:42:13,835 --> 04:42:16,471 SHIFT THAT AS DR. SCHWETZ 7858 04:42:16,471 --> 04:42:16,738 MENTIONED. 7859 04:42:16,738 --> 04:42:20,174 THERE'S VARYING LEVELS OF 7860 04:42:20,174 --> 04:42:22,343 COMFORT, SELF-IDENTIFYING, 7861 04:42:22,343 --> 04:42:22,911 GENERATIONAL DIFFERENCES, 7862 04:42:22,911 --> 04:42:24,546 DIFFERENCES BY DISABILITY TYPE 7863 04:42:24,546 --> 04:42:26,314 WITH A HIERARCHY OF STIGMA WITH 7864 04:42:26,314 --> 04:42:27,715 DIFFERENT TYPES OF DISABILITIES. 7865 04:42:27,715 --> 04:42:36,624 FROM NIH PERSPECTIVE TALKING 7866 04:42:36,624 --> 04:42:38,860 OPENLY AND LEADING THE WAY IS A 7867 04:42:38,860 --> 04:42:41,696 FIRST STEP. 7868 04:42:41,696 --> 04:42:43,264 MAYBE WE COULD HAVE BEST 7869 04:42:43,264 --> 04:42:45,767 PRACTICES TO SHARE WITH 7870 04:42:45,767 --> 04:42:46,267 EXTRAMURAL INSTITUTIONS. 7871 04:42:46,267 --> 04:42:47,735 BUT IT IS SOMETHING NOT UNIQUE 7872 04:42:47,735 --> 04:42:49,604 TO BIOMEDICAL RESEARCH. 7873 04:42:49,604 --> 04:42:52,674 IT'S ACROSS ANY AREA THAT THE 7874 04:42:52,674 --> 04:42:54,576 NEED -- TO GET PEOPLE TO 7875 04:42:54,576 --> 04:42:55,843 SELF-DISCLOSE BECAUSE YOU WANT 7876 04:42:55,843 --> 04:42:57,712 TO SERVE THEM BALANCING WITH 7877 04:42:57,712 --> 04:42:59,681 PRIVACY AND CONFIDENTIAL 7878 04:42:59,681 --> 04:43:01,082 CONCERNS BECAUSE THERE'S 7879 04:43:01,082 --> 04:43:02,951 DISCRIMINATION PEOPLE 7880 04:43:02,951 --> 04:43:03,284 EXPERIENCE. 7881 04:43:03,284 --> 04:43:05,153 IT'S LONGER-TERM CULTURE SHIFTS 7882 04:43:05,153 --> 04:43:08,323 BUT WE'RE LOOKING AT WAYS TO 7883 04:43:08,323 --> 04:43:09,424 DEVELOP POLICIES TO ENABLE THAT 7884 04:43:09,424 --> 04:43:10,058 SHIFT. 7885 04:43:10,058 --> 04:43:13,261 >> I WANT TO CHIME IN BECAUSE 7886 04:43:13,261 --> 04:43:14,996 NOBODY'S HAD TO SAY IT BECAUSE 7887 04:43:14,996 --> 04:43:18,399 IT'S GOTTEN TO BE AN UNDERLYING 7888 04:43:18,399 --> 04:43:19,400 ASSUMPTION, UNDERLYING FEATURING 7889 04:43:19,400 --> 04:43:20,234 WHAT WE DO HERE. 7890 04:43:20,234 --> 04:43:22,437 AND THAT IS THAT THE FIRST PLACE 7891 04:43:22,437 --> 04:43:26,040 WE START WITH IS ASKING PEOPLE 7892 04:43:26,040 --> 04:43:28,576 WHO HAVE EITHER HIDDEN OR 7893 04:43:28,576 --> 04:43:32,547 VISIBLE DISABILITIES, YOU KNOW, 7894 04:43:32,547 --> 04:43:35,717 TAKING THE QUESTION TO THEM, 7895 04:43:35,717 --> 04:43:37,785 TELL US WHAT YOU WANT, TELL US 7896 04:43:37,785 --> 04:43:40,421 HOW YOU MIGHT FEEL ABOUT 7897 04:43:40,421 --> 04:43:41,022 PARTICIPATING IN RESEARCH AND 7898 04:43:41,022 --> 04:43:42,824 TELL US WHAT WE CAN DO THAT 7899 04:43:42,824 --> 04:43:44,792 MIGHT MAKE YOU FEEL MORE 7900 04:43:44,792 --> 04:43:46,327 COMFORTABLE AND MORE SUPPORTED. 7901 04:43:46,327 --> 04:43:48,296 SO WE ALSO TRY REALLY HARD IN 7902 04:43:48,296 --> 04:43:52,066 EVERYTHING WE DO NOT JUST TO 7903 04:43:52,066 --> 04:43:55,003 ASSUME WE KNOW AND TO ASK THOSE 7904 04:43:55,003 --> 04:43:58,172 QUESTIONS THROUGH, YOU KNOW, 7905 04:43:58,172 --> 04:43:59,273 FOCUS GROUPS AND EVEN IN 7906 04:43:59,273 --> 04:44:01,209 INDIVIDUAL, YOU KNOW, THROUGH 7907 04:44:01,209 --> 04:44:01,909 INDIVIDUAL RESEARCH COMMUNITIES 7908 04:44:01,909 --> 04:44:04,412 SO THAT WE CAN LEARN FROM THAT 7909 04:44:04,412 --> 04:44:09,851 POPULATION HOW WE CAN DO THIS 7910 04:44:09,851 --> 04:44:10,084 BETTER. 7911 04:44:10,084 --> 04:44:10,518 RUSS? 7912 04:44:10,518 --> 04:44:12,954 >> YEAH, ALSO I PUT MY TWO CENTS 7913 04:44:12,954 --> 04:44:15,690 IN, THIS IS A FABULOUS 7914 04:44:15,690 --> 04:44:18,526 INITIATIVE, HUGE POPULATION AS 7915 04:44:18,526 --> 04:44:20,094 WAS POINTED OUT, AND IN MY NECK 7916 04:44:20,094 --> 04:44:22,230 OF THE WOODS WE OBVIOUSLY WORK A 7917 04:44:22,230 --> 04:44:23,998 LOT WITH VISUALLY IMPAIRED 7918 04:44:23,998 --> 04:44:25,333 PEOPLE WHO HAVE VISUAL 7919 04:44:25,333 --> 04:44:25,933 DISABILITIES. 7920 04:44:25,933 --> 04:44:27,068 I'VE HAD THE SAME EXPERIENCE 7921 04:44:27,068 --> 04:44:29,904 HAVING LOW VISION FOLKS WORK IN 7922 04:44:29,904 --> 04:44:32,206 MY LAB, JUST REALLY OPENED UP A 7923 04:44:32,206 --> 04:44:33,174 WHOLE WORLD BUT THERE'S A LOT OF 7924 04:44:33,174 --> 04:44:37,011 WORK THAT GOES INTO MAKING THAT 7925 04:44:37,011 --> 04:44:39,180 TYPE OF RESEARCH ACCESSIBLE. 7926 04:44:39,180 --> 04:44:40,415 A TECHNICAL QUESTION, WHAT 7927 04:44:40,415 --> 04:44:42,483 DEFINITION OF DISABILITY ARE WE 7928 04:44:42,483 --> 04:44:43,117 USING FOR THESE? 7929 04:44:43,117 --> 04:44:46,721 THERE ARE A BUNCH OF THEM. 7930 04:44:46,721 --> 04:44:53,861 THERE'S THE ADA, THE WHOR R. 7931 04:44:53,861 --> 04:44:56,064 -- THE 7932 04:44:56,064 --> 04:44:57,699 W.H.O., EDUCATIONAL, IS THERE 7933 04:44:57,699 --> 04:45:00,535 CONSENSUS WHICH FRAMEWORK, ARE 7934 04:45:00,535 --> 04:45:04,138 WE GENERATING A FRAMEWORK FOR 7935 04:45:04,138 --> 04:45:08,342 NIH FRAMEWORK? 7936 04:45:08,342 --> 04:45:09,844 >> THERE'S LIKE 50+ LAWS THAT 7937 04:45:09,844 --> 04:45:10,378 RELATE. 7938 04:45:10,378 --> 04:45:12,447 >> IT'S A GREAT QUESTION. 7939 04:45:12,447 --> 04:45:13,347 MANY DEFINITIONS AND STATUTES. 7940 04:45:13,347 --> 04:45:16,417 SO IF YOU LOOK AT THE RFI FOR 7941 04:45:16,417 --> 04:45:17,919 THE FRAMEWORK WE USE ADA 7942 04:45:17,919 --> 04:45:19,454 DEFINITION TO SET THE STAGE 7943 04:45:19,454 --> 04:45:23,291 BECAUSE WE'RE COMING AT THIS 7944 04:45:23,291 --> 04:45:24,592 THAT DISABILITY IS ONE THING, 7945 04:45:24,592 --> 04:45:28,129 THIS IS RESEARCH FOR ALL PEOPLE 7946 04:45:28,129 --> 04:45:29,197 WITH DISABILITIES, AND SO 7947 04:45:29,197 --> 04:45:31,833 WHETHER OR NOT ACCORDING TO THE 7948 04:45:31,833 --> 04:45:34,902 ADA DEFINITION YOU HAVE A 7949 04:45:34,902 --> 04:45:44,212 DISABILITY OR ARE PERCEIVED YOU 7950 04:45:44,212 --> 04:45:46,614 MAY EXPERIENCE JUST BY BEING 7951 04:45:46,614 --> 04:45:47,014 PERCEIVED. 7952 04:45:47,014 --> 04:45:48,683 IT'S ONE THING WE'LL GET ON 7953 04:45:48,683 --> 04:45:50,585 FURTHER, WHERE DO YOU COME DOWN 7954 04:45:50,585 --> 04:45:53,187 ON THIS BECAUSE IT'S 7955 04:45:53,187 --> 04:45:53,488 COMPLICATED. 7956 04:45:53,488 --> 04:45:57,625 >> WE'RE GOING TO LAND THIS 7957 04:45:57,625 --> 04:45:58,626 PLANE AT 3:45. 7958 04:45:58,626 --> 04:46:02,029 KEVIN, YOU GOT THE LAST WORD. 7959 04:46:02,029 --> 04:46:05,533 >> I WANTED TO HIGHLIGHT ONE 7960 04:46:05,533 --> 04:46:07,168 INITIATIVE WE'VE LAUNCHED WITH 7961 04:46:07,168 --> 04:46:09,270 ASSISTANCE OF OFFICE OF HUMAN 7962 04:46:09,270 --> 04:46:10,805 RESOURCES. 7963 04:46:10,805 --> 04:46:12,807 THAT IS, WHEN WE ISSUE TENTATIVE 7964 04:46:12,807 --> 04:46:14,842 OFFERS TO EMPLOYEES WHO WILL BE 7965 04:46:14,842 --> 04:46:16,711 JOINING THE NIH, ONE OF THE 7966 04:46:16,711 --> 04:46:19,113 THINGS THAT WE'VE NOW DONE IS 7967 04:46:19,113 --> 04:46:22,283 ASKED THEM IF THERE'S A NEED FOR 7968 04:46:22,283 --> 04:46:22,817 REASONABLE ACCOMMODATION. 7969 04:46:22,817 --> 04:46:24,252 AND SO THAT WAY WHEN THEY SHOW 7970 04:46:24,252 --> 04:46:28,189 UP TO THE AGENCY ON DAY 1, THE 7971 04:46:28,189 --> 04:46:29,390 ACCOMMODATION IS AVAILABLE, IT'S 7972 04:46:29,390 --> 04:46:31,526 SITTING THERE WAITING FOR THEM, 7973 04:46:31,526 --> 04:46:37,064 SO THEY DO NOT ON-BOARD AT NIH 7974 04:46:37,064 --> 04:46:40,101 AND WAIT ONE, TWO, THREE WEEKS 7975 04:46:40,101 --> 04:46:41,969 FOR AN ACCOMMODATION TO SHOW UP. 7976 04:46:41,969 --> 04:46:46,808 WE BELIEVE WE'RE FOSTERING AND 7977 04:46:46,808 --> 04:46:48,543 DRIVING INCLUSION FOR COLLEAGUES 7978 04:46:48,543 --> 04:46:50,077 THAT MAY HAVE DISABILITIES. 7979 04:46:50,077 --> 04:46:50,978 >> THANK YOU, EVERYBODY. 7980 04:46:50,978 --> 04:46:52,680 >> YEAH, THANK YOU SO MUCH. 7981 04:46:52,680 --> 04:46:53,014 OKAY. 7982 04:46:53,014 --> 04:46:58,820 NOW WE'RE GOING TO MOVE ON TO A 7983 04:46:58,820 --> 04:47:08,162 DISCUSSION FROM DR. LYRIC 7984 04:47:08,162 --> 04:47:09,597 JORGENSON OF NExTRAC ENGAGE. 7985 04:47:09,597 --> 04:47:11,232 SHE'S ASSOCIATE DIRECTOR FOR 7986 04:47:11,232 --> 04:47:12,867 SCIENCE POLICY AT NIH. 7987 04:47:12,867 --> 04:47:14,836 >> THANK YOU SO MUCH. 7988 04:47:14,836 --> 04:47:19,874 I'M LYRIC, AS YOU'VE HEARD 7989 04:47:19,874 --> 04:47:20,675 THROUGHOUT INCLUSIVE ENGAGEMENT 7990 04:47:20,675 --> 04:47:21,976 EMBEDDED IN THE WORK WE'RE DOING 7991 04:47:21,976 --> 04:47:24,278 AT NIH HOLDS TRUE FOR POLICY 7992 04:47:24,278 --> 04:47:26,147 TEAM THINKING ABOUT POLICY 7993 04:47:26,147 --> 04:47:28,983 CONCEPTION, DEVELOPMENT, 7994 04:47:28,983 --> 04:47:30,418 IMPLEMENTATION AND EVALUATION. 7995 04:47:30,418 --> 04:47:32,186 I'M DELIGHTED TO SHARE UPDATES 7996 04:47:32,186 --> 04:47:35,122 ON ONGOING WORK UNDER THE ENGAGE 7997 04:47:35,122 --> 04:47:35,756 INITIATIVE WHICH IS REFLECTIVE 7998 04:47:35,756 --> 04:47:39,594 OF THE WORK OF MANY, MANY, MANY 7999 04:47:39,594 --> 04:47:41,662 FOLKS ACROSS NIH AND THE 8000 04:47:41,662 --> 04:47:42,129 COUNTRY. 8001 04:47:42,129 --> 04:47:44,065 I'M HONORED TO REPRESENT THIS 8002 04:47:44,065 --> 04:47:46,133 WORK TODAY. 8003 04:47:46,133 --> 04:47:47,702 NEXT SLIDE PLEASE. 8004 04:47:47,702 --> 04:47:50,304 BEFORE WE DIVE IN I'D LIKE TO 8005 04:47:50,304 --> 04:47:51,539 REMIND THE ACD AND THOSE ONLINE 8006 04:47:51,539 --> 04:47:53,274 OF THE CONTEXT FOR TODAY'S 8007 04:47:53,274 --> 04:47:53,608 PRESENTATION. 8008 04:47:53,608 --> 04:47:56,777 YOU MAY RECALL BACK IN AUGUST OF 8009 04:47:56,777 --> 04:47:58,646 2023 THEN ACTING NIH DIRECTOR 8010 04:47:58,646 --> 04:48:01,148 LARRY TABAK CHARGED THE NOVEL 8011 04:48:01,148 --> 04:48:03,551 AND EXCEPTIONAL TECHNOLOGIES 8012 04:48:03,551 --> 04:48:05,620 RESEARCH ADVISORY COMMITTEE, 8013 04:48:05,620 --> 04:48:09,557 AGAIN THE NExTRAC, TO DEVELOP 8014 04:48:09,557 --> 04:48:11,759 VISION AND FRAMEWORK FOR PUBLIC 8015 04:48:11,759 --> 04:48:13,394 VOICES IN NIH-FUNDED CLINICAL 8016 04:48:13,394 --> 04:48:14,262 TRIALS. 8017 04:48:14,262 --> 04:48:15,730 GIVEN THE IMPORTANCE BEING 8018 04:48:15,730 --> 04:48:16,697 BROADLY INCLUSIVE AND NEEDING 8019 04:48:16,697 --> 04:48:18,900 INPUT FROM MULTIPLE PEOPLE 8020 04:48:18,900 --> 04:48:20,101 AROUND THE COUNTRY, MULTIPLE 8021 04:48:20,101 --> 04:48:21,636 ROLES, WE MADE SURE THE GROUP'S 8022 04:48:21,636 --> 04:48:24,372 WORK WAS BROUGHT TO THE ACD'S 8023 04:48:24,372 --> 04:48:25,473 ATTENTION FOR DISCUSSION AND 8024 04:48:25,473 --> 04:48:27,008 INPUT ALONG THE WAY. 8025 04:48:27,008 --> 04:48:30,845 YOU HEARD FROM THE NExTRAC 8026 04:48:30,845 --> 04:48:33,481 WORKING GROUP CHAIRS SUE AND 8027 04:48:33,481 --> 04:48:34,348 CHRIS IN DECEMBER REGARDING 8028 04:48:34,348 --> 04:48:37,518 PROGRESS AND HOW THEY PLANNED TO 8029 04:48:37,518 --> 04:48:38,286 TACKLE THIS CHARGE. 8030 04:48:38,286 --> 04:48:40,888 IN JUNE OF THIS YEAR NIH CREATED 8031 04:48:40,888 --> 04:48:42,456 A CENTRAL SPACE FOR ENGAGE 8032 04:48:42,456 --> 04:48:44,425 EFFORT AND PRODUCT AS WELL AS 8033 04:48:44,425 --> 04:48:46,394 FRONT DOOR FOR REFLECTING NIH 8034 04:48:46,394 --> 04:48:48,162 EXPERTISE AND WORKING COMMUNITY 8035 04:48:48,162 --> 04:48:48,462 ENGAGEMENT. 8036 04:48:48,462 --> 04:48:49,563 WHICH BRINGS US TO THE LAST 8037 04:48:49,563 --> 04:48:51,232 COUPLE WEEKS WHERE THE WORKING 8038 04:48:51,232 --> 04:48:52,900 GROUP IS SHARING PROGRESS WITH 8039 04:48:52,900 --> 04:48:54,502 THE NExTRAC AT A MEETING LAST 8040 04:48:54,502 --> 04:48:57,939 WEEK AND ME HERE WITH YOU ALL 8041 04:48:57,939 --> 04:48:58,205 TODAY. 8042 04:48:58,205 --> 04:48:59,674 NEXT SLIDE PLEASE. 8043 04:48:59,674 --> 04:49:01,642 SO NOW LET'S DIVE IN. 8044 04:49:01,642 --> 04:49:04,045 I WANT TO BE REALLY CLEAR I'M 8045 04:49:04,045 --> 04:49:05,913 REPRESENTING THE WORK OF ALL OF 8046 04:49:05,913 --> 04:49:07,315 THESE AMAZING TALENTED FOLKS, 8047 04:49:07,315 --> 04:49:10,618 THE ENGAGE WORKING GROUP AND 8048 04:49:10,618 --> 04:49:12,253 NExTRAC AND A TEAM OF EXPERTS 8049 04:49:12,253 --> 04:49:12,687 AT NIH. 8050 04:49:12,687 --> 04:49:13,888 IN THE SPIRIT OF THE WORK THAT 8051 04:49:13,888 --> 04:49:16,524 NEEDS TO BE DONE TO ENGAGE THE 8052 04:49:16,524 --> 04:49:18,626 BROAD AND DIVERSE VOICES ACROSS 8053 04:49:18,626 --> 04:49:19,927 THE COUNTRY IN CLINICAL RESEARCH 8054 04:49:19,927 --> 04:49:22,997 AS I MENTIONED THE NIH CHARGED 8055 04:49:22,997 --> 04:49:24,532 THE NExTRAC WITH DEVELOPING 8056 04:49:24,532 --> 04:49:26,600 THIS FRAMEWORK FOR INCLUDING 8057 04:49:26,600 --> 04:49:30,237 PUBLIC VOICES THROUGHOUT THE 8058 04:49:30,237 --> 04:49:31,772 CLINICAL RESEARCH LIFE CYCLE. 8059 04:49:31,772 --> 04:49:32,940 SPECIFICALLY THE FRAMEWORK 8060 04:49:32,940 --> 04:49:34,275 SHOULD THINK ABOUT APPROACHES 8061 04:49:34,275 --> 04:49:38,312 FOR THE BREADTH AND DIVERSITY OF 8062 04:49:38,312 --> 04:49:38,913 NIH-FUNDED CLINICAL RESEARCH 8063 04:49:38,913 --> 04:49:40,181 STUDIES, ASSESS OPPORTUNITIES 8064 04:49:40,181 --> 04:49:42,016 AND CHALLENGES OF LEVELS OF 8065 04:49:42,016 --> 04:49:44,318 ENGAGEMENT ACTIVITIES FOR THE 8066 04:49:44,318 --> 04:49:45,319 RESEARCH STUDIES. 8067 04:49:45,319 --> 04:49:46,954 IMPORTANTLY TO ENSURE ANY VISION 8068 04:49:46,954 --> 04:49:49,490 IS ANCHORED IN INSTITUTIONAL 8069 04:49:49,490 --> 04:49:51,025 PRACTICES, AND REALITIES, 8070 04:49:51,025 --> 04:49:52,960 CHALLENGES OF ACTUAL ENGAGEMENT, 8071 04:49:52,960 --> 04:49:54,729 WE ASKED THE NExTRAC AND ACD 8072 04:49:54,729 --> 04:49:56,797 TO THINK THROUGH RECOMMENDATIONS 8073 04:49:56,797 --> 04:49:58,099 REGARDING HOW ENGAGEMENT METHODS 8074 04:49:58,099 --> 04:50:01,168 COULD BE USED, OPTIMAL TIMING 8075 04:50:01,168 --> 04:50:03,170 FOR MEANINGFUL ENGAGEMENT 8076 04:50:03,170 --> 04:50:04,805 ACTIVITIES, AND ANY APPROACHES 8077 04:50:04,805 --> 04:50:10,978 CONSIDERED THROUGH THE LENS OF 8078 04:50:10,978 --> 04:50:12,513 INCLUSIVITY AND EQUITABILITY. 8079 04:50:12,513 --> 04:50:19,153 WE HAVE TWO EXCELLENT CO-CHAIRS 8080 04:50:19,153 --> 04:50:20,588 LEADING OUR EXTERNAL EFFORTS, 8081 04:50:20,588 --> 04:50:21,822 FIRST ALUMNI PROFESSOR OF SCHOOL 8082 04:50:21,822 --> 04:50:23,858 OF NURSING AND PROFESSOR OF 8083 04:50:23,858 --> 04:50:25,860 BIOMEDICAL INFORMATICS AT 8084 04:50:25,860 --> 04:50:27,061 COLUMBIA UNIVERSITY. 8085 04:50:27,061 --> 04:50:28,262 EXTENSIVE EXPERIENCE WITH 8086 04:50:28,262 --> 04:50:30,064 PATIENT ENGAGEMENT AND RESEARCH, 8087 04:50:30,064 --> 04:50:32,533 SPECIFICALLY THROUGH LENS OF 8088 04:50:32,533 --> 04:50:34,335 PROMOTING HEALTH AND REDUCING 8089 04:50:34,335 --> 04:50:35,703 HEALTH DISPARITIES. 8090 04:50:35,703 --> 04:50:40,641 NEXT WE HAVE A TREMENDOUSLY 8091 04:50:40,641 --> 04:50:44,078 INFLUENTIAL PATIENT ADVOCATE, 8092 04:50:44,078 --> 04:50:45,980 MS. VEASLEY AS SECOND CO-CHAIR, 8093 04:50:45,980 --> 04:50:48,282 CO-FOUNDER AND DIRECTOR OF 8094 04:50:48,282 --> 04:50:50,151 CHRONIC PAIN RESEARCH ALLIANCE, 8095 04:50:50,151 --> 04:50:51,252 HOLDS ADVISORY COMMISSIONS FOR 8096 04:50:51,252 --> 04:50:53,421 PAIN INITIATIVES IN FEDERAL 8097 04:50:53,421 --> 04:50:55,523 AGENCIES, ACADEMIC PAIN RESEARCH 8098 04:50:55,523 --> 04:50:57,625 STUDIES, VARIOUS COLLABORATIVE 8099 04:50:57,625 --> 04:50:58,159 ALLIANCES. 8100 04:50:58,159 --> 04:50:59,360 SHE'S BEEN AN ADVOCATE AT 8101 04:50:59,360 --> 04:51:01,028 CONGRESSIONAL AND FEDERAL AGENCY 8102 04:51:01,028 --> 04:51:03,197 LEVEL FOR BRINGING ABOUT PUBLIC 8103 04:51:03,197 --> 04:51:04,832 AWARENESS OF THE PROFOUND IMPACT 8104 04:51:04,832 --> 04:51:06,367 OF CHRONIC PAIN. 8105 04:51:06,367 --> 04:51:08,369 WE ALSO HAVE 21 OTHER WORKING 8106 04:51:08,369 --> 04:51:10,438 GROUP MEMBERS, I CAN TELL YOU 8107 04:51:10,438 --> 04:51:12,506 THIS IS ONE OF THE LARGEST I'VE 8108 04:51:12,506 --> 04:51:14,608 SEEN IN A LONG TIME, BECAUSE 8109 04:51:14,608 --> 04:51:16,043 THEY ARE ALL ENERGIZED AND READY 8110 04:51:16,043 --> 04:51:17,545 TO CHANGE THE WORLD. 8111 04:51:17,545 --> 04:51:19,113 THIS INCLUDES PATIENTS AND 8112 04:51:19,113 --> 04:51:20,414 PATIENT ADVOCATES REPRESENTING 8113 04:51:20,414 --> 04:51:22,650 AREAS IN CANCER, RARE DISEASE, 8114 04:51:22,650 --> 04:51:24,151 SICKLE CELL DISEASE, DOWN 8115 04:51:24,151 --> 04:51:29,056 SYNDROME, AND MORE AND 8116 04:51:29,056 --> 04:51:31,592 PERSPECTIVES HAVE BEEN 8117 04:51:31,592 --> 04:51:31,859 ESSENTIAL. 8118 04:51:31,859 --> 04:51:34,562 WE HAVE ACADEMICS, FROM 8119 04:51:34,562 --> 04:51:37,832 RESEARCH, RURAL HEALTH, TRIBAL 8120 04:51:37,832 --> 04:51:40,234 HEALTH, AND MORE AND 8121 04:51:40,234 --> 04:51:41,168 REPRESENTATION FROM NON-PROFIT 8122 04:51:41,168 --> 04:51:42,870 ORGANIZATIONS ACTIVE IN THE 8123 04:51:42,870 --> 04:51:44,505 SPACE, IMPORTANT PARTNERS AS WE 8124 04:51:44,505 --> 04:51:45,039 MOVE FORWARD. 8125 04:51:45,039 --> 04:51:50,411 WE'RE ALSO THRILLED TO HAVE 8126 04:51:50,411 --> 04:51:52,379 CURRENT ACD MEMBER AND RECENT 8127 04:51:52,379 --> 04:51:54,014 MEMBER ON THE GROUP. 8128 04:51:54,014 --> 04:51:59,687 I'LL TURN TO ALEXA AT THE END 8129 04:51:59,687 --> 04:52:00,121 FOR HER REFLECTIONS. 8130 04:52:00,121 --> 04:52:01,455 NEXT SLIDE PLEASE. 8131 04:52:01,455 --> 04:52:02,990 NOW AS WE SHARE SLIDES PRESENTED 8132 04:52:02,990 --> 04:52:07,228 AT THE MOST RECENT NExTRAC 8133 04:52:07,228 --> 04:52:08,629 MEETING I'M HONORED TO REFLECT 8134 04:52:08,629 --> 04:52:09,997 THEM TODAY. 8135 04:52:09,997 --> 04:52:11,198 THEY HAVE MADE SIGNIFICANT 8136 04:52:11,198 --> 04:52:12,399 PROGRESS DURING THEIR FIRST YEAR 8137 04:52:12,399 --> 04:52:15,035 AND ARE ON TRACK TO DELIVER THE 8138 04:52:15,035 --> 04:52:17,104 FINAL REPORT AND RECOMMENDATIONS 8139 04:52:17,104 --> 04:52:18,205 IN THE SUMMER OF 2025. 8140 04:52:18,205 --> 04:52:20,841 THEY DID MEET LAST WEEK IN A 8141 04:52:20,841 --> 04:52:24,578 PUBLIC CONVENING AND HEARD THIS 8142 04:52:24,578 --> 04:52:25,146 READOUT. 8143 04:52:25,146 --> 04:52:26,780 I HIGHLIGHT SLIDES ARE NOT MINE. 8144 04:52:26,780 --> 04:52:28,649 YOU CAN SEE THE PRESENTATION ON 8145 04:52:28,649 --> 04:52:31,285 THE PUBLIC WEBCAST. 8146 04:52:31,285 --> 04:52:32,686 SOME WORKING GROUPS 8147 04:52:32,686 --> 04:52:33,587 ACCOMPLISHMENTS INCLUDE FIRST 8148 04:52:33,587 --> 04:52:36,323 DEFINING DEFINITION FOR WHAT WE 8149 04:52:36,323 --> 04:52:38,926 MEAN BY CLINICAL RESEARCH 8150 04:52:38,926 --> 04:52:39,727 ENGAGEMENT, IDENTIFYING KEY 8151 04:52:39,727 --> 04:52:40,528 PLAYERS IN THE PROCESS. 8152 04:52:40,528 --> 04:52:43,631 THEY HAVE DEVELOPED A WORKING 8153 04:52:43,631 --> 04:52:44,732 FRAMEWORK GRAPHIC THAT SERVES AS 8154 04:52:44,732 --> 04:52:47,334 A ROAD MAP FOR INCLUDING 8155 04:52:47,334 --> 04:52:49,003 OBJECTIVES AND DOMAINS FOR 8156 04:52:49,003 --> 04:52:49,637 INCLUSIVE ENGAGEMENT. 8157 04:52:49,637 --> 04:52:54,909 AGAIN, THE GOAL TORE THIS TO BE 8158 04:52:54,909 --> 04:52:57,778 ROAD MAP FOR A MEANINGFUL 8159 04:52:57,778 --> 04:52:58,445 PROCESS. 8160 04:52:58,445 --> 04:53:00,481 FINALLY A TOOLBOX OF RESOURCES 8161 04:53:00,481 --> 04:53:07,621 TO SUPPORT CLINICAL RESEARCH 8162 04:53:07,621 --> 04:53:10,324 ENGAGEMENT TO SERVE AS A MODEL 8163 04:53:10,324 --> 04:53:13,294 AS WE LEARN MORE AND BRING MORE 8164 04:53:13,294 --> 04:53:14,061 PEOPLE TO THE TABLE. 8165 04:53:14,061 --> 04:53:15,696 SO I'LL TALK ABOUT THE THREE 8166 04:53:15,696 --> 04:53:19,533 EFFORTS BRIEFLY IN THE NEXT FEW 8167 04:53:19,533 --> 04:53:19,867 SLIDES. 8168 04:53:19,867 --> 04:53:22,903 NEXT SLIDE PLEASE. 8169 04:53:22,903 --> 04:53:23,904 FIRST THE WORKING GROUP 8170 04:53:23,904 --> 04:53:24,772 DETERMINES COMMUNITY ENGAGEMENT 8171 04:53:24,772 --> 04:53:26,874 IS LIKE A PROBLEM OF MANY PEOPLE 8172 04:53:26,874 --> 04:53:28,943 TOUCHING VARIOUS PARTS OF AN 8173 04:53:28,943 --> 04:53:32,680 ELEPHANT, A CLEAR DEFINITION OF 8174 04:53:32,680 --> 04:53:34,648 WHAT WE'RE TRYING TO ACHIEVE 8175 04:53:34,648 --> 04:53:36,717 ENGAGEMENT IS NEEDED. 8176 04:53:36,717 --> 04:53:37,718 ENGAGEMENT IS INVOLVEMENT THAT 8177 04:53:37,718 --> 04:53:39,553 VARIES BY LEVEL AND TYPE, 8178 04:53:39,553 --> 04:53:41,322 DEPENDING ON RESEARCH AND 8179 04:53:41,322 --> 04:53:42,189 COMMUNITY NEEDS. 8180 04:53:42,189 --> 04:53:43,991 WITH INDIVIDUALS, GROUPS OF 8181 04:53:43,991 --> 04:53:46,126 PEOPLE, COMMUNITIES, AND/OR 8182 04:53:46,126 --> 04:53:47,428 ORGANIZATIONS ACROSS THE VARIOUS 8183 04:53:47,428 --> 04:53:49,196 STAGES OF CLINICAL RESEARCH SO 8184 04:53:49,196 --> 04:53:51,265 THE RESEARCH AND OUTCOMES ARE 8185 04:53:51,265 --> 04:53:55,169 MEANINGFUL AND ACTIONABLE TO ITS 8186 04:53:55,169 --> 04:53:56,003 RELEVANT PARTNERS. 8187 04:53:56,003 --> 04:53:58,706 THIS IS INTENTIONALLY A BROAD 8188 04:53:58,706 --> 04:54:01,909 AND INCLUSIVE DEFINITION THAT'S 8189 04:54:01,909 --> 04:54:04,211 INTENDED TO ENCOMPASS NUMEROUS 8190 04:54:04,211 --> 04:54:06,614 STUDY DESIGNS, CLINICAL TRIALS 8191 04:54:06,614 --> 04:54:07,815 AND TRANSLATIONAL RESEARCH. 8192 04:54:07,815 --> 04:54:11,018 TO HELP UNPACK SOME KEY CONCEPTS 8193 04:54:11,018 --> 04:54:13,387 WITHIN THIS DEFINITION THE 8194 04:54:13,387 --> 04:54:15,356 WORKING GROUP HAS DEVELOPED TWO 8195 04:54:15,356 --> 04:54:16,123 SUPPORTING FIGURES. 8196 04:54:16,123 --> 04:54:17,992 FIRST, WHAT WE MEAN BY THE 8197 04:54:17,992 --> 04:54:20,094 VARIOUS STAGES OF CLINICAL 8198 04:54:20,094 --> 04:54:21,161 RESEARCH. 8199 04:54:21,161 --> 04:54:22,529 AND SECOND, THE RELEVANT 8200 04:54:22,529 --> 04:54:24,131 PARTNERS IN ENGAGEMENT. 8201 04:54:24,131 --> 04:54:29,069 AGAIN, THESE ARE MEANT TO BE 8202 04:54:29,069 --> 04:54:34,908 ILLUSTRATIVE AN NON-EXHAUSTIVE. 8203 04:54:34,908 --> 04:54:36,644 RESOURCES EXIST, TO BE ABLE TO 8204 04:54:36,644 --> 04:54:39,580 ASSESS GAPS AND BARRIERS. 8205 04:54:39,580 --> 04:54:41,215 AND ENGAGE THOSE TRADITIONALLY 8206 04:54:41,215 --> 04:54:42,182 UNREPRESENTED IN RESEARCH TO 8207 04:54:42,182 --> 04:54:43,083 DETERMINE WHAT OTHER 8208 04:54:43,083 --> 04:54:44,718 INFRASTRUCTURE AND TOOLS ARE 8209 04:54:44,718 --> 04:54:48,222 NEEDED TO FORGE A PATH FORWARD. 8210 04:54:48,222 --> 04:54:49,323 NEXT SLIDE PLEASE. 8211 04:54:49,323 --> 04:54:51,191 SO THE WORKING GROUP HAS BEEN 8212 04:54:51,191 --> 04:54:52,926 HARD AT WORK IN DEVELOPING THEIR 8213 04:54:52,926 --> 04:54:56,330 CONCEPT OF A FRAMEWORK FOR 8214 04:54:56,330 --> 04:55:00,834 CLINICAL RESEARCH ENGAGEMENT. 8215 04:55:00,834 --> 04:55:03,237 THEY ENVISION A ROAD MAP 8216 04:55:03,237 --> 04:55:06,307 SUITABLE FOR A BROAD AUDIENCE, 8217 04:55:06,307 --> 04:55:14,982 IT WILL DELIVER OUTCOMES TO 8218 04:55:14,982 --> 04:55:15,716 ENHANCE TRUST, PARTNERSHIP, 8219 04:55:15,716 --> 04:55:16,283 AGENCY. 8220 04:55:16,283 --> 04:55:18,352 WE'RE WORKING ON ILLUSTRATIONS 8221 04:55:18,352 --> 04:55:19,620 TO SIMPLIFY AT SOME LEVEL BUT 8222 04:55:19,620 --> 04:55:22,089 WITHIN THE FRAMEWORK THERE ARE 8223 04:55:22,089 --> 04:55:23,157 ACTIONABLE ELEMENTS DESIGNED 8224 04:55:23,157 --> 04:55:24,491 WITH INTENT OF ENABLING 8225 04:55:24,491 --> 04:55:26,894 INDIVIDUALS USING IT TO CLEARLY 8226 04:55:26,894 --> 04:55:28,395 IDENTIFY CONCRETE STEPS THEY CAN 8227 04:55:28,395 --> 04:55:29,930 TAPE TO IMPROVE PUBLIC 8228 04:55:29,930 --> 04:55:30,698 ENGAGEMENT IN RESEARCH. 8229 04:55:30,698 --> 04:55:32,132 AGAIN, THE GOAL FOR INTENDED 8230 04:55:32,132 --> 04:55:33,767 USER TO FIND WHERE THEY FIT INTO 8231 04:55:33,767 --> 04:55:36,603 THE CYCLE AND GIVE THEM TOOLS 8232 04:55:36,603 --> 04:55:38,505 FOR ENGAGING. 8233 04:55:38,505 --> 04:55:40,774 IT IS COMPLEMENTED BY MATURITY 8234 04:55:40,774 --> 04:55:42,409 MODEL, INTENDED TO SERVE AS 8235 04:55:42,409 --> 04:55:44,044 BASELINE ENTRY POINT FOR 8236 04:55:44,044 --> 04:55:47,014 MEANINGFUL ENGAGEMENT WITH ROAD 8237 04:55:47,014 --> 04:55:48,449 MAP FOR INCREASING ENGAGEMENT 8238 04:55:48,449 --> 04:55:50,718 COMPLEXITY AND INTENSITY OVER 8239 04:55:50,718 --> 04:55:50,984 TIME. 8240 04:55:50,984 --> 04:55:54,988 AS MENTIONED IT'S STILL BEING 8241 04:55:54,988 --> 04:55:55,689 ITERATED UPON THROUGH A PROCESS 8242 04:55:55,689 --> 04:55:56,890 I'LL DESCRIBE. 8243 04:55:56,890 --> 04:55:58,726 THIS IS THE ORIGINAL CONCEPT 8244 04:55:58,726 --> 04:56:00,694 GRAPHIC FRAMEWORK THAT WAS 8245 04:56:00,694 --> 04:56:00,961 PRESENTED. 8246 04:56:00,961 --> 04:56:01,929 IT IS ITERATED AND DEVELOPED 8247 04:56:01,929 --> 04:56:04,131 OVER TIME BUT AGAIN WANTED TO 8248 04:56:04,131 --> 04:56:05,999 SHOW YOU HOW THE GROUP IS 8249 04:56:05,999 --> 04:56:07,534 APPROACHING THE TASK. 8250 04:56:07,534 --> 04:56:12,106 I WON'T GO INTO DETAIL BUT YOU 8251 04:56:12,106 --> 04:56:13,006 SEE RESEARCH LIFE CYCLE, 8252 04:56:13,006 --> 04:56:14,975 ENTITIES WITH A ROLE TO PLAY IN 8253 04:56:14,975 --> 04:56:18,946 SUCCESS ALSO DEFINED AROUND 8254 04:56:18,946 --> 04:56:19,913 CIRCLES. 8255 04:56:19,913 --> 04:56:23,650 YOU CAN SEE FACTORS THAT AFFECT 8256 04:56:23,650 --> 04:56:25,185 BROADER ENTERPRISE, 8257 04:56:25,185 --> 04:56:25,819 CONTEXTUALIZING WHERE RESEARCH 8258 04:56:25,819 --> 04:56:28,355 HAPPENS AS YOU HEARD TODAY FROM 8259 04:56:28,355 --> 04:56:30,324 LEADERSHIP AND MEETING PEOPLE 8260 04:56:30,324 --> 04:56:31,525 WHERE THEY ARE IN COMMUNITIES 8261 04:56:31,525 --> 04:56:42,202 AND STUDIES WHERE THE WORK IS 8262 04:56:42,202 --> 04:56:42,403 OCCURRING. 8263 04:56:42,403 --> 04:56:43,404 THE NEED TO MITIGATE SOCIAL 8264 04:56:43,404 --> 04:56:45,672 DETERMINANTS OF HEALTH THROUGH 8265 04:56:45,672 --> 04:56:47,107 INFRASTRUCTURE AND CAPACITY 8266 04:56:47,107 --> 04:56:47,374 BUILDING. 8267 04:56:47,374 --> 04:56:49,276 THOSE ARE THE EXTERNAL 8268 04:56:49,276 --> 04:56:51,779 PARAMETERS AROUND THE FRAMEWORK. 8269 04:56:51,779 --> 04:56:52,780 NEXT SLIDE PLEASE. 8270 04:56:52,780 --> 04:56:55,349 YOU SAW PART OF THE RESEARCH 8271 04:56:55,349 --> 04:56:59,887 LIFE CYCLE, THE WORKING GROUP 8272 04:56:59,887 --> 04:57:00,120 IS 8273 04:57:00,120 --> 04:57:01,655 UNPACKING TO LAY OUT OBJECTIVES 8274 04:57:01,655 --> 04:57:03,290 AND DOMAINS FOR THE LIFE CYCLE 8275 04:57:03,290 --> 04:57:05,526 WITH THE GOAL TO PROVIDE 8276 04:57:05,526 --> 04:57:06,827 TANGIBLE ACTION ORIENTED STEPS 8277 04:57:06,827 --> 04:57:09,997 THAT COULD BE IMPLEMENTED BY 8278 04:57:09,997 --> 04:57:10,464 USERS. 8279 04:57:10,464 --> 04:57:12,733 WORK CONTINUES TO BE DEVELOPED. 8280 04:57:12,733 --> 04:57:17,204 YOU WILL SEE BRIEFLY THAT DRAFT 8281 04:57:17,204 --> 04:57:19,506 OBJECTIVES IN TERMS OF RESEARCH 8282 04:57:19,506 --> 04:57:20,607 QUESTION, RESEARCH STUDIES 8283 04:57:20,607 --> 04:57:22,242 INFORMED AND DRIVEN BY COMMUNITY 8284 04:57:22,242 --> 04:57:24,278 HEALTH NEEDS AND PRIORITIES. 8285 04:57:24,278 --> 04:57:29,049 YOU ALSO SEE DRAFT OBJECTIVE FOR 8286 04:57:29,049 --> 04:57:30,250 AGENDA SETTING SHARED EQUITABLE 8287 04:57:30,250 --> 04:57:31,685 PRIORITY SETTING PROCESS FOR 8288 04:57:31,685 --> 04:57:32,786 COMMUNITY NEEDS MATCHED TO 8289 04:57:32,786 --> 04:57:33,854 RESEARCH QUESTIONS AND AGAIN 8290 04:57:33,854 --> 04:57:35,255 WE'VE HEARD ABOUT THIS TODAY IN 8291 04:57:35,255 --> 04:57:38,659 TERMS OF CARE FOR HEALTH 8292 04:57:38,659 --> 04:57:39,026 INITIATIVE. 8293 04:57:39,026 --> 04:57:40,194 DRAFT OBJECTIVE FOR DESIGN 8294 04:57:40,194 --> 04:57:42,095 PLANNING TO MAKE SURE RESEARCH 8295 04:57:42,095 --> 04:57:45,899 QUESTIONS OR RESEARCH STUDY IS 8296 04:57:45,899 --> 04:57:47,968 CO-DESIGNED WITH COMMUNITY 8297 04:57:47,968 --> 04:57:48,268 MEMBERS. 8298 04:57:48,268 --> 04:57:52,773 NEXT SLIDE PLEASE. 8299 04:57:52,773 --> 04:57:54,608 FINALLY A TOOLBOX WOULD 8300 04:57:54,608 --> 04:57:56,043 COMPLEMENT THE FRAMEWORK TO 8301 04:57:56,043 --> 04:57:57,711 SUPPORT MEANINGFUL PUBLIC 8302 04:57:57,711 --> 04:57:58,812 ENGAGEMENT AND CLINICAL 8303 04:57:58,812 --> 04:57:59,079 RESEARCH. 8304 04:57:59,079 --> 04:58:00,981 THE TOOLBOX RIGHT NOW IS A 8305 04:58:00,981 --> 04:58:03,584 STARTING POINT FOR IDENTIFYING 8306 04:58:03,584 --> 04:58:04,418 RELEVANT RESOURCES, AGAIN THE 8307 04:58:04,418 --> 04:58:05,686 WORLD HAS BEEN PLAYING IN THIS 8308 04:58:05,686 --> 04:58:07,321 SPACE FOR A DECENT AMOUNT OF 8309 04:58:07,321 --> 04:58:09,089 TIME, WE WANT TO BUILD ON THAT 8310 04:58:09,089 --> 04:58:09,590 EXPERIENCE. 8311 04:58:09,590 --> 04:58:11,725 THE GROUP IS WORKING TO ASSEMBLE 8312 04:58:11,725 --> 04:58:14,761 TOOLS TO HELP BOTH RESEARCHERS 8313 04:58:14,761 --> 04:58:16,196 AND COMMUNITIES TO ENACT 8314 04:58:16,196 --> 04:58:16,997 MEANINGFUL ENGAGEMENT. 8315 04:58:16,997 --> 04:58:18,832 THE GROUP IS WORKING ON 8316 04:58:18,832 --> 04:58:20,133 ORGANIZATIONAL TAGGING SYSTEM 8317 04:58:20,133 --> 04:58:23,103 FOR THESE RESOURCES THAT ALIGNS 8318 04:58:23,103 --> 04:58:25,839 WITH THE FRAMEWORK SO IT CAN 8319 04:58:25,839 --> 04:58:30,410 IMPROVE SEARCHING AND INDEXING 8320 04:58:30,410 --> 04:58:31,178 IN FUTURE ITERATIONS, INCLUDING 8321 04:58:31,178 --> 04:58:32,813 USERS OF THE RESOURCE, ARE YOU A 8322 04:58:32,813 --> 04:58:34,581 COMMUNITY MEMBER OR RESEARCH? 8323 04:58:34,581 --> 04:58:35,649 WHO IS INTENDED AUDIENCE OF THE 8324 04:58:35,649 --> 04:58:36,049 RESOURCE? 8325 04:58:36,049 --> 04:58:38,285 AGAIN, WHO ARE YOU INTENDING TO 8326 04:58:38,285 --> 04:58:38,619 AFFECT? 8327 04:58:38,619 --> 04:58:40,220 WHERE IN THE CLINICAL RESEARCH 8328 04:58:40,220 --> 04:58:42,122 LIFE CYCLE YOU ARE IN STARTING 8329 04:58:42,122 --> 04:58:46,326 TO PLAN YOUR STUDY OR 8330 04:58:46,326 --> 04:58:46,860 DISSEMINATING RESULTS? 8331 04:58:46,860 --> 04:58:47,961 RESEARCH WOULD BE USED AS 8332 04:58:47,961 --> 04:58:50,364 SUPPORT, IN TERMS OF NOVEL OR 8333 04:58:50,364 --> 04:58:51,365 EMERGING TECHNOLOGIES, AGAIN 8334 04:58:51,365 --> 04:58:52,266 BRINGING NEW CONCEPTS TO 8335 04:58:52,266 --> 04:58:53,967 COMMUNITIES AND HOW TO WORK WITH 8336 04:58:53,967 --> 04:59:00,874 THEM ON EMERGING AND UNKNOWN 8337 04:59:00,874 --> 04:59:01,475 INTERVENTIONS. 8338 04:59:01,475 --> 04:59:02,543 NEXT SLIDE PLEASE. 8339 04:59:02,543 --> 04:59:04,378 AS WE'VE BEEN DISCUSSING AGAIN 8340 04:59:04,378 --> 04:59:06,713 TODAY, THE KEY TO ENGAGE 8341 04:59:06,713 --> 04:59:07,748 FUNCTIONING IS UNDERSTANDING HOW 8342 04:59:07,748 --> 04:59:10,083 PEOPLE WANT TO BE ENGAGED, AND 8343 04:59:10,083 --> 04:59:12,052 WHAT ARE STRATEGIES FOR DOING 8344 04:59:12,052 --> 04:59:12,219 SO. 8345 04:59:12,219 --> 04:59:13,921 IN SUPPORT OF THE ENGAGE EFFORT, 8346 04:59:13,921 --> 04:59:16,023 NIH HAS BEEN SEEKING PUBLIC 8347 04:59:16,023 --> 04:59:17,524 INPUT FOR MULTIPLE CHALLENGES TO 8348 04:59:17,524 --> 04:59:19,626 ASSIST WORKING GROUP IN MEETING 8349 04:59:19,626 --> 04:59:21,261 THEIR CHARGE. 8350 04:59:21,261 --> 04:59:23,030 THESE CHANNELS INCLUDE BASELINE 8351 04:59:23,030 --> 04:59:23,697 REQUESTS FOR INFORMATION AGAIN 8352 04:59:23,697 --> 04:59:25,532 GETTING THE WORD OUT TO EVERYONE 8353 04:59:25,532 --> 04:59:28,068 SO THEY CAN PARTICIPATE IN THE 8354 04:59:28,068 --> 04:59:28,602 PROCESS. 8355 04:59:28,602 --> 04:59:30,571 WE'VE ALSO WORKED WITH COMMUNITY 8356 04:59:30,571 --> 04:59:32,873 GROUPS TO HAVE LISTENING 8357 04:59:32,873 --> 04:59:34,508 SESSIONS, AND WE'RE HAVING 12 8358 04:59:34,508 --> 04:59:35,242 CONVERSATIONS WITH COMMUNITIES 8359 04:59:35,242 --> 04:59:38,478 ACROSS THE COUNTRY TO SEEK 8360 04:59:38,478 --> 04:59:39,980 PERSPECTIVES ON DIFFERENT 8361 04:59:39,980 --> 04:59:40,881 ENGAGEMENT METHODS, OPTIMAL 8362 04:59:40,881 --> 04:59:44,618 TIMING FOR ACTIVITIES AND HOW TO 8363 04:59:44,618 --> 04:59:47,020 APPROACH ENGAGEMENT TO ENSURE IT 8364 04:59:47,020 --> 04:59:49,590 IS EQUITY AND INCLUSIVE. 8365 04:59:49,590 --> 04:59:51,091 NEXT SLIDE PLEASE. 8366 04:59:51,091 --> 04:59:54,394 THE FIRST AVENUE WAS REQUEST FOR 8367 04:59:54,394 --> 04:59:56,697 PUBLIC INPUT THROUGH REQUEST FOR 8368 04:59:56,697 --> 04:59:59,533 INFORMATION IN VIRTUAL LISTENING 8369 04:59:59,533 --> 04:59:59,766 SESSION. 8370 04:59:59,766 --> 05:00:00,968 REQUEST FOR INFORMATION RECEIVED 8371 05:00:00,968 --> 05:00:02,502 51 COMMENTS, VIRTUAL LISTENING 8372 05:00:02,502 --> 05:00:04,371 SESSION HAD TEN MEMBERS OF THE 8373 05:00:04,371 --> 05:00:06,907 PUBLIC PROVIDE ORAL COMMENTS AND 8374 05:00:06,907 --> 05:00:08,875 ONE INDIVIDUAL COMMENTED IN 8375 05:00:08,875 --> 05:00:10,644 WRITTEN FORMAT. 8376 05:00:10,644 --> 05:00:11,845 REQUEST FOR INFORMATION HAD FIVE 8377 05:00:11,845 --> 05:00:13,914 AREAS WHICH NIH WAS SEEKING 8378 05:00:13,914 --> 05:00:15,382 INDIVIDUAL PUBLIC INPUT ON A 8379 05:00:15,382 --> 05:00:16,783 RANGE OF ISSUES. 8380 05:00:16,783 --> 05:00:18,852 RESPONSES WERE REALLY, REALLY 8381 05:00:18,852 --> 05:00:19,820 THOUGHTFUL. 8382 05:00:19,820 --> 05:00:21,588 TACKLING STRATEGIES FOR WORKING 8383 05:00:21,588 --> 05:00:23,457 WITH COMMUNITIES, RESOURCES AND 8384 05:00:23,457 --> 05:00:25,125 NEEDS FOR INSTITUTIONAL AND 8385 05:00:25,125 --> 05:00:31,365 FINANCIAL SUPPORT IN TERMS OF 8386 05:00:31,365 --> 05:00:31,999 SUPPORTING ENGAGEMENT, BARRIERS 8387 05:00:31,999 --> 05:00:33,767 FOR COMMUNITIES TO NAME A FEW. 8388 05:00:33,767 --> 05:00:36,403 I WON'T DIVE INTO A DEEP 8389 05:00:36,403 --> 05:00:37,270 ANALYSIS HERE REGARDING THE 8390 05:00:37,270 --> 05:00:39,206 COMMENTS BUT I WOULD LIKE TO 8391 05:00:39,206 --> 05:00:41,108 HIGHLIGHT SOME OF THE BIG 8392 05:00:41,108 --> 05:00:44,277 PICTURE FINDINGS TO DATE. 8393 05:00:44,277 --> 05:00:46,713 NEXT SLIDE PLEASE. 8394 05:00:46,713 --> 05:00:52,052 SO FAR WE'VE SEEN A STRONG 8395 05:00:52,052 --> 05:00:52,586 BELIEF RESEARCHERS SHOULD 8396 05:00:52,586 --> 05:00:56,623 INCORPORATE COMMUNITY INPUT 8397 05:00:56,623 --> 05:00:58,659 INCLUDING PART PARTNERING WITH 8398 05:00:58,659 --> 05:01:01,061 THE COMMUNITY, IDENTIFYING 8399 05:01:01,061 --> 05:01:02,629 COMMUNITY PRIORITIES, SOLICITING 8400 05:01:02,629 --> 05:01:05,232 COMMUNITY INPUT ON THE RESEARCH. 8401 05:01:05,232 --> 05:01:08,835 SECOND, THERE'S A STRONG 8402 05:01:08,835 --> 05:01:10,537 IMPORTANCE REQUIRING 8403 05:01:10,537 --> 05:01:12,372 NON-FINANCIAL INCENTIVES AND 8404 05:01:12,372 --> 05:01:14,241 COMPENSATION FOR ENGAGEMENT 8405 05:01:14,241 --> 05:01:15,008 ACTIVITIES. 8406 05:01:15,008 --> 05:01:17,077 COMPENSATION SHOULD BE SPARE AND 8407 05:01:17,077 --> 05:01:19,179 MEASURED WITH RESPONSIBILITIES. 8408 05:01:19,179 --> 05:01:23,517 AGAIN PARTICIPANTS IN RESEARCH, 8409 05:01:23,517 --> 05:01:24,317 WHETHER PROVIDING INPUT OR 8410 05:01:24,317 --> 05:01:27,054 STRATEGY REALLY SHOULD BE 8411 05:01:27,054 --> 05:01:29,222 COMPENSATED FOR EXPERTISE WITH 8412 05:01:29,222 --> 05:01:32,159 LIVED EXPERIENCES. 8413 05:01:32,159 --> 05:01:35,462 RESPONDENTS HIGHLIGHTED 8414 05:01:35,462 --> 05:01:36,663 CONSIDERING INCENTIVES LIKE 8415 05:01:36,663 --> 05:01:37,764 DURABLE MEDICAL EQUIPMENT OR 8416 05:01:37,764 --> 05:01:39,199 REINVESTMENT INTO THE COMMUNITY 8417 05:01:39,199 --> 05:01:40,067 THROUGH SUSTAINABLE 8418 05:01:40,067 --> 05:01:44,538 INFRASTRUCTURE OR RETURN OF 8419 05:01:44,538 --> 05:01:45,872 RESEARCH RESULTS. 8420 05:01:45,872 --> 05:01:46,973 VARIABLE INFRASTRUCTURE KNOW-HOW 8421 05:01:46,973 --> 05:01:49,810 AND RESOURCES TO INVEST IN 8422 05:01:49,810 --> 05:01:51,678 ACQUIRING THESE TOOLS ARE KEY 8423 05:01:51,678 --> 05:01:53,413 BARRIERS TO ACHIEVING MEANINGFUL 8424 05:01:53,413 --> 05:01:54,414 COMMUNITY ENGAGEMENT, SOMETHING 8425 05:01:54,414 --> 05:01:57,484 WE NEED TO TACKLE. 8426 05:01:57,484 --> 05:01:59,352 NEXT SLIDE PLEASE. 8427 05:01:59,352 --> 05:02:01,521 SO IN SUPPORT OF ENGAGE 8428 05:02:01,521 --> 05:02:02,322 INITIATIVE NIH LARGELY THROUGH 8429 05:02:02,322 --> 05:02:03,323 OFFICE OF SCIENCE POLICY HAS 8430 05:02:03,323 --> 05:02:05,692 TAKEN THIS EFFORT ON THE ROAD. 8431 05:02:05,692 --> 05:02:07,461 WE WORKED TO HEAR FROM COMMUNITY 8432 05:02:07,461 --> 05:02:09,329 ON THE GROUND, TO MAKE THIS 8433 05:02:09,329 --> 05:02:13,033 EFFORT A SUCCESS AND PROVIDE 8434 05:02:13,033 --> 05:02:13,400 SUSTAINABILITY. 8435 05:02:13,400 --> 05:02:14,501 WE'RE GRATEFUL TO ESTABLISH A 8436 05:02:14,501 --> 05:02:16,269 PARTNERSHIP WITH LEADING EXPERTS 8437 05:02:16,269 --> 05:02:18,438 IN COMMUNITY ENGAGEMENT TO HELP 8438 05:02:18,438 --> 05:02:19,639 FACILITATE HOPE AND HONEST 8439 05:02:19,639 --> 05:02:21,041 CONVERSATION IN COMMUNITIES THAT 8440 05:02:21,041 --> 05:02:23,844 STARTED IN OCTOBER AND WILL 8441 05:02:23,844 --> 05:02:25,045 CONCLUDE IN FEBRUARY OF 2025. 8442 05:02:25,045 --> 05:02:26,780 YOU'LL SEE A PICTURE OF THE 8443 05:02:26,780 --> 05:02:28,882 PLACES WE HAVE BEEN OR PLAN TO 8444 05:02:28,882 --> 05:02:31,051 GO, HELD IN PERSON AND 8445 05:02:31,051 --> 05:02:32,486 COMMUNITIES ACROSS THE COUNTRY, 8446 05:02:32,486 --> 05:02:41,061 THEY SPAN RURAL AND URBAN 8447 05:02:41,061 --> 05:02:46,099 COMMUNITIES, AMERICAN INDIAN AND 8448 05:02:46,099 --> 05:02:47,868 ALASKA NATIVES AND MORE. 8449 05:02:47,868 --> 05:02:49,936 TOMORROW AT THE FLINT MICHIGAN 8450 05:02:49,936 --> 05:02:51,805 PUBLIC LIBRARY. 8451 05:02:51,805 --> 05:02:54,207 I WILL JUST SAY THAT THE 8452 05:02:54,207 --> 05:02:55,008 APPROACH HERE TO THE 8453 05:02:55,008 --> 05:02:56,309 CONVERSATIONS HAS BEEN CRITICAL 8454 05:02:56,309 --> 05:02:56,977 TO THEIR SUCCESS. 8455 05:02:56,977 --> 05:02:59,713 A LOT OF WORK GOES INTO HAVING 8456 05:02:59,713 --> 05:03:03,283 CONVERSATIONS TO ENSURE THEY ARE 8457 05:03:03,283 --> 05:03:07,354 MEANINGFUL AND RECEIVE 8458 05:03:07,354 --> 05:03:08,121 BIDIRECTIONAL ENGAGEMENT. 8459 05:03:08,121 --> 05:03:10,824 NExTRAC MEMBERS WORK WITH 8460 05:03:10,824 --> 05:03:12,192 ENGAGEMENT SPECIALISTS TO FIRST 8461 05:03:12,192 --> 05:03:13,160 IDENTIFY A TRUSTED COMMUNITY 8462 05:03:13,160 --> 05:03:14,795 PARTNER TO ASSIST IN PLANNING 8463 05:03:14,795 --> 05:03:16,363 AND HOSTING THE EVENTS. 8464 05:03:16,363 --> 05:03:18,231 THIS IS FINDING PEOPLE ON THE 8465 05:03:18,231 --> 05:03:24,671 GROUPED WHO -- GROUND TO 8466 05:03:24,671 --> 05:03:24,971 FACILITATE. 8467 05:03:24,971 --> 05:03:27,407 WE DEVELOP A GUIDE THAT INCLUDES 8468 05:03:27,407 --> 05:03:29,276 CRITICAL TOPICS INCLUDING 8469 05:03:29,276 --> 05:03:30,177 PRIMERS ON CLINICAL RESEARCH, 8470 05:03:30,177 --> 05:03:31,812 QUESTIONS ABOUT HOW TO 8471 05:03:31,812 --> 05:03:33,880 UNDERSTAND THE VALUE FOR 8472 05:03:33,880 --> 05:03:34,648 COMMUNITIES. 8473 05:03:34,648 --> 05:03:37,050 WE ALSO INCLUDE QUESTIONNAIRE TO 8474 05:03:37,050 --> 05:03:38,919 COLLECT MORE INFORMATION ABOUT 8475 05:03:38,919 --> 05:03:39,786 THESE COMMUNITIES AND 8476 05:03:39,786 --> 05:03:40,954 FAMILIARITY WITH SOME TOPICS 8477 05:03:40,954 --> 05:03:42,455 WE'LL BE DISCUSSING SO WE CAN 8478 05:03:42,455 --> 05:03:45,826 ENGAGE AT THE RIGHT LEVEL. 8479 05:03:45,826 --> 05:03:47,460 DURING THE CONVERSATIONS BETWEEN 8480 05:03:47,460 --> 05:03:50,664 25 AND 30 INDIVIDUALS ATTEND A 8481 05:03:50,664 --> 05:03:51,364 THREE-HOUR CONVERSATION, 8482 05:03:51,364 --> 05:03:52,866 INCLUDING SMALL AND LARGE GROUP 8483 05:03:52,866 --> 05:03:53,233 DISCUSSIONS. 8484 05:03:53,233 --> 05:03:55,569 YOU CAN SEE PHOTOS OF THE EVENTS 8485 05:03:55,569 --> 05:03:58,972 IN IDAHO FALLS WHICH I WAS LUCKY 8486 05:03:58,972 --> 05:04:00,740 ENOUGH TO ATTEND LAST MONTH. 8487 05:04:00,740 --> 05:04:03,443 EACH CONVERSATION HAS A LIVE 8488 05:04:03,443 --> 05:04:04,978 ILLUSTRATOR PRESENT ON ZOOM 8489 05:04:04,978 --> 05:04:06,646 CAPTURING A VISUAL DEPICTION OF 8490 05:04:06,646 --> 05:04:08,615 THE MAIN TOPICS. 8491 05:04:08,615 --> 05:04:09,883 THE ILLUSTRATION UPDATED OVER 8492 05:04:09,883 --> 05:04:13,987 THE COURSE OF THE CONVERSATION, 8493 05:04:13,987 --> 05:04:16,022 SEEN IN REAL TIME. 8494 05:04:16,022 --> 05:04:16,923 AFTER THE CONVERSATION EACH 8495 05:04:16,923 --> 05:04:18,558 ATTENDEE AND HOST RECEIVE A 8496 05:04:18,558 --> 05:04:19,226 THANK YOU E-MAIL PROVIDING 8497 05:04:19,226 --> 05:04:20,627 INFORMATION HOW TO STAY UP TO 8498 05:04:20,627 --> 05:04:22,829 DATE ON THE COMMUNITY 8499 05:04:22,829 --> 05:04:24,264 CONVERSATION PROCESS, THE 8500 05:04:24,264 --> 05:04:26,633 NExTRAC ENGAGEMENT, AND WHEN 8501 05:04:26,633 --> 05:04:27,868 HELPFUL SOME ADDITIONAL 8502 05:04:27,868 --> 05:04:30,537 RESOURCES THAT NIH SHARES ON 8503 05:04:30,537 --> 05:04:33,707 WHAT IS IDENTIFIED IN THE 8504 05:04:33,707 --> 05:04:34,040 CONVERSATIONS. 8505 05:04:34,040 --> 05:04:35,876 NEXT SLIDE PLEASE. 8506 05:04:35,876 --> 05:04:37,177 HERE'S JUST A LARGER 8507 05:04:37,177 --> 05:04:40,347 REPRESENTATION OF ONE OF THE 8508 05:04:40,347 --> 05:04:43,016 VISUAL GRAPHICS, WHICH IS 8509 05:04:43,016 --> 05:04:44,618 FEATURED ON OUR ENGAGE WEBSITE. 8510 05:04:44,618 --> 05:04:47,387 EACH HAS A SECTION DEDICATED TO 8511 05:04:47,387 --> 05:04:48,722 COMMUNITY CONVERSATIONS, FOR 8512 05:04:48,722 --> 05:04:49,789 EACH CONVERSATION THE FLYER, 8513 05:04:49,789 --> 05:04:53,193 MATERIAL PRESENTED DURING THE 8514 05:04:53,193 --> 05:04:54,628 MEETING, ILLUSTRATION, AND A 8515 05:04:54,628 --> 05:04:56,363 SUMMARY REPORT ARE POSTED. 8516 05:04:56,363 --> 05:05:02,502 ILLUSTRATION DEVELOPED HERE IN 8517 05:05:02,502 --> 05:05:04,638 IDAHO FALLS IS ON THE SITE, THE 8518 05:05:04,638 --> 05:05:06,206 COMMUNITY CAN USE IT TO COMPARE 8519 05:05:06,206 --> 05:05:09,175 TO SEE WHERE THEY SHARE VALUES, 8520 05:05:09,175 --> 05:05:11,378 EXPECTATIONS, AND HAVE UNIQUE 8521 05:05:11,378 --> 05:05:11,678 DIFFERENCES. 8522 05:05:11,678 --> 05:05:13,346 IT ALLOWS COMMUNITIES TO SEE HOW 8523 05:05:13,346 --> 05:05:14,648 THE NExTRAC PRODUCTS ARE 8524 05:05:14,648 --> 05:05:16,616 DEVELOPING IN REAL TIME AND HOW 8525 05:05:16,616 --> 05:05:19,452 IT EVOLVES BASED ON FEEDBACK 8526 05:05:19,452 --> 05:05:21,755 FROM THAT CONVERSATION. 8527 05:05:21,755 --> 05:05:22,756 NEXT SLIDE PLEASE. 8528 05:05:22,756 --> 05:05:25,158 SO SHIFTING GEARS A BIT IT'S 8529 05:05:25,158 --> 05:05:26,927 CRITICAL THE COMMUNITY KNOW NIH 8530 05:05:26,927 --> 05:05:28,561 IS SERIOUS ABOUT TURNING 8531 05:05:28,561 --> 05:05:29,296 FEEDBACK INTO ACTION. 8532 05:05:29,296 --> 05:05:31,865 A LOT OF CONVERSATIONS WE HEARD 8533 05:05:31,865 --> 05:05:34,034 TODAY DEMONSTRATE THAT'S INDEED 8534 05:05:34,034 --> 05:05:34,801 THE CASE. 8535 05:05:34,801 --> 05:05:35,869 ACCORDINGLY WE'RE REALLY 8536 05:05:35,869 --> 05:05:38,538 THINKING ABOUT THE LANDING PAD 8537 05:05:38,538 --> 05:05:39,839 FOR ENGAGE INITIATIVE EFFORTS, 8538 05:05:39,839 --> 05:05:43,143 FOR RECOMMENDATIONS AS WELL AS 8539 05:05:43,143 --> 05:05:44,010 MOBILIZING EXPERTS WORKING HARD 8540 05:05:44,010 --> 05:05:45,645 ON THESE TOPICS TO RESPOND TO 8541 05:05:45,645 --> 05:05:47,948 THE NEXT PHASE OF 8542 05:05:47,948 --> 05:05:48,315 IMPLEMENTATION. 8543 05:05:48,315 --> 05:05:49,849 NOW I'M DELIGHTED TO REPRESENT 8544 05:05:49,849 --> 05:05:51,885 THE WORK OF THE DIFFERENT GROUP, 8545 05:05:51,885 --> 05:05:53,186 COMMUNITY ENGAGEMENT EXPERTS 8546 05:05:53,186 --> 05:05:56,890 ACROSS NIH INSTITUTES AND 8547 05:05:56,890 --> 05:05:58,425 CENTERS, MOBILIZING THEIR 8548 05:05:58,425 --> 05:05:59,292 EXPERIENCE AND THE 8549 05:05:59,292 --> 05:06:03,263 INFRASTRUCTURE AT NIH TO TAKE 8550 05:06:03,263 --> 05:06:04,164 RECOMMENDATIONS AND RUN WHEN 8551 05:06:04,164 --> 05:06:05,565 THEY LAND IN THE SUMMER. 8552 05:06:05,565 --> 05:06:06,333 NEXT SLIDE PLEASE. 8553 05:06:06,333 --> 05:06:07,767 BEFORE I TALK ABOUT THEIR 8554 05:06:07,767 --> 05:06:09,936 PROGRESS I WANTED TO REMIND 8555 05:06:09,936 --> 05:06:11,271 EVERYONE NIH REALLY DOES HAVE 8556 05:06:11,271 --> 05:06:13,673 VAST EXPERIENCES IN THIS DOMAIN, 8557 05:06:13,673 --> 05:06:17,944 ACROSS MANY PERHAPS. -- PROGRAM. 8558 05:06:17,944 --> 05:06:20,580 WE HAVE A TON OF MOTIVATED FOLKS 8559 05:06:20,580 --> 05:06:22,015 THINKING ABOUT THIS TOPIC EVERY 8560 05:06:22,015 --> 05:06:22,349 DAY. 8561 05:06:22,349 --> 05:06:24,184 OUR GOAL WAS TO COALESCE 8562 05:06:24,184 --> 05:06:25,518 EXPERTISE INTO A COMMUNITY OF 8563 05:06:25,518 --> 05:06:28,154 PRACTICE THAT COULD SHARE 8564 05:06:28,154 --> 05:06:30,223 LESSONS AND BUILD A STRONGER 8565 05:06:30,223 --> 05:06:30,423 TEAM. 8566 05:06:30,423 --> 05:06:32,325 OVER SIX MONTHS THESE EXPERTS 8567 05:06:32,325 --> 05:06:33,626 HAVE BEEN CONVENING EVERY OTHER 8568 05:06:33,626 --> 05:06:36,062 WEEK TO DO JUST THAT. 8569 05:06:36,062 --> 05:06:38,231 I'M HAPPY TO SHARE A FEW 8570 05:06:38,231 --> 05:06:40,100 SNAPSHOTS OF THE PROGRESS. 8571 05:06:40,100 --> 05:06:42,836 NEXT SLIDE PLEASE. 8572 05:06:42,836 --> 05:06:44,938 FIRST NIH HAS ESTABLISHED A 8573 05:06:44,938 --> 05:06:48,208 CENTER FOR EFFORTS, THIS IS SO 8574 05:06:48,208 --> 05:06:49,409 BROAD ACROSS THE AGENCY, IT 8575 05:06:49,409 --> 05:06:50,944 WON'T HOUSE EVERYTHING WE DO BUT 8576 05:06:50,944 --> 05:06:53,013 IT DOES PROVIDE A SNAPSHOT OF 8577 05:06:53,013 --> 05:06:57,384 HOW TO ENTER INTO ENGAGE 8578 05:06:57,384 --> 05:07:01,321 INITIATIVE AND CONNECT ACROSS 8579 05:07:01,321 --> 05:07:05,158 THE AGENCY, PARTNERS IN RESEARCH 8580 05:07:05,158 --> 05:07:06,626 INCLUDES ENGAGE WORK, WELCOME 8581 05:07:06,626 --> 05:07:08,695 FROM NIH DIRECTOR, INFORMATION 8582 05:07:08,695 --> 05:07:12,132 ABOUT THE ONGOING COMMUNITY 8583 05:07:12,132 --> 05:07:12,532 CONVERSATIONS. 8584 05:07:12,532 --> 05:07:13,833 NEXT SLIDE PLEASE. 8585 05:07:13,833 --> 05:07:15,402 THIS WEBSITE IS BEING BUILT OUT 8586 05:07:15,402 --> 05:07:17,470 TO TAKE IN THE SHARED KNOWLEDGE 8587 05:07:17,470 --> 05:07:18,304 ACROSS THE INSTITUTES AND 8588 05:07:18,304 --> 05:07:20,607 CENTERS ON THE FRONT LINES OF 8589 05:07:20,607 --> 05:07:22,475 PIONEERING THIS WORK. 8590 05:07:22,475 --> 05:07:23,777 WE'RE TRYING TO MAKE THEIR WORK 8591 05:07:23,777 --> 05:07:25,412 VISIBLE FOR ALL TO LEARN AND 8592 05:07:25,412 --> 05:07:25,879 IMPLEMENT. 8593 05:07:25,879 --> 05:07:28,581 YOU'LL SEE A SET OF CASE STUDIES 8594 05:07:28,581 --> 05:07:31,117 DEVELOPED BY OUR INTERNAL NIH 8595 05:07:31,117 --> 05:07:32,085 EXPERTS REFLECTING EXPERIENCES 8596 05:07:32,085 --> 05:07:33,953 IN THEIR INSTITUTES OF HOW THEY 8597 05:07:33,953 --> 05:07:36,156 PUT THESE PLANS INTO ACTION. 8598 05:07:36,156 --> 05:07:39,125 THESE CASE STUDIES WERE 8599 05:07:39,125 --> 05:07:40,660 DEVELOPED FROM BEST PRACTICE 8600 05:07:40,660 --> 05:07:42,629 EXAMPLES FROM THE VARIOUS 8601 05:07:42,629 --> 05:07:47,000 PROGRAMS AND REFLECT DIFFERENT 8602 05:07:47,000 --> 05:07:48,635 TIMES OF ENGAGEMENT, AND 8603 05:07:48,635 --> 05:07:50,136 COMMUNITIES ACROSS POPULATIONS 8604 05:07:50,136 --> 05:07:50,737 WITH UNIQUE NEEDS. 8605 05:07:50,737 --> 05:07:53,106 WE EXPECT THIS TO BE A LIVING 8606 05:07:53,106 --> 05:07:53,773 RESOURCE OVER TIME, THE 8607 05:07:53,773 --> 05:07:54,974 COMMUNITY OF PRACTICE HAS 8608 05:07:54,974 --> 05:07:58,244 REALLY, REALLY BEEN CRITICAL TO 8609 05:07:58,244 --> 05:08:01,147 ITS SUCCESS. 8610 05:08:01,147 --> 05:08:04,751 NEXT SLIDE PLEASE. 8611 05:08:04,751 --> 05:08:05,985 AGAIN, I'M HERE REPRESENTING OF 8612 05:08:05,985 --> 05:08:10,356 THE WORK THAT DOVETAILS WITH 8613 05:08:10,356 --> 05:08:11,758 PRIORITIES DISCUSSED HERE TODAY. 8614 05:08:11,758 --> 05:08:14,027 THE WORK IS TRYING TO MEET 8615 05:08:14,027 --> 05:08:15,895 PEOPLE WHERE THEY ARE, THIS IS 8616 05:08:15,895 --> 05:08:18,198 PART OF THE KEY OF SUCCESSFUL 8617 05:08:18,198 --> 05:08:18,898 ENGAGEMENT. 8618 05:08:18,898 --> 05:08:20,066 WE EXPECT OVER THE NEXT EIGHT TO 8619 05:08:20,066 --> 05:08:21,601 NINE MONTHS THE WORKING GROUP 8620 05:08:21,601 --> 05:08:23,703 WILL CONTINUE TO WORK ON THE 8621 05:08:23,703 --> 05:08:26,439 FRAMEWORK AND TOOLBOX AND MOVE 8622 05:08:26,439 --> 05:08:27,307 FORWARD TO FINAL RECOMMENDATIONS 8623 05:08:27,307 --> 05:08:28,374 TO NIH. 8624 05:08:28,374 --> 05:08:30,477 THE NExTRAC DID DISCUSS THIS 8625 05:08:30,477 --> 05:08:32,445 WORK LAST WEEK, THEIR 8626 05:08:32,445 --> 05:08:34,881 CONVERSATIONS CAN BE VIEWED ON 8627 05:08:34,881 --> 05:08:35,648 VIDEOCAST, ENERGIZED TURNING 8628 05:08:35,648 --> 05:08:37,951 THIS INTO A REALITY. 8629 05:08:37,951 --> 05:08:39,385 NEXT SLIDE PLEASE. 8630 05:08:39,385 --> 05:08:41,387 BEFORE I CLOSE AND TURN TO 8631 05:08:41,387 --> 05:08:43,756 DISCUSSION I DO WANT TO 8632 05:08:43,756 --> 05:08:44,524 HIGHLIGHT HIGH LEVEL 8633 05:08:44,524 --> 05:08:46,059 OBSERVATIONS TO DATE. 8634 05:08:46,059 --> 05:08:48,461 FIRST THE IMPORTANCE OF 8635 05:08:48,461 --> 05:08:48,995 CULTIVATING TRUST-BASED 8636 05:08:48,995 --> 05:08:51,498 RELATIONSHIPS, WITH COMMUNITY 8637 05:08:51,498 --> 05:08:53,266 LEADERS AND INSTITUTIONS, REALLY 8638 05:08:53,266 --> 05:08:54,000 RELYING ON TRUSTED COMMUNITY 8639 05:08:54,000 --> 05:08:55,802 VOICES THAT WOULD BE COMMUNITY 8640 05:08:55,802 --> 05:08:57,203 LEADERS AND INSTITUTIONS WORKING 8641 05:08:57,203 --> 05:09:01,808 ON THE FRONT LINES, CRITICAL AND 8642 05:09:01,808 --> 05:09:03,977 OVERCOMING DISTRESS AND 8643 05:09:03,977 --> 05:09:04,277 SKEPTICISM. 8644 05:09:04,277 --> 05:09:10,783 LESSONS WERE BROUGHT INTO FOCUS 8645 05:09:10,783 --> 05:09:13,419 DURING THE COVID SPANNED WITH 8646 05:09:13,419 --> 05:09:14,821 CEAL PROVIDING EXAMPLES. 8647 05:09:14,821 --> 05:09:15,555 ENGAGEMENT IS BIDIRECTIONAL. 8648 05:09:15,555 --> 05:09:17,023 COMMUNITIES ARE JUST AS 8649 05:09:17,023 --> 05:09:18,658 INTERESTED IN UNDERSTANDING 8650 05:09:18,658 --> 05:09:19,893 RESEARCHERS AS RESEARCHERS ARE 8651 05:09:19,893 --> 05:09:22,162 INTERESTED IN LEARNING ABOUT 8652 05:09:22,162 --> 05:09:22,729 COMMUNITIES. 8653 05:09:22,729 --> 05:09:27,200 IT IS IMPERATIVE WE DEVELOP 8654 05:09:27,200 --> 05:09:28,601 RELEVANT MATERIALS AND 8655 05:09:28,601 --> 05:09:30,803 FACILITATE CONVERSATIONS WITH 8656 05:09:30,803 --> 05:09:33,339 OPEN MIND, RESPECT, CULTURAL 8657 05:09:33,339 --> 05:09:33,606 HUMILITY. 8658 05:09:33,606 --> 05:09:36,309 AND THREE, COMMUNITIES SHOULD BE 8659 05:09:36,309 --> 05:09:37,710 CENTRAL IN RESEARCH AND INVOLVED 8660 05:09:37,710 --> 05:09:39,245 IN DESIGN AND PLANNING, NEW 8661 05:09:39,245 --> 05:09:41,114 PROGRAMS ARE ALREADY UNDERWAY 8662 05:09:41,114 --> 05:09:42,882 MAKING GROUNDBREAKING STRIDES 8663 05:09:42,882 --> 05:09:43,616 TURNING INTO WHAT COMMUNITIES 8664 05:09:43,616 --> 05:09:46,486 WANT TO LEARN ABOUT THEMSELVES 8665 05:09:46,486 --> 05:09:48,555 WITH A RESEARCH FOCUS. 8666 05:09:48,555 --> 05:09:51,057 FINALLY SCIENCE AND SOCIETY WILL 8667 05:09:51,057 --> 05:09:52,492 CONTINUE TO EVOLVE, SOLVING THE 8668 05:09:52,492 --> 05:09:53,793 MOST PRESSING HEALTH PROBLEMS 8669 05:09:53,793 --> 05:09:54,794 WILL REQUIRE BRINGING PEOPLE 8670 05:09:54,794 --> 05:09:56,863 ALONG THE JOURNEY AND NOT JUST 8671 05:09:56,863 --> 05:09:58,064 TELLING THEM DESTINATION. 8672 05:09:58,064 --> 05:10:00,567 WE NEED TO MEET FOLKS WHERE THEY 8673 05:10:00,567 --> 05:10:02,569 ARE TO BUILD TRUSTS WITH 8674 05:10:02,569 --> 05:10:06,940 PARTNERSHIPS, KEY TO MOVING 8675 05:10:06,940 --> 05:10:08,041 FORWARD. 8676 05:10:08,041 --> 05:10:12,078 I WOULD LOVE TO TURN TO ALEXA TO 8677 05:10:12,078 --> 05:10:12,946 REFLECT ON WORK. 8678 05:10:12,946 --> 05:10:14,314 >> CAN YOU HEAR ME? 8679 05:10:14,314 --> 05:10:15,114 >> YES. 8680 05:10:15,114 --> 05:10:17,750 >> SO I HAVE TO SAY THIS IS ONE 8681 05:10:17,750 --> 05:10:18,551 OF THE MOST EXTRAORDINARY 8682 05:10:18,551 --> 05:10:23,590 PROJECTS I'VE BEEN PART OF. 8683 05:10:23,590 --> 05:10:27,060 IT IS MAMMOTH IN SCOPE, 8684 05:10:27,060 --> 05:10:27,594 THOUGHTFUL, REALLY 8685 05:10:27,594 --> 05:10:28,194 SCIENTIFICALLY CONSTRUCTED TO 8686 05:10:28,194 --> 05:10:32,131 BRING THE BEST THAT WE CAN 8687 05:10:32,131 --> 05:10:33,333 AROUND SOCIAL SCIENCE 8688 05:10:33,333 --> 05:10:36,402 ENGAGEMENT, COMMUNITY 8689 05:10:36,402 --> 05:10:38,171 PARTNERSHIP AND DATA TO BUILD 8690 05:10:38,171 --> 05:10:41,341 THIS FORWARD, IN ADDITION TO AN 8691 05:10:41,341 --> 05:10:43,142 ENORMOUS AMOUNT OF COMMUNITY 8692 05:10:43,142 --> 05:10:43,743 ENGAGEMENT. 8693 05:10:43,743 --> 05:10:46,946 AS YOU HEARD FROM LYRIC WE'VE 8694 05:10:46,946 --> 05:10:49,048 ITERATED BASED ON COMMUNITY 8695 05:10:49,048 --> 05:10:51,017 FEEDBACK WHERE OUR FRAMEWORKS 8696 05:10:51,017 --> 05:10:54,087 ARE TOO COMPLICATED TO DIGEST OR 8697 05:10:54,087 --> 05:10:54,954 THEY AREN'T POSITIONING THE 8698 05:10:54,954 --> 05:10:58,558 COMMUNITY IN A WAY THAT IS 8699 05:10:58,558 --> 05:11:00,326 COMPELLING, SO IT IS REALLY BEEN 8700 05:11:00,326 --> 05:11:01,094 AN AMAZING GROUP. 8701 05:11:01,094 --> 05:11:02,962 A HUGE CREDIT TO THE PEOPLE WHO 8702 05:11:02,962 --> 05:11:04,030 SYNTHESIZE ALL THIS INFORMATION 8703 05:11:04,030 --> 05:11:06,332 AND THAT ARE BRINGING IT INTO 8704 05:11:06,332 --> 05:11:06,599 THE WHOLE. 8705 05:11:06,599 --> 05:11:08,301 SO KUDOS TO THE TEAM. 8706 05:11:08,301 --> 05:11:13,106 IT'S BEEN GREAT. 8707 05:11:13,106 --> 05:11:13,706 >> PULL DOWN THE SLIDES. 8708 05:11:13,706 --> 05:11:14,540 >> THANK YOU. 8709 05:11:14,540 --> 05:11:21,681 IF WE COULD PULL THE SLIDES AND 8710 05:11:21,681 --> 05:11:23,316 SEE WHO WANTS TO COMMENT OR HAVE 8711 05:11:23,316 --> 05:11:25,818 HAS QUESTIONS. 8712 05:11:25,818 --> 05:11:31,824 8713 05:11:31,824 --> 05:11:39,499 8714 05:11:39,499 --> 05:11:40,033 >> YES, RUSS? 8715 05:11:40,033 --> 05:11:41,367 >> ONE QUESTION ABOUT THE 8716 05:11:41,367 --> 05:11:43,236 VISION FOR SORT OF WHERE THE 8717 05:11:43,236 --> 05:11:44,404 RUBBER MEETS THE ROAD AT THE END 8718 05:11:44,404 --> 05:11:45,505 OF THIS. 8719 05:11:45,505 --> 05:11:48,241 I COULD ENVISION A PROCESS WHERE 8720 05:11:48,241 --> 05:11:50,009 ANY RFI COMING OUT FROM AN 8721 05:11:50,009 --> 05:11:51,411 INSTITUTE OR CENTER WOULD NEED 8722 05:11:51,411 --> 05:11:53,313 TO GO THROUGH A COMMUNITY 8723 05:11:53,313 --> 05:11:54,580 VETTING PROCESS TO ENSURE THAT 8724 05:11:54,580 --> 05:11:55,915 IT'S MEETING THE NEEDS OF THE 8725 05:11:55,915 --> 05:11:57,450 COMMUNITY AND THE COMMUNITY HAS 8726 05:11:57,450 --> 05:11:58,885 HAD OPPORTUNITY FOR INPUT IN 8727 05:11:58,885 --> 05:12:00,186 THAT REQUEST. 8728 05:12:00,186 --> 05:12:02,822 I COULD ALSO ENVISION A 8729 05:12:02,822 --> 05:12:04,891 SITUATION WHERE IT'S SORT OF A 8730 05:12:04,891 --> 05:12:06,125 REQUIREMENT FOR SUBMITTING AN 8731 05:12:06,125 --> 05:12:09,696 RPG THAT THERE'S BEEN SOME SORT 8732 05:12:09,696 --> 05:12:12,999 OF COMMUNITY VETTING OR AT LEAST 8733 05:12:12,999 --> 05:12:14,067 DISCUSSION PROCESS. 8734 05:12:14,067 --> 05:12:17,804 WHAT IS SORT OF THE -- AT LEAST 8735 05:12:17,804 --> 05:12:20,740 THE NIH LEADERSHIP LEVEL 8736 05:12:20,740 --> 05:12:21,874 ANTICIPATED IMPLEMENTATION OF 8737 05:12:21,874 --> 05:12:24,377 THIS TO ENSURE THAT THIS ISN'T 8738 05:12:24,377 --> 05:12:25,912 JUST A ONE-OFF LISTENING TOUR 8739 05:12:25,912 --> 05:12:30,650 AND TURNS INTO SOME WAY TO HELP 8740 05:12:30,650 --> 05:12:31,851 SHAPE PRIORITIES GOING FORWARD. 8741 05:12:31,851 --> 05:12:33,019 >> YEAH, HAPPY TO START. 8742 05:12:33,019 --> 05:12:35,121 ONE OF THE THINGS WE REALLY 8743 05:12:35,121 --> 05:12:36,456 WANTED, THE GROUP WAS REFERRING 8744 05:12:36,456 --> 05:12:38,458 TO IT AS A TOOLBOX, I REFER TO 8745 05:12:38,458 --> 05:12:40,793 IT AS A MENU. 8746 05:12:40,793 --> 05:12:43,863 IT'S NOT A ONE-SIZE-FITS-ALL 8747 05:12:43,863 --> 05:12:44,397 APPROACH. 8748 05:12:44,397 --> 05:12:47,266 NIH RESEARCH PORTFOLIO BASIC 8749 05:12:47,266 --> 05:12:48,701 THROUGH CLINICAL AND 8750 05:12:48,701 --> 05:12:50,636 TRANSLATIONAL IS VERY DIVERSE 8751 05:12:50,636 --> 05:12:51,571 AND MILD BENEFIT FROM DIFFERENT 8752 05:12:51,571 --> 05:12:52,438 ENGAGEMENT METHODS. 8753 05:12:52,438 --> 05:12:53,706 THE GROUP IS LOOKING AT WHEN IS 8754 05:12:53,706 --> 05:12:56,576 THE BEST TIME TO PUT ENGAGEMENT 8755 05:12:56,576 --> 05:12:58,344 INTO PRACTICE, AT WHAT LEVEL, 8756 05:12:58,344 --> 05:13:03,049 WHAT SCALE IS IT MOST WARRANTE. 8757 05:13:03,049 --> 05:13:05,685 YOU'LL HEAR I LOVE TO 8758 05:13:05,685 --> 05:13:06,986 UNDERSTAND, OTHERS ARE SAYING 8759 05:13:06,986 --> 05:13:08,321 I'M REALLY BUSY, HERE IS WHERE I 8760 05:13:08,321 --> 05:13:09,522 WANT TO HEAR THE CONVERSATION. 8761 05:13:09,522 --> 05:13:12,825 WE WANT TO HAVE AN 8762 05:13:12,825 --> 05:13:13,926 EVIDENCE-BASED PORTFOLIO 8763 05:13:13,926 --> 05:13:16,229 STRATEGY THAT WORKS BASED ON 8764 05:13:16,229 --> 05:13:17,463 WHAT TRYING TO ACHIEVE. 8765 05:13:17,463 --> 05:13:19,165 >> I'LL JUST ADD THERE ARE SOME 8766 05:13:19,165 --> 05:13:20,733 INITIATIVES THAT WE DO WHERE 8767 05:13:20,733 --> 05:13:22,468 THIS IS CLEARLY BAKED IN FROM 8768 05:13:22,468 --> 05:13:25,204 THE VERY BEGINNING. 8769 05:13:25,204 --> 05:13:29,275 ONE, CARE FOR HEALTH INITIATIVE. 8770 05:13:29,275 --> 05:13:33,746 ANOTHER, RECOVER, AND RECOVER 8771 05:13:33,746 --> 05:13:34,514 T.L.C. OBVIOUSLY FUNDAMENTAL 8772 05:13:34,514 --> 05:13:35,915 COMPONENTS OF THOSE ACTIVITIES. 8773 05:13:35,915 --> 05:13:39,852 YOU CAN IMAGINE THOUGH THESE 8774 05:13:39,852 --> 05:13:41,487 KINDS OF EFFORTS OR SMALL PARTS, 8775 05:13:41,487 --> 05:13:43,356 NOT ALL, MIGHT BE APPLIED TO 8776 05:13:43,356 --> 05:13:44,991 MANY OTHER THINGS. 8777 05:13:44,991 --> 05:13:50,129 SO YOU USE THE WORD "REQUIRE," I 8778 05:13:50,129 --> 05:13:51,798 MEAN, I DON'T THINK WE'RE THERE 8779 05:13:51,798 --> 05:13:53,132 WITH THIS. 8780 05:13:53,132 --> 05:13:56,035 I THINK WHERE WE ARE INSTEAD IS 8781 05:13:56,035 --> 05:13:58,371 DEMONSTRATING NOT ONLY TO THE 8782 05:13:58,371 --> 05:14:01,974 PEOPLE WE SERVE BUT ALSO TO THE 8783 05:14:01,974 --> 05:14:02,909 RESEARCH COMMUNITY, THE 8784 05:14:02,909 --> 05:14:04,811 INCREDIBLE VALUE OF THIS KIND OF 8785 05:14:04,811 --> 05:14:06,245 APPROACH TO THE WORK AND THEN 8786 05:14:06,245 --> 05:14:09,449 WE'LL SEE WHERE THAT GOES. 8787 05:14:09,449 --> 05:14:10,650 IS THAT FAIR? 8788 05:14:10,650 --> 05:14:14,187 >> ABSOLUTELY. 8789 05:14:14,187 --> 05:14:15,488 >> GO AHEAD. 8790 05:14:15,488 --> 05:14:19,225 WE HAVE BRIAN AND WAFAA. 8791 05:14:19,225 --> 05:14:22,261 >> I JUST HAVE TO SAY I LOVE THE 8792 05:14:22,261 --> 05:14:23,029 VISUAL NOTE TAKING. 8793 05:14:23,029 --> 05:14:24,664 IT'S A GREAT WAY OF SUMMARIZING 8794 05:14:24,664 --> 05:14:28,401 SO I'M GLAD YOU USE THAT 8795 05:14:28,401 --> 05:14:28,668 APPROACH. 8796 05:14:28,668 --> 05:14:29,669 I APPRECIATE IT. 8797 05:14:29,669 --> 05:14:32,572 YOU KNOW, ONE OF THE THINGS THAT 8798 05:14:32,572 --> 05:14:34,740 I'VE OBSERVED IN WORKING WITH 8799 05:14:34,740 --> 05:14:37,477 COMMUNITY ORGANIZATIONS FOR 8800 05:14:37,477 --> 05:14:39,679 ABOUT 20 YEARS IS THAT OFTEN 8801 05:14:39,679 --> 05:14:44,050 WHEN WE CONNECT WITH COMMUNITY, 8802 05:14:44,050 --> 05:14:46,118 THEY ARE INTERESTED IN A LOT OF 8803 05:14:46,118 --> 05:14:46,986 HEALTH DOMAINS. 8804 05:14:46,986 --> 05:14:49,722 IF WE COME AND SAY WE WANT TO DO 8805 05:14:49,722 --> 05:14:52,091 A PROJECT ON HIV, IT WOULDN'T BE 8806 05:14:52,091 --> 05:14:54,093 UNUSUAL FOR THEM TO SAY WHAT ARE 8807 05:14:54,093 --> 05:14:55,795 YOU DOING ABOUT VIOLENCE, 8808 05:14:55,795 --> 05:14:58,364 ADDICTION, ABOUT MENTAL HEALTH, 8809 05:14:58,364 --> 05:14:59,165 ABOUT CARDIOVASCULAR DISEASE? 8810 05:14:59,165 --> 05:15:00,700 AND, YOU KNOW, THE FRAMEWORK 8811 05:15:00,700 --> 05:15:03,636 WE'VE TRIED TO USE IN OUR 8812 05:15:03,636 --> 05:15:05,838 INSTITUTE IS TO BRING 8813 05:15:05,838 --> 05:15:08,574 INVESTIGATORS TOGETHER ON 8814 05:15:08,574 --> 05:15:10,109 DIFFERENT TOPICS AND FORGE 8815 05:15:10,109 --> 05:15:12,111 RELATIONSHIPS WITH COMMUNITY 8816 05:15:12,111 --> 05:15:14,247 ORGANIZATIONS THAT INVOLVE 8817 05:15:14,247 --> 05:15:14,814 MULTIPLE INVESTIGATORS. 8818 05:15:14,814 --> 05:15:17,583 THAT'S ONE KIND OF APPROACH. 8819 05:15:17,583 --> 05:15:20,319 IT'S ALSO I THINK, YOU KNOW, AS 8820 05:15:20,319 --> 05:15:21,954 YOU SAID, MONICA, IN BIG 8821 05:15:21,954 --> 05:15:23,256 INITIATIVES YOU CAN BAKE IT IN. 8822 05:15:23,256 --> 05:15:25,791 IF IT'S A LARGE INITIATIVE WITH 8823 05:15:25,791 --> 05:15:27,560 MULTIPLE INVESTIGATORS A LOT OF 8824 05:15:27,560 --> 05:15:29,395 RESOURCES, THERE ARE SOME REAL 8825 05:15:29,395 --> 05:15:32,665 INHERENT CHALLENGES IN DOING IT 8826 05:15:32,665 --> 05:15:35,234 IN A SINGLE R01, R34, TIME 8827 05:15:35,234 --> 05:15:39,171 LIMITED, I JUST WONDER HOW THAT 8828 05:15:39,171 --> 05:15:42,542 TENSION WAS BROUGHT INTO THIS 8829 05:15:42,542 --> 05:15:43,442 CONVERSATION AND BECAUSE, YOU 8830 05:15:43,442 --> 05:15:45,278 KNOW, OBVIOUSLY THAT'S THE 8831 05:15:45,278 --> 05:15:48,047 MAJORITY OF NIH FUNDING IS GOING 8832 05:15:48,047 --> 05:15:49,148 OUT IN SINGLE INVESTIGATOR 8833 05:15:49,148 --> 05:15:50,116 INITIATED GRANTS, SO JUST 8834 05:15:50,116 --> 05:15:52,752 WONDERING HOW THAT CAME UP IN 8835 05:15:52,752 --> 05:15:54,887 THE CONVERSATION. 8836 05:15:54,887 --> 05:15:56,022 >> SO IT DEPENDS. 8837 05:15:56,022 --> 05:15:59,058 ARE YOU TALKING ABOUT CLINICAL 8838 05:15:59,058 --> 05:16:02,895 RESEARCH, LARGE, YOU KNOW, 8839 05:16:02,895 --> 05:16:03,796 CLINICAL RESEARCH INITIATIVES? 8840 05:16:03,796 --> 05:16:05,865 YOU ARE, YOU'RE SPOT ON WHY CARE 8841 05:16:05,865 --> 05:16:08,701 FOR HEALTH WAS DEVELOPED. 8842 05:16:08,701 --> 05:16:13,773 THIS IS A STANDING SUSTAINABLE 8843 05:16:13,773 --> 05:16:16,175 LONG-TERM INFRASTRUCTURE THAT 8844 05:16:16,175 --> 05:16:17,944 GOES INTO COMMUNITIES, ENGAGES 8845 05:16:17,944 --> 05:16:21,347 WITH THEM, TO MEET ALL OF HEALTH 8846 05:16:21,347 --> 05:16:21,747 NEEDS. 8847 05:16:21,747 --> 05:16:24,083 THE WAY WE LIKE TO SAY IT WE 8848 05:16:24,083 --> 05:16:25,484 HAVE 27 INSTITUTES AND CENTERS 8849 05:16:25,484 --> 05:16:27,386 ACROSS NIH. 8850 05:16:27,386 --> 05:16:31,223 ALL OF THEM HAVE PROGRAMS THAT 8851 05:16:31,223 --> 05:16:33,492 CAN DUCK INTO AND CONTRIBUTE TO 8852 05:16:33,492 --> 05:16:36,562 THE WORK THAT'S DONE BY PRIMARY 8853 05:16:36,562 --> 05:16:38,464 CARE, BY FOCUS ON PRIMARY CARE 8854 05:16:38,464 --> 05:16:41,500 IN CARE FOR HEALTH. 8855 05:16:41,500 --> 05:16:43,669 OBVIOUSLY THERE ARE OTHER, YOU 8856 05:16:43,669 --> 05:16:45,104 KNOW, SPECIALTY FOCUS AREAS OF 8857 05:16:45,104 --> 05:16:47,940 RESEARCH THAT WE WILL CONTINUE 8858 05:16:47,940 --> 05:16:50,376 TO DO, YOU KNOW, ONCOLOGY 8859 05:16:50,376 --> 05:16:51,978 COMMUNITY IN CANCER TREATMENT, 8860 05:16:51,978 --> 05:16:53,879 NOT SOMETHING LIKELY TO BE DONE 8861 05:16:53,879 --> 05:16:56,949 IN CARE FOR HEALTH BUT CANCER 8862 05:16:56,949 --> 05:16:57,617 SCREENING AND PREVENTION 8863 05:16:57,617 --> 05:16:58,584 MODALITIES CERTAINLY WILL. 8864 05:16:58,584 --> 05:17:01,220 SO, SEE WHAT I MEAN? 8865 05:17:01,220 --> 05:17:05,825 AND CARE FOR HEALTH IS OUR 8866 05:17:05,825 --> 05:17:08,894 SIGNATURE ENDURING REALLY 8867 05:17:08,894 --> 05:17:09,629 COMPREHENSIVE CROSS-NIH 8868 05:17:09,629 --> 05:17:12,398 INITIATIVE TO TO GET RID OF THE 8869 05:17:12,398 --> 05:17:14,734 SMALL ONE-OFF OR GIVE PLATFORM 8870 05:17:14,734 --> 05:17:18,004 FOR SOME RESEARCHER WITH A 8871 05:17:18,004 --> 05:17:20,272 BRILLIANT IDEA FOR ONE TO BE 8872 05:17:20,272 --> 05:17:21,707 ABLE TO DOCK INTO AN 8873 05:17:21,707 --> 05:17:22,675 INFRASTRUCTURE THAT THEY DON'T 8874 05:17:22,675 --> 05:17:25,211 HAVE TO BUILD OFF OF THEIR R01. 8875 05:17:25,211 --> 05:17:27,079 SO THAT'S EXACTLY WHY CARE FOR 8876 05:17:27,079 --> 05:17:28,114 HEALTH IS CREATED. 8877 05:17:28,114 --> 05:17:30,149 WE COULD DO A LOT MORE BUT 8878 05:17:30,149 --> 05:17:35,488 THAT'S RIGHT NOW OUR FOCUS FOR 8879 05:17:35,488 --> 05:17:36,288 AT LEAST AN EXAMPLE 8880 05:17:36,288 --> 05:17:37,790 INFRASTRUCTURE ON HOW TO MAKE 8881 05:17:37,790 --> 05:17:42,395 THIS HAPPEN FOR PRIMARY CARE. 8882 05:17:42,395 --> 05:17:43,362 >> THANK YOU. 8883 05:17:43,362 --> 05:17:43,562 WAFAA? 8884 05:17:43,562 --> 05:17:44,797 >> HI. 8885 05:17:44,797 --> 05:17:47,867 THANK YOU VERY MUCH. 8886 05:17:47,867 --> 05:17:49,835 ACTUALLY FOR THE PRESENTATIONS, 8887 05:17:49,835 --> 05:17:50,836 RATHER REMARKABLE, INITIATIVES 8888 05:17:50,836 --> 05:17:52,938 ARE AMAZING. 8889 05:17:52,938 --> 05:17:55,541 I'M JUST WONDERING I WANTED TO 8890 05:17:55,541 --> 05:17:57,376 MENTION -- I SAW ON THE SLIDE 8891 05:17:57,376 --> 05:18:00,780 THAT WENT BY QUICKLY ALL THE 8892 05:18:00,780 --> 05:18:01,647 COMMUNITY ENGAGEMENT EFFORTS 8893 05:18:01,647 --> 05:18:03,616 EMBEDDED IN LARGE PROGRAMS. 8894 05:18:03,616 --> 05:18:06,385 I WONDER WHETHER YOU HAD THE 8895 05:18:06,385 --> 05:18:08,688 OPPORTUNITY TO CONSIDER THOSE 8896 05:18:08,688 --> 05:18:10,823 THAT EXIST WITHIN THE CLINICAL 8897 05:18:10,823 --> 05:18:12,291 TRIALS NETWORK, THINKING OF THE 8898 05:18:12,291 --> 05:18:15,494 HIV CLINICAL TRIALS NETWORK AND 8899 05:18:15,494 --> 05:18:17,129 OTHER CANCER TREATMENT NETWORKS 8900 05:18:17,129 --> 05:18:21,167 AND SO ON WHERE NOW LIKE THREE 8901 05:18:21,167 --> 05:18:24,336 DECADES OR MORE OF REAL SUCCESS 8902 05:18:24,336 --> 05:18:27,740 AND CHALLENGES AND HOW DO YOU 8903 05:18:27,740 --> 05:18:30,476 MANAGE THESE KIND OF ENGAGEMENTS 8904 05:18:30,476 --> 05:18:34,447 OVER TIME, OVER VERY LONG 8905 05:18:34,447 --> 05:18:35,414 PERIODS OF TIME, AND I THINK 8906 05:18:35,414 --> 05:18:38,918 ALSO THERE MAY BE SOME IMPORTANT 8907 05:18:38,918 --> 05:18:41,654 LESSONS LEARNED THROUGH THESE 8908 05:18:41,654 --> 05:18:42,421 LONGSTANDING COMMUNITY 8909 05:18:42,421 --> 05:18:44,423 ENGAGEMENT IN THESE NETWORKS AS 8910 05:18:44,423 --> 05:18:48,260 WELL AS ALSO DEMONSTRATE SOME 8911 05:18:48,260 --> 05:18:51,397 ISSUES RAISED PREVIOUSLY BY I 8912 05:18:51,397 --> 05:18:55,735 BELIEVE BRIAN IN TERMS OF 8913 05:18:55,735 --> 05:18:56,702 POTENTIAL FOR THINKING OUT OF 8914 05:18:56,702 --> 05:18:58,904 THE BOX AND HOW CAN WE USE THOSE 8915 05:18:58,904 --> 05:18:59,772 ENTITIES TO SUPPORT OTHER 8916 05:18:59,772 --> 05:19:01,774 ENDEAVORS IN THE SAME COMMUNITY 8917 05:19:01,774 --> 05:19:03,375 OR WITHIN THE SAME COUNTRY, 8918 05:19:03,375 --> 05:19:04,910 SINCE THE NETWORKS ARE OFTEN 8919 05:19:04,910 --> 05:19:08,547 U.S. BASED BUT OF COURSE ALSO 8920 05:19:08,547 --> 05:19:08,914 INTERNATIONALLY. 8921 05:19:08,914 --> 05:19:10,282 JUST A THOUGHT, NOT REALLY A 8922 05:19:10,282 --> 05:19:14,220 QUESTION, BUT THERE MAY BE 8923 05:19:14,220 --> 05:19:16,188 ADDITIONAL LESSONS LEARNED THAT 8924 05:19:16,188 --> 05:19:18,390 COULD BE VALUABLE AS YOU MOVE 8925 05:19:18,390 --> 05:19:20,259 FORWARD. 8926 05:19:20,259 --> 05:19:22,228 >> IT'S AN EXCELLENT POINT, ONE 8927 05:19:22,228 --> 05:19:23,863 OF THE KEYS, AND ALEXA PLEASE 8928 05:19:23,863 --> 05:19:26,265 JUMP IN, WHY WE'RE TRYING TO 8929 05:19:26,265 --> 05:19:27,833 PAIR THE GROUP GOING INTO 8930 05:19:27,833 --> 05:19:29,135 COMMUNITY, WHERE WE MAY NOT HAVE 8931 05:19:29,135 --> 05:19:30,469 BEEN BEFORE TO HAVE 8932 05:19:30,469 --> 05:19:32,438 CONVERSATIONS TO UNDERSTAND GAPS 8933 05:19:32,438 --> 05:19:35,608 AND KNOWLEDGE AND BRIDGE THOSE, 8934 05:19:35,608 --> 05:19:37,143 WITH THE INTERNAL GROUP OF NIH 8935 05:19:37,143 --> 05:19:38,911 EXPERTS WHO HAVE BEEN DOING 8936 05:19:38,911 --> 05:19:40,913 THIS, WORKING IN THESE NETWORKS 8937 05:19:40,913 --> 05:19:44,483 AND COMMUNITIES SO WE'RE HAVING 8938 05:19:44,483 --> 05:19:45,584 THAT HOLISTIC APPROACH TO WHO 8939 05:19:45,584 --> 05:19:47,219 HAS DONE THIS BEFORE, WHO IS 8940 05:19:47,219 --> 05:19:53,592 NEW, HOW CAN WE HAVE STRATEGIES 8941 05:19:53,592 --> 05:19:54,226 RECOGNIZING VARIOUS 8942 05:19:54,226 --> 05:19:54,760 PERSPECTIVES. 8943 05:19:54,760 --> 05:19:56,762 >> YEAH, FOCUS GROUPS ARE ALL 8944 05:19:56,762 --> 05:20:00,032 OVER THE COUNTRY AND VERY 8945 05:20:00,032 --> 05:20:01,801 TARGETED TO MAKE SURE THEY ARE 8946 05:20:01,801 --> 05:20:03,869 INCLUSIVE OF REALLY, AGAIN, THE 8947 05:20:03,869 --> 05:20:05,704 UNITED STATES IS VERY 8948 05:20:05,704 --> 05:20:06,472 HETEROGENEOUS, TO INCLUDE A LOT 8949 05:20:06,472 --> 05:20:07,473 OF GROUPS. 8950 05:20:07,473 --> 05:20:10,075 I WOULD SAY ONE GROUP THAT MAYBE 8951 05:20:10,075 --> 05:20:11,944 WE HADN'T ENGAGED THAT I JUST 8952 05:20:11,944 --> 05:20:15,247 BROUGHT INTO THE MIX WAS SOME OF 8953 05:20:15,247 --> 05:20:17,016 THE MORE LIKE PROFESSIONAL 8954 05:20:17,016 --> 05:20:18,984 SOCIETIES, YOU KNOW, AGAIN, 8955 05:20:18,984 --> 05:20:20,085 COORDINATORS ARE GETTING 8956 05:20:20,085 --> 05:20:20,986 CERTIFICATES AND CERTIFICATION. 8957 05:20:20,986 --> 05:20:24,456 WE NEED TO HEAR FROM THEM, SOME 8958 05:20:24,456 --> 05:20:25,357 ARE IN ACADEMIC INSTITUTIONS, 8959 05:20:25,357 --> 05:20:26,559 SOME ARE NOT, BUT THERE'S A 8960 05:20:26,559 --> 05:20:27,893 GROUP THERE. 8961 05:20:27,893 --> 05:20:29,161 THE LISTENING SESSIONS, THEY 8962 05:20:29,161 --> 05:20:31,363 HAVE REPORTED BACK, HAVE BEEN 8963 05:20:31,363 --> 05:20:33,098 VERY COMPELLING AND I THINK 8964 05:20:33,098 --> 05:20:36,068 REALLY CHANGED HOW WE HAVE 8965 05:20:36,068 --> 05:20:42,208 PRESENTED SOME OF THE 8966 05:20:42,208 --> 05:20:42,608 INFORMATION. 8967 05:20:42,608 --> 05:20:44,410 >> TESHIA NEXT PLEASE. 8968 05:20:44,410 --> 05:20:46,145 >> I AGREE WITH WAFAA, IT'S BEEN 8969 05:20:46,145 --> 05:20:47,980 AN EXCITING DAY BECAUSE YOU'RE 8970 05:20:47,980 --> 05:20:52,151 TALKING MY JAM, COMMUNITY 8971 05:20:52,151 --> 05:20:53,552 ENGAGEMENT. 8972 05:20:53,552 --> 05:20:55,387 I GET EXCITED ABOUT THAT. 8973 05:20:55,387 --> 05:20:57,389 I WANT TO COMMEND YOU ALL. 8974 05:20:57,389 --> 05:21:01,193 TARA AND LYRIC AND DR. TABAK 8975 05:21:01,193 --> 05:21:02,728 HAVE ALL BEEN THE SAME, THEY 8976 05:21:02,728 --> 05:21:05,931 HAVE BEEN IN THE SAME ROOM WHEN 8977 05:21:05,931 --> 05:21:09,335 THEY HEARD US AT TRIBAL HEALTH 8978 05:21:09,335 --> 05:21:12,071 ADVISORY COMMITTEE, TALK ABOUT 8979 05:21:12,071 --> 05:21:12,972 WHAT WE NEED. 8980 05:21:12,972 --> 05:21:15,040 WHAT I'VE HEARD TODAY OVER AND 8981 05:21:15,040 --> 05:21:17,676 OVER IS YOU'VE LISTENED TO WHAT 8982 05:21:17,676 --> 05:21:20,512 WE'VE SAID AND IT'S BEING 8983 05:21:20,512 --> 05:21:20,746 APPLIED. 8984 05:21:20,746 --> 05:21:22,147 WE'VE ASKED YOU TO REACH TO 8985 05:21:22,147 --> 05:21:22,481 COMMUNITY. 8986 05:21:22,481 --> 05:21:24,116 WE'VE ASKED YOU ABOUT, YOU KNOW, 8987 05:21:24,116 --> 05:21:26,318 DATA SOVEREIGNTY. 8988 05:21:26,318 --> 05:21:27,853 WE'VE ASKED FOR ALL THESE THINGS 8989 05:21:27,853 --> 05:21:29,255 AND I'M HEARING IT COME TO 8990 05:21:29,255 --> 05:21:29,521 FRUITION. 8991 05:21:29,521 --> 05:21:31,223 I THANK YOU FOR LISTENING AND 8992 05:21:31,223 --> 05:21:32,324 ASKING. 8993 05:21:32,324 --> 05:21:34,326 I THINK THAT WAS SOMETHING THAT 8994 05:21:34,326 --> 05:21:35,961 LYRIC SAID. 8995 05:21:35,961 --> 05:21:37,296 FEEDBACK TO ACTION. 8996 05:21:37,296 --> 05:21:42,668 SO APPRECIATE THAT GREATLY. 8997 05:21:42,668 --> 05:21:45,170 I ALSO -- I'M SO EXCITED ABOUT 8998 05:21:45,170 --> 05:21:46,705 WHAT YOU'RE DOING IN TERMS OF 8999 05:21:46,705 --> 05:21:47,673 COMMUNITY ENGAGEMENT. 9000 05:21:47,673 --> 05:21:49,675 WORKING WITH THE "ALL OF US" 9001 05:21:49,675 --> 05:21:50,242 PROGRAM WE UNDERSTAND HOW 9002 05:21:50,242 --> 05:21:52,711 INCREDIBLY IMPORTANT IT IS TO BE 9003 05:21:52,711 --> 05:21:54,480 SUCCESSFUL, PARTICULARLY IN BIG 9004 05:21:54,480 --> 05:21:56,215 SCALE PROJECTS, TO HAVE THAT 9005 05:21:56,215 --> 05:22:03,455 COMMUNITY PIECE BE THERE AND 9006 05:22:03,455 --> 05:22:06,225 HAVE IT BE MEANINGFUL. 9007 05:22:06,225 --> 05:22:08,060 I'D LIKE TO ASK YOU BE CLEAR IN 9008 05:22:08,060 --> 05:22:11,430 WAYS TO MEASURE THAT SUCCESS 9009 05:22:11,430 --> 05:22:16,936 ACROSS THE LINEAR PARADIGM FROM 9010 05:22:16,936 --> 05:22:19,905 WHERE YOU'RE STARTING, IF IT'S 9011 05:22:19,905 --> 05:22:21,307 THE BENCH SIDE AND YOU'RE 9012 05:22:21,307 --> 05:22:23,709 PUTTING IT OUT THERE, HOW ARE WE 9013 05:22:23,709 --> 05:22:26,779 GETTING TO MOVE THAT, HOW ARE WE 9014 05:22:26,779 --> 05:22:30,382 AFFECTING HEALTH EQUITY, HOW ARE 9015 05:22:30,382 --> 05:22:32,618 WE AFFECTING DISEASE, AFFECTING 9016 05:22:32,618 --> 05:22:36,989 INCLUSION IN RESEARCH, ALL OF 9017 05:22:36,989 --> 05:22:39,725 IT, MEASURE AND SHOW TRAJECTORY 9018 05:22:39,725 --> 05:22:42,027 AND PARTICIPATE IN THIS WAY, 9019 05:22:42,027 --> 05:22:43,095 ENGAGING COMMUNITY IS HAVING 9020 05:22:43,095 --> 05:22:43,395 EFFECT. 9021 05:22:43,395 --> 05:22:45,297 THE MORE WE DO THAT, THE MORE 9022 05:22:45,297 --> 05:22:47,599 THAT WE'RE GOING TO HAVE 9023 05:22:47,599 --> 05:22:48,701 RESPONSIVENESS FROM THE 9024 05:22:48,701 --> 05:22:52,738 COMMUNITY MEMBERS BUT ALSO FROM 9025 05:22:52,738 --> 05:22:54,506 OUR OVERSEER FOR OVERSIGHT, 9026 05:22:54,506 --> 05:22:58,344 WHOEVER THAT MIGHT BE. 9027 05:22:58,344 --> 05:23:02,047 WHATEVER YOU'VE GOTTEN, LET'S BE 9028 05:23:02,047 --> 05:23:03,916 SURE TO DO THAT AND COMMUNICATE 9029 05:23:03,916 --> 05:23:04,783 IT BACK OUT. 9030 05:23:04,783 --> 05:23:05,851 >> THANK YOU, SO IMPORTANT. 9031 05:23:05,851 --> 05:23:07,319 LYRIC SAID IT. 9032 05:23:07,319 --> 05:23:08,687 I WROTE IT DOWN. 9033 05:23:08,687 --> 05:23:12,691 BECAUSE I WANTED TO REPEAT IT. 9034 05:23:12,691 --> 05:23:13,659 THESE FRAMEWORKS, ROAD MAPS, 9035 05:23:13,659 --> 05:23:15,861 EVERY SINGLE ONE OF THEM THAT 9036 05:23:15,861 --> 05:23:18,263 YOU'VE HEARD PRESENTED TODAY IS 9037 05:23:18,263 --> 05:23:19,898 BUILT TO DELIVER NEEDED OUTCOMES 9038 05:23:19,898 --> 05:23:22,301 AND ALSO BUILT INTO THE ROAD 9039 05:23:22,301 --> 05:23:25,170 MAPS ARE TRACKING. 9040 05:23:25,170 --> 05:23:26,405 TWO THINGS. 9041 05:23:26,405 --> 05:23:29,641 BUT TRACKING OF THOSE OUTCOMES, 9042 05:23:29,641 --> 05:23:31,677 BUT ALSO FLEXIBILITY TO RESPOND 9043 05:23:31,677 --> 05:23:34,613 TO EVOLVING CONDITIONS. 9044 05:23:34,613 --> 05:23:36,081 SO, THOSE TWO THINGS ARE 9045 05:23:36,081 --> 05:23:44,590 ESSENTIAL TO THESE ROAD MAPS. 9046 05:23:44,590 --> 05:23:45,424 >> ANY ADDITIONAL COMMENTS? 9047 05:23:45,424 --> 05:23:48,093 >> AND NOW SOMETHING COMPLETELY 9048 05:23:48,093 --> 05:23:48,727 DIFFERENT. 9049 05:23:48,727 --> 05:23:53,899 WHY DON'T WE TAKE A 10-MINUTE 9050 05:23:53,899 --> 05:23:54,099 BREAK. 9051 05:23:54,099 --> 05:23:57,503 AND WE'LL RECONVENE AT 4:30 WHEN 9052 05:23:57,503 --> 05:24:02,975 YOU'RE CONSTRUCTING SCHEDULESES 9053 05:24:02,975 --> 05:24:04,076 YOU PUT THE BOSS AT THE 9054 05:24:04,076 --> 05:24:06,378 BEGINNING AND YOURSELF LAST. 9055 05:24:06,378 --> 05:24:08,347 THAT'S HOW WE'RE HERE IN THE 9056 05:24:08,347 --> 05:24:09,014 LAST TALK. 9057 05:24:09,014 --> 05:24:11,617 WE'LL SEE YOU BACK IN TEN QUICK 9058 05:24:11,617 --> 05:24:12,184 MINUTES. THANKS. 9059 05:24:12,184 --> 05:24:34,228 >> OKAY, THANKS. 9060 05:24:34,228 --> 05:24:35,095 WE'RE GOING TO SWITCH GEARS 9061 05:24:35,095 --> 05:24:37,431 AND TALK ABOUT THE RESTART OF 9062 05:24:37,431 --> 05:24:38,732 THE SCIENTIFIC MANAGEMENT AND 9063 05:24:38,732 --> 05:24:39,400 REVIEW BOARD. 9064 05:24:39,400 --> 05:24:44,438 SO IF WE COULD HAVE THE NEXT 9065 05:24:44,438 --> 05:24:45,172 SLIDE PLEASE. 9066 05:24:45,172 --> 05:24:55,616 JUST BY WAY OF BACKGROUND, 9067 05:24:58,500 --> 05:25:09,092 AUTHORIZED BY NIH FOR 2006, NOT 9068 05:25:09,092 --> 05:25:10,927 DISSIMILAR TO THIS ACD 9069 05:25:10,927 --> 05:25:12,595 COMMITTEE, EQUIVALENT IN THE WAY 9070 05:25:12,595 --> 05:25:15,231 THEY OPERATE IN MANY WAYS BUT 9071 05:25:15,231 --> 05:25:15,832 THERE'S SOME DIFFERENCES WHICH 9072 05:25:15,832 --> 05:25:18,301 I'LL POINT OUT IN A BIT. 9073 05:25:18,301 --> 05:25:20,937 THE PURPOSE OF THESE SCIENTIFIC 9074 05:25:20,937 --> 05:25:26,342 MANAGEMENT REVIEW BOARD IS TO 9075 05:25:26,342 --> 05:25:26,909 ADVISE NIH AND DEPARTMENT OF 9076 05:25:26,909 --> 05:25:27,610 HEALTH AND HUMAN SERVICES 9077 05:25:27,610 --> 05:25:32,181 OFFICIALS ON USE OF THE AGENCY 9078 05:25:32,181 --> 05:25:32,782 ORGANIZATIONAL AUTHORITIES TO 9079 05:25:32,782 --> 05:25:43,359 ESTABLISH OR ABOLISH INSTITUS 9080 05:25:48,798 --> 05:25:51,801 AND CENTERS. 9081 05:25:51,801 --> 05:25:53,870 NEXT PLEASE. 9082 05:25:53,870 --> 05:25:56,939 THE HISTORY IS SUMMARIZED IN THE 9083 05:25:56,939 --> 05:25:58,374 NEXT SLIDE. 9084 05:25:58,374 --> 05:26:00,176 THE SCIENTIFIC MANAGEMENT REVIEW 9085 05:26:00,176 --> 05:26:04,614 BOARD INITIALLY IS PART OF ITS 9086 05:26:04,614 --> 05:26:07,450 FIRST BOARD DEVELOPED A 9087 05:26:07,450 --> 05:26:11,721 FRAMEWORK FOR THE CONSIDERATION 9088 05:26:11,721 --> 05:26:16,292 OF ORGANIZATIONAL CHANGE. 9089 05:26:16,292 --> 05:26:18,060 AMONG NOTABLE RECOMMENDATIONS 9090 05:26:18,060 --> 05:26:20,530 WAS PROPOSED MERGE EVER OF THE 9091 05:26:20,530 --> 05:26:22,098 NATIONAL INSTITUTE ON DRUG ABUSE 9092 05:26:22,098 --> 05:26:26,269 AND NATIONAL INSTITUTES ON 9093 05:26:26,269 --> 05:26:28,070 ALCOHOL ABUSE AND ALCOHOLISM AND 9094 05:26:28,070 --> 05:26:30,239 CREATION OF NATIONAL CENTER FOR 9095 05:26:30,239 --> 05:26:32,074 ADVANCING TRANSLATIONAL 9096 05:26:32,074 --> 05:26:32,875 SCIENCES. 9097 05:26:32,875 --> 05:26:36,245 SO THEY RECOMMENDED CREATION OF 9098 05:26:36,245 --> 05:26:39,515 A NEW INSTITUTE AND RECOMMENDED 9099 05:26:39,515 --> 05:26:44,654 MERGER OF TWO INSTITUTES INTO 9100 05:26:44,654 --> 05:26:44,987 ONE. 9101 05:26:44,987 --> 05:26:48,090 THE COMMITTEE AS PREVIOUSLY 9102 05:26:48,090 --> 05:26:51,360 CONSTITUTED LAST MET IN 2015. 9103 05:26:51,360 --> 05:26:53,529 THE PREVIOUS ADMINISTRATION, THE 9104 05:26:53,529 --> 05:26:55,598 FIRST TRUMP ADMINISTRATION, HAD 9105 05:26:55,598 --> 05:26:59,235 WANTED TO REDUCE NUMBER OF FACA 9106 05:26:59,235 --> 05:26:59,535 COMMITTEES. 9107 05:26:59,535 --> 05:27:01,003 WE PROPOSED THE SCIENTIFIC 9108 05:27:01,003 --> 05:27:03,239 MANAGEMENT REVIEW BOARD BE ONE 9109 05:27:03,239 --> 05:27:07,043 OF THOSE THAT WOULD BE 9110 05:27:07,043 --> 05:27:09,111 ELIMINATED BECAUSE OVER TIME DR. 9111 05:27:09,111 --> 05:27:11,647 COLLINS WAS USING THE ADVISORY 9112 05:27:11,647 --> 05:27:13,583 COMMITTEE TO THE DIRECTOR MORE 9113 05:27:13,583 --> 05:27:16,786 AND MORE FOR BROADER RANGE OF 9114 05:27:16,786 --> 05:27:18,454 ACTIVITIES BUT THAT REQUEST, 9115 05:27:18,454 --> 05:27:20,923 THAT PROPOSAL WAS NEVER ACTED 9116 05:27:20,923 --> 05:27:24,227 UPON BY THE CONGRESS AND SO THE 9117 05:27:24,227 --> 05:27:27,029 SCIENTIFIC MANAGEMENT REVIEW 9118 05:27:27,029 --> 05:27:34,403 BOARD LAY DORMANT FROM 2015 ON. 9119 05:27:34,403 --> 05:27:35,738 NEXT PLEASE. 9120 05:27:35,738 --> 05:27:41,310 SO, IN ADDITION TO THE CHANGE 9121 05:27:41,310 --> 05:27:42,678 AND EFFECTIVENESS REPORT ISSUED 9122 05:27:42,678 --> 05:27:44,480 IN 2010 THERE WERE ALSO REPORTS 9123 05:27:44,480 --> 05:27:47,617 ON SUBSTANCE USE ABUSE AND 9124 05:27:47,617 --> 05:27:51,287 ADDICTION, THAT REFERS TO THE 9125 05:27:51,287 --> 05:27:54,790 RECOMMENDATION THAT NIDA AND 9126 05:27:54,790 --> 05:27:56,192 NIAAA BE MERGED, THERE WAS ALSO 9127 05:27:56,192 --> 05:28:01,364 A REPORT ON THE INTRAMURAL 9128 05:28:01,364 --> 05:28:03,332 PROGRAM, CLINICAL CENTER, AND 9129 05:28:03,332 --> 05:28:05,701 ADDITIONAL REPORT ON TRANSLATION 9130 05:28:05,701 --> 05:28:07,403 MEDICINE AND THERAPEUTICS, ALL 9131 05:28:07,403 --> 05:28:10,973 OF THIS WORK DONE IN 2010. 9132 05:28:10,973 --> 05:28:15,711 SO A QUICK START. 9133 05:28:15,711 --> 05:28:16,812 NEXT PLEASE. 9134 05:28:16,812 --> 05:28:18,881 CONTINUING WITH THOSE HIGHLIGHTS 9135 05:28:18,881 --> 05:28:22,818 IN 2013 A REPORT ON THE 9136 05:28:22,818 --> 05:28:26,455 SO-CALLED SBIR PROGRAM, OUR 9137 05:28:26,455 --> 05:28:27,990 CONGRESSIONALLY MANDATED SMALL 9138 05:28:27,990 --> 05:28:29,392 BUSINESS INNOVATION RESEARCH AND 9139 05:28:29,392 --> 05:28:33,429 SMALL BUSINESS TECH TRANSFER 9140 05:28:33,429 --> 05:28:33,663 PROGRAM. 9141 05:28:33,663 --> 05:28:37,433 IN 2014 APPROACHES TO ASSESSING 9142 05:28:37,433 --> 05:28:42,138 THE VALUE OF BIOMEDICAL 9143 05:28:42,138 --> 05:28:42,405 RESEARCH. 9144 05:28:42,405 --> 05:28:45,875 IN 2015 IN JANUARY A REPORT ON 9145 05:28:45,875 --> 05:28:49,478 PRE-COLLEGE ENGAGEMENT IN 9146 05:28:49,478 --> 05:28:50,479 BIOMEDICAL SCIENCE, HISTORICALLY 9147 05:28:50,479 --> 05:28:56,485 NIH HAS NOT SPENT A LOT OF TIME 9148 05:28:56,485 --> 05:28:57,920 IN THE PRE-COLLEGE SPACE, THREE 9149 05:28:57,920 --> 05:29:00,222 PROGRAMS MODEST IN SIZE. 9150 05:29:00,222 --> 05:29:02,425 FINALLY, THIS REPORT ON GRANT 9151 05:29:02,425 --> 05:29:05,695 REVIEW, AWARD, AND MANAGEMENT 9152 05:29:05,695 --> 05:29:08,564 PROCESSES DOESN'T READ GRUMP, 9153 05:29:08,564 --> 05:29:08,998 IT'S GRAMP. 9154 05:29:08,998 --> 05:29:09,732 [LAUGHTER] 9155 05:29:09,732 --> 05:29:13,336 AND THAT WAS THE FINAL REPORT 9156 05:29:13,336 --> 05:29:16,739 BEFORE THE COMMITTEE SUNSET. 9157 05:29:16,739 --> 05:29:18,507 NEXT PLEASE. 9158 05:29:18,507 --> 05:29:22,511 SO, AS TO WHY WE HAVE RESTARTED 9159 05:29:22,511 --> 05:29:25,715 THE SCIENTIFIC MANAGEMENT AND 9160 05:29:25,715 --> 05:29:27,350 REVIEW BOARD, TWO REASONS. 9161 05:29:27,350 --> 05:29:29,218 THE FIRST IN OUR 2024 9162 05:29:29,218 --> 05:29:30,853 APPROPRIATIONS LANGUAGE IT WAS 9163 05:29:30,853 --> 05:29:33,289 WRITTEN THAT THE COMMITTEE 9164 05:29:33,289 --> 05:29:35,358 DIRECTS NIH TO RECONVENE SMRB 9165 05:29:35,358 --> 05:29:40,996 WITHIN ONE YEAR OF ENACTMENT IN 9166 05:29:40,996 --> 05:29:44,133 ORDER TO FULFILL STATUTORY DUTY 9167 05:29:44,133 --> 05:29:45,067 TO ADVISE CONGRESS, SECRETARY, 9168 05:29:45,067 --> 05:29:46,969 NIH DIRECTOR HOW BEST TO 9169 05:29:46,969 --> 05:29:47,536 ORGANIZE BIOMEDICAL RESEARCH 9170 05:29:47,536 --> 05:29:50,473 FUNDING AND THIS WAS A COMMITTEE 9171 05:29:50,473 --> 05:29:52,975 THAT NEWLY APPOINTED NIH 9172 05:29:52,975 --> 05:29:59,382 DIRECTOR AT THE TIME DR. 9173 05:29:59,382 --> 05:30:00,783 BERTAGNOLLI THOUGHT WOULD BE 9174 05:30:00,783 --> 05:30:05,488 VALUABLE SO THE TWO COALESCED, 9175 05:30:05,488 --> 05:30:06,922 SYNERGIZED, AND WE BEGAN TO 9176 05:30:06,922 --> 05:30:11,627 STAND THIS COMMITTEE BACK UP 9177 05:30:11,627 --> 05:30:12,228 AGAIN. 9178 05:30:12,228 --> 05:30:12,795 NEXT PLEASE. 9179 05:30:12,795 --> 05:30:14,997 THERE ARE A NUMBER OF 9180 05:30:14,997 --> 05:30:18,300 INTERESTING STATUTORY RULES AND 9181 05:30:18,300 --> 05:30:19,735 REQUIREMENTS REGARDING THE SMRB 9182 05:30:19,735 --> 05:30:20,970 WHICH DIFFER FROM THE APPROACH 9183 05:30:20,970 --> 05:30:24,340 THAT WE USE IN THE ADVISORY 9184 05:30:24,340 --> 05:30:25,841 COMMITTEE TO THE DIRECTOR. 9185 05:30:25,841 --> 05:30:28,811 BOTH ARE FACA COMMITTEES, AND 9186 05:30:28,811 --> 05:30:30,346 THEREFORE SIMILAR, THEY ARE 9187 05:30:30,346 --> 05:30:32,415 DISSIMILAR IN SOME SPECIFIC 9188 05:30:32,415 --> 05:30:35,818 RULES AND REQUIREMENTS ON HOW 9189 05:30:35,818 --> 05:30:37,219 THINGS WORK. 9190 05:30:37,219 --> 05:30:40,189 SO, IT IS REQUIRED NOT LESS THAN 9191 05:30:40,189 --> 05:30:42,825 ONCE EACH SEVEN YEARS THE BOARD 9192 05:30:42,825 --> 05:30:46,195 WILL ISSUE A REPORT TO THE NIH 9193 05:30:46,195 --> 05:30:49,165 DIRECTOR AND OTHER APPROPRIATE 9194 05:30:49,165 --> 05:30:52,334 AGENCY OFFICIALS. 9195 05:30:52,334 --> 05:30:55,504 AND SO THAT SEVEN-YEAR 9196 05:30:55,504 --> 05:30:56,906 REQUIREMENT WAS TRIGGERED AND IN 9197 05:30:56,906 --> 05:30:59,775 THE VIEW OF CONGRESS WAS NOT MET 9198 05:30:59,775 --> 05:31:05,047 BECAUSE WE LAST MET IN 2015 WHEN 9199 05:31:05,047 --> 05:31:06,882 REPORTS WERE ISSUED, AND THERE 9200 05:31:06,882 --> 05:31:11,520 WE ARE IN 2024 AND HADN'T ISSUED 9201 05:31:11,520 --> 05:31:12,488 A REPORT, EFFECTIVELY EIGHT TO 9202 05:31:12,488 --> 05:31:14,089 NINE YEARS. 9203 05:31:14,089 --> 05:31:15,891 THE BOARD WILL DETERMINE WHETHER 9204 05:31:15,891 --> 05:31:19,395 AND TO WHAT EXTENT THE NIH 9205 05:31:19,395 --> 05:31:20,329 ORGANIZATIONAL AUTHORITIES 9206 05:31:20,329 --> 05:31:22,465 SHOULD BE USED, SO ONE IS NOT 9207 05:31:22,465 --> 05:31:24,967 OBLIGATED TO USE THOSE BUT 9208 05:31:24,967 --> 05:31:26,635 RATHER THE BOARD IS SUPPOSED TO 9209 05:31:26,635 --> 05:31:27,837 RECOMMEND WHETHER THEY SHOULD 9210 05:31:27,837 --> 05:31:29,438 AND TO WHAT EXTENT THEY SHOULD 9211 05:31:29,438 --> 05:31:30,873 BE USED. 9212 05:31:30,873 --> 05:31:33,509 AND THE REPORT WILL PROVIDE 9213 05:31:33,509 --> 05:31:35,678 RECOMMENDATIONS REGARDING THE 9214 05:31:35,678 --> 05:31:36,912 USE OF ORGANIZATIONAL 9215 05:31:36,912 --> 05:31:40,216 AUTHORITIES AND THE REASONS 9216 05:31:40,216 --> 05:31:41,617 BEHIND THOSE UNDERLYING 9217 05:31:41,617 --> 05:31:41,984 RECOMMENDATIONS. 9218 05:31:41,984 --> 05:31:44,453 BEFORE THIS BOARD CAN ISSUE A 9219 05:31:44,453 --> 05:31:46,121 REPORT, IT NEEDS TO CONSULT WITH 9220 05:31:46,121 --> 05:31:48,724 A VERY BROAD RANGE OF 9221 05:31:48,724 --> 05:31:50,659 STAKEHOLDERS. 9222 05:31:50,659 --> 05:31:52,895 IT HAS TO CONSULT WITH 9223 05:31:52,895 --> 05:31:53,896 NON-MEMBER INSTITUTE AND CENTER 9224 05:31:53,896 --> 05:31:56,298 DIRECTORS BECAUSE YOU'LL SEE IN 9225 05:31:56,298 --> 05:31:59,668 A MOMENT THAT ANOTHER UNUSUAL 9226 05:31:59,668 --> 05:32:01,871 FEATURE OF THE SMRB IS IN 9227 05:32:01,871 --> 05:32:04,306 ADDITION TO OUTSIDE MEMBERS, IT 9228 05:32:04,306 --> 05:32:06,375 ALSO HAS STANDING INSTITUTE AND 9229 05:32:06,375 --> 05:32:09,345 CENTER DIRECTORS AS PART OF THE 9230 05:32:09,345 --> 05:32:10,212 MEMBERS. 9231 05:32:10,212 --> 05:32:11,847 SO, BEFORE ISSUING A REPORT, THE 9232 05:32:11,847 --> 05:32:15,017 BOARD HAS TO CONSULT WITH I.C. 9233 05:32:15,017 --> 05:32:16,785 DIRECTORS NOT ON THE SMRB. 9234 05:32:16,785 --> 05:32:20,389 IT ALSO HAS TO CONSULT WITH 9235 05:32:20,389 --> 05:32:21,924 OTHER NON-MEMBER AGENCY 9236 05:32:21,924 --> 05:32:23,025 SCIENTIFIC LEADERS. 9237 05:32:23,025 --> 05:32:27,263 IT HAS TO CONSULT WITH RELEVANT 9238 05:32:27,263 --> 05:32:29,765 I.C. ADVISORY COUNCILS, SO THAT 9239 05:32:29,765 --> 05:32:32,635 WOULD INCLUDE THINGS LIKE THE 9240 05:32:32,635 --> 05:32:35,471 ACD, COUNCIL OF COUNCILS, AND IF 9241 05:32:35,471 --> 05:32:36,906 INTERPRETED STRICTLY, ALL THE 9242 05:32:36,906 --> 05:32:38,574 COUNCILS OF THE DIFFERENT 9243 05:32:38,574 --> 05:32:40,976 INSTITUTES AND CENTERS. 9244 05:32:40,976 --> 05:32:43,579 FURTHER, IT WOULD REQUIRE 9245 05:32:43,579 --> 05:32:46,215 CONSULTATION WITH ORGANIZATIONS 9246 05:32:46,215 --> 05:32:47,550 BROADLY REPRESENTING THE 9247 05:32:47,550 --> 05:32:49,618 SCIENTIFIC COMMUNITY AND 9248 05:32:49,618 --> 05:32:50,586 ORGANIZATIONS REPRESENTING 9249 05:32:50,586 --> 05:32:50,853 PATIENTS. 9250 05:32:50,853 --> 05:32:54,890 AND SO AGAIN BEFORE ISSUING A 9251 05:32:54,890 --> 05:32:56,091 REPORT THERE'S AN OBLIGATION TO 9252 05:32:56,091 --> 05:33:00,029 DO THIS VERY EXTENSIVE OUTREACH. 9253 05:33:00,029 --> 05:33:00,696 NEXT PLEASE. 9254 05:33:00,696 --> 05:33:02,665 AND OF THE MEETINGS HELD WITH 9255 05:33:02,665 --> 05:33:04,633 RESPECT TO ISSUING A REPORT, ONE 9256 05:33:04,633 --> 05:33:07,570 OR MORE MUST BE DIRECTED TO THE 9257 05:33:07,570 --> 05:33:09,371 SCIENTIFIC COMMUNITY AND ONE OR 9258 05:33:09,371 --> 05:33:11,440 MORE MUST BE DIRECTED TOWARDS 9259 05:33:11,440 --> 05:33:12,775 CONSUMER ORGANIZATIONS. 9260 05:33:12,775 --> 05:33:15,144 SO THERE'S A LOT OF 9261 05:33:15,144 --> 05:33:23,152 SPECIFICATION AS PECIFICATION AE 9262 05:33:23,152 --> 05:33:25,154 SUPPOSED TO WORK TOWARD ISSUING 9263 05:33:25,154 --> 05:33:27,089 A REPORT. 9264 05:33:27,089 --> 05:33:28,624 AND FINALLY THE BOARD MUST MEET 9265 05:33:28,624 --> 05:33:31,827 AT LEAST FIVE TIMES BEFORE IT 9266 05:33:31,827 --> 05:33:36,865 ISSUES A REPORT. 9267 05:33:36,865 --> 05:33:41,537 SO, IT IS BOTH AN APPROACH THAT 9268 05:33:41,537 --> 05:33:42,771 ENSURES EXHAUSTIVE INPUT BUT IT 9269 05:33:42,771 --> 05:33:46,442 IS ALSO AN APPROACH THAT IS NOT 9270 05:33:46,442 --> 05:33:47,276 PARTICULARLY RAPID. 9271 05:33:47,276 --> 05:33:50,980 AND SO WE HAVE THIS SORT OF, YOU 9272 05:33:50,980 --> 05:33:52,948 KNOW, ISSUES THAT WE HAVE TO 9273 05:33:52,948 --> 05:33:55,250 DEAL WITH BUT IT DOES ENSURE 9274 05:33:55,250 --> 05:33:59,188 THAT YOU GET VERY, VERY BROAD 9275 05:33:59,188 --> 05:34:00,589 INPUT. 9276 05:34:00,589 --> 05:34:00,956 NEXT PLEASE. 9277 05:34:00,956 --> 05:34:03,659 SO, IN TERMS OF THE MEMBERSHIP, 9278 05:34:03,659 --> 05:34:05,628 IT'S COMPOSED OF AN ODD NUMBER 9279 05:34:05,628 --> 05:34:08,797 OF MEMBERS, AS I ALLUDED TO 9280 05:34:08,797 --> 05:34:11,200 EARLIER, CONSISTING OF THE 9281 05:34:11,200 --> 05:34:12,968 DIRECTORS, STANDING DIRECTOR OF 9282 05:34:12,968 --> 05:34:16,005 NIH INSTITUTES AND CENTERS, AND 9283 05:34:16,005 --> 05:34:18,974 ALSO CONSISTS OF INDIVIDUALS 9284 05:34:18,974 --> 05:34:20,509 FROM NIH-FUNDED INSTITUTIONS AND 9285 05:34:20,509 --> 05:34:23,512 ALSO A BROAD RANGE OF EXPERTISE 9286 05:34:23,512 --> 05:34:26,982 ON HOW, YOU KNOW, NIH WORKS. 9287 05:34:26,982 --> 05:34:30,119 OUR CURRENT SHARE CHAIR IS DR. 9288 05:34:30,119 --> 05:34:32,321 ANDREA HAYES DIXON, DEAN OF THE 9289 05:34:32,321 --> 05:34:33,756 COLLEGE OF MEDICINE OF HOWARD 9290 05:34:33,756 --> 05:34:34,823 UNIVERSITY. 9291 05:34:34,823 --> 05:34:37,259 THE FULL CURRENT MEMBERSHIP CAN 9292 05:34:37,259 --> 05:34:40,329 BE FOUND AT THAT WEBSITE AND YOU 9293 05:34:40,329 --> 05:34:43,532 CAN CLICK ON THAT AND YOU CAN 9294 05:34:43,532 --> 05:34:49,171 SEE WHO IS ON THE BOARD. 9295 05:34:49,171 --> 05:34:51,240 NEXT PLEASE. 9296 05:34:51,240 --> 05:34:56,078 SO, THE NIH DIRECTOR IN NOVEMBER 9297 05:34:56,078 --> 05:34:58,347 PROVIDED THE FIRST INITIAL 9298 05:34:58,347 --> 05:35:01,350 CHARGE TO THE RESTARTED SMRB 9299 05:35:01,350 --> 05:35:02,251 BOARD. 9300 05:35:02,251 --> 05:35:04,219 SHE REQUESTED THAT THE SMRB 9301 05:35:04,219 --> 05:35:07,089 EVALUATE THE CURRENT STRUCTURE 9302 05:35:07,089 --> 05:35:08,991 OF NIH AND PROPOSE CHANGES TO 9303 05:35:08,991 --> 05:35:11,226 ENHANCE THE ABILITY OF THE 9304 05:35:11,226 --> 05:35:14,830 AGENCY TO FULFILL ITS MISSION 9305 05:35:14,830 --> 05:35:17,900 AND TO ADDRESS THAT CHARGE 9306 05:35:17,900 --> 05:35:20,969 INDICATED THE SMRB SHOULD FIRST 9307 05:35:20,969 --> 05:35:24,606 REEXAMINE THE 2010 SMRB REPORT, 9308 05:35:24,606 --> 05:35:26,241 DELIBERATING ORGANIZATIONAL 9309 05:35:26,241 --> 05:35:26,909 CHANGE AND EFFECTIVENESS, TO 9310 05:35:26,909 --> 05:35:28,544 DECIDE WHETHER OR NOT THE 9311 05:35:28,544 --> 05:35:30,179 CURRENT CRITERIA SHOULD BE 9312 05:35:30,179 --> 05:35:33,682 UPDATED THAT ARE IN THAT REPORT, 9313 05:35:33,682 --> 05:35:34,983 TO DETERMINING WHEN 9314 05:35:34,983 --> 05:35:37,286 ORGANIZATIONAL CHANGE SHOULD BE 9315 05:35:37,286 --> 05:35:39,254 CONTEMPLATED AND SECONDLY SHE 9316 05:35:39,254 --> 05:35:42,124 INDICATED THAT THE SMRB SHOULD 9317 05:35:42,124 --> 05:35:45,828 CONSIDER RECENT PROPOSALS IN THE 9318 05:35:45,828 --> 05:35:46,929 HOUSE ENERGY AND COMMERCE 9319 05:35:46,929 --> 05:35:50,666 COMMITTEE AND SENATE HELP 9320 05:35:50,666 --> 05:35:51,600 COMMITTEE. 9321 05:35:51,600 --> 05:35:53,102 NEXT SLIDE PLEASE. 9322 05:35:53,102 --> 05:35:57,206 THE NIH ALSO REQUESTS THAT THE 9323 05:35:57,206 --> 05:36:00,375 SMRB EVALUATE THE CURRENT 9324 05:36:00,375 --> 05:36:03,112 STRUCTURE WITH REGARD TO 9325 05:36:03,112 --> 05:36:03,912 EVALUATING EXISTING GUIDING 9326 05:36:03,912 --> 05:36:12,554 PRINCIPLES IN THE PROCESS OF 9327 05:36:12,554 --> 05:36:13,088 DELIBERATING PROPOSED 9328 05:36:13,088 --> 05:36:14,289 ORGANIZATIONAL CHANGES AND 9329 05:36:14,289 --> 05:36:15,724 REFINE RECOMMENDATIONS OF ANY 9330 05:36:15,724 --> 05:36:17,226 ORGANIZATIONAL CHANGE THAT THEY 9331 05:36:17,226 --> 05:36:19,661 FEEL WOULD ENHANCE THE ABILITY 9332 05:36:19,661 --> 05:36:23,465 OF THE AGENCY TO FULFILL ITS 9333 05:36:23,465 --> 05:36:24,032 MISSION. 9334 05:36:24,032 --> 05:36:26,201 NEXT PLEASE. 9335 05:36:26,201 --> 05:36:28,937 SO, I'VE MENTIONED THIS REPORT, 9336 05:36:28,937 --> 05:36:31,573 DELIBERATING ORGANIZATIONAL 9337 05:36:31,573 --> 05:36:34,209 CHANGE AND EFFECTIVENESS, THE 9338 05:36:34,209 --> 05:36:37,246 LINK TO THE PDF IS ON THIS SLIDE 9339 05:36:37,246 --> 05:36:38,247 ON THE LEFT. 9340 05:36:38,247 --> 05:36:43,719 AND I MUST SAY IT IS A VERY 9341 05:36:43,719 --> 05:36:45,020 VALUABLE DOCUMENT. 9342 05:36:45,020 --> 05:36:47,022 IT ENUMERATES A SERIES OF 9343 05:36:47,022 --> 05:36:49,391 GUIDING PRINCIPLES AS TO WHY ONE 9344 05:36:49,391 --> 05:36:51,393 WOULD DO THIS. 9345 05:36:51,393 --> 05:36:52,728 FIRST AND FOREMOST TO STRENGTHEN 9346 05:36:52,728 --> 05:36:55,097 THE ABILITY OF NIH TO CARRY OUT 9347 05:36:55,097 --> 05:36:56,532 ITS MISSION. 9348 05:36:56,532 --> 05:36:58,834 TO SECONDLY PROVIDE THE 9349 05:36:58,834 --> 05:37:01,904 ENVIRONMENT FOR COLLABORATION, 9350 05:37:01,904 --> 05:37:03,372 COORDINATION, INTERACTION. 9351 05:37:03,372 --> 05:37:05,440 NOT SURPRISINGLY THE HOPE BEING 9352 05:37:05,440 --> 05:37:06,809 TO BRING TOGETHER SYNERGIES. 9353 05:37:06,809 --> 05:37:10,345 TODAY WE SPENT A LOT OF TIME ON 9354 05:37:10,345 --> 05:37:10,712 PUBLIC OUTREACH. 9355 05:37:10,712 --> 05:37:12,548 THAT'S ONE OF THE GUIDING 9356 05:37:12,548 --> 05:37:13,148 PRINCIPLES. 9357 05:37:13,148 --> 05:37:16,118 WHAT WE DO SHOULD ENHANCE PUBLIC 9358 05:37:16,118 --> 05:37:18,620 UNDERSTANDING, CONFIDENCE, AND 9359 05:37:18,620 --> 05:37:19,087 SUPPORT. 9360 05:37:19,087 --> 05:37:21,390 FINALLY SHOULD INCREASE 9361 05:37:21,390 --> 05:37:25,294 OPERATIONAL EFFICIENCY, IN TERMS 9362 05:37:25,294 --> 05:37:28,263 OF STEPS AS YOU NO DOUBT PREDICT 9363 05:37:28,263 --> 05:37:30,766 FIRST ASSESS NEED FOR CHANGE, 9364 05:37:30,766 --> 05:37:34,336 SECOND EVALUATE OPTIONS FOR SUCH 9365 05:37:34,336 --> 05:37:36,371 CHANGE AND THIRD EVALUATE AND 9366 05:37:36,371 --> 05:37:38,907 IMPLEMENT SUCH CHANGE. 9367 05:37:38,907 --> 05:37:39,675 THROUGHOUT ALL THE ACTIVITIES 9368 05:37:39,675 --> 05:37:43,478 THERE ARE THINGS THAT UNDERGIRD 9369 05:37:43,478 --> 05:37:44,479 EVERYTHING NAMELY TRANSPARENCY, 9370 05:37:44,479 --> 05:37:46,548 COMMUNICATION, ACCOUNTABILITY. 9371 05:37:46,548 --> 05:37:49,718 SO EVEN BACK IN 2010 WE WERE 9372 05:37:49,718 --> 05:37:50,919 TALKING ABOUT THESE VERY 9373 05:37:50,919 --> 05:37:51,220 PRINCIPLES. 9374 05:37:51,220 --> 05:37:53,889 AS YOU CAN SEE THESE HAVE BEEN 9375 05:37:53,889 --> 05:37:55,090 DEVELOPED FURTHER OVER TIME 9376 05:37:55,090 --> 05:38:00,896 WHERE WE NOW HAVE VERY ROBUST 9377 05:38:00,896 --> 05:38:01,230 APPROACHES. 9378 05:38:01,230 --> 05:38:03,765 NEXT SLIDE PLEASE. 9379 05:38:03,765 --> 05:38:06,735 NOW, THERE ARE A SPECTRUM OF 9380 05:38:06,735 --> 05:38:08,370 OPTIONS FOR ORGANIZATIONAL 9381 05:38:08,370 --> 05:38:13,609 CHANGE AND THEY RANGE FROM DOING 9382 05:38:13,609 --> 05:38:15,911 NOTHING TO DOING FUNCTIONAL 9383 05:38:15,911 --> 05:38:17,679 CHANGES SO YOU CAN ACHIEVE THE 9384 05:38:17,679 --> 05:38:23,585 VALUE AND BENEFITS THAT YOU HOPE 9385 05:38:23,585 --> 05:38:28,991 TO WITHOUT GOING THROUGH THE 9386 05:38:28,991 --> 05:38:32,561 SOMETIMES CUMBERSOME REQUIREMENT 9387 05:38:32,561 --> 05:38:34,763 OF EFFECTING A CHANGE IN A 9388 05:38:34,763 --> 05:38:36,164 FEDERAL ENVIRONMENT. 9389 05:38:36,164 --> 05:38:39,234 THE PICTOGRAM HERE TRIES TO 9390 05:38:39,234 --> 05:38:40,002 SUMMARIZE THE VARIOUS 9391 05:38:40,002 --> 05:38:40,335 APPROACHES. 9392 05:38:40,335 --> 05:38:43,405 I WILL TELL YOU THAT WE HAVE 9393 05:38:43,405 --> 05:38:46,241 USED EVERY SINGLE ONE SAVE FOR 9394 05:38:46,241 --> 05:38:47,542 ONE, THE PENULTIMATE READING 9395 05:38:47,542 --> 05:38:50,178 LEFT TO RIGHT, WE CAN GIVE YOU 9396 05:38:50,178 --> 05:38:51,947 EXAMPLES OF EVERY SINGLE ONE. 9397 05:38:51,947 --> 05:38:53,682 NOW, WE MAY HAVE A SITUATION 9398 05:38:53,682 --> 05:38:56,952 WHERE YOU DECIDE NOT TO DO A 9399 05:38:56,952 --> 05:38:58,520 CHANGE. 9400 05:38:58,520 --> 05:39:00,255 THAT'S WHERE USUALLY WHEN PEOPLE 9401 05:39:00,255 --> 05:39:03,525 CLAMOR FOR CHANGE WE SELECT ONE 9402 05:39:03,525 --> 05:39:05,260 OF THE REMAINING OPTIONS. 9403 05:39:05,260 --> 05:39:10,332 OFTEN IT IS A MERGER OF SELECT 9404 05:39:10,332 --> 05:39:15,037 INITIATIVES FROM TWO INSTITUTES 9405 05:39:15,037 --> 05:39:16,204 OTHER CENTERS. 9406 05:39:16,204 --> 05:39:17,439 VERY OFTEN TWO INSTITUTES AND 9407 05:39:17,439 --> 05:39:18,874 CENTERS COME TOGETHER TO CREATE 9408 05:39:18,874 --> 05:39:23,912 A NEW INITIATIVE, NOT ONE THAT'S 9409 05:39:23,912 --> 05:39:24,246 EXISTING. 9410 05:39:24,246 --> 05:39:25,447 INCREASINGLY AND PARTICULARLY 9411 05:39:25,447 --> 05:39:27,416 UNDER MARTHA'S WATCH NEW 9412 05:39:27,416 --> 05:39:29,518 INITIATIVES HAVE BUBBLED UP, OF 9413 05:39:29,518 --> 05:39:33,355 COURSE MULTIPLE INSTITUTES AND 9414 05:39:33,355 --> 05:39:34,122 CENTERS, CLUSTERED FUNCTIONS, 9415 05:39:34,122 --> 05:39:36,625 BUILDING ON STRENGTHS OF TWO OR 9416 05:39:36,625 --> 05:39:39,394 MORE ENTITIES, TO ENSURE THE 9417 05:39:39,394 --> 05:39:41,229 BEST OF CLASS OR ONE INSTITUTES 9418 05:39:41,229 --> 05:39:42,898 MAY DO ONE THING REALLY WELL, 9419 05:39:42,898 --> 05:39:45,634 ANOTHER MAY DO ANOTHER THING 9420 05:39:45,634 --> 05:39:47,035 REALLY WELL. 9421 05:39:47,035 --> 05:39:52,040 AND I THINK THAT WE HAVE HAD 9422 05:39:52,040 --> 05:39:55,911 EXAMPLES OF THAT, IN PARTICULAR 9423 05:39:55,911 --> 05:39:58,013 NIDA AND NIAAA CLUSTERED THEIR 9424 05:39:58,013 --> 05:39:59,514 FUNCTIONS, I THINK THEY HAVE 9425 05:39:59,514 --> 05:40:01,283 EQUAL STRENGTHS IN MANY DOMAINS 9426 05:40:01,283 --> 05:40:04,553 BUT THEY ARE LOOKING AT SIMILAR 9427 05:40:04,553 --> 05:40:07,055 SCIENCE FROM SLIGHTLY DIFFERENT 9428 05:40:07,055 --> 05:40:07,622 PERSPECTIVES. 9429 05:40:07,622 --> 05:40:10,892 AND SO WE HAVE CLUSTERED THEIR 9430 05:40:10,892 --> 05:40:14,096 APPROACH AND EFFORTS IN A VERY 9431 05:40:14,096 --> 05:40:16,398 SERIOUS WAY INCLUDING ONE JOINT 9432 05:40:16,398 --> 05:40:18,600 COUNCIL MEETING A YEAR. 9433 05:40:18,600 --> 05:40:20,902 WE HAVE NEVER MERGED INSTITUTES 9434 05:40:20,902 --> 05:40:24,306 AS A RESULT OF THE SMRB PROCESS. 9435 05:40:24,306 --> 05:40:27,909 ONE WAS PROPOSED, NIDA AND NIAA. 9436 05:40:27,909 --> 05:40:30,545 THAT DID NOT OCCUR. 9437 05:40:30,545 --> 05:40:34,783 BUT THIS CLUSTERED APPROACH DID 9438 05:40:34,783 --> 05:40:37,552 IN FACT OCCUR. 9439 05:40:37,552 --> 05:40:42,791 WE HAVE THE COME-ON LINE WITH A 9440 05:40:42,791 --> 05:40:44,426 NEW INSTITUTE SINCE SMRB, THAT 9441 05:40:44,426 --> 05:40:45,527 OF COURSE IS NCATS. 9442 05:40:45,527 --> 05:40:46,962 SOME OF US HAVE BEEN HERE LONG 9443 05:40:46,962 --> 05:40:49,998 ENOUGH TO REMEMBER OTHER NEW 9444 05:40:49,998 --> 05:40:52,534 INSTITUTES THAT CAME ALONG. 9445 05:40:52,534 --> 05:40:55,137 MOST RECENT BEFORE NCATS WAS 9446 05:40:55,137 --> 05:40:55,837 NIBIB. 9447 05:40:55,837 --> 05:41:01,309 SO WE HAVE IN FACT HAD NEW 9448 05:41:01,309 --> 05:41:03,812 INSTITUTES CREATED. 9449 05:41:03,812 --> 05:41:05,580 NEXT SLIDE PLEASE. 9450 05:41:05,580 --> 05:41:10,786 SO AS PART OF THE CHANGE JUST TO 9451 05:41:10,786 --> 05:41:13,088 REITERATE AND EMPHASIZE, 9452 05:41:13,088 --> 05:41:14,756 REEVALUATE, EXISTING GUIDELINES 9453 05:41:14,756 --> 05:41:16,825 FOR PROCESS OF DELIBERATING 9454 05:41:16,825 --> 05:41:17,592 PROPOSED ORGANIZATIONAL CHANGES 9455 05:41:17,592 --> 05:41:26,034 BE ON THE NEXT SLIDE, AND ALSO 9456 05:41:26,034 --> 05:41:29,004 TO CONSIDER THE CONGRESSIONAL 9457 05:41:29,004 --> 05:41:33,475 INTEREST AT NIH ORGANIZATION 9458 05:41:33,475 --> 05:41:38,847 STRUCTURE, ON THE LEFT IS A 9459 05:41:38,847 --> 05:41:42,918 REPORT FROM THE SENATE, 2024 NIH 9460 05:41:42,918 --> 05:41:46,822 AND 21ST CENTURY REPORT ENSURING 9461 05:41:46,822 --> 05:41:48,824 TRANSPARENCY IN AMERICAN 9462 05:41:48,824 --> 05:41:52,994 BIOMEDICAL LEADERSHIP, RANKING 9463 05:41:52,994 --> 05:41:54,196 MEMBER CASSIDY WAS THE 9464 05:41:54,196 --> 05:41:55,831 COMMUNICATOR OF THAT REPORT. 9465 05:41:55,831 --> 05:41:59,534 AND THEN ON THE RIGHT THE 2024 9466 05:41:59,534 --> 05:42:03,738 REPORT FROM THE HOUSE ENERGY AND 9467 05:42:03,738 --> 05:42:05,340 COMMERCE COMMITTEE, CHAIRMAN 9468 05:42:05,340 --> 05:42:05,941 MCMORRIS RODGERS WAS 9469 05:42:05,941 --> 05:42:11,012 COMMUNICATOR OF THAT REPORT. 9470 05:42:11,012 --> 05:42:12,347 THE FRAMEWORK, THE DISCUSSION, 9471 05:42:12,347 --> 05:42:16,618 2024 REFORMING THE NIH, AND BOTH 9472 05:42:16,618 --> 05:42:19,354 CONTAIN SOME VERY VALUABLE 9473 05:42:19,354 --> 05:42:20,655 RECOMMENDATIONS AND SUGGESTIONS, 9474 05:42:20,655 --> 05:42:24,926 AND THESE TOO SHOULD BE AND WILL 9475 05:42:24,926 --> 05:42:26,995 BE CONSIDERED BY SMRB. 9476 05:42:26,995 --> 05:42:29,631 IF I CAN HAVE THE NEXT SLIDE 9477 05:42:29,631 --> 05:42:30,332 PLEASE. 9478 05:42:30,332 --> 05:42:35,337 SO, WE DID MEET, AS DR. 9479 05:42:35,337 --> 05:42:36,771 BERTAGNOLLI MENTIONED EARLIER 9480 05:42:36,771 --> 05:42:37,072 TODAY. 9481 05:42:37,072 --> 05:42:37,906 ON NOVEMBER 12. 9482 05:42:37,906 --> 05:42:40,142 AND THERE WERE A NUMBER OF 9483 05:42:40,142 --> 05:42:43,011 THEMES THAT EMERGED FROM THAT 9484 05:42:43,011 --> 05:42:44,312 FIRST MEETING. 9485 05:42:44,312 --> 05:42:46,348 I'M SUMMARIZING AN ALL-DAY 9486 05:42:46,348 --> 05:42:48,717 MEETING SO FORGIVE THE BREVITY. 9487 05:42:48,717 --> 05:42:50,752 BUT IN GENERAL HOW DO WE 9488 05:42:50,752 --> 05:42:51,953 REESTABLISH TRUST AND BETTER 9489 05:42:51,953 --> 05:42:56,791 COMMUNICATE THE IMPACT OF NIH 9490 05:42:56,791 --> 05:42:57,559 INVESTMENTS. 9491 05:42:57,559 --> 05:43:01,696 I THINK YOU HEARD MANY IMPORTANT 9492 05:43:01,696 --> 05:43:03,765 IDEAS HERE TODAY WHERE THROUGH 9493 05:43:03,765 --> 05:43:07,068 IMPLEMENTATION AND EXECUTION AND 9494 05:43:07,068 --> 05:43:10,539 BROADENING OUT WE CAN EFFECT 9495 05:43:10,539 --> 05:43:11,540 THAT FOR CERTAIN, ENGAGING 9496 05:43:11,540 --> 05:43:13,508 COMMUNITIES AROUND THE NATION. 9497 05:43:13,508 --> 05:43:15,377 HOW ARE WE INCREASING THE IMPACT 9498 05:43:15,377 --> 05:43:16,478 OF OUR WORK? 9499 05:43:16,478 --> 05:43:18,446 WE'RE ALWAYS LOOKING FOR WAYS TO 9500 05:43:18,446 --> 05:43:21,183 INCREASE AND ENHANCE THE IMPACT 9501 05:43:21,183 --> 05:43:24,586 OF OUR WORK. 9502 05:43:24,586 --> 05:43:25,053 PRIORITIZING COMMUNITY 9503 05:43:25,053 --> 05:43:25,387 PARTNERSHIP. 9504 05:43:25,387 --> 05:43:28,290 AND SO MUCH OF TODAY'S MEETING 9505 05:43:28,290 --> 05:43:31,326 WAS INVOLVED WITH THAT. 9506 05:43:31,326 --> 05:43:33,395 AND OF COURSE PRIORITIZING 9507 05:43:33,395 --> 05:43:34,296 HEALTH DISPARITIES ACTIVITIES 9508 05:43:34,296 --> 05:43:35,130 AND RESEARCH. 9509 05:43:35,130 --> 05:43:37,766 AGAIN, THAT WAS CERTAINLY 9510 05:43:37,766 --> 05:43:39,100 ALLUDED TO THROUGHOUT TODAY'S 9511 05:43:39,100 --> 05:43:42,370 ACTIVITIES AS WELL. 9512 05:43:42,370 --> 05:43:42,904 NEXT PLEASE. 9513 05:43:42,904 --> 05:43:46,541 SO WHAT ARE THE NEXT STEPS FOR 9514 05:43:46,541 --> 05:43:49,144 THE SCIENTIFIC MANAGEMENT REVIEW 9515 05:43:49,144 --> 05:43:50,245 BOARD? 9516 05:43:50,245 --> 05:43:54,082 WE WILL BE MEETING SOMETIME IN 9517 05:43:54,082 --> 05:43:54,950 JANUARY VIRTUALLY. 9518 05:43:54,950 --> 05:43:56,785 WE HAVE DECIDED ON A CADENCE TO 9519 05:43:56,785 --> 05:44:00,855 TRY AND DO A MINIMUM OF FIVE 9520 05:44:00,855 --> 05:44:03,925 MEETINGS IN THE YEAR. 9521 05:44:03,925 --> 05:44:04,893 ALTERNATING BETWEEN IN-PERSON 9522 05:44:04,893 --> 05:44:07,095 MEETINGS WHICH OCCURRED FOR THE 9523 05:44:07,095 --> 05:44:08,930 FIRST MEETING WITH VIRTUAL 9524 05:44:08,930 --> 05:44:10,432 MEETINGS WHICH WILL OCCUR FOR 9525 05:44:10,432 --> 05:44:14,502 THE NEXT MEETING AND SO FORTH. 9526 05:44:14,502 --> 05:44:17,806 WE WANT TO DISCUSS THE GROUP'S 9527 05:44:17,806 --> 05:44:19,140 OVERALL STRATEGY TO COALESCE ON 9528 05:44:19,140 --> 05:44:20,508 THINGS THAT WORKED AND NOT 9529 05:44:20,508 --> 05:44:22,644 WORKED PERHAPS IN THE 9530 05:44:22,644 --> 05:44:24,646 INTERVENING YEAR SINCE THE 9531 05:44:24,646 --> 05:44:26,948 SUNSET, YOU KNOW, STASIS OF THE 9532 05:44:26,948 --> 05:44:27,282 COMMITTEE. 9533 05:44:27,282 --> 05:44:30,218 WE WANT TO BEGIN TO ARTICULATE 9534 05:44:30,218 --> 05:44:33,288 AND IDENTIFY WHAT TYPE OF DATA 9535 05:44:33,288 --> 05:44:37,359 WE NEED OVER TIME TO HELP INFORM 9536 05:44:37,359 --> 05:44:38,760 COMMITTEE'S DELIBERATION. 9537 05:44:38,760 --> 05:44:42,831 WANT TO OUTLINE SOME KEY 9538 05:44:42,831 --> 05:44:46,334 QUESTIONS AND SET PRIORITIES, IN 9539 05:44:46,334 --> 05:44:49,271 SO DOING THE GROUP CAME TO 9540 05:44:49,271 --> 05:44:50,505 CONSENSUS WE REALLY NEED 9541 05:44:50,505 --> 05:44:53,108 TANGIBLE METRICS TO MAKE SURE 9542 05:44:53,108 --> 05:44:54,643 THAT WE'RE DELIVERING WHAT WE 9543 05:44:54,643 --> 05:44:58,713 ARE GOING TO BE DELIVERING. 9544 05:44:58,713 --> 05:45:01,850 BLUE SKY-ING IS FUN BUT I THINK 9545 05:45:01,850 --> 05:45:04,519 WE'RE GOING TO FOCUS ON TACTICAL 9546 05:45:04,519 --> 05:45:07,455 RATHER THAN THE LATTER. 9547 05:45:07,455 --> 05:45:11,159 THERE ARE SOME QUESTIONS AND 9548 05:45:11,159 --> 05:45:12,260 PRIORITIES VIS-A-VIS FISCAL 9549 05:45:12,260 --> 05:45:15,430 STABILITY, AND NO DOUBT THAT 9550 05:45:15,430 --> 05:45:17,065 CONVERSATION COULD INFORM A 9551 05:45:17,065 --> 05:45:18,066 NUMBER OF THINGS. 9552 05:45:18,066 --> 05:45:21,236 THERE WAS SOME QUESTION ABOUT 9553 05:45:21,236 --> 05:45:22,237 IMPLEMENTATION SCIENCE, 9554 05:45:22,237 --> 05:45:23,338 SOMETHING THAT WAS OF COURSE 9555 05:45:23,338 --> 05:45:24,739 BROUGHT UP HERE TODAY. 9556 05:45:24,739 --> 05:45:28,476 AND HAS BEEN IN MANY ACD 9557 05:45:28,476 --> 05:45:29,678 MEETINGS. 9558 05:45:29,678 --> 05:45:31,579 AND THEN FINALLY THE NEED TO 9559 05:45:31,579 --> 05:45:33,882 CONTINUE TO USE THE NIH 9560 05:45:33,882 --> 05:45:35,750 PARTICULARLY THE INTRAMURAL 9561 05:45:35,750 --> 05:45:37,285 RESEARCH PROGRAM AS INCUBATOR 9562 05:45:37,285 --> 05:45:37,752 SPACE. 9563 05:45:37,752 --> 05:45:43,958 YOU HEARD ABOUT SOME PILOT 9564 05:45:43,958 --> 05:45:45,060 PROGRAMS, ALSO WE DO THESE 9565 05:45:45,060 --> 05:45:46,995 THINGS IN THE INTRAMURAL SPACE. 9566 05:45:46,995 --> 05:45:50,065 IN TERMS OF MEETING CADENCE 9567 05:45:50,065 --> 05:45:52,167 WE'RE GOING TO HAVE A SHORTER 9568 05:45:52,167 --> 05:45:52,934 VIRTUAL MEETING, HAVEN'T QUITE 9569 05:45:52,934 --> 05:45:54,803 GOTTEN THE DATE YET BUT WE'LL 9570 05:45:54,803 --> 05:45:57,439 HAVE IT VERY SHORTLY. 9571 05:45:57,439 --> 05:46:00,809 AND IN ORDER TO AMPLIFY WHAT THE 9572 05:46:00,809 --> 05:46:03,545 COMMITTEE IS ABLE TO DO, THE 9573 05:46:03,545 --> 05:46:06,815 CHAIR WILL ESTABLISH A SERIES OF 9574 05:46:06,815 --> 05:46:10,352 WORKING GROUPS SO THAT WE CAN 9575 05:46:10,352 --> 05:46:15,256 DIVIDE AND CONQUER, WORKING IN 9576 05:46:15,256 --> 05:46:20,061 PARALLEL RATHER THAN WORKING CON 9577 05:46:20,061 --> 05:46:21,062 CONSECUTIVELY LEST WE FALL PREY 9578 05:46:21,062 --> 05:46:22,163 TO THE FIVE-MEETING RULE BEFORE 9579 05:46:22,163 --> 05:46:23,465 ISSUING A REPORT. 9580 05:46:23,465 --> 05:46:25,233 IF THERE'S HOPE OF ISSUING MORE 9581 05:46:25,233 --> 05:46:27,502 THAN ONE REPORT, IN THIS YEAR'S 9582 05:46:27,502 --> 05:46:29,471 PERIOD, WE WILL HAVE TO, YOU 9583 05:46:29,471 --> 05:46:32,540 KNOW, DO SOME, YOU KNOW, 9584 05:46:32,540 --> 05:46:34,342 PARALLEL PROCESSING RATHER THAN 9585 05:46:34,342 --> 05:46:39,114 CONSECUTIVE EFFORT. 9586 05:46:39,114 --> 05:46:40,115 NEXT PLEASE. 9587 05:46:40,115 --> 05:46:43,918 SO, WITH THAT QUICK RUN-THROUGH, 9588 05:46:43,918 --> 05:46:46,020 I HOPE I'VE ANSWERED AT LEAST 9589 05:46:46,020 --> 05:46:50,058 SOME QUESTIONS THE ACD MAY HAVE 9590 05:46:50,058 --> 05:46:52,694 ABOUT THIS NEWLY FORMED OR 9591 05:46:52,694 --> 05:46:56,398 REBORN, IF YOU WILL, BOARD. 9592 05:46:56,398 --> 05:47:03,505 WE WILL AS APPROPRIATE BRING 9593 05:47:03,505 --> 05:47:05,473 BACK THE DELIBERATIONS OF THE 9594 05:47:05,473 --> 05:47:08,209 SMRB TO THE ACD AND ULTIMATELY 9595 05:47:08,209 --> 05:47:11,346 TO THE OTHER COMMITTEES AROUND 9596 05:47:11,346 --> 05:47:14,282 THE AGENCY, COUNCIL OF COUNCILS, 9597 05:47:14,282 --> 05:47:17,285 AND THE VARIOUS I.C. BOARDS. 9598 05:47:17,285 --> 05:47:19,587 BUT WE WANTED TO START WITH THE 9599 05:47:19,587 --> 05:47:24,526 ACD AT THIS MOST NASCENT MOMENT 9600 05:47:24,526 --> 05:47:26,161 TO GET SOME FEEDBACK YOU MAY 9601 05:47:26,161 --> 05:47:26,494 HAVE. 9602 05:47:26,494 --> 05:47:29,664 I'LL TURN IT TO MONICA TO 9603 05:47:29,664 --> 05:47:31,733 COMMENT AND WE CAN GET QUESTIONS 9604 05:47:31,733 --> 05:47:33,101 AND COMMENTS FROM EVERYBODY 9605 05:47:33,101 --> 05:47:33,401 ELSE. 9606 05:47:33,401 --> 05:47:36,738 >> A FEW QUICK COMMENTS. 9607 05:47:36,738 --> 05:47:39,073 THANK YOU, LARRY, FOR SETTING IT 9608 05:47:39,073 --> 05:47:41,242 UP, EXACTLY THE HISTORY AND WHY 9609 05:47:41,242 --> 05:47:45,513 THIS NEW BOARD IS NOW 9610 05:47:45,513 --> 05:47:45,914 RECONVENED. 9611 05:47:45,914 --> 05:47:49,884 YOU KNOW, THE SMRB IS A 9612 05:47:49,884 --> 05:47:50,485 CONGRESSIONALLY MANDATED FACA 9613 05:47:50,485 --> 05:47:52,987 COMMITTEE THAT HAS BEEN DORMANT 9614 05:47:52,987 --> 05:47:56,224 FOR EIGHT YEARS BUT IT REMAINS 9615 05:47:56,224 --> 05:47:57,859 CONGRESSIONALLY MANDATED FACA 9616 05:47:57,859 --> 05:47:58,126 COMMITTEE. 9617 05:47:58,126 --> 05:48:01,162 THE REASON I CALLED FOR ITS 9618 05:48:01,162 --> 05:48:03,765 RECONVENING SHORTLY AFTER MY 9619 05:48:03,765 --> 05:48:05,266 ARRIVAL AS DIRECTOR IS THAT IT 9620 05:48:05,266 --> 05:48:08,803 IS THE RESPONSIBILITY OF THE NIH 9621 05:48:08,803 --> 05:48:12,774 DIRECTOR I BELIEVE TO CERTAINLY 9622 05:48:12,774 --> 05:48:14,309 TO BE RESPONSIVE TO REQUIREMENTS 9623 05:48:14,309 --> 05:48:16,277 THAT CONGRESS PUTS FORWARD IN 9624 05:48:16,277 --> 05:48:16,578 LEGISLATION. 9625 05:48:16,578 --> 05:48:19,214 SO, THAT IS WHAT WE ARE DOING 9626 05:48:19,214 --> 05:48:22,484 HERE AND VERY CLEARLY AS LARRY 9627 05:48:22,484 --> 05:48:24,018 OUTLINED ABIDING BY THE 9628 05:48:24,018 --> 05:48:26,421 REQUIREMENTS THAT CONGRESS HAS 9629 05:48:26,421 --> 05:48:27,956 PLACED IN LEGISLATION TOWARDS 9630 05:48:27,956 --> 05:48:30,692 WHAT THIS -- HOW THIS BOARD IS 9631 05:48:30,692 --> 05:48:33,328 CON FIGURED AND WHAT IT IS 9632 05:48:33,328 --> 05:48:35,196 CONVENED TO DO. 9633 05:48:35,196 --> 05:48:37,365 TWO CHARGES RIGHT NOW, TO HELP 9634 05:48:37,365 --> 05:48:38,900 TO REVIEW THE PAST 9635 05:48:38,900 --> 05:48:40,535 RECOMMENDATIONS, THE LAST REPORT 9636 05:48:40,535 --> 05:48:42,237 THAT WAS PROVIDED BY THE GROUP 9637 05:48:42,237 --> 05:48:43,838 WHICH I THINK IF YOU ALL HAVE A 9638 05:48:43,838 --> 05:48:46,241 CHANCE TO LOOK AT IT IS REALLY 9639 05:48:46,241 --> 05:48:50,044 AN OUTSTANDING REVIEW AND SET OF 9640 05:48:50,044 --> 05:48:50,411 RECOMMENDATIONS. 9641 05:48:50,411 --> 05:48:52,981 AND THEN SECOND, WHICH AROSE 9642 05:48:52,981 --> 05:48:58,052 LATER, WAS TO BE ABLE TO RESPOND 9643 05:48:58,052 --> 05:49:00,021 NOW TO CURRENT CONGRESSIONAL 9644 05:49:00,021 --> 05:49:01,222 RECOMMENDATIONS, ONE FROM THE 9645 05:49:01,222 --> 05:49:03,758 HOUSE, ONE FROM THE SENATE. 9646 05:49:03,758 --> 05:49:08,429 FINALLY, I JUST WANT TO 9647 05:49:08,429 --> 05:49:10,532 EMPHASIZE THE CHARGE AND 9648 05:49:10,532 --> 05:49:12,600 EFFECTIVENESS AND VALUE OF THE 9649 05:49:12,600 --> 05:49:14,802 ACD DOESN'T CHANGE A SINGLE BIT 9650 05:49:14,802 --> 05:49:17,772 BY THE REESTABLISHMENT OF THIS 9651 05:49:17,772 --> 05:49:19,707 NEW COMMITTEE. 9652 05:49:19,707 --> 05:49:21,743 THE PARTICULAR FOCUS OF THE ACD 9653 05:49:21,743 --> 05:49:24,112 AT LEAST AS FAR AS WE HAVE 9654 05:49:24,112 --> 05:49:27,815 WORKED TOGETHER HAS BEEN 9655 05:49:27,815 --> 05:49:29,017 SCIENTIFIC INITIATIVES, POLICY 9656 05:49:29,017 --> 05:49:32,086 DEVELOPMENT, AND STRATEGIES FOR 9657 05:49:32,086 --> 05:49:37,959 HOW WE CAN BETTER EXECUTE, 9658 05:49:37,959 --> 05:49:39,160 PRIORITIES FOR OVERALL RESEARCH 9659 05:49:39,160 --> 05:49:41,229 AND EXECUTE ON THOSE PRIORITIES. 9660 05:49:41,229 --> 05:49:46,601 I THINK THE SMRB, IF YOU LOOK AT 9661 05:49:46,601 --> 05:49:48,803 WHAT IT'S CHARGE IS, IT'S MORE 9662 05:49:48,803 --> 05:49:49,604 ABOUT INFRASTRUCTURE, 9663 05:49:49,604 --> 05:49:50,538 ADMINISTRATION, TO DELIVER 9664 05:49:50,538 --> 05:49:54,342 BETTER RESULTS BUT HAS LARRY 9665 05:49:54,342 --> 05:49:56,344 DESCRIBED IN THE REQUIREMENTS IT 9666 05:49:56,344 --> 05:49:58,646 IS ALSO -- THESE CAN'T BE 9667 05:49:58,646 --> 05:50:04,452 SILOED, THE TWO COMMITTEES, AND 9668 05:50:04,452 --> 05:50:05,520 THERE ARE BUILD INTO 9669 05:50:05,520 --> 05:50:07,088 REQUIREMENTS TO INTERACT WITH 9670 05:50:07,088 --> 05:50:08,189 THE ACD BEFORE RECOMMENDATIONS 9671 05:50:08,189 --> 05:50:09,691 OR ACTIONS ARE TAKEN. 9672 05:50:09,691 --> 05:50:11,759 SO I REALLY DON'T -- I THINK 9673 05:50:11,759 --> 05:50:15,063 THIS IS AN ADDITIVE, NOT A 9674 05:50:15,063 --> 05:50:16,864 SUBTRACTION IN ANY WAY FROM THE 9675 05:50:16,864 --> 05:50:21,569 WORK THAT YOU ARE ALL DOING AND 9676 05:50:21,569 --> 05:50:23,571 I REALLY -- I THINK THE PEOPLE 9677 05:50:23,571 --> 05:50:26,341 WHO AGREED TO SERVE ON THIS NEW 9678 05:50:26,341 --> 05:50:27,942 COMMITTEE AND LOOK FORWARD TO 9679 05:50:27,942 --> 05:50:29,944 SEEING WHAT ARISES FROM IT. 9680 05:50:29,944 --> 05:50:30,278 SO THANK YOU. 9681 05:50:30,278 --> 05:50:30,912 >> THANK YOU. 9682 05:50:30,912 --> 05:50:34,616 WHILE WE'RE WAITING FOR PEOPLE 9683 05:50:34,616 --> 05:50:36,551 TO QUEUE UP COMMENTS OR 9684 05:50:36,551 --> 05:50:40,688 QUESTIONS I WANT TO ADD PUTTING 9685 05:50:40,688 --> 05:50:43,224 TOGETHER A FACA COMMITTEE IN A 9686 05:50:43,224 --> 05:50:45,727 VERY, VERY RAPID TIME IT TAKES A 9687 05:50:45,727 --> 05:50:46,594 TEAM EFFORT. 9688 05:50:46,594 --> 05:50:50,098 OKAY? 9689 05:50:50,098 --> 05:50:57,872 SO I WANT TO THANK TYRA, SARAH, 9690 05:50:57,872 --> 05:50:58,640 REBECCA, STEPHANIE, DANA, 9691 05:50:58,640 --> 05:51:00,842 CLAIRE, AND MANY OTHER PEOPLE 9692 05:51:00,842 --> 05:51:02,910 WHO HELPED. 9693 05:51:02,910 --> 05:51:04,646 I KNOW THAT PEOPLE WERE CRITICAL 9694 05:51:04,646 --> 05:51:07,048 WHY DID IT TAKE US SO LONG. 9695 05:51:07,048 --> 05:51:08,583 THIS IS THE FASTEST WE'VE EVER 9696 05:51:08,583 --> 05:51:09,884 PUT TOGETHER A FACA COMMITTEE IN 9697 05:51:09,884 --> 05:51:11,886 THE 25 YEARS I'VE BEEN AT NIH. 9698 05:51:11,886 --> 05:51:15,690 SO I WANT TO THANK THE TEAM FOR 9699 05:51:15,690 --> 05:51:17,358 REALLY MAKING THIS HAPPEN. 9700 05:51:17,358 --> 05:51:20,495 WHO WOULD LIKE TO POSE A 9701 05:51:20,495 --> 05:51:23,798 QUESTION OR MAKE A COMMENT? 9702 05:51:23,798 --> 05:51:26,534 9703 05:51:26,534 --> 05:51:26,834 OKAY. 9704 05:51:26,834 --> 05:51:28,736 BRIAN, YOU'RE UP. 9705 05:51:28,736 --> 05:51:29,937 >> YEAH, SO YOU MENTIONED 9706 05:51:29,937 --> 05:51:31,372 IMPLEMENTATION SCIENCE AS ONE OF 9707 05:51:31,372 --> 05:51:33,107 THE TOPICS WHICH AS YOU 9708 05:51:33,107 --> 05:51:35,510 REFLECTED HAS COME UP A LOT IN 9709 05:51:35,510 --> 05:51:37,245 THE ACD MEETING. 9710 05:51:37,245 --> 05:51:38,913 I'M WONDERING ABOUT TAKE THAT 9711 05:51:38,913 --> 05:51:40,014 EXAMPLE, HEARING HOW THIS 9712 05:51:40,014 --> 05:51:41,749 COMMITTEE WOULD APPROACH IT 9713 05:51:41,749 --> 05:51:43,484 VERSUS WHAT ACD'S ROLE WOULD BE 9714 05:51:43,484 --> 05:51:46,020 IN A SCIENTIFIC INITIATIVE LIKE 9715 05:51:46,020 --> 05:51:47,555 THAT, IT MIGHT HELP US 9716 05:51:47,555 --> 05:51:48,423 UNDERSTAND DIFFERENCES BETWEEN 9717 05:51:48,423 --> 05:51:49,190 THE COMMITTEES. 9718 05:51:49,190 --> 05:51:50,725 >> THANKS, BRIAN. 9719 05:51:50,725 --> 05:51:53,828 THAT'S A VERY GOOD WAY OF 9720 05:51:53,828 --> 05:51:54,529 FRAMING IT. 9721 05:51:54,529 --> 05:51:58,366 I THINK FROM THE PERSPECTIVE OF 9722 05:51:58,366 --> 05:52:02,970 THE SMRB, THEY WONDER IF THERE 9723 05:52:02,970 --> 05:52:05,273 ARE STRUCTURAL BARRIERS THAT 9724 05:52:05,273 --> 05:52:07,675 PREVENT OR MAKE MORE DIFFICULT 9725 05:52:07,675 --> 05:52:12,714 THE ABILITY OF NIH TO IMPLEMENT 9726 05:52:12,714 --> 05:52:14,916 THIS TYPE OF SCIENCE, 9727 05:52:14,916 --> 05:52:16,551 IMPLEMENTATION SCIENCE, RIGHT? 9728 05:52:16,551 --> 05:52:19,120 AND IF THERE ARE STRUCTURAL 9729 05:52:19,120 --> 05:52:22,690 BARRIERS, THAT IT WOULD BE THEIR 9730 05:52:22,690 --> 05:52:25,426 JOB TO RECOMMEND APPROACHES TO 9731 05:52:25,426 --> 05:52:27,261 DISSOLVE THOSE BARRIERS. 9732 05:52:27,261 --> 05:52:28,696 IN CONTRAST I THINK THE ACD 9733 05:52:28,696 --> 05:52:30,131 WHICH YOU'VE ALREADY BEEN 9734 05:52:30,131 --> 05:52:31,532 INVOLVED WITH, YOU KNOW, ARE 9735 05:52:31,532 --> 05:52:35,269 GOING TO TALK MORE ABOUT THE 9736 05:52:35,269 --> 05:52:36,237 VARIOUS SCIENTIFIC QUESTIONS 9737 05:52:36,237 --> 05:52:39,540 THAT MIGHT BE BEST ADDRESSED BY 9738 05:52:39,540 --> 05:52:42,376 IMPLEMENTATION SCIENCE. 9739 05:52:42,376 --> 05:52:46,781 SO I THINK THAT'S THE 9740 05:52:46,781 --> 05:52:47,081 DEMARCATION. 9741 05:52:47,081 --> 05:52:49,050 AND OBVIOUSLY THE TWO HAVE BEEN 9742 05:52:49,050 --> 05:52:50,918 SYNERGIZED VERY WELL. 9743 05:52:50,918 --> 05:52:53,421 >> ALSO I'LL ADD THE ACD, YOU 9744 05:52:53,421 --> 05:52:57,058 KNOW, WHAT KIND OF PRIORITY DOES 9745 05:52:57,058 --> 05:52:57,992 IMPLEMENTATION SCIENCE SIT WITH 9746 05:52:57,992 --> 05:53:01,095 REGARD TO ALL OF THE OTHER 9747 05:53:01,095 --> 05:53:02,396 DISCIPLINES THAT NIH NEEDS TO 9748 05:53:02,396 --> 05:53:06,667 ENCOMPASS THAT MORE OF AN ACD 9749 05:53:06,667 --> 05:53:07,201 ISSUE. 9750 05:53:07,201 --> 05:53:09,504 >> CORRECT. 9751 05:53:09,504 --> 05:53:12,340 OTHER COMMENTS OR QUESTIONS? 9752 05:53:12,340 --> 05:53:16,511 9753 05:53:16,511 --> 05:53:18,246 I HAVE ANESTHETIZED EVERYBODY. 9754 05:53:18,246 --> 05:53:19,046 MY GOODNESS. 9755 05:53:19,046 --> 05:53:20,681 >> NO, YOU MADE IT TOTALLY 9756 05:53:20,681 --> 05:53:26,821 CLEAR. 9757 05:53:26,821 --> 05:53:27,321 >> OKAY. 9758 05:53:27,321 --> 05:53:28,790 ONE MORE CHANCE AND I'M GOING TO 9759 05:53:28,790 --> 05:53:29,657 TURN IT OVER TO MONICA. 9760 05:53:29,657 --> 05:53:31,759 I CAN SEE THE BUBBLES OVER 9761 05:53:31,759 --> 05:53:34,162 EVERYBODY'S HEAD, WE'RE ALMOST 9762 05:53:34,162 --> 05:53:35,997 DONE, WE'RE ALMOST DONE! 9763 05:53:35,997 --> 05:53:37,098 OKAY. 9764 05:53:37,098 --> 05:53:37,365 THAT'S IT. 9765 05:53:37,365 --> 05:53:42,370 MONICA, I'M TURNING IT TO YOU. 9766 05:53:42,370 --> 05:53:47,275 >> I'M GOING TO WRAP US UP 9767 05:53:47,275 --> 05:53:47,508 QUICKLY. 9768 05:53:47,508 --> 05:53:51,212 QUICK RECAP, DAY 1, NEXT SLIDE. 9769 05:53:51,212 --> 05:53:53,181 WE'VE HAD PRESENTATIONS TODAY ON 9770 05:53:53,181 --> 05:53:57,118 LATEST EFFORTS OF NIH INCLUDING 9771 05:53:57,118 --> 05:53:59,220 LEEREDSHIP CHANGES, AWARDS, 9772 05:53:59,220 --> 05:53:59,453 EVENTS. 9773 05:53:59,453 --> 05:54:03,024 THE BUDGET, WHAT'S GOING ON IN 9774 05:54:03,024 --> 05:54:03,391 CONGRESS. 9775 05:54:03,391 --> 05:54:06,627 THE SMRB. 9776 05:54:06,627 --> 05:54:07,295 POLICY UPDATES, MISSION 9777 05:54:07,295 --> 05:54:10,131 STATEMENTS, AND SO OUR 9778 05:54:10,131 --> 05:54:12,233 DEDICATION TO CONTINUING TO 9779 05:54:12,233 --> 05:54:15,069 SERVE AND MAKE EFFECTIVE 9780 05:54:15,069 --> 05:54:15,570 TRANSITION TO INCOMING 9781 05:54:15,570 --> 05:54:18,339 ADMINISTRATION AND CONGRESS. 9782 05:54:18,339 --> 05:54:22,743 WE'VE ALSO GIVEN YOU DETAILED 9783 05:54:22,743 --> 05:54:25,580 FOLLOW-UP TO OUR ACD WORKING 9784 05:54:25,580 --> 05:54:28,082 GROUPS AND PROGRAMS AND 9785 05:54:28,082 --> 05:54:28,382 INITIATIVES. 9786 05:54:28,382 --> 05:54:30,818 I REALLY HOPE WE HAVE 9787 05:54:30,818 --> 05:54:32,787 DEMONSTRATED WHAT I REALLY FIND 9788 05:54:32,787 --> 05:54:40,328 TO BE THE CASE THAT WE HAVE BEEN 9789 05:54:40,328 --> 05:54:41,863 RESPONSIVE TO YOUR 9790 05:54:41,863 --> 05:54:44,065 RECOMMENDATIONS, YOUR INPUT INTO 9791 05:54:44,065 --> 05:54:47,335 WHAT WE'RE DOING AND THAT WE 9792 05:54:47,335 --> 05:54:49,537 HAVE -- WE'RE REALLY DELIVERING 9793 05:54:49,537 --> 05:54:50,238 RESULTS. 9794 05:54:50,238 --> 05:54:53,241 WE'VE GOT SOLID PROGRESS TO SHOW 9795 05:54:53,241 --> 05:54:54,909 ON SOME REALLY IMPORTANT 9796 05:54:54,909 --> 05:54:56,510 RECOMMENDATIONS FROM THE ACD 9797 05:54:56,510 --> 05:54:57,612 WORKING GROUP. 9798 05:54:57,612 --> 05:55:00,248 AND FROM NEW PROGRAMS AND 9799 05:55:00,248 --> 05:55:01,682 INITIATIVES THAT ARE RESPONSIVE 9800 05:55:01,682 --> 05:55:03,317 TO YOUR RECOMMENDATIONS. 9801 05:55:03,317 --> 05:55:05,920 FINALLY WE'VE HAD TIME FOR 9802 05:55:05,920 --> 05:55:06,787 SCIENCE HIGHLIGHTS WHICH TO ME 9803 05:55:06,787 --> 05:55:08,556 ARE ALWAYS THE BEST PART OF THE 9804 05:55:08,556 --> 05:55:11,525 WHOLE MEETING. 9805 05:55:11,525 --> 05:55:13,461 THESE ARE PARTICULARLY 9806 05:55:13,461 --> 05:55:13,895 HIGHLIGHTING YOUNGER 9807 05:55:13,895 --> 05:55:14,962 INVESTIGATORS HERE IN THE 9808 05:55:14,962 --> 05:55:17,732 INTRAMURAL PROGRAM. 9809 05:55:17,732 --> 05:55:18,599 NEXT SLIDE. 9810 05:55:18,599 --> 05:55:19,800 SO, I REALLY APPRECIATE YOUR 9811 05:55:19,800 --> 05:55:23,638 THOUGHTS ON THE WORK WE DO AND 9812 05:55:23,638 --> 05:55:25,506 NEXT STEPS. 9813 05:55:25,506 --> 05:55:26,374 TOPICS DISCUSSED TODAY THAT, YOU 9814 05:55:26,374 --> 05:55:28,676 KNOW, I WOULD APPRECIATE YOUR 9815 05:55:28,676 --> 05:55:29,443 THOUGHTS. 9816 05:55:29,443 --> 05:55:31,846 GIVE US SOME FEEDBACK, THINK 9817 05:55:31,846 --> 05:55:34,148 ABOUT THIS. 9818 05:55:34,148 --> 05:55:35,883 THE SMRB, AND ITS FORTHCOMING 9819 05:55:35,883 --> 05:55:38,419 RECOMMENDATIONS TO GUIDE THE 9820 05:55:38,419 --> 05:55:40,922 FUTURE OF NIH. 9821 05:55:40,922 --> 05:55:43,758 BROAD OWNERSHIP AND BROAD 9822 05:55:43,758 --> 05:55:47,695 APPLICABILITY OF OUR EFFORTS TO 9823 05:55:47,695 --> 05:55:49,430 DIVERSIFY SCIENTIFIC 9824 05:55:49,430 --> 05:55:51,966 PERSPECTIVE, ENGAGEMENT WITH 9825 05:55:51,966 --> 05:55:53,734 DISABILITY COMMUNITY, LONG COVID 9826 05:55:53,734 --> 05:55:58,873 AND RECOVER AND THE INCLUSION OF 9827 05:55:58,873 --> 05:56:00,408 SOCIAL AND BEHAVIORAL EFFORTS IN 9828 05:56:00,408 --> 05:56:03,811 OUR STUDY DESIGN AND CLINICAL 9829 05:56:03,811 --> 05:56:04,211 ASSESSMENT. 9830 05:56:04,211 --> 05:56:06,013 CERTAINLY SPECIFIC TO LONG COVID 9831 05:56:06,013 --> 05:56:08,950 WHERE THESE ARE -- IT'S OBVIOUS 9832 05:56:08,950 --> 05:56:10,284 THEY ARE ABSOLUTELY CRITICAL BUT 9833 05:56:10,284 --> 05:56:13,454 ALSO AS WE APPLY THEM TO OTHER 9834 05:56:13,454 --> 05:56:19,794 KEY INITIATIVES, FOR EXAMPLE, 9835 05:56:19,794 --> 05:56:21,562 CARE FOR HELP AND DATA 9836 05:56:21,562 --> 05:56:21,996 COLLECTION. 9837 05:56:21,996 --> 05:56:24,398 A FRAMEWORK FOR RESPONSIBLY 9838 05:56:24,398 --> 05:56:26,801 ADVANCING RESEARCH WHILE WE 9839 05:56:26,801 --> 05:56:31,639 BUILD TRUST IN SCIENCE, BOTH 9840 05:56:31,639 --> 05:56:34,809 THROUGH OUTREACH OF REALLY BROAD 9841 05:56:34,809 --> 05:56:37,211 COMMUNITIES, ACADEMIC, INDUSTRY, 9842 05:56:37,211 --> 05:56:39,513 COMMUNITIES, PEOPLE WITH LIVED 9843 05:56:39,513 --> 05:56:42,316 EXPERIENCE FROM JUNIOR TO MOST 9844 05:56:42,316 --> 05:56:45,519 SENIOR RESEARCHERS, ALL OF THESE 9845 05:56:45,519 --> 05:56:48,189 ARE ENCOMPASSED BY THE 9846 05:56:48,189 --> 05:56:48,622 FRAMEWORK. 9847 05:56:48,622 --> 05:56:50,491 WE CARE DEEPLY ABOUT THE 9848 05:56:50,491 --> 05:56:53,027 EXPERIENCES WITH EARLY CAREER 9849 05:56:53,027 --> 05:56:54,762 NIH RESEARCHERS, I'LL JUST ADD 9850 05:56:54,762 --> 05:56:56,263 TO THIS ONE THAT EVERYBODY ASKS 9851 05:56:56,263 --> 05:56:57,732 ME WHAT'S THE THING THAT KEEPS 9852 05:56:57,732 --> 05:57:01,235 YOU UP MOST AT NIGHT, AND MY 9853 05:57:01,235 --> 05:57:03,738 ANSWER IS ALWAYS THE NEXT 9854 05:57:03,738 --> 05:57:04,038 GENERATION. 9855 05:57:04,038 --> 05:57:05,506 HOW DO WE NURTURE THEM, TAKE 9856 05:57:05,506 --> 05:57:07,241 CARE OF THEM, MAKE SURE THEY ARE 9857 05:57:07,241 --> 05:57:08,542 READY TO GO SO FAR BEYOND WHAT 9858 05:57:08,542 --> 05:57:10,211 WE'VE BEEN ABLE TO DO. 9859 05:57:10,211 --> 05:57:11,512 FINALLY BEFORE WE WRAP UP TODAY 9860 05:57:11,512 --> 05:57:14,915 I WANT TO THANK OUR WONDERFUL 9861 05:57:14,915 --> 05:57:16,017 PRESENTERS, FOR PROVIDING 9862 05:57:16,017 --> 05:57:18,219 UPDATES TO EXISTING NIH PROGRAMS 9863 05:57:18,219 --> 05:57:21,188 AND HIGHLIGHTING UP AND COMING 9864 05:57:21,188 --> 05:57:22,590 RESEARCH AND INITIATIVES. 9865 05:57:22,590 --> 05:57:24,225 AND THEN FINALLY THANK YOU TO 9866 05:57:24,225 --> 05:57:27,161 ALL OF YOU WHO STUCK WITH US. 9867 05:57:27,161 --> 05:57:29,463 WE ALL UNDERSTAND HOW 9868 05:57:29,463 --> 05:57:31,532 CHALLENGING A VIRTUAL MEETING IS 9869 05:57:31,532 --> 05:57:34,068 FOR SO MANY HOURS, SO WE'RE VERY 9870 05:57:34,068 --> 05:57:34,602 GRATEFUL. 9871 05:57:34,602 --> 05:57:36,570 WE'LL RESUME THE MEETING AT 9:00 9872 05:57:36,570 --> 05:57:38,305 A.M. TOMORROW WHICH IS FRIDAY, 9873 05:57:38,305 --> 05:57:39,407 DECEMBER 13. 9874 05:57:39,407 --> 05:57:40,841 WITH THAT I'M GOING TO ADJOURN 9875 05:57:40,841 --> 05:57:41,909 THE MEETING FOR TODAY. 9876 05:57:41,909 --> 05:57:43,911 THANK YOU ALL SO MUCH. 9877 05:57:43,911 --> 05:57:53,911 EVERYONE, HAVE A NICE EVENING.